{"text_format":"3","workbook":"xlsx","n_sheets":2,"sheets":["up-peak","down-peak"],"read":"whole","date_system":"1900"}

{"sheet":"up-peak","index":0,"n_rows":587,"n_cols":25,"rows_kept":587}
["seqnames","start","end","width","geneId","transcriptId","transcript_biotype","distanceToTSS","geneName","Description","GO","KEGG","score","blockCount","blockSizes","blockStarts","diff.lg.fdr","diff.p","diff.log2.fc","annotation","geneChr","geneStart","geneEnd","geneLength","geneStrand"]
["chr1",1434891,1435657,767,"ENSG00000179403","ENST00000338660","protein_coding",0,"VWA1","von Willebrand factor A domain containing 1 [Source:HGNC Symbol;Acc:HGNC:30910]","GO:0003429(growth plate cartilage chondrocyte morphogenesis);GO:0005201(extracellular matrix structural constituent);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005604(basement membrane);GO:0005614(interstitial matrix);GO:0005615(extracellular space);GO:0005788(endoplasmic reticulum lumen);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0042802(identical protein binding);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process);GO:0048266(behavioral response to pain);GO:0062023(collagen-containing extracellular matrix);GO:0070062(extracellular exosome)","NA",{"v":5e-18,"d":"0.00"},2,"256,135,","0,632",{"v":-0.895,"d":"-0.90"},{"v":0.0288403150312661,"d":"0.03"},1.64,"5' UTR",1,1435523,1440765,5243,1]
["chr7",100689536,100693977,4442,"ENSG00000146830","ENST00000646601","protein_coding",0,"GIGYF1","GRB10 interacting GYF protein 1 [Source:HGNC Symbol;Acc:HGNC:9126]","GO:0005515(protein binding);GO:0008150(biological_process);GO:0032991(protein-containing complex);GO:0048009(insulin-like growth factor receptor signaling pathway)","NA",{"v":0.0044,"d":"0.00"},2,"20,41,","0,4401",{"v":-0.741,"d":"-0.74"},{"v":0.0478630092322638,"d":"0.05"},2,"5' UTR",7,100679507,100693968,14462,2]
["chr1",23371213,23371809,597,"ENSG00000249087","ENST00000458053","antisense",2216,"ZNF436-AS1","ZNF436 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:25122]","NA","NA",{"v":4e-12,"d":"0.00"},1,"597,",0,{"v":-0.918,"d":"-0.92"},{"v":0.0269153480392692,"d":"0.03"},1.46,"Exon (ENST00000458053/ENSG00000249087, exon 3 of 3)",1,23368997,23371783,2787,1]
["chr1",27393945,27394390,446,"ENSG00000181773","ENST00000374024","protein_coding",1323,"GPR3","G protein-coupled receptor 3 [Source:HGNC Symbol;Acc:HGNC:4484]","GO:0004930(G protein-coupled receptor activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0040020(regulation of meiotic nuclear division);GO:0120162(positive regulation of cold-induced thermogenesis)","NA",{"v":6.3e-13,"d":"0.00"},1,"446,",0,-1.41,{"v":0.00575439937337157,"d":"0.01"},1.24,"Exon (ENST00000374024/ENSG00000181773, exon 2 of 2)",1,27392622,27395814,3193,1]
["chr1",44036161,44043939,7779,"ENSG00000230615","ENST00000609636","lincRNA",0,"AL139220","novel transcript","NA","NA",{"v":5e-29,"d":"0.00"},4,"11,367,85,18,","0,3746,7336,7761",-1.17,{"v":0.0120226443461741,"d":"0.01"},1.05,"Exon (ENST00000623351/ENSG00000230615, exon 2 of 2)",1,44043497,44051115,7619,1]
["chr1",46364404,46364823,420,"ENSG00000117481","ENST00000307089","nonsense_mediated_decay",23615,"NSUN4","NOP2/Sun RNA methyltransferase family member 4 [Source:HGNC Symbol;Acc:HGNC:31802]","GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005762(mitochondrial large ribosomal subunit);GO:0006364(rRNA processing);GO:0008168(methyltransferase activity);GO:0009383(rRNA (cytosine-C5-)-methyltransferase activity);GO:0016740(transferase activity);GO:0019843(rRNA binding);GO:0031167(rRNA methylation);GO:0032259(methylation);GO:0042254(ribosome biogenesis);GO:0042256(mature ribosome assembly);GO:0070131(positive regulation of mitochondrial translation);GO:0070181(small ribosomal subunit rRNA binding)","NA",{"v":5e-12,"d":"0.00"},1,"420,",0,-1.22,0.01,1.01,"3' UTR",1,46340789,46365152,24364,1]
["chr1",52033625,52033684,60,"ENSG00000117862","ENST00000371626","protein_coding",22487,"TXNDC12","thioredoxin domain containing 12 [Source:HGNC Symbol;Acc:HGNC:24626]","GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005788(endoplasmic reticulum lumen);GO:0015037(peptide disulfide oxidoreductase activity);GO:0016491(oxidoreductase activity);GO:0019153(protein-disulfide reductase (glutathione) activity);GO:0045454(cell redox homeostasis);GO:0055114(oxidation-reduction process);GO:0060548(negative regulation of cell death);GO:1902236(negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway)","00480(Glutathione metabolism)",{"v":0.0032,"d":"0.00"},1,"60,",0,{"v":-0.738,"d":"-0.74"},{"v":0.0489778819368446,"d":"0.05"},1.68,"3' UTR",1,52020131,52056171,36041,2]
["chr1",52993591,52993830,240,"ENSG00000236360","ENST00000414168","processed_pseudogene",0,"AL445183","pseudogene similar to part of related RAS viral (r-ras) oncogene homolog 2 (RRAS2)","NA","NA",{"v":2.3e-07,"d":"0.00"},1,"240,",0,{"v":-0.878,"d":"-0.88"},{"v":0.0301995172040202,"d":"0.03"},1.45,"3' UTR",1,52993201,52993702,502,2]
["chr1",63323101,63323875,775,"ENSG00000230798","ENST00000431294","antisense",0,"FOXD3-AS1","FOXD3 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:40241]","NA","NA",{"v":1.9e-08,"d":"0.00"},1,"775,",0,-1.67,{"v":2.69153480392692E-3,"d":"0.00"},1.64,"Exon (ENST00000371116/ENSG00000187140, exon 1 of 1)",1,63320884,63323582,2699,2]
["chr1",74204669,74205237,569,"ENSG00000254685","ENST00000370898","protein_coding",6457,"FPGT","fucose-1-phosphate guanylyltransferase [Source:HGNC Symbol;Acc:HGNC:3825]","GO:0000166(nucleotide binding);GO:0003824(catalytic activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006004(fucose metabolic process);GO:0016740(transferase activity);GO:0016772(transferase activity, transferring phosphorus-containing groups);GO:0016779(nucleotidyltransferase activity);GO:0047341(fucose-1-phosphate guanylyltransferase activity)","00051(Fructose and mannose metabolism);00520(Amino sugar and nucleotide sugar metabolism)",{"v":1.3e-37,"d":"0.00"},1,"569,",0,-3.46,{"v":2.08929613085404e-05,"d":"0.00"},1.39,"Exon (ENST00000370898/ENSG00000254685, exon 4 of 4)",1,74198212,74207234,9023,1]
["chr1",86914635,86914934,300,"ENSG00000153936","ENST00000370550","protein_coding",0,"HS2ST1","heparan sulfate 2-O-sulfotransferase 1 [Source:HGNC Symbol;Acc:HGNC:5193]","GO:0000139(Golgi membrane);GO:0004394(heparan sulfate 2-O-sulfotransferase activity);GO:0005794(Golgi apparatus);GO:0006024(glycosaminoglycan biosynthetic process);GO:0008146(sulfotransferase activity);GO:0015014(heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process);GO:0015015(heparan sulfate proteoglycan biosynthetic process, enzymatic modification);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity)","00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)",{"v":1e-128,"d":"0.00"},1,"300,",0,-1.06,{"v":0.0165958690743756,"d":"0.02"},1.27,"5' UTR",1,86914635,87109982,195348,1]
["chr16",78115134,78130145,15012,"ENSG00000186153","ENST00000562639","processed_transcript",0,"WWOX","WW domain containing oxidoreductase [Source:HGNC Symbol;Acc:HGNC:12799]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001649(osteoblast differentiation);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005902(microvillus);GO:0006915(apoptotic process);GO:0008202(steroid metabolic process);GO:0016055(Wnt signaling pathway);GO:0016491(oxidoreductase activity);GO:0019899(enzyme binding);GO:0030178(negative regulation of Wnt signaling pathway);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:0048037(cofactor binding);GO:0048705(skeletal system morphogenesis);GO:0050662(coenzyme binding);GO:0055114(oxidation-reduction process);GO:0071560(cellular response to transforming growth factor beta stimulus);GO:0072332(intrinsic apoptotic signaling pathway by p53 class mediator);GO:0090575(RNA polymerase II transcription factor complex);GO:0097191(extrinsic apoptotic signaling pathway);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway);GO:2001241(positive regulation of extrinsic apoptotic signaling pathway in absence of ligand)","NA",{"v":7.1E-8,"d":"0.00"},3,"21,122,97,","0,3821,14915",-3.31,{"v":3.09029543251359E-5,"d":"0.00"},2,"3' UTR",16,78130049,78432603,302555,1]
["chr6",32948643,32948853,211,"ENSG00000204257","ENST00000480785","retained_intron",818,"HLA-DMA","major histocompatibility complex, class II, DM alpha [Source:HGNC Symbol;Acc:HGNC:4934]","GO:0002376(immune system process);GO:0002503(peptide antigen assembly with MHC class II protein complex);GO:0002504(antigen processing and presentation of peptide or polysaccharide antigen via MHC class II);GO:0005515(protein binding);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0005768(endosome);GO:0006955(immune response);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019882(antigen processing and presentation);GO:0019886(antigen processing and presentation of exogenous peptide antigen via MHC class II);GO:0023026(MHC class II protein complex binding);GO:0031902(late endosome membrane);GO:0042613(MHC class II protein complex);GO:0043231(intracellular membrane-bounded organelle)","04145(Phagosome);04514(Cell adhesion molecules (CAMs));04612(Antigen processing and presentation);04640(Hematopoietic cell lineage);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04672(Intestinal immune network for IgA production);04940(Type I diabetes mellitus);05140(Leishmaniasis);05145(Toxoplasmosis);05150(Staphylococcus aureus infection);05152(Tuberculosis);05164(Influenza A);05166(Human T-cell leukemia virus 1 infection);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection);05310(Asthma);05320(Autoimmune thyroid disease);05321(Inflammatory bowel disease (IBD));05322(Systemic lupus erythematosus);05323(Rheumatoid arthritis);05330(Allograft rejection);05332(Graft-versus-host disease);05416(Viral myocarditis)",{"v":5.4e-05,"d":"0.00"},1,"211,",0,{"v":-0.751,"d":"-0.75"},{"v":0.0467735141287198,"d":"0.05"},2.01,"3' UTR",6,32948613,32949671,1059,2]
["chr1",119140396,119141886,1491,"ENSG00000116874","ENST00000369426","protein_coding",0,"WARS2","tryptophanyl tRNA synthetase 2, mitochondrial [Source:HGNC Symbol;Acc:HGNC:12730]","GO:0000166(nucleotide binding);GO:0001570(vasculogenesis);GO:0004812(aminoacyl-tRNA ligase activity);GO:0004830(tryptophan-tRNA ligase activity);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005886(plasma membrane);GO:0006412(translation);GO:0006418(tRNA aminoacylation for protein translation);GO:0006436(tryptophanyl-tRNA aminoacylation);GO:0016874(ligase activity);GO:0070183(mitochondrial tryptophanyl-tRNA aminoacylation)","00970(Aminoacyl-tRNA biosynthesis)",{"v":5e-39,"d":"0.00"},2,"398,140,","0,1351",-1.25,{"v":0.0091201083935591,"d":"0.01"},1.02,"5' UTR",1,119031216,119140648,109433,2]
["chr12",51271152,51271332,181,"ENSG00000183283","ENST00000604900","protein_coding",32266,"DAZAP2","DAZ associated protein 2 [Source:HGNC Symbol;Acc:HGNC:2684]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016607(nuclear speck);GO:0030971(receptor tyrosine kinase binding);GO:0031435(mitogen-activated protein kinase kinase kinase binding);GO:0032991(protein-containing complex);GO:0042802(identical protein binding);GO:0043539(protein serine/threonine kinase activator activity);GO:0050699(WW domain binding);GO:0071902(positive regulation of protein serine/threonine kinase activity)","NA",{"v":9.1E-4,"d":"0.00"},1,"181,",0,{"v":-0.994,"d":"-0.99"},{"v":0.0208929613085404,"d":"0.02"},2.03,"3' UTR",12,51238886,51271362,32477,1]
["chr1",147177904,147179126,1223,"ENSG00000180867","ENST00000471856","transcribed_processed_pseudogene",0,"PDIA3P1","protein disulfide isomerase family A member 3 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:4607]","NA","NA",{"v":1.3E-25,"d":"0.00"},1,"1223,",0,{"v":-11.3,"d":"-11.30"},{"v":6.30957344480194e-14,"d":"0.00"},1.03,"Exon (ENST00000649713/ENSG00000180867, exon 3 of 3)",1,147178113,147179622,1510,1]
["chr1",151249327,151249536,210,"ENSG00000143398","ENST00000349792","protein_coding",50776,"PIP5K1A","phosphatidylinositol-4-phosphate 5-kinase type 1 alpha [Source:HGNC Symbol;Acc:HGNC:8994]","GO:0000166(nucleotide binding);GO:0001726(ruffle);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005847(mRNA cleavage and polyadenylation specificity factor complex);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006650(glycerophospholipid metabolic process);GO:0006661(phosphatidylinositol biosynthetic process);GO:0006909(phagocytosis);GO:0007165(signal transduction);GO:0008654(phospholipid biosynthetic process);GO:0010761(fibroblast migration);GO:0014066(regulation of phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0016301(kinase activity);GO:0016307(phosphatidylinositol phosphate kinase activity);GO:0016308(1-phosphatidylinositol-4-phosphate 5-kinase activity);GO:0016310(phosphorylation);GO:0016477(cell migration);GO:0016607(nuclear speck);GO:0016740(transferase activity);GO:0019900(kinase binding);GO:0030027(lamellipodium);GO:0030216(keratinocyte differentiation);GO:0031532(actin cytoskeleton reorganization);GO:0032587(ruffle membrane);GO:0042995(cell projection);GO:0046488(phosphatidylinositol metabolic process);GO:0046854(phosphatidylinositol phosphorylation);GO:0048041(focal adhesion assembly);GO:0060326(cell chemotaxis);GO:0072659(protein localization to plasma membrane);GO:0090630(activation of GTPase activity);GO:0097178(ruffle assembly)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system);04072(Phospholipase D signaling pathway);04144(Endocytosis);04666(Fc gamma R-mediated phagocytosis);04810(Regulation of actin cytoskeleton);05231(Choline metabolism in cancer)",{"v":1.6e-48,"d":"0.00"},1,"210,",0,-3.12,{"v":5.12861383991365e-05,"d":"0.00"},1.28,"3' UTR",1,151198551,151249536,50986,1]
["chr1",155613797,155614072,276,"ENSG00000125459","ENST00000649846","protein_coding",3579,"MSTO1","misato mitochondrial distribution and morphology regulator 1 [Source:HGNC Symbol;Acc:HGNC:29678]","GO:0000002(mitochondrial genome maintenance);GO:0000070(mitotic sister chromatid segregation);GO:0003674(molecular_function);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0007005(mitochondrion organization);GO:0016020(membrane);GO:0048311(mitochondrion distribution);GO:0090307(mitotic spindle assembly)","NA",{"v":2.5e-11,"d":"0.00"},2,"256,14,","0,262",{"v":-0.888,"d":"-0.89"},{"v":0.0295120922666639,"d":"0.03"},1.07,"3' UTR",1,155610218,155614933,4716,1]
["chr16",87694427,87694931,505,"ENSG00000154118","ENST00000537256","processed_transcript",92592,"JPH3","junctophilin 3 [Source:HGNC Symbol;Acc:HGNC:14203]","GO:0003674(molecular_function);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005886(plasma membrane);GO:0007612(learning);GO:0007613(memory);GO:0014701(junctional sarcoplasmic reticulum membrane);GO:0015278(calcium-release channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030314(junctional membrane complex);GO:0035640(exploration behavior);GO:0040011(locomotion);GO:0048167(regulation of synaptic plasticity);GO:0048168(regulation of neuronal synaptic plasticity);GO:0050885(neuromuscular process controlling balance);GO:0051209(release of sequestered calcium ion into cytosol);GO:0060314(regulation of ryanodine-sensitive calcium-release channel activity);GO:0060402(calcium ion transport into cytosol)","NA",{"v":2e-11,"d":"0.00"},1,"505,",0,{"v":-0.794,"d":"-0.79"},{"v":0.0398107170553497,"d":"0.04"},2.04,"Exon (ENST00000538868/ENSG00000226180, exon 1 of 1)",16,87601835,87697927,96093,1]
["chr2",120349227,120349946,720,"ENSG00000163083","ENST00000295228","protein_coding",3091,"INHBB","inhibin subunit beta B [Source:HGNC Symbol;Acc:HGNC:6067]","GO:0001541(ovarian follicle development);GO:0005125(cytokine activity);GO:0005160(transforming growth factor beta receptor binding);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006952(defense response);GO:0008083(growth factor activity);GO:0009267(cellular response to starvation);GO:0009611(response to wounding);GO:0010469(regulation of signaling receptor activity);GO:0010862(positive regulation of pathway-restricted SMAD protein phosphorylation);GO:0030154(cell differentiation);GO:0032869(cellular response to insulin stimulus);GO:0032924(activin receptor signaling pathway);GO:0042803(protein homodimerization activity);GO:0042981(regulation of apoptotic process);GO:0043408(regulation of MAPK cascade);GO:0044320(cellular response to leptin stimulus);GO:0044650(adhesion of symbiont to host cell);GO:0045444(fat cell differentiation);GO:0046676(negative regulation of insulin secretion);GO:0046789(host cell surface receptor binding);GO:0046881(positive regulation of follicle-stimulating hormone secretion);GO:0046882(negative regulation of follicle-stimulating hormone secretion);GO:0048178(negative regulation of hepatocyte growth factor biosynthetic process);GO:0048468(cell development);GO:0048471(perinuclear region of cytoplasm);GO:0048599(oocyte development);GO:0060279(positive regulation of ovulation);GO:0060395(SMAD protein signal transduction);GO:0071944(cell periphery);GO:2001235(positive regulation of apoptotic signaling pathway)","04060(Cytokine-cytokine receptor interaction);04350(TGF-beta signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells)",{"v":2E-14,"d":"0.00"},1,"720,",0,{"v":-0.867,"d":"-0.87"},{"v":0.0316227766016838,"d":"0.03"},2.05,"3' UTR",2,120346136,120351803,5668,1]
["chr1",179922035,179922514,480,"ENSG00000143337","ENST00000606911","protein_coding",39723,"TOR1AIP1","torsin 1A interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:29456]","GO:0001671(ATPase activator activity);GO:0005515(protein binding);GO:0005521(lamin binding);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005637(nuclear inner membrane);GO:0008092(cytoskeletal protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031965(nuclear membrane);GO:0032781(positive regulation of ATPase activity);GO:0034504(protein localization to nucleus);GO:0051117(ATPase binding);GO:0071763(nuclear membrane organization)","NA",{"v":1.3e-32,"d":"0.00"},1,"480,",0,{"v":-0.905,"d":"-0.91"},{"v":0.0275422870333817,"d":"0.03"},1.96,"3' UTR",1,179882312,179925000,42689,1]
["chr8",94249669,94249907,239,"ENSG00000164949","ENST00000297596","protein_coding",12412,"GEM","GTP binding protein overexpressed in skeletal muscle [Source:HGNC Symbol;Acc:HGNC:4234]","GO:0000166(nucleotide binding);GO:0000278(mitotic cell cycle);GO:0000287(magnesium ion binding);GO:0003924(GTPase activity);GO:0005246(calcium channel regulator activity);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0006955(immune response);GO:0007165(signal transduction);GO:0007166(cell surface receptor signaling pathway);GO:0009898(cytoplasmic side of plasma membrane);GO:0016020(membrane);GO:0019003(GDP binding);GO:0030496(midbody);GO:0051233(spindle midzone);GO:0051276(chromosome organization);GO:0051310(metaphase plate congression);GO:0072686(mitotic spindle);GO:1901842(negative regulation of high voltage-gated calcium channel activity)","NA",{"v":6.8e-07,"d":"0.00"},1,"239,",0,{"v":-0.754,"d":"-0.75"},{"v":0.0457088189614875,"d":"0.05"},2.05,"3' UTR",8,94249253,94262319,13067,2]
["chr1",210623554,210674620,51067,"ENSG00000054392","ENST00000413764","protein_coding",295302,"HHAT","hedgehog acyltransferase [Source:HGNC Symbol;Acc:HGNC:18270]","GO:0000166(nucleotide binding);GO:0005525(GTP binding);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0007224(smoothened signaling pathway);GO:0007275(multicellular organism development);GO:0008374(O-acyltransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016409(palmitoyltransferase activity);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0018345(protein palmitoylation)","NA",{"v":5E-15,"d":"0.00"},2,"117,333,","0,50734",-1.07,{"v":0.0162181009735893,"d":"0.02"},1.34,"3' UTR",1,210328252,210676296,348045,1]
["chr1",944203,944622,420,"ENSG00000187634","ENST00000342066","protein_coding",18472,"SAMD11","sterile alpha motif domain containing 11 [Source:HGNC Symbol;Acc:HGNC:28706]","GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus)","NA",0,1,"420,",0,{"v":-69.8,"d":"-69.80"},{"v":1.25892541179415E-73,"d":"0.00"},1.21,"3' UTR",1,925731,944574,18844,1]
["chr17",44034635,44035143,509,"ENSG00000161654","ENST00000591247","protein_coding",32476,"LSM12","LSM12 homolog [Source:HGNC Symbol;Acc:HGNC:26407]","GO:0016070(RNA metabolic process)","NA",{"v":3.2e-22,"d":"0.00"},1,"509,",0,{"v":-12.1,"d":"-12.10"},{"v":7.94328234724282e-15,"d":"0.00"},2.05,"3' UTR",17,44034635,44067619,32985,2]
["chr1",37690439,37691206,768,"ENSG00000116922","ENST00000358011","protein_coding",0,"C1orf109","chromosome 1 open reading frame 109 [Source:HGNC Symbol;Acc:HGNC:26039]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm)","NA",{"v":4E-14,"d":"0.00"},2,"82,159,","0,609",-1.63,{"v":0.00295120922666638,"d":"0.00"},1.64,"5' UTR",1,37681570,37690520,8951,2]
["chr1",52033377,52033705,329,"ENSG00000223390","ENST00000425802","antisense",0,"AL445685","novel transcript","NA","NA",{"v":0.00013,"d":"0.00"},1,"329,",0,-1.65,{"v":2.81838293126445E-3,"d":"0.00"},1.21,"3' UTR",1,52033391,52044279,10889,1]
["chr1",85158655,85164649,5995,"ENSG00000097096","ENST00000341460","protein_coding",36367,"SYDE2","synapse defective Rho GTPase homolog 2 [Source:HGNC Symbol;Acc:HGNC:25841]","GO:0005096(GTPase activator activity);GO:0005829(cytosol);GO:0007165(signal transduction);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0090630(activation of GTPase activity)","NA",{"v":1E-107,"d":"0.00"},2,"595,124,","0,5871",-2.47,{"v":0.000288403150312661,"d":"0.00"},1.16,"3' UTR",1,85156889,85201016,44128,2]
["chr1",89104285,89104569,285,"ENSG00000234518","ENST00000439531","processed_pseudogene",198,"PTGES3P1","prostaglandin E synthase 3 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:43824]","NA","NA",{"v":7.9e-30,"d":"0.00"},1,"285,",0,-7.65,{"v":4.89778819368446E-10,"d":"0.00"},1.56,"Exon (ENST00000439531/ENSG00000234518, exon 1 of 1)",1,89104285,89104767,483,2]
["chr1",109504895,109505284,390,"ENSG00000181754","ENST00000369864","protein_coding",4443,"AMIGO1","adhesion molecule with Ig like domain 1 [Source:HGNC Symbol;Acc:HGNC:20824]","GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007157(heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0007275(multicellular organism development);GO:0007399(nervous system development);GO:0007409(axonogenesis);GO:0007413(axonal fasciculation);GO:0007420(brain development);GO:0008076(voltage-gated potassium channel complex);GO:0010976(positive regulation of neuron projection development);GO:0015459(potassium channel regulator activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030154(cell differentiation);GO:0030424(axon);GO:0030425(dendrite);GO:0032809(neuronal cell body membrane);GO:0042552(myelination);GO:0042995(cell projection);GO:0043025(neuronal cell body);GO:0043204(perikaryon);GO:0050772(positive regulation of axonogenesis);GO:0051965(positive regulation of synapse assembly);GO:0106030(neuron projection fasciculation);GO:1901381(positive regulation of potassium ion transmembrane transport);GO:1990030(pericellular basket)","NA",{"v":3.2e-26,"d":"0.00"},1,"390,",0,-1.48,{"v":0.00457088189614875,"d":"0.00"},{"v":1.1,"d":"1.10"},"3' UTR",1,109504178,109509727,5550,2]
["chr19",57308412,57308562,151,"ENSG00000268205","ENST00000593427","lincRNA",4107,"AC005261","novel transcript","NA","NA",{"v":1.7E-5,"d":"0.00"},1,"151,",0,{"v":-0.771,"d":"-0.77"},{"v":0.0426579518801593,"d":"0.04"},2.05,"Exon (ENST00000593427/ENSG00000268205, exon 1 of 1)",19,57304305,57308562,4258,1]
["chr10",46809605,46810618,1014,"ENSG00000204177","ENST00000580094","processed_transcript",22931,"BMS1P1","BMS1, ribosome biogenesis factor pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:23649]","NA","NA",{"v":2e-39,"d":"0.00"},1,"1014,",0,-2.44,{"v":0.000309029543251359,"d":"0.00"},2.06,"Exon (ENST00000580094/ENSG00000204177, exon 9 of 9)",10,46786674,46811989,25316,1]
["chr1",155688366,155688725,360,"ENSG00000163374","ENST00000368339","protein_coding",0,"YY1AP1","YY1 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:30935]","GO:0001650(fibrillar center);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0008283(cell population proliferation);GO:0030154(cell differentiation);GO:0030183(B cell differentiation);GO:0031011(Ino80 complex);GO:0045892(negative regulation of transcription, DNA-templated);GO:0051726(regulation of cell cycle)","NA",{"v":6.3e-12,"d":"0.00"},1,"360,",0,-1.03,{"v":0.0181970085860998,"d":"0.02"},1.43,"5' UTR",1,155659443,155688656,29214,2]
["chr1",173824332,173824600,269,"ENSG00000117593","ENST00000361951","protein_coding",0,"DARS2","aspartyl-tRNA synthetase 2, mitochondrial [Source:HGNC Symbol;Acc:HGNC:25538]","GO:0000049(tRNA binding);GO:0000166(nucleotide binding);GO:0003676(nucleic acid binding);GO:0004812(aminoacyl-tRNA ligase activity);GO:0004815(aspartate-tRNA ligase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006412(translation);GO:0006418(tRNA aminoacylation for protein translation);GO:0016874(ligase activity);GO:0042803(protein homodimerization activity);GO:0043039(tRNA aminoacylation);GO:0050560(aspartate-tRNA(Asn) ligase activity);GO:0070145(mitochondrial asparaginyl-tRNA aminoacylation)","00970(Aminoacyl-tRNA biosynthesis)",{"v":2.2e-05,"d":"0.00"},2,"142,39,","0,230",-1.42,{"v":0.00562341325190349,"d":"0.01"},1.22,"5' UTR",1,173824568,173858546,33979,1]
["chr1",173992888,174022297,29410,"ENSG00000135870","ENST00000258349","protein_coding",0,"RC3H1","ring finger and CCCH-type domains 1 [Source:HGNC Symbol;Acc:HGNC:29434]","GO:0000209(protein polyubiquitination);GO:0000288(nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay);GO:0000932(P-body);GO:0000956(nuclear-transcribed mRNA catabolic process);GO:0001782(B cell homeostasis);GO:0002634(regulation of germinal center formation);GO:0002635(negative regulation of germinal center formation);GO:0003723(RNA binding);GO:0003725(double-stranded RNA binding);GO:0003729(mRNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0010468(regulation of gene expression);GO:0010494(cytoplasmic stress granule);GO:0010608(posttranscriptional regulation of gene expression);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0030889(negative regulation of B cell proliferation);GO:0033962(cytoplasmic mRNA processing body assembly);GO:0035198(miRNA binding);GO:0035613(RNA stem-loop binding);GO:0042098(T cell proliferation);GO:0042129(regulation of T cell proliferation);GO:0043029(T cell homeostasis);GO:0043488(regulation of mRNA stability);GO:0045623(negative regulation of T-helper cell differentiation);GO:0046007(negative regulation of activated T cell proliferation);GO:0046872(metal ion binding);GO:0048535(lymph node development);GO:0048536(spleen development);GO:0050852(T cell receptor signaling pathway);GO:0050856(regulation of T cell receptor signaling pathway);GO:0050863(regulation of T cell activation);GO:0061014(positive regulation of mRNA catabolic process);GO:0061158(3'-UTR-mediated mRNA destabilization);GO:0061470(T follicular helper cell differentiation);GO:0061630(ubiquitin protein ligase activity);GO:0071347(cellular response to interleukin-1);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:2000320(negative regulation of T-helper 17 cell differentiation);GO:2000628(regulation of miRNA metabolic process)","NA",{"v":5e-17,"d":"0.00"},2,"248,202,","0,29208",-1.23,{"v":0.00977237220955811,"d":"0.01"},1.07,"5' UTR",1,173931214,173993064,61851,2]
["chr1",179143053,179229684,86632,"ENSG00000143322","ENST00000502732","protein_coding",0,"ABL2","ABL proto-oncogene 2, non-receptor tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:77]","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0001784(phosphotyrosine residue binding);GO:0003785(actin monomer binding);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004715(non-membrane spanning protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006464(cellular protein modification process);GO:0006468(protein phosphorylation);GO:0007155(cell adhesion);GO:0007165(signal transduction);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0010506(regulation of autophagy);GO:0010863(positive regulation of phospholipase C activity);GO:0010976(positive regulation of neuron projection development);GO:0015629(actin cytoskeleton);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0030100(regulation of endocytosis);GO:0030145(manganese ion binding);GO:0030154(cell differentiation);GO:0030155(regulation of cell adhesion);GO:0035024(negative regulation of Rho protein signal transduction);GO:0035640(exploration behavior);GO:0038083(peptidyl-tyrosine autophosphorylation);GO:0042127(regulation of cell population proliferation);GO:0046872(metal ion binding);GO:0051015(actin filament binding);GO:0051353(positive regulation of oxidoreductase activity);GO:0071300(cellular response to retinoic acid);GO:2000145(regulation of cell motility);GO:2000249(regulation of actin cytoskeleton reorganization)","04012(ErbB signaling pathway);04014(Ras signaling pathway);05416(Viral myocarditis)",{"v":7.9e-43,"d":"0.00"},2,"37,444,","0,86188",-1.32,{"v":0.00758577575029184,"d":"0.01"},1.09,"5' UTR",1,179099330,179229677,130348,2]
["chr1",197159128,197175022,15895,"ENSG00000177888","ENST00000367405","protein_coding",25520,"ZBTB41","zinc finger and BTB domain containing 41 [Source:HGNC Symbol;Acc:HGNC:24819]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","NA",0,3,"887,89,13,","0,13032,15882",-2.19,{"v":0.000616595001861482,"d":"0.00"},{"v":1.2,"d":"1.20"},"3' UTR",1,197153680,197200542,46863,2]
["chr2",131723517,131724279,763,"ENSG00000213222","ENST00000448659","processed_pseudogene",0,"AC093724","translocase of outer mitochondrial membrane 40 (TOMM40) pseudogene","NA","NA",{"v":2.5e-86,"d":"0.00"},1,"763,",0,-4.81,{"v":6.16595001861482e-07,"d":"0.00"},2.08,"Exon (ENST00000448659/ENSG00000213222, exon 1 of 1)",2,131723253,131724279,1027,2]
["chr1",220266176,220267376,1201,"ENSG00000118873","ENST00000358951","protein_coding",5077,"RAB3GAP2","RAB3 GTPase activating non-catalytic protein subunit 2 [Source:HGNC Symbol;Acc:HGNC:17168]","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006886(intracellular protein transport);GO:0008047(enzyme activator activity);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017137(Rab GTPase binding);GO:0030234(enzyme regulator activity);GO:0032991(protein-containing complex);GO:0043085(positive regulation of catalytic activity);GO:0043087(regulation of GTPase activity);GO:0043547(positive regulation of GTPase activity);GO:0046982(protein heterodimerization activity);GO:0097051(establishment of protein localization to endoplasmic reticulum membrane);GO:1903061(positive regulation of protein lipidation);GO:1903373(positive regulation of endoplasmic reticulum tubular network organization);GO:2000786(positive regulation of autophagosome assembly)","NA",{"v":7.9e-13,"d":"0.00"},1,"1201,",0,-1.07,{"v":0.0162181009735893,"d":"0.02"},1.28,"Exon (ENST00000462353/ENSG00000118873, exon 2 of 2)",1,220148293,220272453,124161,2]
["chr1",235168284,235168644,361,"ENSG00000054267","ENST00000474953","nonsense_mediated_decay",25433,"ARID4B","AT-rich interaction domain 4B [Source:HGNC Symbol;Acc:HGNC:15550]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003674(molecular_function);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005575(cellular_component);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006325(chromatin organization);GO:0006349(regulation of gene expression by genetic imprinting);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007283(spermatogenesis);GO:0008150(biological_process);GO:0034773(histone H4-K20 trimethylation);GO:0036124(histone H3-K9 trimethylation);GO:0044212(transcription regulatory region DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0097368(establishment of Sertoli cell barrier)","NA",{"v":2.5e-17,"d":"0.00"},1,"361,",0,{"v":-0.758,"d":"-0.76"},{"v":0.0457088189614875,"d":"0.05"},1.06,"3' UTR",1,235131634,235194077,62444,2]
["chr12",6851259,6851767,509,"ENSG00000111665","ENST00000422785","protein_coding",0,"CDCA3","cell division cycle associated 3 [Source:HGNC Symbol;Acc:HGNC:14624]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005913(cell-cell adherens junction);GO:0007049(cell cycle);GO:0008150(biological_process);GO:0016567(protein ubiquitination);GO:0051301(cell division)","NA",{"v":1.2E-5,"d":"0.00"},1,"509,",0,-1.19,{"v":0.0109647819614319,"d":"0.01"},2.08,"5' UTR",12,6844793,6851269,6477,2]
["chr1",246986255,246988133,1879,"ENSG00000135747","ENST00000465049","nonsense_mediated_decay",90603,"ZNF670-ZNF695","ZNF670-ZNF695 readthrough (NMD candidate) [Source:HGNC Symbol;Acc:HGNC:49200]","GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":4E-73,"d":"0.00"},1,"1879,",0,-3.15,{"v":4.67735141287198e-05,"d":"0.00"},1.19,"3' UTR",1,246945547,247078736,133190,2]
["chr7",151058457,151059145,689,"ENSG00000164889","ENST00000483786","protein_coding",1247,"SLC4A2","solute carrier family 4 member 2 [Source:HGNC Symbol;Acc:HGNC:11028]","GO:0005452(inorganic anion exchanger activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005925(focal adhesion);GO:0006811(ion transport);GO:0006820(anion transport);GO:0007283(spermatogenesis);GO:0008509(anion transmembrane transporter activity);GO:0015297(antiporter activity);GO:0015301(anion:anion antiporter activity);GO:0015698(inorganic anion transport);GO:0015701(bicarbonate transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0019899(enzyme binding);GO:0048565(digestive tract development);GO:0051453(regulation of intracellular pH);GO:0055085(transmembrane transport);GO:0098656(anion transmembrane transport)","04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04976(Bile secretion)",{"v":1e-12,"d":"0.00"},1,"689,",0,{"v":-0.758,"d":"-0.76"},{"v":0.0457088189614875,"d":"0.05"},2.09,"5' UTR",7,151057210,151064744,7535,1]
["chr17",59965188,59973095,7908,"ENSG00000267104","ENST00000587125","processed_transcript",45880,"TBC1D3P1-DHX40P1","TBC1D3P1-DHX40P1 readthrough, transcribed pseudogene [Source:HGNC Symbol;Acc:HGNC:42362]","NA","NA",{"v":5e-33,"d":"0.00"},3,"1,65,261,","0,1215,7647",{"v":-1.4,"d":"-1.40"},{"v":0.00602559586074357,"d":"0.01"},2.11,"3' UTR",17,59962363,60018975,56613,2]
["chr2",55224280,55224863,584,"ENSG00000162994","ENST00000403506","protein_coding",0,"CLHC1","clathrin heavy chain linker domain containing 1 [Source:HGNC Symbol;Acc:HGNC:26453]","GO:0005515(protein binding)","NA",{"v":1.6e-32,"d":"0.00"},2,"231,158,","0,426",{"v":-0.805,"d":"-0.81"},{"v":0.0389045144994281,"d":"0.04"},1.79,"5' UTR",2,55222272,55224398,2127,2]
["chr2",63891442,63891562,121,"ENSG00000169764","ENST00000394417","protein_coding",50502,"UGP2","UDP-glucose pyrophosphorylase 2 [Source:HGNC Symbol;Acc:HGNC:12527]","GO:0003983(UTP:glucose-1-phosphate uridylyltransferase activity);GO:0005515(protein binding);GO:0005536(glucose binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005977(glycogen metabolic process);GO:0005978(glycogen biosynthetic process);GO:0006011(UDP-glucose metabolic process);GO:0006065(UDP-glucuronate biosynthetic process);GO:0016740(transferase activity);GO:0016779(nucleotidyltransferase activity);GO:0019255(glucose 1-phosphate metabolic process);GO:0032557(pyrimidine ribonucleotide binding);GO:0042802(identical protein binding);GO:0046872(metal ion binding);GO:0070062(extracellular exosome);GO:0070569(uridylyltransferase activity)","00040(Pentose and glucuronate interconversions);00052(Galactose metabolism);00500(Starch and sucrose metabolism);00520(Amino sugar and nucleotide sugar metabolism)",{"v":8.1e-09,"d":"0.00"},1,"121,",0,-1.21,{"v":0.010471285480509,"d":"0.01"},1.04,"3' UTR",2,63840940,63891562,50623,1]
["chr2",71433534,71435069,1536,"ENSG00000075292","ENST00000409544","protein_coding",101770,"ZNF638","zinc finger protein 638 [Source:HGNC Symbol;Acc:HGNC:17894]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003690(double-stranded DNA binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0008380(RNA splicing);GO:0016607(nuclear speck);GO:0043231(intracellular membrane-bounded organelle);GO:0046872(metal ion binding)","NA",{"v":1.3e-38,"d":"0.00"},2,"33,328,","0,1208",-1.19,{"v":0.0112201845430196,"d":"0.01"},1.39,"3' UTR",2,71331764,71435061,103298,1]
["chr2",96239743,96240368,626,"ENSG00000204685","ENST00000614453","processed_transcript",0,"STARD7-AS1","STARD7 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:40827]","NA","NA",{"v":2.7E-8,"d":"0.00"},1,"626,",0,-2.98,{"v":7.41310241300918e-05,"d":"0.00"},1.94,"Exon (ENST00000432267/ENSG00000204685, exon 1 of 2)",2,96240239,96240752,514,1]
["chr18",22900486,22900995,510,"ENSG00000265939","ENST00000583290","processed_pseudogene",0,"UBE2CP2","ubiquitin conjugating enzyme E2 C pseudogene 2 [Source:HGNC Symbol;Acc:HGNC:43551]","NA","NA",{"v":1.3e-46,"d":"0.00"},1,"510,",0,-3.74,{"v":9.77237220955811e-06,"d":"0.00"},2.13,"Exon (ENST00000583290/ENSG00000265939, exon 1 of 1)",18,22900486,22900995,510,2]
["chr2",117837787,117839272,1486,"ENSG00000236255","ENST00000420330","lincRNA",3850,"AC009404","novel transcript","NA","NA",{"v":2.1E-10,"d":"0.00"},2,"418,91,","0,1395",{"v":-0.889,"d":"-0.89"},{"v":0.0295120922666639,"d":"0.03"},1.79,"Exon (ENST00000420330/ENSG00000236255, exon 2 of 2)",2,117833937,117841658,7722,1]
["chr18",46679205,46679774,570,"ENSG00000101638","ENST00000538168","protein_coding",77035,"ST8SIA5","ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 [Source:HGNC Symbol;Acc:HGNC:17827]","GO:0000139(Golgi membrane);GO:0003828(alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity);GO:0005515(protein binding);GO:0005794(Golgi apparatus);GO:0005975(carbohydrate metabolic process);GO:0006486(protein glycosylation);GO:0006688(glycosphingolipid biosynthetic process);GO:0008373(sialyltransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0097503(sialylation)","00604(Glycosphingolipid biosynthesis - ganglio series)",{"v":5e-21,"d":"0.00"},1,"570,",0,{"v":-0.959,"d":"-0.96"},{"v":0.0234422881531992,"d":"0.02"},2.13,"3' UTR",18,46667821,46756809,88989,2]
["chr2",130129621,130135293,5673,"ENSG00000223760","ENST00000427638","processed_transcript",0,"MED15P9","mediator complex subunit 15 pseudogene 9 [Source:HGNC Symbol;Acc:HGNC:44130]","NA","NA",{"v":7.9e-31,"d":"0.00"},2,"178,149,","0,5524",-1.23,{"v":0.00977237220955811,"d":"0.01"},1.52,"Exon (ENST00000427638/ENSG00000223760, exon 1 of 6)",2,130129621,130139417,9797,1]
["chr21",6631860,6632339,480,"ENSG00000280145","ENST00000623047","lincRNA",5998,"CU638689","novel transcript","NA","NA",{"v":1.9e-07,"d":"0.00"},1,"480,",0,-1.05,{"v":0.0173780082874938,"d":"0.02"},2.13,"Exon (ENST00000623047/ENSG00000280145, exon 2 of 2)",21,6630182,6638337,8156,2]
["chr2",131046783,131047263,481,"ENSG00000136002","ENST00000636987","nonsense_mediated_decay",130132,"ARHGEF4","Rho guanine nucleotide exchange factor 4 [Source:HGNC Symbol;Acc:HGNC:684]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0019904(protein domain specific binding);GO:0030032(lamellipodium assembly);GO:0030676(Rac guanyl-nucleotide exchange factor activity);GO:0032587(ruffle membrane);GO:0035023(regulation of Rho protein signal transduction);GO:0035556(intracellular signal transduction);GO:0042995(cell projection);GO:0043065(positive regulation of apoptotic process);GO:0046847(filopodium assembly);GO:0051056(regulation of small GTPase mediated signal transduction)","04810(Regulation of actin cytoskeleton)",{"v":6.3e-61,"d":"0.00"},1,"481,",0,{"v":-0.942,"d":"-0.94"},{"v":0.0245470891568503,"d":"0.02"},1.14,"3' UTR",2,130916651,131047253,130603,1]
["chr3",97943244,97943514,271,"ENSG00000080200","ENST00000389622","protein_coding",121233,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0008150(biological_process);GO:0030246(carbohydrate binding);GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":3.6E-10,"d":"0.00"},1,"271,",0,{"v":-0.998,"d":"-1.00"},{"v":0.0204173794466953,"d":"0.02"},2.14,"3' UTR",3,97822011,97944984,122974,1]
["chr4",176683568,176687397,3830,"ENSG00000150630","ENST00000618562","protein_coding",105525,"VEGFC","vascular endothelial growth factor C [Source:HGNC Symbol;Acc:HGNC:12682]","GO:0001525(angiogenesis);GO:0001666(response to hypoxia);GO:0001934(positive regulation of protein phosphorylation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0002040(sprouting angiogenesis);GO:0002052(positive regulation of neuroblast proliferation);GO:0002576(platelet degranulation);GO:0005172(vascular endothelial growth factor receptor binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006929(substrate-dependent cell migration);GO:0007165(signal transduction);GO:0007275(multicellular organism development);GO:0008083(growth factor activity);GO:0008284(positive regulation of cell population proliferation);GO:0009887(animal organ morphogenesis);GO:0010469(regulation of signaling receptor activity);GO:0016020(membrane);GO:0016331(morphogenesis of embryonic epithelium);GO:0030154(cell differentiation);GO:0030947(regulation of vascular endothelial growth factor receptor signaling pathway);GO:0031093(platelet alpha granule lumen);GO:0031954(positive regulation of protein autophosphorylation);GO:0038084(vascular endothelial growth factor signaling pathway);GO:0042056(chemoattractant activity);GO:0042493(response to drug);GO:0043185(vascular endothelial growth factor receptor 3 binding);GO:0043536(positive regulation of blood vessel endothelial cell migration);GO:0045766(positive regulation of angiogenesis);GO:0045776(negative regulation of blood pressure);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0050679(positive regulation of epithelial cell proliferation);GO:0050714(positive regulation of protein secretion);GO:0050918(positive chemotaxis);GO:0050930(induction of positive chemotaxis);GO:0051781(positive regulation of cell division);GO:0060754(positive regulation of mast cell chemotaxis);GO:1901492(positive regulation of lymphangiogenesis);GO:1990830(cellular response to leukemia inhibitory factor)","04010(MAPK signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04668(TNF signaling pathway);04926(Relaxin signaling pathway);04933(AGE-RAGE signaling pathway in diabetic complications);05200(Pathways in cancer)",{"v":2.5e-26,"d":"0.00"},2,"473,211,","0,3619",-2.43,{"v":3.23593656929628E-4,"d":"0.00"},2.14,"3' UTR",4,176683538,176792922,109385,2]
["chr2",201118887,201122492,3606,"ENSG00000003402","ENST00000425030","protein_coding",0,"CFLAR","CASP8 and FADD like apoptosis regulator [Source:HGNC Symbol;Acc:HGNC:1876]","GO:0001666(response to hypoxia);GO:0002020(protease binding);GO:0004197(cysteine-type endopeptidase activity);GO:0005123(death receptor binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0006915(apoptotic process);GO:0007519(skeletal muscle tissue development);GO:0008047(enzyme activator activity);GO:0008234(cysteine-type peptidase activity);GO:0009617(response to bacterium);GO:0010667(negative regulation of cardiac muscle cell apoptotic process);GO:0010952(positive regulation of peptidase activity);GO:0010976(positive regulation of neuron projection development);GO:0014732(skeletal muscle atrophy);GO:0014842(regulation of skeletal muscle satellite cell proliferation);GO:0014866(skeletal myofibril assembly);GO:0016032(viral process);GO:0016504(peptidase activator activity);GO:0031264(death-inducing signaling complex);GO:0031265(CD95 death-inducing signaling complex);GO:0032869(cellular response to insulin stimulus);GO:0033574(response to testosterone);GO:0042981(regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043085(positive regulation of catalytic activity);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043403(skeletal muscle tissue regeneration);GO:0044877(protein-containing complex binding);GO:0045121(membrane raft);GO:0046982(protein heterodimerization activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0060544(regulation of necroptotic process);GO:0060546(negative regulation of necroptotic process);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071364(cellular response to epidermal growth factor stimulus);GO:0071392(cellular response to estradiol stimulus);GO:0071456(cellular response to hypoxia);GO:0071549(cellular response to dexamethasone stimulus);GO:0071732(cellular response to nitric oxide);GO:0072126(positive regulation of glomerular mesangial cell proliferation);GO:0097153(cysteine-type endopeptidase activity involved in apoptotic process);GO:0097342(ripoptosome);GO:1901740(negative regulation of myoblast fusion);GO:1902041(regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902042(negative regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1903055(positive regulation of extracellular matrix organization);GO:1903427(negative regulation of reactive oxygen species biosynthetic process);GO:1903845(negative regulation of cellular response to transforming growth factor beta stimulus);GO:1903944(negative regulation of hepatocyte apoptotic process);GO:1904036(negative regulation of epithelial cell apoptotic process);GO:2000347(positive regulation of hepatocyte proliferation);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04064(NF-kappa B signaling pathway);04140(Autophagy - animal);04210(Apoptosis);04217(Necroptosis);04668(TNF signaling pathway);05142(Chagas disease (American trypanosomiasis));05160(Hepatitis C)",{"v":0.00037,"d":"0.00"},3,"15,150,16,","0,141,3590",-1.05,{"v":0.0173780082874938,"d":"0.02"},{"v":1.6,"d":"1.60"},"5' UTR",2,201122477,201130053,7577,1]
["chr2",206306731,206308228,1498,"ENSG00000204186","ENST00000374423","protein_coding",32068,"ZDBF2","zinc finger DBF-type containing 2 [Source:HGNC Symbol;Acc:HGNC:29313]","GO:0003676(nucleic acid binding);GO:0008270(zinc ion binding);GO:0046872(metal ion binding)","NA",{"v":3.2e-28,"d":"0.00"},1,"1498,",0,-1.13,{"v":0.0138038426460289,"d":"0.01"},1.42,"3' UTR",2,206274663,206314427,39765,1]
["chr2",216100385,216101074,690,"ENSG00000163449","ENST00000454545","protein_coding",18519,"TMEM169","transmembrane protein 169 [Source:HGNC Symbol;Acc:HGNC:25130]","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":4e-27,"d":"0.00"},1,"690,",0,-1.34,{"v":0.00707945784384138,"d":"0.01"},1.34,"3' UTR",2,216081866,216102782,20917,1]
["chr2",218636975,218637184,210,"ENSG00000115556","ENST00000450993","protein_coding",29076,"PLCD4","phospholipase C delta 4 [Source:HGNC Symbol;Acc:HGNC:9062]","GO:0004435(phosphatidylinositol phospholipase C activity);GO:0004629(phospholipase C activity);GO:0005509(calcium ion binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0007340(acrosome reaction);GO:0008081(phosphoric diester hydrolase activity);GO:0016020(membrane);GO:0016042(lipid catabolic process);GO:0016787(hydrolase activity);GO:0031965(nuclear membrane);GO:0032959(inositol trisphosphate biosynthetic process);GO:0035556(intracellular signal transduction);GO:0043647(inositol phosphate metabolic process);GO:0046488(phosphatidylinositol metabolic process);GO:0046872(metal ion binding)","00562(Inositol phosphate metabolism);04020(Calcium signaling pathway);04070(Phosphatidylinositol signaling system);04919(Thyroid hormone signaling pathway);04933(AGE-RAGE signaling pathway in diabetic complications)",{"v":3.5e-07,"d":"0.00"},1,"210,",0,-0.77,{"v":0.0436515832240166,"d":"0.04"},1.02,"3' UTR",2,218607899,218637175,29277,1]
["chr4",139114960,139115344,385,"ENSG00000109381","ENST00000394235","protein_coding",61874,"ELF2","E74 like ETS transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:3317]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0016604(nuclear body);GO:0030154(cell differentiation);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0050855(regulation of B cell receptor signaling pathway)","NA",{"v":1e-15,"d":"0.00"},1,"385,",0,-7.23,{"v":1.38038426460289E-9,"d":"0.00"},2.15,"Exon (ENST00000509033/ENSG00000179967, exon 1 of 1)",4,139057220,139177218,119999,2]
["chr2",23757547,23762312,4766,"ENSG00000119778","ENST00000238789","protein_coding",164811,"ATAD2B","ATPase family, AAA domain containing 2B [Source:HGNC Symbol;Acc:HGNC:29230]","GO:0000166(nucleotide binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016887(ATPase activity);GO:0031936(negative regulation of chromatin silencing);GO:0042393(histone binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0070577(lysine-acetylated histone binding)","NA",{"v":1E-167,"d":"0.00"},2,"555,104,","0,4662",-4.13,{"v":3.46736850452532e-06,"d":"0.00"},1.45,"Exon (ENST00000238789/ENSG00000119778, exon 24 of 28)",2,23748664,23927123,178460,2]
["chr2",27626806,27627913,1108,"ENSG00000176714","ENST00000324364","protein_coding",1099,"CCDC121","coiled-coil domain containing 121 [Source:HGNC Symbol;Acc:HGNC:25833]","GO:0005515(protein binding)","NA",{"v":1E-141,"d":"0.00"},1,"1108,",0,-4.25,{"v":2.63026799189538E-6,"d":"0.00"},1.18,"5' UTR",2,27625639,27629012,3374,2]
["chr11",105996368,106009748,13381,"ENSG00000170903","ENST00000529805","processed_transcript",0,"MSANTD4","Myb/SANT DNA binding domain containing 4 with coiled-coils [Source:HGNC Symbol;Acc:HGNC:29383]","GO:0005634(nucleus)","NA",{"v":2.5e-55,"d":"0.00"},2,"250,166,","0,13215",-2.49,{"v":0.000269153480392692,"d":"0.00"},2.15,"3' UTR",11,105995623,106009748,14126,2]
["chr2",70048736,70049153,418,"ENSG00000179818","ENST00000435880","antisense",37862,"PCBP1-AS1","PCBP1 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:42948]","NA","NA",{"v":6.3e-15,"d":"0.00"},2,"222,109,","0,309",-1.52,{"v":0.00416869383470336,"d":"0.00"},1.68,"Exon (ENST00000413791/ENSG00000179818, exon 5 of 5)",2,69962263,70087015,124753,2]
["chr2",72741413,72826041,84629,"ENSG00000144036","ENST00000272427","protein_coding",0,"EXOC6B","exocyst complex component 6B [Source:HGNC Symbol;Acc:HGNC:17085]","GO:0000145(exocyst);GO:0005515(protein binding);GO:0006887(exocytosis);GO:0006893(Golgi to plasma membrane transport);GO:0006904(vesicle docking involved in exocytosis);GO:0015031(protein transport);GO:0016020(membrane)","NA",{"v":1e-20,"d":"0.00"},2,"57,244,","0,84385",-1.86,{"v":1.54881661891248E-3,"d":"0.00"},1.23,"5' UTR",2,72175984,72826041,650058,2]
["chr2",85839936,85844419,4484,"ENSG00000115525","ENST00000638572","protein_coding",44571,"ST3GAL5","ST3 beta-galactoside alpha-2,3-sialyltransferase 5 [Source:HGNC Symbol;Acc:HGNC:10872]","GO:0000139(Golgi membrane);GO:0001574(ganglioside biosynthetic process);GO:0004513(neolactotetraosylceramide alpha-2,3-sialyltransferase activity);GO:0005794(Golgi apparatus);GO:0005887(integral component of plasma membrane);GO:0005975(carbohydrate metabolic process);GO:0006486(protein glycosylation);GO:0006688(glycosphingolipid biosynthetic process);GO:0008373(sialyltransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0047291(lactosylceramide alpha-2,3-sialyltransferase activity);GO:0097503(sialylation)","00604(Glycosphingolipid biosynthesis - ganglio series)",{"v":3.2e-45,"d":"0.00"},2,"457,24,","0,4460",-1.94,{"v":0.00123026877081238,"d":"0.00"},1.03,"3' UTR",2,85837120,85888990,51871,2]
["chr19",29616699,29617207,509,"ENSG00000105171","ENST00000585603","protein_coding",10416,"POP4","POP4 homolog, ribonuclease P/MRP subunit [Source:HGNC Symbol;Acc:HGNC:30081]","GO:0000171(ribonuclease MRP activity);GO:0000172(ribonuclease MRP complex);GO:0001682(tRNA 5'-leader removal);GO:0003723(RNA binding);GO:0004526(ribonuclease P activity);GO:0004540(ribonuclease activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0006396(RNA processing);GO:0008033(tRNA processing);GO:0016787(hydrolase activity);GO:0030677(ribonuclease P complex);GO:0030681(multimeric ribonuclease P complex);GO:0033204(ribonuclease P RNA binding);GO:0090501(RNA phosphodiester bond hydrolysis);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic)","03008(Ribosome biogenesis in eukaryotes);03013(RNA transport)",{"v":1.6E-15,"d":"0.00"},1,"509,",0,-1.63,{"v":0.00309029543251359,"d":"0.00"},2.15,"3' UTR",19,29606283,29617237,10955,1]
["chr2",96836641,96837091,451,"ENSG00000163126","ENST00000476975","processed_transcript",5026,"ANKRD23","ankyrin repeat domain 23 [Source:HGNC Symbol;Acc:HGNC:24470]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0009612(response to mechanical stimulus);GO:0014704(intercalated disc);GO:0015629(actin cytoskeleton);GO:0030016(myofibril);GO:0031432(titin binding)","NA",{"v":1E-8,"d":"0.00"},1,"451,",0,-1.15,{"v":0.0128824955169313,"d":"0.01"},1.96,"3' UTR",2,96824526,96842117,17592,2]
["chr2",98821945,98822485,541,"ENSG00000196872","ENST00000464413","processed_transcript",0,"KIAA1211L","KIAA1211 like [Source:HGNC Symbol;Acc:HGNC:33454]","NA","NA",{"v":4.8e-05,"d":"0.00"},1,"541,",0,{"v":-0.882,"d":"-0.88"},{"v":0.0301995172040202,"d":"0.03"},1.63,"Exon (ENST00000397899/ENSG00000196872, exon 7 of 10)",2,98809739,98822304,12566,2]
["chrX",130373212,130373361,150,"ENSG00000102078","ENST00000543953","protein_coding",33324,"SLC25A14","solute carrier family 25 member 14 [Source:HGNC Symbol;Acc:HGNC:10984]","GO:0005739(mitochondrion);GO:0005740(mitochondrial envelope);GO:0005743(mitochondrial inner membrane);GO:0005887(integral component of plasma membrane);GO:0006839(mitochondrial transport);GO:0008272(sulfate transport);GO:0009060(aerobic respiration);GO:0015116(sulfate transmembrane transporter activity);GO:0015117(thiosulfate transmembrane transporter activity);GO:0015131(oxaloacetate transmembrane transporter activity);GO:0015140(malate transmembrane transporter activity);GO:0015141(succinate transmembrane transporter activity);GO:0015297(antiporter activity);GO:0015709(thiosulfate transport);GO:0015729(oxaloacetate transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0031966(mitochondrial membrane);GO:0035435(phosphate ion transmembrane transport);GO:0055085(transmembrane transport);GO:0071422(succinate transmembrane transport);GO:0071423(malate transmembrane transport);GO:1902356(oxaloacetate(2-) transmembrane transport);GO:1902358(sulfate transmembrane transport);GO:1902600(proton transmembrane transport)","NA",{"v":0.00013,"d":"0.00"},1,"150,",0,-2.44,{"v":0.000309029543251359,"d":"0.00"},2.15,"3' UTR",23,130339888,130373361,33474,1]
["chr2",176173182,176173361,180,"ENSG00000224189","ENST00000413969","antisense",4738,"HAGLR","HOXD antisense growth-associated long non-coding RNA [Source:HGNC Symbol;Acc:HGNC:43755]","NA","NA",{"v":2e-05,"d":"0.00"},1,"180,",0,{"v":-0.734,"d":"-0.73"},{"v":0.0489778819368446,"d":"0.05"},1.43,"Exon (ENST00000452365/ENSG00000224189, exon 5 of 5)",2,176164051,176178099,14049,2]
["chr2",207766731,207767749,1019,"ENSG00000163251","ENST00000295417","protein_coding",2157,"FZD5","frizzled class receptor 5 [Source:HGNC Symbol;Acc:HGNC:4043]","GO:0000139(Golgi membrane);GO:0000578(embryonic axis specification);GO:0001525(angiogenesis);GO:0001540(amyloid-beta binding);GO:0001944(vasculature development);GO:0002726(positive regulation of T cell cytokine production);GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005515(protein binding);GO:0005769(early endosome);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005923(bicellular tight junction);GO:0007165(signal transduction);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007223(Wnt signaling pathway, calcium modulating pathway);GO:0007275(multicellular organism development);GO:0007416(synapse assembly);GO:0008285(negative regulation of cell population proliferation);GO:0008289(lipid binding);GO:0008595(anterior/posterior axis specification, embryo);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0017147(Wnt-protein binding);GO:0019901(protein kinase binding);GO:0030054(cell junction);GO:0030182(neuron differentiation);GO:0030424(axon);GO:0030425(dendrite);GO:0030669(clathrin-coated endocytic vesicle membrane);GO:0031076(embryonic camera-type eye development);GO:0031077(post-embryonic camera-type eye development);GO:0031625(ubiquitin protein ligase binding);GO:0031901(early endosome membrane);GO:0032729(positive regulation of interferon-gamma production);GO:0033077(T cell differentiation in thymus);GO:0035567(non-canonical Wnt signaling pathway);GO:0042813(Wnt-activated receptor activity);GO:0042995(cell projection);GO:0043204(perikaryon);GO:0043507(positive regulation of JUN kinase activity);GO:0044877(protein-containing complex binding);GO:0045202(synapse);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048469(cell maturation);GO:0048471(perinuclear region of cytoplasm);GO:0048596(embryonic camera-type eye morphogenesis);GO:0050718(positive regulation of interleukin-1 beta secretion);GO:0060061(Spemann organizer formation);GO:0060070(canonical Wnt signaling pathway);GO:0060071(Wnt signaling pathway, planar cell polarity pathway);GO:0060561(apoptotic process involved in morphogenesis);GO:0060670(branching involved in labyrinthine layer morphogenesis);GO:0060715(syncytiotrophoblast cell differentiation involved in labyrinthine layer development);GO:0060716(labyrinthine layer blood vessel development);GO:0060718(chorionic trophoblast cell differentiation);GO:0071219(cellular response to molecule of bacterial origin);GO:1901382(regulation of chorionic trophoblast cell proliferation);GO:1903146(regulation of autophagy of mitochondrion);GO:1903955(positive regulation of protein targeting to mitochondrion);GO:1904469(positive regulation of tumor necrosis factor secretion);GO:1904886(beta-catenin destruction complex disassembly);GO:2000810(regulation of bicellular tight junction assembly)","04150(mTOR signaling pathway);04310(Wnt signaling pathway);04390(Hippo signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);04934(Cushing syndrome);05165(Human papillomavirus infection);05200(Pathways in cancer);05205(Proteoglycans in cancer);05217(Basal cell carcinoma);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer)",{"v":1.6e-24,"d":"0.00"},1,"1019,",0,-2.17,{"v":0.000660693448007596,"d":"0.00"},1.29,"3' UTR",2,207762598,207769906,7309,2]
["chr2",229763838,229764108,271,"ENSG00000153827","ENST00000283943","protein_coding",157901,"TRIP12","thyroid hormone receptor interactor 12 [Source:HGNC Symbol;Acc:HGNC:12306]","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006281(DNA repair);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006974(cellular response to DNA damage stimulus);GO:0008270(zinc ion binding);GO:0016567(protein ubiquitination);GO:0016607(nuclear speck);GO:0016740(transferase activity);GO:0045995(regulation of embryonic development);GO:0046966(thyroid hormone receptor binding);GO:1901315(negative regulation of histone H2A K63-linked ubiquitination);GO:2000780(negative regulation of double-strand break repair)","04120(Ubiquitin mediated proteolysis)",{"v":1.3e-29,"d":"0.00"},1,"271,",0,-1.07,{"v":0.0162181009735893,"d":"0.02"},1.06,"3' UTR",2,229763838,229922009,158172,2]
["chr2",231123458,231125042,1585,"ENSG00000135914","ENST00000258400","protein_coding",0,"HTR2B","5-hydroxytryptamine receptor 2B [Source:HGNC Symbol;Acc:HGNC:5294]","GO:0001755(neural crest cell migration);GO:0001819(positive regulation of cytokine production);GO:0001938(positive regulation of endothelial cell proliferation);GO:0001965(G-protein alpha-subunit binding);GO:0002031(G protein-coupled receptor internalization);GO:0003007(heart morphogenesis);GO:0003300(cardiac muscle hypertrophy);GO:0004930(G protein-coupled receptor activity);GO:0004993(G protein-coupled serotonin receptor activity);GO:0005096(GTPase activator activity);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006874(cellular calcium ion homeostasis);GO:0006939(smooth muscle contraction);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007187(G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger);GO:0007202(activation of phospholipase C activity);GO:0007205(protein kinase C-activating G protein-coupled receptor signaling pathway);GO:0007210(serotonin receptor signaling pathway);GO:0007268(chemical synaptic transmission);GO:0007507(heart development);GO:0007610(behavior);GO:0008144(drug binding);GO:0008284(positive regulation of cell population proliferation);GO:0010507(negative regulation of autophagy);GO:0010513(positive regulation of phosphatidylinositol biosynthetic process);GO:0014033(neural crest cell differentiation);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0014827(intestine smooth muscle contraction);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016310(phosphorylation);GO:0019722(calcium-mediated signaling);GO:0019934(cGMP-mediated signaling);GO:0030054(cell junction);GO:0030425(dendrite);GO:0030594(neurotransmitter receptor activity);GO:0042310(vasoconstriction);GO:0042493(response to drug);GO:0043005(neuron projection);GO:0043066(negative regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043406(positive regulation of MAP kinase activity);GO:0043547(positive regulation of GTPase activity);GO:0045202(synapse);GO:0048598(embryonic morphogenesis);GO:0050715(positive regulation of cytokine secretion);GO:0050795(regulation of behavior);GO:0051000(positive regulation of nitric-oxide synthase activity);GO:0051209(release of sequestered calcium ion into cytosol);GO:0051378(serotonin binding);GO:0051781(positive regulation of cell division);GO:0060548(negative regulation of cell death);GO:0070371(ERK1 and ERK2 cascade);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0070528(protein kinase C signaling);GO:0071502(cellular response to temperature stimulus);GO:0098664(G protein-coupled serotonin receptor signaling pathway)","04020(Calcium signaling pathway);04080(Neuroactive ligand-receptor interaction);04540(Gap junction);04726(Serotonergic synapse);04750(Inflammatory mediator regulation of TRP channels)",{"v":1.3E-59,"d":"0.00"},2,"673,71,","0,1514",{"v":-2.2,"d":"-2.20"},{"v":0.000602559586074357,"d":"0.00"},1.19,"5' UTR",2,231108230,231125042,16813,2]
["chr3",9477866,9478016,151,"ENSG00000168137","ENST00000402198","protein_coding",80147,"SETD5","SET domain containing 5 [Source:HGNC Symbol;Acc:HGNC:25566]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0016569(covalent chromatin modification);GO:0016593(Cdc73/Paf1 complex);GO:0018024(histone-lysine N-methyltransferase activity);GO:0034968(histone lysine methylation);GO:0035065(regulation of histone acetylation);GO:0046974(histone methyltransferase activity (H3-K9 specific));GO:0051567(histone H3-K9 methylation);GO:1902275(regulation of chromatin organization)","NA",{"v":3.1e-05,"d":"0.00"},1,"151,",0,-1.81,{"v":0.00177827941003892,"d":"0.00"},1.42,"3' UTR",3,9397719,9478154,80436,1]
["chr3",15045443,15045922,480,"ENSG00000131368","ENST00000496484","processed_transcript",4045,"MRPS25","mitochondrial ribosomal protein S25 [Source:HGNC Symbol;Acc:HGNC:14511]","GO:0003735(structural constituent of ribosome);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005840(ribosome);GO:0070125(mitochondrial translational elongation);GO:0070126(mitochondrial translational termination)","NA",{"v":5e-33,"d":"0.00"},1,"480,",0,-2.27,{"v":0.000501187233627273,"d":"0.00"},1.01,"3' UTR",3,15042460,15049967,7508,2]
["chr3",15256572,15258869,2298,"ENSG00000224660","ENST00000413977","antisense",0,"SH3BP5-AS1","SH3BP5 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:44501]","NA","NA",{"v":6.3e-24,"d":"0.00"},3,"1035,75,324,","0,1537,1974",-4.47,{"v":1.47910838816821E-6,"d":"0.00"},1.34,"3' UTR",3,15257451,15258953,1503,1]
["chr16",46626433,46626786,354,"ENSG00000259856","ENST00000561790","processed_pseudogene",206,"RAB43P1","RAB43 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:33153]","NA","NA",{"v":4e-28,"d":"0.00"},1,"354,",0,-5.57,{"v":8.91250938133746e-08,"d":"0.00"},2.16,"Exon (ENST00000561790/ENSG00000259856, exon 1 of 1)",16,46626404,46626992,589,2]
["chr3",17011231,17011921,691,"ENSG00000154822","ENST00000615277","protein_coding",126276,"PLCL2","phospholipase C like 2 [Source:HGNC Symbol;Acc:HGNC:9064]","GO:0002322(B cell proliferation involved in immune response);GO:0002337(B-1a B cell differentiation);GO:0004435(phosphatidylinositol phospholipase C activity);GO:0005737(cytoplasm);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0008081(phosphoric diester hydrolase activity);GO:0016042(lipid catabolic process);GO:0016787(hydrolase activity);GO:0032228(regulation of synaptic transmission, GABAergic);GO:0032959(inositol trisphosphate biosynthetic process);GO:0033135(regulation of peptidyl-serine phosphorylation);GO:0035556(intracellular signal transduction);GO:0050811(GABA receptor binding);GO:0050859(negative regulation of B cell receptor signaling pathway);GO:0070679(inositol 1,4,5 trisphosphate binding);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1900122(positive regulation of receptor binding)","NA",{"v":6.3E-48,"d":"0.00"},1,"691,",0,{"v":-1.6,"d":"-1.60"},{"v":3.31131121482591E-3,"d":"0.00"},1.31,"Exon (ENST00000615277/ENSG00000154822, exon 2 of 6)",3,16884955,17090604,205650,1]
["chr5",76716126,76716692,567,"ENSG00000181104","ENST00000319211","protein_coding",0,"F2R","coagulation factor II thrombin receptor [Source:HGNC Symbol;Acc:HGNC:3537]","GO:0000186(activation of MAPKK activity);GO:0001965(G-protein alpha-subunit binding);GO:0002248(connective tissue replacement involved in inflammatory response wound healing);GO:0003105(negative regulation of glomerular filtration);GO:0004930(G protein-coupled receptor activity);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005623(cell);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005901(caveola);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006954(inflammatory response);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007200(phospholipase C-activating G protein-coupled receptor signaling pathway);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0007205(protein kinase C-activating G protein-coupled receptor signaling pathway);GO:0007529(establishment of synaptic specificity at neuromuscular junction);GO:0007596(blood coagulation);GO:0007599(hemostasis);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0009611(response to wounding);GO:0009653(anatomical structure morphogenesis);GO:0009986(cell surface);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0015057(thrombin-activated receptor activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030168(platelet activation);GO:0030193(regulation of blood coagulation);GO:0030194(positive regulation of blood coagulation);GO:0030335(positive regulation of cell migration);GO:0031094(platelet dense tubular network);GO:0031594(neuromuscular junction);GO:0031681(G-protein beta-subunit binding);GO:0032496(response to lipopolysaccharide);GO:0032651(regulation of interleukin-1 beta production);GO:0032967(positive regulation of collagen biosynthetic process);GO:0035025(positive regulation of Rho protein signal transduction);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043410(positive regulation of MAPK cascade);GO:0043524(negative regulation of neuron apoptotic process);GO:0043547(positive regulation of GTPase activity);GO:0045211(postsynaptic membrane);GO:0045217(cell-cell junction maintenance);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045907(positive regulation of vasoconstriction);GO:0045987(positive regulation of smooth muscle contraction);GO:0046427(positive regulation of receptor signaling pathway via JAK-STAT);GO:0048873(homeostasis of number of cells within a tissue);GO:0051209(release of sequestered calcium ion into cytosol);GO:0051281(positive regulation of release of sequestered calcium ion into cytosol);GO:0051482(positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway);GO:0051928(positive regulation of calcium ion transport);GO:0051930(regulation of sensory perception of pain);GO:0060155(platelet dense granule organization);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0070493(thrombin-activated receptor signaling pathway);GO:0099553(trans-synaptic signaling by endocannabinoid, modulating synaptic transmission);GO:1900134(negative regulation of renin secretion into blood stream);GO:2000484(positive regulation of interleukin-8 secretion);GO:2000778(positive regulation of interleukin-6 secretion)","04015(Rap1 signaling pathway);04020(Calcium signaling pathway);04024(cAMP signaling pathway);04072(Phospholipase D signaling pathway);04080(Neuroactive ligand-receptor interaction);04151(PI3K-Akt signaling pathway);04610(Complement and coagulation cascades);04611(Platelet activation);04810(Regulation of actin cytoskeleton);05200(Pathways in cancer)",{"v":1.6E-15,"d":"0.00"},2,"270,149,","0,418",-2.89,{"v":9.54992586021437e-05,"d":"0.00"},2.17,"5' UTR",5,76716126,76735770,19645,1]
["chr7",76389334,76390106,773,"ENSG00000146700","ENST00000492979","processed_transcript",3384,"SSC4D","scavenger receptor cysteine rich family member with 4 domains [Source:HGNC Symbol;Acc:HGNC:14461]","GO:0005044(scavenger receptor activity);GO:0005576(extracellular region);GO:0006898(receptor-mediated endocytosis);GO:0009897(external side of plasma membrane);GO:0016020(membrane)","NA",{"v":1.6e-21,"d":"0.00"},1,"773,",0,-2.28,{"v":0.000478630092322639,"d":"0.00"},2.19,"3' UTR",7,76389334,76393490,4157,2]
["chr3",53813073,53813733,661,"ENSG00000016391","ENST00000315251","protein_coding",32686,"CHDH","choline dehydrogenase [Source:HGNC Symbol;Acc:HGNC:24288]","GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0008812(choline dehydrogenase activity);GO:0016020(membrane);GO:0016491(oxidoreductase activity);GO:0016614(oxidoreductase activity, acting on CH-OH group of donors);GO:0019285(glycine betaine biosynthetic process from choline);GO:0042426(choline catabolic process);GO:0050660(flavin adenine dinucleotide binding);GO:0055114(oxidation-reduction process)","00260(Glycine, serine and threonine metabolism)",{"v":2e-56,"d":"0.00"},1,"661,",0,-2.22,{"v":0.000575439937337157,"d":"0.00"},1.42,"3' UTR",3,53812335,53846419,34085,2]
["chr14",91167576,91167666,91,"ENSG00000133943","ENST00000521334","protein_coding",107243,"DGLUCY","D-glutamate cyclase [Source:HGNC Symbol;Acc:HGNC:20498]","GO:0003674(molecular_function);GO:0005515(protein binding);GO:0005575(cellular_component);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006536(glutamate metabolic process);GO:0008150(biological_process);GO:0016829(lyase activity);GO:0047820(D-glutamate cyclase activity)","00471(D-Glutamine and D-glutamate metabolism)",{"v":1.6e-05,"d":"0.00"},1,"91,",0,{"v":-0.883,"d":"-0.88"},{"v":0.0295120922666639,"d":"0.03"},2.22,"3' UTR",14,91060333,91170201,109869,1]
["chr3",72929217,72929593,377,"ENSG00000172986","ENST00000389617","protein_coding",41144,"GXYLT2","glucoside xylosyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:33383]","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016266(O-glycan processing);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0035252(UDP-xylosyltransferase activity)","00514(Other types of O-glycan biosynthesis)",{"v":7.8e-10,"d":"0.00"},1,"377,",0,{"v":-0.987,"d":"-0.99"},{"v":0.0213796208950223,"d":"0.02"},1.64,"Exon (ENST00000492727/ENSG00000242960, exon 1 of 1)",3,72888073,72976926,88854,1]
["chr3",94128600,94129648,1049,"ENSG00000178694","ENST00000314622","protein_coding",65539,"NSUN3","NOP2/Sun RNA methyltransferase family member 3 [Source:HGNC Symbol;Acc:HGNC:26208]","GO:0000049(tRNA binding);GO:0002127(tRNA wobble base cytosine methylation);GO:0003723(RNA binding);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005762(mitochondrial large ribosomal subunit);GO:0008168(methyltransferase activity);GO:0016428(tRNA (cytosine-5-)-methyltransferase activity);GO:0016740(transferase activity);GO:0031167(rRNA methylation);GO:0032259(methylation);GO:0070129(regulation of mitochondrial translation)","NA",{"v":2e-82,"d":"0.00"},1,"1049,",0,-1.51,{"v":0.00416869383470336,"d":"0.00"},1.23,"3' UTR",3,94063061,94131832,68772,1]
["chr4",86887578,86887787,210,"ENSG00000163633","ENST00000295898","protein_coding",4635,"C4orf36","chromosome 4 open reading frame 36 [Source:HGNC Symbol;Acc:HGNC:28386]","NA","NA",{"v":0.00089,"d":"0.00"},1,"210,",0,-1.29,{"v":0.00831763771102671,"d":"0.01"},2.23,"3' UTR",4,86876205,86892422,16218,2]
["chr3",97875408,97877298,1891,"ENSG00000080200","ENST00000389622","protein_coding",53397,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0008150(biological_process);GO:0030246(carbohydrate binding);GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":2e-29,"d":"0.00"},1,"1891,",0,-1.39,{"v":0.00602559586074357,"d":"0.01"},1.36,"Exon (ENST00000389622/ENSG00000080200, exon 4 of 22)",3,97822011,97944984,122974,1]
["chr3",97877388,97877898,511,"ENSG00000080200","ENST00000389622","protein_coding",55377,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0008150(biological_process);GO:0030246(carbohydrate binding);GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":2.5e-16,"d":"0.00"},1,"511,",0,{"v":-0.758,"d":"-0.76"},{"v":0.0457088189614875,"d":"0.05"},1.88,"Exon (ENST00000389622/ENSG00000080200, exon 4 of 22)",3,97822011,97944984,122974,1]
["chr15",79411405,79412034,630,"ENSG00000166557","ENST00000424155","protein_coding",100260,"TMED3","transmembrane p24 trafficking protein 3 [Source:HGNC Symbol;Acc:HGNC:28889]","GO:0000139(Golgi membrane);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0006886(intracellular protein transport);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0006890(retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum);GO:0007030(Golgi organization);GO:0015031(protein transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030126(COPI vesicle coat);GO:0030133(transport vesicle);GO:0030134(COPII-coated ER to Golgi transport vesicle);GO:0030663(COPI-coated vesicle membrane);GO:0031410(cytoplasmic vesicle);GO:0032580(Golgi cisterna membrane);GO:0033116(endoplasmic reticulum-Golgi intermediate compartment membrane)","NA",{"v":4e-12,"d":"0.00"},1,"630,",0,-1.67,{"v":2.69153480392692E-3,"d":"0.00"},2.24,"3' UTR",15,79311145,79427432,116288,1]
["chr3",119294373,119294733,361,"ENSG00000031081","ENST00000264245","protein_coding",0,"ARHGAP31","Rho GTPase activating protein 31 [Source:HGNC Symbol;Acc:HGNC:29216]","GO:0005096(GTPase activator activity);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0007165(signal transduction);GO:0007264(small GTPase mediated signal transduction);GO:0017124(SH3 domain binding);GO:0030027(lamellipodium);GO:0030054(cell junction);GO:0042995(cell projection);GO:0043547(positive regulation of GTPase activity);GO:0051056(regulation of small GTPase mediated signal transduction)","NA",{"v":4.4e-10,"d":"0.00"},1,"361,",0,{"v":-0.778,"d":"-0.78"},{"v":0.0426579518801593,"d":"0.04"},1.17,"5' UTR",3,119294373,119420714,126342,1]
["chr3",119417536,119417806,271,"ENSG00000031081","ENST00000264245","protein_coding",123163,"ARHGAP31","Rho GTPase activating protein 31 [Source:HGNC Symbol;Acc:HGNC:29216]","GO:0005096(GTPase activator activity);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0007165(signal transduction);GO:0007264(small GTPase mediated signal transduction);GO:0017124(SH3 domain binding);GO:0030027(lamellipodium);GO:0030054(cell junction);GO:0042995(cell projection);GO:0043547(positive regulation of GTPase activity);GO:0051056(regulation of small GTPase mediated signal transduction)","NA",{"v":1.2E-5,"d":"0.00"},1,"271,",0,{"v":-0.953,"d":"-0.95"},{"v":0.0234422881531992,"d":"0.02"},1.87,"3' UTR",3,119294373,119420714,126342,1]
["chr3",130119084,130120579,1496,"ENSG00000249846","ENST00000514145","lincRNA",6534,"LINC02021","long intergenic non-protein coding RNA 2021 [Source:HGNC Symbol;Acc:HGNC:52856]","NA","NA",{"v":7.9e-30,"d":"0.00"},1,"1496,",0,-1.08,{"v":0.0154881661891248,"d":"0.02"},1.47,"Exon (ENST00000514145/ENSG00000249846, exon 3 of 3)",3,130112550,130119174,6625,1]
["chr3",132659900,132660409,510,"ENSG00000081307","ENST00000480955","processed_transcript",0,"UBA5","ubiquitin like modifier activating enzyme 5 [Source:HGNC Symbol;Acc:HGNC:23230]","GO:0000166(nucleotide binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0008641(ubiquitin-like modifier activating enzyme activity);GO:0032446(protein modification by small protein conjugation);GO:0033146(regulation of intracellular estrogen receptor signaling pathway);GO:0034976(response to endoplasmic reticulum stress);GO:0043231(intracellular membrane-bounded organelle);GO:0046872(metal ion binding);GO:0050905(neuromuscular process);GO:0071566(UFM1 activating enzyme activity);GO:0071569(protein ufmylation);GO:1990592(protein K69-linked ufmylation)","NA",{"v":4e-77,"d":"0.00"},1,"510,",0,{"v":-2.8,"d":"-2.80"},{"v":1.20226443461741E-4,"d":"0.00"},1.37,"5' UTR",3,132659918,132660945,1028,1]
["chr3",149377778,149378127,350,"ENSG00000240541","ENST00000496491","antisense",0,"TM4SF1-AS1","TM4SF1 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:40587]","NA","NA",{"v":3.2e-48,"d":"0.00"},1,"350,",0,-1.32,{"v":0.00758577575029184,"d":"0.01"},1.06,"Exon (ENST00000496491/ENSG00000240541, exon 1 of 2)",3,149377778,149386583,8806,1]
["chr9",32979618,32979996,379,"ENSG00000137074","ENST00000379825","protein_coding",21632,"APTX","aprataxin [Source:HGNC Symbol;Acc:HGNC:15984]","GO:0000012(single strand break repair);GO:0000785(chromatin);GO:0000790(nuclear chromatin);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003684(damaged DNA binding);GO:0003690(double-stranded DNA binding);GO:0003697(single-stranded DNA binding);GO:0003725(double-stranded RNA binding);GO:0003824(catalytic activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006266(DNA ligation);GO:0006281(DNA repair);GO:0006302(double-strand break repair);GO:0006974(cellular response to DNA damage stimulus);GO:0008967(phosphoglycolate phosphatase activity);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0030983(mismatched DNA binding);GO:0031647(regulation of protein stability);GO:0033699(DNA 5'-adenosine monophosphate hydrolase activity);GO:0042542(response to hydrogen peroxide);GO:0046872(metal ion binding);GO:0047485(protein N-terminus binding);GO:0051219(phosphoprotein binding);GO:0090305(nucleic acid phosphodiester bond hydrolysis);GO:0120108(DNA-3'-diphospho-5'-guanosine diphosphatase);GO:1990165(single-strand break-containing DNA binding)","NA",{"v":7.4e-05,"d":"0.00"},1,"379,",0,{"v":-0.898,"d":"-0.90"},{"v":0.0281838293126445,"d":"0.03"},2.25,"Exon (ENST00000415066/ENSG00000236184, exon 1 of 1)",9,32972606,33001628,29023,2]
["chr3",194487484,194488169,686,"ENSG00000133657","ENST00000439040","protein_coding",10195,"ATP13A3","ATPase 13A3 [Source:HGNC Symbol;Acc:HGNC:24113]","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005623(cell);GO:0006812(cation transport);GO:0006874(cellular calcium ion homeostasis);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0016887(ATPase activity);GO:0046872(metal ion binding)","NA",{"v":4.6e-07,"d":"0.00"},1,"686,",0,-1.04,{"v":0.0181970085860998,"d":"0.02"},1.91,"Exon (ENST00000448892/ENSG00000233058, exon 1 of 3)",3,194402672,194498364,95693,2]
["chr3",8981521,8981881,361,"ENSG00000196220","ENST00000383836","protein_coding",267765,"SRGAP3","SLIT-ROBO Rho GTPase activating protein 3 [Source:HGNC Symbol;Acc:HGNC:19744]","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007165(signal transduction);GO:0030336(negative regulation of cell migration);GO:0043547(positive regulation of GTPase activity);GO:0048365(Rac GTPase binding);GO:0051056(regulation of small GTPase mediated signal transduction)","04360(Axon guidance)",{"v":1.6e-06,"d":"0.00"},1,"361,",0,{"v":-0.787,"d":"-0.79"},{"v":0.0407380277804113,"d":"0.04"},1.93,"3' UTR",3,8980591,9249646,269056,2]
["chr3",15256910,15257090,181,"ENSG00000131370","ENST00000383791","protein_coding",75496,"SH3BP5","SH3 domain binding protein 5 [Source:HGNC Symbol;Acc:HGNC:10827]","GO:0004860(protein kinase inhibitor activity);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006469(negative regulation of protein kinase activity);GO:0007165(signal transduction);GO:0016020(membrane);GO:0016604(nuclear body);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017124(SH3 domain binding);GO:0030659(cytoplasmic vesicle membrane);GO:0031410(cytoplasmic vesicle);GO:0035556(intracellular signal transduction);GO:0061099(negative regulation of protein tyrosine kinase activity)","NA",{"v":1.8E-5,"d":"0.00"},1,"181,",0,-1.52,{"v":0.00416869383470336,"d":"0.00"},1.22,"3' UTR",3,15254353,15332586,78234,2]
["chr3",29264194,29264689,496,"ENSG00000144642","ENST00000636680","protein_coding",687728,"RBMS3","RNA binding motif single stranded interacting protein 3 [Source:HGNC Symbol;Acc:HGNC:13427]","GO:0002357(defense response to tumor cell);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008143(poly(A) binding);GO:0008266(poly(U) RNA binding);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0035925(mRNA 3'-UTR AU-rich region binding);GO:0045727(positive regulation of translation);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:1990904(ribonucleoprotein complex)","NA",{"v":5e-29,"d":"0.00"},1,"496,",0,{"v":-1.1,"d":"-1.10"},{"v":0.0147910838816821,"d":"0.01"},1.19,"Exon (ENST00000635847/ENSG00000235904, exon 2 of 2)",3,28576466,30004034,1427569,1]
["chr10",96373235,96373775,541,"ENSG00000095587","ENST00000357947","protein_coding",140151,"TLL2","tolloid like 2 [Source:HGNC Symbol;Acc:HGNC:11844]","GO:0004222(metalloendopeptidase activity);GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0006508(proteolysis);GO:0007275(multicellular organism development);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0016787(hydrolase activity);GO:0022617(extracellular matrix disassembly);GO:0030154(cell differentiation);GO:0046872(metal ion binding);GO:0048632(negative regulation of skeletal muscle tissue growth)","NA",{"v":7.4e-06,"d":"0.00"},1,"541,",0,{"v":-0.794,"d":"-0.79"},{"v":0.0398107170553497,"d":"0.04"},2.25,"Exon (ENST00000357947/ENSG00000095587, exon 19 of 21)",10,96364608,96513926,149319,2]
["chr11",72793624,72794007,384,"ENSG00000214530","ENST00000543304","protein_coding",0,"STARD10","StAR related lipid transfer domain containing 10 [Source:HGNC Symbol;Acc:HGNC:10666]","GO:0005515(protein binding);GO:0005548(phospholipid transporter activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005902(microvillus);GO:0005929(cilium);GO:0006656(phosphatidylcholine biosynthetic process);GO:0006869(lipid transport);GO:0008289(lipid binding);GO:0015914(phospholipid transport);GO:0016020(membrane);GO:0031514(motile cilium);GO:0032782(bile acid secretion);GO:0035360(positive regulation of peroxisome proliferator activated receptor signaling pathway);GO:0042995(cell projection);GO:0046581(intercellular canaliculus)","NA",{"v":2.3E-6,"d":"0.00"},1,"384,",0,-1.45,{"v":0.00512861383991365,"d":"0.01"},2.25,"5' UTR",11,72754729,72793657,38929,2]
["chr3",47122160,47122729,570,"ENSG00000181555","ENST00000431180","nonsense_mediated_decay",1058,"SETD2","SET domain containing 2, histone lysine methyltransferase [Source:HGNC Symbol;Acc:HGNC:18420]","GO:0001525(angiogenesis);GO:0001570(vasculogenesis);GO:0001763(morphogenesis of a branching structure);GO:0001843(neural tube closure);GO:0002376(immune system process);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0006281(DNA repair);GO:0006298(mismatch repair);GO:0006325(chromatin organization);GO:0006355(regulation of transcription, DNA-templated);GO:0006368(transcription elongation from RNA polymerase II promoter);GO:0006974(cellular response to DNA damage stimulus);GO:0007275(multicellular organism development);GO:0008168(methyltransferase activity);GO:0010452(histone H3-K36 methylation);GO:0010468(regulation of gene expression);GO:0010569(regulation of double-strand break repair via homologous recombination);GO:0010793(regulation of mRNA export from nucleus);GO:0016279(protein-lysine N-methyltransferase activity);GO:0016740(transferase activity);GO:0018023(peptidyl-lysine trimethylation);GO:0018024(histone-lysine N-methyltransferase activity);GO:0018026(peptidyl-lysine monomethylation);GO:0030154(cell differentiation);GO:0030900(forebrain development);GO:0032259(methylation);GO:0032465(regulation of cytokinesis);GO:0032727(positive regulation of interferon-alpha production);GO:0034340(response to type I interferon);GO:0034728(nucleosome organization);GO:0034968(histone lysine methylation);GO:0035441(cell migration involved in vasculogenesis);GO:0035987(endodermal cell differentiation);GO:0043014(alpha-tubulin binding);GO:0045087(innate immune response);GO:0046872(metal ion binding);GO:0046975(histone methyltransferase activity (H3-K36 specific));GO:0048332(mesoderm morphogenesis);GO:0048568(embryonic organ development);GO:0048701(embryonic cranial skeleton morphogenesis);GO:0048863(stem cell differentiation);GO:0048864(stem cell development);GO:0051607(defense response to virus);GO:0060039(pericardium development);GO:0060669(embryonic placenta morphogenesis);GO:0060977(coronary vasculature morphogenesis);GO:0097198(histone H3-K36 trimethylation);GO:0097676(histone H3-K36 dimethylation);GO:1902850(microtubule cytoskeleton organization involved in mitosis);GO:1905634(regulation of protein localization to chromatin)","00310(Lysine degradation)",{"v":1e-34,"d":"0.00"},1,"570,",0,-2.82,{"v":1.14815362149688E-4,"d":"0.00"},1.38,"Exon (ENST00000431180/ENSG00000181555, exon 1 of 19)",3,47016429,47123787,107359,2]
["chr3",53813054,53814042,989,"ENSG00000016391","ENST00000315251","protein_coding",32377,"CHDH","choline dehydrogenase [Source:HGNC Symbol;Acc:HGNC:24288]","GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0008812(choline dehydrogenase activity);GO:0016020(membrane);GO:0016491(oxidoreductase activity);GO:0016614(oxidoreductase activity, acting on CH-OH group of donors);GO:0019285(glycine betaine biosynthetic process from choline);GO:0042426(choline catabolic process);GO:0050660(flavin adenine dinucleotide binding);GO:0055114(oxidation-reduction process)","00260(Glycine, serine and threonine metabolism)",{"v":2E-55,"d":"0.00"},1,"989,",0,-3.65,{"v":1.25892541179417E-5,"d":"0.00"},1.37,"3' UTR",3,53812335,53846419,34085,2]
["chr5",10649423,10650382,960,"ENSG00000164236","ENST00000296657","protein_coding",85353,"ANKRD33B","ankyrin repeat domain 33B [Source:HGNC Symbol;Acc:HGNC:35240]","GO:0005515(protein binding)","NA",{"v":6.3e-35,"d":"0.00"},1,"960,",0,-2.19,{"v":0.000616595001861482,"d":"0.00"},2.26,"3' UTR",5,10564070,10657816,93747,1]
["chr19",58280225,58285721,5497,"ENSG00000267216","ENST00000591325","nonsense_mediated_decay",1259,"AC020915","novel transcript","NA","NA",{"v":2.5e-08,"d":"0.00"},2,"385,5,","0,5492",-1.12,{"v":0.0141253754462275,"d":"0.01"},2.27,"3' UTR",19,58278966,58315197,36232,1]
["chr12",49389604,49390162,559,"ENSG00000123352","ENST00000550997","protein_coding",23020,"SPATS2","spermatogenesis associated serine rich 2 [Source:HGNC Symbol;Acc:HGNC:18650]","GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol)","NA",{"v":5e-17,"d":"0.00"},1,"559,",0,-2.44,{"v":0.000316227766016838,"d":"0.00"},2.28,"Exon (ENST00000551907/ENSG00000257954, exon 1 of 1)",12,49366584,49494771,128188,1]
["chr3",136149604,136149694,91,"ENSG00000174579","ENST00000309993","protein_coding",46641,"MSL2","MSL complex subunit 2 [Source:HGNC Symbol;Acc:HGNC:25544]","GO:0005654(nucleoplasm);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0043984(histone H4-K16 acetylation);GO:0046872(metal ion binding);GO:0061630(ubiquitin protein ligase activity);GO:0072487(MSL complex)","NA",{"v":0.00089,"d":"0.00"},1,"91,",0,{"v":-0.824,"d":"-0.82"},{"v":0.0363078054770101,"d":"0.04"},1.63,"3' UTR",3,136148917,136196335,47419,2]
["chr3",161086518,161086638,121,"ENSG00000169255","ENST00000320474","protein_coding",18711,"B3GALNT1","beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) [Source:HGNC Symbol;Acc:HGNC:918]","GO:0000139(Golgi membrane);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0006487(protein N-linked glycosylation);GO:0006687(glycosphingolipid metabolic process);GO:0008376(acetylgalactosaminyltransferase activity);GO:0008378(galactosyltransferase activity);GO:0008499(UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity);GO:0009312(oligosaccharide biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0047273(galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity)","00601(Glycosphingolipid biosynthesis - lacto and neolacto series);00603(Glycosphingolipid biosynthesis - globo and isoglobo series)",{"v":4.4e-05,"d":"0.00"},1,"121,",0,{"v":-0.894,"d":"-0.89"},{"v":0.0288403150312661,"d":"0.03"},1.11,"Exon (ENST00000320474/ENSG00000169255, exon 5 of 5)",3,161083883,161105349,21467,2]
["chr3",169115775,169116345,571,"ENSG00000085276","ENST00000264674","protein_coding",29960,"MECOM","MDS1 and EVI1 complex locus [Source:HGNC Symbol;Acc:HGNC:3498]","GO:0000118(histone deacetylase complex);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006915(apoptotic process);GO:0007275(multicellular organism development);GO:0016607(nuclear speck);GO:0018024(histone-lysine N-methyltransferase activity);GO:0030154(cell differentiation);GO:0034968(histone lysine methylation);GO:0043069(negative regulation of programmed cell death);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046329(negative regulation of JNK cascade);GO:0046872(metal ion binding);GO:0046974(histone methyltransferase activity (H3-K9 specific));GO:0051567(histone H3-K9 methylation);GO:0051726(regulation of cell cycle);GO:0070828(heterochromatin organization);GO:0071425(hematopoietic stem cell proliferation)","04010(MAPK signaling pathway);05200(Pathways in cancer);05220(Chronic myeloid leukemia)",{"v":1.3E-7,"d":"0.00"},1,"571,",0,{"v":-0.991,"d":"-0.99"},{"v":0.0208929613085404,"d":"0.02"},1.77,"Exon (ENST00000264674/ENSG00000085276, exon 8 of 17)",3,169083499,169146305,62807,2]
["chr3",182965650,182980151,14502,"ENSG00000043093","ENST00000497606","protein_coding",0,"DCUN1D1","defective in cullin neddylation 1 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:18184]","GO:0000151(ubiquitin ligase complex);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0031624(ubiquitin conjugating enzyme binding);GO:0032182(ubiquitin-like protein binding);GO:0043687(post-translational protein modification);GO:0045116(protein neddylation);GO:0051443(positive regulation of ubiquitin-protein transferase activity);GO:0097602(cullin family protein binding);GO:2000436(positive regulation of protein neddylation)","NA",{"v":6E-10,"d":"0.00"},2,"104,76,","0,14426",-1.03,{"v":0.0181970085860998,"d":"0.02"},1.04,"5' UTR",3,182961315,182980151,18837,2]
["chr3",196948208,196951778,3571,"ENSG00000119227","ENST00000412723","protein_coding",17055,"PIGZ","phosphatidylinositol glycan anchor biosynthesis class Z [Source:HGNC Symbol;Acc:HGNC:30596]","GO:0000026(alpha-1,2-mannosyltransferase activity);GO:0000030(mannosyltransferase activity);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006506(GPI anchor biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016254(preassembly of GPI anchor in ER membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0097502(mannosylation)","00563(Glycosylphosphatidylinositol (GPI)-anchor biosynthesis)",{"v":5e-39,"d":"0.00"},2,"478,241,","0,3330",-1.36,{"v":0.00676082975391982,"d":"0.01"},{"v":1.1,"d":"1.10"},"3' UTR",3,196946356,196968833,22478,2]
["chr4",521933,523565,1633,"ENSG00000174227","ENST00000511247","processed_transcript",0,"PIGG","phosphatidylinositol glycan anchor biosynthesis class G [Source:HGNC Symbol;Acc:HGNC:25985]","GO:0003824(catalytic activity);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006506(GPI anchor biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016254(preassembly of GPI anchor in ER membrane);GO:0016740(transferase activity);GO:0016780(phosphotransferase activity, for other substituted phosphate groups);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0051267(CP2 mannose-ethanolamine phosphotransferase activity);GO:0051377(mannose-ethanolamine phosphotransferase activity)","00563(Glycosylphosphatidylinositol (GPI)-anchor biosynthesis)",{"v":6.3e-86,"d":"0.00"},2,"911,107,","0,1526",-6.89,{"v":3.23593656929628e-09,"d":"0.00"},{"v":1.2,"d":"1.20"},"3' UTR",4,523520,524911,1392,1]
["chr4",1395599,1395989,391,"ENSG00000163945","ENST00000389851","protein_coding",48283,"UVSSA","UV stimulated scaffold protein A [Source:HGNC Symbol;Acc:HGNC:29304]","GO:0000993(RNA polymerase II complex binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006281(DNA repair);GO:0006283(transcription-coupled nucleotide-excision repair);GO:0006469(negative regulation of protein kinase activity);GO:0006974(cellular response to DNA damage stimulus);GO:0009411(response to UV);GO:0016020(membrane);GO:0016567(protein ubiquitination);GO:0033147(negative regulation of intracellular estrogen receptor signaling pathway);GO:0043627(response to estrogen);GO:0051493(regulation of cytoskeleton organization)","NA",{"v":3.1E-9,"d":"0.00"},1,"391,",0,-1.68,{"v":2.63026799189538E-3,"d":"0.00"},1.56,"3' UTR",4,1347316,1395989,48674,1]
["chr4",3492801,3493668,868,"ENSG00000175920","ENST00000340083","protein_coding",29495,"DOK7","docking protein 7 [Source:HGNC Symbol;Acc:HGNC:26594]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005886(plasma membrane);GO:0008289(lipid binding);GO:0016020(membrane);GO:0019901(protein kinase binding);GO:0030054(cell junction);GO:0045202(synapse);GO:0061098(positive regulation of protein tyrosine kinase activity)","NA",{"v":1.6e-24,"d":"0.00"},1,"868,",0,-1.62,{"v":0.00309029543251359,"d":"0.00"},1.24,"5' UTR",4,3463306,3494482,31177,1]
["chr4",4320655,4321161,507,"ENSG00000168826","ENST00000515012","nonsense_mediated_decay",30404,"ZBTB49","zinc finger and BTB domain containing 49 [Source:HGNC Symbol;Acc:HGNC:19883]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001223(transcription coactivator binding);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007049(cell cycle);GO:0007050(cell cycle arrest);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell population proliferation);GO:0015630(microtubule cytoskeleton);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","NA",{"v":3.2e-31,"d":"0.00"},1,"507,",0,{"v":-0.983,"d":"-0.98"},{"v":0.0213796208950223,"d":"0.02"},1.02,"3' UTR",4,4290251,4321398,31148,1]
["chr4",40243469,40244157,689,"ENSG00000168421","ENST00000505618","protein_coding",52416,"RHOH","ras homolog family member H [Source:HGNC Symbol;Acc:HGNC:686]","GO:0000166(nucleotide binding);GO:0001772(immunological synapse);GO:0003924(GTPase activity);GO:0005095(GTPase inhibitor activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005622(intracellular);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005938(cell cortex);GO:0006355(regulation of transcription, DNA-templated);GO:0007015(actin filament organization);GO:0007163(establishment or maintenance of cell polarity);GO:0007264(small GTPase mediated signal transduction);GO:0007266(Rho protein signal transduction);GO:0008360(regulation of cell shape);GO:0016020(membrane);GO:0017048(Rho GTPase binding);GO:0019210(kinase inhibitor activity);GO:0019901(protein kinase binding);GO:0030036(actin cytoskeleton organization);GO:0030217(T cell differentiation);GO:0032956(regulation of actin cytoskeleton organization);GO:0033673(negative regulation of kinase activity);GO:0034260(negative regulation of GTPase activity);GO:0042995(cell projection);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0045576(mast cell activation);GO:0051056(regulation of small GTPase mediated signal transduction)","04670(Leukocyte transendothelial migration)",{"v":1.5E-10,"d":"0.00"},1,"689,",0,{"v":-0.742,"d":"-0.74"},{"v":0.0478630092322638,"d":"0.05"},1.54,"3' UTR",4,40191053,40243995,52943,1]
["chr2",23707024,23707413,390,"ENSG00000119771","ENST00000486442","protein_coding",321845,"KLHL29","kelch like family member 29 [Source:HGNC Symbol;Acc:HGNC:29404]","GO:0005515(protein binding)","NA",{"v":4.9e-06,"d":"0.00"},1,"390,",0,{"v":-1.1,"d":"-1.10"},{"v":0.0151356124843621,"d":"0.02"},2.29,"3' UTR",2,23385179,23708606,323428,1]
["chr4",78910625,78912301,1677,"ENSG00000138756","ENST00000335016","protein_coding",134247,"BMP2K","BMP2 inducible kinase [Source:HGNC Symbol;Acc:HGNC:18041]","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016607(nuclear speck);GO:0016740(transferase activity);GO:0019208(phosphatase regulator activity);GO:0030500(regulation of bone mineralization);GO:0050790(regulation of catalytic activity)","05202(Transcriptional misregulation in cancer)",{"v":1e-133,"d":"0.00"},1,"1677,",0,-5.37,{"v":1.47910838816821E-7,"d":"0.00"},{"v":1.1,"d":"1.10"},"3' UTR",4,78776378,78912185,135808,1]
["chr4",125449686,125450106,421,"ENSG00000196159","ENST00000394329","protein_coding",133287,"FAT4","FAT atypical cadherin 4 [Source:HGNC Symbol;Acc:HGNC:23109]","GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001822(kidney development);GO:0003007(heart morphogenesis);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0007009(plasma membrane organization);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007157(heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0007219(Notch signaling pathway);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0021987(cerebral cortex development);GO:0022008(neurogenesis);GO:0035329(hippo signaling);GO:0043931(ossification involved in bone maturation);GO:0045177(apical part of cell);GO:0048565(digestive tract development);GO:0060122(inner ear receptor cell stereocilium organization);GO:0070062(extracellular exosome);GO:0072006(nephron development);GO:0072137(condensed mesenchymal cell proliferation);GO:0072307(regulation of metanephric nephron tubule epithelial cell differentiation)","04392(Hippo signaling pathway - multiple species)",{"v":7.2E-10,"d":"0.00"},1,"421,",0,-1.03,{"v":0.0186208713666287,"d":"0.02"},{"v":2.3,"d":"2.30"},"Exon (ENST00000394329/ENSG00000196159, exon 9 of 17)",4,125316399,125492932,176534,1]
["chr4",89112755,89114899,2145,"ENSG00000180346","ENST00000317005","protein_coding",0,"TIGD2","tigger transposable element derived 2 [Source:HGNC Symbol;Acc:HGNC:18333]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus)","NA",{"v":1E-183,"d":"0.00"},1,"2145,",0,-9.29,{"v":7.94328234724282e-12,"d":"0.00"},1.01,"5' UTR",4,89112817,89114899,2083,1]
["chr4",98443382,98443831,450,"ENSG00000138698","ENST00000408927","protein_coding",181929,"RAP1GDS1","Rap1 GTPase-GDP dissociation stimulator 1 [Source:HGNC Symbol;Acc:HGNC:9859]","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0014829(vascular smooth muscle contraction);GO:0031034(myosin filament assembly);GO:0032471(negative regulation of endoplasmic reticulum calcium ion concentration);GO:0043547(positive regulation of GTPase activity);GO:0051561(positive regulation of mitochondrial calcium ion concentration);GO:0070062(extracellular exosome)","NA",{"v":1.6e-21,"d":"0.00"},1,"450,",0,-2.12,{"v":0.000741310241300918,"d":"0.00"},1.07,"3' UTR",4,98261453,98443861,182409,1]
["chr4",118631847,118632474,628,"ENSG00000260404","ENST00000567913","processed_transcript",40074,"AC110079","general transcription factor IIi (GTF2I) pseudogene","NA","NA",{"v":2e-38,"d":"0.00"},1,"628,",0,-2.41,{"v":3.38844156139203E-4,"d":"0.00"},1.09,"Exon (ENST00000567913/ENSG00000260404, exon 10 of 10)",4,118591773,118633729,41957,1]
["chr4",122894280,122894489,210,"ENSG00000138685","ENST00000264498","protein_coding",67572,"FGF2","fibroblast growth factor 2 [Source:HGNC Symbol;Acc:HGNC:3676]","GO:0000165(MAPK cascade);GO:0000187(activation of MAPK activity);GO:0001525(angiogenesis);GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001938(positive regulation of endothelial cell proliferation);GO:0002042(cell migration involved in sprouting angiogenesis);GO:0005104(fibroblast growth factor receptor binding);GO:0005125(cytokine activity);GO:0005178(integrin binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0006661(phosphatidylinositol biosynthetic process);GO:0006935(chemotaxis);GO:0007165(signal transduction);GO:0007265(Ras protein signal transduction);GO:0007275(multicellular organism development);GO:0007399(nervous system development);GO:0008083(growth factor activity);GO:0008201(heparin binding);GO:0008284(positive regulation of cell population proliferation);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0009887(animal organ morphogenesis);GO:0010469(regulation of signaling receptor activity);GO:0010764(negative regulation of fibroblast migration);GO:0010863(positive regulation of phospholipase C activity);GO:0014843(growth factor dependent regulation of skeletal muscle satellite cell proliferation);GO:0019221(cytokine-mediated signaling pathway);GO:0030154(cell differentiation);GO:0030198(extracellular matrix organization);GO:0030214(hyaluronan catabolic process);GO:0030374(nuclear receptor transcription coactivator activity);GO:0032958(inositol phosphate biosynthetic process);GO:0035019(somatic stem cell population maintenance);GO:0038001(paracrine signaling);GO:0042056(chemoattractant activity);GO:0042060(wound healing);GO:0042660(positive regulation of cell fate specification);GO:0043406(positive regulation of MAP kinase activity);GO:0043536(positive regulation of blood vessel endothelial cell migration);GO:0043537(negative regulation of blood vessel endothelial cell migration);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity);GO:0045765(regulation of angiogenesis);GO:0045766(positive regulation of angiogenesis);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048598(embryonic morphogenesis);GO:0050918(positive chemotaxis);GO:0051209(release of sequestered calcium ion into cytosol);GO:0051781(positive regulation of cell division);GO:0051897(positive regulation of protein kinase B signaling);GO:0060045(positive regulation of cardiac muscle cell proliferation);GO:0060548(negative regulation of cell death);GO:0060591(chondroblast differentiation);GO:0061045(negative regulation of wound healing);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0072089(stem cell proliferation);GO:0090050(positive regulation of cell migration involved in sprouting angiogenesis);GO:0090722(receptor-receptor interaction);GO:1903672(positive regulation of sprouting angiogenesis);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1905564(positive regulation of vascular endothelial cell proliferation);GO:2000544(regulation of endothelial cell chemotaxis to fibroblast growth factor);GO:2000546(positive regulation of endothelial cell chemotaxis to fibroblast growth factor);GO:2000573(positive regulation of DNA biosynthetic process);GO:2001028(positive regulation of endothelial cell chemotaxis)","01521(EGFR tyrosine kinase inhibitor resistance);04010(MAPK signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04151(PI3K-Akt signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04810(Regulation of actin cytoskeleton);05167(Kaposi sarcoma-associated herpesvirus infection);05200(Pathways in cancer);05205(Proteoglycans in cancer);05218(Melanoma);05224(Breast cancer);05226(Gastric cancer)",{"v":5.5e-09,"d":"0.00"},1,"210,",0,-1.33,{"v":0.00741310241300918,"d":"0.01"},1.47,"3' UTR",4,122826708,122898236,71529,1]
["chr22",20981361,20981755,395,"ENSG00000272829","ENST00000610278","lincRNA",0,"AC002470","novel transcript","NA","NA",{"v":1.3E-14,"d":"0.00"},1,"395,",0,-1.48,{"v":0.00467735141287198,"d":"0.00"},{"v":2.3,"d":"2.30"},"Exon (ENST00000610278/ENSG00000272829, exon 1 of 1)",22,20981361,20981755,395,2]
["chr4",139301505,139302046,542,"ENSG00000164134","ENST00000296543","protein_coding",0,"NAA15","N(alpha)-acetyltransferase 15, NatA auxiliary subunit [Source:HGNC Symbol;Acc:HGNC:30782]","GO:0001525(angiogenesis);GO:0003723(RNA binding);GO:0004596(peptide alpha-N-acetyltransferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006474(N-terminal protein amino acid acetylation);GO:0007275(multicellular organism development);GO:0016020(membrane);GO:0016407(acetyltransferase activity);GO:0017196(N-terminal peptidyl-methionine acetylation);GO:0030154(cell differentiation);GO:0031415(NatA complex);GO:0043022(ribosome binding);GO:0043066(negative regulation of apoptotic process);GO:0045893(positive regulation of transcription, DNA-templated);GO:0050821(protein stabilization)","NA",{"v":2E-45,"d":"0.00"},2,"327,63,","0,479",-2.91,{"v":8.91250938133746e-05,"d":"0.00"},{"v":1.2,"d":"1.20"},"5' UTR",4,139301505,139391384,89880,1]
["chr4",143215549,143220566,5018,"ENSG00000170185","ENST00000510377","protein_coding",30632,"USP38","ubiquitin specific peptidase 38 [Source:HGNC Symbol;Acc:HGNC:20067]","GO:0004197(cysteine-type endopeptidase activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0006508(proteolysis);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0016579(protein deubiquitination);GO:0016787(hydrolase activity);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity)","NA",{"v":5e-37,"d":"0.00"},2,"29,272,","0,4746",-0.98,{"v":0.0218776162394955,"d":"0.02"},{"v":1.1,"d":"1.10"},"3' UTR",4,143184917,143215577,30661,1]
["chr4",176331946,176332215,270,"ENSG00000129128","ENST00000503362","protein_coding",11980,"SPCS3","signal peptidase complex subunit 3 [Source:HGNC Symbol;Acc:HGNC:26212]","GO:0005783(endoplasmic reticulum);GO:0005787(signal peptidase complex);GO:0005789(endoplasmic reticulum membrane);GO:0006465(signal peptide processing);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0031090(organelle membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0045047(protein targeting to ER)","03060(Protein export)",{"v":2.5e-16,"d":"0.00"},1,"270,",0,-2.39,{"v":3.54813389233575E-4,"d":"0.00"},1.14,"3' UTR",4,176319966,176332245,12280,1]
["chr4",184021037,184021397,361,"ENSG00000173320","ENST00000308497","protein_coding",115730,"STOX2","storkhead box 2 [Source:HGNC Symbol;Acc:HGNC:25450]","GO:0001893(maternal placenta development);GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0006357(regulation of transcription by RNA polymerase II);GO:0009617(response to bacterium);GO:0009792(embryo development ending in birth or egg hatching)","NA",{"v":1.3e-29,"d":"0.00"},1,"361,",0,-1.67,{"v":2.69153480392692E-3,"d":"0.00"},1.44,"3' UTR",4,183905307,184023526,118220,1]
["chr4",574328,575165,838,"ENSG00000273238","ENST00000610212","protein_coding",1135,"TMEM271","transmembrane protein 271 [Source:NCBI gene;Acc:112441426]","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":4E-73,"d":"0.00"},1,"838,",0,-3.55,{"v":1.58489319246111e-05,"d":"0.00"},1.56,"3' UTR",4,573880,576300,2421,2]
["chr4",1235378,1235768,391,"ENSG00000159692","ENST00000382952","protein_coding",13344,"CTBP1","C-terminal binding protein 1 [Source:HGNC Symbol;Acc:HGNC:2494]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003700(DNA-binding transcription factor activity);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0006342(chromatin silencing);GO:0006468(protein phosphorylation);GO:0008022(protein C-terminus binding);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell population proliferation);GO:0016032(viral process);GO:0016491(oxidoreductase activity);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0017053(transcriptional repressor complex);GO:0019079(viral genome replication);GO:0019904(protein domain specific binding);GO:0030154(cell differentiation);GO:0031065(positive regulation of histone deacetylation);GO:0035067(negative regulation of histone acetylation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0050872(white fat cell differentiation);GO:0051287(NAD binding);GO:0051726(regulation of cell cycle);GO:0055114(oxidation-reduction process);GO:0070491(repressing transcription factor binding);GO:0090241(negative regulation of histone H4 acetylation);GO:0098831(presynaptic active zone cytoplasmic component);GO:0098978(glutamatergic synapse);GO:0098982(GABA-ergic synapse)","04310(Wnt signaling pathway);04330(Notch signaling pathway);05200(Pathways in cancer);05220(Chronic myeloid leukemia)",{"v":9.1e-08,"d":"0.00"},1,"391,",0,{"v":-0.824,"d":"-0.82"},{"v":0.0363078054770101,"d":"0.04"},1.28,"3' UTR",4,1211448,1249112,37665,2]
["chr4",10454271,10457166,2896,"ENSG00000178163","ENST00000326756","protein_coding",260,"ZNF518B","zinc finger protein 518B [Source:HGNC Symbol;Acc:HGNC:29365]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","NA",{"v":4e-49,"d":"0.00"},2,"718,33,","0,2863",-2.78,{"v":0.000125892541179417,"d":"0.00"},1.44,"5' UTR",4,10439880,10457426,17547,2]
["chr4",25003426,25004234,809,"ENSG00000153012","ENST00000382114","protein_coding",26712,"LGI2","leucine rich repeat LGI family member 2 [Source:HGNC Symbol;Acc:HGNC:18710]","GO:0005515(protein binding);GO:0005576(extracellular region)","NA",{"v":1e-12,"d":"0.00"},1,"809,",0,-2.94,{"v":8.31763771102671e-05,"d":"0.00"},1.98,"3' UTR",4,24998847,25030946,32100,2]
["chr4",68322531,68322770,240,"ENSG00000083896","ENST00000344157","protein_coding",27319,"YTHDC1","YTH domain containing 1 [Source:HGNC Symbol;Acc:HGNC:30626]","GO:0000398(mRNA splicing, via spliceosome);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0006376(mRNA splice site selection);GO:0006397(mRNA processing);GO:0006406(mRNA export from nucleus);GO:0008380(RNA splicing);GO:0009048(dosage compensation by inactivation of X chromosome);GO:0010608(posttranscriptional regulation of gene expression);GO:0016604(nuclear body);GO:0016607(nuclear speck);GO:0048024(regulation of mRNA splicing, via spliceosome);GO:1990247(N6-methyladenosine-containing RNA binding)","NA",{"v":5e-31,"d":"0.00"},1,"240,",0,-4.96,{"v":4.26579518801593e-07,"d":"0.00"},1.92,"Exon (ENST00000344157/ENSG00000083896, exon 11 of 17)",4,68310387,68350089,39703,2]
["chr4",78906137,78912310,6174,"ENSG00000138756","ENST00000335016","protein_coding",129759,"BMP2K","BMP2 inducible kinase [Source:HGNC Symbol;Acc:HGNC:18041]","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016607(nuclear speck);GO:0016740(transferase activity);GO:0019208(phosphatase regulator activity);GO:0030500(regulation of bone mineralization);GO:0050790(regulation of catalytic activity)","05202(Transcriptional misregulation in cancer)",{"v":1e-133,"d":"0.00"},2,"25,1473,","0,4701",-3.73,{"v":1e-05,"d":"0.00"},1.02,"3' UTR",4,78776378,78912185,135808,1]
["chr4",82924843,82928198,3356,"ENSG00000189308","ENST00000505905","processed_transcript",0,"LIN54","lin-54 DREAM MuvB core complex component [Source:HGNC Symbol;Acc:HGNC:25397]","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0007049(cell cycle);GO:0046872(metal ion binding);GO:0051726(regulation of cell cycle)","04218(Cellular senescence)",{"v":1.6E-49,"d":"0.00"},2,"8,143,","0,3213",-1.09,{"v":0.0154881661891248,"d":"0.02"},1.86,"3' UTR",4,82909973,82928198,18226,2]
["chr13",110868692,110869652,961,"ENSG00000255874","ENST00000538077","lincRNA",599,"LINC00346","long intergenic non-protein coding RNA 346 [Source:HGNC Symbol;Acc:HGNC:27492]","NA","NA",{"v":4e-16,"d":"0.00"},1,"961,",0,-1.18,{"v":0.0114815362149688,"d":"0.01"},2.31,"Exon (ENST00000538077/ENSG00000255874, exon 1 of 1)",13,110863987,110870251,6265,2]
["chr4",86887571,86887750,180,"ENSG00000163633","ENST00000295898","protein_coding",4672,"C4orf36","chromosome 4 open reading frame 36 [Source:HGNC Symbol;Acc:HGNC:28386]","NA","NA",{"v":0.00089,"d":"0.00"},1,"180,",0,-1.12,{"v":0.0141253754462275,"d":"0.01"},2.32,"3' UTR",4,86876205,86892422,16218,2]
["chr4",103106046,103114522,8477,"ENSG00000138778","ENST00000265148","protein_coding",83887,"CENPE","centromere protein E [Source:HGNC Symbol;Acc:HGNC:1856]","GO:0000166(nucleotide binding);GO:0000278(mitotic cell cycle);GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000777(condensed chromosome kinetochore);GO:0000779(condensed chromosome, centromeric region);GO:0003774(motor activity);GO:0003777(microtubule motor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005737(cytoplasm);GO:0005819(spindle);GO:0005828(kinetochore microtubule);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005871(kinesin complex);GO:0005874(microtubule);GO:0006890(retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum);GO:0007018(microtubule-based movement);GO:0007049(cell cycle);GO:0007052(mitotic spindle organization);GO:0007059(chromosome segregation);GO:0007079(mitotic chromosome movement towards spindle pole);GO:0007080(mitotic metaphase plate congression);GO:0007275(multicellular organism development);GO:0008017(microtubule binding);GO:0015630(microtubule cytoskeleton);GO:0016020(membrane);GO:0016887(ATPase activity);GO:0019886(antigen processing and presentation of exogenous peptide antigen via MHC class II);GO:0030071(regulation of mitotic metaphase/anaphase transition);GO:0030496(midbody);GO:0043515(kinetochore binding);GO:0045860(positive regulation of protein kinase activity);GO:0051233(spindle midzone);GO:0051301(cell division);GO:0051310(metaphase plate congression);GO:0051315(attachment of mitotic spindle microtubules to kinetochore);GO:0051382(kinetochore assembly);GO:0099606(microtubule plus-end directed mitotic chromosome migration);GO:0099607(lateral attachment of mitotic spindle microtubules to kinetochore);GO:1990023(mitotic spindle midzone)","NA",{"v":1E-13,"d":"0.00"},4,"271,287,184,68,","0,2757,4782,8409",-1.54,{"v":0.0038904514499428,"d":"0.00"},1.62,"3' UTR",4,103105806,103198409,92604,2]
["chr4",103145898,103158822,12925,"ENSG00000138778","ENST00000265148","protein_coding",39587,"CENPE","centromere protein E [Source:HGNC Symbol;Acc:HGNC:1856]","GO:0000166(nucleotide binding);GO:0000278(mitotic cell cycle);GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000777(condensed chromosome kinetochore);GO:0000779(condensed chromosome, centromeric region);GO:0003774(motor activity);GO:0003777(microtubule motor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005737(cytoplasm);GO:0005819(spindle);GO:0005828(kinetochore microtubule);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005871(kinesin complex);GO:0005874(microtubule);GO:0006890(retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum);GO:0007018(microtubule-based movement);GO:0007049(cell cycle);GO:0007052(mitotic spindle organization);GO:0007059(chromosome segregation);GO:0007079(mitotic chromosome movement towards spindle pole);GO:0007080(mitotic metaphase plate congression);GO:0007275(multicellular organism development);GO:0008017(microtubule binding);GO:0015630(microtubule cytoskeleton);GO:0016020(membrane);GO:0016887(ATPase activity);GO:0019886(antigen processing and presentation of exogenous peptide antigen via MHC class II);GO:0030071(regulation of mitotic metaphase/anaphase transition);GO:0030496(midbody);GO:0043515(kinetochore binding);GO:0045860(positive regulation of protein kinase activity);GO:0051233(spindle midzone);GO:0051301(cell division);GO:0051310(metaphase plate congression);GO:0051315(attachment of mitotic spindle microtubules to kinetochore);GO:0051382(kinetochore assembly);GO:0099606(microtubule plus-end directed mitotic chromosome migration);GO:0099607(lateral attachment of mitotic spindle microtubules to kinetochore);GO:1990023(mitotic spindle midzone)","NA",{"v":7.9e-21,"d":"0.00"},8,"210,291,156,291,159,204,159,209,","0,1458,2946,3220,5321,7149,12402,12716",-2,{"v":0.0010471285480509,"d":"0.00"},1.24,"Exon (ENST00000265148/ENSG00000138778, exon 23 of 49)",4,103105806,103198409,92604,2]
["chr4",107910391,107978739,68349,"ENSG00000155016","ENST00000332884","protein_coding",0,"CYP2U1","cytochrome P450 family 2 subfamily U member 1 [Source:HGNC Symbol;Acc:HGNC:20582]","GO:0004497(monooxygenase activity);GO:0005506(iron ion binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006082(organic acid metabolic process);GO:0006805(xenobiotic metabolic process);GO:0008395(steroid hydroxylase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0016712(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen);GO:0020037(heme binding);GO:0031090(organelle membrane);GO:0042738(exogenous drug catabolic process);GO:0043231(intracellular membrane-bounded organelle);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process);GO:0070330(aromatase activity);GO:0097267(omega-hydroxylase P450 pathway)","00590(Arachidonic acid metabolism)",{"v":2e-32,"d":"0.00"},3,"159,149,20,","0,21580,68329",-1.41,{"v":0.00562341325190349,"d":"0.01"},1.18,"5' UTR",4,107931549,107953461,21913,1]
["chr15",52017316,52017555,240,"ENSG00000069956","ENST00000560802","processed_transcript",65210,"MAPK6","mitogen-activated protein kinase 6 [Source:HGNC Symbol;Acc:HGNC:6879]","GO:0000165(MAPK cascade);GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004707(MAP kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0010468(regulation of gene expression);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0019901(protein kinase binding);GO:0032156(septin cytoskeleton);GO:0032991(protein-containing complex);GO:0035556(intracellular signal transduction);GO:0046982(protein heterodimerization activity);GO:0060999(positive regulation of dendritic spine development);GO:0071310(cellular response to organic substance)","04657(IL-17 signaling pathway)",{"v":3.3E-3,"d":"0.00"},1,"240,",0,{"v":-0.823,"d":"-0.82"},{"v":0.0363078054770101,"d":"0.04"},2.32,"Exon (ENST00000612566/ENSG00000274528, exon 1 of 1)",15,51952106,52046065,93960,1]
["chr19",55096918,55098817,1900,"ENSG00000125503","ENST00000586197","retained_intron",0,"PPP1R12C","protein phosphatase 1 regulatory subunit 12C [Source:HGNC Symbol;Acc:HGNC:14947]","GO:0004857(enzyme inhibitor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0007165(signal transduction);GO:0019208(phosphatase regulator activity);GO:0019901(protein kinase binding);GO:0043086(negative regulation of catalytic activity);GO:0050790(regulation of catalytic activity)","04270(Vascular smooth muscle contraction);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04921(Oxytocin signaling pathway);05205(Proteoglycans in cancer)",{"v":1e-31,"d":"0.00"},2,"147,34,","0,1866",-2.88,{"v":9.77237220955811e-05,"d":"0.00"},2.33,"Exon (ENST00000263433/ENSG00000125503, exon 6 of 22)",19,55096077,55097064,988,2]
["chr20",32690267,32690728,462,"ENSG00000175730","ENST00000317045","processed_pseudogene",87,"BAK1P1","BCL2 antagonist/killer 1 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:996]","NA","NA",{"v":3.2e-12,"d":"0.00"},1,"462,",0,{"v":-0.964,"d":"-0.96"},{"v":0.0229086765276777,"d":"0.02"},2.33,"Exon (ENST00000317045/ENSG00000175730, exon 1 of 1)",20,32690180,32690815,636,2]
["chr1",975680,975918,239,"ENSG00000187583","ENST00000491024","protein_coding",2168,"PLEKHN1","pleckstrin homology domain containing N1 [Source:HGNC Symbol;Acc:HGNC:25284]","GO:0001666(response to hypoxia);GO:0001786(phosphatidylserine binding);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0031966(mitochondrial membrane);GO:0043065(positive regulation of apoptotic process);GO:0061158(3'-UTR-mediated mRNA destabilization);GO:0070300(phosphatidic acid binding);GO:1901612(cardiolipin binding);GO:1901981(phosphatidylinositol phosphate binding)","NA",{"v":4.6e-09,"d":"0.00"},1,"239,",0,{"v":-0.822,"d":"-0.82"},{"v":0.0363078054770101,"d":"0.04"},2.34,"3' UTR",1,973512,975865,2354,1]
["chr4",186595805,186597057,1253,"ENSG00000083857","ENST00000512772","protein_coding",0,"FAT1","FAT atypical cadherin 1 [Source:HGNC Symbol;Acc:HGNC:3595]","GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005911(cell-cell junction);GO:0005925(focal adhesion);GO:0007015(actin filament organization);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007163(establishment or maintenance of cell polarity);GO:0007267(cell-cell signaling);GO:0009653(anatomical structure morphogenesis);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016477(cell migration);GO:0030027(lamellipodium);GO:0030054(cell junction);GO:0030175(filopodium);GO:0048471(perinuclear region of cytoplasm);GO:0070062(extracellular exosome);GO:0098609(cell-cell adhesion)","NA",{"v":6.3e-55,"d":"0.00"},2,"22,518,","0,735",-1.73,{"v":0.00223872113856834,"d":"0.00"},1.14,"Exon (ENST00000441802/ENSG00000083857, exon 25 of 27)",4,186588392,186596841,8450,2]
["chr3",184581313,184581928,616,"ENSG00000182580","ENST00000330394","protein_coding",19528,"EPHB3","EPH receptor B3 [Source:HGNC Symbol;Acc:HGNC:3394]","GO:0000166(nucleotide binding);GO:0001525(angiogenesis);GO:0001655(urogenital system development);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005005(transmembrane-ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005576(extracellular region);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007275(multicellular organism development);GO:0007399(nervous system development);GO:0007411(axon guidance);GO:0007413(axonal fasciculation);GO:0008046(axon guidance receptor activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016477(cell migration);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0021952(central nervous system projection neuron axonogenesis);GO:0022038(corpus callosum development);GO:0022407(regulation of cell-cell adhesion);GO:0030425(dendrite);GO:0031290(retinal ganglion cell axon guidance);GO:0034446(substrate adhesion-dependent cell spreading);GO:0042995(cell projection);GO:0043005(neuron projection);GO:0043087(regulation of GTPase activity);GO:0043235(receptor complex);GO:0046777(protein autophosphorylation);GO:0048013(ephrin receptor signaling pathway);GO:0048538(thymus development);GO:0048546(digestive tract morphogenesis);GO:0050770(regulation of axonogenesis);GO:0051965(positive regulation of synapse assembly);GO:0060021(roof of mouth development);GO:0060996(dendritic spine development);GO:0060997(dendritic spine morphogenesis)","04360(Axon guidance)",{"v":6.3e-18,"d":"0.00"},2,"96,415,","0,201",-1.25,{"v":0.00933254300796992,"d":"0.01"},2.34,"3' UTR",3,184561785,184582408,20624,1]
["chr5",43041664,43042270,607,"ENSG00000215068","ENST00000505541","antisense",0,"AC025171","novel transcript, antisense to ANXA2R","NA","NA",{"v":3E-10,"d":"0.00"},2,"211,178,","0,429",{"v":-0.808,"d":"-0.81"},{"v":0.0380189396320561,"d":"0.04"},1.47,"Exon (ENST00000451894/ENSG00000215068, exon 1 of 3)",5,43041757,43044886,3130,1]
["chr6",80065809,80066018,210,"ENSG00000218418","ENST00000401578","processed_pseudogene",4181,"AL591135","Rho GTPase activating protein 21 (ARHGAP21) pseudogene","NA","NA",{"v":6.9e-05,"d":"0.00"},1,"210,",0,-2.41,{"v":3.38844156139203E-4,"d":"0.00"},2.35,"Exon (ENST00000401578/ENSG00000218418, exon 1 of 1)",6,80064286,80070199,5914,2]
["chr5",55944656,55944733,78,"ENSG00000264281","ENST00000582508","processed_pseudogene",0,"AC016596","ribosomal protein L41 (RPL41) pseudogene","NA","NA",{"v":2.9e-08,"d":"0.00"},1,"78,",0,-1.87,{"v":0.00147910838816821,"d":"0.00"},1.91,"Exon (ENST00000582508/ENSG00000264281, exon 1 of 1)",5,55944656,55944733,78,1]
["chr5",61375588,61375855,268,"ENSG00000130449","ENST00000252744","protein_coding",43330,"ZSWIM6","zinc finger SWIM-type containing 6 [Source:HGNC Symbol;Acc:HGNC:29316]","GO:0008270(zinc ion binding);GO:0031462(Cul2-RING ubiquitin ligase complex);GO:0046872(metal ion binding);GO:1902667(regulation of axon guidance)","NA",{"v":4e-11,"d":"0.00"},1,"268,",0,-0.84,{"v":0.0346736850452532,"d":"0.03"},1.04,"Exon (ENST00000439448/ENSG00000250461, exon 1 of 1)",5,61332258,61546172,213915,1]
["chr5",72199808,72200078,271,"ENSG00000131711","ENST00000296755","protein_coding",92333,"MAP1B","microtubule associated protein 1B [Source:HGNC Symbol;Acc:HGNC:6836]","GO:0000226(microtubule cytoskeleton organization);GO:0001578(microtubule bundle formation);GO:0001750(photoreceptor outer segment);GO:0001764(neuron migration);GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005515(protein binding);GO:0005543(phospholipid binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005875(microtubule associated complex);GO:0005886(plasma membrane);GO:0007026(negative regulation of microtubule depolymerization);GO:0007399(nervous system development);GO:0007409(axonogenesis);GO:0007416(synapse assembly);GO:0008017(microtubule binding);GO:0009611(response to wounding);GO:0009612(response to mechanical stimulus);GO:0009743(response to carbohydrate);GO:0009987(cellular process);GO:0010035(response to inorganic substance);GO:0014012(peripheral nervous system axon regeneration);GO:0014069(postsynaptic density);GO:0015631(tubulin binding);GO:0016358(dendrite development);GO:0017085(response to insecticide);GO:0021700(developmental maturation);GO:0030054(cell junction);GO:0030424(axon);GO:0030425(dendrite);GO:0030426(growth cone);GO:0031114(regulation of microtubule depolymerization);GO:0031116(positive regulation of microtubule polymerization);GO:0031667(response to nutrient levels);GO:0032355(response to estradiol);GO:0032387(negative regulation of intracellular transport);GO:0033189(response to vitamin A);GO:0036477(somatodendritic compartment);GO:0042493(response to drug);GO:0042995(cell projection);GO:0043025(neuronal cell body);GO:0043196(varicosity);GO:0043197(dendritic spine);GO:0043204(perikaryon);GO:0044877(protein-containing complex binding);GO:0045202(synapse);GO:0045666(positive regulation of neuron differentiation);GO:0045773(positive regulation of axon extension);GO:0047497(mitochondrion transport along microtubule);GO:0048471(perinuclear region of cytoplasm);GO:0048666(neuron development);GO:0048675(axon extension);GO:0048678(response to axon injury);GO:0051915(induction of synaptic plasticity by chemical substance);GO:0061162(establishment of monopolar cell polarity);GO:0071363(cellular response to growth factor stimulus);GO:0071375(cellular response to peptide hormone stimulus);GO:0097440(apical dendrite);GO:0097441(basal dendrite);GO:0097457(hippocampal mossy fiber)","NA",{"v":1.7e-09,"d":"0.00"},1,"271,",0,{"v":-0.828,"d":"-0.83"},{"v":0.0354813389233576,"d":"0.04"},1.45,"Exon (ENST00000296755/ENSG00000131711, exon 5 of 7)",5,72107475,72209565,102091,1]
["chr5",73446357,73446984,628,"ENSG00000247993","ENST00000514661","lincRNA",0,"FOXD1-AS1","FOXD1 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:50658]","NA","NA",{"v":2e-34,"d":"0.00"},2,"399,25,","0,603",-3.48,{"v":1.94984459975805E-5,"d":"0.00"},1.04,"3' UTR",5,73446357,73446984,628,1]
["chr14",73885811,73886498,688,"ENSG00000140043","ENST00000555661","protein_coding",33965,"PTGR2","prostaglandin reductase 2 [Source:HGNC Symbol;Acc:HGNC:20149]","GO:0005737(cytoplasm);GO:0006693(prostaglandin metabolic process);GO:0016491(oxidoreductase activity);GO:0036132(13-prostaglandin reductase activity);GO:0047522(15-oxoprostaglandin 13-oxidase activity);GO:0055114(oxidation-reduction process)","NA",{"v":5.1E-8,"d":"0.00"},1,"688,",0,-1.77,{"v":0.00199526231496888,"d":"0.00"},2.35,"3' UTR",14,73851846,73886827,34982,1]
["chr5",88286046,88287654,1609,"ENSG00000247828","ENST00000504922","antisense",17130,"TMEM161B-AS1","TMEM161B antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:43839]","NA","NA",{"v":5e-20,"d":"0.00"},2,"22,219,","0,1390",-0.75,{"v":0.0467735141287198,"d":"0.05"},1.35,"Exon (ENST00000504769/ENSG00000247828, exon 4 of 4)",5,88268916,88436685,167770,1]
["chr5",95555403,95556835,1433,"ENSG00000164291","ENST00000380009","protein_coding",329,"ARSK","arylsulfatase family member K [Source:HGNC Symbol;Acc:HGNC:25239]","GO:0003824(catalytic activity);GO:0004065(arylsulfatase activity);GO:0005576(extracellular region);GO:0005788(endoplasmic reticulum lumen);GO:0008484(sulfuric ester hydrolase activity);GO:0016787(hydrolase activity);GO:0046872(metal ion binding)","NA",{"v":7.9e-59,"d":"0.00"},2,"2,628,","0,805",-2.01,{"v":0.00102329299228075,"d":"0.00"},1.15,"3' UTR",5,95555074,95605064,49991,1]
["chr5",132815370,132815727,358,"ENSG00000198944","ENST00000378693","protein_coding",1783,"SOWAHA","sosondowah ankyrin repeat domain family member A [Source:HGNC Symbol;Acc:HGNC:27033]","GO:0005515(protein binding)","NA",{"v":4e-28,"d":"0.00"},1,"358,",0,-1.43,{"v":0.00549540873857625,"d":"0.01"},1.14,"3' UTR",5,132813587,132816797,3211,1]
["chr5",173888349,173889037,689,"ENSG00000113742","ENST00000265085","protein_coding",0,"CPEB4","cytoplasmic polyadenylation element binding protein 4 [Source:HGNC Symbol;Acc:HGNC:21747]","GO:0000900(translation repressor activity, mRNA regulatory element binding);GO:0002931(response to ischemia);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006412(translation);GO:0006417(regulation of translation);GO:0008135(translation factor activity, RNA binding);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0030054(cell junction);GO:0030424(axon);GO:0030425(dendrite);GO:0030426(growth cone);GO:0035235(ionotropic glutamate receptor signaling pathway);GO:0036294(cellular response to decreased oxygen levels);GO:0042149(cellular response to glucose starvation);GO:0042995(cell projection);GO:0043005(neuron projection);GO:0043022(ribosome binding);GO:0043197(dendritic spine);GO:0043524(negative regulation of neuron apoptotic process);GO:0045182(translation regulator activity);GO:0045202(synapse);GO:0045211(postsynaptic membrane);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0071230(cellular response to amino acid stimulus);GO:0098794(postsynapse);GO:1990124(messenger ribonucleoprotein complex);GO:2000766(negative regulation of cytoplasmic translation)","04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation)",{"v":2.5e-31,"d":"0.00"},1,"689,",0,-1.07,{"v":0.0162181009735893,"d":"0.02"},1.12,"5' UTR",5,173888349,173961980,73632,1]
["chr5",179550554,179555713,5160,"ENSG00000176783","ENST00000319449","protein_coding",0,"RUFY1","RUN and FYVE domain containing 1 [Source:HGNC Symbol;Acc:HGNC:19760]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005829(cytosol);GO:0006661(phosphatidylinositol biosynthetic process);GO:0006897(endocytosis);GO:0008289(lipid binding);GO:0008565(protein transporter activity);GO:0015031(protein transport);GO:0016020(membrane);GO:0016607(nuclear speck);GO:0017124(SH3 domain binding);GO:0030100(regulation of endocytosis);GO:0031901(early endosome membrane);GO:0042169(SH2 domain binding);GO:0043231(intracellular membrane-bounded organelle);GO:0046872(metal ion binding)","04144(Endocytosis)",{"v":1.7E-5,"d":"0.00"},2,"326,64,","0,5096",-1.17,{"v":0.0120226443461741,"d":"0.01"},1.15,"5' UTR",5,179550554,179610012,59459,1]
["chr5",180494379,180495545,1167,"ENSG00000113300","ENST00000393356","protein_coding",0,"CNOT6","CCR4-NOT transcription complex subunit 6 [Source:HGNC Symbol;Acc:HGNC:14099]","GO:0000289(nuclear-transcribed mRNA poly(A) tail shortening);GO:0003723(RNA binding);GO:0004518(nuclease activity);GO:0004527(exonuclease activity);GO:0004532(exoribonuclease activity);GO:0004535(poly(A)-specific ribonuclease activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006417(regulation of translation);GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest);GO:0008284(positive regulation of cell population proliferation);GO:0010606(positive regulation of cytoplasmic mRNA processing body assembly);GO:0016020(membrane);GO:0016787(hydrolase activity);GO:0030014(CCR4-NOT complex);GO:0031047(gene silencing by RNA);GO:0035195(gene silencing by miRNA);GO:0043928(exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay);GO:0046872(metal ion binding);GO:0070966(nuclear-transcribed mRNA catabolic process, no-go decay);GO:0090305(nucleic acid phosphodiester bond hydrolysis);GO:0090503(RNA phosphodiester bond hydrolysis, exonucleolytic);GO:2000327(positive regulation of nuclear receptor transcription coactivator activity)","03018(RNA degradation)",{"v":5e-46,"d":"0.00"},2,"385,125,","0,1042",-2.27,{"v":0.000501187233627273,"d":"0.00"},1.46,"5' UTR",5,180494379,180578405,84027,1]
["chr5",1293531,1294606,1076,"ENSG00000164362","ENST00000310581","protein_coding",441,"TERT","telomerase reverse transcriptase [Source:HGNC Symbol;Acc:HGNC:11730]","GO:0000049(tRNA binding);GO:0000333(telomerase catalytic core complex);GO:0000723(telomere maintenance);GO:0000781(chromosome, telomeric region);GO:0000783(nuclear telomere cap complex);GO:0000784(nuclear chromosome, telomeric region);GO:0001172(transcription, RNA-templated);GO:0001223(transcription coactivator binding);GO:0003677(DNA binding);GO:0003720(telomerase activity);GO:0003721(telomerase RNA reverse transcriptase activity);GO:0003723(RNA binding);GO:0003964(RNA-directed DNA polymerase activity);GO:0003968(RNA-directed 5'-3' RNA polymerase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005697(telomerase holoenzyme complex);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006278(RNA-dependent DNA biosynthetic process);GO:0007004(telomere maintenance via telomerase);GO:0007005(mitochondrion organization);GO:0008022(protein C-terminus binding);GO:0010629(negative regulation of gene expression);GO:0016605(PML body);GO:0016607(nuclear speck);GO:0016740(transferase activity);GO:0016779(nucleotidyltransferase activity);GO:0022616(DNA strand elongation);GO:0030177(positive regulation of Wnt signaling pathway);GO:0030422(production of siRNA involved in RNA interference);GO:0031379(RNA-directed RNA polymerase complex);GO:0031647(regulation of protein stability);GO:0032092(positive regulation of protein binding);GO:0042162(telomeric DNA binding);GO:0042635(positive regulation of hair cycle);GO:0042645(mitochondrial nucleoid);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043066(negative regulation of apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0045766(positive regulation of angiogenesis);GO:0046326(positive regulation of glucose import);GO:0046686(response to cadmium ion);GO:0046872(metal ion binding);GO:0047485(protein N-terminus binding);GO:0051000(positive regulation of nitric-oxide synthase activity);GO:0051087(chaperone binding);GO:0060253(negative regulation of glial cell proliferation);GO:0070034(telomerase RNA binding);GO:0070200(establishment of protein localization to telomere);GO:0071456(cellular response to hypoxia);GO:0071897(DNA biosynthetic process);GO:0090399(replicative senescence);GO:0098680(template-free RNA nucleotidyltransferase);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1902895(positive regulation of pri-miRNA transcription by RNA polymerase II);GO:1903620(positive regulation of transdifferentiation);GO:1903704(negative regulation of production of siRNA involved in RNA interference);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1904751(positive regulation of protein localization to nucleolus);GO:1904754(positive regulation of vascular associated smooth muscle cell migration);GO:1904837(beta-catenin-TCF complex assembly);GO:1990572(TERT-RMRP complex);GO:2000352(negative regulation of endothelial cell apoptotic process);GO:2000648(positive regulation of stem cell proliferation);GO:2000773(negative regulation of cellular senescence);GO:2001240(negative regulation of extrinsic apoptotic signaling pathway in absence of ligand)","05165(Human papillomavirus infection);05166(Human T-cell leukemia virus 1 infection);05200(Pathways in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer)",{"v":7.8e-09,"d":"0.00"},1,"1076,",0,{"v":-0.975,"d":"-0.98"},{"v":0.0218776162394955,"d":"0.02"},1.14,"Exon (ENST00000310581/ENSG00000164362, exon 2 of 16)",5,1253167,1295047,41881,2]
["chr5",14713579,14716797,3219,"ENSG00000154122","ENST00000284268","protein_coding",154981,"ANKH","ANKH inorganic pyrophosphate transport regulator [Source:HGNC Symbol;Acc:HGNC:15492]","GO:0001501(skeletal system development);GO:0005315(inorganic phosphate transmembrane transporter activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006817(phosphate ion transport);GO:0007626(locomotory behavior);GO:0015114(phosphate ion transmembrane transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019867(outer membrane);GO:0030500(regulation of bone mineralization);GO:0030504(inorganic diphosphate transmembrane transporter activity);GO:0030505(inorganic diphosphate transport);GO:0035435(phosphate ion transmembrane transport);GO:0055085(transmembrane transport)","NA",{"v":1.1e-06,"d":"0.00"},2,"89,92,","0,3127",-1.89,{"v":0.00141253754462275,"d":"0.00"},1.16,"Exon (ENST00000284268/ENSG00000154122, exon 9 of 12)",5,14704800,14871778,166979,2]
["chr2",61190817,61191086,270,"ENSG00000115464","ENST00000411912","protein_coding",50528,"USP34","ubiquitin specific peptidase 34 [Source:HGNC Symbol;Acc:HGNC:20066]","GO:0004197(cysteine-type endopeptidase activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0016055(Wnt signaling pathway);GO:0016579(protein deubiquitination);GO:0016787(hydrolase activity);GO:0031647(regulation of protein stability);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0071108(protein K48-linked deubiquitination);GO:0090263(positive regulation of canonical Wnt signaling pathway)","NA",{"v":2.6e-08,"d":"0.00"},1,"270,",0,{"v":-0.897,"d":"-0.90"},{"v":0.0288403150312661,"d":"0.03"},2.37,"Exon (ENST00000394457/ENSG00000173209, exon 6 of 6)",2,61187463,61241614,54152,2]
["chr2",30160444,30160533,90,"ENSG00000119801","ENST00000379519","protein_coding",13503,"YPEL5","yippee like 5 [Source:HGNC Symbol;Acc:HGNC:18329]","GO:0000151(ubiquitin ligase complex);GO:0000922(spindle pole);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005856(cytoskeleton);GO:0008283(cell population proliferation);GO:0030496(midbody);GO:0043312(neutrophil degranulation);GO:0046872(metal ion binding);GO:0097431(mitotic spindle pole);GO:1904724(tertiary granule lumen);GO:1904813(ficolin-1-rich granule lumen)","NA",{"v":0.00025,"d":"0.00"},1,"90,",0,-1.05,{"v":0.0173780082874938,"d":"0.02"},2.38,"3' UTR",2,30146941,30160533,13593,1]
["chr5",75511421,75511661,241,"ENSG00000113163","ENST00000261415","protein_coding",0,"COL4A3BP","collagen type IV alpha 3 binding protein [Source:HGNC Symbol;Acc:HGNC:2205]","GO:0000902(cell morphogenesis);GO:0001701(in utero embryonic development);GO:0003007(heart morphogenesis);GO:0005515(protein binding);GO:0005581(collagen trimer);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006672(ceramide metabolic process);GO:0006869(lipid transport);GO:0006936(muscle contraction);GO:0006955(immune response);GO:0007029(endoplasmic reticulum organization);GO:0007165(signal transduction);GO:0008283(cell population proliferation);GO:0008289(lipid binding);GO:0016020(membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0030148(sphingolipid biosynthetic process);GO:0034976(response to endoplasmic reticulum stress);GO:0035621(ER to Golgi ceramide transport);GO:0035627(ceramide transport);GO:0048471(perinuclear region of cytoplasm);GO:0055088(lipid homeostasis);GO:0070273(phosphatidylinositol-4-phosphate binding);GO:0070584(mitochondrion morphogenesis);GO:0097001(ceramide binding);GO:0120009(intermembrane lipid transfer);GO:0120012(intermembrane sphingolipid transfer);GO:0120017(intermembrane ceramide transfer activity);GO:1902387(ceramide 1-phosphate binding);GO:1902388(ceramide 1-phosphate transporter activity);GO:1902389(ceramide 1-phosphate transport)","NA",{"v":5.9e-08,"d":"0.00"},1,"241,",0,-1.08,{"v":0.0158489319246111,"d":"0.02"},1.69,"5' UTR",5,75368488,75511617,143130,2]
["chr5",81238469,81244897,6429,"ENSG00000248794","ENST00000510537","processed_pseudogene",0,"AC026436","ribosomal protein S12 (RPS12) pseudogene","NA","NA",{"v":5E-36,"d":"0.00"},2,"892,154,","0,6275",-1.48,{"v":0.00467735141287198,"d":"0.00"},1.06,"5' UTR",5,81242330,81242599,270,2]
["chr2",112742430,112742639,210,"ENSG00000144130","ENST00000327581","protein_coding",20944,"NT5DC4","5'-nucleotidase domain containing 4 [Source:HGNC Symbol;Acc:HGNC:27678]","GO:0008253(5'-nucleotidase activity);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0046872(metal ion binding)","NA",{"v":8.7e-06,"d":"0.00"},1,"210,",0,{"v":-0.912,"d":"-0.91"},{"v":0.0275422870333817,"d":"0.03"},2.38,"3' UTR",2,112721486,112742879,21394,1]
["chr5",97165089,97166762,1674,"ENSG00000058729","ENST00000283109","protein_coding",16485,"RIOK2","RIO kinase 2 [Source:HGNC Symbol;Acc:HGNC:18999]","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0007049(cell cycle);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0030071(regulation of mitotic metaphase/anaphase transition);GO:0030490(maturation of SSU-rRNA);GO:0030688(preribosome, small subunit precursor);GO:0042254(ribosome biogenesis);GO:0042274(ribosomal small subunit biogenesis);GO:0046777(protein autophosphorylation);GO:0046872(metal ion binding);GO:2000208(positive regulation of ribosomal small subunit export from nucleus);GO:2000234(positive regulation of rRNA processing)","03008(Ribosome biogenesis in eukaryotes)",{"v":9.8e-07,"d":"0.00"},3,"59,105,17,","0,1178,1657",-1.28,{"v":0.00831763771102671,"d":"0.01"},1.13,"3' UTR",5,97160867,97183247,22381,2]
["chr9",67725717,67725902,186,"ENSG00000278763","ENST00000610601","processed_pseudogene",0,"FAM27B","family with sequence similarity 27 member B [Source:HGNC Symbol;Acc:HGNC:23667]","NA","NA",{"v":3.2e-11,"d":"0.00"},1,"186,",0,-8.97,{"v":1.99526231496888e-11,"d":"0.00"},2.39,"Exon (ENST00000610601/ENSG00000278763, exon 1 of 1)",9,67725690,67725902,213,2]
["chr1",202584405,202584555,151,"ENSG00000077157","ENST00000608999","protein_coding",235706,"PPP1R12B","protein phosphatase 1 regulatory subunit 12B [Source:HGNC Symbol;Acc:HGNC:7619]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0004857(enzyme inhibitor activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006937(regulation of muscle contraction);GO:0007165(signal transduction);GO:0008047(enzyme activator activity);GO:0019208(phosphatase regulator activity);GO:0019901(protein kinase binding);GO:0030018(Z disc);GO:0031672(A band);GO:0043085(positive regulation of catalytic activity);GO:0043086(negative regulation of catalytic activity);GO:0050790(regulation of catalytic activity)","04270(Vascular smooth muscle contraction);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04921(Oxytocin signaling pathway);05205(Proteoglycans in cancer)",{"v":7.8e-05,"d":"0.00"},1,"151,",0,{"v":-0.824,"d":"-0.82"},{"v":0.0363078054770101,"d":"0.04"},{"v":2.4,"d":"2.40"},"3' UTR",1,202348699,202592702,244004,1]
["chr3",97943284,97943523,240,"ENSG00000080200","ENST00000389622","protein_coding",121273,"CRYBG3","crystallin beta-gamma domain containing 3 [Source:HGNC Symbol;Acc:HGNC:34427]","GO:0008150(biological_process);GO:0030246(carbohydrate binding);GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA",{"v":9.3e-09,"d":"0.00"},1,"240,",0,{"v":-0.982,"d":"-0.98"},{"v":0.0213796208950223,"d":"0.02"},{"v":2.4,"d":"2.40"},"3' UTR",3,97822011,97944984,122974,1]
["chr5",179082766,179083194,429,"ENSG00000253144","ENST00000523735","processed_pseudogene",0,"AC104117","pseudogene similat to part of cold shock domain containing E1, RNA-binding CSDE1","NA","NA",{"v":1.6e-92,"d":"0.00"},1,"429,",0,-2,{"v":0.0010471285480509,"d":"0.00"},1.23,"3' UTR",5,179082680,179083194,515,2]
["chr5",175965058,175967228,2171,"ENSG00000051596","ENST00000513118","retained_intron",0,"THOC3","THO complex 3 [Source:HGNC Symbol;Acc:HGNC:19072]","GO:0000346(transcription export complex);GO:0000445(THO complex part of transcription export complex);GO:0000784(nuclear chromosome, telomeric region);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006397(mRNA processing);GO:0006405(RNA export from nucleus);GO:0006406(mRNA export from nucleus);GO:0008380(RNA splicing);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016607(nuclear speck);GO:0031124(mRNA 3'-end processing);GO:0046784(viral mRNA export from host cell nucleus);GO:0051028(mRNA transport)","03013(RNA transport);03040(Spliceosome)",{"v":1.6e-14,"d":"0.00"},2,"211,118,","0,2053",-4.54,{"v":1.25892541179417e-06,"d":"0.00"},{"v":2.4,"d":"2.40"},"3' UTR",5,175961142,175965268,4127,2]
["chr6",2990515,2991083,569,"ENSG00000124588","ENST00000426637","protein_coding",2528,"NQO2","N-ribosyldihydronicotinamide:quinone reductase 2 [Source:HGNC Symbol;Acc:HGNC:7856]","GO:0001512(dihydronicotinamide riboside quinone reductase activity);GO:0003955(NAD(P)H dehydrogenase (quinone) activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006805(xenobiotic metabolic process);GO:0007613(memory);GO:0008270(zinc ion binding);GO:0009055(electron transfer activity);GO:0016491(oxidoreductase activity);GO:0016661(oxidoreductase activity, acting on other nitrogenous compounds as donors);GO:0022900(electron transport chain);GO:0031404(chloride ion binding);GO:0042803(protein homodimerization activity);GO:0043525(positive regulation of neuron apoptotic process);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process);GO:0070062(extracellular exosome);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071949(FAD binding);GO:1904408(melatonin binding);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1905594(resveratrol binding);GO:2000379(positive regulation of reactive oxygen species metabolic process)","NA",{"v":2E-41,"d":"0.00"},1,"569,",0,-2.86,{"v":0.000102329299228075,"d":"0.00"},1.22,"Exon (ENST00000445000/ENSG00000244041, exon 2 of 2)",6,2987987,3012561,24575,1]
["chr6",5042735,5043419,685,"ENSG00000271978","ENST00000606227","lincRNA",11004,"AL359643","novel transcript","NA","NA",{"v":2e-13,"d":"0.00"},1,"685,",0,-1.43,{"v":0.00549540873857625,"d":"0.01"},1.08,"Exon (ENST00000606761/ENSG00000272142, exon 2 of 2)",6,5031756,5054423,22668,2]
["chr6",7107717,7107986,270,"ENSG00000124782","ENST00000491191","protein_coding",0,"RREB1","ras responsive element binding protein 1 [Source:HGNC Symbol;Acc:HGNC:10449]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001650(fibrillar center);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006366(transcription by RNA polymerase II);GO:0007265(Ras protein signal transduction);GO:0007275(multicellular organism development);GO:0010634(positive regulation of epithelial cell migration);GO:0016604(nuclear body);GO:0016607(nuclear speck);GO:0033601(positive regulation of mammary gland epithelial cell proliferation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0070062(extracellular exosome);GO:1900026(positive regulation of substrate adhesion-dependent cell spreading);GO:1903691(positive regulation of wound healing, spreading of epidermal cells);GO:2000394(positive regulation of lamellipodium morphogenesis)","NA",{"v":5e-17,"d":"0.00"},2,"52,188,","0,82",-1.49,{"v":0.00457088189614875,"d":"0.00"},1.58,"5' UTR",6,7107799,7189306,81508,1]
["chr9",128315824,128316123,300,"ENSG00000167112","ENST00000372890","protein_coding",6324,"TRUB2","TruB pseudouridine synthase family member 2 [Source:HGNC Symbol;Acc:HGNC:17170]","GO:0001522(pseudouridine synthesis);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005829(cytosol);GO:0006396(RNA processing);GO:0006397(mRNA processing);GO:0009451(RNA modification);GO:0009982(pseudouridine synthase activity);GO:0016853(isomerase activity);GO:0070131(positive regulation of mitochondrial translation)","NA",{"v":2.5e-11,"d":"0.00"},1,"300,",0,{"v":-0.762,"d":"-0.76"},{"v":0.0446683592150963,"d":"0.04"},{"v":2.4,"d":"2.40"},"3' UTR",9,128305159,128322447,17289,2]
["chr6",26452906,26453385,480,"ENSG00000111801","ENST00000244519","protein_coding",12402,"BTN3A3","butyrophilin subfamily 3 member A3 [Source:HGNC Symbol;Acc:HGNC:1140]","GO:0002250(adaptive immune response);GO:0002376(immune system process);GO:0002456(T cell mediated immunity);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0009897(external side of plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0050776(regulation of immune response);GO:0050852(T cell receptor signaling pathway)","NA",{"v":4e-26,"d":"0.00"},1,"480,",0,-1.22,{"v":0.0102329299228075,"d":"0.01"},1.07,"3' UTR",6,26440504,26453415,12912,1]
["chr8",51849812,51860510,10699,"ENSG00000168300","ENST00000544451","protein_coding",38676,"PCMTD1","protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:30483]","GO:0004719(protein-L-isoaspartate (D-aspartate) O-methyltransferase activity);GO:0005737(cytoplasm);GO:0006464(cellular protein modification process);GO:0006479(protein methylation);GO:0016020(membrane);GO:0032259(methylation)","NA",{"v":4.5e-07,"d":"0.00"},2,"275,25,","0,10674",{"v":-0.914,"d":"-0.91"},{"v":0.0269153480392692,"d":"0.03"},2.42,"3' UTR",8,51817575,51899186,81612,2]
["chr6",28267209,28281492,14284,"ENSG00000197062","ENST00000614088","protein_coding",0,"ZSCAN26","zinc finger and SCAN domain containing 26 [Source:HGNC Symbol;Acc:HGNC:12978]","GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0042552(myelination);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","NA",{"v":3.2e-24,"d":"0.00"},4,"5,81,118,177,","0,4645,5461,14107",-1.89,{"v":0.00141253754462275,"d":"0.00"},1.14,"5' UTR",6,28267359,28278221,10863,1]
["chr6",30557305,30560077,2773,"ENSG00000204576","ENST00000481741","processed_transcript",0,"PRR3","proline rich 3 [Source:HGNC Symbol;Acc:HGNC:21149]","GO:0003723(RNA binding);GO:0005515(protein binding);GO:0046872(metal ion binding)","NA",{"v":5e-22,"d":"0.00"},3,"146,287,47,","0,845,2726",-5.66,{"v":7.07945784384137e-08,"d":"0.00"},1.01,"5' UTR",6,30557314,30563723,6410,1]
["chr6",31399844,31400384,541,"ENSG00000204520","ENST00000616296","protein_coding",60,"MICA","MHC class I polypeptide-related sequence A [Source:HGNC Symbol;Acc:HGNC:7090]","GO:0016021(integral component of membrane)","04650(Natural killer cell mediated cytotoxicity);05167(Kaposi sarcoma-associated herpesvirus infection)",{"v":9.8e-06,"d":"0.00"},1,"541,",0,-1.04,{"v":0.0177827941003892,"d":"0.02"},1.02,"5' UTR",6,31399784,31415313,15530,1]
["chr6",32968594,32968834,241,"ENSG00000204256","ENST00000374825","protein_coding",0,"BRD2","bromodomain containing 2 [Source:HGNC Symbol;Acc:HGNC:1103]","GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006325(chromatin organization);GO:0006334(nucleosome assembly);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007283(spermatogenesis);GO:0016032(viral process);GO:0016607(nuclear speck);GO:0070577(lysine-acetylated histone binding)","NA",{"v":4.5E-10,"d":"0.00"},1,"241,",0,{"v":-0.843,"d":"-0.84"},{"v":0.0338844156139203,"d":"0.03"},1.12,"5' UTR",6,32968594,32981501,12908,1]
["chr6",57053565,57054552,988,"ENSG00000168116","ENST00000545356","protein_coding",7033,"KIAA1586","KIAA1586 [Source:HGNC Symbol;Acc:HGNC:21360]","GO:0016740(transferase activity);GO:0016925(protein sumoylation);GO:0061665(SUMO ligase activity)","NA",{"v":2.5e-14,"d":"0.00"},1,"988,",0,-1.58,{"v":0.00346736850452532,"d":"0.00"},1.04,"Exon (ENST00000545356/ENSG00000168116, exon 3 of 3)",6,57046532,57055239,8708,1]
["chr6",83964096,83964876,781,"ENSG00000065615","ENST00000369681","protein_coding",104407,"CYB5R4","cytochrome b5 reductase 4 [Source:HGNC Symbol;Acc:HGNC:20147]","GO:0003032(detection of oxygen);GO:0004128(cytochrome-b5 reductase activity, acting on NAD(P)H);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006091(generation of precursor metabolites and energy);GO:0006801(superoxide metabolic process);GO:0015701(bicarbonate transport);GO:0016174(NAD(P)H oxidase activity);GO:0016491(oxidoreductase activity);GO:0016653(oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor);GO:0020037(heme binding);GO:0030073(insulin secretion);GO:0042593(glucose homeostasis);GO:0046677(response to antibiotic);GO:0046872(metal ion binding);GO:0048468(cell development);GO:0048471(perinuclear region of cytoplasm);GO:0055114(oxidation-reduction process)","00520(Amino sugar and nucleotide sugar metabolism)",{"v":1.6e-23,"d":"0.00"},1,"781,",0,-1.58,{"v":0.00354813389233575,"d":"0.00"},1.87,"3' UTR",6,83859689,83967423,107735,1]
["chr6",108522260,108522709,450,"ENSG00000135537","ENST00000368977","protein_coding",227366,"AFG1L","AFG1 like ATPase [Source:HGNC Symbol;Acc:HGNC:16411]","GO:0000166(nucleotide binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006123(mitochondrial electron transport, cytochrome c to oxygen);GO:0007005(mitochondrion organization);GO:0016020(membrane);GO:0016787(hydrolase activity);GO:0016887(ATPase activity);GO:0031966(mitochondrial membrane);GO:0035694(mitochondrial protein catabolic process)","NA",{"v":3.2e-21,"d":"0.00"},1,"450,",0,{"v":-0.962,"d":"-0.96"},{"v":0.0229086765276777,"d":"0.02"},{"v":1.2,"d":"1.20"},"3' UTR",6,108294894,108526001,231108,1]
["chr6",142753527,142753759,233,"ENSG00000010818","ENST00000012134","protein_coding",191272,"HIVEP2","human immunodeficiency virus type I enhancer binding protein 2 [Source:HGNC Symbol;Acc:HGNC:4921]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","NA",{"v":4e-11,"d":"0.00"},1,"233,",0,{"v":-0.737,"d":"-0.74"},{"v":0.0489778819368446,"d":"0.05"},1.09,"Exon (ENST00000437067/ENSG00000233138, exon 2 of 2)",6,142751469,142945031,193563,2]
["chr5",122078000,122078330,331,"ENSG00000113083","ENST00000231004","protein_coding",0,"LOX","lysyl oxidase [Source:HGNC Symbol;Acc:HGNC:6664]","GO:0001568(blood vessel development);GO:0001649(osteoblast differentiation);GO:0001932(regulation of protein phosphorylation);GO:0004720(protein-lysine 6-oxidase activity);GO:0005507(copper ion binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005581(collagen trimer);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0006464(cellular protein modification process);GO:0007507(heart development);GO:0009725(response to hormone);GO:0010468(regulation of gene expression);GO:0016202(regulation of striated muscle tissue development);GO:0016491(oxidoreductase activity);GO:0016641(oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor);GO:0017015(regulation of transforming growth factor beta receptor signaling pathway);GO:0018057(peptidyl-lysine oxidation);GO:0018158(protein oxidation);GO:0030198(extracellular matrix organization);GO:0030199(collagen fibril organization);GO:0030282(bone mineralization);GO:0030324(lung development);GO:0031012(extracellular matrix);GO:0035791(platelet-derived growth factor receptor-beta signaling pathway);GO:0035904(aorta development);GO:0035905(ascending aorta development);GO:0035906(descending aorta development);GO:0042060(wound healing);GO:0042493(response to drug);GO:0042981(regulation of apoptotic process);GO:0043491(protein kinase B signaling);GO:0045652(regulation of megakaryocyte differentiation);GO:0046716(muscle cell cellular homeostasis);GO:0046872(metal ion binding);GO:0048251(elastic fiber assembly);GO:0048514(blood vessel morphogenesis);GO:0048545(response to steroid hormone);GO:0048747(muscle fiber development);GO:0055114(oxidation-reduction process);GO:0060326(cell chemotaxis);GO:0061448(connective tissue development);GO:0071310(cellular response to organic substance);GO:0071897(DNA biosynthetic process);GO:1900120(regulation of receptor binding);GO:1903010(regulation of bone development);GO:1990869(cellular response to chemokine);GO:2000586(regulation of platelet-derived growth factor receptor-beta signaling pathway)","NA",{"v":2e-11,"d":"0.00"},1,"331,",0,{"v":-0.786,"d":"-0.79"},{"v":0.0407380277804113,"d":"0.04"},2.44,"5' UTR",5,122063195,122078259,15065,2]
["chr6",167971813,167972023,211,"ENSG00000130396","ENST00000392112","protein_coding",144822,"AFDN","afadin, adherens junction formation factor [Source:HGNC Symbol;Acc:HGNC:7137]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005912(adherens junction);GO:0005913(cell-cell adherens junction);GO:0007155(cell adhesion);GO:0007165(signal transduction);GO:0007267(cell-cell signaling);GO:0008022(protein C-terminus binding);GO:0010628(positive regulation of gene expression);GO:0016607(nuclear speck);GO:0017016(Ras GTPase binding);GO:0021537(telencephalon development);GO:0021987(cerebral cortex development);GO:0022409(positive regulation of cell-cell adhesion);GO:0030054(cell junction);GO:0030336(negative regulation of cell migration);GO:0032880(regulation of protein localization);GO:0034332(adherens junction organization);GO:0034334(adherens junction maintenance);GO:0043296(apical junction complex);GO:0043547(positive regulation of GTPase activity);GO:0044291(cell-cell contact zone);GO:0044331(cell-cell adhesion mediated by cadherin);GO:0045177(apical part of cell);GO:0045296(cadherin binding);GO:0048854(brain morphogenesis);GO:0048872(homeostasis of number of cells);GO:0050839(cell adhesion molecule binding);GO:0051015(actin filament binding);GO:0060019(radial glial cell differentiation);GO:0060563(neuroepithelial cell differentiation);GO:0061951(establishment of protein localization to plasma membrane);GO:0070160(tight junction);GO:0070445(regulation of oligodendrocyte progenitor proliferation);GO:0070830(bicellular tight junction assembly);GO:0090557(establishment of endothelial intestinal barrier);GO:1902414(protein localization to cell junction);GO:2000049(positive regulation of cell-cell adhesion mediated by cadherin)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04024(cAMP signaling pathway);04520(Adherens junction);04530(Tight junction);04670(Leukocyte transendothelial migration)",{"v":6.3e-14,"d":"0.00"},1,"211,",0,{"v":-0.735,"d":"-0.74"},{"v":0.0489778819368446,"d":"0.05"},1.12,"3' UTR",6,167826991,167972020,145030,1]
["chr6",3023171,3023772,602,"ENSG00000271361","ENST00000604204","processed_pseudogene",0,"HTATSF1P2","HIV-1 Tat specific factor 1 pseudogene 2 [Source:HGNC Symbol;Acc:HGNC:38586]","NA","NA",{"v":7.9e-28,"d":"0.00"},1,"602,",0,-1.72,{"v":0.00234422881531992,"d":"0.00"},1.11,"3' UTR",6,3023142,3023772,631,2]
["chr6",13364385,13365552,1168,"ENSG00000145990","ENST00000379284","protein_coding",42585,"GFOD1","glucose-fructose oxidoreductase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:21096]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","NA",{"v":1e-115,"d":"0.00"},1,"1168,",0,-5.72,{"v":6.16595001861482e-08,"d":"0.00"},1.46,"3' UTR",6,13357830,13408137,50308,2]
["chr6",13469797,13486041,16245,"ENSG00000145990","ENST00000605067","processed_transcript",0,"GFOD1","glucose-fructose oxidoreductase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:21096]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","NA",{"v":2e-17,"d":"0.00"},3,"834,64,31,","0,2184,16214",-1.04,{"v":0.0177827941003892,"d":"0.02"},1.05,"5' UTR",6,13469268,13472044,2777,2]
["chr11",124747651,124748443,793,"ENSG00000019102","ENST00000326621","protein_coding",3812,"VSIG2","V-set and immunoglobulin domain containing 2 [Source:HGNC Symbol;Acc:HGNC:17149]","GO:0005887(integral component of plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":0.00016,"d":"0.00"},2,"17,338,","0,455",{"v":-0.752,"d":"-0.75"},{"v":0.0457088189614875,"d":"0.05"},2.44,"3' UTR",11,124747474,124752255,4782,2]
["chr6",27450921,27451991,1071,"ENSG00000096654","ENST00000211936","protein_coding",21127,"ZNF184","zinc finger protein 184 [Source:HGNC Symbol;Acc:HGNC:12975]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008270(zinc ion binding);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":1E-176,"d":"0.00"},1,"1071,",0,-4.01,{"v":4.89778819368447e-06,"d":"0.00"},1.15,"3' UTR",6,27450743,27473118,22376,2]
["chr6",30556935,30557174,240,"ENSG00000204590","ENST00000376621","protein_coding",0,"GNL1","G protein nucleolar 1 (putative) [Source:HGNC Symbol;Acc:HGNC:4413]","GO:0000166(nucleotide binding);GO:0002456(T cell mediated immunity);GO:0005198(structural molecule activity);GO:0005525(GTP binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0006974(cellular response to DNA damage stimulus);GO:0007165(signal transduction)","NA",{"v":8.5e-05,"d":"0.00"},1,"240,",0,{"v":-0.739,"d":"-0.74"},{"v":0.0489778819368446,"d":"0.05"},1.25,"5' UTR",6,30541377,30557174,15798,2]
["chr6",31157630,31158208,579,"ENSG00000204536","ENST00000396268","protein_coding",0,"CCHCR1","coiled-coil alpha-helical rod protein 1 [Source:HGNC Symbol;Acc:HGNC:13930]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005814(centriole);GO:0005829(cytosol);GO:0006611(protein export from nucleus);GO:0007275(multicellular organism development);GO:0030154(cell differentiation)","NA",{"v":3.2e-52,"d":"0.00"},3,"162,276,42,","0,255,537",-1.16,{"v":0.0123026877081238,"d":"0.01"},1.44,"5' UTR",6,31142439,31157789,15351,2]
["chr17",1634515,1634963,449,"ENSG00000074660","ENST00000263071","protein_coding",10769,"SCARF1","scavenger receptor class F member 1 [Source:HGNC Symbol;Acc:HGNC:16820]","GO:0004888(transmembrane signaling receptor activity);GO:0005044(scavenger receptor activity);GO:0005886(plasma membrane);GO:0006707(cholesterol catabolic process);GO:0006898(receptor-mediated endocytosis);GO:0007155(cell adhesion);GO:0010976(positive regulation of neuron projection development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016322(neuron remodeling);GO:0016358(dendrite development);GO:0030169(low-density lipoprotein particle binding);GO:0030666(endocytic vesicle membrane);GO:0048680(positive regulation of axon regeneration)","NA",{"v":1.3E-6,"d":"0.00"},1,"449,",0,-1.53,{"v":0.00398107170553497,"d":"0.00"},2.44,"3' UTR",17,1633858,1645732,11875,2]
["chr22",20067136,20069108,1973,"ENSG00000236540","ENST00000600937","antisense",54,"AC006547","novel transcript, antisense to C22orf25","NA","NA",{"v":6e-07,"d":"0.00"},2,"114,66,","0,1907",{"v":-0.965,"d":"-0.97"},{"v":0.0229086765276777,"d":"0.02"},2.45,"Exon (ENST00000600937/ENSG00000236540, exon 1 of 4)",22,20063011,20069162,6152,2]
["chr17",74432060,74432240,181,"ENSG00000170412","ENST00000392628","protein_coding",0,"GPRC5C","G protein-coupled receptor class C group 5 member C [Source:HGNC Symbol;Acc:HGNC:13309]","GO:0004930(G protein-coupled receptor activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030295(protein kinase activator activity);GO:0030659(cytoplasmic vesicle membrane);GO:0031410(cytoplasmic vesicle);GO:0031982(vesicle);GO:0032147(activation of protein kinase activity);GO:0043235(receptor complex);GO:0070062(extracellular exosome)","NA",{"v":1.5E-3,"d":"0.00"},1,"181,",0,-1.19,{"v":0.0112201845430196,"d":"0.01"},2.46,"5' UTR",17,74432116,74449509,17394,1]
["chr6",89642768,89642978,211,"ENSG00000112159","ENST00000369393","protein_coding",176816,"MDN1","midasin AAA ATPase 1 [Source:HGNC Symbol;Acc:HGNC:18302]","GO:0000027(ribosomal large subunit assembly);GO:0000166(nucleotide binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006364(rRNA processing);GO:0016020(membrane);GO:0016887(ATPase activity);GO:0045111(intermediate filament cytoskeleton);GO:0051082(unfolded protein binding);GO:0065003(protein-containing complex assembly)","03008(Ribosome biogenesis in eukaryotes)",{"v":1.5e-07,"d":"0.00"},1,"211,",0,{"v":-0.812,"d":"-0.81"},{"v":0.0380189396320561,"d":"0.04"},1.23,"3' UTR",6,89642498,89819794,177297,2]
["chr6",96798322,96799042,721,"ENSG00000112218","ENST00000229955","protein_coding",38435,"GPR63","G protein-coupled receptor 63 [Source:HGNC Symbol;Acc:HGNC:13302]","GO:0003674(molecular_function);GO:0004930(G protein-coupled receptor activity);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0008150(biological_process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043235(receptor complex)","NA",{"v":6.3e-26,"d":"0.00"},1,"721,",0,{"v":-0.762,"d":"-0.76"},{"v":0.0446683592150963,"d":"0.04"},{"v":1.1,"d":"1.10"},"3' UTR",6,96794125,96837477,43353,2]
["chr6",100509271,100509391,121,"ENSG00000112249","ENST00000369162","protein_coding",371938,"ASCC3","activating signal cointegrator 1 complex subunit 3 [Source:HGNC Symbol;Acc:HGNC:18697]","GO:0000166(nucleotide binding);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0004386(helicase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006281(DNA repair);GO:0006307(DNA dealkylation involved in DNA repair);GO:0006974(cellular response to DNA damage stimulus);GO:0008026(ATP-dependent helicase activity);GO:0008283(cell population proliferation);GO:0016020(membrane);GO:0016607(nuclear speck);GO:0016787(hydrolase activity);GO:0032508(DNA duplex unwinding);GO:0043140(ATP-dependent 3'-5' DNA helicase activity);GO:0099053(activating signal cointegrator 1 complex)","NA",{"v":0.00028,"d":"0.00"},1,"121,",0,{"v":-0.791,"d":"-0.79"},{"v":0.0407380277804113,"d":"0.04"},1.23,"3' UTR",6,100508194,100881329,373136,2]
["chr6",107070101,107070700,600,"ENSG00000178409","ENST00000369042","protein_coding",44569,"BEND3","BEN domain containing 3 [Source:HGNC Symbol;Acc:HGNC:23040]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000182(rDNA binding);GO:0000183(chromatin silencing at rDNA);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005720(nuclear heterochromatin);GO:0005730(nucleolus);GO:0006306(DNA methylation);GO:0006325(chromatin organization);GO:0034773(histone H4-K20 trimethylation);GO:0036124(histone H3-K9 trimethylation);GO:0043967(histone H4 acetylation);GO:0051260(protein homooligomerization);GO:0080182(histone H3-K4 trimethylation);GO:0098532(histone H3-K27 trimethylation);GO:1903580(positive regulation of ATP metabolic process)","NA",{"v":4e-13,"d":"0.00"},1,"600,",0,-2.17,{"v":6.45654229034656E-4,"d":"0.00"},1.23,"Exon (ENST00000369042/ENSG00000178409, exon 4 of 4)",6,107065182,107115269,50088,2]
["chr6",110813574,110815447,1874,"ENSG00000155111","ENST00000413605","protein_coding",0,"CDK19","cyclin dependent kinase 19 [Source:HGNC Symbol;Acc:HGNC:19338]","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004693(cyclin-dependent protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016592(mediator complex);GO:0016740(transferase activity);GO:0043065(positive regulation of apoptotic process);GO:0050729(positive regulation of inflammatory response);GO:0051726(regulation of cell cycle);GO:0071222(cellular response to lipopolysaccharide)","NA",{"v":3.2e-76,"d":"0.00"},2,"551,439,","0,1435",-3.39,{"v":2.45470891568503e-05,"d":"0.00"},1.85,"5' UTR",6,110609978,110815209,205232,2]
["chr2",174395998,174396237,240,"ENSG00000144306","ENST00000437944","nonsense_mediated_decay",268,"SCRN3","secernin 3 [Source:HGNC Symbol;Acc:HGNC:30382]","GO:0006508(proteolysis);GO:0006887(exocytosis);GO:0016805(dipeptidase activity)","NA",{"v":0.0011,"d":"0.00"},1,"240,",0,{"v":-0.937,"d":"-0.94"},{"v":0.0251188643150958,"d":"0.03"},2.49,"5' UTR",2,174395730,174427864,32135,1]
["chr6",145626720,145627619,900,"ENSG00000112425","ENST00000638717","protein_coding",107662,"EPM2A","EPM2A, laforin glucan phosphatase [Source:HGNC Symbol;Acc:HGNC:3413]","GO:0000045(autophagosome assembly);GO:0001558(regulation of cell growth);GO:0001932(regulation of protein phosphorylation);GO:0004721(phosphoprotein phosphatase activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0005844(polysome);GO:0005886(plasma membrane);GO:0005975(carbohydrate metabolic process);GO:0005977(glycogen metabolic process);GO:0005978(glycogen biosynthetic process);GO:0006470(protein dephosphorylation);GO:0006816(calcium ion transport);GO:0006914(autophagy);GO:0007005(mitochondrion organization);GO:0007399(nervous system development);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0010468(regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0014009(glial cell proliferation);GO:0015813(L-glutamate transmembrane transport);GO:0016020(membrane);GO:0016055(Wnt signaling pathway);GO:0016239(positive regulation of macroautophagy);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0016791(phosphatase activity);GO:0019203(carbohydrate phosphatase activity);GO:0030246(carbohydrate binding);GO:0030247(polysaccharide binding);GO:0030425(dendrite);GO:0031396(regulation of protein ubiquitination);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0042306(regulation of protein import into nucleus);GO:0042325(regulation of phosphorylation);GO:0042803(protein homodimerization activity);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0043204(perikaryon);GO:0044260(cellular macromolecule metabolic process);GO:0045786(negative regulation of cell cycle);GO:0045859(regulation of protein kinase activity);GO:0046838(phosphorylated carbohydrate dephosphorylation);GO:0046959(habituation);GO:0051260(protein homooligomerization);GO:0061136(regulation of proteasomal protein catabolic process);GO:0098554(cytoplasmic side of endoplasmic reticulum membrane);GO:0098556(cytoplasmic side of rough endoplasmic reticulum membrane);GO:1903076(regulation of protein localization to plasma membrane);GO:1904666(regulation of ubiquitin protein ligase activity);GO:2000465(regulation of glycogen (starch) synthase activity);GO:2001069(glycogen binding);GO:2001070(starch binding)","NA",{"v":7.9e-53,"d":"0.00"},1,"900,",0,-1.93,{"v":0.00125892541179417,"d":"0.00"},{"v":1.2,"d":"1.20"},"3' UTR",6,145382535,145735281,352747,2]
["chr6",167993691,167994369,679,"ENSG00000229921","ENST00000456585","lincRNA",2708,"KIF25-AS1","KIF25 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:20953]","NA","NA",{"v":1.3E-18,"d":"0.00"},2,"463,198,","0,481",-1.48,{"v":0.00467735141287198,"d":"0.00"},1.41,"Exon (ENST00000456585/ENSG00000229921, exon 3 of 3)",6,167992822,167997077,4256,2]
["chr6",169216020,169216649,630,"ENSG00000186340","ENST00000366787","protein_coding",37395,"THBS2","thrombospondin 2 [Source:HGNC Symbol;Acc:HGNC:11786]","GO:0005201(extracellular matrix structural constituent);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005604(basement membrane);GO:0007155(cell adhesion);GO:0008201(heparin binding);GO:0016525(negative regulation of angiogenesis);GO:0031012(extracellular matrix);GO:0031091(platelet alpha granule);GO:0051965(positive regulation of synapse assembly);GO:0062023(collagen-containing extracellular matrix)","04145(Phagosome);04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04512(ECM-receptor interaction);05144(Malaria);05165(Human papillomavirus infection)",{"v":5E-51,"d":"0.00"},1,"630,",0,-1.44,{"v":0.00524807460249772,"d":"0.01"},1.25,"3' UTR",6,169215780,169254044,38265,2]
["chr6",169694654,169701588,6935,"ENSG00000184465","ENST00000423258","protein_coding",0,"WDR27","WD repeat domain 27 [Source:HGNC Symbol;Acc:HGNC:21248]","GO:0005515(protein binding);GO:0005654(nucleoplasm)","NA",{"v":7.9e-22,"d":"0.00"},2,"412,38,","0,6897",-1.62,{"v":0.00309029543251359,"d":"0.00"},1.83,"5' UTR",6,169457355,169701586,244232,2]
["chr7",874766,874916,151,"ENSG00000164828","ENST00000389574","protein_coding",58151,"SUN1","Sad1 and UNC84 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:18587]","GO:0001503(ossification);GO:0005515(protein binding);GO:0005521(lamin binding);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005637(nuclear inner membrane);GO:0005639(integral component of nuclear inner membrane);GO:0005737(cytoplasm);GO:0006998(nuclear envelope organization);GO:0007129(synapsis);GO:0007283(spermatogenesis);GO:0009612(response to mechanical stimulus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0021817(nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration);GO:0030154(cell differentiation);GO:0031965(nuclear membrane);GO:0034993(meiotic nuclear membrane microtubule tethering complex);GO:0043231(intracellular membrane-bounded organelle);GO:0043495(protein membrane anchor);GO:0051321(meiotic cell cycle);GO:0051642(centrosome localization);GO:0070197(meiotic attachment of telomere to nuclear envelope);GO:0090286(cytoskeletal anchoring at nuclear membrane);GO:0090292(nuclear matrix anchoring at nuclear membrane)","NA",{"v":1.2E-9,"d":"0.00"},1,"151,",0,-4.23,{"v":2.75422870333816E-6,"d":"0.00"},1.88,"3' UTR",7,816615,874902,58288,1]
["chr7",5067718,5069127,1410,"ENSG00000146587","ENST00000396912","protein_coding",21858,"RBAK","RB associated KRAB zinc finger [Source:HGNC Symbol;Acc:HGNC:17680]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008270(zinc ion binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":1e-208,"d":"0.00"},1,"1410,",0,-3.95,{"v":5.75439937337157e-06,"d":"0.00"},1.17,"3' UTR",7,5045860,5069487,23628,1]
["chr4",139412465,139413003,539,"ENSG00000164134","ENST00000515576","protein_coding",26297,"NAA15","N(alpha)-acetyltransferase 15, NatA auxiliary subunit [Source:HGNC Symbol;Acc:HGNC:30782]","GO:0001525(angiogenesis);GO:0003723(RNA binding);GO:0004596(peptide alpha-N-acetyltransferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006474(N-terminal protein amino acid acetylation);GO:0007275(multicellular organism development);GO:0016020(membrane);GO:0016407(acetyltransferase activity);GO:0017196(N-terminal peptidyl-methionine acetylation);GO:0030154(cell differentiation);GO:0031415(NatA complex);GO:0043022(ribosome binding);GO:0043066(negative regulation of apoptotic process);GO:0045893(positive regulation of transcription, DNA-templated);GO:0050821(protein stabilization)","NA",{"v":1.6e-09,"d":"0.00"},1,"539,",0,{"v":-0.816,"d":"-0.82"},{"v":0.0371535229097173,"d":"0.04"},2.49,"Exon (ENST00000608661/ENSG00000273247, exon 3 of 3)",4,139386168,139420033,33866,1]
["chr7",7673406,7689358,15953,"ENSG00000106399","ENST00000223129","protein_coding",29249,"RPA3","replication protein A3 [Source:HGNC Symbol;Acc:HGNC:10291]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0000723(telomere maintenance);GO:0000724(double-strand break repair via homologous recombination);GO:0003677(DNA binding);GO:0003684(damaged DNA binding);GO:0003697(single-stranded DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005662(DNA replication factor A complex);GO:0006260(DNA replication);GO:0006281(DNA repair);GO:0006283(transcription-coupled nucleotide-excision repair);GO:0006284(base-excision repair);GO:0006289(nucleotide-excision repair);GO:0006293(nucleotide-excision repair, preincision complex stabilization);GO:0006294(nucleotide-excision repair, preincision complex assembly);GO:0006295(nucleotide-excision repair, DNA incision, 3'-to lesion);GO:0006296(nucleotide-excision repair, DNA incision, 5'-to lesion);GO:0006297(nucleotide-excision repair, DNA gap filling);GO:0006298(mismatch repair);GO:0006310(DNA recombination);GO:0006974(cellular response to DNA damage stimulus);GO:0007346(regulation of mitotic cell cycle);GO:0019985(translesion synthesis);GO:0032201(telomere maintenance via semi-conservative replication);GO:0033683(nucleotide-excision repair, DNA incision);GO:0035861(site of double-strand break);GO:0036297(interstrand cross-link repair);GO:0042127(regulation of cell population proliferation);GO:0042276(error-prone translesion synthesis);GO:0042769(DNA damage response, detection of DNA damage);GO:0070987(error-free translesion synthesis);GO:1900034(regulation of cellular response to heat);GO:1901796(regulation of signal transduction by p53 class mediator)","03030(DNA replication);03420(Nucleotide excision repair);03430(Mismatch repair);03440(Homologous recombination);03460(Fanconi anemia pathway)",{"v":1.8E-5,"d":"0.00"},3,"48,107,24,","0,2696,15929",-2.01,{"v":1E-3,"d":"0.00"},1.64,"5' UTR",7,7636518,7718607,82090,2]
["chr7",12686856,12687325,470,"ENSG00000122644","ENST00000396662","protein_coding",0,"ARL4A","ADP ribosylation factor like GTPase 4A [Source:HGNC Symbol;Acc:HGNC:695]","GO:0000166(nucleotide binding);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006886(intracellular protein transport);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0050873(brown fat cell differentiation)","NA",{"v":5e-98,"d":"0.00"},2,"188,201,","0,269",-2.93,{"v":8.51138038202376e-05,"d":"0.00"},1.13,"5' UTR",7,12686856,12689179,2324,1]
["chr7",23611215,23643278,32064,"ENSG00000227436","ENST00000432690","processed_pseudogene",0,"FCF1P1","FCF1 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:44613]","NA","NA",{"v":1e-148,"d":"0.00"},2,"339,348,","0,31716",-3.45,{"v":2.13796208950223e-05,"d":"0.00"},1.22,"5' UTR",7,23619333,23622826,3494,1]
["chr7",66642753,66643023,271,"ENSG00000243335","ENST00000639828","protein_coding",13986,"KCTD7","potassium channel tetramerization domain containing 7 [Source:HGNC Symbol;Acc:HGNC:21957]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030007(cellular potassium ion homeostasis);GO:0032411(positive regulation of transporter activity);GO:0043687(post-translational protein modification);GO:0051260(protein homooligomerization);GO:0060081(membrane hyperpolarization);GO:0090461(glutamate homeostasis)","NA",{"v":1.6E-18,"d":"0.00"},1,"271,",0,-1.33,{"v":0.00741310241300918,"d":"0.01"},1.33,"3' UTR",7,66628767,66644015,15249,1]
["chr7",72940476,72940866,391,"ENSG00000196313","ENST00000395270","protein_coding",61111,"POM121","POM121 transmembrane nucleoporin [Source:HGNC Symbol;Acc:HGNC:19702]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005643(nuclear pore);GO:0005654(nucleoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006110(regulation of glycolytic process);GO:0006406(mRNA export from nucleus);GO:0006409(tRNA export from nucleus);GO:0006606(protein import into nucleus);GO:0008139(nuclear localization sequence binding);GO:0015031(protein transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016032(viral process);GO:0016925(protein sumoylation);GO:0017056(structural constituent of nuclear pore);GO:0019083(viral transcription);GO:0031965(nuclear membrane);GO:0043657(host cell);GO:0051028(mRNA transport);GO:0060964(regulation of gene silencing by miRNA);GO:0075733(intracellular transport of virus);GO:1900034(regulation of cellular response to heat)","03013(RNA transport)",{"v":0.00014,"d":"0.00"},2,"41,50,","0,341",-1.26,{"v":0.00891250938133746,"d":"0.01"},1.27,"Exon (ENST00000395270/ENSG00000196313, exon 12 of 16)",7,72879365,72951440,72076,1]
["chr19",21034130,21034280,151,"ENSG00000118620","ENST00000599548","protein_coding",13496,"ZNF430","zinc finger protein 430 [Source:HGNC Symbol;Acc:HGNC:20808]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0021762(substantia nigra development);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":0.0017,"d":"0.00"},1,"151,",0,{"v":-0.876,"d":"-0.88"},{"v":0.0309029543251359,"d":"0.03"},2.49,"3' UTR",19,21020634,21053544,32911,1]
["chr3",56557191,56557794,604,"ENSG00000180376","ENST00000459746","processed_transcript",0,"CCDC66","coiled-coil domain containing 66 [Source:HGNC Symbol;Acc:HGNC:27709]","GO:0001578(microtubule bundle formation);GO:0001750(photoreceptor outer segment);GO:0001895(retina homeostasis);GO:0001917(photoreceptor inner segment);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005929(cilium);GO:0008017(microtubule binding);GO:0030030(cell projection organization);GO:0034451(centriolar satellite);GO:0036064(ciliary basal body);GO:0042803(protein homodimerization activity);GO:0042995(cell projection);GO:0046548(retinal rod cell development);GO:0050908(detection of light stimulus involved in visual perception);GO:0060271(cilium assembly);GO:1903564(regulation of protein localization to cilium)","NA",{"v":0.00081,"d":"0.00"},2,"63,88,","0,516",{"v":-0.771,"d":"-0.77"},{"v":0.0436515832240166,"d":"0.04"},2.51,"5' UTR",3,56557191,56564125,6935,1]
["chr1",154155334,154155514,181,"ENSG00000143549","ENST00000611659","protein_coding",27735,"TPM3","tropomyosin 3 [Source:HGNC Symbol;Acc:HGNC:12012]","GO:0001725(stress fiber);GO:0003674(molecular_function);GO:0003779(actin binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005862(muscle thin filament tropomyosin);GO:0005884(actin filament);GO:0006936(muscle contraction);GO:0007015(actin filament organization);GO:0015629(actin cytoskeleton);GO:0030049(muscle filament sliding);GO:0051015(actin filament binding);GO:0070062(extracellular exosome)","04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);05200(Pathways in cancer);05216(Thyroid cancer);05410(Hypertrophic cardiomyopathy (HCM));05414(Dilated cardiomyopathy (DCM))",{"v":1.9e-05,"d":"0.00"},1,"181,",0,-1.06,{"v":0.0169824365246174,"d":"0.02"},2.53,"3' UTR",1,154155304,154183249,27946,2]
["chr7",111124292,111125424,1133,"ENSG00000173114","ENST00000451085","protein_coding",33286,"LRRN3","leucine rich repeat neuronal 3 [Source:HGNC Symbol;Acc:HGNC:17200]","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0051965(positive regulation of synapse assembly)","NA",{"v":2.5e-34,"d":"0.00"},1,"1133,",0,-1.32,{"v":0.00758577575029184,"d":"0.01"},1.55,"3' UTR",7,111091006,111125451,34446,1]
["chr7",140178771,140179400,630,"ENSG00000260231","ENST00000566699","bidirectional_promoter_lncRNA",1587,"KDM7A-DT","KDM7A divergent transcript [Source:HGNC Symbol;Acc:HGNC:48959]","NA","NA",{"v":2e-62,"d":"0.00"},1,"630,",0,-2.51,{"v":0.000257039578276886,"d":"0.00"},1.09,"Exon (ENST00000566699/ENSG00000260231, exon 1 of 1)",7,140177184,140179640,2457,1]
["chr7",4797234,4797772,539,"ENSG00000157927","ENST00000445392","nonsense_mediated_decay",85882,"RADIL","Rap associating with DIL domain [Source:HGNC Symbol;Acc:HGNC:22226]","GO:0005515(protein binding);GO:0005874(microtubule);GO:0007155(cell adhesion);GO:0007165(signal transduction);GO:0007275(multicellular organism development);GO:0032991(protein-containing complex);GO:0034446(substrate adhesion-dependent cell spreading)","NA",{"v":1e-09,"d":"0.00"},1,"539,",0,-1.56,{"v":0.00363078054770101,"d":"0.00"},2.54,"3' UTR",7,4797055,4883654,86600,2]
["chr7",154949221,154951379,2159,"ENSG00000272760","ENST00000608064","antisense",0,"AC093726","novel transcript, antisense to PAXIP1","NA","NA",{"v":1E-169,"d":"0.00"},1,"2159,",0,-2.92,{"v":8.70963589956081e-05,"d":"0.00"},1.08,"Exon (ENST00000646803/ENSG00000214106, exon 3 of 3)",7,154951226,154952188,963,1]
["chr7",155458129,155458992,864,"ENSG00000164778","ENST00000297375","protein_coding",0,"EN2","engrailed homeobox 2 [Source:HGNC Symbol;Acc:HGNC:3343]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001650(fibrillar center);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007275(multicellular organism development);GO:0016020(membrane);GO:0016586(RSC-type complex);GO:0030182(neuron differentiation);GO:0030901(midbrain development);GO:0030902(hindbrain development);GO:0043524(negative regulation of neuron apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048666(neuron development);GO:1990403(embryonic brain development)","NA",{"v":5e-18,"d":"0.00"},1,"864,",0,{"v":-0.751,"d":"-0.75"},{"v":0.0467735141287198,"d":"0.05"},1.33,"5' UTR",7,155458129,155464831,6703,1]
["chr17",4933707,4933886,180,"ENSG00000108556","ENST00000649830","protein_coding",552,"CHRNE","cholinergic receptor nicotinic epsilon subunit [Source:HGNC Symbol;Acc:HGNC:1966]","GO:0004888(transmembrane signaling receptor activity);GO:0005216(ion channel activity);GO:0005230(extracellular ligand-gated ion channel activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005892(acetylcholine-gated channel complex);GO:0006811(ion transport);GO:0006936(muscle contraction);GO:0007165(signal transduction);GO:0007268(chemical synaptic transmission);GO:0007271(synaptic transmission, cholinergic);GO:0007274(neuromuscular synaptic transmission);GO:0008324(cation transmembrane transporter activity);GO:0015464(acetylcholine receptor activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022848(acetylcholine-gated cation-selective channel activity);GO:0030054(cell junction);GO:0031594(neuromuscular junction);GO:0034220(ion transmembrane transport);GO:0035094(response to nicotine);GO:0042166(acetylcholine binding);GO:0042391(regulation of membrane potential);GO:0043005(neuron projection);GO:0045202(synapse);GO:0045211(postsynaptic membrane);GO:0050877(nervous system process);GO:0060078(regulation of postsynaptic membrane potential);GO:0060079(excitatory postsynaptic potential);GO:0098655(cation transmembrane transport);GO:0099060(integral component of postsynaptic specialization membrane);GO:1904315(transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential)","04080(Neuroactive ligand-receptor interaction)",{"v":9.1e-05,"d":"0.00"},1,"180,",0,{"v":-0.806,"d":"-0.81"},{"v":0.0389045144994281,"d":"0.04"},2.57,"Exon (ENST00000329125/ENSG00000185245, exon 2 of 2)",17,4898085,4934438,36354,2]
["chr7",6688851,6689718,868,"ENSG00000164631","ENST00000404360","protein_coding",11196,"ZNF12","zinc finger protein 12 [Source:HGNC Symbol;Acc:HGNC:12902]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":1E-187,"d":"0.00"},1,"868,",0,-2.67,{"v":0.000165958690743756,"d":"0.00"},1.04,"3' UTR",7,6688433,6700914,12482,2]
["chr7",64976567,64977765,1199,"ENSG00000152926","ENST00000282869","protein_coding",13271,"ZNF117","zinc finger protein 117 [Source:HGNC Symbol;Acc:HGNC:12897]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008270(zinc ion binding);GO:0046872(metal ion binding)","NA",{"v":3.2e-37,"d":"0.00"},1,"1199,",0,{"v":-0.841,"d":"-0.84"},{"v":0.0346736850452532,"d":"0.03"},1.62,"3' UTR",7,64971776,64991036,19261,2]
["chr7",72575325,72575595,271,"ENSG00000277149","ENST00000612372","protein_coding",252579,"TYW1B","tRNA-yW synthesizing protein 1 homolog B [Source:HGNC Symbol;Acc:HGNC:33908]","GO:0000166(nucleotide binding);GO:0003824(catalytic activity);GO:0008033(tRNA processing);GO:0010181(FMN binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016829(lyase activity);GO:0046872(metal ion binding);GO:0051536(iron-sulfur cluster binding);GO:0051539(4 iron, 4 sulfur cluster binding);GO:0055114(oxidation-reduction process);GO:0102521(tRNA-4-demethylwyosine synthase activity)","NA",{"v":9.3e-06,"d":"0.00"},1,"271,",0,{"v":-0.779,"d":"-0.78"},{"v":0.0416869383470335,"d":"0.04"},1.41,"3' UTR",7,72558744,72828174,269431,2]
["chr17",21528766,21529066,301,"ENSG00000212719","ENST00000540508","lincRNA",0,"C17orf51","chromosome 17 open reading frame 51 [Source:HGNC Symbol;Acc:HGNC:27904]","NA","NA",{"v":5.1E-5,"d":"0.00"},1,"301,",0,{"v":-0.922,"d":"-0.92"},{"v":0.0263026799189538,"d":"0.03"},2.58,"3' UTR",17,21524790,21529066,4277,2]
["chr7",83960721,83963207,2487,"ENSG00000075213","ENST00000265362","protein_coding",231582,"SEMA3A","semaphorin 3A [Source:HGNC Symbol;Acc:HGNC:10723]","GO:0001755(neural crest cell migration);GO:0001764(neuron migration);GO:0002027(regulation of heart rate);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005887(integral component of plasma membrane);GO:0006915(apoptotic process);GO:0007275(multicellular organism development);GO:0007399(nervous system development);GO:0007411(axon guidance);GO:0007413(axonal fasciculation);GO:0008045(motor neuron axon guidance);GO:0010633(negative regulation of epithelial cell migration);GO:0010977(negative regulation of neuron projection development);GO:0021612(facial nerve structural organization);GO:0021637(trigeminal nerve structural organization);GO:0021675(nerve development);GO:0021772(olfactory bulb development);GO:0021785(branchiomotor neuron axon guidance);GO:0021828(gonadotrophin-releasing hormone neuronal migration to the hypothalamus);GO:0030154(cell differentiation);GO:0030215(semaphorin receptor binding);GO:0030335(positive regulation of cell migration);GO:0030424(axon);GO:0030425(dendrite);GO:0030517(negative regulation of axon extension);GO:0036486(ventral trunk neural crest cell migration);GO:0038191(neuropilin binding);GO:0045499(chemorepellent activity);GO:0046330(positive regulation of JNK cascade);GO:0048485(sympathetic nervous system development);GO:0048813(dendrite morphogenesis);GO:0048841(regulation of axon extension involved in axon guidance);GO:0048843(negative regulation of axon extension involved in axon guidance);GO:0048846(axon extension involved in axon guidance);GO:0048880(sensory system development);GO:0050919(negative chemotaxis);GO:0060385(axonogenesis involved in innervation);GO:0060666(dichotomous subdivision of terminal units involved in salivary gland branching);GO:0061549(sympathetic ganglion development);GO:0061551(trigeminal ganglion development);GO:0071526(semaphorin-plexin signaling pathway);GO:0097490(sympathetic neuron projection extension);GO:0097491(sympathetic neuron projection guidance);GO:0150020(basal dendrite arborization);GO:1901166(neural crest cell migration involved in autonomic nervous system development);GO:1902285(semaphorin-plexin signaling pathway involved in neuron projection guidance);GO:1902287(semaphorin-plexin signaling pathway involved in axon guidance);GO:1903045(neural crest cell migration involved in sympathetic nervous system development);GO:1903375(facioacoustic ganglion development);GO:2000020(positive regulation of male gonad development);GO:2001224(positive regulation of neuron migration)","04360(Axon guidance)",{"v":2e-37,"d":"0.00"},2,"1106,3,","0,2484",-1.19,{"v":0.0112201845430196,"d":"0.01"},1.25,"3' UTR",7,83955777,84194789,239013,2]
["chr19",16236267,16237285,1019,"ENSG00000072958","ENST00000291439","protein_coding",38689,"AP1M1","adaptor related protein complex 1 subunit mu 1 [Source:HGNC Symbol;Acc:HGNC:13667]","GO:0000139(Golgi membrane);GO:0005515(protein binding);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006886(intracellular protein transport);GO:0015031(protein transport);GO:0016020(membrane);GO:0016032(viral process);GO:0016192(vesicle-mediated transport);GO:0019886(antigen processing and presentation of exogenous peptide antigen via MHC class II);GO:0030131(clathrin adaptor complex);GO:0030659(cytoplasmic vesicle membrane);GO:0030665(clathrin-coated vesicle membrane);GO:0031410(cytoplasmic vesicle);GO:0032438(melanosome organization);GO:0032588(trans-Golgi network membrane);GO:0035579(specific granule membrane);GO:0035646(endosome to melanosome transport);GO:0043312(neutrophil degranulation);GO:0050690(regulation of defense response to virus by virus);GO:0070062(extracellular exosome)","04142(Lysosome);05170(Human immunodeficiency virus 1 infection)",{"v":5e-14,"d":"0.00"},1,"1019,",0,-1.14,{"v":0.0131825673855641,"d":"0.01"},2.59,"3' UTR",19,16197578,16245907,48330,1]
["chr7",99901213,99901571,359,"ENSG00000146833","ENST00000447480","protein_coding",17534,"TRIM4","tripartite motif containing 4 [Source:HGNC Symbol;Acc:HGNC:16275]","GO:0002376(immune system process);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0008270(zinc ion binding);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0045087(innate immune response);GO:0046872(metal ion binding);GO:0070206(protein trimerization)","NA",{"v":3.2e-21,"d":"0.00"},1,"359,",0,{"v":-1.6,"d":"-1.60"},{"v":0.00323593656929628,"d":"0.00"},1.33,"3' UTR",7,99876958,99919105,42148,2]
["chr5",58454132,58454761,630,"ENSG00000145632","ENST00000274289","protein_coding",5325,"PLK2","polo like kinase 2 [Source:HGNC Symbol;Acc:HGNC:19699]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0000166(nucleotide binding);GO:0000278(mitotic cell cycle);GO:0000785(chromatin);GO:0000922(spindle pole);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest);GO:0007052(mitotic spindle organization);GO:0007093(mitotic cell cycle checkpoint);GO:0007265(Ras protein signal transduction);GO:0007613(memory);GO:0010508(positive regulation of autophagy);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016525(negative regulation of angiogenesis);GO:0016740(transferase activity);GO:0018105(peptidyl-serine phosphorylation);GO:0030425(dendrite);GO:0032092(positive regulation of protein binding);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0032465(regulation of cytokinesis);GO:0032486(Rap protein signal transduction);GO:0042995(cell projection);GO:0043008(ATP-dependent protein binding);GO:0043066(negative regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0044877(protein-containing complex binding);GO:0045732(positive regulation of protein catabolic process);GO:0046599(regulation of centriole replication);GO:0048167(regulation of synaptic plasticity);GO:0060291(long-term synaptic potentiation);GO:0060292(long-term synaptic depression);GO:0061000(negative regulation of dendritic spine development);GO:0071866(negative regulation of apoptotic process in bone marrow cell);GO:0090050(positive regulation of cell migration involved in sprouting angiogenesis);GO:2000773(negative regulation of cellular senescence)","04068(FoxO signaling pathway)",{"v":1.3E-11,"d":"0.00"},1,"630,",0,-2.22,{"v":0.000562341325190349,"d":"0.00"},2.63,"3' UTR",5,58453982,58460086,6105,2]
["chr7",103119581,103126864,7284,"ENSG00000161048","ENST00000420631","nonsense_mediated_decay",0,"NAPEPLD","N-acyl phosphatidylethanolamine phospholipase D [Source:HGNC Symbol;Acc:HGNC:21683]","GO:0000139(Golgi membrane);GO:0001523(retinoid metabolic process);GO:0001659(temperature homeostasis);GO:0004620(phospholipase activity);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005654(nucleoplasm);GO:0005768(endosome);GO:0005769(early endosome);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006629(lipid metabolic process);GO:0006644(phospholipid metabolic process);GO:0007568(aging);GO:0008270(zinc ion binding);GO:0009395(phospholipid catabolic process);GO:0016020(membrane);GO:0016042(lipid catabolic process);GO:0016787(hydrolase activity);GO:0031901(early endosome membrane);GO:0035900(response to isolation stress);GO:0042622(photoreceptor outer segment membrane);GO:0042802(identical protein binding);GO:0043227(membrane-bounded organelle);GO:0046872(metal ion binding);GO:0048874(host-mediated regulation of intestinal microbiota composition);GO:0050729(positive regulation of inflammatory response);GO:0070062(extracellular exosome);GO:0070290(N-acylphosphatidylethanolamine-specific phospholipase D activity);GO:0070291(N-acylethanolamine metabolic process);GO:0070292(N-acylphosphatidylethanolamine metabolic process);GO:0090336(positive regulation of brown fat cell differentiation);GO:0102200(N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity);GO:1903999(negative regulation of eating behavior)","04723(Retrograde endocannabinoid signaling)",{"v":1e-55,"d":"0.00"},2,"643,75,","0,7209",-5.05,{"v":3.38844156139203e-07,"d":"0.00"},1.42,"Exon (ENST00000341533/ENSG00000161048, exon 3 of 6)",7,103102524,103119766,17243,2]
["chr7",112783770,112783980,211,"ENSG00000146802","ENST00000312814","protein_coding",6612,"TMEM168","transmembrane protein 168 [Source:HGNC Symbol;Acc:HGNC:25826]","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030133(transport vesicle)","NA",{"v":7.2e-06,"d":"0.00"},1,"211,",0,-1.48,{"v":0.00467735141287198,"d":"0.00"},{"v":1.7,"d":"1.70"},"5' UTR",7,112762382,112790592,28211,2]
["chr7",113116718,113116926,209,"ENSG00000214194","ENST00000397764","protein_coding",1628,"SMIM30","small integral membrane protein 30 [Source:HGNC Symbol;Acc:HGNC:48953]","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":2.3e-09,"d":"0.00"},1,"209,",0,-1.63,{"v":3.01995172040202E-3,"d":"0.00"},{"v":1.3,"d":"1.30"},"3' UTR",7,113116718,113118554,1837,2]
["chr7",140090738,140092072,1335,"ENSG00000006459","ENST00000397560","protein_coding",84911,"KDM7A","lysine demethylase 7A [Source:HGNC Symbol;Acc:HGNC:22224]","GO:0005506(iron ion binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006325(chromatin organization);GO:0007399(nervous system development);GO:0008270(zinc ion binding);GO:0016491(oxidoreductase activity);GO:0016706(2-oxoglutarate-dependent dioxygenase activity);GO:0030901(midbrain development);GO:0032454(histone demethylase activity (H3-K9 specific));GO:0033169(histone H3-K9 demethylation);GO:0035064(methylated histone binding);GO:0035574(histone H4-K20 demethylation);GO:0035575(histone demethylase activity (H4-K20 specific));GO:0045893(positive regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0051213(dioxygenase activity);GO:0051864(histone demethylase activity (H3-K36 specific));GO:0055114(oxidation-reduction process);GO:0070544(histone H3-K36 demethylation);GO:0071557(histone H3-K27 demethylation);GO:0071558(histone demethylase activity (H3-K27 specific))","NA",{"v":1E-107,"d":"0.00"},2,"451,269,","0,1066",-8.21,{"v":1.17489755493953e-10,"d":"0.00"},1.81,"3' UTR",7,140084746,140176983,92238,2]
["chr3",40506063,40508676,2614,"ENSG00000177842","ENST00000433723","nonsense_mediated_decay",0,"ZNF620","zinc finger protein 620 [Source:HGNC Symbol;Acc:HGNC:28742]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":1.4e-07,"d":"0.00"},4,"76,73,99,21,","0,241,1780,2593",{"v":-0.832,"d":"-0.83"},{"v":0.0354813389233576,"d":"0.04"},2.66,"5' UTR",3,40506108,40512472,6365,1]
["chr7",157010245,157010633,389,"ENSG00000130675","ENST00000252971","protein_coding",30,"MNX1","motor neuron and pancreas homeobox 1 [Source:HGNC Symbol;Acc:HGNC:4979]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006959(humoral immune response);GO:0009653(anatomical structure morphogenesis);GO:0021520(spinal cord motor neuron cell fate specification);GO:0031018(endocrine pancreas development);GO:0043565(sequence-specific DNA binding);GO:0048812(neuron projection morphogenesis)","04950(Maturity onset diabetes of the young)",{"v":4e-26,"d":"0.00"},1,"389,",0,-3.39,{"v":2.51188643150958e-05,"d":"0.00"},1.93,"5' UTR",7,157004854,157010663,5810,2]
["chrX",55486504,55487104,601,"ENSG00000247746","ENST00000500968","protein_coding",2098,"USP51","ubiquitin specific peptidase 51 [Source:HGNC Symbol;Acc:HGNC:23086]","GO:0003682(chromatin binding);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005694(chromosome);GO:0006281(DNA repair);GO:0006508(proteolysis);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006974(cellular response to DNA damage stimulus);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0008270(zinc ion binding);GO:0010564(regulation of cell cycle process);GO:0010569(regulation of double-strand break repair via homologous recombination);GO:0016578(histone deubiquitination);GO:0016579(protein deubiquitination);GO:0016787(hydrolase activity);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042393(histone binding);GO:0046872(metal ion binding);GO:2001020(regulation of response to DNA damage stimulus);GO:2001032(regulation of double-strand break repair via nonhomologous end joining)","NA",{"v":1.5e-07,"d":"0.00"},1,"601,",0,-1.66,{"v":2.81838293126445E-3,"d":"0.00"},2.67,"3' UTR",23,55484616,55489202,4587,2]
["chr8",23102738,23114520,11783,"ENSG00000173535","ENST00000517558","nonsense_mediated_decay",0,"TNFRSF10C","TNF receptor superfamily member 10c [Source:HGNC Symbol;Acc:HGNC:11906]","GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006915(apoptotic process);GO:0009986(cell surface);GO:0016020(membrane);GO:0031225(anchored component of membrane);GO:0036462(TRAIL-activated apoptotic signaling pathway);GO:0042981(regulation of apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0045569(TRAIL binding)","04060(Cytokine-cytokine receptor interaction)",{"v":2.5e-31,"d":"0.00"},3,"444,106,14,","0,8982,11769",{"v":-1.3,"d":"-1.30"},{"v":0.00794328234724281,"d":"0.01"},1.51,"5' UTR",8,23102921,23117050,14130,1]
["chr8",53880257,53913853,33597,"ENSG00000147509","ENST00000522225","protein_coding",0,"RGS20","regulator of G protein signaling 20 [Source:HGNC Symbol;Acc:HGNC:14600]","GO:0003924(GTPase activity);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005802(trans-Golgi network);GO:0005886(plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0008277(regulation of G protein-coupled receptor signaling pathway);GO:0009968(negative regulation of signal transduction);GO:0016020(membrane);GO:0043547(positive regulation of GTPase activity)","NA",{"v":3.2e-76,"d":"0.00"},3,"30,213,357,","0,615,33240",-3.89,{"v":6.60693448007596e-06,"d":"0.00"},1.03,"5' UTR",8,53880872,53959296,78425,1]
["chr8",80485649,80513912,28264,"ENSG00000205189","ENST00000430430","protein_coding",0,"ZBTB10","zinc finger and BTB domain containing 10 [Source:HGNC Symbol;Acc:HGNC:30953]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0046872(metal ion binding)","NA",{"v":1e-114,"d":"0.00"},4,"235,1570,889,3,","0,564,13845,28261",-5.68,{"v":6.60693448007596e-08,"d":"0.00"},1,"5' UTR",8,80485667,80526265,40599,1]
["chr8",106271983,106272751,769,"ENSG00000254615","ENST00000521369","lincRNA",1839,"AC027031","novel transcript","NA","NA",{"v":5e-22,"d":"0.00"},1,"769,",0,{"v":-1.8,"d":"-1.80"},{"v":0.00186208713666287,"d":"0.00"},1.62,"Exon (ENST00000521369/ENSG00000254615, exon 2 of 2)",8,106270144,106272899,2756,1]
["chr8",144261335,144261940,606,"ENSG00000179832","ENST00000534366","protein_coding",112690,"MROH1","maestro heat like repeat family member 1 [Source:HGNC Symbol;Acc:HGNC:26958]","GO:0005515(protein binding)","NA",{"v":3.2e-22,"d":"0.00"},2,"15,286,","0,320",-1.39,{"v":0.00602559586074357,"d":"0.01"},1.91,"3' UTR",8,144148645,144261809,113165,1]
["chr11",101987039,101997949,10911,"ENSG00000110318","ENST00000263468","protein_coding",72024,"CEP126","centrosomal protein 126 [Source:HGNC Symbol;Acc:HGNC:29264]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005856(cytoskeleton);GO:0007052(mitotic spindle organization);GO:0030030(cell projection organization);GO:0030496(midbody);GO:0031122(cytoplasmic microtubule organization);GO:0042995(cell projection);GO:0060271(cilium assembly);GO:0097546(ciliary base);GO:1905515(non-motile cilium assembly)","NA",{"v":4e-17,"d":"0.00"},3,"3,65,351,","0,5739,10560",{"v":-0.833,"d":"-0.83"},{"v":0.0354813389233576,"d":"0.04"},2.73,"3' UTR",11,101915015,102001058,86044,1]
["chr8",31031650,31032817,1168,"ENSG00000172733","ENST00000339382","protein_coding",898,"PURG","purine rich element binding protein G [Source:HGNC Symbol;Acc:HGNC:17930]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003690(double-stranded DNA binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0032422(purine-rich negative regulatory element binding);GO:0043565(sequence-specific DNA binding)","NA",{"v":2.4E-9,"d":"0.00"},1,"1168,",0,-1.21,{"v":0.010471285480509,"d":"0.01"},1.87,"5' UTR",8,30995802,31033715,37914,2]
["chr8",41828195,41828855,661,"ENSG00000029534","ENST00000265709","protein_coding",67907,"ANK1","ankyrin 1 [Source:HGNC Symbol;Acc:HGNC:492]","GO:0005198(structural molecule activity);GO:0005200(structural constituent of cytoskeleton);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0006887(exocytosis);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0007010(cytoskeleton organization);GO:0007165(signal transduction);GO:0008093(cytoskeletal adaptor activity);GO:0009898(cytoplasmic side of plasma membrane);GO:0010638(positive regulation of organelle organization);GO:0014731(spectrin-associated cytoskeleton);GO:0016020(membrane);GO:0016323(basolateral plasma membrane);GO:0016529(sarcoplasmic reticulum);GO:0019899(enzyme binding);GO:0019903(protein phosphatase binding);GO:0030018(Z disc);GO:0030507(spectrin binding);GO:0030673(axolemma);GO:0031430(M band);GO:0031672(A band);GO:0042383(sarcolemma);GO:0043005(neuron projection);GO:0043194(axon initial segment);GO:0044325(ion channel binding);GO:0045199(maintenance of epithelial cell apical/basal polarity);GO:0045211(postsynaptic membrane);GO:0051117(ATPase binding);GO:0072659(protein localization to plasma membrane)","05205(Proteoglycans in cancer)",{"v":5E-15,"d":"0.00"},1,"661,",0,-1.54,{"v":0.0038904514499428,"d":"0.00"},1.85,"Exon (ENST00000563810/ENSG00000260588, exon 1 of 1)",8,41653225,41896762,243538,2]
["chr6",160093508,160093993,486,"ENSG00000197081","ENST00000356956","protein_coding",124409,"IGF2R","insulin like growth factor 2 receptor [Source:HGNC Symbol;Acc:HGNC:5467]","GO:0001889(liver development);GO:0001965(G-protein alpha-subunit binding);GO:0001972(retinoic acid binding);GO:0005010(insulin-like growth factor-activated receptor activity);GO:0005515(protein binding);GO:0005520(insulin-like growth factor binding);GO:0005537(mannose binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005641(nuclear envelope lumen);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0005768(endosome);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005925(focal adhesion);GO:0006892(post-Golgi vesicle-mediated transport);GO:0006898(receptor-mediated endocytosis);GO:0007041(lysosomal transport);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007283(spermatogenesis);GO:0009791(post-embryonic development);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019899(enzyme binding);GO:0030118(clathrin coat);GO:0030133(transport vesicle);GO:0030136(clathrin-coated vesicle);GO:0030139(endocytic vesicle);GO:0030140(trans-Golgi network transport vesicle);GO:0030665(clathrin-coated vesicle membrane);GO:0030667(secretory granule membrane);GO:0031100(animal organ regeneration);GO:0031995(insulin-like growth factor II binding);GO:0032526(response to retinoic acid);GO:0032588(trans-Golgi network membrane);GO:0036143(kringle domain binding);GO:0038023(signaling receptor activity);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0043312(neutrophil degranulation);GO:0048009(insulin-like growth factor receptor signaling pathway);GO:0048471(perinuclear region of cytoplasm);GO:0051219(phosphoprotein binding);GO:0061024(membrane organization);GO:0070062(extracellular exosome)","04142(Lysosome);04144(Endocytosis)",{"v":3.2e-12,"d":"0.00"},1,"486,",0,-1.48,{"v":0.00467735141287198,"d":"0.00"},2.75,"Exon (ENST00000569097/ENSG00000213073, exon 1 of 1)",6,159969099,160111504,142406,1]
["chr8",79767648,79767767,120,"ENSG00000164683","ENST00000354724","protein_coding",0,"HEY1","hes related family bHLH transcription factor with YRPW motif 1 [Source:HGNC Symbol;Acc:HGNC:4880]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001525(angiogenesis);GO:0001568(blood vessel development);GO:0003184(pulmonary valve morphogenesis);GO:0003190(atrioventricular valve formation);GO:0003203(endocardial cushion morphogenesis);GO:0003208(cardiac ventricle morphogenesis);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0007219(Notch signaling pathway);GO:0007275(multicellular organism development);GO:0007507(heart development);GO:0008134(transcription factor binding);GO:0010628(positive regulation of gene expression);GO:0030154(cell differentiation);GO:0035912(dorsal aorta morphogenesis);GO:0035939(microsatellite binding);GO:0036304(umbilical cord morphogenesis);GO:0043565(sequence-specific DNA binding);GO:0045746(negative regulation of Notch signaling pathway);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:0050767(regulation of neurogenesis);GO:0060317(cardiac epithelial to mesenchymal transition);GO:0060347(heart trabecula formation);GO:0060411(cardiac septum morphogenesis);GO:0060412(ventricular septum morphogenesis);GO:0060716(labyrinthine layer blood vessel development);GO:0060842(arterial endothelial cell differentiation);GO:0061314(Notch signaling involved in heart development);GO:0070168(negative regulation of biomineral tissue development);GO:1990837(sequence-specific double-stranded DNA binding);GO:2000678(negative regulation of transcription regulatory region DNA binding);GO:2000820(negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation);GO:2001212(regulation of vasculogenesis)","05165(Human papillomavirus infection);05200(Pathways in cancer);05224(Breast cancer)",{"v":0.00032,"d":"0.00"},1,"120,",0,{"v":-0.993,"d":"-0.99"},{"v":0.0208929613085404,"d":"0.02"},1.24,"5' UTR",8,79764010,79767767,3758,2]
["chr20",63974116,63974265,150,"ENSG00000130590","ENST00000369886","protein_coding",5377,"SAMD10","sterile alpha motif domain containing 10 [Source:HGNC Symbol;Acc:HGNC:16129]","GO:0005515(protein binding)","NA",{"v":0.00025,"d":"0.00"},1,"150,",0,-2.09,{"v":0.000812830516164099,"d":"0.00"},2.75,"3' UTR",20,63974116,63979642,5527,2]
["chr13",99499096,99499306,211,"ENSG00000280734","ENST00000625254","lincRNA",0,"LINC01232","long intergenic non-protein coding RNA 1232 [Source:HGNC Symbol;Acc:HGNC:49755]","NA","NA",{"v":4.3e-07,"d":"0.00"},1,"211,",0,-1.07,{"v":0.0165958690743756,"d":"0.02"},2.78,"5' UTR",13,99496418,99499306,2889,2]
["chr8",141218516,141218966,451,"ENSG00000022567","ENST00000519067","protein_coding",9604,"SLC45A4","solute carrier family 45 member 4 [Source:HGNC Symbol;Acc:HGNC:29196]","GO:0008506(sucrose:proton symporter activity);GO:0015770(sucrose transport);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":5.2e-10,"d":"0.00"},1,"451,",0,-1.41,{"v":0.00575439937337157,"d":"0.01"},1.23,"Exon (ENST00000519067/ENSG00000022567, exon 4 of 7)",8,141207166,141228570,21405,2]
["chr9",745956,746106,151,"ENSG00000107104","ENST00000382303","protein_coding",275665,"KANK1","KN motif and ankyrin repeat domains 1 [Source:HGNC Symbol;Acc:HGNC:19309]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0008013(beta-catenin binding);GO:0008283(cell population proliferation);GO:0010977(negative regulation of neuron projection development);GO:0016020(membrane);GO:0030036(actin cytoskeleton organization);GO:0030177(positive regulation of Wnt signaling pathway);GO:0030336(negative regulation of cell migration);GO:0030837(negative regulation of actin filament polymerization);GO:0032587(ruffle membrane);GO:0035023(regulation of Rho protein signal transduction);GO:0035024(negative regulation of Rho protein signal transduction);GO:0042995(cell projection);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:0090303(positive regulation of wound healing);GO:0090521(glomerular visceral epithelial cell migration);GO:1900025(negative regulation of substrate adhesion-dependent cell spreading);GO:1900028(negative regulation of ruffle assembly);GO:2000114(regulation of establishment of cell polarity);GO:2000393(negative regulation of lamellipodium morphogenesis)","NA",{"v":0.00018,"d":"0.00"},1,"151,",0,-1.44,{"v":0.00524807460249772,"d":"0.01"},1.33,"3' UTR",9,470291,746105,275815,1]
["chr9",17135192,17166825,31634,"ENSG00000044459","ENST00000484374","processed_transcript",210,"CNTLN","centlein [Source:HGNC Symbol;Acc:HGNC:23432]","GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0010457(centriole-centriole cohesion);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0030674(protein binding, bridging);GO:0033365(protein localization to organelle);GO:0070062(extracellular exosome)","NA",{"v":2.8e-07,"d":"0.00"},3,"234,89,8,","0,8096,31626",-1.36,{"v":6.60693448007596E-3,"d":"0.01"},1.25,"Exon (ENST00000484374/ENSG00000044459, exon 1 of 3)",9,17134982,17168556,33575,1]
["chr9",19371802,19372736,935,"ENSG00000272842","ENST00000609609","antisense",0,"AL391834","novel transcript, antisense to DENND4C","NA","NA",{"v":1E-141,"d":"0.00"},2,"19,700,","0,235",-3,{"v":6.91830970918936e-05,"d":"0.00"},{"v":1.2,"d":"1.20"},"3' UTR",9,19371386,19371945,560,2]
["chr9",21699314,21699596,283,"ENSG00000244230","ENST00000460537","misc_RNA",0,"RN7SL151P","RNA, 7SL, cytoplasmic 151, pseudogene [Source:HGNC Symbol;Acc:HGNC:46167]","NA","NA",{"v":7.9e-17,"d":"0.00"},1,"283,",0,-0.88,{"v":0.0301995172040202,"d":"0.03"},1.72,"Exon (ENST00000460537/ENSG00000244230, exon 1 of 1)",9,21699314,21699596,283,1]
["chr9",21994958,22012253,17296,"ENSG00000147883","ENST00000276925","protein_coding",0,"CDKN2B","cyclin dependent kinase inhibitor 2B [Source:HGNC Symbol;Acc:HGNC:1788]","GO:0000079(regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0000086(G2/M transition of mitotic cell cycle);GO:0004861(cyclin-dependent protein serine/threonine kinase inhibitor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007049(cell cycle);GO:0007050(cell cycle arrest);GO:0007093(mitotic cell cycle checkpoint);GO:0008285(negative regulation of cell population proliferation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0019901(protein kinase binding);GO:0030219(megakaryocyte differentiation);GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway);GO:0031668(cellular response to extracellular stimulus);GO:0031670(cellular response to nutrient);GO:0042326(negative regulation of phosphorylation);GO:0045736(negative regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048536(spleen development);GO:0050680(negative regulation of epithelial cell proliferation);GO:0090398(cellular senescence);GO:2000134(negative regulation of G1/S transition of mitotic cell cycle)","04068(FoxO signaling pathway);04110(Cell cycle);04218(Cellular senescence);04350(TGF-beta signaling pathway);04934(Cushing syndrome);05166(Human T-cell leukemia virus 1 infection);05200(Pathways in cancer);05203(Viral carcinogenesis);05222(Small cell lung cancer);05226(Gastric cancer)",{"v":2.4e-05,"d":"0.00"},2,"204,126,","0,17170",-1.17,{"v":0.0117489755493953,"d":"0.01"},1.83,"5' UTR",9,22002903,22009305,6403,2]
["chr9",32946056,32947222,1167,"ENSG00000237437","ENST00000452496","processed_pseudogene",60,"ASS1P12","argininosuccinate synthetase 1 pseudogene 12 [Source:HGNC Symbol;Acc:HGNC:762]","NA","NA",{"v":2.5e-11,"d":"0.00"},1,"1167,",0,-1.74,{"v":0.00218776162394955,"d":"0.00"},1.79,"Exon (ENST00000452496/ENSG00000237437, exon 1 of 1)",9,32945996,32947222,1227,1]
["chr9",34318585,34319447,863,"ENSG00000229207","ENST00000419794","processed_pseudogene",178,"SERPINH1P1","serpin family H member 1 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:19917]","NA","NA",{"v":7.9e-13,"d":"0.00"},1,"863,",0,-1.34,{"v":0.00707945784384138,"d":"0.01"},1.67,"Exon (ENST00000419794/ENSG00000229207, exon 1 of 1)",9,34318407,34319655,1249,1]
["chr9",41479989,41480548,560,"ENSG00000275160","ENST00000619764","processed_pseudogene",29,"AL354718","ribosomal protein L7a (RPL7A) pseudogene","NA","NA",{"v":1.3e-46,"d":"0.00"},1,"560,",0,-3.17,{"v":4.46683592150963e-05,"d":"0.00"},1.88,"Exon (ENST00000619764/ENSG00000275160, exon 1 of 1)",9,41479960,41480548,589,1]
["chr9",127453762,127454544,783,"ENSG00000148356","ENST00000300417","protein_coding",2276,"LRSAM1","leucine rich repeat and sterile alpha motif containing 1 [Source:HGNC Symbol;Acc:HGNC:25135]","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006914(autophagy);GO:0015031(protein transport);GO:0016020(membrane);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0030163(protein catabolic process);GO:0045806(negative regulation of endocytosis);GO:0046755(viral budding);GO:0046872(metal ion binding);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity);GO:0070086(ubiquitin-dependent endocytosis);GO:1904417(positive regulation of xenophagy);GO:2000786(positive regulation of autophagosome assembly)","NA",{"v":7.9e-24,"d":"0.00"},2,"251,49,","0,734",-1.58,{"v":0.00346736850452532,"d":"0.00"},1.68,"5' UTR",9,127451486,127503501,52016,1]
["chr10",93073079,93073466,388,"ENSG00000279607","ENST00000624651","lincRNA",1107,"AL358613","novel transcript","NA","NA",{"v":0.00015,"d":"0.00"},1,"388,",0,{"v":-0.823,"d":"-0.82"},{"v":0.0363078054770101,"d":"0.04"},2.79,"Exon (ENST00000624651/ENSG00000279607, exon 2 of 2)",10,93071972,93073466,1495,1]
["chr9",128316423,128316909,487,"ENSG00000167112","ENST00000372890","protein_coding",5538,"TRUB2","TruB pseudouridine synthase family member 2 [Source:HGNC Symbol;Acc:HGNC:17170]","GO:0001522(pseudouridine synthesis);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005829(cytosol);GO:0006396(RNA processing);GO:0006397(mRNA processing);GO:0009451(RNA modification);GO:0009982(pseudouridine synthase activity);GO:0016853(isomerase activity);GO:0070131(positive regulation of mitochondrial translation)","NA",{"v":7.9e-29,"d":"0.00"},1,"487,",0,-1.73,{"v":0.00229086765276777,"d":"0.00"},1.65,"Exon (ENST00000609315/ENSG00000272696, exon 1 of 1)",9,128305159,128322447,17289,2]
["chr9",128702652,128702920,269,"ENSG00000160447","ENST00000291906","protein_coding",149,"PKN3","protein kinase N3 [Source:HGNC Symbol;Acc:HGNC:17999]","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004697(protein kinase C activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0006468(protein phosphorylation);GO:0007165(signal transduction);GO:0010631(epithelial cell migration);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0017049(GTP-Rho binding);GO:0018105(peptidyl-serine phosphorylation);GO:0035556(intracellular signal transduction);GO:0048471(perinuclear region of cytoplasm)","04151(PI3K-Akt signaling pathway);05132(Salmonella infection)",{"v":0.00087,"d":"0.00"},1,"269,",0,{"v":-0.918,"d":"-0.92"},{"v":0.0269153480392692,"d":"0.03"},1.01,"5' UTR",9,128702503,128720916,18414,1]
["chr21",43056835,43058911,2077,"ENSG00000160200","ENST00000461686","retained_intron",9493,"CBS","cystathionine-beta-synthase [Source:HGNC Symbol;Acc:HGNC:1550]","GO:0003824(catalytic activity);GO:0004122(cystathionine beta-synthase activity);GO:0004124(cysteine synthase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006535(cysteine biosynthetic process from serine);GO:0006563(L-serine metabolic process);GO:0006565(L-serine catabolic process);GO:0008152(metabolic process);GO:0008652(cellular amino acid biosynthetic process);GO:0016829(lyase activity);GO:0019343(cysteine biosynthetic process via cystathionine);GO:0019344(cysteine biosynthetic process);GO:0019346(transsulfuration);GO:0019448(L-cysteine catabolic process);GO:0019825(oxygen binding);GO:0019899(enzyme binding);GO:0020037(heme binding);GO:0030170(pyridoxal phosphate binding);GO:0031625(ubiquitin protein ligase binding);GO:0042262(DNA protection);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043418(homocysteine catabolic process);GO:0046872(metal ion binding);GO:0050421(nitrite reductase (NO-forming) activity);GO:0050667(homocysteine metabolic process);GO:0055114(oxidation-reduction process);GO:0070025(carbon monoxide binding);GO:0070026(nitric oxide binding);GO:0070814(hydrogen sulfide biosynthetic process);GO:0072341(modified amino acid binding);GO:1904047(S-adenosyl-L-methionine binding)","00260(Glycine, serine and threonine metabolism);00270(Cysteine and methionine metabolism)",{"v":1.4e-10,"d":"0.00"},3,"53,109,78,","0,1310,1999",-1.78,{"v":0.00194984459975805,"d":"0.00"},2.82,"Exon (ENST00000461686/ENSG00000160200, exon 11 of 14)",21,43053191,43068404,15214,2]
["chr9",136354840,136355646,807,"ENSG00000160360","ENST00000291775","protein_coding",0,"GPSM1","G protein signaling modulator 1 [Source:HGNC Symbol;Acc:HGNC:17858]","GO:0000139(Golgi membrane);GO:0005092(GDP-dissociation inhibitor activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005938(cell cortex);GO:0007275(multicellular organism development);GO:0007399(nervous system development);GO:0016020(membrane);GO:0016239(positive regulation of macroautophagy);GO:0030154(cell differentiation);GO:0030695(GTPase regulator activity);GO:0032991(protein-containing complex);GO:0034260(negative regulation of GTPase activity);GO:0050790(regulation of catalytic activity);GO:1905098(negative regulation of guanyl-nucleotide exchange factor activity)","05030(Cocaine addiction)",{"v":1.6e-24,"d":"0.00"},2,"183,117,","0,690",{"v":-0.999,"d":"-1.00"},{"v":0.0204173794466953,"d":"0.02"},1.26,"5' UTR",9,136355530,136359601,4072,1]
["chr9",137057799,137062461,4663,"ENSG00000186193","ENST00000409687","protein_coding",8096,"SAPCD2","suppressor APC domain containing 2 [Source:HGNC Symbol;Acc:HGNC:28055]","GO:0000132(establishment of mitotic spindle orientation);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005923(bicellular tight junction);GO:0005938(cell cortex);GO:0007049(cell cycle);GO:0008284(positive regulation of cell population proliferation);GO:0016020(membrane);GO:0016324(apical plasma membrane);GO:0030054(cell junction);GO:0043296(apical junction complex);GO:0045179(apical cortex);GO:0051301(cell division);GO:0090175(regulation of establishment of planar polarity);GO:0098725(symmetric cell division);GO:1904777(negative regulation of protein localization to cell cortex)","NA",{"v":3.2e-100,"d":"0.00"},2,"31,134,","0,4529",{"v":-2.7,"d":"-2.70"},{"v":1.54881661891248E-4,"d":"0.00"},1.24,"3' UTR",9,137062127,137070557,8431,2]
["chr9",21994598,21995301,704,"ENSG00000147889","ENST00000579755","protein_coding",0,"CDKN2A","cyclin dependent kinase inhibitor 2A [Source:HGNC Symbol;Acc:HGNC:1787]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0000209(protein polyubiquitination);GO:0001953(negative regulation of cell-matrix adhesion);GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0004861(cyclin-dependent protein serine/threonine kinase inhibitor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006364(rRNA processing);GO:0006469(negative regulation of protein kinase activity);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0007049(cell cycle);GO:0007050(cell cycle arrest);GO:0007265(Ras protein signal transduction);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell population proliferation);GO:0008637(apoptotic mitochondrial changes);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0010628(positive regulation of gene expression);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016925(protein sumoylation);GO:0019789(SUMO transferase activity);GO:0019901(protein kinase binding);GO:0030308(negative regulation of cell growth);GO:0030889(negative regulation of B cell proliferation);GO:0031647(regulation of protein stability);GO:0031648(protein destabilization);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0033088(negative regulation of immature T cell proliferation in thymus);GO:0033235(positive regulation of protein sumoylation);GO:0034393(positive regulation of smooth muscle cell apoptotic process);GO:0035985(senescence-associated heterochromatin focus);GO:0035986(senescence-associated heterochromatin focus assembly);GO:0042326(negative regulation of phosphorylation);GO:0043065(positive regulation of apoptotic process);GO:0045736(negative regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048103(somatic stem cell division);GO:0050821(protein stabilization);GO:0051059(NF-kappaB binding);GO:0051444(negative regulation of ubiquitin-protein transferase activity);GO:0055105(ubiquitin-protein transferase inhibitor activity);GO:0070534(protein K63-linked ubiquitination);GO:0090398(cellular senescence);GO:0090399(replicative senescence);GO:0097718(disordered domain specific binding);GO:1902510(regulation of apoptotic DNA fragmentation);GO:1904667(negative regulation of ubiquitin protein ligase activity);GO:1990000(amyloid fibril formation);GO:1990948(ubiquitin ligase inhibitor activity);GO:2000059(negative regulation of ubiquitin-dependent protein catabolic process);GO:2000111(positive regulation of macrophage apoptotic process);GO:2000134(negative regulation of G1/S transition of mitotic cell cycle);GO:2000435(negative regulation of protein neddylation);GO:2000774(positive regulation of cellular senescence)","01522(Endocrine resistance);01524(Platinum drug resistance);04110(Cell cycle);04115(p53 signaling pathway);04218(Cellular senescence);04934(Cushing syndrome);05163(Human cytomegalovirus infection);05166(Human T-cell leukemia virus 1 infection);05200(Pathways in cancer);05203(Viral carcinogenesis);05206(MicroRNAs in cancer);05212(Pancreatic cancer);05214(Glioma);05218(Melanoma);05219(Bladder cancer);05220(Chronic myeloid leukemia);05223(Non-small cell lung cancer);05225(Hepatocellular carcinoma)",{"v":1e-05,"d":"0.00"},2,"27,481,","0,223",-1.28,{"v":0.00851138038202377,"d":"0.01"},1.85,"5' UTR",9,21967753,21994624,26872,2]
["chr9",32550912,32552586,1675,"ENSG00000197579","ENST00000360538","protein_coding",0,"TOPORS","TOP1 binding arginine/serine rich protein [Source:HGNC Symbol;Acc:HGNC:21653]","GO:0000151(ubiquitin ligase complex);GO:0000209(protein polyubiquitination);GO:0000922(spindle pole);GO:0000930(gamma-tubulin complex);GO:0003677(DNA binding);GO:0003823(antigen binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005814(centriole);GO:0005868(cytoplasmic dynein complex);GO:0006351(transcription, DNA-templated);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006513(protein monoubiquitination);GO:0006974(cellular response to DNA damage stimulus);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0010842(retina layer formation);GO:0016605(PML body);GO:0016607(nuclear speck);GO:0016740(transferase activity);GO:0016925(protein sumoylation);GO:0019789(SUMO transferase activity);GO:0030496(midbody);GO:0032391(photoreceptor connecting cilium);GO:0034504(protein localization to nucleus);GO:0035845(photoreceptor cell outer segment organization);GO:0036064(ciliary basal body);GO:0042127(regulation of cell population proliferation);GO:0042771(intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:0043066(negative regulation of apoptotic process);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0044547(DNA topoisomerase binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046548(retinal rod cell development);GO:0046549(retinal cone cell development);GO:0046872(metal ion binding);GO:0051443(positive regulation of ubiquitin-protein transferase activity);GO:0051457(maintenance of protein location in nucleus);GO:0061630(ubiquitin protein ligase activity);GO:0070936(protein K48-linked ubiquitination)","NA",{"v":4.5e-09,"d":"0.00"},2,"57,153,","0,1522",-0.81,{"v":0.0380189396320561,"d":"0.04"},1.08,"5' UTR",9,32540544,32552586,12043,2]
["chr8",232884,240345,7462,"ENSG00000272240","ENST00000606572","antisense",0,"AC004908","novel transcript, antisense to ZNF596","NA","NA",{"v":2.5e-05,"d":"0.00"},2,"166,44,","0,7418",{"v":-0.782,"d":"-0.78"},{"v":0.0416869383470335,"d":"0.04"},2.87,"5' UTR",8,234347,234887,541,2]
["chr9",39445636,39447189,1554,"ENSG00000198416","ENST00000615961","processed_transcript",0,"ZNF658B","zinc finger protein 658B (pseudogene) [Source:HGNC Symbol;Acc:HGNC:32033]","NA","NA",{"v":6.3e-60,"d":"0.00"},1,"1554,",0,{"v":-0.761,"d":"-0.76"},{"v":0.0446683592150963,"d":"0.04"},1.37,"Exon (ENST00000615961/ENSG00000198416, exon 1 of 1)",9,39443815,39447189,3375,2]
["chr9",130237124,130237273,150,"ENSG00000107130","ENST00000372398","protein_coding",64720,"NCS1","neuronal calcium sensor 1 [Source:HGNC Symbol;Acc:HGNC:3953]","GO:0000287(magnesium ion binding);GO:0005245(voltage-gated calcium channel activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0010975(regulation of neuron projection development);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0019901(protein kinase binding);GO:0030054(cell junction);GO:0030424(axon);GO:0030425(dendrite);GO:0031045(dense core granule);GO:0031410(cytoplasmic vesicle);GO:0043231(intracellular membrane-bounded organelle);GO:0044305(calyx of Held);GO:0045202(synapse);GO:0045211(postsynaptic membrane);GO:0045921(positive regulation of exocytosis);GO:0046872(metal ion binding);GO:0048015(phosphatidylinositol-mediated signaling);GO:0048471(perinuclear region of cytoplasm);GO:0070588(calcium ion transmembrane transport);GO:0098794(postsynapse);GO:0098978(glutamatergic synapse);GO:0099509(regulation of presynaptic cytosolic calcium ion concentration);GO:0099523(presynaptic cytosol);GO:0099524(postsynaptic cytosol);GO:0099626(voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels);GO:2000300(regulation of synaptic vesicle exocytosis)","NA",{"v":0.0032,"d":"0.00"},1,"150,",0,-1.74,{"v":0.00218776162394955,"d":"0.00"},2.89,"3' UTR",9,130172404,130237303,64900,1]
["chr9",107485388,107487084,1697,"ENSG00000136826","ENST00000497048","retained_intron",1363,"KLF4","Kruppel like factor 4 [Source:HGNC Symbol;Acc:HGNC:6348]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000785(chromatin);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0000987(proximal promoter sequence-specific DNA binding);GO:0001010(RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity);GO:0001085(RNA polymerase II transcription factor binding);GO:0001221(transcription cofactor binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003690(double-stranded DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005719(nuclear euchromatin);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006366(transcription by RNA polymerase II);GO:0007500(mesodermal cell fate determination);GO:0008013(beta-catenin binding);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0008285(negative regulation of cell population proliferation);GO:0009913(epidermal cell differentiation);GO:0010033(response to organic substance);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0014067(negative regulation of phosphatidylinositol 3-kinase signaling);GO:0014740(negative regulation of muscle hyperplasia);GO:0016525(negative regulation of angiogenesis);GO:0019827(stem cell population maintenance);GO:0030154(cell differentiation);GO:0030336(negative regulation of cell migration);GO:0031077(post-embryonic camera-type eye development);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0032270(positive regulation of cellular protein metabolic process);GO:0032526(response to retinoic acid);GO:0034115(negative regulation of heterotypic cell-cell adhesion);GO:0035014(phosphatidylinositol 3-kinase regulator activity);GO:0035019(somatic stem cell population maintenance);GO:0035166(post-embryonic hemopoiesis);GO:0042127(regulation of cell population proliferation);GO:0042826(histone deacetylase binding);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0043551(regulation of phosphatidylinositol 3-kinase activity);GO:0043565(sequence-specific DNA binding);GO:0044212(transcription regulatory region DNA binding);GO:0044798(nuclear transcription factor complex);GO:0045415(negative regulation of interleukin-8 biosynthetic process);GO:0045429(positive regulation of nitric oxide biosynthetic process);GO:0045444(fat cell differentiation);GO:0045595(regulation of cell differentiation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0046985(positive regulation of hemoglobin biosynthetic process);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0048679(regulation of axon regeneration);GO:0048730(epidermis morphogenesis);GO:0050728(negative regulation of inflammatory response);GO:0051247(positive regulation of protein metabolic process);GO:0051898(negative regulation of protein kinase B signaling);GO:0051973(positive regulation of telomerase activity);GO:0060070(canonical Wnt signaling pathway);GO:0060761(negative regulation of response to cytokine stimulus);GO:0061614(pri-miRNA transcription by RNA polymerase II);GO:0070301(cellular response to hydrogen peroxide);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0071300(cellular response to retinoic acid);GO:0071363(cellular response to growth factor stimulus);GO:0071407(cellular response to organic cyclic compound);GO:0071409(cellular response to cycloheximide);GO:0071499(cellular response to laminar fluid shear stress);GO:0090051(negative regulation of cell migration involved in sprouting angiogenesis);GO:1901653(cellular response to peptide);GO:1903672(positive regulation of sprouting angiogenesis);GO:1904798(positive regulation of core promoter binding);GO:1904998(negative regulation of leukocyte adhesion to arterial endothelial cell);GO:1990830(cellular response to leukemia inhibitory factor);GO:1990841(promoter-specific chromatin binding);GO:2000134(negative regulation of G1/S transition of mitotic cell cycle);GO:2000342(negative regulation of chemokine (C-X-C motif) ligand 2 production)","04550(Signaling pathways regulating pluripotency of stem cells)",{"v":3.2e-16,"d":"0.00"},2,"539,57,","0,1640",-1.19,{"v":0.0114815362149688,"d":"0.01"},1.31,"3' UTR",9,107484852,107488447,3596,2]
["chr9",120579930,120580170,241,"ENSG00000136861","ENST00000360822","protein_coding",0,"CDK5RAP2","CDK5 regulatory subunit associated protein 2 [Source:HGNC Symbol;Acc:HGNC:18672]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0000132(establishment of mitotic spindle orientation);GO:0000226(microtubule cytoskeleton organization);GO:0000242(pericentriolar material);GO:0000922(spindle pole);GO:0001578(microtubule bundle formation);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0007059(chromosome segregation);GO:0007098(centrosome cycle);GO:0007099(centriole replication);GO:0007420(brain development);GO:0008017(microtubule binding);GO:0008274(gamma-tubulin ring complex);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0015631(tubulin binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019901(protein kinase binding);GO:0022008(neurogenesis);GO:0030054(cell junction);GO:0031023(microtubule organizing center organization);GO:0031116(positive regulation of microtubule polymerization);GO:0035371(microtubule plus-end);GO:0043015(gamma-tubulin binding);GO:0044212(transcription regulatory region DNA binding);GO:0045664(regulation of neuron differentiation);GO:0045665(negative regulation of neuron differentiation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046600(negative regulation of centriole replication);GO:0048471(perinuclear region of cytoplasm);GO:0070062(extracellular exosome);GO:0090266(regulation of mitotic cell cycle spindle assembly checkpoint);GO:0097431(mitotic spindle pole);GO:0097711(ciliary basal body-plasma membrane docking)","NA",{"v":7.9e-22,"d":"0.00"},1,"241,",0,{"v":-0.738,"d":"-0.74"},{"v":0.0489778819368446,"d":"0.05"},1.27,"5' UTR",9,120388869,120580170,191302,2]
["chr9",120952335,120952605,271,"ENSG00000106804","ENST00000223642","protein_coding",97671,"C5","complement C5 [Source:HGNC Symbol;Acc:HGNC:1331]","GO:0000187(activation of MAPK activity);GO:0001701(in utero embryonic development);GO:0002376(immune system process);GO:0004866(endopeptidase inhibitor activity);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005579(membrane attack complex);GO:0005615(extracellular space);GO:0006935(chemotaxis);GO:0006954(inflammatory response);GO:0006956(complement activation);GO:0006957(complement activation, alternative pathway);GO:0006958(complement activation, classical pathway);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0008009(chemokine activity);GO:0010575(positive regulation of vascular endothelial growth factor production);GO:0010760(negative regulation of macrophage chemotaxis);GO:0010951(negative regulation of endopeptidase activity);GO:0019835(cytolysis);GO:0030449(regulation of complement activation);GO:0045087(innate immune response);GO:0045766(positive regulation of angiogenesis);GO:0060326(cell chemotaxis);GO:0070062(extracellular exosome);GO:0090197(positive regulation of chemokine secretion)","04080(Neuroactive ligand-receptor interaction);04610(Complement and coagulation cascades);05020(Prion diseases);05133(Pertussis);05150(Staphylococcus aureus infection);05168(Herpes simplex virus 1 infection);05322(Systemic lupus erythematosus)",{"v":6.2e-09,"d":"0.00"},1,"271,",0,{"v":-0.962,"d":"-0.96"},{"v":0.0229086765276777,"d":"0.02"},1.85,"3' UTR",9,120952335,121050276,97942,2]
["chr9",123109494,123109973,480,"ENSG00000165209","ENST00000530364","processed_transcript",12250,"STRBP","spermatid perinuclear RNA binding protein [Source:HGNC Symbol;Acc:HGNC:16462]","GO:0002177(manchette);GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0003725(double-stranded RNA binding);GO:0003727(single-stranded RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0007275(multicellular organism development);GO:0007283(spermatogenesis);GO:0007286(spermatid development);GO:0007638(mechanosensory behavior);GO:0008017(microtubule binding);GO:0015630(microtubule cytoskeleton);GO:0015631(tubulin binding);GO:0030154(cell differentiation)","NA",{"v":2e-42,"d":"0.00"},1,"480,",0,-1.34,{"v":0.00707945784384138,"d":"0.01"},1.28,"3' UTR",9,123109500,123122223,12724,2]
["chr9",123109500,123116005,6506,"ENSG00000236901","ENST00000449175","sense_intronic",0,"MIR600HG","MIR600 host gene [Source:HGNC Symbol;Acc:HGNC:23642]","NA","NA",{"v":7.9e-41,"d":"0.00"},3,"254,120,77,","0,6264,6429",-1.01,{"v":0.0194984459975805,"d":"0.02"},1.08,"3' UTR",9,123109494,123115477,5984,2]
["chr9",123381933,123382443,511,"ENSG00000119522","ENST00000473039","processed_transcript",416072,"DENND1A","DENN domain containing 1A [Source:HGNC Symbol;Acc:HGNC:29324]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006897(endocytosis);GO:0008289(lipid binding);GO:0015031(protein transport);GO:0016020(membrane);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017124(SH3 domain binding);GO:0017137(Rab GTPase binding);GO:0030054(cell junction);GO:0030136(clathrin-coated vesicle);GO:0030425(dendrite);GO:0030665(clathrin-coated vesicle membrane);GO:0031410(cytoplasmic vesicle);GO:0032266(phosphatidylinositol-3-phosphate binding);GO:0032456(endocytic recycling);GO:0032483(regulation of Rab protein signal transduction);GO:0042734(presynaptic membrane);GO:0043025(neuronal cell body);GO:0043231(intracellular membrane-bounded organelle);GO:0043547(positive regulation of GTPase activity);GO:0045202(synapse);GO:0048488(synaptic vesicle endocytosis);GO:1901981(phosphatidylinositol phosphate binding)","NA",{"v":5.9e-09,"d":"0.00"},1,"511,",0,-1.78,{"v":0.00194984459975805,"d":"0.00"},1.28,"Exon (ENST00000473039/ENSG00000119522, exon 18 of 18)",9,123379654,123798515,418862,2]
["chr9",124952353,124952593,241,"ENSG00000173611","ENST00000336505","protein_coding",190903,"SCAI","suppressor of cancer cell invasion [Source:HGNC Symbol;Acc:HGNC:26709]","GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-templated);GO:0009968(negative regulation of signal transduction);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030336(negative regulation of cell migration);GO:0031965(nuclear membrane);GO:0035024(negative regulation of Rho protein signal transduction);GO:1903507(negative regulation of nucleic acid-templated transcription)","NA",{"v":4.5e-06,"d":"0.00"},1,"241,",0,{"v":-0.993,"d":"-0.99"},{"v":0.0208929613085404,"d":"0.02"},1.86,"3' UTR",9,124942608,125143496,200889,2]
["chr9",127980212,127980451,240,"ENSG00000167106","ENST00000373095","protein_coding",538,"FAM102A","family with sequence similarity 102 member A [Source:HGNC Symbol;Acc:HGNC:31419]","GO:0005515(protein binding)","NA",{"v":4.1e-06,"d":"0.00"},1,"240,",0,{"v":-0.924,"d":"-0.92"},{"v":0.0263026799189538,"d":"0.03"},1.39,"5' UTR",9,127940582,127980989,40408,2]
["chr9",133663590,133663859,270,"ENSG00000123453","ENST00000439388","protein_coding",74493,"SARDH","sarcosine dehydrogenase [Source:HGNC Symbol;Acc:HGNC:10536]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0008150(biological_process);GO:0008480(sarcosine dehydrogenase activity);GO:0016491(oxidoreductase activity);GO:0042426(choline catabolic process);GO:0055114(oxidation-reduction process);GO:1901053(sarcosine catabolic process)","00260(Glycine, serine and threonine metabolism)",{"v":2.3E-6,"d":"0.00"},1,"270,",0,{"v":-0.737,"d":"-0.74"},{"v":0.0489778819368446,"d":"0.05"},1.87,"3' UTR",9,133663560,133738352,74793,2]
["chr9",137618608,137618757,150,"ENSG00000203993","ENST00000371417","antisense",56,"ARRDC1-AS1","ARRDC1 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:23395]","NA","NA",{"v":0.0035,"d":"0.00"},1,"150,",0,-1.67,{"v":2.63026799189538E-3,"d":"0.00"},1.25,"Exon (ENST00000371417/ENSG00000203993, exon 1 of 3)",9,137615332,137618813,3482,2]
["chr10",38017325,38017534,210,"ENSG00000189180","ENST00000307441","protein_coding",6675,"ZNF33A","zinc finger protein 33A [Source:HGNC Symbol;Acc:HGNC:13096]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":5e-13,"d":"0.00"},1,"210,",0,{"v":-0.769,"d":"-0.77"},{"v":0.0436515832240166,"d":"0.04"},1.09,"5' UTR",10,38010650,38060063,49414,1]
["chr10",38123411,38124610,1200,"ENSG00000075407","ENST00000638053","protein_coding",29077,"ZNF37A","zinc finger protein 37A [Source:HGNC Symbol;Acc:HGNC:13102]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":1e-131,"d":"0.00"},1,"1200,",0,-1.88,{"v":0.00144543977074593,"d":"0.00"},1.02,"3' UTR",10,38094334,38150293,55960,1]
["chr22",29438613,29438852,240,"ENSG00000128250","ENST00000354373","protein_coding",30,"RFPL1","ret finger protein like 1 [Source:HGNC Symbol;Acc:HGNC:9977]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0007049(cell cycle);GO:0008285(negative regulation of cell population proliferation);GO:0010972(negative regulation of G2/M transition of mitotic cell cycle);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0043065(positive regulation of apoptotic process);GO:0045930(negative regulation of mitotic cell cycle);GO:0046872(metal ion binding);GO:0051782(negative regulation of cell division);GO:2001272(positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis)","NA",{"v":8.1e-07,"d":"0.00"},1,"240,",0,-1.79,{"v":0.00190546071796325,"d":"0.00"},2.89,"5' UTR",22,29438583,29442455,3873,1]
["chr10",4650395,4651174,780,"ENSG00000231298","ENST00000430998","lincRNA",26980,"MANCR","mitotically associated long non coding RNA [Source:HGNC Symbol;Acc:HGNC:44678]","NA","NA",{"v":5e-11,"d":"0.00"},1,"780,",0,-1.23,0.01,2.91,"Exon (ENST00000430998/ENSG00000231298, exon 4 of 4)",10,4650185,4678154,27970,2]
["chr10",50630682,50631612,931,"ENSG00000231588","ENST00000437111","processed_pseudogene",0,"SHQ1P1","SHQ1, H/ACA ribonucleoprotein assembly factor pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:45013]","NA","NA",{"v":1.3E-11,"d":"0.00"},1,"931,",0,{"v":-0.773,"d":"-0.77"},{"v":0.0426579518801593,"d":"0.04"},1.21,"Exon (ENST00000443374/ENSG00000226200, exon 4 of 4)",10,50629532,50631075,1544,2]
["chr10",50658635,50660268,1634,"ENSG00000231345","ENST00000449695","processed_transcript",2668,"BEND3P1","BEN domain containing 3 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:45014]","NA","NA",{"v":1.3e-91,"d":"0.00"},1,"1634,",0,-4.69,{"v":8.51138038202376e-07,"d":"0.00"},1.18,"Exon (ENST00000449695/ENSG00000231345, exon 2 of 2)",10,50655967,50660268,4302,1]
["chr17",754312,754888,577,"ENSG00000231784","ENST00000536214","processed_transcript",1652,"DBIL5P","diazepam binding inhibitor-like 5, pseudogene [Source:HGNC Symbol;Acc:HGNC:38519]","NA","NA",{"v":2E-12,"d":"0.00"},2,"20,481,","0,96",-1.77,{"v":0.00199526231496888,"d":"0.00"},2.91,"Exon (ENST00000536214/ENSG00000231784, exon 1 of 1)",17,752660,755336,2677,1]
["chr10",79826498,79826737,240,"ENSG00000225484","ENST00000601369","antisense",0,"NUTM2B-AS1","NUTM2B antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:51204]","NA","NA",{"v":7.6e-06,"d":"0.00"},1,"240,",0,{"v":-0.959,"d":"-0.96"},{"v":0.0234422881531992,"d":"0.02"},{"v":1.6,"d":"1.60"},"Exon (ENST00000605920/ENSG00000272447, exon 1 of 1)",10,79691502,79826516,135015,2]
["chr5",65591778,65594529,2752,"ENSG00000113595","ENST00000231524","protein_coding",29804,"TRIM23","tripartite motif containing 23 [Source:HGNC Symbol;Acc:HGNC:660]","GO:0000139(Golgi membrane);GO:0000166(nucleotide binding);GO:0002376(immune system process);GO:0003676(nucleic acid binding);GO:0003924(GTPase activity);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0006886(intracellular protein transport);GO:0006893(Golgi to plasma membrane transport);GO:0008047(enzyme activator activity);GO:0008270(zinc ion binding);GO:0012505(endomembrane system);GO:0016020(membrane);GO:0016032(viral process);GO:0016192(vesicle-mediated transport);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0019003(GDP binding);GO:0042802(identical protein binding);GO:0043085(positive regulation of catalytic activity);GO:0045087(innate immune response);GO:0046872(metal ion binding)","NA",{"v":2.6e-05,"d":"0.00"},2,"171,9,","0,2743",-1.68,{"v":0.00257039578276886,"d":"0.00"},2.92,"Exon (ENST00000231524/ENSG00000113595, exon 10 of 11)",5,65589690,65624333,34644,2]
["chr10",110871855,110880325,8471,"ENSG00000150593","ENST00000467574","processed_transcript",0,"PDCD4","programmed cell death 4 [Source:HGNC Symbol;Acc:HGNC:8763]","GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006915(apoptotic process);GO:0007569(cell aging);GO:0030509(BMP signaling pathway);GO:0034393(positive regulation of smooth muscle cell apoptotic process);GO:0035722(interleukin-12-mediated signaling pathway);GO:0043066(negative regulation of apoptotic process);GO:0043508(negative regulation of JUN kinase activity);GO:0045786(negative regulation of cell cycle);GO:0045892(negative regulation of transcription, DNA-templated);GO:0050729(positive regulation of inflammatory response);GO:0051246(regulation of protein metabolic process);GO:0060940(epithelial to mesenchymal transition involved in cardiac fibroblast development);GO:0071222(cellular response to lipopolysaccharide);GO:1900016(negative regulation of cytokine production involved in inflammatory response);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:1904706(negative regulation of vascular smooth muscle cell proliferation);GO:1904761(negative regulation of myofibroblast differentiation);GO:1905064(negative regulation of vascular smooth muscle cell differentiation);GO:1905461(positive regulation of vascular associated smooth muscle cell apoptotic process);GO:2000353(positive regulation of endothelial cell apoptotic process)","05205(Proteoglycans in cancer);05206(MicroRNAs in cancer)",{"v":1.6E-51,"d":"0.00"},4,"164,105,84,7,","0,4111,4815,8464",-1.99,{"v":0.00107151930523761,"d":"0.00"},{"v":1.2,"d":"1.20"},"5' UTR",10,110871893,110887761,15869,1]
["chr10",46634831,46634975,145,"ENSG00000165874","ENST00000497389","transcribed_unprocessed_pseudogene",17050,"SHLD2P1","shieldin complex subunit 2 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:31425]","NA","NA",{"v":1.6E-11,"d":"0.00"},1,"145,",0,-5.79,{"v":5.01187233627272e-08,"d":"0.00"},2.92,"Exon (ENST00000605984/ENSG00000272430, exon 3 of 4)",10,46610474,46652025,41552,2]
["chr10",118040139,118045304,5166,"ENSG00000107560","ENST00000483413","retained_intron",0,"RAB11FIP2","RAB11 family interacting protein 2 [Source:HGNC Symbol;Acc:HGNC:29152]","GO:0003091(renal water homeostasis);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005768(endosome);GO:0005886(plasma membrane);GO:0015031(protein transport);GO:0016020(membrane);GO:0017137(Rab GTPase binding);GO:0019901(protein kinase binding);GO:0030010(establishment of cell polarity);GO:0030659(cytoplasmic vesicle membrane);GO:0035773(insulin secretion involved in cellular response to glucose stimulus);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043231(intracellular membrane-bounded organelle);GO:0045055(regulated exocytosis);GO:0055038(recycling endosome membrane);GO:1903078(positive regulation of protein localization to plasma membrane)","04144(Endocytosis)",{"v":1e-36,"d":"0.00"},3,"204,125,29,","0,3302,5137",{"v":-0.765,"d":"-0.77"},{"v":0.0446683592150963,"d":"0.04"},{"v":1.1,"d":"1.10"},"Exon (ENST00000451610/ENSG00000231104, exon 2 of 3)",10,118038924,118040312,1389,2]
["chr10",132167960,132169950,1991,"ENSG00000188385","ENST00000298622","protein_coding",63289,"JAKMIP3","Janus kinase and microtubule interacting protein 3 [Source:HGNC Symbol;Acc:HGNC:23523]","GO:0005794(Golgi apparatus);GO:0008017(microtubule binding);GO:0019900(kinase binding)","NA",{"v":1.6e-30,"d":"0.00"},2,"1074,95,","0,1896",-2.95,{"v":8.12830516164099e-05,"d":"0.00"},{"v":1.6,"d":"1.60"},"3' UTR",10,132104671,132184809,80139,1]
["chr1",173894372,173894822,451,"ENSG00000185278","ENST00000367701","protein_coding",25416,"ZBTB37","zinc finger and BTB domain containing 37 [Source:HGNC Symbol;Acc:HGNC:28365]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","NA",{"v":2.5E-15,"d":"0.00"},1,"451,",0,-1.46,{"v":0.00489778819368446,"d":"0.00"},2.97,"3' UTR",1,173868956,173903549,34594,1]
["chr10",17590048,17590316,269,"ENSG00000165996","ENST00000361271","protein_coding",27058,"HACD1","3-hydroxyacyl-CoA dehydratase 1 [Source:HGNC Symbol;Acc:HGNC:9639]","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0007275(multicellular organism development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016829(lyase activity);GO:0018812(3-hydroxyacyl-CoA dehydratase activity);GO:0030148(sphingolipid biosynthetic process);GO:0030497(fatty acid elongation);GO:0035338(long-chain fatty-acyl-CoA biosynthetic process);GO:0042761(very long-chain fatty acid biosynthetic process);GO:0102158(very-long-chain 3-hydroxyacyl-CoA dehydratase activity);GO:0102343(3-hydroxy-arachidoyl-CoA dehydratase activity);GO:0102344(3-hydroxy-behenoyl-CoA dehydratase activity);GO:0102345(3-hydroxy-lignoceroyl-CoA dehydratase activity)","00062(Fatty acid elongation);01040(Biosynthesis of unsaturated fatty acids)",{"v":7.9e-18,"d":"0.00"},1,"269,",0,{"v":-0.928,"d":"-0.93"},{"v":0.0257039578276886,"d":"0.03"},1.03,"3' UTR",10,17589032,17617374,28343,2]
["chr10",37828934,37829923,990,"ENSG00000198105","ENST00000615949","protein_coding",27274,"ZNF248","zinc finger protein 248 [Source:HGNC Symbol;Acc:HGNC:13041]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":9.99999999999999e-220,"d":"0.00"},1,"990,",0,-4.34,{"v":2.04173794466953e-06,"d":"0.00"},1.54,"3' UTR",10,37776526,37857197,80672,2]
["chr11",64778982,64779405,424,"ENSG00000269038","ENST00000594089","lincRNA",28,"AP001462","novel transcript","NA","NA",{"v":7.6e-07,"d":"0.00"},1,"424,",0,-0.82,{"v":0.0371535229097173,"d":"0.04"},2.98,"Exon (ENST00000594089/ENSG00000269038, exon 1 of 1)",11,64778954,64779405,452,1]
["chr10",73805957,73806397,441,"ENSG00000166507","ENST00000299641","protein_coding",2334,"NDST2","N-deacetylase and N-sulfotransferase 2 [Source:HGNC Symbol;Acc:HGNC:7681]","GO:0000139(Golgi membrane);GO:0003824(catalytic activity);GO:0005794(Golgi apparatus);GO:0006024(glycosaminoglycan biosynthetic process);GO:0008146(sulfotransferase activity);GO:0008152(metabolic process);GO:0015012(heparan sulfate proteoglycan biosynthetic process);GO:0015014(heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process);GO:0015016([heparan sulfate]-glucosamine N-sulfotransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016787(hydrolase activity);GO:0019213(deacetylase activity);GO:0030210(heparin biosynthetic process);GO:0034483(heparan sulfate sulfotransferase activity);GO:0042328(heparan sulfate N-acetylglucosaminyltransferase activity)","00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)",{"v":5e-32,"d":"0.00"},2,"72,109,","0,332",-8.18,{"v":1.28824955169313e-10,"d":"0.00"},1.94,"Exon (ENST00000603027/ENSG00000272916, exon 6 of 17)",10,73801911,73808731,6821,2]
["chr10",73805953,73806392,440,"ENSG00000166507","ENST00000299641","protein_coding",2339,"NDST2","N-deacetylase and N-sulfotransferase 2 [Source:HGNC Symbol;Acc:HGNC:7681]","GO:0000139(Golgi membrane);GO:0003824(catalytic activity);GO:0005794(Golgi apparatus);GO:0006024(glycosaminoglycan biosynthetic process);GO:0008146(sulfotransferase activity);GO:0008152(metabolic process);GO:0015012(heparan sulfate proteoglycan biosynthetic process);GO:0015014(heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process);GO:0015016([heparan sulfate]-glucosamine N-sulfotransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016787(hydrolase activity);GO:0019213(deacetylase activity);GO:0030210(heparin biosynthetic process);GO:0034483(heparan sulfate sulfotransferase activity);GO:0042328(heparan sulfate N-acetylglucosaminyltransferase activity)","00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)",{"v":3.2e-33,"d":"0.00"},2,"76,104,","0,336",-8.07,{"v":1.69824365246175e-10,"d":"0.00"},1.94,"Exon (ENST00000603027/ENSG00000272916, exon 6 of 17)",10,73801911,73808731,6821,2]
["chr4",77169743,77170012,270,"ENSG00000138764","ENST00000316355","protein_coding",12536,"CCNG2","cyclin G2 [Source:HGNC Symbol;Acc:HGNC:1593]","GO:0000079(regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0000278(mitotic cell cycle);GO:0000307(cyclin-dependent protein kinase holoenzyme complex);GO:0004672(protein kinase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0007049(cell cycle);GO:0007088(regulation of mitotic nuclear division);GO:0008284(positive regulation of cell population proliferation);GO:0016538(cyclin-dependent protein serine/threonine kinase regulator activity);GO:0019901(protein kinase binding);GO:0045787(positive regulation of cell cycle);GO:0051301(cell division);GO:0051726(regulation of cell cycle)","04068(FoxO signaling pathway);04115(p53 signaling pathway)",{"v":3.8e-05,"d":"0.00"},1,"270,",0,-1.27,{"v":0.0087096358995608,"d":"0.01"},3,"3' UTR",4,77157207,77170060,12854,1]
["chr10",89278468,89292193,13726,"ENSG00000119922","ENST00000638108","protein_coding",0,"IFIT2","interferon induced protein with tetratricopeptide repeats 2 [Source:HGNC Symbol;Acc:HGNC:5409]","GO:0002376(immune system process);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006915(apoptotic process);GO:0008637(apoptotic mitochondrial changes);GO:0009615(response to virus);GO:0032091(negative regulation of protein binding);GO:0035457(cellular response to interferon-alpha);GO:0043065(positive regulation of apoptotic process);GO:0045087(innate immune response);GO:0051607(defense response to virus);GO:0060337(type I interferon signaling pathway)","NA",{"v":4.8E-8,"d":"0.00"},2,"36,203,","0,13523",{"v":-2.7,"d":"-2.70"},{"v":1.54881661891248E-4,"d":"0.00"},1.89,"5' UTR",10,89283694,89308900,25207,1]
["chr10",94361822,94362929,1108,"ENSG00000173145","ENST00000371361","protein_coding",10,"NOC3L","NOC3 like DNA replication regulator [Source:HGNC Symbol;Acc:HGNC:24034]","GO:0003682(chromatin binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005739(mitochondrion);GO:0016607(nuclear speck);GO:0045444(fat cell differentiation)","NA",{"v":0.0012,"d":"0.00"},2,"51,100,","0,1008",{"v":-0.903,"d":"-0.90"},{"v":0.0281838293126445,"d":"0.03"},1.36,"5' UTR",10,94333226,94362939,29714,2]
["chr12",65851639,65857157,5519,"ENSG00000149948","ENST00000403681","protein_coding",27508,"HMGA2","high mobility group AT-hook 2 [Source:HGNC Symbol;Acc:HGNC:5009]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000228(nuclear chromosome);GO:0000785(chromatin);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001837(epithelial to mesenchymal transition);GO:0002062(chondrocyte differentiation);GO:0003131(mesodermal-endodermal cell signaling);GO:0003677(DNA binding);GO:0003680(AT DNA binding);GO:0003712(transcription coregulator activity);GO:0003906(DNA-(apurinic or apyrimidinic site) endonuclease activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006284(base-excision repair);GO:0006325(chromatin organization);GO:0006355(regulation of transcription, DNA-templated);GO:0007049(cell cycle);GO:0007095(mitotic G2 DNA damage checkpoint);GO:0007275(multicellular organism development);GO:0008134(transcription factor binding);GO:0008301(DNA binding, bending);GO:0009615(response to virus);GO:0010564(regulation of cell cycle process);GO:0010628(positive regulation of gene expression);GO:0030261(chromosome condensation);GO:0031052(chromosome breakage);GO:0031492(nucleosomal DNA binding);GO:0031507(heterochromatin assembly);GO:0032993(protein-DNA complex);GO:0035497(cAMP response element binding);GO:0035500(MH2 domain binding);GO:0035501(MH1 domain binding);GO:0035978(histone H2A-S139 phosphorylation);GO:0035985(senescence-associated heterochromatin focus);GO:0035986(senescence-associated heterochromatin focus assembly);GO:0035987(endodermal cell differentiation);GO:0035988(chondrocyte proliferation);GO:0040008(regulation of growth);GO:0042769(DNA damage response, detection of DNA damage);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043392(negative regulation of DNA binding);GO:0043922(negative regulation by host of viral transcription);GO:0044212(transcription regulatory region DNA binding);GO:0045444(fat cell differentiation);GO:0045766(positive regulation of angiogenesis);GO:0045869(negative regulation of single stranded viral RNA replication via double stranded DNA intermediate);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046332(SMAD binding);GO:0048333(mesodermal cell differentiation);GO:0048762(mesenchymal cell differentiation);GO:0048863(stem cell differentiation);GO:0051301(cell division);GO:0051575(5'-deoxyribose-5-phosphate lyase activity);GO:0070742(C2H2 zinc finger domain binding);GO:0071141(SMAD protein complex);GO:0071158(positive regulation of cell cycle arrest);GO:0071864(positive regulation of cell proliferation in bone marrow);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:0090402(oncogene-induced cell senescence);GO:2000036(regulation of stem cell population maintenance);GO:2000648(positive regulation of stem cell proliferation);GO:2000679(positive regulation of transcription regulatory region DNA binding);GO:2000685(positive regulation of cellular response to X-ray);GO:2000773(negative regulation of cellular senescence);GO:2000774(positive regulation of cellular senescence);GO:2001022(positive regulation of response to DNA damage stimulus);GO:2001033(negative regulation of double-strand break repair via nonhomologous end joining);GO:2001038(regulation of cellular response to drug)","05202(Transcriptional misregulation in cancer);05206(MicroRNAs in cancer)",{"v":6.3e-43,"d":"0.00"},2,"14,1211,","0,4308",-2.92,{"v":8.70963589956081e-05,"d":"0.00"},3,"Exon (ENST00000439236/ENSG00000197301, exon 3 of 3)",12,65824131,65966295,142165,1]
["chr10",101784443,101784593,151,"ENSG00000198408","ENST00000439817","protein_coding",33872,"OGA","O-GlcNAcase [Source:HGNC Symbol;Acc:HGNC:7056]","GO:0004415(hyalurononglucosaminidase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006044(N-acetylglucosamine metabolic process);GO:0006493(protein O-linked glycosylation);GO:0006516(glycoprotein catabolic process);GO:0006517(protein deglycosylation);GO:0008152(metabolic process);GO:0009100(glycoprotein metabolic process);GO:0016020(membrane);GO:0016032(viral process);GO:0016231(beta-N-acetylglucosaminidase activity);GO:0016787(hydrolase activity);GO:0016798(hydrolase activity, acting on glycosyl bonds);GO:0102166([protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity);GO:0102167([protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity);GO:0102571([protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity)","04931(Insulin resistance)",{"v":9.5e-05,"d":"0.00"},1,"151,",0,{"v":-0.765,"d":"-0.77"},{"v":0.0446683592150963,"d":"0.04"},1.32,"3' UTR",10,101784443,101818465,34023,2]
["chr10",114135009,114145660,10652,"ENSG00000165813","ENST00000428953","protein_coding",0,"CCDC186","coiled-coil domain containing 186 [Source:HGNC Symbol;Acc:HGNC:24349]","GO:0009617(response to bacterium)","NA",{"v":1.9e-09,"d":"0.00"},6,"47,87,99,105,120,112,","0,882,1139,2177,9488,10540",{"v":-0.747,"d":"-0.75"},{"v":0.0467735141287198,"d":"0.05"},1.85,"Exon (ENST00000369287/ENSG00000165813, exon 5 of 16)",10,114124929,114144602,19674,2]
["chr15",81311385,81311833,449,"ENSG00000172345","ENST00000302824","protein_coding",12308,"STARD5","StAR related lipid transfer domain containing 5 [Source:HGNC Symbol;Acc:HGNC:18065]","GO:0005829(cytosol);GO:0006869(lipid transport);GO:0008289(lipid binding);GO:0015485(cholesterol binding);GO:0015721(bile acid and bile salt transport);GO:0017127(cholesterol transporter activity);GO:0032052(bile acid binding);GO:0070508(cholesterol import)","NA",{"v":1.4E-5,"d":"0.00"},1,"449,",0,{"v":-0.966,"d":"-0.97"},{"v":0.0223872113856834,"d":"0.02"},3.01,"3' UTR",15,81309053,81324141,15089,2]
["chr10",116885692,116886021,330,"ENSG00000187164","ENST00000355371","protein_coding",119166,"SHTN1","shootin 1 [Source:HGNC Symbol;Acc:HGNC:29319]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005875(microtubule associated complex);GO:0006930(substrate-dependent cell migration, cell extension);GO:0007265(Ras protein signal transduction);GO:0007275(multicellular organism development);GO:0007409(axonogenesis);GO:0015630(microtubule cytoskeleton);GO:0019894(kinesin binding);GO:0030027(lamellipodium);GO:0030175(filopodium);GO:0030424(axon);GO:0030426(growth cone);GO:0031252(cell leading edge);GO:0032488(Cdc42 protein signal transduction);GO:0038007(netrin-activated signaling pathway);GO:0042995(cell projection);GO:0043204(perikaryon);GO:0044295(axonal growth cone);GO:0045296(cadherin binding);GO:0045773(positive regulation of axon extension);GO:0048471(perinuclear region of cytoplasm);GO:0048812(neuron projection morphogenesis);GO:0051015(actin filament binding);GO:0060327(cytoplasmic actin-based contraction involved in cell motility);GO:0061163(endoplasmic reticulum polarization);GO:0061573(actin filament bundle retrograde transport);GO:2000114(regulation of establishment of cell polarity);GO:2001222(regulation of neuron migration);GO:2001224(positive regulation of neuron migration)","NA",{"v":4e-27,"d":"0.00"},1,"330,",0,-2.35,{"v":0.000398107170553497,"d":"0.00"},1.13,"3' UTR",10,116881477,117005187,123711,2]
["chr10",125707238,125707716,479,"ENSG00000224023","ENST00000419400","lincRNA",0,"EDRF1-DT","EDRF1 divergent transcript [Source:HGNC Symbol;Acc:HGNC:54128]","NA","NA",{"v":7.9e-23,"d":"0.00"},1,"479,",0,-1.02,{"v":0.0190546071796325,"d":"0.02"},1.13,"Exon (ENST00000415305/ENSG00000228021, exon 5 of 5)",10,125700437,125707549,7113,2]
["chr11",700625,700834,210,"ENSG00000177030","ENST00000525626","processed_transcript",5881,"DEAF1","DEAF1 transcription factor [Source:HGNC Symbol;Acc:HGNC:14677]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001650(fibrillar center);GO:0001662(behavioral fear response);GO:0001843(neural tube closure);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006366(transcription by RNA polymerase II);GO:0007275(multicellular organism development);GO:0007281(germ cell development);GO:0007399(nervous system development);GO:0008542(visual learning);GO:0009653(anatomical structure morphogenesis);GO:0033599(regulation of mammary gland epithelial cell proliferation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0048706(embryonic skeletal system development)","NA",{"v":3.2e-08,"d":"0.00"},1,"210,",0,-0.91,{"v":0.0275422870333817,"d":"0.03"},1.02,"3' UTR",11,686932,706715,19784,2]
["chr11",18588811,18599805,10995,"ENSG00000247595","ENST00000634992","protein_coding",0,"SPTY2D1OS","SPTY2D1 opposite strand [Source:HGNC Symbol;Acc:HGNC:44122]","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":1e-16,"d":"0.00"},3,"185,93,19,","0,6806,10976",-1.69,{"v":0.00251188643150958,"d":"0.00"},1.65,"5' UTR",11,18599787,18603822,4036,1]
["chr11",64357235,64357534,300,"ENSG00000168071","ENST00000356786","protein_coding",17031,"CCDC88B","coiled-coil domain containing 88B [Source:HGNC Symbol;Acc:HGNC:26757]","GO:0001819(positive regulation of cytokine production);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005856(cytoskeleton);GO:0008017(microtubule binding);GO:0016020(membrane);GO:0030705(cytoskeleton-dependent intracellular transport);GO:0031122(cytoplasmic microtubule organization);GO:0042102(positive regulation of T cell proliferation);GO:0042832(defense response to protozoan);GO:0050870(positive regulation of T cell activation);GO:0051959(dynein light intermediate chain binding)","NA",{"v":4.9E-9,"d":"0.00"},1,"300,",0,{"v":-1.5,"d":"-1.50"},{"v":0.00436515832240166,"d":"0.00"},1.32,"3' UTR",11,64340204,64357534,17331,1]
["chr2",171923535,171923864,330,"ENSG00000115840","ENST00000472748","processed_transcript",75991,"SLC25A12","solute carrier family 25 member 12 [Source:HGNC Symbol;Acc:HGNC:10982]","GO:0005313(L-glutamate transmembrane transporter activity);GO:0005509(calcium ion binding);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0006094(gluconeogenesis);GO:0006537(glutamate biosynthetic process);GO:0006851(mitochondrial calcium ion transmembrane transport);GO:0010907(positive regulation of glucose metabolic process);GO:0015183(L-aspartate transmembrane transporter activity);GO:0015810(aspartate transmembrane transport);GO:0015813(L-glutamate transmembrane transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0031643(positive regulation of myelination);GO:0042802(identical protein binding);GO:0043490(malate-aspartate shuttle);GO:0046872(metal ion binding);GO:0051592(response to calcium ion);GO:0055085(transmembrane transport);GO:0070778(L-aspartate transmembrane transport);GO:1904024(negative regulation of glucose catabolic process to lactate via pyruvate);GO:2001171(positive regulation of ATP biosynthetic process)","NA",{"v":4.7e-06,"d":"0.00"},1,"330,",0,-1.09,{"v":0.0151356124843621,"d":"0.02"},3.02,"Exon (ENST00000494601/ENSG00000128708, exon 1 of 11)",2,171844369,171999855,155487,2]
["chr11",71903253,71903844,592,"ENSG00000254469","ENST00000532852","protein_coding",15113,"AP002495","Putative short transient receptor potential channel 2-like protein  [Source:UniProtKB/Swiss-Prot;Acc:Q6ZNB5]","GO:0000012(single strand break repair);GO:0003684(damaged DNA binding);GO:0005634(nucleus);GO:0006284(base-excision repair)","NA",{"v":7.9e-16,"d":"0.00"},1,"592,",0,-1.06,{"v":0.0169824365246174,"d":"0.02"},1.22,"Exon (ENST00000526217/ENSG00000254593, exon 1 of 1)",11,71865509,71918957,53449,2]
["chr11",77821109,77841064,19956,"ENSG00000087884","ENST00000532481","protein_coding",0,"AAMDC","adipogenesis associated Mth938 domain containing [Source:HGNC Symbol;Acc:HGNC:30205]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0045600(positive regulation of fat cell differentiation)","NA",{"v":4e-43,"d":"0.00"},3,"133,121,46,","0,10783,19910",-3.39,{"v":2.51188643150958e-05,"d":"0.00"},1.18,"5' UTR",11,77821109,77918432,97324,1]
["chr10",86935719,86936168,450,"ENSG00000173269","ENST00000372027","protein_coding",21447,"MMRN2","multimerin 2 [Source:HGNC Symbol;Acc:HGNC:19888]","GO:0001525(angiogenesis);GO:0002042(cell migration involved in sprouting angiogenesis);GO:0005201(extracellular matrix structural constituent);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005604(basement membrane);GO:0005615(extracellular space);GO:0010811(positive regulation of cell-substrate adhesion);GO:0030948(negative regulation of vascular endothelial growth factor receptor signaling pathway);GO:0031012(extracellular matrix);GO:0062023(collagen-containing extracellular matrix);GO:0070062(extracellular exosome);GO:0090051(negative regulation of cell migration involved in sprouting angiogenesis)","NA",{"v":1.9e-07,"d":"0.00"},1,"450,",0,-1.28,{"v":0.00831763771102671,"d":"0.01"},3.06,"3' UTR",10,86935540,86957615,22076,2]
["chr11",118546174,118546652,479,"ENSG00000118096","ENST00000264021","protein_coding",19424,"IFT46","intraflagellar transport 46 [Source:HGNC Symbol;Acc:HGNC:26146]","GO:0003674(molecular_function);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005856(cytoskeleton);GO:0005929(cilium);GO:0007224(smoothened signaling pathway);GO:0008022(protein C-terminus binding);GO:0008150(biological_process);GO:0030992(intraciliary transport particle B);GO:0031514(motile cilium);GO:0035735(intraciliary transport involved in cilium assembly);GO:0036064(ciliary basal body);GO:0042073(intraciliary transport);GO:0042995(cell projection);GO:0050821(protein stabilization);GO:0060271(cilium assembly);GO:0097542(ciliary tip)","NA",{"v":4e-12,"d":"0.00"},1,"479,",0,-1.08,{"v":0.0158489319246111,"d":"0.02"},{"v":1.8,"d":"1.80"},"3' UTR",11,118544528,118566076,21549,2]
["chr11",1734772,1735011,240,"ENSG00000244242","ENST00000340134","protein_coding",15584,"IFITM10","interferon induced transmembrane protein 10 [Source:HGNC Symbol;Acc:HGNC:40022]","GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":5e-12,"d":"0.00"},1,"240,",0,{"v":-0.839,"d":"-0.84"},{"v":0.0346736850452532,"d":"0.03"},1.63,"3' UTR",11,1732406,1750595,18190,2]
["chr11",1734821,1735000,180,"ENSG00000244242","ENST00000340134","protein_coding",15595,"IFITM10","interferon induced transmembrane protein 10 [Source:HGNC Symbol;Acc:HGNC:40022]","GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":0.00049,"d":"0.00"},1,"180,",0,{"v":-0.754,"d":"-0.75"},{"v":0.0457088189614875,"d":"0.05"},1.98,"3' UTR",11,1732406,1750595,18190,2]
["chr11",10857866,10858076,211,"ENSG00000236287","ENST00000533925","processed_transcript",0,"ZBED5","zinc finger BED-type containing 5 [Source:HGNC Symbol;Acc:HGNC:30803]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","NA",{"v":5e-12,"d":"0.00"},1,"211,",0,{"v":-0.794,"d":"-0.79"},{"v":0.0398107170553497,"d":"0.04"},1.29,"5' UTR",11,10849897,10858073,8177,2]
["chr11",46856867,46857166,300,"ENSG00000134569","ENST00000378623","protein_coding",61384,"LRP4","LDL receptor related protein 4 [Source:HGNC Symbol;Acc:HGNC:6696]","GO:0001822(kidney development);GO:0001932(regulation of protein phosphorylation);GO:0001942(hair follicle development);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006897(endocytosis);GO:0007275(multicellular organism development);GO:0008104(protein localization);GO:0009953(dorsal/ventral pattern formation);GO:0009954(proximal/distal pattern formation);GO:0009986(cell surface);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0030154(cell differentiation);GO:0030178(negative regulation of Wnt signaling pathway);GO:0030279(negative regulation of ossification);GO:0030326(embryonic limb morphogenesis);GO:0030425(dendrite);GO:0030509(BMP signaling pathway);GO:0030971(receptor tyrosine kinase binding);GO:0031594(neuromuscular junction);GO:0034185(apolipoprotein binding);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042733(embryonic digit morphogenesis);GO:0042803(protein homodimerization activity);GO:0043025(neuronal cell body);GO:0043113(receptor clustering);GO:0044853(plasma membrane raft);GO:0048513(animal organ development);GO:0048813(dendrite morphogenesis);GO:0048856(anatomical structure development);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050771(negative regulation of axonogenesis);GO:0050808(synapse organization);GO:0051124(synaptic growth at neuromuscular junction);GO:0051290(protein heterotetramerization);GO:0060173(limb development);GO:0060828(regulation of canonical Wnt signaling pathway);GO:0071340(skeletal muscle acetylcholine-gated channel clustering);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0097060(synaptic membrane);GO:0097104(postsynaptic membrane assembly);GO:0097105(presynaptic membrane assembly);GO:0097110(scaffold protein binding);GO:0150094(amyloid-beta clearance by cellular catabolic process);GO:1901631(positive regulation of presynaptic membrane organization);GO:1904395(positive regulation of skeletal muscle acetylcholine-gated channel clustering)","NA",{"v":7.9e-19,"d":"0.00"},1,"300,",0,-1.21,{"v":0.010471285480509,"d":"0.01"},1.03,"3' UTR",11,46856717,46918550,61834,2]
["chr11",64823771,64824040,270,"ENSG00000171219","ENST00000342711","protein_coding",20613,"CDC42BPG","CDC42 binding protein kinase gamma [Source:HGNC Symbol;Acc:HGNC:29829]","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0031252(cell leading edge);GO:0031532(actin cytoskeleton reorganization);GO:0035556(intracellular signal transduction);GO:0046872(metal ion binding)","NA",{"v":7.9e-09,"d":"0.00"},1,"270,",0,{"v":-0.806,"d":"-0.81"},{"v":0.0389045144994281,"d":"0.04"},3.06,"3' UTR",11,64823052,64844653,21602,2]
["chr11",67435223,67435399,177,"ENSG00000255949","ENST00000535922","antisense",0,"RPS6KB2-AS1","RPS6KB2 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:53744]","NA","NA",{"v":7.9e-34,"d":"0.00"},1,"177,",0,-2.29,{"v":0.000478630092322639,"d":"0.00"},1.04,"3' UTR",11,67431367,67435399,4033,2]
["chr13",113529639,113529818,180,"ENSG00000150403","ENST00000434316","protein_coding",38618,"TMCO3","transmembrane and coiled-coil domains 3 [Source:HGNC Symbol;Acc:HGNC:20329]","GO:0006811(ion transport);GO:0006812(cation transport);GO:0015297(antiporter activity);GO:0015299(solute:proton antiporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport);GO:1902600(proton transmembrane transport)","NA",{"v":0.00072,"d":"0.00"},1,"180,",0,{"v":-0.765,"d":"-0.77"},{"v":0.0436515832240166,"d":"0.04"},3.09,"Exon (ENST00000619092/ENSG00000276248, exon 1 of 1)",13,113491021,113550229,59209,1]
["chr11",102766801,102767927,1127,"ENSG00000256254","ENST00000535634","processed_pseudogene",0,"AP000619","spastic ataxia of Charlevoix-Saguenay (SACS) pseudogene","NA","NA",{"v":1e-106,"d":"0.00"},1,"1127,",0,{"v":-3.8,"d":"-3.80"},{"v":8.31763771102671e-06,"d":"0.00"},1.06,"Exon (ENST00000535634/ENSG00000256254, exon 1 of 1)",11,102766801,102767927,1127,2]
["chr3",50226322,50226682,361,"ENSG00000114353","ENST00000422163","protein_coding",30,"GNAI2","G protein subunit alpha i2 [Source:HGNC Symbol;Acc:HGNC:4385]","GO:0000166(nucleotide binding);GO:0001664(G protein-coupled receptor binding);GO:0001973(adenosine receptor signaling pathway);GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0006457(protein folding);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G protein-coupled receptor signaling pathway);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway);GO:0007194(negative regulation of adenylate cyclase activity);GO:0007213(G protein-coupled acetylcholine receptor signaling pathway);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0007584(response to nutrient);GO:0008283(cell population proliferation);GO:0008284(positive regulation of cell population proliferation);GO:0016020(membrane);GO:0019001(guanyl nucleotide binding);GO:0030335(positive regulation of cell migration);GO:0030425(dendrite);GO:0030496(midbody);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0032930(positive regulation of superoxide anion generation);GO:0033864(positive regulation of NAD(P)H oxidase activity);GO:0035810(positive regulation of urine volume);GO:0035815(positive regulation of renal sodium excretion);GO:0044297(cell body);GO:0045121(membrane raft);GO:0045955(negative regulation of calcium ion-dependent exocytosis);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0046872(metal ion binding);GO:0050805(negative regulation of synaptic transmission);GO:0051301(cell division);GO:0051924(regulation of calcium ion transport);GO:0070062(extracellular exosome);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0140199(negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process);GO:1903561(extracellular vesicle);GO:1903614(negative regulation of protein tyrosine phosphatase activity);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:2000179(positive regulation of neural precursor cell proliferation);GO:2001234(negative regulation of apoptotic signaling pathway)","04015(Rap1 signaling pathway);04022(cGMP-PKG signaling pathway);04024(cAMP signaling pathway);04062(Chemokine signaling pathway);04071(Sphingolipid signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04360(Axon guidance);04371(Apelin signaling pathway);04540(Gap junction);04611(Platelet activation);04670(Leukocyte transendothelial migration);04713(Circadian entrainment);04723(Retrograde endocannabinoid signaling);04724(Glutamatergic synapse);04725(Cholinergic synapse);04726(Serotonergic synapse);04727(GABAergic synapse);04728(Dopaminergic synapse);04730(Long-term depression);04914(Progesterone-mediated oocyte maturation);04915(Estrogen signaling pathway);04916(Melanogenesis);04921(Oxytocin signaling pathway);04923(Regulation of lipolysis in adipocytes);04924(Renin secretion);04926(Relaxin signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);04934(Cushing syndrome);04971(Gastric acid secretion);05012(Parkinson disease);05030(Cocaine addiction);05032(Morphine addiction);05034(Alcoholism);05133(Pertussis);05142(Chagas disease (American trypanosomiasis));05145(Toxoplasmosis);05163(Human cytomegalovirus infection);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer)",{"v":3.9e-06,"d":"0.00"},1,"361,",0,{"v":-0.821,"d":"-0.82"},{"v":0.0363078054770101,"d":"0.04"},3.11,"5' UTR",3,50226292,50258898,32607,1]
["chr11",108173336,108173816,481,"ENSG00000149308","ENST00000278612","protein_coding",48822,"NPAT","nuclear protein, coactivator of histone transcription [Source:HGNC Symbol;Acc:HGNC:7896]","GO:0000083(regulation of transcription involved in G1/S transition of mitotic cell cycle);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0007049(cell cycle);GO:0008022(protein C-terminus binding);GO:0010468(regulation of gene expression);GO:0015030(Cajal body);GO:0045893(positive regulation of transcription, DNA-templated);GO:0047485(protein N-terminus binding);GO:0097504(Gemini of coiled bodies);GO:1903507(negative regulation of nucleic acid-templated transcription)","NA",{"v":1e-47,"d":"0.00"},1,"481,",0,{"v":-1.1,"d":"-1.10"},{"v":0.0147910838816821,"d":"0.01"},1.12,"Exon (ENST00000278612/ENSG00000149308, exon 13 of 18)",11,108157215,108222638,65424,2]
["chr6",116258523,116259056,534,"ENSG00000111817","ENST00000430252","protein_coding",4350,"DSE","dermatan sulfate epimerase [Source:HGNC Symbol;Acc:HGNC:21144]","GO:0000139(Golgi membrane);GO:0005654(nucleoplasm);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0015012(heparan sulfate proteoglycan biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016853(isomerase activity);GO:0030206(chondroitin sulfate biosynthetic process);GO:0030208(dermatan sulfate biosynthetic process);GO:0047757(chondroitin-glucuronate 5-epimerase activity)","00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate)",{"v":4.6e-08,"d":"0.00"},1,"534,",0,-3.69,{"v":1.12201845430196E-5,"d":"0.00"},3.13,"5' UTR",6,116254173,116426589,172417,1]
["chr1",235808690,235809410,721,"ENSG00000143669","ENST00000389793","protein_coding",57510,"LYST","lysosomal trafficking regulator [Source:HGNC Symbol;Acc:HGNC:1968]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0007040(lysosome organization);GO:0015031(protein transport);GO:0015630(microtubule cytoskeleton);GO:0030595(leukocyte chemotaxis);GO:0032438(melanosome organization);GO:0032510(endosome to lysosome transport via multivesicular body sorting pathway);GO:0033364(mast cell secretory granule organization);GO:0042267(natural killer cell mediated cytotoxicity);GO:0042742(defense response to bacterium);GO:0042832(defense response to protozoan);GO:0043473(pigmentation);GO:0051607(defense response to virus)","NA",{"v":1.4e-09,"d":"0.00"},1,"721,",0,{"v":-0.934,"d":"-0.93"},{"v":0.0251188643150958,"d":"0.03"},3.15,"Exon (ENST00000389793/ENSG00000143669, exon 5 of 53)",1,235661041,235866920,205880,2]
["chr12",8940360,8941258,899,"ENSG00000003056","ENST00000000412","protein_coding",8387,"M6PR","mannose-6-phosphate receptor, cation dependent [Source:HGNC Symbol;Acc:HGNC:6752]","GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005537(mannose binding);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0005768(endosome);GO:0005770(late endosome);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006622(protein targeting to lysosome);GO:0006898(receptor-mediated endocytosis);GO:0007041(lysosomal transport);GO:0008333(endosome to lysosome transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019904(protein domain specific binding);GO:0030133(transport vesicle);GO:0030665(clathrin-coated vesicle membrane);GO:0030904(retromer complex);GO:0032588(trans-Golgi network membrane);GO:0033299(secretion of lysosomal enzymes);GO:0048471(perinuclear region of cytoplasm);GO:0061024(membrane organization);GO:1905394(retromer complex binding)","04142(Lysosome);04145(Phagosome)",{"v":1e-245,"d":"0.00"},1,"899,",0,-36,{"v":1.99526231496887e-39,"d":"0.00"},1.46,"3' UTR",12,8940361,8949645,9285,2]
["chr12",10222949,10223128,180,"ENSG00000139112","ENST00000266458","protein_coding",10072,"GABARAPL1","GABA type A receptor associated protein like 1 [Source:HGNC Symbol;Acc:HGNC:4068]","GO:0000045(autophagosome assembly);GO:0000421(autophagosome membrane);GO:0000422(autophagy of mitochondrion);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005776(autophagosome);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0006914(autophagy);GO:0006995(cellular response to nitrogen starvation);GO:0016020(membrane);GO:0016236(macroautophagy);GO:0030659(cytoplasmic vesicle membrane);GO:0030957(Tat protein binding);GO:0031410(cytoplasmic vesicle);GO:0031625(ubiquitin protein ligase binding);GO:0032590(dendrite membrane);GO:0032839(dendrite cytoplasm);GO:0044297(cell body);GO:0048487(beta-tubulin binding);GO:0050811(GABA receptor binding);GO:0097352(autophagosome maturation)","04068(FoxO signaling pathway);04136(Autophagy - other);04137(Mitophagy - animal);04140(Autophagy - animal);04371(Apelin signaling pathway);04621(NOD-like receptor signaling pathway);04727(GABAergic synapse);05167(Kaposi sarcoma-associated herpesvirus infection)",{"v":4e-32,"d":"0.00"},1,"180,",0,-1.11,{"v":0.0144543977074593,"d":"0.01"},1.34,"3' UTR",12,10212877,10223128,10252,1]
["chr12",31970337,31983222,12886,"ENSG00000174718","ENST00000541981","processed_transcript",10967,"RESF1","retroelement silencing factor 1 [Source:HGNC Symbol;Acc:HGNC:25559]","GO:0000930(gamma-tubulin complex);GO:0005634(nucleus);GO:0042393(histone binding);GO:0045869(negative regulation of single stranded viral RNA replication via double stranded DNA intermediate);GO:0090309(positive regulation of methylation-dependent chromatin silencing)","NA",{"v":2.5e-65,"d":"0.00"},2,"20,2345,","0,10541",-3.15,{"v":4.67735141287198e-05,"d":"0.00"},1.23,"5' UTR",12,31959370,31992834,33465,1]
["chr12",32640332,32640691,360,"ENSG00000139132","ENST00000534526","protein_coding",240803,"FGD4","FYVE, RhoGEF and PH domain containing 4 [Source:HGNC Symbol;Acc:HGNC:19125]","GO:0001726(ruffle);GO:0003779(actin binding);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0007010(cytoskeleton organization);GO:0007186(G protein-coupled receptor signaling pathway);GO:0008360(regulation of cell shape);GO:0030027(lamellipodium);GO:0030032(lamellipodium assembly);GO:0030035(microspike assembly);GO:0030036(actin cytoskeleton organization);GO:0030175(filopodium);GO:0031267(small GTPase binding);GO:0035023(regulation of Rho protein signal transduction);GO:0042995(cell projection);GO:0043065(positive regulation of apoptotic process);GO:0043087(regulation of GTPase activity);GO:0046847(filopodium assembly);GO:0046872(metal ion binding);GO:0051056(regulation of small GTPase mediated signal transduction)","NA",{"v":1e-16,"d":"0.00"},1,"360,",0,{"v":-0.787,"d":"-0.79"},{"v":0.0407380277804113,"d":"0.04"},1.93,"3' UTR",12,32399529,32640533,241005,1]
["chr12",49331581,49331731,151,"ENSG00000135451","ENST00000551245","protein_coding",8337,"TROAP","trophinin associated protein [Source:HGNC Symbol;Acc:HGNC:12327]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0007155(cell adhesion)","NA",{"v":4.4e-07,"d":"0.00"},1,"151,",0,-1.66,{"v":0.00275422870333817,"d":"0.00"},1.64,"3' UTR",12,49323244,49331670,8427,1]
["chr5",180071903,180072053,151,"ENSG00000113269","ENST00000261947","protein_coding",48,"RNF130","ring finger protein 130 [Source:HGNC Symbol;Acc:HGNC:18280]","GO:0004842(ubiquitin-protein transferase activity);GO:0005737(cytoplasm);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006915(apoptotic process);GO:0012501(programmed cell death);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0046872(metal ion binding);GO:0061630(ubiquitin protein ligase activity)","NA",{"v":0.00068,"d":"0.00"},1,"151,",0,{"v":-0.882,"d":"-0.88"},{"v":0.0301995172040202,"d":"0.03"},3.17,"5' UTR",5,179955453,180072101,116649,2]
["chr12",48054933,48055352,420,"ENSG00000240399","ENST00000463559","transcribed_processed_pseudogene",0,"AC004801","ribosomal protein L37 (RPL37) pseudogene","NA","NA",{"v":7.6e-07,"d":"0.00"},1,"420,",0,{"v":-0.818,"d":"-0.82"},{"v":0.0371535229097173,"d":"0.04"},3.17,"Exon (ENST00000468202/ENSG00000240399, exon 1 of 1)",12,48054971,48055253,283,2]
["chr12",53293523,53293643,121,"ENSG00000135476","ENST00000257934","protein_coding",25224,"ESPL1","extra spindle pole bodies like 1, separase [Source:HGNC Symbol;Acc:HGNC:16856]","GO:0000070(mitotic sister chromatid segregation);GO:0000212(meiotic spindle organization);GO:0000278(mitotic cell cycle);GO:0000281(mitotic cytokinesis);GO:0003824(catalytic activity);GO:0004197(cysteine-type endopeptidase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0006915(apoptotic process);GO:0007059(chromosome segregation);GO:0007127(meiosis I);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0016787(hydrolase activity);GO:0040001(establishment of mitotic spindle localization);GO:0045143(homologous chromosome segregation);GO:0045842(positive regulation of mitotic metaphase/anaphase transition);GO:0045875(negative regulation of sister chromatid cohesion);GO:0051307(meiotic chromosome separation);GO:0072686(mitotic spindle)","04110(Cell cycle);04114(Oocyte meiosis);05166(Human T-cell leukemia virus 1 infection)",{"v":2.9e-07,"d":"0.00"},1,"121,",0,-1.02,{"v":0.0190546071796325,"d":"0.02"},1.37,"3' UTR",12,53268299,53293643,25345,1]
["chr12",57586364,57586633,270,"ENSG00000155980","ENST00000455537","protein_coding",36320,"KIF5A","kinesin family member 5A [Source:HGNC Symbol;Acc:HGNC:6323]","GO:0000166(nucleotide binding);GO:0003774(motor activity);GO:0003777(microtubule motor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005871(kinesin complex);GO:0005874(microtubule);GO:0006890(retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum);GO:0007018(microtubule-based movement);GO:0007268(chemical synaptic transmission);GO:0007411(axon guidance);GO:0008017(microtubule binding);GO:0008574(ATP-dependent microtubule motor activity, plus-end-directed);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0016887(ATPase activity);GO:0019886(antigen processing and presentation of exogenous peptide antigen via MHC class II);GO:0019894(kinesin binding);GO:0032839(dendrite cytoplasm);GO:0035253(ciliary rootlet);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0045202(synapse);GO:0048471(perinuclear region of cytoplasm);GO:0048489(synaptic vesicle transport);GO:0098971(anterograde dendritic transport of neurotransmitter receptor complex);GO:0099641(anterograde axonal protein transport);GO:1904115(axon cytoplasm);GO:1990049(retrograde neuronal dense core vesicle transport)","04144(Endocytosis);04728(Dopaminergic synapse)",{"v":1E-10,"d":"0.00"},1,"270,",0,-2.75,{"v":0.000134896288259165,"d":"0.00"},{"v":1.9,"d":"1.90"},"3' UTR",12,57550044,57586633,36590,1]
["chr12",74541299,74541449,151,"ENSG00000253719","ENST00000519948","protein_coding",3472,"ATXN7L3B","ataxin 7 like 3B [Source:HGNC Symbol;Acc:HGNC:37931]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0010468(regulation of gene expression)","NA",{"v":1.6E-12,"d":"0.00"},1,"151,",0,-2.09,{"v":0.000812830516164099,"d":"0.00"},1.31,"3' UTR",12,74537827,74545430,7604,1]
["chr12",104102131,104103384,1254,"ENSG00000111727","ENST00000229330","protein_coding",37600,"HCFC2","host cell factor C2 [Source:HGNC Symbol;Acc:HGNC:24972]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006357(regulation of transcription by RNA polymerase II);GO:0016032(viral process);GO:0071339(MLL1 complex);GO:1903508(positive regulation of nucleic acid-templated transcription)","05168(Herpes simplex virus 1 infection)",{"v":2E-70,"d":"0.00"},2,"23,426,","0,828",-1.36,{"v":6.60693448007596E-3,"d":"0.01"},1.08,"3' UTR",12,104064531,104106524,41994,1]
["chr12",106346315,106346793,479,"ENSG00000166046","ENST00000299045","protein_coding",43582,"TCP11L2","t-complex 11 like 2 [Source:HGNC Symbol;Acc:HGNC:28627]","NA","NA",{"v":4e-69,"d":"0.00"},1,"479,",0,-1.75,{"v":2.13796208950223E-3,"d":"0.00"},{"v":1.4,"d":"1.40"},"3' UTR",12,106302733,106347003,44271,1]
["chr12",123932073,123933480,1408,"ENSG00000119242","ENST00000542348","processed_transcript",10015,"CCDC92","coiled-coil domain containing 92 [Source:HGNC Symbol;Acc:HGNC:29563]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005856(cytoskeleton);GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":2e-23,"d":"0.00"},3,"36,114,150,","0,545,1258",{"v":-0.915,"d":"-0.92"},{"v":0.0269153480392692,"d":"0.03"},1.11,"3' UTR",12,123918660,123943495,24836,2]
["chr17",58157376,58157853,478,"ENSG00000141194","ENST00000641449","protein_coding",8927,"OR4D1","olfactory receptor family 4 subfamily D member 1 [Source:HGNC Symbol;Acc:HGNC:8293]","GO:0004930(G protein-coupled receptor activity);GO:0004984(olfactory receptor activity);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007608(sensory perception of smell);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0050896(response to stimulus);GO:0050911(detection of chemical stimulus involved in sensory perception of smell)","04740(Olfactory transduction)",{"v":5.1E-8,"d":"0.00"},1,"478,",0,-0.75,{"v":0.0467735141287198,"d":"0.05"},3.18,"3' UTR",17,58148449,58159555,11107,1]
["chr12",6362201,6363852,1652,"ENSG00000111319","ENST00000542966","processed_transcript",0,"SCNN1A","sodium channel epithelial 1 alpha subunit [Source:HGNC Symbol;Acc:HGNC:10599]","GO:0001669(acrosomal vesicle);GO:0005272(sodium channel activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005929(cilium);GO:0006811(ion transport);GO:0006814(sodium ion transport);GO:0015280(ligand-gated sodium channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0031514(motile cilium);GO:0034220(ion transmembrane transport);GO:0034706(sodium channel complex);GO:0035725(sodium ion transmembrane transport);GO:0042995(cell projection);GO:0050699(WW domain binding);GO:0050891(multicellular organismal water homeostasis);GO:0050896(response to stimulus);GO:0050909(sensory perception of taste);GO:0055078(sodium ion homeostasis);GO:0060170(ciliary membrane);GO:0070062(extracellular exosome);GO:0097228(sperm principal piece)","04742(Taste transduction);04960(Aldosterone-regulated sodium reabsorption)",{"v":2.3e-09,"d":"0.00"},2,"41,410,","0,1242",{"v":-0.965,"d":"-0.97"},{"v":0.0229086765276777,"d":"0.02"},1.29,"5' UTR",12,6355337,6363625,8289,2]
["chr12",6693912,6694062,151,"ENSG00000139200","ENST00000540656","protein_coding",6368,"PIANP","PILR alpha associated neural protein [Source:HGNC Symbol;Acc:HGNC:25338]","GO:0005886(plasma membrane);GO:0005912(adherens junction);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0050776(regulation of immune response)","NA",{"v":0.00024,"d":"0.00"},1,"151,",0,-1.17,{"v":0.0120226443461741,"d":"0.01"},1.27,"3' UTR",12,6693792,6700430,6639,2]
["chr2",85851090,85851449,360,"ENSG00000115525","ENST00000638572","protein_coding",37541,"ST3GAL5","ST3 beta-galactoside alpha-2,3-sialyltransferase 5 [Source:HGNC Symbol;Acc:HGNC:10872]","GO:0000139(Golgi membrane);GO:0001574(ganglioside biosynthetic process);GO:0004513(neolactotetraosylceramide alpha-2,3-sialyltransferase activity);GO:0005794(Golgi apparatus);GO:0005887(integral component of plasma membrane);GO:0005975(carbohydrate metabolic process);GO:0006486(protein glycosylation);GO:0006688(glycosphingolipid biosynthetic process);GO:0008373(sialyltransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0047291(lactosylceramide alpha-2,3-sialyltransferase activity);GO:0097503(sialylation)","00604(Glycosphingolipid biosynthesis - ganglio series)",{"v":5.2e-05,"d":"0.00"},1,"360,",0,-1.33,{"v":0.00741310241300918,"d":"0.01"},3.19,"3' UTR",2,85837120,85888990,51871,2]
["chr12",8940361,8941257,897,"ENSG00000003056","ENST00000000412","protein_coding",8388,"M6PR","mannose-6-phosphate receptor, cation dependent [Source:HGNC Symbol;Acc:HGNC:6752]","GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005537(mannose binding);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0005768(endosome);GO:0005770(late endosome);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006622(protein targeting to lysosome);GO:0006898(receptor-mediated endocytosis);GO:0007041(lysosomal transport);GO:0008333(endosome to lysosome transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019904(protein domain specific binding);GO:0030133(transport vesicle);GO:0030665(clathrin-coated vesicle membrane);GO:0030904(retromer complex);GO:0032588(trans-Golgi network membrane);GO:0033299(secretion of lysosomal enzymes);GO:0048471(perinuclear region of cytoplasm);GO:0061024(membrane organization);GO:1905394(retromer complex binding)","04142(Lysosome);04145(Phagosome)",{"v":1e-245,"d":"0.00"},1,"897,",0,{"v":-40.4,"d":"-40.40"},{"v":7.94328234724279e-44,"d":"0.00"},1.58,"3' UTR",12,8940361,8949645,9285,2]
["chrX",55487883,55488273,391,"ENSG00000247746","ENST00000500968","protein_coding",929,"USP51","ubiquitin specific peptidase 51 [Source:HGNC Symbol;Acc:HGNC:23086]","GO:0003682(chromatin binding);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005694(chromosome);GO:0006281(DNA repair);GO:0006508(proteolysis);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006974(cellular response to DNA damage stimulus);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0008270(zinc ion binding);GO:0010564(regulation of cell cycle process);GO:0010569(regulation of double-strand break repair via homologous recombination);GO:0016578(histone deubiquitination);GO:0016579(protein deubiquitination);GO:0016787(hydrolase activity);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042393(histone binding);GO:0046872(metal ion binding);GO:2001020(regulation of response to DNA damage stimulus);GO:2001032(regulation of double-strand break repair via nonhomologous end joining)","NA",{"v":3.9e-07,"d":"0.00"},1,"391,",0,{"v":-0.837,"d":"-0.84"},{"v":0.0346736850452532,"d":"0.03"},3.21,"Exon (ENST00000500968/ENSG00000247746, exon 2 of 2)",23,55484616,55489202,4587,2]
["chr12",10848397,10884194,35798,"ENSG00000111215","ENST00000542881","processed_transcript",0,"PRR4","proline rich 4 [Source:HGNC Symbol;Acc:HGNC:18020]","GO:0001895(retina homeostasis);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0007601(visual perception)","04970(Salivary secretion)",{"v":5e-45,"d":"0.00"},4,"11,482,36,41,","0,33820,34664,35757",{"v":-0.855,"d":"-0.86"},{"v":0.0323593656929628,"d":"0.03"},1.06,"5' UTR",12,10845849,10848934,3086,2]
["chr12",10882228,10884169,1942,"ENSG00000231887","ENST00000538332","protein_coding",0,"PRH1","proline rich protein HaeIII subfamily 1 [Source:HGNC Symbol;Acc:HGNC:9366]","NA","04970(Salivary secretion)",{"v":7.9e-45,"d":"0.00"},4,"244,164,36,16,","0,307,833,1926",{"v":-0.743,"d":"-0.74"},{"v":0.0478630092322638,"d":"0.05"},1.23,"3' UTR",12,10824960,10882657,57698,2]
["chr12",45726458,45727565,1108,"ENSG00000273015","ENST00000609803","lincRNA",210,"AC008124","novel transcript","NA","NA",{"v":5e-62,"d":"0.00"},1,"1108,",0,-3.94,{"v":5.88843655355588e-06,"d":"0.00"},1,"Exon (ENST00000609803/ENSG00000273015, exon 1 of 1)",12,45718046,45727775,9730,2]
["chr12",54230942,54231152,211,"ENSG00000094916","ENST00000209875","protein_coding",48970,"CBX5","chromobox 5 [Source:HGNC Symbol;Acc:HGNC:1555]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000784(nuclear chromosome, telomeric region);GO:0000792(heterochromatin);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005720(nuclear heterochromatin);GO:0005721(pericentric heterochromatin);GO:0005730(nucleolus);GO:0006974(cellular response to DNA damage stimulus);GO:0007596(blood coagulation);GO:0010369(chromocenter);GO:0016032(viral process);GO:0016605(PML body);GO:0017053(transcriptional repressor complex);GO:0030674(protein binding, bridging);GO:0031618(nuclear pericentric heterochromatin);GO:0032991(protein-containing complex);GO:0035064(methylated histone binding);GO:0035097(histone methyltransferase complex);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0042826(histone deacetylase binding);GO:0043021(ribonucleoprotein complex binding);GO:0044877(protein-containing complex binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0070317(negative regulation of G0 to G1 transition);GO:0070491(repressing transcription factor binding);GO:0090734(site of DNA damage);GO:1990904(ribonucleoprotein complex)","NA",{"v":3.2E-13,"d":"0.00"},1,"211,",0,-2.41,{"v":3.38844156139203E-4,"d":"0.00"},1.27,"3' UTR",12,54230942,54280122,49181,2]
["chr17",58157384,58157770,387,"ENSG00000141194","ENST00000641449","protein_coding",8935,"OR4D1","olfactory receptor family 4 subfamily D member 1 [Source:HGNC Symbol;Acc:HGNC:8293]","GO:0004930(G protein-coupled receptor activity);GO:0004984(olfactory receptor activity);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007608(sensory perception of smell);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0050896(response to stimulus);GO:0050911(detection of chemical stimulus involved in sensory perception of smell)","04740(Olfactory transduction)",{"v":5.1E-8,"d":"0.00"},1,"387,",0,{"v":-0.749,"d":"-0.75"},{"v":0.0467735141287198,"d":"0.05"},3.22,"3' UTR",17,58148449,58159555,11107,1]
["chr12",71609711,71610011,301,"ENSG00000133858","ENST00000378743","protein_coding",53958,"ZFC3H1","zinc finger C3H1-type containing [Source:HGNC Symbol;Acc:HGNC:28328]","GO:0000178(exosome (RNase complex));GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0006396(RNA processing);GO:0046872(metal ion binding)","NA",{"v":2e-24,"d":"0.00"},1,"301,",0,{"v":-0.752,"d":"-0.75"},{"v":0.0457088189614875,"d":"0.05"},1.48,"3' UTR",12,71609472,71663969,54498,2]
["chr12",95210386,95210985,600,"ENSG00000180263","ENST00000343958","protein_coding",6482,"FGD6","FYVE, RhoGEF and PH domain containing 6 [Source:HGNC Symbol;Acc:HGNC:21740]","GO:0001726(ruffle);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005856(cytoskeleton);GO:0007010(cytoskeleton organization);GO:0008360(regulation of cell shape);GO:0030027(lamellipodium);GO:0030036(actin cytoskeleton organization);GO:0031267(small GTPase binding);GO:0035023(regulation of Rho protein signal transduction);GO:0043087(regulation of GTPase activity);GO:0046847(filopodium assembly);GO:0046872(metal ion binding)","NA",{"v":3.2e-56,"d":"0.00"},1,"600,",0,-1.28,{"v":0.00851138038202377,"d":"0.01"},1.06,"Exon (ENST00000343958/ENSG00000180263, exon 2 of 21)",12,95076749,95217467,140719,2]
["chr12",106977515,106977843,329,"ENSG00000120832","ENST00000240050","protein_coding",9303,"MTERF2","mitochondrial transcription termination factor 2 [Source:HGNC Symbol;Acc:HGNC:30779]","GO:0003677(DNA binding);GO:0003690(double-stranded DNA binding);GO:0005739(mitochondrion);GO:0006355(regulation of transcription, DNA-templated);GO:0006393(termination of mitochondrial transcription);GO:0042645(mitochondrial nucleoid)","NA",{"v":1.6e-29,"d":"0.00"},1,"329,",0,-1.84,{"v":1.65958690743756E-3,"d":"0.00"},1.36,"3' UTR",12,106977277,106987146,9870,2]
["chr12",113816738,113817061,324,"ENSG00000122965","ENST00000553232","processed_transcript",1118,"RBM19","RNA binding motif protein 19 [Source:HGNC Symbol;Acc:HGNC:29098]","GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0007275(multicellular organism development);GO:0016020(membrane);GO:0016607(nuclear speck);GO:0040019(positive regulation of embryonic development);GO:0045292(mRNA cis splicing, via spliceosome)","NA",{"v":6.3e-35,"d":"0.00"},1,"324,",0,{"v":-0.784,"d":"-0.78"},{"v":0.0416869383470335,"d":"0.04"},1.07,"3' UTR",12,113816738,113818179,1442,2]
["chr12",124784179,124784269,91,"ENSG00000073060","ENST00000261693","protein_coding",79595,"SCARB1","scavenger receptor class B member 1 [Source:HGNC Symbol;Acc:HGNC:1664]","GO:0001530(lipopolysaccharide binding);GO:0001540(amyloid-beta binding);GO:0001618(virus receptor activity);GO:0001786(phosphatidylserine binding);GO:0001875(lipopolysaccharide receptor activity);GO:0001935(endothelial cell proliferation);GO:0005044(scavenger receptor activity);GO:0005215(transporter activity);GO:0005515(protein binding);GO:0005545(1-phosphatidylinositol binding);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005901(caveola);GO:0006702(androgen biosynthetic process);GO:0006707(cholesterol catabolic process);GO:0006869(lipid transport);GO:0006898(receptor-mediated endocytosis);GO:0006910(phagocytosis, recognition);GO:0008035(high-density lipoprotein particle binding);GO:0009986(cell surface);GO:0010595(positive regulation of endothelial cell migration);GO:0010867(positive regulation of triglyceride biosynthetic process);GO:0010886(positive regulation of cholesterol storage);GO:0010899(regulation of phosphatidylcholine catabolic process);GO:0015914(phospholipid transport);GO:0015920(lipopolysaccharide transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016032(viral process);GO:0030169(low-density lipoprotein particle binding);GO:0030301(cholesterol transport);GO:0030666(endocytic vesicle membrane);GO:0031528(microvillus membrane);GO:0031663(lipopolysaccharide-mediated signaling pathway);GO:0032497(detection of lipopolysaccharide);GO:0033344(cholesterol efflux);GO:0034185(apolipoprotein binding);GO:0034186(apolipoprotein A-I binding);GO:0034375(high-density lipoprotein particle remodeling);GO:0034383(low-density lipoprotein particle clearance);GO:0034384(high-density lipoprotein particle clearance);GO:0035461(vitamin transmembrane transport);GO:0042060(wound healing);GO:0042632(cholesterol homeostasis);GO:0042803(protein homodimerization activity);GO:0043231(intracellular membrane-bounded organelle);GO:0043534(blood vessel endothelial cell migration);GO:0043654(recognition of apoptotic cell);GO:0043691(reverse cholesterol transport);GO:0044406(adhesion of symbiont to host);GO:0046718(viral entry into host cell);GO:0050764(regulation of phagocytosis);GO:0050892(intestinal absorption);GO:0051000(positive regulation of nitric-oxide synthase activity);GO:0070062(extracellular exosome);GO:0070328(triglyceride homeostasis);GO:0070506(high-density lipoprotein particle receptor activity);GO:0070508(cholesterol import)","04145(Phagosome);04913(Ovarian steroidogenesis);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04934(Cushing syndrome);04975(Fat digestion and absorption);04976(Bile secretion);04977(Vitamin digestion and absorption);04979(Cholesterol metabolism);05160(Hepatitis C)",{"v":8.9e-05,"d":"0.00"},1,"91,",0,{"v":-0.823,"d":"-0.82"},{"v":0.0363078054770101,"d":"0.04"},1.11,"Exon (ENST00000538291/ENSG00000073060, exon 11 of 12)",12,124776856,124863864,87009,2]
["chr13",23470572,23486745,16174,"ENSG00000232977","ENST00000575689","lincRNA",4001,"LINC00327","long intergenic non-protein coding RNA 327 [Source:HGNC Symbol;Acc:HGNC:42009]","NA","NA",{"v":2.5e-16,"d":"0.00"},2,"119,511,","0,15663",{"v":-0.877,"d":"-0.88"},{"v":0.0301995172040202,"d":"0.03"},1.28,"Exon (ENST00000575689/ENSG00000232977, exon 2 of 2)",13,23466571,23470642,4072,1]
["chr13",27620772,27621311,540,"ENSG00000186184","ENST00000637180","protein_coding",0,"POLR1D","RNA polymerase I and III subunit D [Source:HGNC Symbol;Acc:HGNC:20422]","GO:0003677(DNA binding);GO:0003899(DNA-directed 5'-3' RNA polymerase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005736(RNA polymerase I complex);GO:0005829(cytosol);GO:0006351(transcription, DNA-templated);GO:0006361(transcription initiation from RNA polymerase I promoter);GO:0006362(transcription elongation from RNA polymerase I promoter);GO:0006363(termination of RNA polymerase I transcription);GO:0032481(positive regulation of type I interferon production);GO:0045815(positive regulation of gene expression, epigenetic);GO:0046983(protein dimerization activity)","03020(RNA polymerase);04623(Cytosolic DNA-sensing pathway)",{"v":4e-25,"d":"0.00"},1,"540,",0,{"v":-1.7,"d":"-1.70"},{"v":0.00245470891568503,"d":"0.00"},1.05,"5' UTR",13,27620919,27667353,46435,1]
["chr13",31330987,31331437,451,"ENSG00000187676","ENST00000343307","protein_coding",131012,"B3GLCT","beta 3-glucosyltransferase [Source:HGNC Symbol;Acc:HGNC:20207]","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005975(carbohydrate metabolic process);GO:0006004(fucose metabolic process);GO:0006486(protein glycosylation);GO:0008375(acetylglucosaminyltransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0036066(protein O-linked fucosylation)","00514(Other types of O-glycan biosynthesis)",{"v":5e-20,"d":"0.00"},1,"451,",0,-1.43,{"v":0.00537031796370253,"d":"0.01"},1.44,"3' UTR",13,31199975,31332276,132302,1]
["chr13",51766239,51766809,571,"ENSG00000139668","ENST00000298125","protein_coding",181777,"WDFY2","WD repeat and FYVE domain containing 2 [Source:HGNC Symbol;Acc:HGNC:20482]","GO:0001934(positive regulation of protein phosphorylation);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005769(early endosome);GO:0031982(vesicle);GO:0045600(positive regulation of fat cell differentiation);GO:0046872(metal ion binding)","NA",{"v":7.9e-16,"d":"0.00"},1,"571,",0,-1.89,{"v":0.00141253754462275,"d":"0.00"},1.47,"3' UTR",13,51584462,51767709,183248,1]
["chr12",133213931,133214321,391,"ENSG00000090612","ENST00000536435","protein_coding",32522,"ZNF268","zinc finger protein 268 [Source:HGNC Symbol;Acc:HGNC:13061]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0007346(regulation of mitotic cell cycle);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0015629(actin cytoskeleton);GO:0030154(cell differentiation);GO:0030335(positive regulation of cell migration);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0045597(positive regulation of cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0071157(negative regulation of cell cycle arrest)","05168(Herpes simplex virus 1 infection)",{"v":3.7E-7,"d":"0.00"},1,"391,",0,{"v":-0.847,"d":"-0.85"},{"v":0.0338844156139203,"d":"0.03"},3.23,"3' UTR",12,133181409,133214831,33423,1]
["chr13",24512718,24512778,61,"ENSG00000102699","ENST00000381989","protein_coding",0,"PARP4","poly(ADP-ribose) polymerase family member 4 [Source:HGNC Symbol;Acc:HGNC:271]","GO:0003677(DNA binding);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005819(spindle);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005876(spindle microtubule);GO:0006281(DNA repair);GO:0006464(cellular protein modification process);GO:0006471(protein ADP-ribosylation);GO:0006954(inflammatory response);GO:0006974(cellular response to DNA damage stimulus);GO:0008219(cell death);GO:0016020(membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0019899(enzyme binding);GO:0042493(response to drug);GO:0051972(regulation of telomerase activity);GO:0070062(extracellular exosome);GO:0140289(protein mono-ADP-ribosylation);GO:1990404(protein ADP-ribosylase activity);GO:1990904(ribonucleoprotein complex)","03410(Base excision repair);04210(Apoptosis);04217(Necroptosis)",{"v":3.7e-05,"d":"0.00"},1,"61,",0,{"v":-0.983,"d":"-0.98"},{"v":0.0213796208950223,"d":"0.02"},1.44,"5' UTR",13,24420931,24512778,91848,2]
["chr13",29509414,29509564,151,"ENSG00000139514","ENST00000380752","protein_coding",86124,"SLC7A1","solute carrier family 7 member 1 [Source:HGNC Symbol;Acc:HGNC:11057]","GO:0000064(L-ornithine transmembrane transporter activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006865(amino acid transport);GO:0015171(amino acid transmembrane transporter activity);GO:0015181(arginine transmembrane transporter activity);GO:0015189(L-lysine transmembrane transporter activity);GO:0015809(arginine transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0032991(protein-containing complex);GO:0055085(transmembrane transport);GO:0097638(L-arginine import across plasma membrane);GO:1903352(L-ornithine transmembrane transport);GO:1903401(L-lysine transmembrane transport);GO:1903826(arginine transmembrane transport)","05206(MicroRNAs in cancer)",{"v":1e-11,"d":"0.00"},1,"151,",0,-1.42,{"v":0.00562341325190349,"d":"0.01"},1.07,"3' UTR",13,29509414,29595688,86275,2]
["chr13",36879324,36920193,40870,"ENSG00000120693","ENST00000399275","protein_coding",0,"SMAD9","SMAD family member 9 [Source:HGNC Symbol;Acc:HGNC:6774]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0030509(BMP signaling pathway);GO:0030618(transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity);GO:0046872(metal ion binding);GO:0060395(SMAD protein signal transduction);GO:0071141(SMAD protein complex);GO:0071773(cellular response to BMP stimulus);GO:1901522(positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus)","04350(TGF-beta signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells)",{"v":2.5e-95,"d":"0.00"},2,"552,78,","0,40792",-3.42,{"v":2.29086765276777e-05,"d":"0.00"},1.26,"5' UTR",13,36844831,36879829,34999,2]
["chr13",41061082,41061410,329,"ENSG00000120690","ENST00000405737","protein_coding",30,"ELF1","E74 like ETS transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:3316]","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001817(regulation of cytokine production);GO:0001959(regulation of cytokine-mediated signaling pathway);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0030154(cell differentiation);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050855(regulation of B cell receptor signaling pathway);GO:0050860(negative regulation of T cell receptor signaling pathway)","NA",{"v":2.2e-07,"d":"0.00"},1,"329,",0,-1.02,{"v":0.0190546071796325,"d":"0.02"},1.02,"5' UTR",13,40981983,41061440,79458,2]
["chr13",51766226,51766825,600,"ENSG00000139668","ENST00000298125","protein_coding",181764,"WDFY2","WD repeat and FYVE domain containing 2 [Source:HGNC Symbol;Acc:HGNC:20482]","GO:0001934(positive regulation of protein phosphorylation);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005769(early endosome);GO:0031982(vesicle);GO:0045600(positive regulation of fat cell differentiation);GO:0046872(metal ion binding)","NA",{"v":6.3e-16,"d":"0.00"},1,"600,",0,-1.73,{"v":0.00223872113856834,"d":"0.00"},1.39,"3' UTR",13,51584462,51767709,183248,1]
["chr13",77007089,77015305,8217,"ENSG00000283208","ENST00000461131","retained_intron",0,"AC001226","novel protein","GO:0005764(lysosome)","NA",{"v":1e-185,"d":"0.00"},2,"700,141,","0,8076",-2.59,{"v":0.000208929613085404,"d":"0.00"},1.04,"3' UTR",13,77008602,77077178,68577,1]
["chr7",100015572,100019237,3666,"ENSG00000106261","ENST00000535170","protein_coding",0,"ZKSCAN1","zinc finger with KRAB and SCAN domains 1 [Source:HGNC Symbol;Acc:HGNC:13101]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","NA",{"v":3.5e-10,"d":"0.00"},3,"155,109,7,","0,1250,3659",-3.09,{"v":5.49540873857625e-05,"d":"0.00"},3.24,"5' UTR",7,100015572,100041688,26117,1]
["chr7",75147751,75148140,390,"ENSG00000174428","ENST00000472837","protein_coding",55355,"GTF2IRD2B","GTF2I repeat domain containing 2B [Source:HGNC Symbol;Acc:HGNC:33125]","GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0014883(transition between fast and slow fiber)","NA",{"v":2.9E-5,"d":"0.00"},1,"390,",0,-1.35,{"v":0.00691830970918936,"d":"0.01"},3.25,"3' UTR",7,75092396,75149817,57422,1]
["chr13",113483892,113489145,5254,"ENSG00000150401","ENST00000465938","protein_coding",0,"DCUN1D2","defective in cullin neddylation 1 domain containing 2 [Source:HGNC Symbol;Acc:HGNC:20328]","GO:0000151(ubiquitin ligase complex);GO:0005515(protein binding);GO:0031624(ubiquitin conjugating enzyme binding);GO:0032182(ubiquitin-like protein binding);GO:0045116(protein neddylation);GO:0051443(positive regulation of ubiquitin-protein transferase activity);GO:0097602(cullin family protein binding)","NA",{"v":3.1e-10,"d":"0.00"},2,"305,56,","0,5198",-0.92,{"v":0.0263026799189538,"d":"0.03"},1.29,"5' UTR",13,113474197,113484190,9994,2]
["chr14",45115565,45115864,300,"ENSG00000100442","ENST00000396062","protein_coding",18617,"FKBP3","FKBP prolyl isomerase 3 [Source:HGNC Symbol;Acc:HGNC:3719]","GO:0000413(protein peptidyl-prolyl isomerization);GO:0003723(RNA binding);GO:0003755(peptidyl-prolyl cis-trans isomerase activity);GO:0005515(protein binding);GO:0005528(FK506 binding);GO:0005634(nucleus);GO:0016853(isomerase activity);GO:0038023(signaling receptor activity)","NA",{"v":7.9e-38,"d":"0.00"},1,"300,",0,{"v":-0.959,"d":"-0.96"},{"v":0.0234422881531992,"d":"0.02"},1.12,"3' UTR",14,45115599,45134481,18883,2]
["chr14",50329554,50330213,660,"ENSG00000100490","ENST00000395834","protein_coding",65686,"CDKL1","cyclin dependent kinase like 1 [Source:HGNC Symbol;Acc:HGNC:1781]","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004693(cyclin-dependent protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0007507(heart development);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0035869(ciliary transition zone);GO:0043231(intracellular membrane-bounded organelle);GO:0051726(regulation of cell cycle);GO:0070062(extracellular exosome);GO:1902017(regulation of cilium assembly)","NA",{"v":4e-33,"d":"0.00"},1,"660,",0,-1.63,{"v":3.01995172040202E-3,"d":"0.00"},1.02,"3' UTR",14,50329404,50395899,66496,2]
["chr14",61321764,61322064,301,"ENSG00000027075","ENST00000555185","protein_coding",134205,"PRKCH","protein kinase C eta [Source:HGNC Symbol;Acc:HGNC:9403]","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004697(protein kinase C activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0007165(signal transduction);GO:0010744(positive regulation of macrophage derived foam cell differentiation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018105(peptidyl-serine phosphorylation);GO:0019899(enzyme binding);GO:0030154(cell differentiation);GO:0030168(platelet activation);GO:0034351(negative regulation of glial cell apoptotic process);GO:0035556(intracellular signal transduction);GO:0045618(positive regulation of keratinocyte differentiation);GO:0046872(metal ion binding);GO:0050861(positive regulation of B cell receptor signaling pathway);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0060252(positive regulation of glial cell proliferation);GO:0070062(extracellular exosome);GO:1903078(positive regulation of protein localization to plasma membrane);GO:2000810(regulation of bicellular tight junction assembly)","04270(Vascular smooth muscle contraction);04750(Inflammatory mediator regulation of TRP channels)",{"v":2.7e-09,"d":"0.00"},1,"301,",0,{"v":-0.922,"d":"-0.92"},{"v":0.0263026799189538,"d":"0.03"},1.17,"5' UTR",14,61187559,61530584,343026,1]
["chr14",63598874,63599248,375,"ENSG00000258800","ENST00000553983","lincRNA",0,"AL136038","novel transcript","NA","NA",{"v":9.99999999999998e-248,"d":"0.00"},2,"137,146,","0,229",-1.59,{"v":0.00338844156139203,"d":"0.00"},{"v":1.1,"d":"1.10"},"Exon (ENST00000553983/ENSG00000258800, exon 1 of 2)",14,63598874,63599248,375,1]
["chr14",69352365,69352874,510,"ENSG00000100626","ENST00000337827","protein_coding",92401,"GALNT16","polypeptide N-acetylgalactosaminyltransferase 16 [Source:HGNC Symbol;Acc:HGNC:23233]","GO:0000139(Golgi membrane);GO:0004653(polypeptide N-acetylgalactosaminyltransferase activity);GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0018242(protein O-linked glycosylation via serine);GO:0018243(protein O-linked glycosylation via threonine);GO:0030246(carbohydrate binding);GO:0046872(metal ion binding)","00512(Mucin type O-glycan biosynthesis)",{"v":2.4E-10,"d":"0.00"},1,"510,",0,{"v":-0.985,"d":"-0.99"},{"v":0.0213796208950223,"d":"0.02"},1.02,"3' UTR",14,69259964,69357033,97070,1]
["chr19",11351308,11352315,1008,"ENSG00000183401","ENST00000586479","processed_transcript",0,"CCDC159","coiled-coil domain containing 159 [Source:HGNC Symbol;Acc:HGNC:26996]","NA","NA",{"v":4e-11,"d":"0.00"},3,"179,250,259,","0,440,749",-4.65,{"v":9.33254300796991e-07,"d":"0.00"},3.25,"Exon (ENST00000588790/ENSG00000183401, exon 8 of 13)",19,11351748,11353749,2002,1]
["chr2",241582309,241582726,418,"ENSG00000273113","ENST00000608316","lincRNA",387,"AC133528","novel transcript","NA","NA",{"v":2.5e-11,"d":"0.00"},1,"418,",0,{"v":-0.997,"d":"-1.00"},{"v":0.0204173794466953,"d":"0.02"},3.29,"Exon (ENST00000608316/ENSG00000273113, exon 1 of 1)",2,241581922,241582726,805,1]
["chr14",95179366,95179933,568,"ENSG00000235706","ENST00000554631","antisense",21721,"DICER1-AS1","DICER1 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:43017]","NA","NA",{"v":1.3E-94,"d":"0.00"},2,"13,435,","0,133",{"v":-0.883,"d":"-0.88"},{"v":0.0295120922666639,"d":"0.03"},1.29,"Exon (ENST00000554631/ENSG00000235706, exon 2 of 3)",14,95157645,95179933,22289,1]
["chr8",133457509,133457808,300,"ENSG00000008513","ENST00000522652","protein_coding",114079,"ST3GAL1","ST3 beta-galactoside alpha-2,3-sialyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:10862]","GO:0000139(Golgi membrane);GO:0003836(beta-galactoside (CMP) alpha-2,3-sialyltransferase activity);GO:0005576(extracellular region);GO:0005794(Golgi apparatus);GO:0006054(N-acetylneuraminate metabolic process);GO:0006464(cellular protein modification process);GO:0006468(protein phosphorylation);GO:0006486(protein glycosylation);GO:0006487(protein N-linked glycosylation);GO:0008373(sialyltransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016266(O-glycan processing);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0018146(keratan sulfate biosynthetic process);GO:0032580(Golgi cisterna membrane);GO:0070062(extracellular exosome);GO:0097503(sialylation)","00512(Mucin type O-glycan biosynthesis);00533(Glycosaminoglycan biosynthesis - keratan sulfate);00603(Glycosphingolipid biosynthesis - globo and isoglobo series);00604(Glycosphingolipid biosynthesis - ganglio series)",{"v":0.0003,"d":"0.00"},1,"300,",0,-1.18,{"v":0.0114815362149688,"d":"0.01"},{"v":3.3,"d":"3.30"},"3' UTR",8,133454848,133571887,117040,2]
["chr14",32271857,32272123,267,"ENSG00000259086","ENST00000556746","processed_pseudogene",178,"AL136298","KIAA1143 (KIAA1143) pseudogene","NA","NA",{"v":9.1e-09,"d":"0.00"},1,"267,",0,{"v":-0.925,"d":"-0.93"},{"v":0.0263026799189538,"d":"0.03"},1.21,"Exon (ENST00000556746/ENSG00000259086, exon 1 of 1)",14,32271857,32272301,445,2]
["chr14",33925009,33925697,689,"ENSG00000129521","ENST00000250457","protein_coding",25384,"EGLN3","egl-9 family hypoxia inducible factor 3 [Source:HGNC Symbol;Acc:HGNC:14661]","GO:0001666(response to hypoxia);GO:0005506(iron ion binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006974(cellular response to DNA damage stimulus);GO:0016491(oxidoreductase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0016706(2-oxoglutarate-dependent dioxygenase activity);GO:0018126(protein hydroxylation);GO:0018401(peptidyl-proline hydroxylation to 4-hydroxy-L-proline);GO:0031418(L-ascorbic acid binding);GO:0031545(peptidyl-proline 4-dioxygenase activity);GO:0042127(regulation of cell population proliferation);GO:0043523(regulation of neuron apoptotic process);GO:0046872(metal ion binding);GO:0051213(dioxygenase activity);GO:0055114(oxidation-reduction process);GO:0061418(regulation of transcription from RNA polymerase II promoter in response to hypoxia)","04066(HIF-1 signaling pathway);05200(Pathways in cancer);05211(Renal cell carcinoma)",{"v":1E-26,"d":"0.00"},1,"689,",0,-1.72,{"v":0.00234422881531992,"d":"0.00"},{"v":1.1,"d":"1.10"},"3' UTR",14,33924231,33951081,26851,2]
["chr14",36678431,36679444,1014,"ENSG00000183032","ENST00000555449","protein_coding",492979,"SLC25A21","solute carrier family 25 member 21 [Source:HGNC Symbol;Acc:HGNC:14411]","GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0006554(lysine catabolic process);GO:0015139(alpha-ketoglutarate transmembrane transporter activity);GO:0015742(alpha-ketoglutarate transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":1e-130,"d":"0.00"},2,"54,156,","0,858",-1.96,{"v":0.00114815362149688,"d":"0.00"},{"v":1.5,"d":"1.50"},"3' UTR",14,36678431,37172423,493993,2]
["chr14",44962172,45042172,80001,"ENSG00000179454","ENST00000557468","protein_coding",0,"KLHL28","kelch like family member 28 [Source:HGNC Symbol;Acc:HGNC:19741]","GO:0005515(protein binding)","NA",{"v":5E-42,"d":"0.00"},4,"19,242,101,57,","0,1679,16026,79944",{"v":-0.858,"d":"-0.86"},{"v":0.0323593656929628,"d":"0.03"},1.05,"5' UTR",14,44945792,44962190,16399,2]
["chr14",45115599,45115867,269,"ENSG00000100442","ENST00000396062","protein_coding",18614,"FKBP3","FKBP prolyl isomerase 3 [Source:HGNC Symbol;Acc:HGNC:3719]","GO:0000413(protein peptidyl-prolyl isomerization);GO:0003723(RNA binding);GO:0003755(peptidyl-prolyl cis-trans isomerase activity);GO:0005515(protein binding);GO:0005528(FK506 binding);GO:0005634(nucleus);GO:0016853(isomerase activity);GO:0038023(signaling receptor activity)","NA",{"v":4e-38,"d":"0.00"},1,"269,",0,{"v":-0.748,"d":"-0.75"},{"v":0.0467735141287198,"d":"0.05"},1,"3' UTR",14,45115599,45134481,18883,2]
["chr14",50329554,50331958,2405,"ENSG00000100490","ENST00000395834","protein_coding",63941,"CDKL1","cyclin dependent kinase like 1 [Source:HGNC Symbol;Acc:HGNC:1781]","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004693(cyclin-dependent protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0007507(heart development);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0035869(ciliary transition zone);GO:0043231(intracellular membrane-bounded organelle);GO:0051726(regulation of cell cycle);GO:0070062(extracellular exosome);GO:1902017(regulation of cilium assembly)","NA",{"v":2.5e-32,"d":"0.00"},2,"628,33,","0,2372",-1.67,{"v":2.69153480392692E-3,"d":"0.00"},1.04,"3' UTR",14,50329404,50395899,66496,2]
["chr14",63727767,63728065,299,"ENSG00000126821","ENST00000247225","protein_coding",0,"SGPP1","sphingosine-1-phosphate phosphatase 1 [Source:HGNC Symbol;Acc:HGNC:17720]","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005886(plasma membrane);GO:0006665(sphingolipid metabolic process);GO:0006668(sphinganine-1-phosphate metabolic process);GO:0006670(sphingosine metabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0030148(sphingolipid biosynthetic process);GO:0042392(sphingosine-1-phosphate phosphatase activity);GO:0097191(extrinsic apoptotic signaling pathway);GO:0097193(intrinsic apoptotic signaling pathway)","00600(Sphingolipid metabolism);04071(Sphingolipid signaling pathway)",{"v":3.2e-22,"d":"0.00"},1,"299,",0,-2.08,{"v":0.000831763771102671,"d":"0.00"},1.43,"5' UTR",14,63684216,63728065,43850,2]
["chr15",24989543,24991313,1771,"ENSG00000214265","ENST00000551312","nonsense_mediated_decay",34509,"AC124312","novel transcript","GO:0016607(nuclear speck)","NA",{"v":3.2E-78,"d":"0.00"},1,"1771,",0,-3.51,{"v":1.77827941003892e-05,"d":"0.00"},1.57,"Exon (ENST00000557108/ENSG00000224078, exon 3 of 3)",15,24955034,25000276,45243,1]
["chr15",34102083,34102412,330,"ENSG00000182405","ENST00000397766","protein_coding",0,"PGBD4","piggyBac transposable element derived 4 [Source:HGNC Symbol;Acc:HGNC:19401]","NA","NA",{"v":3.2e-23,"d":"0.00"},1,"330,",0,-1.14,{"v":0.0128824955169313,"d":"0.01"},1.55,"5' UTR",15,34102083,34108686,6604,1]
["chr15",38354317,38354646,330,"ENSG00000166068","ENST00000299084","protein_coding",101481,"SPRED1","sprouty related EVH1 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:20249]","GO:0000165(MAPK cascade);GO:0000188(inactivation of MAPK activity);GO:0005173(stem cell factor receptor binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0006469(negative regulation of protein kinase activity);GO:0007275(multicellular organism development);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0009966(regulation of signal transduction);GO:0010801(negative regulation of peptidyl-threonine phosphorylation);GO:0010923(negative regulation of phosphatase activity);GO:0016020(membrane);GO:0016525(negative regulation of angiogenesis);GO:0019901(protein kinase binding);GO:0019902(phosphatase binding);GO:0030291(protein serine/threonine kinase inhibitor activity);GO:0031410(cytoplasmic vesicle);GO:0043408(regulation of MAPK cascade);GO:0043409(negative regulation of MAPK cascade);GO:0043517(positive regulation of DNA damage response, signal transduction by p53 class mediator);GO:0060979(vasculogenesis involved in coronary vascular morphogenesis);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0090051(negative regulation of cell migration involved in sprouting angiogenesis);GO:0090311(regulation of protein deacetylation)","NA",{"v":5e-25,"d":"0.00"},1,"330,",0,-1.11,{"v":0.0144543977074593,"d":"0.01"},1.34,"3' UTR",15,38252836,38357249,104414,1]
["chr15",50560356,50560500,145,"ENSG00000092439","ENST00000561267","protein_coding",14508,"TRPM7","transient receptor potential cation channel subfamily M member 7 [Source:HGNC Symbol;Acc:HGNC:17994]","GO:0000166(nucleotide binding);GO:0001726(ruffle);GO:0003779(actin binding);GO:0004674(protein serine/threonine kinase activity);GO:0005216(ion channel activity);GO:0005262(calcium channel activity);GO:0005524(ATP binding);GO:0005623(cell);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0006811(ion transport);GO:0006812(cation transport);GO:0006816(calcium ion transport);GO:0010961(cellular magnesium ion homeostasis);GO:0012501(programmed cell death);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016340(calcium-dependent cell-matrix adhesion);GO:0016740(transferase activity);GO:0017022(myosin binding);GO:0031032(actomyosin structure organization);GO:0034220(ion transmembrane transport);GO:0046777(protein autophosphorylation);GO:0046872(metal ion binding);GO:0051262(protein tetramerization);GO:0055085(transmembrane transport);GO:0070266(necroptotic process);GO:0070588(calcium ion transmembrane transport)","04217(Necroptosis);04218(Cellular senescence);04621(NOD-like receptor signaling pathway);04978(Mineral absorption)",{"v":4.2e-05,"d":"0.00"},1,"145,",0,-1.07,{"v":0.0162181009735893,"d":"0.02"},1.76,"3' UTR",15,50552473,50575008,22536,2]
["chr15",69255805,69256345,541,"ENSG00000138604","ENST00000261858","protein_coding",95170,"GLCE","glucuronic acid epimerase [Source:HGNC Symbol;Acc:HGNC:17855]","GO:0000139(Golgi membrane);GO:0005794(Golgi apparatus);GO:0015012(heparan sulfate proteoglycan biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016853(isomerase activity);GO:0016857(racemase and epimerase activity, acting on carbohydrates and derivatives);GO:0030210(heparin biosynthetic process);GO:0047464(heparosan-N-sulfate-glucuronate 5-epimerase activity)","00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)",{"v":1e-110,"d":"0.00"},1,"541,",0,-2.49,{"v":2.75422870333817E-4,"d":"0.00"},1.04,"5' UTR",15,69160635,69272207,111573,1]
["chr15",75348412,75348901,490,"ENSG00000140398","ENST00000564500","protein_coding",1457,"NEIL1","nei like DNA glycosylase 1 [Source:HGNC Symbol;Acc:HGNC:18448]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003684(damaged DNA binding);GO:0003824(catalytic activity);GO:0003906(DNA-(apurinic or apyrimidinic site) endonuclease activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005737(cytoplasm);GO:0005815(microtubule organizing center);GO:0005856(cytoskeleton);GO:0006281(DNA repair);GO:0006284(base-excision repair);GO:0006289(nucleotide-excision repair);GO:0006974(cellular response to DNA damage stimulus);GO:0006979(response to oxidative stress);GO:0008022(protein C-terminus binding);GO:0008152(metabolic process);GO:0008270(zinc ion binding);GO:0016787(hydrolase activity);GO:0016798(hydrolase activity, acting on glycosyl bonds);GO:0016799(hydrolase activity, hydrolyzing N-glycosyl compounds);GO:0016829(lyase activity);GO:0019104(DNA N-glycosylase activity);GO:0032074(negative regulation of nuclease activity);GO:0045008(depyrimidination);GO:0140078(class I DNA-(apurinic or apyrimidinic site) endonuclease activity)","03410(Base excision repair)",{"v":4e-15,"d":"0.00"},2,"312,18,","0,472",-0.85,{"v":0.0331131121482591,"d":"0.03"},1.84,"5' UTR",15,75346955,75348971,2017,1]
["chr14",103709422,103709931,510,"ENSG00000126214","ENST00000348520","protein_coding",80245,"KLC1","kinesin light chain 1 [Source:HGNC Symbol;Acc:HGNC:6387]","GO:0003774(motor activity);GO:0003777(microtubule motor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005871(kinesin complex);GO:0005874(microtubule);GO:0006890(retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum);GO:0007018(microtubule-based movement);GO:0016020(membrane);GO:0016032(viral process);GO:0019886(antigen processing and presentation of exogenous peptide antigen via MHC class II);GO:0030426(growth cone);GO:0031410(cytoplasmic vesicle);GO:0035617(stress granule disassembly);GO:0042995(cell projection)","05132(Salmonella infection)",{"v":2.6e-06,"d":"0.00"},1,"510,",0,-1.54,{"v":0.0038904514499428,"d":"0.00"},3.36,"3' UTR",14,103629177,103714249,85073,1]
["chr15",82282147,82282806,660,"ENSG00000188659","ENST00000339465","protein_coding",19336,"SAXO2","stabilizer of axonemal microtubules 2 [Source:HGNC Symbol;Acc:HGNC:33727]","GO:0005814(centriole);GO:0005856(cytoskeleton);GO:0005879(axonemal microtubule);GO:0008017(microtubule binding);GO:0031514(motile cilium);GO:0034453(microtubule anchoring);GO:0036064(ciliary basal body);GO:0036126(sperm flagellum)","NA",{"v":2.4E-9,"d":"0.00"},1,"660,",0,-1.51,{"v":0.00426579518801593,"d":"0.00"},1.81,"Exon (ENST00000339465/ENSG00000188659, exon 3 of 3)",15,82262811,82284930,22120,1]
["chr15",85749058,85749358,301,"ENSG00000170776","ENST00000394518","protein_coding",368343,"AKAP13","A-kinase anchoring protein 13 [Source:HGNC Symbol;Acc:HGNC:371]","GO:0004691(cAMP-dependent protein kinase activity);GO:0005078(MAP-kinase scaffold activity);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005884(actin filament);GO:0005938(cell cortex);GO:0006468(protein phosphorylation);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007507(heart development);GO:0015629(actin cytoskeleton);GO:0016020(membrane);GO:0017048(Rho GTPase binding);GO:0030864(cortical actin cytoskeleton);GO:0032947(protein-containing complex scaffold activity);GO:0035023(regulation of Rho protein signal transduction);GO:0035025(positive regulation of Rho protein signal transduction);GO:0035556(intracellular signal transduction);GO:0043065(positive regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043406(positive regulation of MAP kinase activity);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0051018(protein kinase A binding);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0051168(nuclear export);GO:0055007(cardiac muscle cell differentiation);GO:0060297(regulation of sarcomere organization);GO:0060348(bone development);GO:0061049(cell growth involved in cardiac muscle cell development);GO:0071875(adrenergic receptor signaling pathway);GO:0086023(adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process);GO:1900169(regulation of glucocorticoid mediated signaling pathway)","04928(Parathyroid hormone synthesis, secretion and action);05163(Human cytomegalovirus infection)",{"v":1.6e-20,"d":"0.00"},1,"301,",0,-1.78,{"v":0.00194984459975805,"d":"0.00"},1.42,"3' UTR",15,85380715,85749355,368641,1]
["chr15",100651345,100651705,361,"ENSG00000183475","ENST00000332783","protein_coding",48811,"ASB7","ankyrin repeat and SOCS box containing 7 [Source:HGNC Symbol;Acc:HGNC:17182]","GO:0005515(protein binding);GO:0005829(cytosol);GO:0016567(protein ubiquitination);GO:0035556(intracellular signal transduction);GO:0043687(post-translational protein modification)","NA",{"v":1e-23,"d":"0.00"},1,"361,",0,-1.68,{"v":0.00257039578276886,"d":"0.00"},{"v":1.2,"d":"1.20"},"3' UTR",15,100602534,100651705,49172,1]
["chr15",21293683,21294754,1072,"ENSG00000237161","ENST00000556425","processed_pseudogene",447,"AC068446","p21 protein (Cdc42/Rac)-activated kinase 2 (PAK2) pseudogene","NA","NA",{"v":7.9e-14,"d":"0.00"},1,"1072,",0,{"v":-0.797,"d":"-0.80"},{"v":0.0398107170553497,"d":"0.04"},{"v":1.6,"d":"1.60"},"Exon (ENST00000556425/ENSG00000237161, exon 1 of 1)",15,21293653,21295201,1549,2]
["chr15",40088339,40088518,180,"ENSG00000104081","ENST00000354670","protein_coding",20361,"BMF","Bcl2 modifying factor [Source:HGNC Symbol;Acc:HGNC:24132]","GO:0001669(acrosomal vesicle);GO:0001844(protein insertion into mitochondrial membrane involved in apoptotic signaling pathway);GO:0005515(protein binding);GO:0005741(mitochondrial outer membrane);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006915(apoptotic process);GO:0010507(negative regulation of autophagy);GO:0016459(myosin complex);GO:0032464(positive regulation of protein homooligomerization);GO:0034644(cellular response to UV);GO:0043065(positive regulation of apoptotic process);GO:0043276(anoikis);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway)","05206(MicroRNAs in cancer)",{"v":7.1e-07,"d":"0.00"},1,"180,",0,{"v":-0.905,"d":"-0.91"},{"v":0.0275422870333817,"d":"0.03"},1.73,"3' UTR",15,40087890,40108879,20990,2]
["chr15",40531791,40534460,2670,"ENSG00000128891","ENST00000560305","protein_coding",30551,"CCDC32","coiled-coil domain containing 32 [Source:HGNC Symbol;Acc:HGNC:28295]","GO:0005515(protein binding)","NA",{"v":1.6e-16,"d":"0.00"},2,"512,118,","0,2552",-1.08,{"v":0.0158489319246111,"d":"0.02"},1.42,"3' UTR",15,40528683,40565011,36329,2]
["chr10",49018458,49019207,750,"ENSG00000165633","ENST00000332853","protein_coding",96315,"VSTM4","V-set and transmembrane domain containing 4 [Source:HGNC Symbol;Acc:HGNC:26470]","GO:0005576(extracellular region);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":2E-12,"d":"0.00"},1,"750,",0,-1.19,{"v":0.0112201845430196,"d":"0.01"},3.43,"3' UTR",10,49014236,49115522,101287,2]
["chr15",56631440,56635212,3773,"ENSG00000276696","ENST00000614892","misc_RNA",0,"RF00019","NA","NA","NA",{"v":7.9E-75,"d":"0.00"},2,"683,38,","0,3735",-1.03,{"v":0.0181970085860998,"d":"0.02"},1.12,"3' UTR",15,56634038,56634167,130,2]
["chr15",67407897,67413522,5626,"ENSG00000103599","ENST00000335894","protein_coding",153111,"IQCH","IQ motif containing H [Source:HGNC Symbol;Acc:HGNC:25721]","GO:0003674(molecular_function);GO:0005515(protein binding);GO:0005575(cellular_component);GO:0008150(biological_process)","NA",{"v":4e-12,"d":"0.00"},2,"579,20,","0,5606",{"v":-0.785,"d":"-0.79"},{"v":0.0416869383470335,"d":"0.04"},{"v":1.4,"d":"1.40"},"Exon (ENST00000559298/ENSG00000259673, exon 6 of 6)",15,67254786,67501804,247019,1]
["chr15",82845458,82849727,4270,"ENSG00000103942","ENST00000558090","protein_coding",0,"HOMER2","homer scaffold protein 2 [Source:HGNC Symbol;Acc:HGNC:17513]","GO:0003779(actin binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007216(G protein-coupled glutamate receptor signaling pathway);GO:0007605(sensory perception of sound);GO:0008277(regulation of G protein-coupled receptor signaling pathway);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0019904(protein domain specific binding);GO:0030054(cell junction);GO:0030160(GKAP/Homer scaffold activity);GO:0030425(dendrite);GO:0032420(stereocilium);GO:0032426(stereocilium tip);GO:0032703(negative regulation of interleukin-2 production);GO:0035254(glutamate receptor binding);GO:0035256(G protein-coupled glutamate receptor binding);GO:0035584(calcium-mediated signaling using intracellular calcium source);GO:0042803(protein homodimerization activity);GO:0042995(cell projection);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0045177(apical part of cell);GO:0045202(synapse);GO:0045211(postsynaptic membrane);GO:0046982(protein heterodimerization activity);GO:0048148(behavioral response to cocaine);GO:0048875(chemical homeostasis within a tissue);GO:0070885(negative regulation of calcineurin-NFAT signaling cascade);GO:0098978(glutamatergic synapse);GO:2001256(regulation of store-operated calcium entry)","04068(FoxO signaling pathway);04724(Glutamatergic synapse)",{"v":5e-82,"d":"0.00"},2,"1790,39,","0,4231",-6.75,{"v":4.67735141287198e-09,"d":"0.00"},1.09,"3' UTR",15,82836946,82849727,12782,2]
["chr15",83004837,83005616,780,"ENSG00000169609","ENST00000514272","protein_coding",3000,"C15orf40","chromosome 15 open reading frame 40 [Source:HGNC Symbol;Acc:HGNC:28443]","NA","NA",{"v":2e-32,"d":"0.00"},1,"780,",0,-5.17,{"v":2.51188643150958e-07,"d":"0.00"},1.03,"3' UTR",15,82988441,83008616,20176,2]
["chr15",88467300,88467390,91,"ENSG00000259494","ENST00000312475","protein_coding",0,"MRPL46","mitochondrial ribosomal protein L46 [Source:HGNC Symbol;Acc:HGNC:1192]","GO:0003674(molecular_function);GO:0003735(structural constituent of ribosome);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005762(mitochondrial large ribosomal subunit);GO:0005840(ribosome);GO:0008150(biological_process);GO:0016787(hydrolase activity);GO:0030054(cell junction);GO:0070125(mitochondrial translational elongation);GO:0070126(mitochondrial translational termination)","NA",{"v":0.00068,"d":"0.00"},1,"91,",0,-0.95,{"v":0.0239883291901949,"d":"0.02"},{"v":1.2,"d":"1.20"},"5' UTR",15,88459478,88467388,7911,2]
["chr16",583777,584136,360,"ENSG00000007541","ENST00000321878","protein_coding",13830,"PIGQ","phosphatidylinositol glycan anchor biosynthesis class Q [Source:HGNC Symbol;Acc:HGNC:14135]","GO:0000506(glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex);GO:0005789(endoplasmic reticulum membrane);GO:0005975(carbohydrate metabolic process);GO:0006506(GPI anchor biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016254(preassembly of GPI anchor in ER membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0017176(phosphatidylinositol N-acetylglucosaminyltransferase activity)","00563(Glycosylphosphatidylinositol (GPI)-anchor biosynthesis)",{"v":2.5e-57,"d":"0.00"},1,"360,",0,-1.92,{"v":0.00131825673855641,"d":"0.00"},1.06,"3' UTR",16,569947,584136,14190,1]
["chr16",735017,735525,509,"ENSG00000103245","ENST00000568545","protein_coding",2364,"CIAO3","cytosolic iron-sulfur assembly component 3 [Source:HGNC Symbol;Acc:HGNC:14179]","GO:0001666(response to hypoxia);GO:0002244(hematopoietic progenitor cell differentiation);GO:0005515(protein binding);GO:0010468(regulation of gene expression);GO:0016226(iron-sulfur cluster assembly);GO:0032364(oxygen homeostasis);GO:0046872(metal ion binding);GO:0051536(iron-sulfur cluster binding);GO:0051539(4 iron, 4 sulfur cluster binding);GO:0097361(CIA complex)","NA",{"v":2e-27,"d":"0.00"},1,"509,",0,-1.08,{"v":0.0158489319246111,"d":"0.02"},1.55,"Exon (ENST00000647875/ENSG00000103253, exon 3 of 3)",16,729760,737889,8130,2]
["chr16",3661077,3661916,840,"ENSG00000126602","ENST00000575707","nonsense_mediated_decay",74,"TRAP1","TNF receptor associated protein 1 [Source:HGNC Symbol;Acc:HGNC:16264]","GO:0000166(nucleotide binding);GO:0003723(RNA binding);GO:0005164(tumor necrosis factor receptor binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005758(mitochondrial intermembrane space);GO:0005759(mitochondrial matrix);GO:0006457(protein folding);GO:0009386(translational attenuation);GO:0016020(membrane);GO:0019901(protein kinase binding);GO:0051082(unfolded protein binding);GO:0061077(chaperone-mediated protein folding);GO:1901856(negative regulation of cellular respiration);GO:1903427(negative regulation of reactive oxygen species biosynthetic process);GO:1903751(negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide)","NA",{"v":1.6e-19,"d":"0.00"},1,"840,",0,-1.75,{"v":2.13796208950223E-3,"d":"0.00"},1.16,"3' UTR",16,3651639,3661990,10352,2]
["chr19",49850765,49850975,211,"ENSG00000104960","ENST00000601638","protein_coding",0,"PTOV1","PTOV1, extended AT-hook containing adaptor protein [Source:HGNC Symbol;Acc:HGNC:9632]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0044798(nuclear transcription factor complex);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048471(perinuclear region of cytoplasm)","NA",{"v":2.7e-05,"d":"0.00"},1,"211,",0,{"v":-0.945,"d":"-0.95"},{"v":0.0245470891568503,"d":"0.02"},3.43,"5' UTR",19,49850828,49860713,9886,1]
["chr16",31462573,31462813,241,"ENSG00000140691","ENST00000408912","protein_coding",4493,"ARMC5","armadillo repeat containing 5 [Source:HGNC Symbol;Acc:HGNC:25781]","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005925(focal adhesion)","04934(Cushing syndrome)",{"v":7.9e-12,"d":"0.00"},1,"241,",0,{"v":-0.741,"d":"-0.74"},{"v":0.0478630092322638,"d":"0.05"},1.49,"Exon (ENST00000408912/ENSG00000140691, exon 5 of 8)",16,31458080,31467105,9026,1]
["chr16",50153842,50211324,57483,"ENSG00000121274","ENST00000562717","processed_transcript",0,"TENT4B","terminal nucleotidyltransferase 4B [Source:HGNC Symbol;Acc:HGNC:30758]","GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0003887(DNA-directed DNA polymerase activity);GO:0004652(polynucleotide adenylyltransferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006364(rRNA processing);GO:0006378(mRNA polyadenylation);GO:0006397(mRNA processing);GO:0007049(cell cycle);GO:0010587(miRNA catabolic process);GO:0016740(transferase activity);GO:0016779(nucleotidyltransferase activity);GO:0031499(TRAMP complex);GO:0032211(negative regulation of telomere maintenance via telomerase);GO:0033500(carbohydrate homeostasis);GO:0043629(ncRNA polyadenylation);GO:0043630(ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process);GO:0043631(RNA polyadenylation);GO:0046872(metal ion binding);GO:0051301(cell division);GO:0060212(negative regulation of nuclear-transcribed mRNA poly(A) tail shortening);GO:0070034(telomerase RNA binding);GO:0070568(guanylyltransferase activity);GO:0071044(histone mRNA catabolic process);GO:0071050(snoRNA polyadenylation);GO:0071076(RNA 3' uridylation);GO:0071897(DNA biosynthetic process);GO:1905870(positive regulation of 3'-UTR-mediated mRNA stabilization)","03018(RNA degradation)",{"v":1.5E-6,"d":"0.00"},2,"418,2,","0,57481",{"v":-0.944,"d":"-0.94"},{"v":0.0245470891568503,"d":"0.02"},1,"5' UTR",16,50154161,50235306,81146,1]
["chr16",67437133,67437553,421,"ENSG00000176387","ENST00000326152","protein_coding",6012,"HSD11B2","hydroxysteroid 11-beta dehydrogenase 2 [Source:HGNC Symbol;Acc:HGNC:5209]","GO:0001666(response to hypoxia);GO:0002017(regulation of blood volume by renal aldosterone);GO:0003845(11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity);GO:0005496(steroid binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006704(glucocorticoid biosynthetic process);GO:0007565(female pregnancy);GO:0008211(glucocorticoid metabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0032094(response to food);GO:0032868(response to insulin);GO:0042493(response to drug);GO:0043231(intracellular membrane-bounded organelle);GO:0048545(response to steroid hormone);GO:0051287(NAD binding);GO:0051384(response to glucocorticoid);GO:0055114(oxidation-reduction process)","00140(Steroid hormone biosynthesis);04960(Aldosterone-regulated sodium reabsorption)",{"v":5e-11,"d":"0.00"},1,"421,",0,{"v":-0.744,"d":"-0.74"},{"v":0.0478630092322638,"d":"0.05"},1.27,"3' UTR",16,67431121,67437553,6433,1]
["chr6",53349000,53349179,180,"ENSG00000012660","ENST00000370918","protein_coding",0,"ELOVL5","ELOVL fatty acid elongase 5 [Source:HGNC Symbol;Acc:HGNC:21308]","GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0006636(unsaturated fatty acid biosynthetic process);GO:0009922(fatty acid elongase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0019367(fatty acid elongation, saturated fatty acid);GO:0030148(sphingolipid biosynthetic process);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0030425(dendrite);GO:0034625(fatty acid elongation, monounsaturated fatty acid);GO:0034626(fatty acid elongation, polyunsaturated fatty acid);GO:0035338(long-chain fatty-acyl-CoA biosynthetic process);GO:0036109(alpha-linolenic acid metabolic process);GO:0042761(very long-chain fatty acid biosynthetic process);GO:0042995(cell projection);GO:0043025(neuronal cell body);GO:0043651(linoleic acid metabolic process);GO:0045723(positive regulation of fatty acid biosynthetic process);GO:0097447(dendritic tree);GO:0102336(3-oxo-arachidoyl-CoA synthase activity);GO:0102337(3-oxo-cerotoyl-CoA synthase activity);GO:0102338(3-oxo-lignoceronyl-CoA synthase activity);GO:0102756(very-long-chain 3-ketoacyl-CoA synthase activity)","00062(Fatty acid elongation);01040(Biosynthesis of unsaturated fatty acids)",{"v":4.6E-6,"d":"0.00"},1,"180,",0,{"v":-0.964,"d":"-0.96"},{"v":0.0229086765276777,"d":"0.02"},3.46,"5' UTR",6,53267398,53349179,81782,2]
["chr16",89498718,89499198,481,"ENSG00000197912","ENST00000647079","protein_coding",7801,"SPG7","SPG7, paraplegin matrix AAA peptidase subunit [Source:HGNC Symbol;Acc:HGNC:11237]","GO:0000166(nucleotide binding);GO:0004222(metalloendopeptidase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005745(m-AAA complex);GO:0005757(mitochondrial permeability transition pore complex);GO:0006508(proteolysis);GO:0006851(mitochondrial calcium ion transmembrane transport);GO:0007005(mitochondrion organization);GO:0007399(nervous system development);GO:0008089(anterograde axonal transport);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0046872(metal ion binding);GO:0046902(regulation of mitochondrial membrane permeability);GO:0051082(unfolded protein binding);GO:1902686(mitochondrial outer membrane permeabilization involved in programmed cell death);GO:1904115(axon cytoplasm)","NA",{"v":2.5e-16,"d":"0.00"},1,"481,",0,{"v":-0.793,"d":"-0.79"},{"v":0.0407380277804113,"d":"0.04"},1.12,"Exon (ENST00000568509/ENSG00000197912, exon 2 of 2)",16,89490917,89557748,66832,1]
["chr16",722582,722850,269,"ENSG00000103254","ENST00000566525","retained_intron",2001,"FAM173A","family with sequence similarity 173 member A [Source:HGNC Symbol;Acc:HGNC:14152]","GO:0008168(methyltransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0032259(methylation)","NA",{"v":8.3e-07,"d":"0.00"},1,"269,",0,-1.33,{"v":7.2443596007499E-3,"d":"0.01"},1.67,"3' UTR",16,720581,722589,2009,1]
["chr16",2088710,2088950,241,"ENSG00000008710","ENST00000262304","protein_coding",46948,"PKD1","polycystin 1, transient receptor potential channel interacting [Source:HGNC Symbol;Acc:HGNC:9008]","GO:0000139(Golgi membrane);GO:0001502(cartilage condensation);GO:0001568(blood vessel development);GO:0001701(in utero embryonic development);GO:0001822(kidney development);GO:0001889(liver development);GO:0001892(embryonic placenta development);GO:0002133(polycystin complex);GO:0005262(calcium channel activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005929(cilium);GO:0006611(protein export from nucleus);GO:0006807(nitrogen compound metabolic process);GO:0006816(calcium ion transport);GO:0007050(cell cycle arrest);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007160(cell-matrix adhesion);GO:0007161(calcium-independent cell-matrix adhesion);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0007259(receptor signaling pathway via JAK-STAT);GO:0007507(heart development);GO:0009653(anatomical structure morphogenesis);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0016323(basolateral plasma membrane);GO:0016328(lateral plasma membrane);GO:0018105(peptidyl-serine phosphorylation);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0021510(spinal cord development);GO:0021915(neural tube development);GO:0030010(establishment of cell polarity);GO:0030155(regulation of cell adhesion);GO:0030246(carbohydrate binding);GO:0030660(Golgi-associated vesicle membrane);GO:0031514(motile cilium);GO:0032092(positive regulation of protein binding);GO:0034405(response to fluid shear stress);GO:0034703(cation channel complex);GO:0034704(calcium channel complex);GO:0036303(lymph vessel morphogenesis);GO:0042813(Wnt-activated receptor activity);GO:0042994(cytoplasmic sequestering of transcription factor);GO:0042995(cell projection);GO:0043588(skin development);GO:0044325(ion channel binding);GO:0045737(positive regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048565(digestive tract development);GO:0048754(branching morphogenesis of an epithelial tube);GO:0048806(genitalia development);GO:0050982(detection of mechanical stimulus);GO:0051216(cartilage development);GO:0051290(protein heterotetramerization);GO:0060170(ciliary membrane);GO:0060236(regulation of mitotic spindle organization);GO:0060428(lung epithelium development);GO:0060674(placenta blood vessel development);GO:0061136(regulation of proteasomal protein catabolic process);GO:0070062(extracellular exosome);GO:0070588(calcium ion transmembrane transport);GO:0072164(mesonephric tubule development);GO:0072177(mesonephric duct development);GO:0072205(metanephric collecting duct development);GO:0072218(metanephric ascending thin limb development);GO:0072237(metanephric proximal tubule development);GO:0072287(metanephric distal tubule morphogenesis);GO:0098609(cell-cell adhesion);GO:0198738(cell-cell signaling by wnt);GO:2000045(regulation of G1/S transition of mitotic cell cycle)","NA",{"v":1.5E-9,"d":"0.00"},1,"241,",0,-1.29,{"v":0.00831763771102671,"d":"0.01"},1.03,"3' UTR",16,2088710,2135898,47189,2]
["chr16",3156826,3157483,658,"ENSG00000261889","ENST00000570843","lincRNA",0,"AC108134","novel transcript","NA","NA",{"v":1e-17,"d":"0.00"},1,"658,",0,{"v":-1.2,"d":"-1.20"},{"v":0.0109647819614319,"d":"0.01"},1,"Exon (ENST00000570843/ENSG00000261889, exon 1 of 1)",16,3156736,3157483,748,2]
["chr16",10938854,10939332,479,"ENSG00000179583","ENST00000644232","nonsense_mediated_decay",16687,"CIITA","class II major histocompatibility complex transactivator [Source:HGNC Symbol;Acc:HGNC:7067]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000166(nucleotide binding);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006954(inflammatory response);GO:0006955(immune response);GO:0007568(aging);GO:0008022(protein C-terminus binding);GO:0009986(cell surface);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016605(PML body);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0032966(negative regulation of collagen biosynthetic process);GO:0033613(activating transcription factor binding);GO:0034341(response to interferon-gamma);GO:0044212(transcription regulatory region DNA binding);GO:0044877(protein-containing complex binding);GO:0045345(positive regulation of MHC class I biosynthetic process);GO:0045348(positive regulation of MHC class II biosynthetic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046677(response to antibiotic);GO:0060333(interferon-gamma-mediated signaling pathway);GO:0071257(cellular response to electrical stimulus);GO:0071346(cellular response to interferon-gamma);GO:0071360(cellular response to exogenous dsRNA)","04612(Antigen processing and presentation);05145(Toxoplasmosis);05152(Tuberculosis);05164(Influenza A);05340(Primary immunodeficiency)",{"v":1.2e-07,"d":"0.00"},1,"479,",0,-1.21,{"v":0.010471285480509,"d":"0.01"},{"v":1.4,"d":"1.40"},"3' UTR",16,10922167,10943021,20855,1]
["chr16",30894242,30894960,719,"ENSG00000099385","ENST00000380317","protein_coding",0,"BCL7C","BCL7C, BAF complex component [Source:HGNC Symbol;Acc:HGNC:1006]","GO:0006915(apoptotic process)","NA",{"v":5e-30,"d":"0.00"},1,"719,",0,-1.13,{"v":0.0134896288259165,"d":"0.01"},1.01,"5' UTR",16,30833626,30894302,60677,2]
["chr4",82919581,82919730,150,"ENSG00000168152","ENST00000302236","protein_coding",18846,"THAP9","THAP domain containing 9 [Source:HGNC Symbol;Acc:HGNC:23192]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0004803(transposase activity);GO:0006310(DNA recombination);GO:0006313(transposition, DNA-mediated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0015074(DNA integration);GO:0016740(transferase activity);GO:0043565(sequence-specific DNA binding);GO:0046872(metal ion binding)","NA",{"v":0.00081,"d":"0.00"},1,"150,",0,-0.86,{"v":0.0323593656929628,"d":"0.03"},3.49,"3' UTR",4,82900735,82919969,19235,1]
["chr16",74312698,74313390,693,"ENSG00000239763","ENST00000493458","processed_pseudogene",0,"AC009120","ribosomal protein L21 (RPL21) pseudogene","NA","NA",{"v":1.3E-28,"d":"0.00"},2,"22,362,","0,331",-1.54,{"v":0.0038904514499428,"d":"0.00"},1.56,"Exon (ENST00000564455/ENSG00000260884, exon 1 of 2)",16,74312609,74313390,782,2]
["chr17",7855779,7856041,263,"ENSG00000167874","ENST00000301599","protein_coding",714,"TMEM88","transmembrane protein 88 [Source:HGNC Symbol;Acc:HGNC:32371]","GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007275(multicellular organism development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0030165(PDZ domain binding);GO:0050821(protein stabilization);GO:0072659(protein localization to plasma membrane);GO:0090090(negative regulation of canonical Wnt signaling pathway)","NA",{"v":9.1e-05,"d":"0.00"},1,"263,",0,{"v":-0.893,"d":"-0.89"},{"v":0.0288403150312661,"d":"0.03"},3.49,"3' UTR",17,7855065,7856099,1035,1]
["chr16",89971882,89972185,304,"ENSG00000177946","ENST00000565150","transcribed_unitary_pseudogene",0,"CENPBD1","CENPB DNA-binding domain containing 1 [Source:HGNC Symbol;Acc:HGNC:28272]","GO:0003677(DNA binding);GO:0005634(nucleus)","NA",{"v":8.9e-09,"d":"0.00"},2,"41,257,","0,47",-0.75,{"v":0.0467735141287198,"d":"0.05"},1.11,"5' UTR",16,89969983,89971922,1940,2]
["chr21",8393776,8394014,239,"ENSG00000280441","ENST00000623860","lincRNA",13133,"FP236383","novel transcript","NA","NA",{"v":0.00085,"d":"0.00"},1,"239,",0,-1.82,{"v":1.73780082874938E-3,"d":"0.00"},3.49,"Exon (ENST00000625598/ENSG00000280614, exon 1 of 1)",21,8380643,8410645,30003,1]
["chr17",3668871,3669134,264,"ENSG00000127774","ENST00000248378","protein_coding",59,"EMC6","ER membrane protein complex subunit 6 [Source:HGNC Symbol;Acc:HGNC:28430]","GO:0000045(autophagosome assembly);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0034975(protein folding in endoplasmic reticulum);GO:0072546(ER membrane protein complex);GO:0097631(integral component of omegasome membrane)","NA",{"v":7.4e-08,"d":"0.00"},2,"142,37,","0,227",-3.23,{"v":3.80189396320561e-05,"d":"0.00"},1.02,"5' UTR",17,3668812,3669665,854,1]
["chr17",4789083,4789877,795,"ENSG00000182327","ENST00000331264","protein_coding",119,"GLTPD2","glycolipid transfer protein domain containing 2 [Source:HGNC Symbol;Acc:HGNC:33756]","GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008289(lipid binding);GO:0016020(membrane);GO:0035627(ceramide transport);GO:0120009(intermembrane lipid transfer);GO:0120013(intermembrane lipid transfer activity);GO:1902387(ceramide 1-phosphate binding);GO:1902388(ceramide 1-phosphate transporter activity);GO:1902389(ceramide 1-phosphate transport)","NA",{"v":2.1e-09,"d":"0.00"},4,"35,65,167,119,","0,143,428,676",-1.45,{"v":0.00512861383991365,"d":"0.01"},1.78,"Exon (ENST00000623798/ENSG00000280254, exon 1 of 1)",17,4788964,4790589,1626,1]
["chr19",49850779,49850957,179,"ENSG00000104960","ENST00000601638","protein_coding",0,"PTOV1","PTOV1, extended AT-hook containing adaptor protein [Source:HGNC Symbol;Acc:HGNC:9632]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0044798(nuclear transcription factor complex);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048471(perinuclear region of cytoplasm)","NA",{"v":8.3e-06,"d":"0.00"},1,"179,",0,{"v":-0.967,"d":"-0.97"},{"v":0.0223872113856834,"d":"0.02"},{"v":3.5,"d":"3.50"},"5' UTR",19,49850828,49860713,9886,1]
["chr21",36132637,36132937,301,"ENSG00000214889","ENST00000419943","processed_pseudogene",187,"RPS9P1","ribosomal protein S9 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:10443]","NA","NA",{"v":3.9e-06,"d":"0.00"},1,"301,",0,{"v":-0.947,"d":"-0.95"},{"v":0.0239883291901949,"d":"0.02"},3.54,"Exon (ENST00000419943/ENSG00000214889, exon 1 of 1)",21,36132450,36133032,583,1]
["chr17",8278231,8278436,206,"ENSG00000269947","ENST00000602597","lincRNA",468,"AC135178","novel transcript","NA","NA",{"v":1.1E-4,"d":"0.00"},1,"206,",0,{"v":-0.783,"d":"-0.78"},{"v":0.0416869383470335,"d":"0.04"},1.84,"Exon (ENST00000602597/ENSG00000269947, exon 1 of 1)",17,8277763,8278436,674,1]
["chr17",15706401,15708412,2012,"ENSG00000187607","ENST00000421016","protein_coding",6824,"ZNF286A","zinc finger protein 286A [Source:HGNC Symbol;Acc:HGNC:13501]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":1.6e-33,"d":"0.00"},2,"101,258,","0,1754",-2.29,{"v":0.000467735141287198,"d":"0.00"},1.26,"5' UTR",17,15699577,15720782,21206,1]
["chr17",18006241,18007019,779,"ENSG00000171962","ENST00000470048","retained_intron",0,"DRC3","dynein regulatory complex subunit 3 [Source:HGNC Symbol;Acc:HGNC:25384]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005929(cilium);GO:0005930(axoneme);GO:0031514(motile cilium);GO:0042995(cell projection)","NA",{"v":2.8e-09,"d":"0.00"},1,"779,",0,-1.19,{"v":0.0112201845430196,"d":"0.01"},1.78,"3' UTR",17,18006880,18007934,1055,1]
["chr17",18206802,18208585,1784,"ENSG00000091542","ENST00000541285","protein_coding",23724,"ALKBH5","alkB homolog 5, RNA demethylase [Source:HGNC Symbol;Acc:HGNC:25996]","GO:0001666(response to hypoxia);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006307(DNA dealkylation involved in DNA repair);GO:0006397(mRNA processing);GO:0006406(mRNA export from nucleus);GO:0007283(spermatogenesis);GO:0016491(oxidoreductase activity);GO:0016607(nuclear speck);GO:0016706(2-oxoglutarate-dependent dioxygenase activity);GO:0030154(cell differentiation);GO:0035515(oxidative RNA demethylase activity);GO:0035553(oxidative single-stranded RNA demethylation);GO:0043488(regulation of mRNA stability);GO:0046872(metal ion binding);GO:0051213(dioxygenase activity);GO:0055114(oxidation-reduction process);GO:1990931(RNA N6-methyladenosine dioxygenase activity)","NA",{"v":1e-199,"d":"0.00"},2,"169,367,","0,1417",-105,{"v":1e-109,"d":"0.00"},1.65,"5' UTR",17,18183078,18209398,26321,1]
["chr17",18411189,18412020,832,"ENSG00000220161","ENST00000577684","lincRNA",30,"LINC02076","long intergenic non-protein coding RNA 2076 [Source:HGNC Symbol;Acc:HGNC:52924]","NA","NA",{"v":7.9e-38,"d":"0.00"},1,"832,",0,-1.58,{"v":0.00346736850452532,"d":"0.00"},1.85,"Exon (ENST00000577684/ENSG00000220161, exon 1 of 2)",17,18411159,18414380,3222,1]
["chr17",36601939,36602206,268,"ENSG00000278619","ENST00000612760","protein_coding",0,"MRM1","mitochondrial rRNA methyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:26202]","GO:0000451(rRNA 2'-O-methylation);GO:0001510(RNA methylation);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006364(rRNA processing);GO:0006396(RNA processing);GO:0008168(methyltransferase activity);GO:0008173(RNA methyltransferase activity);GO:0016740(transferase activity);GO:0032259(methylation);GO:0070039(rRNA (guanosine-2'-O-)-methyltransferase activity)","NA",{"v":4.8e-05,"d":"0.00"},1,"268,",0,{"v":-0.804,"d":"-0.80"},{"v":0.0389045144994281,"d":"0.04"},1.24,"5' UTR",17,36601962,36608964,7003,1]
["chr17",42680333,42681381,1049,"ENSG00000184451","ENST00000332438","protein_coding",462,"CCR10","C-C motif chemokine receptor 10 [Source:HGNC Symbol;Acc:HGNC:4474]","GO:0004930(G protein-coupled receptor activity);GO:0004950(chemokine receptor activity);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006935(chemotaxis);GO:0006955(immune response);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016493(C-C chemokine receptor activity);GO:0019722(calcium-mediated signaling);GO:0019956(chemokine binding);GO:0019957(C-C chemokine binding);GO:0060326(cell chemotaxis);GO:0070098(chemokine-mediated signaling pathway)","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway);04672(Intestinal immune network for IgA production)",{"v":0.00043,"d":"0.00"},2,"69,18,","0,1031",-6.19,{"v":1.86208713666287e-08,"d":"0.00"},1.68,"5' UTR",17,42678889,42681843,2955,2]
["chr17",44070735,44070915,181,"ENSG00000141349","ENST00000269097","protein_coding",0,"G6PC3","glucose-6-phosphatase catalytic subunit 3 [Source:HGNC Symbol;Acc:HGNC:24861]","GO:0004346(glucose-6-phosphatase activity);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006094(gluconeogenesis);GO:0006796(phosphate-containing compound metabolic process);GO:0015760(glucose-6-phosphate transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0051156(glucose 6-phosphate metabolic process)","00010(Glycolysis / Gluconeogenesis);00052(Galactose metabolism);00500(Starch and sucrose metabolism);04068(FoxO signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04910(Insulin signaling pathway);04920(Adipocytokine signaling pathway);04922(Glucagon signaling pathway);04931(Insulin resistance);04973(Carbohydrate digestion and absorption)",{"v":2.5e-14,"d":"0.00"},1,"181,",0,{"v":-0.978,"d":"-0.98"},{"v":0.0218776162394955,"d":"0.02"},1.38,"5' UTR",17,44070735,44076304,5570,1]
["chr7",143853797,143857326,3530,"ENSG00000198420","ENST00000479870","protein_coding",44850,"TCAF1","TRPM8 channel associated factor 1 [Source:HGNC Symbol;Acc:HGNC:22201]","GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030336(negative regulation of cell migration);GO:0044325(ion channel binding);GO:0090314(positive regulation of protein targeting to membrane);GO:1901529(positive regulation of anion channel activity)","NA",{"v":2e-36,"d":"0.00"},2,"346,253,","0,3277",-2.87,{"v":1E-4,"d":"0.00"},3.58,"3' UTR",7,143851375,143902176,50802,2]
["chr17",56862683,56863342,660,"ENSG00000121060","ENST00000648772","nonsense_mediated_decay",50738,"TRIM25","tripartite motif containing 25 [Source:HGNC Symbol;Acc:HGNC:12932]","GO:0002376(immune system process);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006513(protein monoubiquitination);GO:0008270(zinc ion binding);GO:0016032(viral process);GO:0016567(protein ubiquitination);GO:0016604(nuclear body);GO:0016740(transferase activity);GO:0016874(ligase activity);GO:0019985(translesion synthesis);GO:0030433(ubiquitin-dependent ERAD pathway);GO:0032480(negative regulation of type I interferon production);GO:0033280(response to vitamin D);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043627(response to estrogen);GO:0045087(innate immune response);GO:0045296(cadherin binding);GO:0046596(regulation of viral entry into host cell);GO:0046597(negative regulation of viral entry into host cell);GO:0046872(metal ion binding);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051607(defense response to virus);GO:0060333(interferon-gamma-mediated signaling pathway);GO:0061630(ubiquitin protein ligase activity);GO:1902186(regulation of viral release from host cell);GO:1902187(negative regulation of viral release from host cell);GO:1990830(cellular response to leukemia inhibitory factor)","04064(NF-kappa B signaling pathway);04622(RIG-I-like receptor signaling pathway);05164(Influenza A)",{"v":4e-42,"d":"0.00"},1,"660,",0,-2.46,{"v":0.000295120922666638,"d":"0.00"},{"v":1.2,"d":"1.20"},"3' UTR",17,56836387,56914080,77694,2]
["chr5",132987767,132988053,287,"ENSG00000229738","ENST00000429606","processed_pseudogene",57,"AC010240","putative nucleic acid binding protein RY-1 (RY1) pseudogene","NA","NA",{"v":2.1E-10,"d":"0.00"},1,"287,",0,-1.89,{"v":0.00141253754462275,"d":"0.00"},3.61,"Exon (ENST00000429606/ENSG00000229738, exon 1 of 1)",5,132987652,132988110,459,2]
["chr19",3613751,3613900,150,"ENSG00000105298","ENST00000429344","protein_coding",12890,"CACTIN","cactin, spliceosome C complex subunit [Source:HGNC Symbol;Acc:HGNC:29938]","GO:0000398(mRNA splicing, via spliceosome);GO:0001933(negative regulation of protein phosphorylation);GO:0002376(immune system process);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex);GO:0005829(cytosol);GO:0006397(mRNA processing);GO:0007275(multicellular organism development);GO:0008380(RNA splicing);GO:0016607(nuclear speck);GO:0031665(negative regulation of lipopolysaccharide-mediated signaling pathway);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0032688(negative regulation of interferon-beta production);GO:0032717(negative regulation of interleukin-8 production);GO:0032720(negative regulation of tumor necrosis factor production);GO:0034122(negative regulation of toll-like receptor signaling pathway);GO:0045087(innate immune response);GO:0060339(negative regulation of type I interferon-mediated signaling pathway);GO:0071013(catalytic step 2 spliceosome);GO:0071222(cellular response to lipopolysaccharide);GO:0071347(cellular response to interleukin-1);GO:0071356(cellular response to tumor necrosis factor)","NA",{"v":0.00025,"d":"0.00"},1,"150,",0,-1.03,{"v":0.0186208713666287,"d":"0.02"},3.68,"Exon (ENST00000592274/ENSG00000226800, exon 4 of 4)",19,3610645,3626790,16146,2]
["chr17",59972847,59973101,255,"ENSG00000267104","ENST00000587125","processed_transcript",45874,"TBC1D3P1-DHX40P1","TBC1D3P1-DHX40P1 readthrough, transcribed pseudogene [Source:HGNC Symbol;Acc:HGNC:42362]","NA","NA",{"v":6.3e-32,"d":"0.00"},1,"255,",0,{"v":-0.773,"d":"-0.77"},{"v":0.0426579518801593,"d":"0.04"},1.06,"3' UTR",17,59962363,60018975,56613,2]
["chr1",92182080,92182589,510,"ENSG00000189195","ENST00000635934","nonsense_mediated_decay",101775,"BTBD8","BTB domain containing 8 [Source:HGNC Symbol;Acc:HGNC:21019]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0098793(presynapse);GO:0150007(clathrin-dependent synaptic vesicle endocytosis)","NA",{"v":1.3e-26,"d":"0.00"},1,"510,",0,-1.74,{"v":0.00218776162394955,"d":"0.00"},{"v":3.7,"d":"3.70"},"3' UTR",1,92080305,92184725,104421,1]
["chr17",61404853,61404943,91,"ENSG00000121068","ENST00000240328","protein_coding",5010,"TBX2","T-box 2 [Source:HGNC Symbol;Acc:HGNC:11597]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001947(heart looping);GO:0003007(heart morphogenesis);GO:0003148(outflow tract septum morphogenesis);GO:0003151(outflow tract morphogenesis);GO:0003203(endocardial cushion morphogenesis);GO:0003256(regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0006355(regulation of transcription, DNA-templated);GO:0007219(Notch signaling pathway);GO:0007275(multicellular organism development);GO:0007521(muscle cell fate determination);GO:0007569(cell aging);GO:0008016(regulation of heart contraction);GO:0008284(positive regulation of cell population proliferation);GO:0035050(embryonic heart tube development);GO:0035909(aorta morphogenesis);GO:0036302(atrioventricular canal development);GO:0042733(embryonic digit morphogenesis);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0048596(embryonic camera-type eye morphogenesis);GO:0048738(cardiac muscle tissue development);GO:0060021(roof of mouth development);GO:0060045(positive regulation of cardiac muscle cell proliferation);GO:0060465(pharynx development);GO:0060560(developmental growth involved in morphogenesis);GO:0060596(mammary placode formation);GO:0090398(cellular senescence);GO:1901208(negative regulation of heart looping);GO:1901211(negative regulation of cardiac chamber formation)","NA",{"v":7.1e-10,"d":"0.00"},1,"91,",0,-1.51,{"v":0.00416869383470336,"d":"0.00"},1.01,"Exon (ENST00000477081/ENSG00000121068, exon 5 of 5)",17,61399843,61409466,9624,1]
["chr21",36132654,36132945,292,"ENSG00000214889","ENST00000419943","processed_pseudogene",204,"RPS9P1","ribosomal protein S9 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:10443]","NA","NA",{"v":7.2e-06,"d":"0.00"},1,"292,",0,-1.03,{"v":0.0186208713666287,"d":"0.02"},3.71,"Exon (ENST00000419943/ENSG00000214889, exon 1 of 1)",21,36132450,36133032,583,1]
["chr17",76672297,76673658,1362,"ENSG00000182534","ENST00000355797","protein_coding",37297,"MXRA7","matrix remodeling associated 7 [Source:HGNC Symbol;Acc:HGNC:7541]","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0062023(collagen-containing extracellular matrix)","NA",{"v":2e-18,"d":"0.00"},1,"1362,",0,-1.14,{"v":0.0131825673855641,"d":"0.01"},1.16,"3' UTR",17,76672551,76710955,38405,2]
["chr6",19325407,19325705,299,"ENSG00000228412","ENST00000636202","antisense",365171,"AL022068","novel transcript, antisense to ID4","NA","NA",{"v":3e-06,"d":"0.00"},1,"299,",0,{"v":-0.927,"d":"-0.93"},{"v":0.0257039578276886,"d":"0.03"},3.72,"Exon (ENST00000636202/ENSG00000228412, exon 10 of 10)",6,19324988,19690876,365889,2]
["chr17",11977421,11977594,174,"ENSG00000266368","ENST00000580270","antisense",0,"AC005410","novel transcript, antisense to DNAH9","NA","NA",{"v":3.2e-15,"d":"0.00"},1,"174,",0,{"v":-0.832,"d":"-0.83"},{"v":0.0354813389233576,"d":"0.04"},1.32,"3' UTR",17,11953889,11977594,23706,2]
["chr3",96350526,96350703,178,"ENSG00000243547","ENST00000485383","processed_pseudogene",972,"HNRNPKP4","heterogeneous nuclear ribonucleoprotein K pseudogene 4 [Source:HGNC Symbol;Acc:HGNC:42377]","NA","NA",{"v":2e-07,"d":"0.00"},1,"178,",0,{"v":-13.5,"d":"-13.50"},{"v":2.51188643150958E-16,"d":"0.00"},3.73,"Exon (ENST00000485383/ENSG00000243547, exon 1 of 1)",3,96349554,96350939,1386,1]
["chr17",28905370,28905430,61,"ENSG00000109118","ENST00000332830","protein_coding",46088,"PHF12","PHD finger protein 12 [Source:HGNC Symbol;Acc:HGNC:20816]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001222(transcription corepressor binding);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016580(Sin3 complex);GO:0017053(transcriptional repressor complex);GO:0035091(phosphatidylinositol binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0070822(Sin3-type complex)","NA",{"v":0.0036,"d":"0.00"},1,"61,",0,{"v":-0.892,"d":"-0.89"},{"v":0.0288403150312661,"d":"0.03"},1.46,"3' UTR",17,28905250,28951518,46269,2]
["chr17",38674432,38674971,540,"ENSG00000273604","ENST00000621654","protein_coding",450,"EPOP","elongin BC and polycomb repressive complex 2 associated protein [Source:HGNC Symbol;Acc:HGNC:34493]","GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0006357(regulation of transcription by RNA polymerase II);GO:0035098(ESC/E(Z) complex);GO:0035616(histone H2B conserved C-terminal lysine deubiquitination);GO:0048663(neuron fate commitment);GO:0048863(stem cell differentiation);GO:0070449(elongin complex)","NA",{"v":4e-28,"d":"0.00"},1,"540,",0,-1.67,{"v":2.63026799189538E-3,"d":"0.00"},1.06,"5' UTR",17,38671703,38675421,3719,2]
["chr10",58716052,58716169,118,"ENSG00000122870","ENST00000373886","protein_coding",202912,"BICC1","BicC family RNA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:19351]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0007275(multicellular organism development);GO:0007368(determination of left/right symmetry);GO:0007507(heart development);GO:0090090(negative regulation of canonical Wnt signaling pathway)","NA",{"v":2E-3,"d":"0.00"},1,"118,",0,{"v":-0.746,"d":"-0.75"},{"v":0.0478630092322638,"d":"0.05"},3.74,"Exon (ENST00000332869/ENSG00000183055, exon 1 of 1)",10,58513140,58831437,318298,1]
["chr17",50693198,50693407,210,"ENSG00000154945","ENST00000285243","protein_coding",14507,"ANKRD40","ankyrin repeat domain 40 [Source:HGNC Symbol;Acc:HGNC:28233]","GO:0003674(molecular_function);GO:0005515(protein binding);GO:0005575(cellular_component);GO:0008150(biological_process)","NA",{"v":3.1E-7,"d":"0.00"},1,"210,",0,-1.54,{"v":0.00398107170553497,"d":"0.00"},1.59,"3' UTR",17,50693198,50707914,14717,2]
["chr17",58003719,58003958,240,"ENSG00000136450","ENST00000258962","protein_coding",3288,"SRSF1","serine and arginine rich splicing factor 1 [Source:HGNC Symbol;Acc:HGNC:10780]","GO:0000380(alternative mRNA splicing, via spliceosome);GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0000395(mRNA 5'-splice site recognition);GO:0000398(mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex);GO:0005737(cytoplasm);GO:0006376(mRNA splice site selection);GO:0006397(mRNA processing);GO:0006405(RNA export from nucleus);GO:0006406(mRNA export from nucleus);GO:0008380(RNA splicing);GO:0016607(nuclear speck);GO:0031124(mRNA 3'-end processing);GO:0035145(exon-exon junction complex);GO:0044547(DNA topoisomerase binding);GO:0045292(mRNA cis splicing, via spliceosome);GO:0051028(mRNA transport);GO:0071013(catalytic step 2 spliceosome)","03040(Spliceosome);04657(IL-17 signaling pathway);05168(Herpes simplex virus 1 infection)",{"v":3.2e-19,"d":"0.00"},1,"240,",0,{"v":-47.2,"d":"-47.20"},{"v":7.94328234724279E-51,"d":"0.00"},1.32,"3' UTR",17,58000919,58007246,6328,2]
["chr17",64968015,64972594,4580,"ENSG00000214174","ENST00000430983","processed_transcript",2974,"AMZ2P1","archaelysin family metallopeptidase 2 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:26491]","NA","NA",{"v":7.9e-40,"d":"0.00"},3,"367,111,61,","0,1300,4519",-1.92,{"v":0.00131825673855641,"d":"0.00"},1.17,"Exon (ENST00000430983/ENSG00000214174, exon 4 of 5)",17,64966550,64975568,9019,2]
["chr17",46949055,46949205,151,"ENSG00000108433","ENST00000640792","nonsense_mediated_decay",25974,"GOSR2","golgi SNAP receptor complex member 2 [Source:HGNC Symbol;Acc:HGNC:4431]","GO:0000139(Golgi membrane);GO:0000149(SNARE binding);GO:0005484(SNAP receptor activity);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006623(protein targeting to vacuole);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0006891(intra-Golgi vesicle-mediated transport);GO:0006896(Golgi to vacuole transport);GO:0012507(ER to Golgi transport vesicle membrane);GO:0015031(protein transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016192(vesicle-mediated transport);GO:0031201(SNARE complex);GO:0031902(late endosome membrane);GO:0033116(endoplasmic reticulum-Golgi intermediate compartment membrane);GO:0036498(IRE1-mediated unfolded protein response);GO:0042147(retrograde transport, endosome to Golgi);GO:0048208(COPII vesicle coating);GO:0048280(vesicle fusion with Golgi apparatus);GO:0061025(membrane fusion)","04130(SNARE interactions in vesicular transport)",{"v":0.0013,"d":"0.00"},1,"151,",0,{"v":-0.961,"d":"-0.96"},{"v":0.0229086765276777,"d":"0.02"},3.78,"3' UTR",17,46923081,46966947,43867,1]
["chr17",75405530,75405709,180,"ENSG00000177885","ENST00000316804","protein_coding",0,"GRB2","growth factor receptor bound protein 2 [Source:HGNC Symbol;Acc:HGNC:4566]","GO:0000165(MAPK cascade);GO:0001784(phosphotyrosine residue binding);GO:0003723(RNA binding);GO:0005070(SH3/SH2 adaptor activity);GO:0005154(epidermal growth factor receptor binding);GO:0005168(neurotrophin TRKA receptor binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007265(Ras protein signal transduction);GO:0007267(cell-cell signaling);GO:0007411(axon guidance);GO:0007568(aging);GO:0008180(COP9 signalosome);GO:0008286(insulin receptor signaling pathway);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0009967(positive regulation of signal transduction);GO:0012506(vesicle membrane);GO:0016020(membrane);GO:0016032(viral process);GO:0017124(SH3 domain binding);GO:0019221(cytokine-mediated signaling pathway);GO:0019899(enzyme binding);GO:0019901(protein kinase binding);GO:0019903(protein phosphatase binding);GO:0019904(protein domain specific binding);GO:0030154(cell differentiation);GO:0030838(positive regulation of actin filament polymerization);GO:0031295(T cell costimulation);GO:0031623(receptor internalization);GO:0032991(protein-containing complex);GO:0035635(entry of bacterium into host cell);GO:0035723(interleukin-15-mediated signaling pathway);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0038096(Fc-gamma receptor signaling pathway involved in phagocytosis);GO:0038128(ERBB2 signaling pathway);GO:0042059(negative regulation of epidermal growth factor receptor signaling pathway);GO:0042770(signal transduction in response to DNA damage);GO:0042802(identical protein binding);GO:0043408(regulation of MAPK cascade);GO:0043560(insulin receptor substrate binding);GO:0046579(positive regulation of Ras protein signal transduction);GO:0046875(ephrin receptor binding);GO:0048011(neurotrophin TRK receptor signaling pathway);GO:0048646(anatomical structure formation involved in morphogenesis);GO:0050900(leukocyte migration);GO:0051219(phosphoprotein binding);GO:0051291(protein heterooligomerization);GO:0051897(positive regulation of protein kinase B signaling);GO:0060670(branching involved in labyrinthine layer morphogenesis);GO:0061024(membrane organization);GO:0070062(extracellular exosome);GO:0070436(Grb2-EGFR complex);GO:0071479(cellular response to ionizing radiation);GO:2000379(positive regulation of reactive oxygen species metabolic process)","01521(EGFR tyrosine kinase inhibitor resistance);01522(Endocrine resistance);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04014(Ras signaling pathway);04062(Chemokine signaling pathway);04068(FoxO signaling pathway);04072(Phospholipase D signaling pathway);04150(mTOR signaling pathway);04151(PI3K-Akt signaling pathway);04380(Osteoclast differentiation);04510(Focal adhesion);04540(Gap junction);04550(Signaling pathways regulating pluripotency of stem cells);04630(Jak-STAT signaling pathway);04650(Natural killer cell mediated cytotoxicity);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04714(Thermogenesis);04722(Neurotrophin signaling pathway);04910(Insulin signaling pathway);04912(GnRH signaling pathway);04915(Estrogen signaling pathway);04917(Prolactin signaling pathway);04926(Relaxin signaling pathway);05034(Alcoholism);05160(Hepatitis C);05161(Hepatitis B);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05200(Pathways in cancer);05203(Viral carcinogenesis);05205(Proteoglycans in cancer);05206(MicroRNAs in cancer);05210(Colorectal cancer);05211(Renal cell carcinoma);05213(Endometrial cancer);05214(Glioma);05215(Prostate cancer);05220(Chronic myeloid leukemia);05221(Acute myeloid leukemia);05223(Non-small cell lung cancer);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05231(Choline metabolism in cancer)",{"v":2.8e-06,"d":"0.00"},1,"180,",0,-1.91,{"v":0.00134896288259165,"d":"0.00"},1.31,"5' UTR",17,75318076,75405678,87603,2]
["chr17",75941507,75941776,270,"ENSG00000161533","ENST00000293217","protein_coding",37390,"ACOX1","acyl-CoA oxidase 1 [Source:HGNC Symbol;Acc:HGNC:119]","GO:0000038(very long-chain fatty acid metabolic process);GO:0003997(acyl-CoA oxidase activity);GO:0005102(signaling receptor binding);GO:0005504(fatty acid binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005777(peroxisome);GO:0005778(peroxisomal membrane);GO:0005782(peroxisomal matrix);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006091(generation of precursor metabolites and energy);GO:0006625(protein targeting to peroxisome);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0006635(fatty acid beta-oxidation);GO:0006693(prostaglandin metabolic process);GO:0007283(spermatogenesis);GO:0016020(membrane);GO:0016401(palmitoyl-CoA oxidase activity);GO:0016491(oxidoreductase activity);GO:0016627(oxidoreductase activity, acting on the CH-CH group of donors);GO:0019216(regulation of lipid metabolic process);GO:0019395(fatty acid oxidation);GO:0030165(PDZ domain binding);GO:0033540(fatty acid beta-oxidation using acyl-CoA oxidase);GO:0036109(alpha-linolenic acid metabolic process);GO:0043231(intracellular membrane-bounded organelle);GO:0047485(protein N-terminus binding);GO:0050660(flavin adenine dinucleotide binding);GO:0055088(lipid homeostasis);GO:0055114(oxidation-reduction process);GO:0071949(FAD binding)","00071(Fatty acid degradation);00592(alpha-Linolenic acid metabolism);01040(Biosynthesis of unsaturated fatty acids);03320(PPAR signaling pathway);04024(cAMP signaling pathway);04146(Peroxisome)",{"v":1e-18,"d":"0.00"},1,"270,",0,{"v":-0.864,"d":"-0.86"},{"v":0.0316227766016838,"d":"0.03"},1.21,"3' UTR",17,75941507,75979166,37660,2]
["chr17",79934923,79935043,121,"ENSG00000167291","ENST00000310924","protein_coding",100829,"TBC1D16","TBC1 domain family member 16 [Source:HGNC Symbol;Acc:HGNC:28356]","GO:0001919(regulation of receptor recycling);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005769(early endosome);GO:0005829(cytosol);GO:0006886(intracellular protein transport);GO:0017137(Rab GTPase binding);GO:0090630(activation of GTPase activity)","NA",{"v":0.0022,"d":"0.00"},1,"121,",0,{"v":-0.926,"d":"-0.93"},{"v":0.0257039578276886,"d":"0.03"},1.21,"3' UTR",17,79932343,80035872,103530,2]
["chr17",81918330,81918569,240,"ENSG00000187531","ENST00000572902","protein_coding",2754,"SIRT7","sirtuin 7 [Source:HGNC Symbol;Acc:HGNC:14935]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005731(nucleolus organizer region);GO:0005737(cytoplasm);GO:0006325(chromatin organization);GO:0007072(positive regulation of transcription involved in exit from mitosis);GO:0009303(rRNA transcription);GO:0016787(hydrolase activity);GO:0046872(metal ion binding);GO:0070403(NAD+ binding);GO:0070932(histone H3 deacetylation);GO:0070933(histone H4 deacetylation);GO:0097372(NAD-dependent histone deacetylase activity (H3-K18 specific))","NA",{"v":2.6e-06,"d":"0.00"},1,"240,",0,{"v":-0.806,"d":"-0.81"},{"v":0.0389045144994281,"d":"0.04"},1.13,"3' UTR",17,81914087,81921323,7237,2]
["chr18",36187587,36200058,12472,"ENSG00000274849","ENST00000612081","sense_intronic",0,"AC023043","novel transcript, sense intronic to MOCOS","NA","NA",{"v":9.8e-10,"d":"0.00"},4,"95,90,67,376,","0,7670,11103,12096",-1.51,{"v":0.00416869383470336,"d":"0.00"},1.07,"Exon (ENST00000261326/ENSG00000075643, exon 1 of 15)",18,36189824,36190272,449,1]
["chr18",75285436,75285795,360,"ENSG00000179981","ENST00000322038","protein_coding",74681,"TSHZ1","teashirt zinc finger homeobox 1 [Source:HGNC Symbol;Acc:HGNC:10669]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0010468(regulation of gene expression);GO:0042474(middle ear morphogenesis);GO:0046872(metal ion binding);GO:0060023(soft palate development)","NA",{"v":1E-35,"d":"0.00"},1,"360,",0,-1.29,{"v":0.00812830516164099,"d":"0.01"},1.03,"5' UTR",18,75210755,75289950,79196,1]
["chr18",649636,649902,267,"ENSG00000079101","ENST00000400606","protein_coding",52638,"CLUL1","clusterin like 1 [Source:HGNC Symbol;Acc:HGNC:2096]","GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0051787(misfolded protein binding)","NA",{"v":2e-10,"d":"0.00"},1,"267,",0,-1.35,{"v":0.00676082975391982,"d":"0.01"},1.17,"3' UTR",18,596998,650298,53301,1]
["chr19",50334065,50334509,445,"ENSG00000131401","ENST00000531692","retained_intron",52,"NAPSB","napsin B aspartic peptidase, pseudogene [Source:HGNC Symbol;Acc:HGNC:13396]","NA","NA",{"v":5.6e-07,"d":"0.00"},2,"37,203,","0,242",-1.07,{"v":0.0162181009735893,"d":"0.02"},3.78,"Exon (ENST00000531692/ENSG00000131401, exon 1 of 2)",19,50333796,50334561,766,2]
["chr18",31625214,31627059,1846,"ENSG00000118276","ENST00000578114","retained_intron",31405,"B4GALT6","beta-1,4-galactosyltransferase 6 [Source:HGNC Symbol;Acc:HGNC:929]","GO:0000139(Golgi membrane);GO:0001572(lactosylceramide biosynthetic process);GO:0005794(Golgi apparatus);GO:0005975(carbohydrate metabolic process);GO:0006486(protein glycosylation);GO:0006629(lipid metabolic process);GO:0006665(sphingolipid metabolic process);GO:0008378(galactosyltransferase activity);GO:0008489(UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity);GO:0010706(ganglioside biosynthetic process via lactosylceramide);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0018146(keratan sulfate biosynthetic process);GO:0021955(central nervous system neuron axonogenesis);GO:0022010(central nervous system myelination);GO:0032580(Golgi cisterna membrane);GO:0042551(neuron maturation);GO:0046872(metal ion binding)","00600(Sphingolipid metabolism)",{"v":6.3e-50,"d":"0.00"},3,"548,102,71,","0,1069,1775",-1.41,{"v":0.00575439937337157,"d":"0.01"},1.02,"3' UTR",18,31622247,31658464,36218,2]
["chr1",145631664,145644057,12394,"ENSG00000117262","ENST00000313835","protein_coding",23676,"GPR89A","G protein-coupled receptor 89A [Source:HGNC Symbol;Acc:HGNC:31984]","GO:0000139(Golgi membrane);GO:0005244(voltage-gated ion channel activity);GO:0005794(Golgi apparatus);GO:0006811(ion transport);GO:0008308(voltage-gated anion channel activity);GO:0015031(protein transport);GO:0015698(inorganic anion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030660(Golgi-associated vesicle membrane);GO:0032580(Golgi cisterna membrane);GO:0034220(ion transmembrane transport);GO:0034765(regulation of ion transmembrane transport);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0051452(intracellular pH reduction)","NA",{"v":1.3E-14,"d":"0.00"},2,"81,189,","0,12205",{"v":-25.5,"d":"-25.50"},{"v":1e-28,"d":"0.00"},3.85,"3' UTR",1,145607988,145670650,62663,1]
["chr18",50282343,50282523,181,"ENSG00000154832","ENST00000412036","protein_coding",5113,"CXXC1","CXXC finger protein 1 [Source:HGNC Symbol;Acc:HGNC:24343]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0000987(proximal promoter sequence-specific DNA binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008270(zinc ion binding);GO:0016363(nuclear matrix);GO:0016607(nuclear speck);GO:0035097(histone methyltransferase complex);GO:0036498(IRE1-mediated unfolded protein response);GO:0042800(histone methyltransferase activity (H3-K4 specific));GO:0045322(unmethylated CpG binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0048188(Set1C/COMPASS complex);GO:0051568(histone H3-K4 methylation)","NA",{"v":1.2E-8,"d":"0.00"},1,"181,",0,-1.38,{"v":0.00630957344480193,"d":"0.01"},1.39,"3' UTR",18,50282343,50287636,5294,2]
["chr18",54406917,54407114,198,"ENSG00000264350","ENST00000580909","processed_pseudogene",0,"SNRPGP2","small nuclear ribonucleoprotein polypeptide G pseudogene 2 [Source:HGNC Symbol;Acc:HGNC:30999]","NA","NA",{"v":1.4e-10,"d":"0.00"},1,"198,",0,{"v":-0.788,"d":"-0.79"},{"v":0.0407380277804113,"d":"0.04"},{"v":1.7,"d":"1.70"},"Exon (ENST00000580909/ENSG00000264350, exon 1 of 1)",18,54406889,54407114,226,2]
["chr4",139718671,139718880,210,"ENSG00000085871","ENST00000616265","protein_coding",52903,"MGST2","microsomal glutathione S-transferase 2 [Source:HGNC Symbol;Acc:HGNC:7063]","GO:0004364(glutathione transferase activity);GO:0004464(leukotriene-C4 synthase activity);GO:0004602(glutathione peroxidase activity);GO:0005515(protein binding);GO:0005635(nuclear envelope);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005886(plasma membrane);GO:0006629(lipid metabolic process);GO:0006691(leukotriene metabolic process);GO:0006750(glutathione biosynthetic process);GO:0006805(xenobiotic metabolic process);GO:0008047(enzyme activator activity);GO:0010243(response to organonitrogen compound);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0019370(leukotriene biosynthetic process);GO:0031090(organelle membrane);GO:0032496(response to lipopolysaccharide);GO:0043085(positive regulation of catalytic activity);GO:0043231(intracellular membrane-bounded organelle);GO:0046466(membrane lipid catabolic process);GO:0050729(positive regulation of inflammatory response);GO:0098869(cellular oxidant detoxification);GO:1901687(glutathione derivative biosynthetic process)","00480(Glutathione metabolism);00980(Metabolism of xenobiotics by cytochrome P450);00982(Drug metabolism - cytochrome P450);00983(Drug metabolism - other enzymes);01524(Platinum drug resistance);05200(Pathways in cancer);05204(Chemical carcinogenesis);05225(Hepatocellular carcinoma);05418(Fluid shear stress and atherosclerosis)",{"v":5.9e-05,"d":"0.00"},1,"210,",0,{"v":-0.755,"d":"-0.76"},{"v":0.0457088189614875,"d":"0.05"},3.91,"3' UTR",4,139665768,139740745,74978,1]
["chr19",3750604,3750813,210,"ENSG00000011132","ENST00000316757","protein_coding",10879,"APBA3","amyloid beta precursor protein binding family A member 3 [Source:HGNC Symbol;Acc:HGNC:580]","GO:0001540(amyloid-beta binding);GO:0001701(in utero embryonic development);GO:0004857(enzyme inhibitor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007268(chemical synaptic transmission);GO:0010468(regulation of gene expression);GO:0015031(protein transport);GO:0019899(enzyme binding);GO:0043086(negative regulation of catalytic activity);GO:0043197(dendritic spine);GO:0045202(synapse);GO:0048471(perinuclear region of cytoplasm);GO:0050790(regulation of catalytic activity)","NA",{"v":2e-11,"d":"0.00"},1,"210,",0,-1.02,{"v":0.0190546071796325,"d":"0.02"},1.06,"3' UTR",19,3750772,3761692,10921,2]
["chr19",10284940,10285806,867,"ENSG00000266978","ENST00000592893","antisense",0,"AC011511","novel transcript, antisense to MRPL4 and ICAM1","NA","NA",{"v":4e-18,"d":"0.00"},2,"89,692,","0,175",-2.07,{"v":0.000851138038202377,"d":"0.00"},{"v":1.7,"d":"1.70"},"3' UTR",19,10252268,10285108,32841,2]
["chr3",36833446,36833745,300,"ENSG00000168016","ENST00000429976","protein_coding",111312,"TRANK1","tetratricopeptide repeat and ankyrin repeat containing 1 [Source:HGNC Symbol;Acc:HGNC:29011]","GO:0005515(protein binding);GO:0005524(ATP binding)","NA",{"v":1.3e-08,"d":"0.00"},1,"300,",0,{"v":-0.905,"d":"-0.91"},{"v":0.0275422870333817,"d":"0.03"},3.95,"3' UTR",3,36826820,36945057,118238,2]
["chr19",11778393,11782018,3626,"ENSG00000197044","ENST00000357901","protein_coding",11393,"ZNF441","zinc finger protein 441 [Source:HGNC Symbol;Acc:HGNC:20875]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","NA",{"v":6.3e-47,"d":"0.00"},2,"1,2000,","0,1626",-1.11,{"v":0.0144543977074593,"d":"0.01"},1.08,"3' UTR",19,11767000,11784078,17079,1]
["chr19",12633451,12633840,390,"ENSG00000173875","ENST00000446165","protein_coding",22533,"ZNF791","zinc finger protein 791 [Source:HGNC Symbol;Acc:HGNC:26895]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":4e-46,"d":"0.00"},1,"390,",0,-1.09,{"v":0.0151356124843621,"d":"0.02"},1.02,"3' UTR",19,12610918,12633840,22923,1]
["chrX",23076054,23076737,684,"ENSG00000174028","ENST00000312214","processed_pseudogene",296,"FAM3C2","family with sequence similarity 3 member C2 (pseudogene) [Source:HGNC Symbol;Acc:HGNC:34501]","NA","NA",{"v":2.5e-32,"d":"0.00"},2,"286,69,","0,615",-6.86,{"v":3.54813389233576e-09,"d":"0.00"},3.99,"Exon (ENST00000312214/ENSG00000174028, exon 1 of 2)",23,23075758,23076767,1010,1]
["chr19",18592097,18592336,240,"ENSG00000006015","ENST00000598375","retained_intron",3412,"REX1BD","required for excision 1-B domain containing [Source:HGNC Symbol;Acc:HGNC:26098]","GO:0005515(protein binding)","NA",{"v":4e-36,"d":"0.00"},1,"240,",0,-4.55,{"v":1.23026877081238e-06,"d":"0.00"},1.08,"3' UTR",19,18588685,18592334,3650,1]
["chr1",112963975,112964035,61,"ENSG00000226419","ENST00000416193","antisense",7560,"SLC16A1-AS1","SLC16A1 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:49445]","NA","NA",{"v":0.006,"d":"0.01"},1,"61,",0,{"v":-0.875,"d":"-0.88"},{"v":0.0309029543251359,"d":"0.03"},4,"Exon (ENST00000416193/ENSG00000226419, exon 3 of 3)",1,112956415,112964072,7658,1]
["chr19",21098814,21117377,18564,"ENSG00000201035","ENST00000364165","rRNA_pseudogene",0,"RNA5SP469","RNA, 5S ribosomal pseudogene 469 [Source:HGNC Symbol;Acc:HGNC:43369]","NA","NA",{"v":2e-49,"d":"0.00"},3,"97,22,571,","0,10809,17993",-1.86,{"v":1.58489319246111E-3,"d":"0.00"},1.01,"5' UTR",19,21113128,21113236,109,2]
["chr19",21537462,21538001,540,"ENSG00000197013","ENST00000358491","protein_coding",31860,"ZNF429","zinc finger protein 429 [Source:HGNC Symbol;Acc:HGNC:20817]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":2e-15,"d":"0.00"},1,"540,",0,-1.33,{"v":0.00741310241300918,"d":"0.01"},1.78,"Exon (ENST00000358491/ENSG00000197013, exon 4 of 4)",19,21505602,21540668,35067,1]
["chr11",108512151,108512540,390,"ENSG00000110723","ENST00000265843","protein_coding",81228,"EXPH5","exophilin 5 [Source:HGNC Symbol;Acc:HGNC:30578]","GO:0003334(keratinocyte development);GO:0005768(endosome);GO:0006886(intracellular protein transport);GO:0017137(Rab GTPase binding);GO:0045921(positive regulation of exocytosis);GO:0050714(positive regulation of protein secretion);GO:0071985(multivesicular body sorting pathway)","NA",{"v":3.1E-9,"d":"0.00"},1,"390,",0,-1.54,{"v":0.0038904514499428,"d":"0.00"},4.11,"Exon (ENST00000265843/ENSG00000110723, exon 6 of 6)",11,108505435,108593768,88334,2]
["chr19",37483901,37485276,1376,"ENSG00000171827","ENST00000586475","protein_coding",16129,"ZNF570","zinc finger protein 570 [Source:HGNC Symbol;Acc:HGNC:26416]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":1e-122,"d":"0.00"},1,"1376,",0,-3.01,{"v":6.76082975391982e-05,"d":"0.00"},1.08,"3' UTR",19,37467772,37485320,17549,1]
["chr19",39031058,39031323,266,"ENSG00000161243","ENST00000292853","protein_coding",1226,"FBXO27","F-box protein 27 [Source:HGNC Symbol;Acc:HGNC:18753]","GO:0000209(protein polyubiquitination);GO:0005515(protein binding);GO:0005829(cytosol);GO:0019005(SCF ubiquitin ligase complex);GO:0043687(post-translational protein modification)","NA",{"v":2.9E-5,"d":"0.00"},1,"266,",0,-1.13,{"v":0.0134896288259165,"d":"0.01"},1.23,"Exon (ENST00000597303/ENSG00000267992, exon 2 of 2)",19,39024021,39032549,8529,2]
["chr19",40011344,40015730,4387,"ENSG00000187187","ENST00000599504","protein_coding",14308,"ZNF546","zinc finger protein 546 [Source:HGNC Symbol;Acc:HGNC:28671]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":2e-53,"d":"0.00"},2,"5,2066,","0,2321",-2.39,{"v":0.000363078054770101,"d":"0.00"},1.32,"3' UTR",19,39997036,40013803,16768,1]
["chr19",43997909,43998326,418,"ENSG00000204920","ENST00000611002","protein_coding",13739,"ZNF155","zinc finger protein 155 [Source:HGNC Symbol;Acc:HGNC:12940]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":1.2e-07,"d":"0.00"},1,"418,",0,-1.25,{"v":0.00933254300796992,"d":"0.01"},1.15,"3' UTR",19,43984170,43998325,14156,1]
["chr19",45642370,45642781,412,"ENSG00000125746","ENST00000588889","retained_intron",0,"EML2","EMAP like 2 [Source:HGNC Symbol;Acc:HGNC:18035]","GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005819(spindle);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005875(microtubule associated complex);GO:0007601(visual perception);GO:0007605(sensory perception of sound);GO:0008017(microtubule binding);GO:0008022(protein C-terminus binding);GO:0010968(regulation of microtubule nucleation);GO:0015630(microtubule cytoskeleton);GO:0015631(tubulin binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031115(negative regulation of microtubule polymerization);GO:0072686(mitotic spindle)","NA",{"v":6.3e-63,"d":"0.00"},1,"412,",0,{"v":-0.977,"d":"-0.98"},{"v":0.0218776162394955,"d":"0.02"},1.01,"5' UTR",19,45632861,45642381,9521,2]
["chr19",45768874,45769053,180,"ENSG00000177045","ENST00000622857","protein_coding",0,"SIX5","SIX homeobox 5 [Source:HGNC Symbol;Acc:HGNC:10891]","GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0002088(lens development in camera-type eye);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0007286(spermatid development);GO:0008285(negative regulation of cell population proliferation);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048856(anatomical structure development);GO:1902723(negative regulation of skeletal muscle satellite cell proliferation)","NA",{"v":1E-215,"d":"0.00"},1,"180,",0,-1.61,{"v":0.00323593656929628,"d":"0.00"},1.16,"5' UTR",19,45764786,45769053,4268,2]
["chr19",48465663,48466022,360,"ENSG00000268465","ENST00000595676","protein_coding",0,"AC008403","novel protein","GO:0005086(ARF guanyl-nucleotide exchange factor activity);GO:0032012(regulation of ARF protein signal transduction)","NA",{"v":1.7E-5,"d":"0.00"},1,"360,",0,-1.14,{"v":0.0131825673855641,"d":"0.01"},{"v":1.6,"d":"1.60"},"5' UTR",19,48465837,48472431,6595,1]
["chr19",48479772,48479951,180,"ENSG00000105443","ENST00000600597","processed_transcript",0,"CYTH2","cytohesin 2 [Source:HGNC Symbol;Acc:HGNC:9502]","GO:0000139(Golgi membrane);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005086(ARF guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005912(adherens junction);GO:0005923(bicellular tight junction);GO:0006897(endocytosis);GO:0008289(lipid binding);GO:0016020(membrane);GO:0030036(actin cytoskeleton organization);GO:0030054(cell junction);GO:0030426(growth cone);GO:0032012(regulation of ARF protein signal transduction);GO:0042995(cell projection);GO:0070679(inositol 1,4,5 trisphosphate binding)","04072(Phospholipase D signaling pathway);04144(Endocytosis)",{"v":8.3e-06,"d":"0.00"},1,"180,",0,{"v":-0.943,"d":"-0.94"},{"v":0.0245470891568503,"d":"0.02"},1.01,"3' UTR",19,48479926,48480879,954,1]
["chr19",48954845,48955112,268,"ENSG00000087088","ENST00000345358","protein_coding",0,"BAX","BCL2 associated X, apoptosis regulator [Source:HGNC Symbol;Acc:HGNC:959]","GO:0001541(ovarian follicle development);GO:0001764(neuron migration);GO:0001776(leukocyte homeostasis);GO:0001777(T cell homeostatic proliferation);GO:0001782(B cell homeostasis);GO:0001783(B cell apoptotic process);GO:0001822(kidney development);GO:0001836(release of cytochrome c from mitochondria);GO:0001844(protein insertion into mitochondrial membrane involved in apoptotic signaling pathway);GO:0001974(blood vessel remodeling);GO:0002262(myeloid cell homeostasis);GO:0002352(B cell negative selection);GO:0002358(B cell homeostatic proliferation);GO:0002904(positive regulation of B cell apoptotic process);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005757(mitochondrial permeability transition pore complex);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0006687(glycosphingolipid metabolic process);GO:0006808(regulation of nitrogen utilization);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006974(cellular response to DNA damage stimulus);GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest);GO:0007281(germ cell development);GO:0007283(spermatogenesis);GO:0007399(nervous system development);GO:0007548(sex differentiation);GO:0008053(mitochondrial fusion);GO:0008283(cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008289(lipid binding);GO:0008584(male gonad development);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0008635(activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c);GO:0008637(apoptotic mitochondrial changes);GO:0009566(fertilization);GO:0009611(response to wounding);GO:0009636(response to toxic substance);GO:0009651(response to salt stress);GO:0009791(post-embryonic development);GO:0010212(response to ionizing radiation);GO:0010248(establishment or maintenance of transmembrane electrochemical gradient);GO:0010332(response to gamma radiation);GO:0010524(positive regulation of calcium ion transport into cytosol);GO:0010917(negative regulation of mitochondrial membrane potential);GO:0015267(channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016032(viral process);GO:0021854(hypothalamus development);GO:0021987(cerebral cortex development);GO:0030544(Hsp70 protein binding);GO:0031966(mitochondrial membrane);GO:0032091(negative regulation of protein binding);GO:0032461(positive regulation of protein oligomerization);GO:0032469(endoplasmic reticulum calcium ion homeostasis);GO:0032471(negative regulation of endoplasmic reticulum calcium ion concentration);GO:0032976(release of matrix enzymes from mitochondria);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0033599(regulation of mammary gland epithelial cell proliferation);GO:0034620(cellular response to unfolded protein);GO:0034644(cellular response to UV);GO:0035108(limb morphogenesis);GO:0035234(ectopic germ cell programmed cell death);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0042981(regulation of apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0043281(regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043496(regulation of protein homodimerization activity);GO:0043497(regulation of protein heterodimerization activity);GO:0043523(regulation of neuron apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0043525(positive regulation of neuron apoptotic process);GO:0043653(mitochondrial fragmentation involved in apoptotic process);GO:0045136(development of secondary sexual characteristics);GO:0046666(retinal cell programmed cell death);GO:0046930(pore complex);GO:0046982(protein heterodimerization activity);GO:0048087(positive regulation of developmental pigmentation);GO:0048147(negative regulation of fibroblast proliferation);GO:0048515(spermatid differentiation);GO:0048597(post-embryonic camera-type eye morphogenesis);GO:0048678(response to axon injury);GO:0048872(homeostasis of number of cells);GO:0048873(homeostasis of number of cells within a tissue);GO:0051087(chaperone binding);GO:0051259(protein complex oligomerization);GO:0051260(protein homooligomerization);GO:0051281(positive regulation of release of sequestered calcium ion into cytosol);GO:0051402(neuron apoptotic process);GO:0051434(BH3 domain binding);GO:0051726(regulation of cell cycle);GO:0051881(regulation of mitochondrial membrane potential);GO:0060011(Sertoli cell proliferation);GO:0060041(retina development in camera-type eye);GO:0060058(positive regulation of apoptotic process involved in mammary gland involution);GO:0060068(vagina development);GO:0070059(intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress);GO:0070062(extracellular exosome);GO:0070242(thymocyte apoptotic process);GO:0070584(mitochondrion morphogenesis);GO:0071310(cellular response to organic substance);GO:0071944(cell periphery);GO:0072332(intrinsic apoptotic signaling pathway by p53 class mediator);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0097136(Bcl-2 family protein complex);GO:0097144(BAX complex);GO:0097190(apoptotic signaling pathway);GO:0097191(extrinsic apoptotic signaling pathway);GO:0097192(extrinsic apoptotic signaling pathway in absence of ligand);GO:0097193(intrinsic apoptotic signaling pathway);GO:0097296(activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway);GO:1900103(positive regulation of endoplasmic reticulum unfolded protein response);GO:1901030(positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway);GO:1902108(regulation of mitochondrial membrane permeability involved in apoptotic process);GO:1902110(positive regulation of mitochondrial membrane permeability involved in apoptotic process);GO:1902262(apoptotic process involved in blood vessel morphogenesis);GO:1902263(apoptotic process involved in embryonic digit morphogenesis);GO:1902445(regulation of mitochondrial membrane permeability involved in programmed necrotic cell death);GO:1902512(positive regulation of apoptotic DNA fragmentation);GO:1903896(positive regulation of IRE1-mediated unfolded protein response);GO:1990117(B cell receptor apoptotic signaling pathway);GO:2001234(negative regulation of apoptotic signaling pathway);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway)","01521(EGFR tyrosine kinase inhibitor resistance);01522(Endocrine resistance);01524(Platinum drug resistance);04071(Sphingolipid signaling pathway);04115(p53 signaling pathway);04141(Protein processing in endoplasmic reticulum);04210(Apoptosis);04211(Longevity regulating pathway);04215(Apoptosis - multiple species);04217(Necroptosis);04722(Neurotrophin signaling pathway);04932(Non-alcoholic fatty liver disease (NAFLD));04933(AGE-RAGE signaling pathway in diabetic complications);05014(Amyotrophic lateral sclerosis (ALS));05016(Huntington disease);05020(Prion diseases);05152(Tuberculosis);05160(Hepatitis C);05161(Hepatitis B);05162(Measles);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05166(Human T-cell leukemia virus 1 infection);05167(Kaposi sarcoma-associated herpesvirus infection);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer);05202(Transcriptional misregulation in cancer);05203(Viral carcinogenesis);05210(Colorectal cancer);05212(Pancreatic cancer);05213(Endometrial cancer);05214(Glioma);05216(Thyroid cancer);05217(Basal cell carcinoma);05218(Melanoma);05220(Chronic myeloid leukemia);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer)",{"v":3.2e-18,"d":"0.00"},1,"268,",0,-2.18,{"v":0.000630957344480193,"d":"0.00"},1.07,"5' UTR",19,48954875,48961798,6924,1]
["chr17",74775899,74776337,439,"ENSG00000109065","ENST00000357814","protein_coding",0,"NAT9","N-acetyltransferase 9 (putative) [Source:HGNC Symbol;Acc:HGNC:23133]","GO:0005515(protein binding);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0016747(transferase activity, transferring acyl groups other than amino-acyl groups);GO:0032991(protein-containing complex)","NA",{"v":9.3e-05,"d":"0.00"},2,"230,71,","0,368",-1.28,{"v":0.00851138038202377,"d":"0.01"},4.12,"5' UTR",17,74770547,74776331,5785,2]
["chr20",50186085,50186382,298,"ENSG00000277449","ENST00000613921","antisense",5116,"CEBPB-AS1","CEBPB antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:51226]","NA","NA",{"v":1.9e-07,"d":"0.00"},1,"298,",0,-1.16,{"v":0.0123026877081238,"d":"0.01"},4.17,"Exon (ENST00000613921/ENSG00000277449, exon 6 of 6)",20,50184598,50191498,6901,2]
["chr19",52563385,52564464,1080,"ENSG00000242255","ENST00000477141","transcribed_unprocessed_pseudogene",0,"RPL39P34","ribosomal protein L39 pseudogene 34 [Source:HGNC Symbol;Acc:HGNC:36528]","NA","NA",{"v":2.5E-36,"d":"0.00"},1,"1080,",0,-1.73,{"v":0.00229086765276777,"d":"0.00"},1.16,"3' UTR",19,52564076,52564231,156,1]
["chr19",53351948,53352694,747,"ENSG00000213799","ENST00000458035","protein_coding",18202,"ZNF845","zinc finger protein 845 [Source:HGNC Symbol;Acc:HGNC:25112]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":1e-16,"d":"0.00"},1,"747,",0,-1.68,{"v":2.63026799189538E-3,"d":"0.00"},1.47,"Exon (ENST00000458035/ENSG00000213799, exon 4 of 4)",19,53333746,53356906,23161,1]
["chr19",55302287,55302778,492,"ENSG00000160469","ENST00000590333","protein_coding",20215,"BRSK1","BR serine/threonine kinase 1 [Source:HGNC Symbol;Acc:HGNC:18994]","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0006974(cellular response to DNA damage stimulus);GO:0007049(cell cycle);GO:0007095(mitotic G2 DNA damage checkpoint);GO:0007269(neurotransmitter secretion);GO:0007399(nervous system development);GO:0007409(axonogenesis);GO:0008021(synaptic vesicle);GO:0008306(associative learning);GO:0009411(response to UV);GO:0010975(regulation of neuron projection development);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0019901(protein kinase binding);GO:0030010(establishment of cell polarity);GO:0030054(cell junction);GO:0030182(neuron differentiation);GO:0035556(intracellular signal transduction);GO:0043015(gamma-tubulin binding);GO:0043066(negative regulation of apoptotic process);GO:0045202(synapse);GO:0046872(metal ion binding);GO:0048156(tau protein binding);GO:0048167(regulation of synaptic plasticity);GO:0048786(presynaptic active zone);GO:0048812(neuron projection morphogenesis);GO:0050321(tau-protein kinase activity);GO:0050770(regulation of axonogenesis);GO:0051298(centrosome duplication);GO:0090176(microtubule cytoskeleton organization involved in establishment of planar polarity);GO:0099504(synaptic vesicle cycle);GO:0150034(distal axon);GO:2000807(regulation of synaptic vesicle clustering)","NA",{"v":7.9e-17,"d":"0.00"},2,"97,82,","0,410",-1.01,{"v":0.0194984459975805,"d":"0.02"},1.45,"5' UTR",19,55282072,55312533,30462,1]
["chr3",99804648,99805038,391,"ENSG00000273374","ENST00000608028","lincRNA",1020,"AC069222","novel transcript","NA","NA",{"v":8.7e-07,"d":"0.00"},1,"391,",0,{"v":-0.775,"d":"-0.78"},{"v":0.0426579518801593,"d":"0.04"},4.25,"Exon (ENST00000608028/ENSG00000273374, exon 1 of 1)",3,99802699,99806058,3360,2]
["chr19",57378126,57378606,481,"ENSG00000152433","ENST00000282282","protein_coding",14560,"ZNF547","zinc finger protein 547 [Source:HGNC Symbol;Acc:HGNC:26432]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":1.3E-14,"d":"0.00"},1,"481,",0,{"v":-0.968,"d":"-0.97"},{"v":0.0223872113856834,"d":"0.02"},1.38,"3' UTR",19,57363566,57379565,16000,1]
["chr19",57753308,57753575,268,"ENSG00000152443","ENST00000317178","protein_coding",6493,"ZNF776","zinc finger protein 776 [Source:HGNC Symbol;Acc:HGNC:26765]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","NA",{"v":1.3e-50,"d":"0.00"},1,"268,",0,-3.24,{"v":3.71535229097173e-05,"d":"0.00"},{"v":1.7,"d":"1.70"},"3' UTR",19,57746815,57758148,11334,1]
["chr1",150548591,150554548,5958,"ENSG00000143382","ENST00000271643","protein_coding",0,"ADAMTSL4","ADAMTS like 4 [Source:HGNC Symbol;Acc:HGNC:19706]","GO:0002020(protease binding);GO:0002064(epithelial cell development);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005614(interstitial matrix);GO:0005788(endoplasmic reticulum lumen);GO:0006508(proteolysis);GO:0006915(apoptotic process);GO:0008233(peptidase activity);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0043065(positive regulation of apoptotic process);GO:0062023(collagen-containing extracellular matrix)","NA",{"v":0.0017,"d":"0.00"},2,"160,14,","0,5944",{"v":-0.815,"d":"-0.82"},{"v":0.0371535229097173,"d":"0.04"},4.29,"5' UTR",1,150549369,150560932,11564,1]
["chr19",2917008,2926807,9800,"ENSG00000253392","ENST00000520090","antisense",0,"AC119403","novel transcript, antisense to ZNF57","NA","NA",{"v":5e-11,"d":"0.00"},2,"99,111,","0,9689",{"v":-0.764,"d":"-0.76"},{"v":0.0446683592150963,"d":"0.04"},1.11,"3' UTR",19,2915146,2926807,11662,2]
["chr19",12699254,12699373,120,"ENSG00000105576","ENST00000425528","protein_coding",24623,"TNPO2","transportin 2 [Source:HGNC Symbol;Acc:HGNC:19998]","GO:0005515(protein binding);GO:0005623(cell);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006606(protein import into nucleus);GO:0006607(NLS-bearing protein import into nucleus);GO:0006610(ribosomal protein import into nucleus);GO:0006886(intracellular protein transport);GO:0008139(nuclear localization sequence binding);GO:0008536(Ran GTPase binding);GO:0008565(protein transporter activity);GO:0015031(protein transport);GO:0031965(nuclear membrane);GO:0034399(nuclear periphery)","NA",{"v":1.5E-3,"d":"0.00"},1,"120,",0,-0.89,{"v":0.0288403150312661,"d":"0.03"},1,"3' UTR",19,12699194,12723996,24803,2]
["chr19",18990888,18991097,210,"ENSG00000064607","ENST00000593795","nonsense_mediated_decay",10577,"SUGP2","SURP and G-patch domain containing 2 [Source:HGNC Symbol;Acc:HGNC:18641]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006396(RNA processing);GO:0006397(mRNA processing);GO:0008380(RNA splicing);GO:0016604(nuclear body)","NA",{"v":1.6e-14,"d":"0.00"},1,"210,",0,-1.25,{"v":0.00933254300796992,"d":"0.01"},1.12,"3' UTR",19,18990888,19001674,10787,2]
["chr19",19515039,19515548,510,"ENSG00000178093","ENST00000587522","nonsense_mediated_decay",0,"TSSK6","testis specific serine kinase 6 [Source:HGNC Symbol;Acc:HGNC:30410]","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0007275(multicellular organism development);GO:0007283(spermatogenesis);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018105(peptidyl-serine phosphorylation);GO:0030154(cell differentiation);GO:0035092(sperm chromatin condensation);GO:0035556(intracellular signal transduction);GO:0044877(protein-containing complex binding);GO:0046872(metal ion binding)","NA",{"v":4e-96,"d":"0.00"},1,"510,",0,-4.21,{"v":2.88403150312661e-06,"d":"0.00"},1.43,"5' UTR",19,19512418,19515548,3131,2]
["chr19",23362286,23373781,11496,"ENSG00000167232","ENST00000596989","processed_transcript",21690,"ZNF91","zinc finger protein 91 [Source:HGNC Symbol;Acc:HGNC:13166]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008270(zinc ion binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0070895(negative regulation of transposon integration)","05168(Herpes simplex virus 1 infection)",{"v":1e-20,"d":"0.00"},2,"440,40,","0,11456",-1.65,{"v":2.81838293126445E-3,"d":"0.00"},1.84,"5' UTR",19,23308903,23395471,86569,2]
["chr19",36545902,36547764,1863,"ENSG00000186020","ENST00000452073","protein_coding",0,"ZNF529","zinc finger protein 529 [Source:HGNC Symbol;Acc:HGNC:29328]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":1E-155,"d":"0.00"},3,"32,139,207,","0,1488,1656",-1.78,{"v":0.00194984459975805,"d":"0.00"},1.55,"3' UTR",19,36534774,36547764,12991,2]
["chr19",36747704,36761717,14014,"ENSG00000267041","ENST00000589390","protein_coding",11108,"ZNF850","zinc finger protein 850 [Source:HGNC Symbol;Acc:HGNC:27994]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":1e-110,"d":"0.00"},2,"3101,75,","0,13939",-7.95,{"v":2.29086765276777e-10,"d":"0.00"},1.12,"3' UTR",19,36714383,36772825,58443,2]
["chr19",38893470,38893679,210,"ENSG00000068903","ENST00000358931","protein_coding",6183,"SIRT2","sirtuin 2 [Source:HGNC Symbol;Acc:HGNC:10886]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000183(chromatin silencing at rDNA);GO:0000781(chromosome, telomeric region);GO:0002376(immune system process);GO:0003682(chromatin binding);GO:0004407(histone deacetylase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005677(chromatin silencing complex);GO:0005694(chromosome);GO:0005720(nuclear heterochromatin);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005813(centrosome);GO:0005814(centriole);GO:0005815(microtubule organizing center);GO:0005819(spindle);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005886(plasma membrane);GO:0006342(chromatin silencing);GO:0006348(chromatin silencing at telomere);GO:0006471(protein ADP-ribosylation);GO:0006476(protein deacetylation);GO:0006914(autophagy);GO:0007049(cell cycle);GO:0007096(regulation of exit from mitosis);GO:0007399(nervous system development);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0008285(negative regulation of cell population proliferation);GO:0010507(negative regulation of autophagy);GO:0010801(negative regulation of peptidyl-threonine phosphorylation);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0016458(gene silencing);GO:0016575(histone deacetylation);GO:0016787(hydrolase activity);GO:0017136(NAD-dependent histone deacetylase activity);GO:0021762(substantia nigra development);GO:0022011(myelination in peripheral nervous system);GO:0030154(cell differentiation);GO:0030426(growth cone);GO:0030496(midbody);GO:0031641(regulation of myelination);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0033010(paranodal junction);GO:0033270(paranode region of axon);GO:0033558(protein deacetylase activity);GO:0034599(cellular response to oxidative stress);GO:0034979(NAD-dependent protein deacetylase activity);GO:0034983(peptidyl-lysine deacetylation);GO:0035035(histone acetyltransferase binding);GO:0035729(cellular response to hepatocyte growth factor stimulus);GO:0042177(negative regulation of protein catabolic process);GO:0042325(regulation of phosphorylation);GO:0042826(histone deacetylase binding);GO:0042903(tubulin deacetylase activity);GO:0042995(cell projection);GO:0043130(ubiquitin binding);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0043204(perikaryon);GO:0043209(myelin sheath);GO:0043219(lateral loop);GO:0043220(Schmidt-Lanterman incisure);GO:0043388(positive regulation of DNA binding);GO:0043491(protein kinase B signaling);GO:0044224(juxtaparanode region of axon);GO:0044242(cellular lipid catabolic process);GO:0045087(innate immune response);GO:0045598(regulation of fat cell differentiation);GO:0045599(negative regulation of fat cell differentiation);GO:0045836(positive regulation of meiotic nuclear division);GO:0045843(negative regulation of striated muscle tissue development);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0046970(NAD-dependent histone deacetylase activity (H4-K16 specific));GO:0048012(hepatocyte growth factor receptor signaling pathway);GO:0048471(perinuclear region of cytoplasm);GO:0051301(cell division);GO:0051321(meiotic cell cycle);GO:0051726(regulation of cell cycle);GO:0051775(response to redox state);GO:0051781(positive regulation of cell division);GO:0051987(positive regulation of attachment of spindle microtubules to kinetochore);GO:0061428(negative regulation of transcription from RNA polymerase II promoter in response to hypoxia);GO:0061433(cellular response to caloric restriction);GO:0070403(NAD+ binding);GO:0070446(negative regulation of oligodendrocyte progenitor proliferation);GO:0070932(histone H3 deacetylation);GO:0070933(histone H4 deacetylation);GO:0071219(cellular response to molecule of bacterial origin);GO:0071456(cellular response to hypoxia);GO:0071872(cellular response to epinephrine stimulus);GO:0072686(mitotic spindle);GO:0072687(meiotic spindle);GO:0090042(tubulin deacetylation);GO:0097386(glial cell projection);GO:1900119(positive regulation of execution phase of apoptosis);GO:1900195(positive regulation of oocyte maturation);GO:1900226(negative regulation of NLRP3 inflammasome complex assembly);GO:1900425(negative regulation of defense response to bacterium);GO:2000378(negative regulation of reactive oxygen species metabolic process);GO:2000777(positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia)","NA",{"v":4.6E-6,"d":"0.00"},1,"210,",0,-1.58,{"v":0.00346736850452532,"d":"0.00"},1.13,"Exon (ENST00000358931/ENSG00000068903, exon 3 of 13)",19,38878555,38899862,21308,2]
["chr19",39031069,39031890,822,"ENSG00000161243","ENST00000595166","retained_intron",0,"FBXO27","F-box protein 27 [Source:HGNC Symbol;Acc:HGNC:18753]","GO:0000209(protein polyubiquitination);GO:0005515(protein binding);GO:0005829(cytosol);GO:0019005(SCF ubiquitin ligase complex);GO:0043687(post-translational protein modification)","NA",{"v":3e-06,"d":"0.00"},2,"334,27,","0,795",-1.73,{"v":0.00223872113856834,"d":"0.00"},1.22,"Exon (ENST00000597303/ENSG00000267992, exon 2 of 2)",19,39025519,39031402,5884,2]
["chr19",43997885,43998365,481,"ENSG00000204920","ENST00000611002","protein_coding",13715,"ZNF155","zinc finger protein 155 [Source:HGNC Symbol;Acc:HGNC:12940]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":1.3E-7,"d":"0.00"},1,"481,",0,-1.31,{"v":0.00794328234724281,"d":"0.01"},{"v":1.1,"d":"1.10"},"3' UTR",19,43984170,43998325,14156,1]
["chr19",45642387,45642775,389,"ENSG00000125746","ENST00000588172","protein_coding",0,"EML2","EMAP like 2 [Source:HGNC Symbol;Acc:HGNC:18035]","GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005819(spindle);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005875(microtubule associated complex);GO:0007601(visual perception);GO:0007605(sensory perception of sound);GO:0008017(microtubule binding);GO:0008022(protein C-terminus binding);GO:0010968(regulation of microtubule nucleation);GO:0015630(microtubule cytoskeleton);GO:0015631(tubulin binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031115(negative regulation of microtubule polymerization);GO:0072686(mitotic spindle)","NA",{"v":5e-61,"d":"0.00"},1,"389,",0,{"v":-0.945,"d":"-0.95"},{"v":0.0245470891568503,"d":"0.02"},1.04,"5' UTR",19,45641641,45642562,922,2]
["chr19",45710659,45710808,150,"ENSG00000177051","ENST00000317683","protein_coding",20088,"FBXO46","F-box protein 46 [Source:HGNC Symbol;Acc:HGNC:25069]","GO:0005515(protein binding)","NA",{"v":0.00087,"d":"0.00"},1,"150,",0,-1.44,{"v":0.00524807460249772,"d":"0.01"},1.52,"3' UTR",19,45710629,45730896,20268,2]
["chr19",48297054,48297591,538,"ENSG00000105479","ENST00000315396","protein_coding",22484,"CCDC114","coiled-coil domain containing 114 [Source:HGNC Symbol;Acc:HGNC:26560]","GO:0003341(cilium movement);GO:0005515(protein binding);GO:0005929(cilium);GO:0005930(axoneme);GO:0036157(outer dynein arm);GO:0036158(outer dynein arm assembly);GO:0042995(cell projection)","NA",{"v":4.7E-7,"d":"0.00"},1,"538,",0,-1.36,{"v":6.60693448007596E-3,"d":"0.01"},1.85,"Exon (ENST00000315396/ENSG00000105479, exon 13 of 14)",19,48296457,48320075,23619,2]
["chr19",48465652,48469069,3418,"ENSG00000268465","ENST00000595676","protein_coding",0,"AC008403","novel protein","GO:0005086(ARF guanyl-nucleotide exchange factor activity);GO:0032012(regulation of ARF protein signal transduction)","NA",{"v":1.4E-5,"d":"0.00"},3,"287,369,59,","0,917,3359",{"v":-0.995,"d":"-1.00"},{"v":0.0204173794466953,"d":"0.02"},1.17,"5' UTR",19,48465837,48472431,6595,1]
["chr1",3916568,3916956,389,"ENSG00000236423","ENST00000442673","lincRNA",16164,"LINC01134","long intergenic non-protein coding RNA 1134 [Source:HGNC Symbol;Acc:HGNC:49449]","NA","NA",{"v":5.9e-05,"d":"0.00"},1,"389,",0,-1.25,{"v":0.00933254300796992,"d":"0.01"},4.38,"Exon (ENST00000442673/ENSG00000236423, exon 2 of 2)",1,3900404,3917225,16822,1]
["chr1",172407808,172408048,241,"ENSG00000135845","ENST00000489002","processed_transcript",7278,"PIGC","phosphatidylinositol glycan anchor biosynthesis class C [Source:HGNC Symbol;Acc:HGNC:8960]","GO:0000506(glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex);GO:0003824(catalytic activity);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006506(GPI anchor biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016254(preassembly of GPI anchor in ER membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0017176(phosphatidylinositol N-acetylglucosaminyltransferase activity)","00563(Glycosylphosphatidylinositol (GPI)-anchor biosynthesis)",{"v":2.5e-06,"d":"0.00"},1,"241,",0,-1.07,{"v":0.0165958690743756,"d":"0.02"},4.44,"3' UTR",1,172370189,172415326,45138,2]
["chr19",52015527,52017657,2131,"ENSG00000142556","ENST00000356322","protein_coding",10692,"ZNF614","zinc finger protein 614 [Source:HGNC Symbol;Acc:HGNC:24722]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003674(molecular_function);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005575(cellular_component);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008150(biological_process);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":5E-91,"d":"0.00"},2,"1833,82,","0,2049",-4.37,{"v":1.94984459975805e-06,"d":"0.00"},1.05,"3' UTR",19,52012765,52028349,15585,2]
["chr19",52907459,52917298,9840,"ENSG00000213793","ENST00000638862","protein_coding",6183,"ZNF888","zinc finger protein 888 [Source:HGNC Symbol;Acc:HGNC:38695]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","NA",{"v":4e-47,"d":"0.00"},3,"721,127,77,","0,7737,9763",-1.75,{"v":2.13796208950223E-3,"d":"0.00"},{"v":1.1,"d":"1.10"},"Exon (ENST00000638862/ENSG00000213793, exon 4 of 5)",19,52904417,52923481,19065,2]
["chr19",53069123,53073005,3883,"ENSG00000170949","ENST00000599056","protein_coding",30346,"ZNF160","zinc finger protein 160 [Source:HGNC Symbol;Acc:HGNC:12948]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0030097(hemopoiesis);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":1e-137,"d":"0.00"},2,"1140,120,","0,3763",-5.17,{"v":2.51188643150958e-07,"d":"0.00"},1.05,"3' UTR",19,53066606,53103351,36746,2]
["chr5",83644459,83652113,7655,"ENSG00000145681","ENST00000274341","protein_coding",69500,"HAPLN1","hyaluronan and proteoglycan link protein 1 [Source:HGNC Symbol;Acc:HGNC:2380]","GO:0001501(skeletal system development);GO:0005540(hyaluronic acid binding);GO:0005576(extracellular region);GO:0007155(cell adhesion);GO:0007417(central nervous system development);GO:0030021(extracellular matrix structural constituent conferring compression resistance);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0045202(synapse);GO:0062023(collagen-containing extracellular matrix)","NA",{"v":2e-06,"d":"0.00"},2,"207,94,","0,7561",{"v":-0.808,"d":"-0.81"},{"v":0.0380189396320561,"d":"0.04"},4.46,"3' UTR",5,83637805,83721613,83809,2]
["chr19",58346852,58347001,150,"ENSG00000121410","ENST00000596924","processed_transcript",633,"A1BG","alpha-1-B glycoprotein [Source:HGNC Symbol;Acc:HGNC:5]","GO:0002576(platelet degranulation);GO:0003674(molecular_function);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0008150(biological_process);GO:0031093(platelet alpha granule lumen);GO:0034774(secretory granule lumen);GO:0043312(neutrophil degranulation);GO:0062023(collagen-containing extracellular matrix);GO:0070062(extracellular exosome);GO:0072562(blood microparticle);GO:1904813(ficolin-1-rich granule lumen)","NA",{"v":5.4E-6,"d":"0.00"},1,"150,",0,{"v":-0.932,"d":"-0.93"},{"v":0.0257039578276886,"d":"0.03"},{"v":1.3,"d":"1.30"},"3' UTR",19,58345178,58347634,2457,2]
["chr19",58346854,58347003,150,"ENSG00000121410","ENST00000596924","processed_transcript",631,"A1BG","alpha-1-B glycoprotein [Source:HGNC Symbol;Acc:HGNC:5]","GO:0002576(platelet degranulation);GO:0003674(molecular_function);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0008150(biological_process);GO:0031093(platelet alpha granule lumen);GO:0034774(secretory granule lumen);GO:0043312(neutrophil degranulation);GO:0062023(collagen-containing extracellular matrix);GO:0070062(extracellular exosome);GO:0072562(blood microparticle);GO:1904813(ficolin-1-rich granule lumen)","NA",{"v":1.1e-06,"d":"0.00"},1,"150,",0,{"v":-0.945,"d":"-0.95"},{"v":0.0245470891568503,"d":"0.02"},1.32,"3' UTR",19,58345178,58347634,2457,2]
["chr20",1180924,1181643,720,"ENSG00000125818","ENST00000652336","nonsense_mediated_decay",67684,"PSMF1","proteasome inhibitor subunit 1 [Source:HGNC Symbol;Acc:HGNC:9571]","GO:0000165(MAPK cascade);GO:0000209(protein polyubiquitination);GO:0000502(proteasome complex);GO:0002223(stimulatory C-type lectin receptor signaling pathway);GO:0002479(antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent);GO:0004866(endopeptidase inhibitor activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005839(proteasome core complex);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006521(regulation of cellular amino acid metabolic process);GO:0010951(negative regulation of endopeptidase activity);GO:0010972(negative regulation of G2/M transition of mitotic cell cycle);GO:0016020(membrane);GO:0016579(protein deubiquitination);GO:0031145(anaphase-promoting complex-dependent catabolic process);GO:0031146(SCF-dependent proteasomal ubiquitin-dependent protein catabolic process);GO:0033209(tumor necrosis factor-mediated signaling pathway);GO:0038061(NIK/NF-kappaB signaling);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0042803(protein homodimerization activity);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0043488(regulation of mRNA stability);GO:0043687(post-translational protein modification);GO:0046982(protein heterodimerization activity);GO:0048471(perinuclear region of cytoplasm);GO:0050852(T cell receptor signaling pathway);GO:0055085(transmembrane transport);GO:0060071(Wnt signaling pathway, planar cell polarity pathway);GO:0061418(regulation of transcription from RNA polymerase II promoter in response to hypoxia);GO:0070498(interleukin-1-mediated signaling pathway);GO:0070628(proteasome binding);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1901799(negative regulation of proteasomal protein catabolic process);GO:1901990(regulation of mitotic cell cycle phase transition);GO:1902036(regulation of hematopoietic stem cell differentiation)","03050(Proteasome)",{"v":4e-17,"d":"0.00"},1,"720,",0,-1.07,{"v":0.0165958690743756,"d":"0.02"},1.26,"3' UTR",20,1113240,1182081,68842,1]
["chr20",5995207,5996104,898,"ENSG00000125885","ENST00000610722","protein_coding",44555,"MCM8","minichromosome maintenance 8 homologous recombination repair factor [Source:HGNC Symbol;Acc:HGNC:16147]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0000166(nucleotide binding);GO:0000724(double-strand break repair via homologous recombination);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0004386(helicase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0006260(DNA replication);GO:0006270(DNA replication initiation);GO:0006281(DNA repair);GO:0006974(cellular response to DNA damage stimulus);GO:0007049(cell cycle);GO:0007292(female gamete generation);GO:0016787(hydrolase activity);GO:0019899(enzyme binding);GO:0032406(MutLbeta complex binding);GO:0032407(MutSalpha complex binding);GO:0032408(MutSbeta complex binding);GO:0036298(recombinational interstrand cross-link repair);GO:0048232(male gamete generation);GO:0050821(protein stabilization);GO:0071168(protein localization to chromatin);GO:0097362(MCM8-MCM9 complex)","NA",{"v":7.9e-48,"d":"0.00"},1,"898,",0,-2.59,{"v":0.000208929613085404,"d":"0.00"},1.03,"3' UTR",20,5950652,5998977,48326,1]
["chr20",25221860,25222518,659,"ENSG00000197586","ENST00000481322","processed_transcript",0,"ENTPD6","ectonucleoside triphosphate diphosphohydrolase 6 (putative) [Source:HGNC Symbol;Acc:HGNC:3368]","GO:0000139(Golgi membrane);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0008894(guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0017110(nucleoside-diphosphatase activity);GO:0017111(nucleoside-triphosphatase activity);GO:0032026(response to magnesium ion);GO:0034656(nucleobase-containing small molecule catabolic process);GO:0045134(uridine-diphosphatase activity);GO:0051592(response to calcium ion)","00230(Purine metabolism);00240(Pyrimidine metabolism)",{"v":3.2e-88,"d":"0.00"},1,"659,",0,{"v":-10.3,"d":"-10.30"},{"v":6.30957344480194e-13,"d":"0.00"},1.52,"Exon (ENST00000485936/ENSG00000197586, exon 1 of 4)",20,25222059,25222883,825,1]
["chr20",64207698,64208476,779,"ENSG00000196132","ENST00000360149","protein_coding",55907,"MYT1","myelin transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:7622]","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007275(multicellular organism development);GO:0007399(nervous system development);GO:0008270(zinc ion binding);GO:0030154(cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0140110(transcription regulator activity)","NA",{"v":1e-38,"d":"0.00"},1,"779,",0,-1.14,{"v":0.0131825673855641,"d":"0.01"},1.08,"Exon (ENST00000328439/ENSG00000196132, exon 7 of 23)",20,64151791,64228102,76312,1]
["chr20",1180591,1183789,3199,"ENSG00000125818","ENST00000652336","nonsense_mediated_decay",67351,"PSMF1","proteasome inhibitor subunit 1 [Source:HGNC Symbol;Acc:HGNC:9571]","GO:0000165(MAPK cascade);GO:0000209(protein polyubiquitination);GO:0000502(proteasome complex);GO:0002223(stimulatory C-type lectin receptor signaling pathway);GO:0002479(antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent);GO:0004866(endopeptidase inhibitor activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005839(proteasome core complex);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006521(regulation of cellular amino acid metabolic process);GO:0010951(negative regulation of endopeptidase activity);GO:0010972(negative regulation of G2/M transition of mitotic cell cycle);GO:0016020(membrane);GO:0016579(protein deubiquitination);GO:0031145(anaphase-promoting complex-dependent catabolic process);GO:0031146(SCF-dependent proteasomal ubiquitin-dependent protein catabolic process);GO:0033209(tumor necrosis factor-mediated signaling pathway);GO:0038061(NIK/NF-kappaB signaling);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0042803(protein homodimerization activity);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0043488(regulation of mRNA stability);GO:0043687(post-translational protein modification);GO:0046982(protein heterodimerization activity);GO:0048471(perinuclear region of cytoplasm);GO:0050852(T cell receptor signaling pathway);GO:0055085(transmembrane transport);GO:0060071(Wnt signaling pathway, planar cell polarity pathway);GO:0061418(regulation of transcription from RNA polymerase II promoter in response to hypoxia);GO:0070498(interleukin-1-mediated signaling pathway);GO:0070628(proteasome binding);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1901799(negative regulation of proteasomal protein catabolic process);GO:1901990(regulation of mitotic cell cycle phase transition);GO:1902036(regulation of hematopoietic stem cell differentiation)","03050(Proteasome)",{"v":1.3E-36,"d":"0.00"},2,"997,19,","0,3180",-1.01,{"v":0.0194984459975805,"d":"0.02"},1.03,"3' UTR",20,1113240,1182081,68842,1]
["chr20",7977795,7978035,241,"ENSG00000125827","ENST00000246024","protein_coding",41726,"TMX4","thioredoxin related transmembrane protein 4 [Source:HGNC Symbol;Acc:HGNC:25237]","GO:0005623(cell);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0045454(cell redox homeostasis);GO:0055114(oxidation-reduction process)","NA",{"v":5e-11,"d":"0.00"},1,"241,",0,-1,{"v":0.0204173794466953,"d":"0.02"},1.65,"3' UTR",20,7977346,8019761,42416,2]
["chr20",28563850,28564870,1021,"ENSG00000282826","ENST00000650751","processed_transcript",37903,"FRG1CP","FSHD region gene 1 family member C, pseudogene [Source:HGNC Symbol;Acc:HGNC:51762]","NA","NA",{"v":2.5e-12,"d":"0.00"},1,"1021,",0,{"v":-1.5,"d":"-1.50"},{"v":0.00436515832240166,"d":"0.00"},1,"Exon (ENST00000650751/ENSG00000282826, exon 8 of 8)",20,28563850,28602773,38924,2]
["chr7",94656018,94656197,180,"ENSG00000127990","ENST00000647351","protein_coding",0,"SGCE","sarcoglycan epsilon [Source:HGNC Symbol;Acc:HGNC:10808]","GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007160(cell-matrix adhesion);GO:0007517(muscle organ development);GO:0016010(dystrophin-associated glycoprotein complex);GO:0016012(sarcoglycan complex);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030425(dendrite);GO:0032590(dendrite membrane);GO:0042383(sarcolemma);GO:0042995(cell projection)","NA",{"v":2.6e-05,"d":"0.00"},1,"180,",0,-1.01,{"v":0.0199526231496888,"d":"0.02"},4.46,"5' UTR",7,94584980,94656126,71147,2]
["chr20",37501989,37502588,600,"ENSG00000166619","ENST00000411780","processed_transcript",6643,"BLCAP","BLCAP, apoptosis inducing factor [Source:HGNC Symbol;Acc:HGNC:1055]","GO:0005515(protein binding);GO:0006915(apoptotic process);GO:0007049(cell cycle);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030262(apoptotic nuclear changes)","NA",{"v":1.9e-07,"d":"0.00"},1,"600,",0,{"v":-0.879,"d":"-0.88"},{"v":0.0301995172040202,"d":"0.03"},1.55,"Exon (ENST00000613961/ENSG00000166619, exon 1 of 1)",20,37492472,37509231,16760,2]
["chr10",116881668,116882085,418,"ENSG00000187164","ENST00000355371","protein_coding",123102,"SHTN1","shootin 1 [Source:HGNC Symbol;Acc:HGNC:29319]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005875(microtubule associated complex);GO:0006930(substrate-dependent cell migration, cell extension);GO:0007265(Ras protein signal transduction);GO:0007275(multicellular organism development);GO:0007409(axonogenesis);GO:0015630(microtubule cytoskeleton);GO:0019894(kinesin binding);GO:0030027(lamellipodium);GO:0030175(filopodium);GO:0030424(axon);GO:0030426(growth cone);GO:0031252(cell leading edge);GO:0032488(Cdc42 protein signal transduction);GO:0038007(netrin-activated signaling pathway);GO:0042995(cell projection);GO:0043204(perikaryon);GO:0044295(axonal growth cone);GO:0045296(cadherin binding);GO:0045773(positive regulation of axon extension);GO:0048471(perinuclear region of cytoplasm);GO:0048812(neuron projection morphogenesis);GO:0051015(actin filament binding);GO:0060327(cytoplasmic actin-based contraction involved in cell motility);GO:0061163(endoplasmic reticulum polarization);GO:0061573(actin filament bundle retrograde transport);GO:2000114(regulation of establishment of cell polarity);GO:2001222(regulation of neuron migration);GO:2001224(positive regulation of neuron migration)","NA",{"v":7.2e-06,"d":"0.00"},1,"418,",0,{"v":-0.822,"d":"-0.82"},{"v":0.0363078054770101,"d":"0.04"},{"v":4.5,"d":"4.50"},"3' UTR",10,116881477,117005187,123711,2]
["chr3",37143542,37143958,417,"ENSG00000224080","ENST00000416536","processed_pseudogene",0,"UBE2FP1","UBE2F pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:44535]","NA","NA",{"v":5.6e-07,"d":"0.00"},1,"417,",0,-3.16,{"v":4.57088189614875e-05,"d":"0.00"},4.55,"Exon (ENST00000416536/ENSG00000224080, exon 1 of 1)",3,37143512,37143958,447,2]
["chr12",10589231,10589501,271,"ENSG00000256667","ENST00000535939","processed_transcript",10064,"KLRA1P","killer cell lectin like receptor A1, pseudogene [Source:HGNC Symbol;Acc:HGNC:6372]","NA","NA",{"v":7.2e-06,"d":"0.00"},1,"271,",0,{"v":-0.779,"d":"-0.78"},{"v":0.0416869383470335,"d":"0.04"},4.58,"Exon (ENST00000535939/ENSG00000256667, exon 7 of 7)",12,10588063,10599565,11503,2]
["chr21",37202932,37203112,181,"ENSG00000182670","ENST00000355666","protein_coding",129661,"TTC3","tetratricopeptide repeat domain 3 [Source:HGNC Symbol;Acc:HGNC:12393]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0046872(metal ion binding);GO:0070936(protein K48-linked ubiquitination)","NA",{"v":3.2e-17,"d":"0.00"},1,"181,",0,-2.03,{"v":0.000954992586021436,"d":"0.00"},1.56,"3' UTR",21,37073271,37203103,129833,1]
["chr21",38824146,38824895,750,"ENSG00000157557","ENST00000360214","protein_coding",18839,"ETS2","ETS proto-oncogene 2, transcription factor [Source:HGNC Symbol;Acc:HGNC:3489]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001501(skeletal system development);GO:0001712(ectodermal cell fate commitment);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007498(mesoderm development);GO:0019904(protein domain specific binding);GO:0030154(cell differentiation);GO:0035259(glucocorticoid receptor binding);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0090009(primitive streak formation)","04014(Ras signaling pathway);05166(Human T-cell leukemia virus 1 infection)",{"v":4.4e-10,"d":"0.00"},1,"750,",0,-1.16,{"v":0.0123026877081238,"d":"0.01"},1.17,"3' UTR",21,38805307,38824955,19649,1]
["chr21",44130731,44131181,451,"ENSG00000241945","ENST00000291576","protein_coding",23332,"PWP2","PWP2, small subunit processome component [Source:HGNC Symbol;Acc:HGNC:9711]","GO:0000028(ribosomal small subunit assembly);GO:0000462(maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0032040(small-subunit processome);GO:0034388(Pwp2p-containing subcomplex of 90S preribosome)","03008(Ribosome biogenesis in eukaryotes)",0,1,"451,",0,-4.63,{"v":9.772372209558111E-7,"d":"0.00"},1.27,"3' UTR",21,44107399,44131181,23783,1]
["chr3",125375144,125375324,181,"ENSG00000163848","ENST00000468369","protein_coding",0,"ZNF148","zinc finger protein 148 [Source:HGNC Symbol;Acc:HGNC:12933]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003690(double-stranded DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0006366(transcription by RNA polymerase II);GO:0006968(cellular defense response);GO:0007276(gamete generation);GO:0010629(negative regulation of gene expression);GO:0021762(substantia nigra development);GO:0043565(sequence-specific DNA binding);GO:0044212(transcription regulatory region DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0065003(protein-containing complex assembly)","NA",{"v":7.1e-05,"d":"0.00"},1,"181,",0,-1.67,{"v":2.69153480392692E-3,"d":"0.00"},{"v":4.6,"d":"4.60"},"5' UTR",3,125232059,125375278,143220,2]
["chr19",52385315,52385615,301,"ENSG00000221923","ENST00000422689","protein_coding",15392,"ZNF880","zinc finger protein 880 [Source:HGNC Symbol;Acc:HGNC:37249]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","NA",{"v":1e-07,"d":"0.00"},1,"301,",0,{"v":-0.819,"d":"-0.82"},{"v":0.0371535229097173,"d":"0.04"},{"v":4.7,"d":"4.70"},"3' UTR",19,52369923,52385795,15873,1]
["chr21",9809612,9809912,301,"ENSG00000280081","ENST00000623933","processed_transcript",0,"LINC01667","long intergenic non-protein coding RNA 1667 [Source:HGNC Symbol;Acc:HGNC:52455]","NA","NA",{"v":6.5e-09,"d":"0.00"},1,"301,",0,-0.76,{"v":0.0446683592150963,"d":"0.04"},1.62,"Exon (ENST00000623933/ENSG00000280081, exon 1 of 5)",21,9806875,9809723,2849,2]
["chr21",33432515,33432664,150,"ENSG00000142188","ENST00000484377","processed_transcript",16300,"TMEM50B","transmembrane protein 50B [Source:HGNC Symbol;Acc:HGNC:1280]","GO:0000139(Golgi membrane);GO:0003674(molecular_function);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0008150(biological_process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032511(late endosome to vacuole transport via multivesicular body sorting pathway)","NA",{"v":0.00023,"d":"0.00"},1,"150,",0,{"v":-0.971,"d":"-0.97"},{"v":0.0223872113856834,"d":"0.02"},1.73,"3' UTR",21,33432485,33448964,16480,2]
["chr2",130202371,130204394,2024,"ENSG00000227632","ENST00000430381","unprocessed_pseudogene",59,"AC018804","pseudogene similar to part of CDC42 binding protein kinase beta (DMPK-like) CDC42BPB","NA","NA",{"v":2.1e-08,"d":"0.00"},2,"69,226,","0,1798",-1.21,{"v":0.010471285480509,"d":"0.01"},4.71,"Exon (ENST00000430381/ENSG00000227632, exon 1 of 5)",2,130202312,130212628,10317,1]
["chr21",39422777,39423465,689,"ENSG00000157578","ENST00000380671","protein_coding",5057,"LCA5L","LCA5L, lebercilin like [Source:HGNC Symbol;Acc:HGNC:1255]","GO:0005515(protein binding);GO:0005930(axoneme);GO:0042073(intraciliary transport)","NA",{"v":1.6e-55,"d":"0.00"},1,"689,",0,-2.69,{"v":0.000158489319246111,"d":"0.00"},1.31,"3' UTR",21,39405844,39428522,22679,2]
["chr21",43053221,43055235,2015,"ENSG00000160200","ENST00000461686","retained_intron",13169,"CBS","cystathionine-beta-synthase [Source:HGNC Symbol;Acc:HGNC:1550]","GO:0003824(catalytic activity);GO:0004122(cystathionine beta-synthase activity);GO:0004124(cysteine synthase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006535(cysteine biosynthetic process from serine);GO:0006563(L-serine metabolic process);GO:0006565(L-serine catabolic process);GO:0008152(metabolic process);GO:0008652(cellular amino acid biosynthetic process);GO:0016829(lyase activity);GO:0019343(cysteine biosynthetic process via cystathionine);GO:0019344(cysteine biosynthetic process);GO:0019346(transsulfuration);GO:0019448(L-cysteine catabolic process);GO:0019825(oxygen binding);GO:0019899(enzyme binding);GO:0020037(heme binding);GO:0030170(pyridoxal phosphate binding);GO:0031625(ubiquitin protein ligase binding);GO:0042262(DNA protection);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043418(homocysteine catabolic process);GO:0046872(metal ion binding);GO:0050421(nitrite reductase (NO-forming) activity);GO:0050667(homocysteine metabolic process);GO:0055114(oxidation-reduction process);GO:0070025(carbon monoxide binding);GO:0070026(nitric oxide binding);GO:0070814(hydrogen sulfide biosynthetic process);GO:0072341(modified amino acid binding);GO:1904047(S-adenosyl-L-methionine binding)","00260(Glycine, serine and threonine metabolism);00270(Cysteine and methionine metabolism)",{"v":5e-84,"d":"0.00"},2,"763,164,","0,1851",-2.35,{"v":0.000398107170553497,"d":"0.00"},1.55,"3' UTR",21,43053191,43068404,15214,2]
["chr6",28092392,28092895,504,"ENSG00000219891","ENST00000406489","transcribed_unprocessed_pseudogene",0,"ZSCAN12P1","zinc finger and SCAN domain containing 12 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:13850]","NA","NA",{"v":1.6e-10,"d":"0.00"},1,"504,",0,-1.95,{"v":1.20226443461741E-3,"d":"0.00"},4.78,"Exon (ENST00000529104/ENSG00000219891, exon 2 of 2)",6,28092427,28092845,419,1]
["chr22",23856703,23857070,368,"ENSG00000133460","ENST00000345044","protein_coding",0,"SLC2A11","solute carrier family 2 member 11 [Source:HGNC Symbol;Acc:HGNC:14239]","GO:0005215(transporter activity);GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0008643(carbohydrate transport);GO:0008645(hexose transmembrane transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0030054(cell junction);GO:0055085(transmembrane transport)","NA",{"v":7.9e-33,"d":"0.00"},2,"289,71,","0,297",{"v":-0.875,"d":"-0.88"},{"v":0.0309029543251359,"d":"0.03"},1.74,"5' UTR",22,23856703,23886309,29607,1]
["chr22",27922022,27922178,157,"ENSG00000276150","ENST00000611117","misc_RNA",0,"RF02199","NA","NA","NA",{"v":1.3e-85,"d":"0.00"},1,"157,",0,-1.75,{"v":0.00208929613085404,"d":"0.00"},1.29,"Exon (ENST00000436996/ENSG00000235954, exon 2 of 2)",22,27922022,27922178,157,1]
["chr10",116881686,116882075,390,"ENSG00000187164","ENST00000355371","protein_coding",123112,"SHTN1","shootin 1 [Source:HGNC Symbol;Acc:HGNC:29319]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005875(microtubule associated complex);GO:0006930(substrate-dependent cell migration, cell extension);GO:0007265(Ras protein signal transduction);GO:0007275(multicellular organism development);GO:0007409(axonogenesis);GO:0015630(microtubule cytoskeleton);GO:0019894(kinesin binding);GO:0030027(lamellipodium);GO:0030175(filopodium);GO:0030424(axon);GO:0030426(growth cone);GO:0031252(cell leading edge);GO:0032488(Cdc42 protein signal transduction);GO:0038007(netrin-activated signaling pathway);GO:0042995(cell projection);GO:0043204(perikaryon);GO:0044295(axonal growth cone);GO:0045296(cadherin binding);GO:0045773(positive regulation of axon extension);GO:0048471(perinuclear region of cytoplasm);GO:0048812(neuron projection morphogenesis);GO:0051015(actin filament binding);GO:0060327(cytoplasmic actin-based contraction involved in cell motility);GO:0061163(endoplasmic reticulum polarization);GO:0061573(actin filament bundle retrograde transport);GO:2000114(regulation of establishment of cell polarity);GO:2001222(regulation of neuron migration);GO:2001224(positive regulation of neuron migration)","NA",{"v":1.4E-5,"d":"0.00"},1,"390,",0,-0.91,{"v":0.0275422870333817,"d":"0.03"},4.95,"3' UTR",10,116881477,117005187,123711,2]
["chr22",35667745,35668224,480,"ENSG00000221963","ENST00000409652","protein_coding",19299,"APOL6","apolipoprotein L6 [Source:HGNC Symbol;Acc:HGNC:14870]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005737(cytoplasm);GO:0006869(lipid transport);GO:0008289(lipid binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042157(lipoprotein metabolic process)","NA",{"v":7.9e-36,"d":"0.00"},1,"480,",0,{"v":-0.922,"d":"-0.92"},{"v":0.0263026799189538,"d":"0.03"},1.27,"3' UTR",22,35648446,35668404,19959,1]
["chr22",46357071,46357340,270,"ENSG00000100416","ENST00000441818","nonsense_mediated_decay",21670,"TRMU","tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase [Source:HGNC Symbol;Acc:HGNC:25481]","GO:0000049(tRNA binding);GO:0000166(nucleotide binding);GO:0002143(tRNA wobble position uridine thiolation);GO:0003723(RNA binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0008033(tRNA processing);GO:0008168(methyltransferase activity);GO:0016740(transferase activity);GO:0016783(sulfurtransferase activity);GO:0032259(methylation)","NA",{"v":2e-13,"d":"0.00"},1,"270,",0,{"v":-1.7,"d":"-1.70"},{"v":0.00245470891568503,"d":"0.00"},1.47,"3' UTR",22,46335401,46357335,21935,1]
["chr22",50783220,50783921,702,"ENSG00000079974","ENST00000435118","protein_coding",0,"RABL2B","RAB, member of RAS oncogene family like 2B [Source:HGNC Symbol;Acc:HGNC:9800]","GO:0000166(nucleotide binding);GO:0000242(pericentriolar material);GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005814(centriole);GO:0005856(cytoskeleton);GO:0005929(cilium);GO:0006886(intracellular protein transport);GO:0030030(cell projection organization);GO:0032482(Rab protein signal transduction);GO:0036064(ciliary basal body);GO:0042073(intraciliary transport);GO:0042995(cell projection);GO:0060271(cilium assembly)","NA",{"v":4.2e-06,"d":"0.00"},2,"75,165,","0,537",-1.21,{"v":0.010471285480509,"d":"0.01"},1.19,"5' UTR",22,50767501,50783662,16162,2]
["chr1",211660336,211660512,177,"ENSG00000117650","ENST00000540251","protein_coding",15118,"NEK2","NIMA related kinase 2 [Source:HGNC Symbol;Acc:HGNC:7745]","GO:0000070(mitotic sister chromatid segregation);GO:0000086(G2/M transition of mitotic cell cycle);GO:0000166(nucleotide binding);GO:0000278(mitotic cell cycle);GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000777(condensed chromosome kinetochore);GO:0000794(condensed nuclear chromosome);GO:0000922(spindle pole);GO:0001824(blastocyst development);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0006468(protein phosphorylation);GO:0007049(cell cycle);GO:0007059(chromosome segregation);GO:0007088(regulation of mitotic nuclear division);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0019903(protein phosphatase binding);GO:0030496(midbody);GO:0032212(positive regulation of telomere maintenance via telomerase);GO:0032991(protein-containing complex);GO:0043392(negative regulation of DNA binding);GO:0046602(regulation of mitotic centrosome separation);GO:0046777(protein autophosphorylation);GO:0046872(metal ion binding);GO:0051225(spindle assembly);GO:0051299(centrosome separation);GO:0051301(cell division);GO:0051321(meiotic cell cycle);GO:0051973(positive regulation of telomerase activity);GO:0051988(regulation of attachment of spindle microtubules to kinetochore);GO:0090307(mitotic spindle assembly);GO:0097711(ciliary basal body-plasma membrane docking);GO:1903126(negative regulation of centriole-centriole cohesion);GO:1904355(positive regulation of telomere capping)","NA",{"v":4.2e-05,"d":"0.00"},1,"177,",0,{"v":-0.756,"d":"-0.76"},{"v":0.0457088189614875,"d":"0.05"},5,"Exon (ENST00000438304/ENSG00000224763, exon 1 of 1)",1,211658657,211675630,16974,2]
["chr8",144503943,144504153,211,"ENSG00000167701","ENST00000531330","retained_intron",0,"GPT","glutamic--pyruvic transaminase [Source:HGNC Symbol;Acc:HGNC:4552]","GO:0003824(catalytic activity);GO:0004021(L-alanine:2-oxoglutarate aminotransferase activity);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008483(transaminase activity);GO:0008652(cellular amino acid biosynthetic process);GO:0009058(biosynthetic process);GO:0016740(transferase activity);GO:0030170(pyridoxal phosphate binding);GO:0042853(L-alanine catabolic process);GO:0070062(extracellular exosome)","00220(Arginine biosynthesis);00250(Alanine, aspartate and glutamate metabolism)",{"v":1.2E-4,"d":"0.00"},1,"211,",0,{"v":-0.756,"d":"-0.76"},{"v":0.0457088189614875,"d":"0.05"},5,"5' UTR",8,144504140,144504836,697,1]
["chr22",23856514,23857039,526,"ENSG00000133460","ENST00000345044","protein_coding",0,"SLC2A11","solute carrier family 2 member 11 [Source:HGNC Symbol;Acc:HGNC:14239]","GO:0005215(transporter activity);GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0008643(carbohydrate transport);GO:0008645(hexose transmembrane transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0030054(cell junction);GO:0055085(transmembrane transport)","NA",{"v":7.9e-46,"d":"0.00"},1,"526,",0,-1.16,{"v":0.0123026877081238,"d":"0.01"},1.64,"5' UTR",22,23856703,23886309,29607,1]
["chr22",30653906,30654552,647,"ENSG00000100036","ENST00000406566","protein_coding",17583,"SLC35E4","solute carrier family 35 member E4 [Source:HGNC Symbol;Acc:HGNC:17058]","GO:0005794(Golgi apparatus);GO:0015165(pyrimidine nucleotide-sugar transmembrane transporter activity);GO:0015297(antiporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport);GO:0090481(pyrimidine nucleotide-sugar transmembrane transport)","NA",{"v":1.8E-10,"d":"0.00"},2,"66,255,","0,392",-1.06,{"v":0.0169824365246174,"d":"0.02"},1.45,"3' UTR",22,30636323,30663299,26977,1]
["chr22",46761923,46762563,641,"ENSG00000260708","ENST00000564152","antisense",0,"AL118516","novel transcript, antisense to TBC1D22A","NA","NA",{"v":5e-88,"d":"0.00"},1,"641,",0,-2.48,{"v":2.75422870333817E-4,"d":"0.00"},1.14,"Exon (ENST00000564152/ENSG00000260708, exon 1 of 1)",22,46761894,46762563,670,2]
["chr22",49933227,49934074,848,"ENSG00000278869","ENST00000623759","lincRNA",0,"BX539320","novel transcript","NA","NA",{"v":1.4e-09,"d":"0.00"},1,"848,",0,-1.14,{"v":0.0131825673855641,"d":"0.01"},1.37,"Exon (ENST00000623759/ENSG00000278869, exon 1 of 1)",22,49933198,49934074,877,2]
["chr5",43061724,43062023,300,"ENSG00000177738","ENST00000503152","sense_overlapping",5396,"AC025171","novel transcript, sense overlapping to ANXA2R","NA","NA",{"v":3.5e-06,"d":"0.00"},1,"300,",0,{"v":-0.938,"d":"-0.94"},{"v":0.0251188643150958,"d":"0.03"},5.52,"Exon (ENST00000607250/ENSG00000272144, exon 1 of 1)",5,43014736,43067419,52684,2]
["chrX",48521799,48522216,418,"ENSG00000147155","ENST00000276096","processed_transcript",0,"EBP","EBP, cholestenol delta-isomerase [Source:HGNC Symbol;Acc:HGNC:3133]","GO:0000247(C-8 sterol isomerase activity);GO:0001501(skeletal system development);GO:0004769(steroid delta-isomerase activity);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005887(integral component of plasma membrane);GO:0006629(lipid metabolic process);GO:0006694(steroid biosynthetic process);GO:0006695(cholesterol biosynthetic process);GO:0006855(drug transmembrane transport);GO:0008202(steroid metabolic process);GO:0008203(cholesterol metabolic process);GO:0015238(drug transmembrane transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016125(sterol metabolic process);GO:0016126(sterol biosynthetic process);GO:0016853(isomerase activity);GO:0031410(cytoplasmic vesicle);GO:0033489(cholesterol biosynthetic process via desmosterol);GO:0033490(cholesterol biosynthetic process via lathosterol);GO:0047750(cholestenol delta-isomerase activity)","00100(Steroid biosynthesis)",{"v":8.5e-08,"d":"0.00"},2,"109,72,","0,346",-2.15,{"v":0.000691830970918936,"d":"0.00"},1.32,"5' UTR",23,48521799,48528710,6912,1]
["chrX",48521806,48523775,1970,"ENSG00000147155","ENST00000495186","protein_coding",0,"EBP","EBP, cholestenol delta-isomerase [Source:HGNC Symbol;Acc:HGNC:3133]","GO:0000247(C-8 sterol isomerase activity);GO:0001501(skeletal system development);GO:0004769(steroid delta-isomerase activity);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005887(integral component of plasma membrane);GO:0006629(lipid metabolic process);GO:0006694(steroid biosynthetic process);GO:0006695(cholesterol biosynthetic process);GO:0006855(drug transmembrane transport);GO:0008202(steroid metabolic process);GO:0008203(cholesterol metabolic process);GO:0015238(drug transmembrane transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016125(sterol metabolic process);GO:0016126(sterol biosynthetic process);GO:0016853(isomerase activity);GO:0031410(cytoplasmic vesicle);GO:0033489(cholesterol biosynthetic process via desmosterol);GO:0033490(cholesterol biosynthetic process via lathosterol);GO:0047750(cholestenol delta-isomerase activity)","00100(Steroid biosynthesis)",{"v":4.9e-07,"d":"0.00"},2,"102,77,","0,1893",-3.82,{"v":7.94328234724282e-06,"d":"0.00"},1.09,"5' UTR",23,48521808,48528716,6909,1]
["chr3",15602179,15606519,4341,"ENSG00000169814","ENST00000427382","protein_coding",838,"BTD","biotinidase [Source:HGNC Symbol;Acc:HGNC:1122]","GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005759(mitochondrial matrix);GO:0006768(biotin metabolic process);GO:0006807(nitrogen compound metabolic process);GO:0007417(central nervous system development);GO:0016787(hydrolase activity);GO:0016811(hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides);GO:0047708(biotinidase activity);GO:0070062(extracellular exosome)","00780(Biotin metabolism);04977(Vitamin digestion and absorption)",{"v":0.00032,"d":"0.00"},2,"132,79,","0,4262",-1.18,{"v":0.0114815362149688,"d":"0.01"},5.58,"5' UTR",3,15601341,15645822,44482,1]
["chrX",153182701,153183438,738,"ENSG00000198681","ENST00000356661","protein_coding",3417,"MAGEA1","MAGE family member A1 [Source:HGNC Symbol;Acc:HGNC:6796]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0042826(histone deacetylase binding);GO:0045746(negative regulation of Notch signaling pathway)","NA",{"v":2.5e-08,"d":"0.00"},1,"738,",0,-1.21,{"v":0.0107151930523761,"d":"0.01"},1.21,"3' UTR",23,153179284,153183880,4597,1]
["chrX",154476461,154477210,750,"ENSG00000130827","ENST00000369682","protein_coding",18180,"PLXNA3","plexin A3 [Source:HGNC Symbol;Acc:HGNC:9101]","GO:0002116(semaphorin receptor complex);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007162(negative regulation of cell adhesion);GO:0007165(signal transduction);GO:0007275(multicellular organism development);GO:0007411(axon guidance);GO:0008360(regulation of cell shape);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017154(semaphorin receptor activity);GO:0021612(facial nerve structural organization);GO:0021637(trigeminal nerve structural organization);GO:0021766(hippocampus development);GO:0021785(branchiomotor neuron axon guidance);GO:0021860(pyramidal neuron development);GO:0030054(cell junction);GO:0030334(regulation of cell migration);GO:0043087(regulation of GTPase activity);GO:0043231(intracellular membrane-bounded organelle);GO:0048843(negative regulation of axon extension involved in axon guidance);GO:0050772(positive regulation of axonogenesis);GO:0050919(negative chemotaxis);GO:0051495(positive regulation of cytoskeleton organization);GO:0071526(semaphorin-plexin signaling pathway);GO:0097485(neuron projection guidance);GO:1902287(semaphorin-plexin signaling pathway involved in axon guidance);GO:1990138(neuron projection extension)","04360(Axon guidance)",{"v":3.2e-24,"d":"0.00"},1,"750,",0,{"v":-0.891,"d":"-0.89"},{"v":0.0288403150312661,"d":"0.03"},1.17,"3' UTR",23,154458281,154477779,19499,1]
["chrX",101615118,101615538,421,"ENSG00000198960","ENST00000497931","processed_transcript",2372,"ARMCX6","armadillo repeat containing X-linked 6 [Source:HGNC Symbol;Acc:HGNC:26094]","GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":3.8e-07,"d":"0.00"},1,"421,",0,{"v":-13.3,"d":"-13.30"},{"v":3.98107170553497E-16,"d":"0.00"},1.67,"3' UTR",23,101615118,101617910,2793,2]
["chrX",110317858,110426699,108842,"ENSG00000101935","ENST00000262844","protein_coding",0,"AMMECR1","Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 [Source:HGNC Symbol;Acc:HGNC:467]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0008150(biological_process)","NA",{"v":3.8e-10,"d":"0.00"},2,"228,42,","0,108800",-1.35,{"v":0.00676082975391982,"d":"0.01"},1.78,"5' UTR",23,110194186,110318085,123900,2]
["chrX",136848571,136869324,20754,"ENSG00000147274","ENST00000561733","processed_transcript",4101,"RBMX","RNA binding motif protein X-linked [Source:HGNC Symbol;Acc:HGNC:9910]","GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0000398(mRNA splicing, via spliceosome);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001649(osteoblast differentiation);GO:0003676(nucleic acid binding);GO:0003682(chromatin binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex);GO:0005719(nuclear euchromatin);GO:0006366(transcription by RNA polymerase II);GO:0006397(mRNA processing);GO:0006509(membrane protein ectodomain proteolysis);GO:0008380(RNA splicing);GO:0016020(membrane);GO:0016070(RNA metabolic process);GO:0019904(protein domain specific binding);GO:0042802(identical protein binding);GO:0044530(supraspliceosomal complex);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048025(negative regulation of mRNA splicing, via spliceosome);GO:0048026(positive regulation of mRNA splicing, via spliceosome);GO:0051259(protein complex oligomerization);GO:0051260(protein homooligomerization);GO:0070062(extracellular exosome);GO:0071013(catalytic step 2 spliceosome);GO:0071347(cellular response to interleukin-1);GO:1990904(ribonucleoprotein complex)","03040(Spliceosome)",{"v":4.5e-05,"d":"0.00"},2,"12,138,","0,20616",-1.36,{"v":0.00676082975391982,"d":"0.01"},1.23,"3' UTR",23,136848004,136873425,25422,2]
["chrX",154397772,154398250,479,"ENSG00000147403","ENST00000424325","protein_coding",0,"RPL10","ribosomal protein L10 [Source:HGNC Symbol;Acc:HGNC:10298]","GO:0000027(ribosomal large subunit assembly);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0003723(RNA binding);GO:0003735(structural constituent of ribosome);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005783(endoplasmic reticulum);GO:0005790(smooth endoplasmic reticulum);GO:0005829(cytosol);GO:0005840(ribosome);GO:0006412(translation);GO:0006413(translational initiation);GO:0006417(regulation of translation);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0007275(multicellular organism development);GO:0016020(membrane);GO:0019083(viral transcription);GO:0022625(cytosolic large ribosomal subunit);GO:0032991(protein-containing complex);GO:0043066(negative regulation of apoptotic process);GO:0045182(translation regulator activity);GO:1990403(embryonic brain development)","03010(Ribosome)",{"v":7.9e-10,"d":"0.00"},1,"479,",0,{"v":-0.794,"d":"-0.79"},{"v":0.0398107170553497,"d":"0.04"},1.32,"5' UTR",23,154398230,154402339,4110,1]
["chr3",22381975,22382482,508,"ENSG00000132967","ENST00000255320","transcribed_processed_pseudogene",156,"HMGB1P5","high mobility group box 1 pseudogene 5 [Source:HGNC Symbol;Acc:HGNC:4997]","NA","NA",{"v":9.99999999999998e-259,"d":"0.00"},1,"508,",0,-7.22,{"v":1.41253754462276E-9,"d":"0.00"},1.17,"Exon (ENST00000255320/ENSG00000132967, exon 1 of 1)",3,22381819,22382460,642,1]
["chr4",1395605,1395992,388,"ENSG00000163945","ENST00000389851","protein_coding",48289,"UVSSA","UV stimulated scaffold protein A [Source:HGNC Symbol;Acc:HGNC:29304]","GO:0000993(RNA polymerase II complex binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006281(DNA repair);GO:0006283(transcription-coupled nucleotide-excision repair);GO:0006469(negative regulation of protein kinase activity);GO:0006974(cellular response to DNA damage stimulus);GO:0009411(response to UV);GO:0016020(membrane);GO:0016567(protein ubiquitination);GO:0033147(negative regulation of intracellular estrogen receptor signaling pathway);GO:0043627(response to estrogen);GO:0051493(regulation of cytoskeleton organization)","NA",{"v":2.1e-09,"d":"0.00"},1,"388,",0,-1.47,{"v":0.00478630092322639,"d":"0.00"},1.46,"3' UTR",4,1347316,1395989,48674,1]
["chr6",160093499,160094215,717,"ENSG00000197081","ENST00000356956","protein_coding",124400,"IGF2R","insulin like growth factor 2 receptor [Source:HGNC Symbol;Acc:HGNC:5467]","GO:0001889(liver development);GO:0001965(G-protein alpha-subunit binding);GO:0001972(retinoic acid binding);GO:0005010(insulin-like growth factor-activated receptor activity);GO:0005515(protein binding);GO:0005520(insulin-like growth factor binding);GO:0005537(mannose binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005641(nuclear envelope lumen);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0005768(endosome);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005925(focal adhesion);GO:0006892(post-Golgi vesicle-mediated transport);GO:0006898(receptor-mediated endocytosis);GO:0007041(lysosomal transport);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007283(spermatogenesis);GO:0009791(post-embryonic development);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019899(enzyme binding);GO:0030118(clathrin coat);GO:0030133(transport vesicle);GO:0030136(clathrin-coated vesicle);GO:0030139(endocytic vesicle);GO:0030140(trans-Golgi network transport vesicle);GO:0030665(clathrin-coated vesicle membrane);GO:0030667(secretory granule membrane);GO:0031100(animal organ regeneration);GO:0031995(insulin-like growth factor II binding);GO:0032526(response to retinoic acid);GO:0032588(trans-Golgi network membrane);GO:0036143(kringle domain binding);GO:0038023(signaling receptor activity);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0043312(neutrophil degranulation);GO:0048009(insulin-like growth factor receptor signaling pathway);GO:0048471(perinuclear region of cytoplasm);GO:0051219(phosphoprotein binding);GO:0061024(membrane organization);GO:0070062(extracellular exosome)","04142(Lysosome);04144(Endocytosis)",{"v":3.2E-13,"d":"0.00"},1,"717,",0,-1.66,{"v":0.00275422870333817,"d":"0.00"},1.88,"Exon (ENST00000569097/ENSG00000213073, exon 1 of 1)",6,159969099,160111504,142406,1]
["chr7",106660679,106661158,480,"ENSG00000253276","ENST00000523505","protein_coding",0,"CCDC71L","coiled-coil domain containing 71 like [Source:HGNC Symbol;Acc:HGNC:26685]","GO:0044255(cellular lipid metabolic process);GO:0045600(positive regulation of fat cell differentiation)","NA",{"v":1e-130,"d":"0.00"},1,"480,",0,-2.48,{"v":0.000281838293126446,"d":"0.00"},1.06,"5' UTR",7,106654360,106661158,6799,2]
["chr10",50658619,50660293,1675,"ENSG00000231345","ENST00000449695","processed_transcript",2652,"BEND3P1","BEN domain containing 3 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:45014]","NA","NA",{"v":4E-90,"d":"0.00"},1,"1675,",0,-4.41,{"v":1.69824365246175e-06,"d":"0.00"},1.15,"Exon (ENST00000449695/ENSG00000231345, exon 2 of 2)",10,50655967,50660268,4302,1]
["chr10",30047568,30047837,270,"ENSG00000165757","ENST00000375377","protein_coding",11749,"JCAD","junctional cadherin 5 associated [Source:HGNC Symbol;Acc:HGNC:29283]","GO:0005911(cell-cell junction);GO:0005912(adherens junction);GO:0007155(cell adhesion);GO:0030054(cell junction);GO:0032587(ruffle membrane);GO:0043410(positive regulation of MAPK cascade);GO:0048471(perinuclear region of cytoplasm);GO:0090050(positive regulation of cell migration involved in sprouting angiogenesis);GO:1900748(positive regulation of vascular endothelial growth factor signaling pathway);GO:1903589(positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis);GO:1903672(positive regulation of sprouting angiogenesis)","NA",{"v":0.00016,"d":"0.00"},1,"270,",0,-1.07,{"v":0.0162181009735893,"d":"0.02"},1.76,"5' UTR",10,30012803,30059586,46784,2]
["chr7",73194675,73196029,1355,"ENSG00000233369","ENST00000544802","processed_transcript",39737,"GTF2IP4","general transcription factor IIi pseudogene 4 [Source:HGNC Symbol;Acc:HGNC:51716]","NA","NA",{"v":7.9e-07,"d":"0.00"},3,"53,66,151,","0,961,1204",-3.51,{"v":1.77827941003892e-05,"d":"0.00"},5.61,"Exon (ENST00000544802/ENSG00000233369, exon 13 of 24)",7,73154938,73207283,52346,1]
["chr12",113816742,113817071,330,"ENSG00000122965","ENST00000553232","processed_transcript",1108,"RBM19","RNA binding motif protein 19 [Source:HGNC Symbol;Acc:HGNC:29098]","GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0007275(multicellular organism development);GO:0016020(membrane);GO:0016607(nuclear speck);GO:0040019(positive regulation of embryonic development);GO:0045292(mRNA cis splicing, via spliceosome)","NA",{"v":7.9e-36,"d":"0.00"},1,"330,",0,{"v":-0.805,"d":"-0.81"},{"v":0.0389045144994281,"d":"0.04"},1.08,"3' UTR",12,113816738,113818179,1442,2]
["chr16",16390855,16393954,3100,"ENSG00000214967","ENST00000530217","protein_coding",11800,"NPIPA7","nuclear pore complex interacting protein family member A7 [Source:HGNC Symbol;Acc:HGNC:41982]","GO:0005515(protein binding);GO:0005654(nucleoplasm)","NA",{"v":2.5e-24,"d":"0.00"},5,"20,61,36,70,499,","0,1036,1206,1738,2601",{"v":-14.9,"d":"-14.90"},{"v":7.94328234724279e-18,"d":"0.00"},{"v":5.7,"d":"5.70"},"3' UTR",16,16379055,16393954,14900,1]
["chr16",30395726,30395991,266,"ENSG00000180096","ENST00000570039","processed_transcript",0,"SEPT1","septin 1 [Source:HGNC Symbol;Acc:HGNC:2879]","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005815(microtubule organizing center);GO:0005856(cytoskeleton);GO:0005940(septin ring);GO:0007049(cell cycle);GO:0007056(spindle assembly involved in female meiosis);GO:0008021(synaptic vesicle);GO:0015630(microtubule cytoskeleton);GO:0017157(regulation of exocytosis);GO:0030496(midbody);GO:0031105(septin complex);GO:0032947(protein-containing complex scaffold activity);GO:0042802(identical protein binding);GO:0051301(cell division);GO:0051311(meiotic metaphase plate congression);GO:0061640(cytoskeleton-dependent cytokinesis);GO:0072687(meiotic spindle)","05100(Bacterial invasion of epithelial cells)",{"v":4e-37,"d":"0.00"},1,"266,",0,-1.01,{"v":0.0194984459975805,"d":"0.02"},1.55,"5' UTR",16,30382752,30395991,13240,2]
["chr16",89971878,89972266,389,"ENSG00000177946","ENST00000565150","transcribed_unitary_pseudogene",0,"CENPBD1","CENPB DNA-binding domain containing 1 [Source:HGNC Symbol;Acc:HGNC:28272]","GO:0003677(DNA binding);GO:0005634(nucleus)","NA",{"v":5.2e-09,"d":"0.00"},1,"389,",0,-1.28,{"v":0.00851138038202377,"d":"0.01"},1.31,"5' UTR",16,89969983,89971922,1940,2]
["chr16",89971872,89972262,391,"ENSG00000177946","ENST00000565150","transcribed_unitary_pseudogene",0,"CENPBD1","CENPB DNA-binding domain containing 1 [Source:HGNC Symbol;Acc:HGNC:28272]","GO:0003677(DNA binding);GO:0005634(nucleus)","NA",{"v":3.5e-09,"d":"0.00"},1,"391,",0,-1.12,{"v":0.0141253754462275,"d":"0.01"},{"v":1.2,"d":"1.20"},"5' UTR",16,89969983,89971922,1940,2]
["chr17",18272774,18273043,270,"ENSG00000177302","ENST00000493648","nonsense_mediated_decay",1915,"TOP3A","DNA topoisomerase III alpha [Source:HGNC Symbol;Acc:HGNC:11992]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003697(single-stranded DNA binding);GO:0003916(DNA topoisomerase activity);GO:0003917(DNA topoisomerase type I activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006260(DNA replication);GO:0006265(DNA topological change);GO:0008270(zinc ion binding);GO:0016605(PML body);GO:0016853(isomerase activity);GO:0032042(mitochondrial DNA metabolic process);GO:0046872(metal ion binding);GO:0051304(chromosome separation);GO:0051321(meiotic cell cycle);GO:1901796(regulation of signal transduction by p53 class mediator)","03440(Homologous recombination);03460(Fanconi anemia pathway)",{"v":1.5E-5,"d":"0.00"},1,"270,",0,-2.07,{"v":0.000870963589956081,"d":"0.00"},1.89,"3' UTR",17,18271428,18274958,3531,2]
["chr19",37738764,37755252,16489,"ENSG00000189144","ENST00000590674","processed_transcript",0,"ZNF573","zinc finger protein 573 [Source:HGNC Symbol;Acc:HGNC:26420]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","NA",{"v":3.2e-59,"d":"0.00"},3,"1431,70,52,","0,1877,16437",-2.54,{"v":0.000234422881531992,"d":"0.00"},{"v":1.1,"d":"1.10"},"3' UTR",19,37735833,37740138,4306,2]
["chr22",26513642,26514478,837,"ENSG00000261188","ENST00000566814","antisense",1105,"Z95115","novel transcript, antisense to TFIP11","NA","NA",{"v":4e-53,"d":"0.00"},1,"837,",0,{"v":-2.9,"d":"-2.90"},{"v":9.1201083935591e-05,"d":"0.00"},1.48,"Exon (ENST00000566814/ENSG00000261188, exon 1 of 1)",22,26512537,26514568,2032,1]
["chr6",16129086,16129235,150,"ENSG00000007944","ENST00000356840","protein_coding",0,"MYLIP","myosin regulatory light chain interacting protein [Source:HGNC Symbol;Acc:HGNC:21155]","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007399(nervous system development);GO:0008092(cytoskeletal protein binding);GO:0010977(negative regulation of neuron projection development);GO:0010989(negative regulation of low-density lipoprotein particle clearance);GO:0016020(membrane);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0031648(protein destabilization);GO:0032802(low-density lipoprotein particle receptor catabolic process);GO:0032803(regulation of low-density lipoprotein particle receptor catabolic process);GO:0042632(cholesterol homeostasis);GO:0045732(positive regulation of protein catabolic process);GO:0046872(metal ion binding);GO:0061630(ubiquitin protein ligase activity)","04979(Cholesterol metabolism)",{"v":0.00072,"d":"0.00"},1,"150,",0,-2.25,{"v":0.000524807460249772,"d":"0.00"},6.57,"5' UTR",6,16129086,16148248,19163,1]
["chr7",5900388,5900687,300,"ENSG00000122674","ENST00000461592","retained_intron",1663,"CCZ1","CCZ1 homolog, vacuolar protein trafficking and biogenesis associated [Source:HGNC Symbol;Acc:HGNC:21691]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0005829(cytosol);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0016235(aggresome);GO:0035658(Mon1-Ccz1 complex);GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":1.6e-08,"d":"0.00"},1,"300,",0,{"v":-10.7,"d":"-10.70"},{"v":2.51188643150958E-13,"d":"0.00"},6.57,"Exon (ENST00000461592/ENSG00000122674, exon 2 of 2)",7,5898725,5900633,1909,1]

{"sheet":"down-peak","index":1,"n_rows":793,"n_cols":24,"rows_kept":793}
["start","end","width","geneId","transcriptId","transcript_biotype","distanceToTSS","geneName","Description","GO","KEGG","score","blockCount","blockSizes","blockStarts","diff.lg.fdr","diff.p","diff.log2.fc","annotation","geneChr","geneStart","geneEnd","geneLength","geneStrand"]
[3437393,3437662,270,"ENSG00000142611","ENST00000270722","protein_coding",368190,"PRDM16","PR/SET domain 16 [Source:HGNC Symbol;Acc:HGNC:14000]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0016235(aggresome);GO:0017053(transcriptional repressor complex);GO:0018024(histone-lysine N-methyltransferase activity);GO:0019827(stem cell population maintenance);GO:0022008(neurogenesis);GO:0030154(cell differentiation);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0033613(activating transcription factor binding);GO:0034968(histone lysine methylation);GO:0035019(somatic stem cell population maintenance);GO:0043457(regulation of cellular respiration);GO:0043565(sequence-specific DNA binding);GO:0043586(tongue development);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046332(SMAD binding);GO:0046872(metal ion binding);GO:0046974(histone methyltransferase activity (H3-K9 specific));GO:0050872(white fat cell differentiation);GO:0050873(brown fat cell differentiation);GO:0051567(histone H3-K9 methylation);GO:0060021(roof of mouth development);GO:0070828(heterochromatin organization);GO:0090336(positive regulation of brown fat cell differentiation);GO:0120162(positive regulation of cold-induced thermogenesis)","04714(Thermogenesis)",{"v":2.6E-7,"d":"0.00"},1,"270,",0,{"v":-0.861,"d":"-0.86"},{"v":0.0323593656929628,"d":"0.03"},-1.39,"3' UTR",1,3069203,3438621,369419,1]
[9983795,9983975,181,"ENSG00000173614","ENST00000377205","protein_coding",40320,"NMNAT1","nicotinamide nucleotide adenylyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:17877]","GO:0000166(nucleotide binding);GO:0000309(nicotinamide-nucleotide adenylyltransferase activity);GO:0003824(catalytic activity);GO:0004515(nicotinate-nucleotide adenylyltransferase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0009058(biosynthetic process);GO:0009435(NAD biosynthetic process);GO:0009611(response to wounding);GO:0016604(nuclear body);GO:0016740(transferase activity);GO:0016779(nucleotidyltransferase activity);GO:0019363(pyridine nucleotide biosynthetic process);GO:0019674(NAD metabolic process);GO:0034628('de novo' NAD biosynthetic process from aspartate);GO:0042802(identical protein binding);GO:0043410(positive regulation of MAPK cascade);GO:0043524(negative regulation of neuron apoptotic process);GO:1902511(negative regulation of apoptotic DNA fragmentation);GO:1990966(ATP generation from poly-ADP-D-ribose)","00760(Nicotinate and nicotinamide metabolism)",{"v":2.3E-5,"d":"0.00"},1,"181,",0,{"v":-0.828,"d":"-0.83"},{"v":0.0354813389233576,"d":"0.04"},{"v":-1.5,"d":"-1.50"},"3' UTR",1,9943475,9985498,42024,1]
[12276158,12276637,480,"ENSG00000048707","ENST00000620676","protein_coding",46128,"VPS13D","vacuolar protein sorting 13 homolog D [Source:HGNC Symbol;Acc:HGNC:23595]","GO:0005515(protein binding);GO:0005623(cell);GO:0006623(protein targeting to vacuole);GO:0007005(mitochondrion organization);GO:0019898(extrinsic component of membrane);GO:0045053(protein retention in Golgi apparatus);GO:0070062(extracellular exosome);GO:1901526(positive regulation of mitophagy)","NA",{"v":6.8E-8,"d":"0.00"},1,"480,",0,-5.26,{"v":1.99526231496888E-7,"d":"0.00"},-1.27,"Exon (ENST00000620676/ENSG00000048707, exon 19 of 70)",1,12230030,12512047,282018,1]
[12282979,12283159,181,"ENSG00000048707","ENST00000620676","protein_coding",52949,"VPS13D","vacuolar protein sorting 13 homolog D [Source:HGNC Symbol;Acc:HGNC:23595]","GO:0005515(protein binding);GO:0005623(cell);GO:0006623(protein targeting to vacuole);GO:0007005(mitochondrion organization);GO:0019898(extrinsic component of membrane);GO:0045053(protein retention in Golgi apparatus);GO:0070062(extracellular exosome);GO:1901526(positive regulation of mitophagy)","NA",{"v":9.3e-10,"d":"0.00"},1,"181,",0,-3.59,{"v":1.44543977074593e-05,"d":"0.00"},{"v":-1.7,"d":"-1.70"},"Exon (ENST00000620676/ENSG00000048707, exon 21 of 70)",1,12230030,12512047,282018,1]
[16972664,16972934,271,"ENSG00000058453","ENST00000375541","protein_coding",50733,"CROCC","ciliary rootlet coiled-coil, rootletin [Source:HGNC Symbol;Acc:HGNC:21299]","GO:0001917(photoreceptor inner segment);GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005929(cilium);GO:0007049(cell cycle);GO:0007098(centrosome cycle);GO:0008104(protein localization);GO:0010457(centriole-centriole cohesion);GO:0010669(epithelial structure maintenance);GO:0015629(actin cytoskeleton);GO:0019894(kinesin binding);GO:0030030(cell projection organization);GO:0032053(ciliary basal body organization);GO:0033365(protein localization to organelle);GO:0035253(ciliary rootlet);GO:0042995(cell projection);GO:0045494(photoreceptor cell maintenance);GO:0045724(positive regulation of cilium assembly);GO:0051656(establishment of organelle localization);GO:0070062(extracellular exosome);GO:1903566(positive regulation of protein localization to cilium)","NA",{"v":4.2e-08,"d":"0.00"},1,"271,",0,{"v":-0.751,"d":"-0.75"},{"v":0.0467735141287198,"d":"0.05"},-1.77,"3' UTR",1,16921931,16972964,51034,1]
[22511772,22511922,151,"ENSG00000184677","ENST00000375647","protein_coding",59921,"ZBTB40","zinc finger and BTB domain containing 40 [Source:HGNC Symbol;Acc:HGNC:29045]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003674(molecular_function);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006974(cellular response to DNA damage stimulus);GO:0030282(bone mineralization);GO:0046872(metal ion binding)","NA",{"v":1.3E-7,"d":"0.00"},1,"151,",0,-5.15,{"v":2.63026799189538E-7,"d":"0.00"},-1.51,"Exon (ENST00000375647/ENSG00000184677, exon 11 of 18)",1,22451851,22531154,79304,1]
[26946601,26946871,271,"ENSG00000090273","ENST00000321265","protein_coding",24858,"NUDC","nuclear distribution C, dynein complex regulator [Source:HGNC Symbol;Acc:HGNC:8045]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0006457(protein folding);GO:0007049(cell cycle);GO:0007275(multicellular organism development);GO:0008283(cell population proliferation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032502(developmental process);GO:0045296(cadherin binding);GO:0051082(unfolded protein binding);GO:0051301(cell division)","NA",{"v":6.3e-11,"d":"0.00"},1,"271,",0,-1.37,{"v":0.00645654229034656,"d":"0.01"},-1.02,"3' UTR",1,26921743,26946871,25129,1]
[35295958,35361255,65298,"ENSG00000201542","ENST00000364672","snoRNA",0,"RF00091","NA","NA","NA",{"v":1E-167,"d":"0.00"},4,"31,46,522,62,","0,29402,62967,65236",-8.76,{"v":3.16227766016838E-11,"d":"0.00"},-1.09,"5' UTR",1,35310274,35310425,152,1]
[39387316,39387586,271,"ENSG00000127603","ENST00000567887","protein_coding",303254,"MACF1","microtubule-actin crosslinking factor 1 [Source:HGNC Symbol;Acc:HGNC:13664]","GO:0003723(RNA binding);GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005882(intermediate filament);GO:0005886(plasma membrane);GO:0007010(cytoskeleton organization);GO:0008017(microtubule binding);GO:0008092(cytoskeletal protein binding);GO:0010632(regulation of epithelial cell migration);GO:0015629(actin cytoskeleton);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0016887(ATPase activity);GO:0030054(cell junction);GO:0030177(positive regulation of Wnt signaling pathway);GO:0030334(regulation of cell migration);GO:0032587(ruffle membrane);GO:0032886(regulation of microtubule-based process);GO:0042060(wound healing);GO:0042995(cell projection);GO:0043001(Golgi to plasma membrane protein transport);GO:0045104(intermediate filament cytoskeleton organization);GO:0045296(cadherin binding);GO:0045773(positive regulation of axon extension);GO:0046872(metal ion binding);GO:0051011(microtubule minus-end binding);GO:0051015(actin filament binding);GO:0051893(regulation of focal adhesion assembly)","NA",{"v":4E-14,"d":"0.00"},1,"271,",0,-2.32,{"v":4.36515832240166E-4,"d":"0.00"},-1.19,"Exon (ENST00000567887/ENSG00000127603, exon 58 of 101)",1,39084062,39487177,403116,1]
[40495535,40496253,719,"ENSG00000187815","ENST00000372706","protein_coding",18245,"ZFP69","ZFP69 zinc finger protein [Source:HGNC Symbol;Acc:HGNC:24708]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006629(lipid metabolic process);GO:0019216(regulation of lipid metabolic process);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":1.6e-25,"d":"0.00"},1,"719,",0,{"v":-0.807,"d":"-0.81"},{"v":0.0380189396320561,"d":"0.04"},-1.04,"3' UTR",1,40477290,40496343,19054,1]
[5126686,5127015,330,"ENSG00000096968","ENST00000381652","protein_coding",141441,"JAK2","Janus kinase 2 [Source:HGNC Symbol;Acc:HGNC:6192]","GO:0000165(MAPK cascade);GO:0000166(nucleotide binding);GO:0000186(activation of MAPKK activity);GO:0002250(adaptive immune response);GO:0002376(immune system process);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004715(non-membrane spanning protein tyrosine kinase activity);GO:0005102(signaling receptor binding);GO:0005131(growth hormone receptor binding);GO:0005143(interleukin-12 receptor binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0005925(focal adhesion);GO:0006325(chromatin organization);GO:0006468(protein phosphorylation);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006979(response to oxidative stress);GO:0007165(signal transduction);GO:0007167(enzyme linked receptor protein signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0007259(receptor signaling pathway via JAK-STAT);GO:0007260(tyrosine phosphorylation of STAT protein);GO:0007498(mesoderm development);GO:0007596(blood coagulation);GO:0008022(protein C-terminus binding);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008631(intrinsic apoptotic signaling pathway in response to oxidative stress);GO:0009755(hormone-mediated signaling pathway);GO:0010667(negative regulation of cardiac muscle cell apoptotic process);GO:0010811(positive regulation of cell-substrate adhesion);GO:0012505(endomembrane system);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016363(nuclear matrix);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019221(cytokine-mediated signaling pathway);GO:0019901(protein kinase binding);GO:0020037(heme binding);GO:0022408(negative regulation of cell-cell adhesion);GO:0030041(actin filament polymerization);GO:0030154(cell differentiation);GO:0030218(erythrocyte differentiation);GO:0030335(positive regulation of cell migration);GO:0031103(axon regeneration);GO:0031702(type 1 angiotensin receptor binding);GO:0031904(endosome lumen);GO:0031959(mineralocorticoid receptor signaling pathway);GO:0032024(positive regulation of insulin secretion);GO:0032496(response to lipopolysaccharide);GO:0032516(positive regulation of phosphoprotein phosphatase activity);GO:0032731(positive regulation of interleukin-1 beta production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0033130(acetylcholine receptor binding);GO:0033194(response to hydroperoxide);GO:0033209(tumor necrosis factor-mediated signaling pathway);GO:0034612(response to tumor necrosis factor);GO:0035401(histone kinase activity (H3-Y41 specific));GO:0035409(histone H3-Y41 phosphorylation);GO:0035556(intracellular signal transduction);GO:0035722(interleukin-12-mediated signaling pathway);GO:0038155(interleukin-23-mediated signaling pathway);GO:0042169(SH2 domain binding);GO:0042393(histone binding);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042802(identical protein binding);GO:0042976(activation of Janus kinase activity);GO:0043065(positive regulation of apoptotic process);GO:0043388(positive regulation of DNA binding);GO:0043392(negative regulation of DNA binding);GO:0043524(negative regulation of neuron apoptotic process);GO:0043548(phosphatidylinositol 3-kinase binding);GO:0043560(insulin receptor substrate binding);GO:0045087(innate immune response);GO:0045121(membrane raft);GO:0045428(regulation of nitric oxide biosynthetic process);GO:0045429(positive regulation of nitric oxide biosynthetic process);GO:0045597(positive regulation of cell differentiation);GO:0045822(negative regulation of heart contraction);GO:0046425(regulation of receptor signaling pathway via JAK-STAT);GO:0046579(positive regulation of Ras protein signal transduction);GO:0046677(response to antibiotic);GO:0046777(protein autophosphorylation);GO:0046872(metal ion binding);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0050727(regulation of inflammatory response);GO:0050729(positive regulation of inflammatory response);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050804(modulation of chemical synaptic transmission);GO:0050867(positive regulation of cell activation);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051428(peptide hormone receptor binding);GO:0051770(positive regulation of nitric-oxide synthase biosynthetic process);GO:0060333(interferon-gamma-mediated signaling pathway);GO:0060334(regulation of interferon-gamma-mediated signaling pathway);GO:0060396(growth hormone receptor signaling pathway);GO:0060397(growth hormone receptor signaling pathway via JAK-STAT);GO:0060399(positive regulation of growth hormone receptor signaling pathway);GO:0060548(negative regulation of cell death);GO:0061180(mammary gland epithelium development);GO:0070102(interleukin-6-mediated signaling pathway);GO:0070106(interleukin-27-mediated signaling pathway);GO:0070671(response to interleukin-12);GO:0070757(interleukin-35-mediated signaling pathway);GO:0097191(extrinsic apoptotic signaling pathway);GO:0097296(activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway);GO:0098794(postsynapse);GO:0098978(glutamatergic synapse);GO:0099527(postsynapse to nucleus signaling pathway);GO:0120162(positive regulation of cold-induced thermogenesis);GO:1902728(positive regulation of growth factor dependent skeletal muscle satellite cell proliferation);GO:1904037(positive regulation of epithelial cell apoptotic process);GO:1904707(positive regulation of vascular smooth muscle cell proliferation)","01521(EGFR tyrosine kinase inhibitor resistance);04062(Chemokine signaling pathway);04151(PI3K-Akt signaling pathway);04217(Necroptosis);04550(Signaling pathways regulating pluripotency of stem cells);04630(Jak-STAT signaling pathway);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04725(Cholinergic synapse);04917(Prolactin signaling pathway);04920(Adipocytokine signaling pathway);04933(AGE-RAGE signaling pathway in diabetic complications);05140(Leishmaniasis);05145(Toxoplasmosis);05152(Tuberculosis);05161(Hepatitis B);05164(Influenza A);05167(Kaposi sarcoma-associated herpesvirus infection);05168(Herpes simplex virus 1 infection);05200(Pathways in cancer)",{"v":2.5e-20,"d":"0.00"},1,"330,",0,-0.84,{"v":0.0346736850452532,"d":"0.03"},-2,"3' UTR",9,4985245,5128183,142939,1]
[43603687,43604909,1223,"ENSG00000142949","ENST00000359947","protein_coding",72804,"PTPRF","protein tyrosine phosphatase, receptor type F [Source:HGNC Symbol;Acc:HGNC:9670]","GO:0004721(phosphoprotein phosphatase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0005001(transmembrane receptor protein tyrosine phosphatase activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006470(protein dephosphorylation);GO:0007155(cell adhesion);GO:0007185(transmembrane receptor protein tyrosine phosphatase signaling pathway);GO:0008201(heparin binding);GO:0010975(regulation of neuron projection development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016311(dephosphorylation);GO:0016477(cell migration);GO:0016787(hydrolase activity);GO:0016791(phosphatase activity);GO:0031102(neuron projection regeneration);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0035373(chondroitin sulfate proteoglycan binding);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0044877(protein-containing complex binding);GO:0048679(regulation of axon regeneration);GO:0050839(cell adhesion molecule binding);GO:0070062(extracellular exosome);GO:0099560(synaptic membrane adhesion);GO:1900121(negative regulation of receptor binding)","04514(Cell adhesion molecules (CAMs));04520(Adherens junction);04910(Insulin signaling pathway);04931(Insulin resistance)",{"v":1E-175,"d":"0.00"},2,"503,7,","0,1216",{"v":-51.3,"d":"-51.30"},{"v":5.01187233627276e-55,"d":"0.00"},-1.25,"Exon (ENST00000359947/ENSG00000142949, exon 16 of 34)",1,43530883,43623666,92784,1]
[43972532,43972711,180,"ENSG00000132768","ENST00000524776","nonsense_mediated_decay",2524,"DPH2","DPH2 homolog [Source:HGNC Symbol;Acc:HGNC:3004]","GO:0005515(protein binding);GO:0005829(cytosol);GO:0016740(transferase activity);GO:0017183(peptidyl-diphthamide biosynthetic process from peptidyl-histidine);GO:0090560(2-(3-amino-3-carboxypropyl)histidine synthase activity)","NA",{"v":4.7E-7,"d":"0.00"},1,"180,",0,-3.47,{"v":1.99526231496888E-5,"d":"0.00"},-1.35,"3' UTR",1,43970008,43972721,2714,1]
[563059,563419,361,"ENSG00000139044","ENST00000266383","protein_coding",102695,"B4GALNT3","beta-1,4-N-acetyl-galactosaminyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:24137]","GO:0005794(Golgi apparatus);GO:0008376(acetylgalactosaminyltransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0032580(Golgi cisterna membrane);GO:0033842(N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity)","NA",{"v":1.7E-5,"d":"0.00"},1,"361,",0,-1.03,{"v":0.0186208713666287,"d":"0.02"},-2.01,"3' UTR",12,460364,563509,103146,1]
[46513599,46513808,210,"ENSG00000197587","ENST00000371956","protein_coding",6603,"DMBX1","diencephalon/mesencephalon homeobox 1 [Source:HGNC Symbol;Acc:HGNC:19026]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0007417(central nervous system development);GO:0007420(brain development);GO:0008343(adult feeding behavior);GO:0008344(adult locomotory behavior);GO:0042803(protein homodimerization activity);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046982(protein heterodimerization activity);GO:0048589(developmental growth)","NA",{"v":2.3E-5,"d":"0.00"},1,"210,",0,-1.14,{"v":0.0131825673855641,"d":"0.01"},-1.09,"3' UTR",1,46506996,46514212,7217,1]
[131177736,131178946,1211,"ENSG00000230450","ENST00000425793","processed_pseudogene",0,"NEK2P4","NEK2 pseudogene 4 [Source:HGNC Symbol;Acc:HGNC:37818]","NA","NA",{"v":5.2e-09,"d":"0.00"},1,"1211,",0,-1.29,{"v":0.00812830516164099,"d":"0.01"},-2.02,"Exon (ENST00000425793/ENSG00000230450, exon 1 of 1)",2,131177618,131178946,1329,2]
[64831020,64831319,300,"ENSG00000162437","ENST00000294428","protein_coding",85925,"RAVER2","ribonucleoprotein, PTB binding 2 [Source:HGNC Symbol;Acc:HGNC:25577]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm)","NA",{"v":5e-29,"d":"0.00"},1,"300,",0,-5.91,{"v":3.71535229097173e-08,"d":"0.00"},-1.15,"3' UTR",1,64745095,64833229,88135,1]
[75724706,75728486,3781,"ENSG00000117054","ENST00000526129","nonsense_mediated_decay",0,"ACADM","acyl-CoA dehydrogenase medium chain [Source:HGNC Symbol;Acc:HGNC:89]","GO:0001889(liver development);GO:0003995(acyl-CoA dehydrogenase activity);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005978(glycogen biosynthetic process);GO:0006082(organic acid metabolic process);GO:0006111(regulation of gluconeogenesis);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0006635(fatty acid beta-oxidation);GO:0007507(heart development);GO:0009409(response to cold);GO:0009437(carnitine metabolic process);GO:0009791(post-embryonic development);GO:0016491(oxidoreductase activity);GO:0016607(nuclear speck);GO:0016627(oxidoreductase activity, acting on the CH-CH group of donors);GO:0019216(regulation of lipid metabolic process);GO:0019254(carnitine metabolic process, CoA-linked);GO:0030424(axon);GO:0031966(mitochondrial membrane);GO:0033539(fatty acid beta-oxidation using acyl-CoA dehydrogenase);GO:0042594(response to starvation);GO:0042802(identical protein binding);GO:0045329(carnitine biosynthetic process);GO:0050660(flavin adenine dinucleotide binding);GO:0051791(medium-chain fatty acid metabolic process);GO:0051793(medium-chain fatty acid catabolic process);GO:0055007(cardiac muscle cell differentiation);GO:0055114(oxidation-reduction process);GO:0070991(medium-chain-acyl-CoA dehydrogenase activity)","00071(Fatty acid degradation);00280(Valine, leucine and isoleucine degradation);00410(beta-Alanine metabolism);00640(Propanoate metabolism);03320(PPAR signaling pathway)",{"v":3E-9,"d":"0.00"},2,"112,98,","0,3683",-2.46,{"v":0.000295120922666638,"d":"0.00"},-1.15,"5' UTR",1,75724706,75761615,36910,1]
[77926825,77931704,4880,"ENSG00000162614","ENST00000480732","processed_transcript",0,"NEXN","nexilin F-actin binding protein [Source:HGNC Symbol;Acc:HGNC:29557]","GO:0003779(actin binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005912(adherens junction);GO:0005925(focal adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007411(axon guidance);GO:0008307(structural constituent of muscle);GO:0009617(response to bacterium);GO:0030018(Z disc);GO:0030054(cell junction);GO:0030334(regulation of cell migration);GO:0030424(axon);GO:0051015(actin filament binding);GO:0051493(regulation of cytoskeleton organization);GO:0070593(dendrite self-avoidance);GO:0098632(cell-cell adhesion mediator activity)","NA",{"v":7.1e-07,"d":"0.00"},3,"68,189,43,","0,2491,4837",{"v":-0.866,"d":"-0.87"},{"v":0.0316227766016838,"d":"0.03"},{"v":-1.5,"d":"-1.50"},"Exon (ENST00000401035/ENSG00000162614, exon 7 of 9)",1,77931662,77943199,11538,1]
[81989690,81991807,2118,"ENSG00000117114","ENST00000370721","protein_coding",683524,"ADGRL2","adhesion G protein-coupled receptor L2 [Source:HGNC Symbol;Acc:HGNC:18582]","GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005887(integral component of plasma membrane);GO:0007165(signal transduction);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0007420(brain development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016524(latrotoxin receptor activity);GO:0030246(carbohydrate binding);GO:0043005(neuron projection)","NA",{"v":5e-24,"d":"0.00"},2,"20,1417,","0,701",{"v":-1.6,"d":"-1.60"},{"v":3.31131121482591E-3,"d":"0.00"},-1.06,"3' UTR",1,81306166,81991368,685203,1]
[92063148,92063358,211,"ENSG00000172031","ENST00000370383","protein_coding",33163,"EPHX4","epoxide hydrolase 4 [Source:HGNC Symbol;Acc:HGNC:23758]","GO:0003824(catalytic activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity)","NA",{"v":5.9e-09,"d":"0.00"},1,"211,",0,-1,{"v":0.0204173794466953,"d":"0.02"},-1.72,"3' UTR",1,92029985,92063538,33554,1]
[92387436,92388065,630,"ENSG00000122484","ENST00000610020","protein_coding",88377,"RPAP2","RNA polymerase II associated protein 2 [Source:HGNC Symbol;Acc:HGNC:25791]","GO:0004721(phosphoprotein phosphatase activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008420(RNA polymerase II CTD heptapeptide repeat phosphatase activity);GO:0009301(snRNA transcription);GO:0016591(RNA polymerase II, holoenzyme);GO:0016787(hydrolase activity);GO:0042795(snRNA transcription by RNA polymerase II);GO:0043175(RNA polymerase core enzyme binding);GO:0046872(metal ion binding);GO:0070940(dephosphorylation of RNA polymerase II C-terminal domain)","NA",{"v":7.9e-21,"d":"0.00"},1,"630,",0,-1.01,{"v":0.0194984459975805,"d":"0.02"},-1.86,"3' UTR",1,92299059,92402056,102998,1]
[110201873,110202202,330,"ENSG00000197106","ENST00000331565","protein_coding",51379,"SLC6A17","solute carrier family 6 member 17 [Source:HGNC Symbol;Acc:HGNC:31399]","GO:0005328(neurotransmitter:sodium symporter activity);GO:0005887(integral component of plasma membrane);GO:0006836(neurotransmitter transport);GO:0007420(brain development);GO:0008021(synaptic vesicle);GO:0015293(symporter activity);GO:0015804(neutral amino acid transport);GO:0015816(glycine transport);GO:0015820(leucine transport);GO:0015824(proline transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030054(cell junction);GO:0030285(integral component of synaptic vesicle membrane);GO:0030672(synaptic vesicle membrane);GO:0031410(cytoplasmic vesicle);GO:0032328(alanine transport);GO:0045202(synapse);GO:0055085(transmembrane transport);GO:0098978(glutamatergic synapse);GO:0098982(GABA-ergic synapse)","NA",{"v":1e-12,"d":"0.00"},1,"330,",0,-1.49,{"v":0.00457088189614875,"d":"0.00"},-1.12,"3' UTR",1,110150494,110202202,51709,1]
[117367808,117405573,37766,"ENSG00000198162","ENST00000482811","processed_transcript",0,"MAN1A2","mannosidase alpha class 1A member 2 [Source:HGNC Symbol;Acc:HGNC:6822]","GO:0000139(Golgi membrane);GO:0003824(catalytic activity);GO:0004571(mannosyl-oligosaccharide 1,2-alpha-mannosidase activity);GO:0005509(calcium ion binding);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0006491(N-glycan processing);GO:0007585(respiratory gaseous exchange);GO:0008152(metabolic process);GO:0009100(glycoprotein metabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0016798(hydrolase activity, acting on glycosyl bonds);GO:0046872(metal ion binding);GO:0048286(lung alveolus development);GO:0070062(extracellular exosome);GO:1904381(Golgi apparatus mannose trimming)","00510(N-Glycan biosynthesis);04141(Protein processing in endoplasmic reticulum)",{"v":5e-31,"d":"0.00"},3,"678,256,25,","0,34378,37741",-8.85,{"v":2.51188643150958e-11,"d":"0.00"},{"v":-1.1,"d":"-1.10"},"5' UTR",1,117367943,117420630,52688,1]
[144063339,144068350,5012,"ENSG00000270872","ENST00000605551","unprocessed_pseudogene",88252,"SRGAP2D","SLIT-ROBO Rho GTPase activating protein 2D (pseudogene) [Source:HGNC Symbol;Acc:HGNC:43932]","NA","NA",{"v":1.6E-11,"d":"0.00"},3,"56,102,222,","0,3662,4790",-0.95,{"v":0.0239883291901949,"d":"0.02"},-1.05,"Exon (ENST00000605551/ENSG00000270872, exon 5 of 7)",1,143975087,144068350,93264,1]
[134253145,134254088,944,"ENSG00000152127","ENST00000281923","protein_coding",0,"MGAT5","alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase [Source:HGNC Symbol;Acc:HGNC:7049]","GO:0000139(Golgi membrane);GO:0004864(protein phosphatase inhibitor activity);GO:0005576(extracellular region);GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0006487(protein N-linked glycosylation);GO:0008375(acetylglucosaminyltransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0018279(protein N-linked glycosylation via asparagine);GO:0030144(alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity);GO:0030145(manganese ion binding);GO:0030335(positive regulation of cell migration);GO:0070062(extracellular exosome);GO:1903614(negative regulation of protein tyrosine phosphatase activity);GO:1904894(positive regulation of receptor signaling pathway via STAT)","00510(N-Glycan biosynthesis)",{"v":0.0052,"d":"0.01"},2,"74,17,","0,927",-2.04,{"v":0.000933254300796991,"d":"0.00"},-2.03,"5' UTR",2,134254072,134454621,200550,1]
[150067309,150067638,330,"ENSG00000136631","ENST00000369130","protein_coding",0,"VPS45","vacuolar protein sorting 45 homolog [Source:HGNC Symbol;Acc:HGNC:14579]","GO:0000139(Golgi membrane);GO:0003674(molecular_function);GO:0005515(protein binding);GO:0005575(cellular_component);GO:0005768(endosome);GO:0005794(Golgi apparatus);GO:0006886(intracellular protein transport);GO:0006904(vesicle docking involved in exocytosis);GO:0007596(blood coagulation);GO:0008021(synaptic vesicle);GO:0010008(endosome membrane);GO:0015031(protein transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016192(vesicle-mediated transport)","04144(Endocytosis)",{"v":4e-11,"d":"0.00"},1,"330,",0,{"v":-1.2,"d":"-1.20"},{"v":0.0109647819614319,"d":"0.01"},{"v":-1.4,"d":"-1.40"},"5' UTR",1,150067312,150145327,78016,1]
[150145269,150145329,61,"ENSG00000136631","ENST00000535106","protein_coding",77976,"VPS45","vacuolar protein sorting 45 homolog [Source:HGNC Symbol;Acc:HGNC:14579]","GO:0000139(Golgi membrane);GO:0003674(molecular_function);GO:0005515(protein binding);GO:0005575(cellular_component);GO:0005768(endosome);GO:0005794(Golgi apparatus);GO:0006886(intracellular protein transport);GO:0006904(vesicle docking involved in exocytosis);GO:0007596(blood coagulation);GO:0008021(synaptic vesicle);GO:0010008(endosome membrane);GO:0015031(protein transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016192(vesicle-mediated transport)","04144(Endocytosis)",{"v":8.3e-05,"d":"0.00"},1,"61,",0,{"v":-0.778,"d":"-0.78"},{"v":0.0426579518801593,"d":"0.04"},-1.33,"3' UTR",1,150067293,150145326,78034,1]
[150560339,150560429,91,"ENSG00000143382","ENST00000271643","protein_coding",10970,"ADAMTSL4","ADAMTS like 4 [Source:HGNC Symbol;Acc:HGNC:19706]","GO:0002020(protease binding);GO:0002064(epithelial cell development);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005614(interstitial matrix);GO:0005788(endoplasmic reticulum lumen);GO:0006508(proteolysis);GO:0006915(apoptotic process);GO:0008233(peptidase activity);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0043065(positive regulation of apoptotic process);GO:0062023(collagen-containing extracellular matrix)","NA",{"v":6.8e-05,"d":"0.00"},1,"91,",0,{"v":-1.3,"d":"-1.30"},{"v":0.00794328234724281,"d":"0.01"},-1.31,"3' UTR",1,150549369,150560932,11564,1]
[151070638,151073131,2494,"ENSG00000143458","ENST00000368918","protein_coding",0,"GABPB2","GA binding protein transcription factor subunit beta 2 [Source:HGNC Symbol;Acc:HGNC:28441]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0042803(protein homodimerization activity);GO:0044212(transcription regulatory region DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046982(protein heterodimerization activity)","NA",{"v":2e-11,"d":"0.00"},2,"297,93,","0,2401",-1.42,{"v":0.00549540873857625,"d":"0.01"},-1.11,"5' UTR",1,151070761,151125542,54782,1]
[151234206,151234296,91,"ENSG00000143398","ENST00000349792","protein_coding",35655,"PIP5K1A","phosphatidylinositol-4-phosphate 5-kinase type 1 alpha [Source:HGNC Symbol;Acc:HGNC:8994]","GO:0000166(nucleotide binding);GO:0001726(ruffle);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005847(mRNA cleavage and polyadenylation specificity factor complex);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006650(glycerophospholipid metabolic process);GO:0006661(phosphatidylinositol biosynthetic process);GO:0006909(phagocytosis);GO:0007165(signal transduction);GO:0008654(phospholipid biosynthetic process);GO:0010761(fibroblast migration);GO:0014066(regulation of phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0016301(kinase activity);GO:0016307(phosphatidylinositol phosphate kinase activity);GO:0016308(1-phosphatidylinositol-4-phosphate 5-kinase activity);GO:0016310(phosphorylation);GO:0016477(cell migration);GO:0016607(nuclear speck);GO:0016740(transferase activity);GO:0019900(kinase binding);GO:0030027(lamellipodium);GO:0030216(keratinocyte differentiation);GO:0031532(actin cytoskeleton reorganization);GO:0032587(ruffle membrane);GO:0042995(cell projection);GO:0046488(phosphatidylinositol metabolic process);GO:0046854(phosphatidylinositol phosphorylation);GO:0048041(focal adhesion assembly);GO:0060326(cell chemotaxis);GO:0072659(protein localization to plasma membrane);GO:0090630(activation of GTPase activity);GO:0097178(ruffle assembly)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system);04072(Phospholipase D signaling pathway);04144(Endocytosis);04666(Fc gamma R-mediated phagocytosis);04810(Regulation of actin cytoskeleton);05231(Choline metabolism in cancer)",{"v":7.6e-06,"d":"0.00"},1,"91,",0,-9.34,{"v":7.94328234724282e-12,"d":"0.00"},-1.13,"Exon (ENST00000349792/ENSG00000143398, exon 7 of 15)",1,151198551,151249536,50986,1]
[155282632,155282781,150,"ENSG00000143630","ENST00000368358","protein_coding",5169,"HCN3","hyperpolarization activated cyclic nucleotide gated potassium channel 3 [Source:HGNC Symbol;Acc:HGNC:19183]","GO:0000166(nucleotide binding);GO:0005216(ion channel activity);GO:0005244(voltage-gated ion channel activity);GO:0005248(voltage-gated sodium channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005267(potassium channel activity);GO:0005272(sodium channel activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0006814(sodium ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030424(axon);GO:0030425(dendrite);GO:0030552(cAMP binding);GO:0034765(regulation of ion transmembrane transport);GO:0035725(sodium ion transmembrane transport);GO:0042391(regulation of membrane potential);GO:0043025(neuronal cell body);GO:0044316(cone cell pedicle);GO:0045202(synapse);GO:0055085(transmembrane transport);GO:0071805(potassium ion transmembrane transport);GO:0072718(response to cisplatin);GO:1903351(cellular response to dopamine)","NA",{"v":0.0013,"d":"0.00"},1,"150,",0,{"v":-0.839,"d":"-0.84"},{"v":0.0346736850452532,"d":"0.03"},-1.26,"Exon (ENST00000368358/ENSG00000143630, exon 2 of 8)",1,155277463,155289848,12386,1]
[163343837,163345971,2135,"ENSG00000143228","ENST00000524800","protein_coding",21937,"NUF2","NDC80 kinetochore complex component NUF2 [Source:HGNC Symbol;Acc:HGNC:14621]","GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000777(condensed chromosome kinetochore);GO:0000778(condensed nuclear chromosome kinetochore);GO:0003674(molecular_function);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0005829(cytosol);GO:0007049(cell cycle);GO:0007052(mitotic spindle organization);GO:0007059(chromosome segregation);GO:0016020(membrane);GO:0031262(Ndc80 complex);GO:0044877(protein-containing complex binding);GO:0045132(meiotic chromosome segregation);GO:0051301(cell division);GO:0051315(attachment of mitotic spindle microtubules to kinetochore);GO:0051383(kinetochore organization)","NA",{"v":3.2e-18,"d":"0.00"},2,"34,294,","0,1841",-1.95,{"v":1.20226443461741E-3,"d":"0.00"},-1.06,"3' UTR",1,163321900,163355727,33828,1]
[173733727,173734324,598,"ENSG00000076321","ENST00000479505","processed_transcript",18786,"KLHL20","kelch like family member 20 [Source:HGNC Symbol;Acc:HGNC:25056]","GO:0003779(actin binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0006895(Golgi to endosome transport);GO:0007010(cytoskeleton organization);GO:0015031(protein transport);GO:0015629(actin cytoskeleton);GO:0016567(protein ubiquitination);GO:0016605(PML body);GO:0019964(interferon-gamma binding);GO:0030424(axon);GO:0030425(dendrite);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0035455(response to interferon-alpha);GO:0042995(cell projection);GO:0043066(negative regulation of apoptotic process);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0043687(post-translational protein modification);GO:0048471(perinuclear region of cytoplasm);GO:1990390(protein K33-linked ubiquitination)","NA",{"v":5e-78,"d":"0.00"},1,"598,",0,{"v":-13.8,"d":"-13.80"},{"v":1.25892541179417e-16,"d":"0.00"},-1.44,"Exon (ENST00000479505/ENSG00000076321, exon 4 of 4)",1,173714941,173733828,18888,1]
[178441564,178443131,1568,"ENSG00000075391","ENST00000367649","protein_coding",347423,"RASAL2","RAS protein activator like 2 [Source:HGNC Symbol;Acc:HGNC:9874]","GO:0000165(MAPK cascade);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0007165(signal transduction);GO:0043087(regulation of GTPase activity);GO:0043547(positive regulation of GTPase activity)","04014(Ras signaling pathway)",{"v":3.2e-32,"d":"0.00"},2,"84,457,","0,1111",-8.47,{"v":6.30957344480194e-11,"d":"0.00"},-1.32,"Exon (ENST00000367649/ENSG00000075391, exon 7 of 18)",1,178094141,178473422,379282,1]
[180094282,180095825,1544,"ENSG00000135837","ENST00000496440","processed_transcript",0,"CEP350","centrosomal protein 350 [Source:HGNC Symbol;Acc:HGNC:24238]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005815(microtubule organizing center);GO:0005819(spindle);GO:0005856(cytoskeleton);GO:0008017(microtubule binding);GO:0016020(membrane);GO:0034453(microtubule anchoring);GO:0042995(cell projection)","NA",{"v":2.5e-22,"d":"0.00"},3,"335,52,303,","0,865,1241",-3.29,{"v":3.23593656929628e-05,"d":"0.00"},-1.77,"Exon (ENST00000367607/ENSG00000135837, exon 34 of 38)",1,180095147,180111031,15885,1]
[203847259,203848352,1094,"ENSG00000058673","ENST00000453771","protein_coding",51605,"ZC3H11A","zinc finger CCCH-type containing 11A [Source:HGNC Symbol;Acc:HGNC:29093]","GO:0000346(transcription export complex);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0006405(RNA export from nucleus);GO:0006406(mRNA export from nucleus);GO:0016973(poly(A)+ mRNA export from nucleus);GO:0031124(mRNA 3'-end processing);GO:0046872(metal ion binding);GO:0051028(mRNA transport)","NA",{"v":4E-50,"d":"0.00"},2,"429,22,","0,1072",{"v":-24.5,"d":"-24.50"},{"v":1.25892541179417E-27,"d":"0.00"},-1.14,"3' UTR",1,203795654,203847687,52034,1]
[203852242,203852631,390,"ENSG00000058673","ENST00000367210","protein_coding",56582,"ZC3H11A","zinc finger CCCH-type containing 11A [Source:HGNC Symbol;Acc:HGNC:29093]","GO:0000346(transcription export complex);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0006405(RNA export from nucleus);GO:0006406(mRNA export from nucleus);GO:0016973(poly(A)+ mRNA export from nucleus);GO:0031124(mRNA 3'-end processing);GO:0046872(metal ion binding);GO:0051028(mRNA transport)","NA",{"v":2e-94,"d":"0.00"},1,"390,",0,-12,{"v":1E-14,"d":"0.00"},-1.16,"3' UTR",1,203795660,203854121,58462,1]
[203847283,203848345,1063,"ENSG00000058673","ENST00000453771","protein_coding",51629,"ZC3H11A","zinc finger CCCH-type containing 11A [Source:HGNC Symbol;Acc:HGNC:29093]","GO:0000346(transcription export complex);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0006405(RNA export from nucleus);GO:0006406(mRNA export from nucleus);GO:0016973(poly(A)+ mRNA export from nucleus);GO:0031124(mRNA 3'-end processing);GO:0046872(metal ion binding);GO:0051028(mRNA transport)","NA",{"v":4E-50,"d":"0.00"},2,"405,15,","0,1048",{"v":-24.3,"d":"-24.30"},{"v":1.99526231496888e-27,"d":"0.00"},-1.18,"3' UTR",1,203795654,203847687,52034,1]
[203852246,203852635,390,"ENSG00000058673","ENST00000367210","protein_coding",56586,"ZC3H11A","zinc finger CCCH-type containing 11A [Source:HGNC Symbol;Acc:HGNC:29093]","GO:0000346(transcription export complex);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0006405(RNA export from nucleus);GO:0006406(mRNA export from nucleus);GO:0016973(poly(A)+ mRNA export from nucleus);GO:0031124(mRNA 3'-end processing);GO:0046872(metal ion binding);GO:0051028(mRNA transport)","NA",{"v":7.9E-94,"d":"0.00"},1,"390,",0,{"v":-11.9,"d":"-11.90"},{"v":1.25892541179417e-14,"d":"0.00"},-1.16,"3' UTR",1,203795660,203854121,58462,1]
[205530687,205531565,879,"ENSG00000117266","ENST00000429964","protein_coding",26092,"CDK18","cyclin dependent kinase 18 [Source:HGNC Symbol;Acc:HGNC:8751]","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004693(cyclin-dependent protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005575(cellular_component);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0051726(regulation of cell cycle)","NA",{"v":3.2e-07,"d":"0.00"},2,"19,222,","0,657",-3.67,{"v":1.17489755493953e-05,"d":"0.00"},-1.24,"3' UTR",1,205504595,205531378,26784,1]
[209836925,209837075,151,"ENSG00000117597","ENST00000491415","protein_coding",8953,"UTP25","UTP25, small subunit processor component [Source:HGNC Symbol;Acc:HGNC:28440]","GO:0000462(maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0007275(multicellular organism development);GO:0019843(rRNA binding);GO:0030163(protein catabolic process);GO:0031648(protein destabilization);GO:0032040(small-subunit processome);GO:0034511(U3 snoRNA binding);GO:0040019(positive regulation of embryonic development)","NA",{"v":1e-05,"d":"0.00"},1,"151,",0,-1.59,{"v":0.00338844156139203,"d":"0.00"},-1.04,"Exon (ENST00000491415/ENSG00000117597, exon 6 of 12)",1,209827972,209857565,29594,1]
[214603195,214615085,11891,"ENSG00000117724","ENST00000464322","processed_transcript",0,"CENPF","centromere protein F [Source:HGNC Symbol;Acc:HGNC:1857]","GO:0000278(mitotic cell cycle);GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000777(condensed chromosome kinetochore);GO:0000785(chromatin);GO:0000922(spindle pole);GO:0000940(condensed chromosome outer kinetochore);GO:0001822(kidney development);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005819(spindle);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005930(axoneme);GO:0007049(cell cycle);GO:0007059(chromosome segregation);GO:0007094(mitotic spindle assembly checkpoint);GO:0007275(multicellular organism development);GO:0007517(muscle organ development);GO:0008022(protein C-terminus binding);GO:0008134(transcription factor binding);GO:0008283(cell population proliferation);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0015031(protein transport);GO:0016202(regulation of striated muscle tissue development);GO:0016363(nuclear matrix);GO:0021591(ventricular system development);GO:0030154(cell differentiation);GO:0030496(midbody);GO:0036064(ciliary basal body);GO:0042493(response to drug);GO:0042803(protein homodimerization activity);GO:0045120(pronucleus);GO:0045892(negative regulation of transcription, DNA-templated);GO:0048471(perinuclear region of cytoplasm);GO:0051301(cell division);GO:0051310(metaphase plate congression);GO:0051382(kinetochore assembly);GO:0051726(regulation of cell cycle);GO:0070840(dynein complex binding);GO:0071897(DNA biosynthetic process);GO:0097539(ciliary transition fiber)","NA",{"v":2.5E-15,"d":"0.00"},4,"127,165,203,254,","0,289,10519,11637",-1.41,{"v":0.00588843655355589,"d":"0.01"},-1.03,"5' UTR",1,214603195,214615190,11996,1]
[222665311,222665701,391,"ENSG00000154305","ENST00000344922","protein_coding",47214,"MIA3","MIA SH3 domain ER export factor 3 [Source:HGNC Symbol;Acc:HGNC:24008]","GO:0000139(Golgi membrane);GO:0002042(cell migration involved in sprouting angiogenesis);GO:0002687(positive regulation of leukocyte migration);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005788(endoplasmic reticulum lumen);GO:0005789(endoplasmic reticulum membrane);GO:0006887(exocytosis);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0007029(endoplasmic reticulum organization);GO:0007162(negative regulation of cell adhesion);GO:0009306(protein secretion);GO:0015031(protein transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016192(vesicle-mediated transport);GO:0030336(negative regulation of cell migration);GO:0042060(wound healing);GO:0042953(lipoprotein transport);GO:0042954(lipoprotein transporter activity);GO:0043231(intracellular membrane-bounded organelle);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process);GO:0070971(endoplasmic reticulum exit site);GO:0070973(protein localization to endoplasmic reticulum exit site);GO:0090110(COPII-coated vesicle cargo loading);GO:0140052(cellular response to oxidised low-density lipoprotein particle stimulus);GO:1903038(negative regulation of leukocyte cell-cell adhesion);GO:2000402(negative regulation of lymphocyte migration)","NA",{"v":3.2E-51,"d":"0.00"},1,"391,",0,-7.43,{"v":8.51138038202376e-10,"d":"0.00"},-1.38,"3' UTR",1,222618097,222668007,49911,1]
[229637904,229638234,331,"ENSG00000135763","ENST00000258243","protein_coding",11657,"URB2","URB2 ribosome biogenesis homolog [Source:HGNC Symbol;Acc:HGNC:28967]","GO:0005634(nucleus);GO:0005730(nucleolus);GO:0016235(aggresome);GO:0030496(midbody);GO:0042254(ribosome biogenesis)","NA",{"v":7.9e-24,"d":"0.00"},1,"331,",0,-1.88,{"v":0.00147910838816821,"d":"0.00"},-1.17,"Exon (ENST00000258243/ENSG00000135763, exon 4 of 10)",1,229626247,229660200,33954,1]
[230543809,230544408,600,"ENSG00000067066","ENST00000340126","protein_coding",127608,"SP100","SP100 nuclear antigen [Source:HGNC Symbol;Acc:HGNC:11206]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000723(telomere maintenance);GO:0000784(nuclear chromosome, telomeric region);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006978(DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator);GO:0010596(negative regulation of endothelial cell migration);GO:0016032(viral process);GO:0016604(nuclear body);GO:0016605(PML body);GO:0019900(kinase binding);GO:0019904(protein domain specific binding);GO:0030870(Mre11 complex);GO:0034340(response to type I interferon);GO:0034341(response to interferon-gamma);GO:0043392(negative regulation of DNA binding);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0045185(maintenance of protein location);GO:0045765(regulation of angiogenesis);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046826(negative regulation of protein export from nucleus);GO:0046872(metal ion binding);GO:0046983(protein dimerization activity);GO:0051271(negative regulation of cellular component movement);GO:0060333(interferon-gamma-mediated signaling pathway);GO:0060337(type I interferon signaling pathway);GO:0070087(chromo shadow domain binding);GO:1902041(regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902044(regulation of Fas signaling pathway)","05168(Herpes simplex virus 1 infection);05203(Viral carcinogenesis)",{"v":6.3e-20,"d":"0.00"},1,"600,",0,{"v":-0.885,"d":"-0.89"},{"v":0.0295120922666639,"d":"0.03"},-2.03,"3' UTR",2,230416201,230545606,129406,1]
[68135400,68135935,536,"ENSG00000267352","ENST00000590010","processed_pseudogene",0,"SH3GL1P3","SH3 domain containing GRB2 like 1, endophilin A2 pseudogene 3 [Source:HGNC Symbol;Acc:HGNC:10837]","NA","NA",{"v":4e-12,"d":"0.00"},1,"536,",0,-1.01,{"v":0.0194984459975805,"d":"0.02"},-2.03,"Exon (ENST00000622750/ENSG00000277476, exon 1 of 1)",17,68134675,68135604,930,2]
[236550734,236551003,270,"ENSG00000116977","ENST00000526589","protein_coding",32461,"LGALS8","galectin 8 [Source:HGNC Symbol;Acc:HGNC:6569]","GO:0005178(integrin binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006914(autophagy);GO:0016020(membrane);GO:0030246(carbohydrate binding);GO:0031410(cytoplasmic vesicle);GO:0098586(cellular response to virus);GO:0098792(xenophagy);GO:1904977(lymphatic endothelial cell migration)","NA",{"v":1.9e-10,"d":"0.00"},1,"270,",0,-4.76,{"v":6.91830970918936e-07,"d":"0.00"},-1.13,"3' UTR",1,236518273,236552981,34709,1]
[241872238,241878977,6740,"ENSG00000174371","ENST00000366548","protein_coding",24034,"EXO1","exonuclease 1 [Source:HGNC Symbol;Acc:HGNC:3511]","GO:0002376(immune system process);GO:0002455(humoral immune response mediated by circulating immunoglobulin);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003824(catalytic activity);GO:0004518(nuclease activity);GO:0004519(endonuclease activity);GO:0004523(RNA-DNA hybrid ribonuclease activity);GO:0004527(exonuclease activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0006260(DNA replication);GO:0006281(DNA repair);GO:0006298(mismatch repair);GO:0006310(DNA recombination);GO:0006974(cellular response to DNA damage stimulus);GO:0008409(5'-3' exonuclease activity);GO:0016446(somatic hypermutation of immunoglobulin genes);GO:0016604(nuclear body);GO:0016787(hydrolase activity);GO:0016788(hydrolase activity, acting on ester bonds);GO:0017108(5'-flap endonuclease activity);GO:0035312(5'-3' exodeoxyribonuclease activity);GO:0045145(single-stranded DNA 5'-3' exodeoxyribonuclease activity);GO:0045190(isotype switching);GO:0046872(metal ion binding);GO:0048256(flap endonuclease activity);GO:0051321(meiotic cell cycle);GO:0051908(double-stranded DNA 5'-3' exodeoxyribonuclease activity);GO:0090305(nucleic acid phosphodiester bond hydrolysis);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic);GO:0090656(t-circle formation);GO:1901796(regulation of signal transduction by p53 class mediator)","03430(Mismatch repair)",{"v":2e-17,"d":"0.00"},2,"41,229,","0,6511",-5.05,{"v":3.38844156139203e-07,"d":"0.00"},-1.05,"Exon (ENST00000366548/ENSG00000174371, exon 12 of 16)",1,241848204,241889939,41736,1]
[38568379,38570174,1796,"ENSG00000100206","ENST00000428462","protein_coding",0,"DMC1","DNA meiotic recombinase 1 [Source:HGNC Symbol;Acc:HGNC:2927]","GO:0000150(recombinase activity);GO:0000166(nucleotide binding);GO:0000730(DNA recombinase assembly);GO:0000781(chromosome, telomeric region);GO:0000794(condensed nuclear chromosome);GO:0001541(ovarian follicle development);GO:0001556(oocyte maturation);GO:0003677(DNA binding);GO:0003690(double-stranded DNA binding);GO:0003697(single-stranded DNA binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0006259(DNA metabolic process);GO:0006281(DNA repair);GO:0006312(mitotic recombination);GO:0007049(cell cycle);GO:0007129(synapsis);GO:0007131(reciprocal meiotic recombination);GO:0007141(male meiosis I);GO:0007276(gamete generation);GO:0007283(spermatogenesis);GO:0007286(spermatid development);GO:0007292(female gamete generation);GO:0008094(DNA-dependent ATPase activity);GO:0042148(strand invasion);GO:0051321(meiotic cell cycle)","NA",{"v":1.4e-10,"d":"0.00"},3,"31,107,132,","0,905,1664",{"v":-0.908,"d":"-0.91"},{"v":0.0275422870333817,"d":"0.03"},-2.03,"5' UTR",22,38518949,38568409,49461,2]
[826655,826954,300,"ENSG00000228794","ENST00000623808","lincRNA",0,"LINC01128","long intergenic non-protein coding RNA 1128 [Source:HGNC Symbol;Acc:HGNC:49377]","NA","NA",{"v":1.4e-07,"d":"0.00"},1,"300,",0,{"v":-0.952,"d":"-0.95"},{"v":0.0239883291901949,"d":"0.02"},{"v":-1.8,"d":"-1.80"},"Exon (ENST00000623808/ENSG00000228794, exon 1 of 3)",1,826832,852225,25394,1]
[957829,957978,150,"ENSG00000188976","ENST00000327044","protein_coding",1278,"NOC2L","NOC2 like nucleolar associated transcriptional repressor [Source:HGNC Symbol;Acc:HGNC:24517]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0002903(negative regulation of B cell apoptotic process);GO:0003682(chromatin binding);GO:0003714(transcription corepressor activity);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006915(apoptotic process);GO:0030690(Noc1p-Noc2p complex);GO:0030691(Noc2p-Noc3p complex);GO:0031491(nucleosome binding);GO:0031497(chromatin assembly);GO:0034644(cellular response to UV);GO:0035067(negative regulation of histone acetylation);GO:0042273(ribosomal large subunit biogenesis);GO:0042393(histone binding);GO:0070491(repressing transcription factor binding);GO:1901796(regulation of signal transduction by p53 class mediator);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","NA",{"v":0.00014,"d":"0.00"},1,"150,",0,-1.12,{"v":0.0138038426460289,"d":"0.01"},-1.92,"Exon (ENST00000477976/ENSG00000188976, exon 1 of 17)",1,944203,959256,15054,2]
[235670078,235670857,780,"ENSG00000157985","ENST00000304032","protein_coding",176035,"AGAP1","ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 [Source:HGNC Symbol;Acc:HGNC:16922]","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005543(phospholipid binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0015031(protein transport);GO:0043547(positive regulation of GTPase activity);GO:0046872(metal ion binding)","04144(Endocytosis)",{"v":1.3e-12,"d":"0.00"},1,"780,",0,-1.63,{"v":3.01995172040202E-3,"d":"0.00"},-2.04,"5' UTR",2,235494043,236131793,637751,1]
[34376138,34385736,9599,"ENSG00000205670","ENST00000481710","processed_transcript",658,"SMIM11A","small integral membrane protein 11A [Source:HGNC Symbol;Acc:HGNC:1293]","GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0008150(biological_process);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":2.5e-84,"d":"0.00"},3,"42,89,259,","0,3290,9340",{"v":-1.5,"d":"-1.50"},{"v":0.00446683592150963,"d":"0.00"},-2.05,"5' UTR",21,34375480,34402777,27298,1]
[1728176,1728594,419,"ENSG00000215790","ENST00000647043","processed_transcript",17325,"SLC35E2A","solute carrier family 35 member E2A [Source:HGNC Symbol;Acc:HGNC:20863]","GO:0005794(Golgi apparatus);GO:0015165(pyrimidine nucleotide-sugar transmembrane transporter activity);GO:0015297(antiporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport);GO:0090481(pyrimidine nucleotide-sugar transmembrane transport)","NA",{"v":2.2e-05,"d":"0.00"},1,"419,",0,-2.97,{"v":7.58577575029184e-05,"d":"0.00"},-1.14,"3' UTR",1,1724838,1745919,21082,2]
[3631276,3631455,180,"ENSG00000116213","ENST00000378322","protein_coding",18603,"WRAP73","WD repeat containing, antisense to TP73 [Source:HGNC Symbol;Acc:HGNC:12759]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005815(microtubule organizing center);GO:0005856(cytoskeleton);GO:0030030(cell projection organization);GO:0036064(ciliary basal body);GO:0090307(mitotic spindle assembly);GO:1902857(positive regulation of non-motile cilium assembly)","NA",{"v":9.8e-08,"d":"0.00"},1,"180,",0,-2.39,{"v":3.54813389233575E-4,"d":"0.00"},-1.92,"3' UTR",1,3630767,3650058,19292,2]
[3742874,3745397,2524,"ENSG00000227372","ENST00000608600","processed_transcript",0,"TP73-AS1","TP73 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:29052]","NA","NA",{"v":9.3e-09,"d":"0.00"},4,"110,201,92,17,","0,187,406,2507",-2.78,{"v":0.000125892541179417,"d":"0.00"},-1.02,"Exon (ENST00000648526/ENSG00000227372, exon 2 of 7)",1,3738447,3743370,4924,2]
[6155713,6168205,12493,"ENSG00000116254","ENST00000262450","protein_coding",12116,"CHD5","chromodomain helicase DNA binding protein 5 [Source:HGNC Symbol;Acc:HGNC:16816]","GO:0000166(nucleotide binding);GO:0000792(heterochromatin);GO:0003677(DNA binding);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006325(chromatin organization);GO:0007283(spermatogenesis);GO:0007399(nervous system development);GO:0008285(negative regulation of cell population proliferation);GO:0016020(membrane);GO:0016581(NuRD complex);GO:0016607(nuclear speck);GO:0016787(hydrolase activity);GO:0021895(cerebral cortex neuron differentiation);GO:0030154(cell differentiation);GO:0035093(spermatogenesis, exchange of chromosomal proteins);GO:0043967(histone H4 acetylation);GO:0046872(metal ion binding);GO:0060850(regulation of transcription involved in cell fate commitment);GO:0061628(H3K27me3 modified histone binding);GO:0098532(histone H3-K27 trimethylation);GO:1901798(positive regulation of signal transduction by p53 class mediator)","NA",{"v":4.7E-7,"d":"0.00"},3,"5,180,56,","0,3623,12437",-3.05,{"v":6.16595001861482e-05,"d":"0.00"},-1.69,"3' UTR",1,6101787,6180321,78535,2]
[20899883,20929550,29668,"ENSG00000075151","ENST00000374935","protein_coding",247338,"EIF4G3","eukaryotic translation initiation factor 4 gamma 3 [Source:HGNC Symbol;Acc:HGNC:3298]","GO:0000339(RNA cap binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0006412(translation);GO:0006413(translational initiation);GO:0006417(regulation of translation);GO:0006446(regulation of translational initiation);GO:0008135(translation factor activity, RNA binding);GO:0016281(eukaryotic translation initiation factor 4F complex)","03013(RNA transport);05416(Viral myocarditis)",{"v":4e-28,"d":"0.00"},3,"61,89,181,","0,5000,29487",-5.27,{"v":1.94984459975805E-7,"d":"0.00"},-1.02,"Exon (ENST00000374935/ENSG00000075151, exon 11 of 33)",1,20806292,21176888,370597,2]
[32231658,32231897,240,"ENSG00000220785","ENST00000423995","processed_transcript",8893,"MTMR9LP","myotubularin related protein 9-like, pseudogene [Source:HGNC Symbol;Acc:HGNC:27920]","NA","NA",{"v":1.3e-09,"d":"0.00"},1,"240,",0,-1.17,{"v":0.0120226443461741,"d":"0.01"},-1.97,"Exon (ENST00000423995/ENSG00000220785, exon 6 of 6)",1,32231658,32240790,9133,2]
[34987065,34987844,780,"ENSG00000163867","ENST00000493328","processed_transcript",43867,"ZMYM6","zinc finger MYM-type containing 6 [Source:HGNC Symbol;Acc:HGNC:13050]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0007010(cytoskeleton organization);GO:0007275(multicellular organism development);GO:0008270(zinc ion binding);GO:0022604(regulation of cell morphogenesis);GO:0046872(metal ion binding)","NA",{"v":2e-57,"d":"0.00"},1,"780,",0,-1.02,{"v":0.0190546071796325,"d":"0.02"},-1.15,"3' UTR",1,34986165,35031711,45547,2]
[35506684,35507103,420,"ENSG00000142687","ENST00000431916","protein_coding",0,"KIAA0319L","KIAA0319 like [Source:HGNC Symbol;Acc:HGNC:30071]","GO:0000139(Golgi membrane);GO:0005515(protein binding);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031410(cytoplasmic vesicle)","NA",{"v":2.5e-34,"d":"0.00"},1,"420,",0,-3.92,{"v":6.16595001861482e-06,"d":"0.00"},{"v":-1.2,"d":"-1.20"},"Exon (ENST00000325722/ENSG00000142687, exon 3 of 21)",1,35460308,35506867,46560,2]
[46061940,46062060,121,"ENSG00000117461","ENST00000262741","protein_coding",70569,"PIK3R3","phosphoinositide-3-kinase regulatory subunit 3 [Source:HGNC Symbol;Acc:HGNC:8981]","GO:0001784(phosphotyrosine residue binding);GO:0001934(positive regulation of protein phosphorylation);GO:0002042(cell migration involved in sprouting angiogenesis);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005942(phosphatidylinositol 3-kinase complex);GO:0006661(phosphatidylinositol biosynthetic process);GO:0008286(insulin receptor signaling pathway);GO:0010628(positive regulation of gene expression);GO:0016303(1-phosphatidylinositol-3-kinase activity);GO:0030335(positive regulation of cell migration);GO:0035014(phosphatidylinositol 3-kinase regulator activity);GO:0036092(phosphatidylinositol-3-phosphate biosynthetic process);GO:0043491(protein kinase B signaling);GO:0043551(regulation of phosphatidylinositol 3-kinase activity);GO:0046854(phosphatidylinositol phosphorylation);GO:0046935(1-phosphatidylinositol-3-kinase regulator activity)","01521(EGFR tyrosine kinase inhibitor resistance);01522(Endocrine resistance);01524(Platinum drug resistance);04012(ErbB signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04024(cAMP signaling pathway);04062(Chemokine signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04070(Phosphatidylinositol signaling system);04071(Sphingolipid signaling pathway);04072(Phospholipase D signaling pathway);04140(Autophagy - animal);04150(mTOR signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04210(Apoptosis);04211(Longevity regulating pathway);04213(Longevity regulating pathway - multiple species);04218(Cellular senescence);04360(Axon guidance);04370(VEGF signaling pathway);04380(Osteoclast differentiation);04510(Focal adhesion);04550(Signaling pathways regulating pluripotency of stem cells);04611(Platelet activation);04620(Toll-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04630(Jak-STAT signaling pathway);04650(Natural killer cell mediated cytotoxicity);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04666(Fc gamma R-mediated phagocytosis);04668(TNF signaling pathway);04670(Leukocyte transendothelial migration);04722(Neurotrophin signaling pathway);04725(Cholinergic synapse);04750(Inflammatory mediator regulation of TRP channels);04810(Regulation of actin cytoskeleton);04910(Insulin signaling pathway);04914(Progesterone-mediated oocyte maturation);04915(Estrogen signaling pathway);04917(Prolactin signaling pathway);04919(Thyroid hormone signaling pathway);04923(Regulation of lipolysis in adipocytes);04926(Relaxin signaling pathway);04930(Type II diabetes mellitus);04931(Insulin resistance);04932(Non-alcoholic fatty liver disease (NAFLD));04933(AGE-RAGE signaling pathway in diabetic complications);04960(Aldosterone-regulated sodium reabsorption);04973(Carbohydrate digestion and absorption);05100(Bacterial invasion of epithelial cells);05142(Chagas disease (American trypanosomiasis));05146(Amoebiasis);05160(Hepatitis C);05161(Hepatitis B);05162(Measles);05163(Human cytomegalovirus infection);05164(Influenza A);05165(Human papillomavirus infection);05166(Human T-cell leukemia virus 1 infection);05167(Kaposi sarcoma-associated herpesvirus infection);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer);05203(Viral carcinogenesis);05205(Proteoglycans in cancer);05210(Colorectal cancer);05211(Renal cell carcinoma);05212(Pancreatic cancer);05213(Endometrial cancer);05214(Glioma);05215(Prostate cancer);05218(Melanoma);05220(Chronic myeloid leukemia);05221(Acute myeloid leukemia);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05230(Central carbon metabolism in cancer);05231(Choline metabolism in cancer);05418(Fluid shear stress and atherosclerosis)",{"v":2.8e-07,"d":"0.00"},1,"121,",0,-1.44,{"v":0.00512861383991365,"d":"0.01"},{"v":-1.1,"d":"-1.10"},"Exon (ENST00000262741/ENSG00000117461, exon 6 of 10)",1,46040140,46132629,92490,2]
[52055814,52056141,328,"ENSG00000117862","ENST00000371626","protein_coding",30,"TXNDC12","thioredoxin domain containing 12 [Source:HGNC Symbol;Acc:HGNC:24626]","GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005788(endoplasmic reticulum lumen);GO:0015037(peptide disulfide oxidoreductase activity);GO:0016491(oxidoreductase activity);GO:0019153(protein-disulfide reductase (glutathione) activity);GO:0045454(cell redox homeostasis);GO:0055114(oxidation-reduction process);GO:0060548(negative regulation of cell death);GO:1902236(negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway)","00480(Glutathione metabolism)",{"v":1.1e-07,"d":"0.00"},1,"328,",0,{"v":-0.823,"d":"-0.82"},{"v":0.0363078054770101,"d":"0.04"},-1.07,"5' UTR",1,52020131,52056171,36041,2]
[58538971,58541570,2600,"ENSG00000162600","ENST00000371226","protein_coding",5156,"OMA1","OMA1 zinc metallopeptidase [Source:HGNC Symbol;Acc:HGNC:29661]","GO:0002024(diet induced thermogenesis);GO:0004222(metalloendopeptidase activity);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0006006(glucose metabolic process);GO:0006508(proteolysis);GO:0006515(protein quality control for misfolded or incompletely synthesized proteins);GO:0006629(lipid metabolic process);GO:0007005(mitochondrion organization);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0010637(negative regulation of mitochondrial fusion);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0031966(mitochondrial membrane);GO:0034982(mitochondrial protein processing);GO:0042407(cristae formation);GO:0042981(regulation of apoptotic process);GO:0046872(metal ion binding);GO:0097009(energy homeostasis);GO:0120162(positive regulation of cold-induced thermogenesis)","NA",{"v":7.9e-31,"d":"0.00"},2,"340,80,","0,2520",-4.48,{"v":1.44543977074593e-06,"d":"0.00"},-1.31,"5' UTR",1,58480719,58546726,66008,2]
[85018891,85021123,2233,"ENSG00000055732","ENST00000370589","protein_coding",27377,"MCOLN3","mucolipin 3 [Source:HGNC Symbol;Acc:HGNC:13358]","GO:0000421(autophagosome membrane);GO:0005261(cation channel activity);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0005768(endosome);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0007626(locomotory behavior);GO:0008289(lipid binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031410(cytoplasmic vesicle);GO:0031901(early endosome membrane);GO:0031902(late endosome membrane);GO:0034220(ion transmembrane transport);GO:0042491(inner ear auditory receptor cell differentiation);GO:0051209(release of sequestered calcium ion into cytosol);GO:0070588(calcium ion transmembrane transport);GO:0072345(NAADP-sensitive calcium-release channel activity);GO:0098655(cation transmembrane transport)","NA",{"v":1.3E-11,"d":"0.00"},2,"367,54,","0,2179",-1.15,{"v":0.0128824955169313,"d":"0.01"},-1.75,"3' UTR",1,85018082,85048500,30419,2]
[72562645,72567827,5183,"ENSG00000147099","ENST00000373573","protein_coding",5016,"HDAC8","histone deacetylase 8 [Source:HGNC Symbol;Acc:HGNC:13315]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000228(nuclear chromosome);GO:0004407(histone deacetylase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006325(chromatin organization);GO:0006333(chromatin assembly or disassembly);GO:0007062(sister chromatid cohesion);GO:0008134(transcription factor binding);GO:0016575(histone deacetylation);GO:0016787(hydrolase activity);GO:0030544(Hsp70 protein binding);GO:0031397(negative regulation of protein ubiquitination);GO:0031647(regulation of protein stability);GO:0032041(NAD-dependent histone deacetylase activity (H3-K14 specific));GO:0032204(regulation of telomere maintenance);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0051879(Hsp90 protein binding);GO:0070932(histone H3 deacetylation);GO:0070933(histone H4 deacetylation);GO:0071922(regulation of cohesin loading)","05034(Alcoholism);05203(Viral carcinogenesis)",{"v":1.7E-6,"d":"0.00"},2,"25,246,","0,4937",-1.33,{"v":7.2443596007499E-3,"d":"0.01"},-2.05,"3' UTR",23,72329516,72572843,243328,2]
[137618992,137637602,18611,"ENSG00000181090","ENST00000462484","protein_coding",0,"EHMT1","euchromatic histone lysine methyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:24650]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0002039(p53 binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0006306(DNA methylation);GO:0006325(chromatin organization);GO:0008168(methyltransferase activity);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016279(protein-lysine N-methyltransferase activity);GO:0016571(histone methylation);GO:0016604(nuclear body);GO:0016740(transferase activity);GO:0018024(histone-lysine N-methyltransferase activity);GO:0018026(peptidyl-lysine monomethylation);GO:0018027(peptidyl-lysine dimethylation);GO:0032259(methylation);GO:0034968(histone lysine methylation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045995(regulation of embryonic development);GO:0046872(metal ion binding);GO:0046974(histone methyltransferase activity (H3-K9 specific));GO:0046976(histone methyltransferase activity (H3-K27 specific));GO:0051567(histone H3-K9 methylation);GO:0060992(response to fungicide);GO:0070317(negative regulation of G0 to G1 transition);GO:0070734(histone H3-K27 methylation);GO:0070742(C2H2 zinc finger domain binding);GO:0120162(positive regulation of cold-induced thermogenesis);GO:1901796(regulation of signal transduction by p53 class mediator)","00310(Lysine degradation);04211(Longevity regulating pathway)",{"v":2.4E-10,"d":"0.00"},3,"58,22,101,","0,1055,18510",-1.31,{"v":7.76247116628692E-3,"d":"0.01"},-2.06,"5' UTR",9,137618992,137784393,165402,1]
[105009633,105009782,150,"ENSG00000140104","ENST00000548178","processed_transcript",18111,"CLBA1","clathrin binding box of aftiphilin containing 1 [Source:HGNC Symbol;Acc:HGNC:20126]","GO:0005737(cytoplasm);GO:0008565(protein transporter activity);GO:0015031(protein transport);GO:0030121(AP-1 adaptor complex);GO:0030276(clathrin binding);GO:0032588(trans-Golgi network membrane);GO:0046907(intracellular transport)","NA",{"v":1E-4,"d":"0.00"},1,"150,",0,{"v":-0.842,"d":"-0.84"},{"v":0.0338844156139203,"d":"0.03"},-2.06,"3' UTR",14,104991522,105010482,18961,1]
[150560291,150560410,120,"ENSG00000143382","ENST00000271643","protein_coding",10922,"ADAMTSL4","ADAMTS like 4 [Source:HGNC Symbol;Acc:HGNC:19706]","GO:0002020(protease binding);GO:0002064(epithelial cell development);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005614(interstitial matrix);GO:0005788(endoplasmic reticulum lumen);GO:0006508(proteolysis);GO:0006915(apoptotic process);GO:0008233(peptidase activity);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0043065(positive regulation of apoptotic process);GO:0062023(collagen-containing extracellular matrix)","NA",{"v":9.5e-05,"d":"0.00"},1,"120,",0,-1.32,{"v":0.00758577575029184,"d":"0.01"},-1.35,"3' UTR",1,150549369,150560932,11564,1]
[151002400,151002579,180,"ENSG00000143409","ENST00000622754","protein_coding",3825,"MINDY1","MINDY lysine 48 deubiquitinase 1 [Source:HGNC Symbol;Acc:HGNC:25648]","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0008150(biological_process);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0016604(nuclear body);GO:0016787(hydrolase activity);GO:0016807(cysteine-type carboxypeptidase activity);GO:0036435(K48-linked polyubiquitin modification-dependent protein binding);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0071108(protein K48-linked deubiquitination);GO:1990380(Lys48-specific deubiquitinase activity)","NA",{"v":5.6e-09,"d":"0.00"},1,"180,",0,-3.31,{"v":3.09029543251359E-5,"d":"0.00"},-1.33,"5' UTR",1,150996086,151006404,10319,2]
[155479834,155480133,300,"ENSG00000116539","ENST00000368346","protein_coding",82560,"ASH1L","ASH1 like histone lysine methyltransferase [Source:HGNC Symbol;Acc:HGNC:19088]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001501(skeletal system development);GO:0002674(negative regulation of acute inflammatory response);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005794(Golgi apparatus);GO:0005923(bicellular tight junction);GO:0006323(DNA packaging);GO:0006325(chromatin organization);GO:0006366(transcription by RNA polymerase II);GO:0007267(cell-cell signaling);GO:0007338(single fertilization);GO:0008168(methyltransferase activity);GO:0009791(post-embryonic development);GO:0010468(regulation of gene expression);GO:0016740(transferase activity);GO:0018024(histone-lysine N-methyltransferase activity);GO:0030054(cell junction);GO:0030317(flagellated sperm motility);GO:0032259(methylation);GO:0032635(interleukin-6 production);GO:0042800(histone methyltransferase activity (H3-K4 specific));GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043409(negative regulation of MAPK cascade);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046697(decidualization);GO:0046872(metal ion binding);GO:0046974(histone methyltransferase activity (H3-K9 specific));GO:0046975(histone methyltransferase activity (H3-K36 specific));GO:0048733(sebaceous gland development);GO:0050728(negative regulation of inflammatory response);GO:0051567(histone H3-K9 methylation);GO:0051568(histone H3-K4 methylation);GO:0061038(uterus morphogenesis);GO:0097676(histone H3-K36 dimethylation);GO:1903699(tarsal gland development);GO:1903709(uterine gland development)","00310(Lysine degradation)",{"v":2E-14,"d":"0.00"},1,"300,",0,-4.85,{"v":5.62341325190349e-07,"d":"0.00"},-1.32,"Exon (ENST00000368346/ENSG00000116539, exon 3 of 28)",1,155335268,155562693,227426,2]
[156072013,156072342,330,"ENSG00000254726","ENST00000532414","protein_coding",10123,"MEX3A","mex-3 RNA binding family member A [Source:HGNC Symbol;Acc:HGNC:33482]","GO:0000932(P-body);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0046872(metal ion binding)","NA",{"v":1e-29,"d":"0.00"},1,"330,",0,{"v":-1.5,"d":"-1.50"},{"v":0.00436515832240166,"d":"0.00"},-1.21,"3' UTR",1,156072013,156082465,10453,2]
[156266076,156266316,241,"ENSG00000198952","ENST00000361813","protein_coding",16509,"SMG5","SMG5, nonsense mediated mRNA decay factor [Source:HGNC Symbol;Acc:HGNC:24644]","GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005697(telomerase holoenzyme complex);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006406(mRNA export from nucleus);GO:0007004(telomere maintenance via telomerase);GO:0031625(ubiquitin protein ligase binding);GO:0032204(regulation of telomere maintenance);GO:0032210(regulation of telomere maintenance via telomerase);GO:0035303(regulation of dephosphorylation);GO:0042162(telomeric DNA binding);GO:0042826(histone deacetylase binding);GO:0051721(protein phosphatase 2A binding);GO:0070034(telomerase RNA binding)","03015(mRNA surveillance pathway)",{"v":7.9e-50,"d":"0.00"},1,"241,",0,{"v":-23.2,"d":"-23.20"},{"v":2.51188643150957e-26,"d":"0.00"},-1.44,"Exon (ENST00000361813/ENSG00000198952, exon 12 of 22)",1,156249224,156282825,33602,2]
[186325762,186327505,1744,"ENSG00000047410","ENST00000492973","retained_intron",0,"TPR","translocated promoter region, nuclear basket protein [Source:HGNC Symbol;Acc:HGNC:12017]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0003682(chromatin binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005643(nuclear pore);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005737(cytoplasm);GO:0005819(spindle);GO:0005856(cytoskeleton);GO:0005868(cytoplasmic dynein complex);GO:0006110(regulation of glycolytic process);GO:0006404(RNA import into nucleus);GO:0006405(RNA export from nucleus);GO:0006406(mRNA export from nucleus);GO:0006409(tRNA export from nucleus);GO:0006606(protein import into nucleus);GO:0006999(nuclear pore organization);GO:0007049(cell cycle);GO:0007094(mitotic spindle assembly checkpoint);GO:0010965(regulation of mitotic sister chromatid separation);GO:0015031(protein transport);GO:0015631(tubulin binding);GO:0016020(membrane);GO:0016032(viral process);GO:0016925(protein sumoylation);GO:0017056(structural constituent of nuclear pore);GO:0019083(viral transcription);GO:0019898(extrinsic component of membrane);GO:0031072(heat shock protein binding);GO:0031453(positive regulation of heterochromatin assembly);GO:0031965(nuclear membrane);GO:0031990(mRNA export from nucleus in response to heat stress);GO:0032880(regulation of protein localization);GO:0034399(nuclear periphery);GO:0034605(cellular response to heat);GO:0035457(cellular response to interferon-alpha);GO:0042307(positive regulation of protein import into nucleus);GO:0042405(nuclear inclusion body);GO:0042803(protein homodimerization activity);GO:0043657(host cell);GO:0044615(nuclear pore nuclear basket);GO:0045947(negative regulation of translational initiation);GO:0046827(positive regulation of protein export from nucleus);GO:0046832(negative regulation of RNA export from nucleus);GO:0051019(mitogen-activated protein kinase binding);GO:0051028(mRNA transport);GO:0051301(cell division);GO:0060964(regulation of gene silencing by miRNA);GO:0070840(dynein complex binding);GO:0070849(response to epidermal growth factor);GO:0072686(mitotic spindle);GO:0075733(intracellular transport of virus);GO:0090267(positive regulation of mitotic cell cycle spindle assembly checkpoint);GO:0090316(positive regulation of intracellular protein transport);GO:1900034(regulation of cellular response to heat);GO:1901673(regulation of mitotic spindle assembly)","03013(RNA transport);05200(Pathways in cancer);05216(Thyroid cancer)",{"v":2.5e-41,"d":"0.00"},3,"93,132,46,","0,342,1698",-4.37,{"v":1.90546071796325E-6,"d":"0.00"},-1.26,"Exon (ENST00000367478/ENSG00000047410, exon 40 of 51)",1,186325519,186326220,702,2]
[27878404,27878703,300,"ENSG00000232859","ENST00000379103","protein_coding",13618,"LYRM9","LYR motif containing 9 [Source:HGNC Symbol;Acc:HGNC:27314]","NA","NA",{"v":6.8E-8,"d":"0.00"},1,"300,",0,-1.26,{"v":0.0091201083935591,"d":"0.01"},-2.06,"3' UTR",17,27878314,27892321,14008,2]
[236550739,236550978,240,"ENSG00000116977","ENST00000526589","protein_coding",32466,"LGALS8","galectin 8 [Source:HGNC Symbol;Acc:HGNC:6569]","GO:0005178(integrin binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006914(autophagy);GO:0016020(membrane);GO:0030246(carbohydrate binding);GO:0031410(cytoplasmic vesicle);GO:0098586(cellular response to virus);GO:0098792(xenophagy);GO:1904977(lymphatic endothelial cell migration)","NA",{"v":3.2e-11,"d":"0.00"},1,"240,",0,-4.55,{"v":1.20226443461741E-6,"d":"0.00"},-1.14,"3' UTR",1,236518273,236552981,34709,1]
[243191049,243191438,390,"ENSG00000143702","ENST00000366542","protein_coding",63843,"CEP170","centrosomal protein 170 [Source:HGNC Symbol;Acc:HGNC:28920]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005819(spindle);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0120103(centriolar subdistal appendage)","NA",{"v":3.2e-14,"d":"0.00"},1,"390,",0,-3.75,{"v":9.33254300796991e-06,"d":"0.00"},-1.17,"Exon (ENST00000366542/ENSG00000143702, exon 8 of 20)",1,243124428,243255281,130854,2]
[3387717,3388376,660,"ENSG00000171853","ENST00000411973","nonsense_mediated_decay",0,"TRAPPC12","trafficking protein particle complex 12 [Source:HGNC Symbol;Acc:HGNC:24284]","GO:0000776(kinetochore);GO:0004175(endopeptidase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0007030(Golgi organization);GO:0016192(vesicle-mediated transport);GO:0030008(TRAPP complex);GO:0048471(perinuclear region of cytoplasm);GO:0051259(protein complex oligomerization);GO:0051310(metaphase plate congression);GO:0090234(regulation of kinetochore assembly);GO:1905342(positive regulation of protein localization to kinetochore)","NA",{"v":2.5e-16,"d":"0.00"},1,"660,",0,-5.46,{"v":1.20226443461741e-07,"d":"0.00"},-1.05,"Exon (ENST00000382110/ENSG00000171853, exon 2 of 12)",2,3388127,3421970,33844,1]
[3479287,3485004,5718,"ENSG00000225234","ENST00000453806","antisense",0,"TRAPPC12-AS1","TRAPPC12 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:41046]","NA","NA",{"v":1.6e-21,"d":"0.00"},2,"285,285,","0,5433",{"v":-4.6,"d":"-4.60"},{"v":1.07151930523761E-6,"d":"0.00"},-1.11,"3' UTR",2,3481242,3482409,1168,2]
[62890571,62890871,301,"ENSG00000101191","ENST00000266070","protein_coding",47081,"DIDO1","death inducer-obliterator 1 [Source:HGNC Symbol;Acc:HGNC:2680]","GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005819(spindle);GO:0005856(cytoskeleton);GO:0006351(transcription, DNA-templated);GO:0006915(apoptotic process);GO:0046872(metal ion binding);GO:0097190(apoptotic signaling pathway)","NA",{"v":3.7E-8,"d":"0.00"},1,"301,",0,-3.45,{"v":2.13796208950223e-05,"d":"0.00"},-2.06,"3' UTR",20,62877738,62937952,60215,2]
[33398489,33398789,301,"ENSG00000049323","ENST00000404816","protein_coding",451536,"LTBP1","latent transforming growth factor beta binding protein 1 [Source:HGNC Symbol;Acc:HGNC:6714]","GO:0001527(microfibril);GO:0003281(ventricular septum development);GO:0005024(transforming growth factor beta-activated receptor activity);GO:0005201(extracellular matrix structural constituent);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005788(endoplasmic reticulum lumen);GO:0007178(transmembrane receptor protein serine/threonine kinase signaling pathway);GO:0019838(growth factor binding);GO:0031012(extracellular matrix);GO:0032991(protein-containing complex);GO:0035583(sequestering of TGFbeta in extracellular matrix);GO:0035904(aorta development);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process);GO:0050431(transforming growth factor beta binding);GO:0050436(microfibril binding);GO:0060976(coronary vasculature development);GO:0062023(collagen-containing extracellular matrix);GO:1901388(regulation of transforming growth factor beta activation)","04350(TGF-beta signaling pathway)",{"v":5e-20,"d":"0.00"},1,"301,",0,-1.31,{"v":7.76247116628692E-3,"d":"0.01"},-1.06,"3' UTR",2,32946953,33399509,452557,1]
[62706724,62707226,503,"ENSG00000115504","ENST00000405289","protein_coding",0,"EHBP1","EH domain binding protein 1 [Source:HGNC Symbol;Acc:HGNC:29144]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006897(endocytosis);GO:0015031(protein transport);GO:0016020(membrane)","NA",{"v":2.5E-36,"d":"0.00"},2,"31,330,","0,173",-8.61,{"v":3.98107170553497e-11,"d":"0.00"},-1.99,"5' UTR",2,62707192,63045500,338309,1]
[73448096,73448366,271,"ENSG00000116127","ENST00000484298","protein_coding",62338,"ALMS1","ALMS1, centrosome and basal body associated protein [Source:HGNC Symbol;Acc:HGNC:428]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0000922(spindle pole);GO:0003674(molecular_function);GO:0005515(protein binding);GO:0005623(cell);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005929(cilium);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0016197(endosomal transport);GO:0042995(cell projection);GO:0046599(regulation of centriole replication);GO:0051393(alpha-actinin binding);GO:0051492(regulation of stress fiber assembly);GO:0097711(ciliary basal body-plasma membrane docking);GO:0120162(positive regulation of cold-induced thermogenesis)","NA",{"v":1.3e-08,"d":"0.00"},1,"271,",0,{"v":-0.954,"d":"-0.95"},{"v":0.0234422881531992,"d":"0.02"},-1.27,"Exon (ENST00000484298/ENSG00000116127, exon 7 of 22)",2,73385758,73609715,223958,1]
[73986014,73986343,330,"ENSG00000235499","ENST00000441217","lincRNA",882,"AC073046","novel transcript (LOC100132318)","NA","NA",{"v":2e-34,"d":"0.00"},1,"330,",0,-0.93,{"v":0.0257039578276886,"d":"0.03"},-1.01,"Exon (ENST00000441217/ENSG00000235499, exon 2 of 2)",2,73985132,73986343,1212,1]
[74504172,74504678,507,"ENSG00000257702","ENST00000603175","antisense",1577,"LBX2-AS1","LBX2 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:25136]","NA","NA",{"v":1.6e-20,"d":"0.00"},1,"507,",0,-1.41,{"v":0.00562341325190349,"d":"0.01"},-1.94,"Exon (ENST00000603175/ENSG00000257702, exon 1 of 1)",2,74502595,74504677,2083,1]
[112028289,112029022,734,"ENSG00000153208","ENST00000295408","protein_coding",129810,"MERTK","MER proto-oncogene, tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:7027]","GO:0000166(nucleotide binding);GO:0001750(photoreceptor outer segment);GO:0001779(natural killer cell differentiation);GO:0001818(negative regulation of cytokine production);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0006909(phagocytosis);GO:0007166(cell surface receptor signaling pathway);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007267(cell-cell signaling);GO:0007283(spermatogenesis);GO:0007399(nervous system development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016028(rhabdomere);GO:0016055(Wnt signaling pathway);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016477(cell migration);GO:0016740(transferase activity);GO:0017147(Wnt-protein binding);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0030168(platelet activation);GO:0032940(secretion by cell);GO:0034446(substrate adhesion-dependent cell spreading);GO:0043235(receptor complex);GO:0043277(apoptotic cell clearance);GO:0043491(protein kinase B signaling);GO:0050766(positive regulation of phagocytosis);GO:0050900(leukocyte migration);GO:0051250(negative regulation of lymphocyte activation);GO:0060041(retina development in camera-type eye);GO:0060068(vagina development);GO:0097350(neutrophil clearance);GO:2000107(negative regulation of leukocyte apoptotic process)","NA",{"v":1E-89,"d":"0.00"},2,"17,672,","0,62",-5.48,{"v":1.12201845430196E-7,"d":"0.00"},-1.11,"3' UTR",2,111898479,112029561,131083,1]
[112187261,112188218,958,"ENSG00000144152","ENST00000331203","protein_coding",48876,"FBLN7","fibulin 7 [Source:HGNC Symbol;Acc:HGNC:26740]","GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0005925(focal adhesion);GO:0007155(cell adhesion);GO:0008201(heparin binding)","NA",{"v":4e-24,"d":"0.00"},1,"958,",0,{"v":-2.9,"d":"-2.90"},{"v":9.1201083935591e-05,"d":"0.00"},-1.62,"3' UTR",2,112138385,112188218,49834,1]
[113597567,113598475,909,"ENSG00000146556","ENST00000453662","transcribed_unprocessed_pseudogene",9017,"WASH2P","WAS protein family homolog 2, pseudogene [Source:HGNC Symbol;Acc:HGNC:33145]","NA","NA",{"v":2.3E-3,"d":"0.00"},2,"72,78,","0,831",{"v":-0.813,"d":"-0.81"},{"v":0.0380189396320561,"d":"0.04"},-1.62,"Exon (ENST00000453662/ENSG00000146556, exon 8 of 10)",2,113588550,113599034,10485,1]
[6487141,6487321,181,"ENSG00000275895","ENST00000637320","retained_intron",291,"U2AF1L5","U2 small nuclear RNA auxiliary factor 1 like 5 [Source:HGNC Symbol;Acc:HGNC:51830]","GO:0000398(mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex);GO:0016607(nuclear speck);GO:0030628(pre-mRNA 3'-splice site binding);GO:0046872(metal ion binding);GO:0050733(RS domain binding);GO:0089701(U2AF)","03040(Spliceosome);05131(Shigellosis)",{"v":5.1E-5,"d":"0.00"},1,"181,",0,-3.17,{"v":4.46683592150963e-05,"d":"0.00"},-2.06,"3' UTR",21,6484623,6487612,2990,2]
[135780329,135782932,2604,"ENSG00000144224","ENST00000272638","protein_coding",38474,"UBXN4","UBX domain protein 4 [Source:HGNC Symbol;Acc:HGNC:14860]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0006986(response to unfolded protein);GO:0016020(membrane);GO:0030433(ubiquitin-dependent ERAD pathway)","NA",{"v":1e-31,"d":"0.00"},2,"57,184,","0,2420",-8.41,{"v":7.94328234724282e-11,"d":"0.00"},-1.02,"3' UTR",2,135741855,135785056,43202,1]
[43128671,43128821,151,"ENSG00000165731","ENST00000615310","protein_coding",51602,"RET","ret proto-oncogene [Source:HGNC Symbol;Acc:HGNC:9967]","GO:0000165(MAPK cascade);GO:0000166(nucleotide binding);GO:0000187(activation of MAPK activity);GO:0001657(ureteric bud development);GO:0001755(neural crest cell migration);GO:0001838(embryonic epithelial tube formation);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005768(endosome);GO:0005769(early endosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007158(neuron cell-cell adhesion);GO:0007165(signal transduction);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007399(nervous system development);GO:0007411(axon guidance);GO:0007497(posterior midgut development);GO:0010008(endosome membrane);GO:0010628(positive regulation of gene expression);GO:0010976(positive regulation of neuron projection development);GO:0014042(positive regulation of neuron maturation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0022008(neurogenesis);GO:0030154(cell differentiation);GO:0030155(regulation of cell adhesion);GO:0030182(neuron differentiation);GO:0030335(positive regulation of cell migration);GO:0030424(axon);GO:0030425(dendrite);GO:0033141(positive regulation of peptidyl-serine phosphorylation of STAT protein);GO:0033619(membrane protein proteolysis);GO:0033630(positive regulation of cell adhesion mediated by integrin);GO:0035799(ureter maturation);GO:0035860(glial cell-derived neurotrophic factor receptor signaling pathway);GO:0038023(signaling receptor activity);GO:0042493(response to drug);GO:0042551(neuron maturation);GO:0043025(neuronal cell body);GO:0043231(intracellular membrane-bounded organelle);GO:0043235(receptor complex);GO:0043410(positive regulation of MAPK cascade);GO:0045121(membrane raft);GO:0045793(positive regulation of cell size);GO:0045893(positive regulation of transcription, DNA-templated);GO:0048265(response to pain);GO:0048484(enteric nervous system development);GO:0050770(regulation of axonogenesis);GO:0051897(positive regulation of protein kinase B signaling);GO:0060041(retina development in camera-type eye);GO:0060384(innervation);GO:0061146(Peyer's patch morphogenesis);GO:0071300(cellular response to retinoic acid);GO:0072300(positive regulation of metanephric glomerulus development);GO:0097021(lymphocyte migration into lymphoid organs);GO:0098797(plasma membrane protein complex);GO:2001241(positive regulation of extrinsic apoptotic signaling pathway in absence of ligand)","05200(Pathways in cancer);05216(Thyroid cancer);05230(Central carbon metabolism in cancer)",{"v":0.0012,"d":"0.00"},1,"151,",0,{"v":-0.972,"d":"-0.97"},{"v":0.0223872113856834,"d":"0.02"},-2.07,"3' UTR",10,43077069,43130345,53277,1]
[201479501,201480157,657,"ENSG00000082146","ENST00000194530","protein_coding",27761,"STRADB","STE20 related adaptor beta [Source:HGNC Symbol;Acc:HGNC:13205]","GO:0000165(MAPK cascade);GO:0000166(nucleotide binding);GO:0000902(cell morphogenesis);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0006611(protein export from nucleus);GO:0007049(cell cycle);GO:0007050(cell cycle arrest);GO:0007254(JNK cascade);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016235(aggresome);GO:0023014(signal transduction by protein phosphorylation);GO:0031098(stress-activated protein kinase signaling cascade);GO:0032147(activation of protein kinase activity);GO:0048812(neuron projection morphogenesis);GO:2001240(negative regulation of extrinsic apoptotic signaling pathway in absence of ligand)","04150(mTOR signaling pathway);04152(AMPK signaling pathway)",{"v":2e-11,"d":"0.00"},2,"31,150,","0,507",-4.12,{"v":3.63078054770101e-06,"d":"0.00"},{"v":-1.5,"d":"-1.50"},"3' UTR",2,201451740,201480846,29107,1]
[216096160,216100235,4076,"ENSG00000163449","ENST00000433112","protein_coding",14294,"TMEM169","transmembrane protein 169 [Source:HGNC Symbol;Acc:HGNC:25130]","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":1.3e-10,"d":"0.00"},2,"75,316,","0,3760",{"v":-0.734,"d":"-0.73"},{"v":0.0489778819368446,"d":"0.05"},-1.08,"Exon (ENST00000433112/ENSG00000163449, exon 2 of 3)",2,216081866,216099998,18133,1]
[216415211,216415331,121,"ENSG00000138375","ENST00000357276","protein_coding",2797,"SMARCAL1","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1 [Source:HGNC Symbol;Acc:HGNC:11102]","GO:0000166(nucleotide binding);GO:0000733(DNA strand renaturation);GO:0004386(helicase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005662(DNA replication factor A complex);GO:0006259(DNA metabolic process);GO:0006281(DNA repair);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006974(cellular response to DNA damage stimulus);GO:0008094(DNA-dependent ATPase activity);GO:0016787(hydrolase activity);GO:0031297(replication fork processing);GO:0035861(site of double-strand break);GO:0036292(DNA rewinding);GO:0036310(annealing helicase activity);GO:0043596(nuclear replication fork);GO:0048478(replication fork protection);GO:0090656(t-circle formation)","NA",{"v":0.00028,"d":"0.00"},1,"121,",0,{"v":-3.8,"d":"-3.80"},{"v":8.31763771102671e-06,"d":"0.00"},-1.27,"Exon (ENST00000357276/ENSG00000138375, exon 3 of 18)",2,216412414,216483053,70640,1]
[218755176,218755296,121,"ENSG00000135912","ENST00000392102","protein_coding",44341,"TTLL4","tubulin tyrosine ligase like 4 [Source:HGNC Symbol;Acc:HGNC:28976]","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005929(cilium);GO:0006464(cellular protein modification process);GO:0015631(tubulin binding);GO:0016874(ligase activity);GO:0018095(protein polyglutamylation);GO:0018200(peptidyl-glutamic acid modification);GO:0042995(cell projection);GO:0070739(protein-glutamic acid ligase activity)","NA",{"v":0.0039,"d":"0.00"},1,"121,",0,{"v":-0.875,"d":"-0.88"},{"v":0.0309029543251359,"d":"0.03"},-1.81,"3' UTR",2,218710835,218755416,44582,1]
[219641682,219641980,299,"ENSG00000114923","ENST00000373760","protein_coding",14288,"SLC4A3","solute carrier family 4 member 3 [Source:HGNC Symbol;Acc:HGNC:11029]","GO:0005452(inorganic anion exchanger activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006811(ion transport);GO:0006820(anion transport);GO:0008509(anion transmembrane transporter activity);GO:0015297(antiporter activity);GO:0015301(anion:anion antiporter activity);GO:0015698(inorganic anion transport);GO:0015701(bicarbonate transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0051453(regulation of intracellular pH);GO:0055085(transmembrane transport);GO:0098656(anion transmembrane transport)","NA",{"v":5e-10,"d":"0.00"},1,"299,",0,-2.52,{"v":0.000251188643150958,"d":"0.00"},-1.43,"3' UTR",2,219627394,219641971,14578,1]
[1083166,1083346,181,"ENSG00000131591","ENST00000379339","protein_coding",32735,"C1orf159","chromosome 1 open reading frame 159 [Source:HGNC Symbol;Acc:HGNC:26062]","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":2.2e-07,"d":"0.00"},1,"181,",0,-1.07,{"v":0.0165958690743756,"d":"0.02"},-2.08,"Exon (ENST00000487177/ENSG00000131591, exon 3 of 3)",1,1081818,1116081,34264,2]
[233294297,233294596,300,"ENSG00000085978","ENST00000347464","protein_coding",42726,"ATG16L1","autophagy related 16 like 1 [Source:HGNC Symbol;Acc:HGNC:21498]","GO:0000045(autophagosome assembly);GO:0000421(autophagosome membrane);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005776(autophagosome);GO:0005829(cytosol);GO:0005930(axoneme);GO:0006914(autophagy);GO:0010508(positive regulation of autophagy);GO:0015031(protein transport);GO:0016020(membrane);GO:0016236(macroautophagy);GO:0019787(ubiquitin-like protein transferase activity);GO:0034045(phagophore assembly site membrane);GO:0034497(protein localization to phagophore assembly site);GO:0039689(negative stranded viral RNA replication);GO:0042802(identical protein binding);GO:0051020(GTPase binding);GO:0051260(protein homooligomerization);GO:0061739(protein lipidation involved in autophagosome assembly);GO:0098792(xenophagy)","04136(Autophagy - other);04140(Autophagy - animal);04621(NOD-like receptor signaling pathway)",{"v":2.5e-19,"d":"0.00"},1,"300,",0,-5.52,{"v":1e-07,"d":"0.00"},-1.23,"3' UTR",2,233251571,233295673,44103,1]
[6498142,6498652,511,"ENSG00000179532","ENST00000527990","protein_coding",0,"DNHD1","dynein heavy chain domain 1 [Source:HGNC Symbol;Acc:HGNC:26532]","GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0007018(microtubule-based movement);GO:0008569(ATP-dependent microtubule motor activity, minus-end-directed);GO:0030286(dynein complex);GO:0045503(dynein light chain binding);GO:0045505(dynein intermediate chain binding);GO:0051959(dynein light intermediate chain binding);GO:0070062(extracellular exosome)","NA",{"v":1.3E-11,"d":"0.00"},1,"511,",0,-2.16,{"v":0.000676082975391982,"d":"0.00"},-2.08,"5' UTR",11,6498216,6572022,73807,1]
[241091883,241092273,391,"ENSG00000122085","ENST00000464344","processed_transcript",10059,"MTERF4","mitochondrial transcription termination factor 4 [Source:HGNC Symbol;Acc:HGNC:28785]","GO:0003690(double-stranded DNA binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005762(mitochondrial large ribosomal subunit);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006364(rRNA processing);GO:0006390(mitochondrial transcription);GO:0006626(protein targeting to mitochondrion);GO:0007507(heart development);GO:0019843(rRNA binding);GO:0031167(rRNA methylation);GO:0032543(mitochondrial translation);GO:0042255(ribosome assembly);GO:0043010(camera-type eye development);GO:0061668(mitochondrial ribosome assembly)","NA",{"v":3.5e-05,"d":"0.00"},1,"391,",0,-1.35,{"v":0.00691830970918936,"d":"0.01"},-1.54,"3' UTR",2,241072169,241102332,30164,2]
[241441864,241442134,271,"ENSG00000006607","ENST00000264042","protein_coding",85579,"FARP2","FERM, ARH/RhoGEF and pleckstrin domain protein 2 [Source:HGNC Symbol;Acc:HGNC:16460]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0007155(cell adhesion);GO:0008092(cytoskeletal protein binding);GO:0016322(neuron remodeling);GO:0016601(Rac protein signal transduction);GO:0022405(hair cycle process);GO:0030316(osteoclast differentiation);GO:0030676(Rac guanyl-nucleotide exchange factor activity);GO:0031532(actin cytoskeleton reorganization);GO:0033623(regulation of integrin activation);GO:0035023(regulation of Rho protein signal transduction);GO:0071526(semaphorin-plexin signaling pathway);GO:0071800(podosome assembly)","04015(Rap1 signaling pathway);04520(Adherens junction)",{"v":3e-07,"d":"0.00"},1,"271,",0,-4.02,{"v":4.67735141287198e-06,"d":"0.00"},-1.01,"Exon (ENST00000413432/ENSG00000006607, exon 4 of 4)",2,241356285,241494841,138557,1]
[187554362,187554663,302,"ENSG00000003436","ENST00000233156","protein_coding",0,"TFPI","tissue factor pathway inhibitor [Source:HGNC Symbol;Acc:HGNC:11760]","GO:0004866(endopeptidase inhibitor activity);GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0007596(blood coagulation);GO:0007598(blood coagulation, extrinsic pathway);GO:0007599(hemostasis);GO:0009986(cell surface);GO:0010466(negative regulation of peptidase activity);GO:0010951(negative regulation of endopeptidase activity);GO:0016020(membrane);GO:0030195(negative regulation of blood coagulation);GO:0030414(peptidase inhibitor activity);GO:0031090(organelle membrane);GO:0031225(anchored component of membrane);GO:0032355(response to estradiol);GO:0032496(response to lipopolysaccharide);GO:0043231(intracellular membrane-bounded organelle);GO:0071222(cellular response to lipopolysaccharide);GO:0071347(cellular response to interleukin-1);GO:0071383(cellular response to steroid hormone stimulus)","04610(Complement and coagulation cascades)",{"v":2.8E-3,"d":"0.00"},2,"32,87,","0,215",-1.25,{"v":0.0091201083935591,"d":"0.01"},-2.09,"5' UTR",2,187464230,187554435,90206,2]
[24918370,24918879,510,"ENSG00000138031","ENST00000260600","protein_coding",960,"ADCY3","adenylate cyclase 3 [Source:HGNC Symbol;Acc:HGNC:234]","GO:0000166(nucleotide binding);GO:0003091(renal water homeostasis);GO:0004016(adenylate cyclase activity);GO:0005516(calmodulin binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005929(cilium);GO:0006171(cAMP biosynthetic process);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0007190(activation of adenylate cyclase activity);GO:0007193(adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway);GO:0007338(single fertilization);GO:0007340(acrosome reaction);GO:0007608(sensory perception of smell);GO:0008355(olfactory learning);GO:0009190(cyclic nucleotide biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016829(lyase activity);GO:0016849(phosphorus-oxygen lyase activity);GO:0030317(flagellated sperm motility);GO:0034199(activation of protein kinase A activity);GO:0035556(intracellular signal transduction);GO:0042995(cell projection);GO:0046872(metal ion binding);GO:0050896(response to stimulus);GO:0071377(cellular response to glucagon stimulus);GO:1904322(cellular response to forskolin)","00230(Purine metabolism);01522(Endocrine resistance);04015(Rap1 signaling pathway);04020(Calcium signaling pathway);04022(cGMP-PKG signaling pathway);04024(cAMP signaling pathway);04062(Chemokine signaling pathway);04072(Phospholipase D signaling pathway);04114(Oocyte meiosis);04211(Longevity regulating pathway);04213(Longevity regulating pathway - multiple species);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04371(Apelin signaling pathway);04540(Gap junction);04611(Platelet activation);04713(Circadian entrainment);04714(Thermogenesis);04723(Retrograde endocannabinoid signaling);04724(Glutamatergic synapse);04725(Cholinergic synapse);04727(GABAergic synapse);04740(Olfactory transduction);04750(Inflammatory mediator regulation of TRP channels);04911(Insulin secretion);04912(GnRH signaling pathway);04913(Ovarian steroidogenesis);04914(Progesterone-mediated oocyte maturation);04915(Estrogen signaling pathway);04916(Melanogenesis);04918(Thyroid hormone synthesis);04921(Oxytocin signaling pathway);04923(Regulation of lipolysis in adipocytes);04925(Aldosterone synthesis and secretion);04926(Relaxin signaling pathway);04927(Cortisol synthesis and secretion);04928(Parathyroid hormone synthesis, secretion and action);04934(Cushing syndrome);04962(Vasopressin-regulated water reabsorption);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04976(Bile secretion);05032(Morphine addiction);05110(Vibrio cholerae infection);05163(Human cytomegalovirus infection);05166(Human T-cell leukemia virus 1 infection);05200(Pathways in cancer);05414(Dilated cardiomyopathy (DCM))",{"v":3.2E-50,"d":"0.00"},1,"510,",0,-8.47,{"v":6.30957344480194e-11,"d":"0.00"},-1.15,"Exon (ENST00000260600/ENSG00000138031, exon 1 of 21)",2,24819169,24919839,100671,2]
[39022752,39024089,1338,"ENSG00000115904","ENST00000472480","processed_transcript",0,"SOS1","SOS Ras/Rac guanine nucleotide exchange factor 1 [Source:HGNC Symbol;Acc:HGNC:11187]","GO:0000165(MAPK cascade);GO:0000786(nucleosome);GO:0001782(B cell homeostasis);GO:0001942(hair follicle development);GO:0002260(lymphocyte homeostasis);GO:0003007(heart morphogenesis);GO:0003209(cardiac atrium morphogenesis);GO:0003344(pericardium morphogenesis);GO:0003677(DNA binding);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005088(Ras guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007264(small GTPase mediated signal transduction);GO:0007265(Ras protein signal transduction);GO:0007296(vitellogenesis);GO:0007411(axon guidance);GO:0008286(insulin receptor signaling pathway);GO:0014069(postsynaptic density);GO:0017124(SH3 domain binding);GO:0019221(cytokine-mediated signaling pathway);GO:0033081(regulation of T cell differentiation in thymus);GO:0035023(regulation of Rho protein signal transduction);GO:0035264(multicellular organism growth);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0038128(ERBB2 signaling pathway);GO:0042129(regulation of T cell proliferation);GO:0043025(neuronal cell body);GO:0043065(positive regulation of apoptotic process);GO:0043547(positive regulation of GTPase activity);GO:0045742(positive regulation of epidermal growth factor receptor signaling pathway);GO:0046982(protein heterodimerization activity);GO:0048011(neurotrophin TRK receptor signaling pathway);GO:0048514(blood vessel morphogenesis);GO:0050900(leukocyte migration);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0051057(positive regulation of small GTPase mediated signal transduction);GO:0060021(roof of mouth development);GO:0061029(eyelid development in camera-type eye);GO:0061384(heart trabecula morphogenesis);GO:1904693(midbrain morphogenesis);GO:2000973(regulation of pro-B cell differentiation)","01521(EGFR tyrosine kinase inhibitor resistance);01522(Endocrine resistance);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04014(Ras signaling pathway);04062(Chemokine signaling pathway);04068(FoxO signaling pathway);04072(Phospholipase D signaling pathway);04150(mTOR signaling pathway);04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04540(Gap junction);04630(Jak-STAT signaling pathway);04650(Natural killer cell mediated cytotoxicity);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04714(Thermogenesis);04722(Neurotrophin signaling pathway);04810(Regulation of actin cytoskeleton);04910(Insulin signaling pathway);04912(GnRH signaling pathway);04915(Estrogen signaling pathway);04917(Prolactin signaling pathway);04926(Relaxin signaling pathway);05034(Alcoholism);05160(Hepatitis C);05161(Hepatitis B);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05200(Pathways in cancer);05205(Proteoglycans in cancer);05206(MicroRNAs in cancer);05210(Colorectal cancer);05211(Renal cell carcinoma);05213(Endometrial cancer);05214(Glioma);05215(Prostate cancer);05220(Chronic myeloid leukemia);05221(Acute myeloid leukemia);05223(Non-small cell lung cancer);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05231(Choline metabolism in cancer)",{"v":1e-120,"d":"0.00"},3,"474,46,80,","0,1026,1258",-9.04,{"v":1.58489319246111e-11,"d":"0.00"},-1.48,"Exon (ENST00000426016/ENSG00000115904, exon 10 of 24)",2,39022876,39023823,948,2]
[61214358,61214418,61,"ENSG00000115464","ENST00000411912","protein_coding",27196,"USP34","ubiquitin specific peptidase 34 [Source:HGNC Symbol;Acc:HGNC:20066]","GO:0004197(cysteine-type endopeptidase activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0016055(Wnt signaling pathway);GO:0016579(protein deubiquitination);GO:0016787(hydrolase activity);GO:0031647(regulation of protein stability);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0071108(protein K48-linked deubiquitination);GO:0090263(positive regulation of canonical Wnt signaling pathway)","NA",{"v":0.0035,"d":"0.00"},1,"61,",0,-0.94,{"v":0.0245470891568503,"d":"0.02"},{"v":-1.4,"d":"-1.40"},"Exon (ENST00000411912/ENSG00000115464, exon 16 of 26)",2,61187463,61241614,54152,2]
[61347894,61348194,301,"ENSG00000115464","ENST00000460004","processed_transcript",0,"USP34","ubiquitin specific peptidase 34 [Source:HGNC Symbol;Acc:HGNC:20066]","GO:0004197(cysteine-type endopeptidase activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0016055(Wnt signaling pathway);GO:0016579(protein deubiquitination);GO:0016787(hydrolase activity);GO:0031647(regulation of protein stability);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0071108(protein K48-linked deubiquitination);GO:0090263(positive regulation of canonical Wnt signaling pathway)","NA",{"v":6.3E-21,"d":"0.00"},1,"301,",0,-6.62,{"v":6.30957344480194e-09,"d":"0.00"},-1.93,"Exon (ENST00000398571/ENSG00000115464, exon 15 of 80)",2,61339575,61348028,8454,2]
[63404266,63404476,211,"ENSG00000143951","ENST00000272321","protein_coding",184001,"WDPCP","WD repeat containing planar cell polarity effector [Source:HGNC Symbol;Acc:HGNC:28027]","GO:0001822(kidney development);GO:0002093(auditory receptor cell morphogenesis);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005929(cilium);GO:0005930(axoneme);GO:0005938(cell cortex);GO:0007224(smoothened signaling pathway);GO:0007399(nervous system development);GO:0010762(regulation of fibroblast migration);GO:0016020(membrane);GO:0016324(apical plasma membrane);GO:0016476(regulation of embryonic cell shape);GO:0030030(cell projection organization);GO:0032185(septin cytoskeleton organization);GO:0032880(regulation of protein localization);GO:0042733(embryonic digit morphogenesis);GO:0042995(cell projection);GO:0043010(camera-type eye development);GO:0044782(cilium organization);GO:0045184(establishment of protein localization);GO:0048568(embryonic organ development);GO:0051893(regulation of focal adhesion assembly);GO:0055123(digestive system development);GO:0060021(roof of mouth development);GO:0060271(cilium assembly);GO:0060541(respiratory system development);GO:0072358(cardiovascular system development);GO:0090521(glomerular visceral epithelial cell migration);GO:0097541(axonemal basal plate);GO:1900027(regulation of ruffle assembly);GO:2000114(regulation of establishment of cell polarity)","NA",{"v":7.2e-05,"d":"0.00"},1,"211,",0,{"v":-0.9,"d":"-0.90"},{"v":0.0281838293126445,"d":"0.03"},-1.58,"3' UTR",2,63119559,63588477,468919,2]
[68464190,68466254,2065,"ENSG00000204923","ENST00000377957","protein_coding",1040,"FBXO48","F-box protein 48 [Source:HGNC Symbol;Acc:HGNC:33857]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0016567(protein ubiquitination);GO:0019005(SCF ubiquitin ligase complex);GO:0031146(SCF-dependent proteasomal ubiquitin-dependent protein catabolic process)","NA",{"v":7.9e-18,"d":"0.00"},3,"181,339,111,","0,650,1954",-1.21,{"v":0.0102329299228075,"d":"0.01"},-1.99,"5' UTR",2,68459422,68467294,7873,2]
[22532239,22532388,150,"ENSG00000243716","ENST00000415654","processed_transcript",53118,"NPIPB5","nuclear pore complex interacting protein family member B5 [Source:HGNC Symbol;Acc:HGNC:37233]","GO:0005654(nucleoplasm);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":0.00054,"d":"0.00"},1,"150,",0,-6.43,{"v":1.02329299228075e-08,"d":"0.00"},-2.11,"3' UTR",16,22479121,22536513,57393,1]
[85549090,85549629,540,"ENSG00000115486","ENST00000233838","protein_coding",11864,"GGCX","gamma-glutamyl carboxylase [Source:HGNC Symbol;Acc:HGNC:4247]","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006464(cellular protein modification process);GO:0007596(blood coagulation);GO:0008488(gamma-glutamyl carboxylase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016829(lyase activity);GO:0017187(peptidyl-glutamic acid carboxylation)","00130(Ubiquinone and other terpenoid-quinone biosynthesis)",{"v":1.3E-25,"d":"0.00"},1,"540,",0,-5.21,{"v":2.29086765276777E-7,"d":"0.00"},-1.21,"3' UTR",2,85544720,85561493,16774,2]
[110168527,110178061,9535,"ENSG00000144061","ENST00000316534","protein_coding",26981,"NPHP1","nephrocystin 1 [Source:HGNC Symbol;Acc:HGNC:7905]","GO:0005198(structural molecule activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005911(cell-cell junction);GO:0005912(adherens junction);GO:0005923(bicellular tight junction);GO:0005929(cilium);GO:0007165(signal transduction);GO:0007283(spermatogenesis);GO:0007588(excretion);GO:0007632(visual behavior);GO:0016020(membrane);GO:0030030(cell projection organization);GO:0030036(actin cytoskeleton organization);GO:0030054(cell junction);GO:0030154(cell differentiation);GO:0031514(motile cilium);GO:0032391(photoreceptor connecting cilium);GO:0035869(ciliary transition zone);GO:0042995(cell projection);GO:0048515(spermatid differentiation);GO:0060041(retina development in camera-type eye);GO:0097711(ciliary basal body-plasma membrane docking);GO:0098609(cell-cell adhesion);GO:1903348(positive regulation of bicellular tight junction assembly)","NA",{"v":1.5E-5,"d":"0.00"},3,"27,193,21,","0,1279,9514",{"v":-1.2,"d":"-1.20"},{"v":0.0109647819614319,"d":"0.01"},-1.79,"3' UTR",2,110122311,110205042,82732,2]
[127291966,127292175,210,"ENSG00000163161","ENST00000426778","nonsense_mediated_decay",1970,"ERCC3","ERCC excision repair 3, TFIIH core complex helicase subunit [Source:HGNC Symbol;Acc:HGNC:3435]","GO:0000112(nucleotide-excision repair factor 3 complex);GO:0000166(nucleotide binding);GO:0000439(transcription factor TFIIH core complex);GO:0000717(nucleotide-excision repair, DNA duplex unwinding);GO:0001666(response to hypoxia);GO:0003677(DNA binding);GO:0003684(damaged DNA binding);GO:0004003(ATP-dependent DNA helicase activity);GO:0004386(helicase activity);GO:0004672(protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005669(transcription factor TFIID complex);GO:0005675(transcription factor TFIIH holo complex);GO:0006265(DNA topological change);GO:0006281(DNA repair);GO:0006283(transcription-coupled nucleotide-excision repair);GO:0006289(nucleotide-excision repair);GO:0006293(nucleotide-excision repair, preincision complex stabilization);GO:0006294(nucleotide-excision repair, preincision complex assembly);GO:0006295(nucleotide-excision repair, DNA incision, 3'-to lesion);GO:0006296(nucleotide-excision repair, DNA incision, 5'-to lesion);GO:0006361(transcription initiation from RNA polymerase I promoter);GO:0006362(transcription elongation from RNA polymerase I promoter);GO:0006363(termination of RNA polymerase I transcription);GO:0006366(transcription by RNA polymerase II);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0006368(transcription elongation from RNA polymerase II promoter);GO:0006370(7-methylguanosine mRNA capping);GO:0006468(protein phosphorylation);GO:0006915(apoptotic process);GO:0006974(cellular response to DNA damage stimulus);GO:0006979(response to oxidative stress);GO:0008022(protein C-terminus binding);GO:0008094(DNA-dependent ATPase activity);GO:0008104(protein localization);GO:0008134(transcription factor binding);GO:0008353(RNA polymerase II CTD heptapeptide repeat kinase activity);GO:0009411(response to UV);GO:0009650(UV protection);GO:0016032(viral process);GO:0016787(hydrolase activity);GO:0016887(ATPase activity);GO:0032508(DNA duplex unwinding);GO:0033683(nucleotide-excision repair, DNA incision);GO:0035315(hair cell differentiation);GO:0043065(positive regulation of apoptotic process);GO:0043138(3'-5' DNA helicase activity);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0047485(protein N-terminus binding);GO:0048568(embryonic organ development);GO:0070911(global genome nucleotide-excision repair);GO:0097550(transcriptional preinitiation complex);GO:1901990(regulation of mitotic cell cycle phase transition)","03022(Basal transcription factors);03420(Nucleotide excision repair)",{"v":0.00069,"d":"0.00"},1,"210,",0,{"v":-0.749,"d":"-0.75"},{"v":0.0467735141287198,"d":"0.05"},-1.68,"3' UTR",2,127257290,127294145,36856,2]
[127307510,127308710,1201,"ENSG00000169967","ENST00000409947","protein_coding",79755,"MAP3K2","mitogen-activated protein kinase kinase kinase 2 [Source:HGNC Symbol;Acc:HGNC:6854]","GO:0000165(MAPK cascade);GO:0000166(nucleotide binding);GO:0000186(activation of MAPKK activity);GO:0000187(activation of MAPK activity);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004709(MAP kinase kinase kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0007257(activation of JUN kinase activity);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0019901(protein kinase binding);GO:0023014(signal transduction by protein phosphorylation);GO:0031098(stress-activated protein kinase signaling cascade);GO:0032147(activation of protein kinase activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0071260(cellular response to mechanical stimulus)","04010(MAPK signaling pathway);04540(Gap junction);04912(GnRH signaling pathway)",{"v":1.6E-50,"d":"0.00"},2,"295,126,","0,1075",-2.55,{"v":0.000229086765276777,"d":"0.00"},-1.07,"3' UTR",2,127298730,127388465,89736,2]
[130075224,130077090,1867,"ENSG00000196604","ENST00000409914","protein_coding",52132,"POTEF","POTE ankyrin domain family member F [Source:HGNC Symbol;Acc:HGNC:33905]","GO:0001895(retina homeostasis);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005938(cell cortex);GO:0070062(extracellular exosome);GO:0072562(blood microparticle)","NA",{"v":3.7E-7,"d":"0.00"},2,"349,10,","0,1857",{"v":-0.878,"d":"-0.88"},{"v":0.0301995172040202,"d":"0.03"},-1.58,"Exon (ENST00000409914/ENSG00000196604, exon 16 of 17)",2,130074030,130129222,55193,2]
[83138685,83138985,301,"ENSG00000083097","ENST00000237163","protein_coding",71019,"DOP1A","DOP1 leucine zipper like protein A [Source:HGNC Symbol;Acc:HGNC:21194]","GO:0000139(Golgi membrane);GO:0005768(endosome);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0006895(Golgi to endosome transport);GO:0007029(endoplasmic reticulum organization);GO:0015031(protein transport);GO:0016020(membrane)","NA",{"v":2.4e-07,"d":"0.00"},1,"301,",0,{"v":-0.827,"d":"-0.83"},{"v":0.0363078054770101,"d":"0.04"},-2.12,"Exon (ENST00000237163/ENSG00000083097, exon 21 of 40)",6,83067666,83168471,100806,1]
[159282703,159283088,386,"ENSG00000196151","ENST00000359774","protein_coding",3711,"WDSUB1","WD repeat, sterile alpha motif and U-box domain containing 1 [Source:HGNC Symbol;Acc:HGNC:26697]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0016567(protein ubiquitination)","NA",{"v":7.9e-29,"d":"0.00"},1,"386,",0,-7.54,{"v":6.45654229034656e-10,"d":"0.00"},-1.42,"5' UTR",2,159235793,159286799,51007,2]
[159386605,159404522,17918,"ENSG00000123636","ENST00000551504","processed_transcript",0,"BAZ2B","bromodomain adjacent to zinc finger domain 2B [Source:HGNC Symbol;Acc:HGNC:963]","GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006338(chromatin remodeling);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","NA",{"v":2E-14,"d":"0.00"},10,"3,141,89,66,27,45,37,66,66,151,","0,2740,5514,9164,10469,10740,11565,12224,13994,17767",-1.05,{"v":0.0173780082874938,"d":"0.02"},-1.39,"3' UTR",2,159385165,159398206,13042,2]
[178576191,178577324,1134,"ENSG00000271011","ENST00000604215","antisense",0,"AC010680","novel transcript, antisense to TTN","NA","NA",{"v":1.6E-12,"d":"0.00"},3,"226,303,402,","0,338,732",-1.04,{"v":0.0177827941003892,"d":"0.02"},-1.46,"Exon (ENST00000627564/ENSG00000237298, exon 6 of 6)",2,178577103,178577622,520,1]
[190699765,190701481,1717,"ENSG00000228509","ENST00000411949","antisense",7235,"AC006460","novel transcript","NA","NA",{"v":4e-13,"d":"0.00"},2,"100,19,","0,1698",{"v":-0.846,"d":"-0.85"},{"v":0.0338844156139203,"d":"0.03"},-1.19,"Exon (ENST00000411949/ENSG00000228509, exon 2 of 3)",2,190677035,190708716,31682,2]
[199271626,199272464,839,"ENSG00000119042","ENST00000614512","protein_coding",192644,"SATB2","SATB homeobox 2 [Source:HGNC Symbol;Acc:HGNC:21637]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001764(neuron migration);GO:0002076(osteoblast development);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0006325(chromatin organization);GO:0006338(chromatin remodeling);GO:0007275(multicellular organism development);GO:0009880(embryonic pattern specification);GO:0010468(regulation of gene expression);GO:0016363(nuclear matrix);GO:0021902(commitment of neuronal cell to specific neuron type in forebrain);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048704(embryonic skeletal system morphogenesis);GO:0051216(cartilage development);GO:0060021(roof of mouth development);GO:0071310(cellular response to organic substance)","NA",{"v":2.3e-09,"d":"0.00"},1,"839,",0,-1,{"v":0.0204173794466953,"d":"0.02"},-1.55,"3' UTR",2,199269500,199465108,195609,2]
[200949623,200958044,8422,"ENSG00000115942","ENST00000234296","protein_coding",5616,"ORC2","origin recognition complex subunit 2 [Source:HGNC Symbol;Acc:HGNC:8488]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000784(nuclear chromosome, telomeric region);GO:0000785(chromatin);GO:0000792(heterochromatin);GO:0000808(origin recognition complex);GO:0000939(condensed chromosome inner kinetochore);GO:0003688(DNA replication origin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005664(nuclear origin of replication recognition complex);GO:0005813(centrosome);GO:0006260(DNA replication);GO:0006270(DNA replication initiation);GO:0016020(membrane)","04110(Cell cycle)",{"v":2.3e-08,"d":"0.00"},3,"21,144,15,","0,7778,8407",-5.76,{"v":5.49540873857625e-08,"d":"0.00"},-1.28,"Exon (ENST00000234296/ENSG00000115942, exon 3 of 18)",2,200908977,200963660,54684,2]
[210153434,210155246,1813,"ENSG00000144445","ENST00000428655","protein_coding",0,"KANSL1L","KAT8 regulatory NSL complex subunit 1 like [Source:HGNC Symbol;Acc:HGNC:26310]","GO:0000123(histone acetyltransferase complex);GO:0035035(histone acetyltransferase binding);GO:0043981(histone H4-K5 acetylation);GO:0043982(histone H4-K8 acetylation);GO:0043984(histone H4-K16 acetylation);GO:0043995(histone acetyltransferase activity (H4-K5 specific));GO:0043996(histone acetyltransferase activity (H4-K8 specific));GO:0044545(NSL complex);GO:0046972(histone acetyltransferase activity (H4-K16 specific))","NA",{"v":1e-103,"d":"0.00"},2,"1178,53,","0,1760",-1.83,{"v":1.65958690743756E-3,"d":"0.00"},{"v":-1.4,"d":"-1.40"},"5' UTR",2,210043433,210153665,110233,2]
[219209772,219209922,151,"ENSG00000115657","ENST00000487380","retained_intron",1117,"ABCB6","ATP binding cassette subfamily B member 6 (Langereis blood group) [Source:HGNC Symbol;Acc:HGNC:47]","GO:0000139(Golgi membrane);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005740(mitochondrial envelope);GO:0005741(mitochondrial outer membrane);GO:0005768(endosome);GO:0005774(vacuolar membrane);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006779(porphyrin-containing compound biosynthetic process);GO:0006879(cellular iron ion homeostasis);GO:0007420(brain development);GO:0010008(endosome membrane);GO:0015439(heme-transporting ATPase activity);GO:0015562(efflux transmembrane transporter activity);GO:0015886(heme transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0020037(heme binding);GO:0031307(integral component of mitochondrial outer membrane);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0043190(ATP-binding cassette (ABC) transporter complex);GO:0043588(skin development);GO:0055085(transmembrane transport);GO:0070062(extracellular exosome)","02010(ABC transporters)",{"v":1.3E-15,"d":"0.00"},1,"151,",0,-3.41,{"v":2.39883291901949E-5,"d":"0.00"},-1.66,"3' UTR",2,219209772,219211039,1268,2]
[219209772,219209922,151,"ENSG00000115657","ENST00000487380","retained_intron",1117,"ABCB6","ATP binding cassette subfamily B member 6 (Langereis blood group) [Source:HGNC Symbol;Acc:HGNC:47]","GO:0000139(Golgi membrane);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005740(mitochondrial envelope);GO:0005741(mitochondrial outer membrane);GO:0005768(endosome);GO:0005774(vacuolar membrane);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006779(porphyrin-containing compound biosynthetic process);GO:0006879(cellular iron ion homeostasis);GO:0007420(brain development);GO:0010008(endosome membrane);GO:0015439(heme-transporting ATPase activity);GO:0015562(efflux transmembrane transporter activity);GO:0015886(heme transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0020037(heme binding);GO:0031307(integral component of mitochondrial outer membrane);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0043190(ATP-binding cassette (ABC) transporter complex);GO:0043588(skin development);GO:0055085(transmembrane transport);GO:0070062(extracellular exosome)","02010(ABC transporters)",{"v":1.3E-15,"d":"0.00"},1,"151,",0,-3.41,{"v":2.39883291901949E-5,"d":"0.00"},-1.66,"3' UTR",2,219209772,219211039,1268,2]
[219250873,219251081,209,"ENSG00000127824","ENST00000248437","protein_coding",2837,"TUBA4A","tubulin alpha 4a [Source:HGNC Symbol;Acc:HGNC:12407]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0000166(nucleotide binding);GO:0000226(microtubule cytoskeleton organization);GO:0000278(mitotic cell cycle);GO:0002576(platelet degranulation);GO:0003924(GTPase activity);GO:0005200(structural constituent of cytoskeleton);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005576(extracellular region);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0007010(cytoskeleton organization);GO:0007017(microtubule-based process);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0015630(microtubule cytoskeleton);GO:0019899(enzyme binding);GO:0019901(protein kinase binding);GO:0070062(extracellular exosome);GO:0097711(ciliary basal body-plasma membrane docking)","04145(Phagosome);04210(Apoptosis);04530(Tight junction);04540(Gap junction);05130(Pathogenic Escherichia coli infection)",{"v":2.5e-06,"d":"0.00"},1,"209,",0,-3.17,{"v":4.46683592150963e-05,"d":"0.00"},-1.28,"Exon (ENST00000248437/ENSG00000127824, exon 4 of 4)",2,219249710,219253918,4209,2]
[15255348,15255498,151,"ENSG00000131370","ENST00000383791","protein_coding",77088,"SH3BP5","SH3 domain binding protein 5 [Source:HGNC Symbol;Acc:HGNC:10827]","GO:0004860(protein kinase inhibitor activity);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006469(negative regulation of protein kinase activity);GO:0007165(signal transduction);GO:0016020(membrane);GO:0016604(nuclear body);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017124(SH3 domain binding);GO:0030659(cytoplasmic vesicle membrane);GO:0031410(cytoplasmic vesicle);GO:0035556(intracellular signal transduction);GO:0061099(negative regulation of protein tyrosine kinase activity)","NA",{"v":5e-07,"d":"0.00"},1,"151,",0,{"v":-0.785,"d":"-0.79"},{"v":0.0416869383470335,"d":"0.04"},-1.16,"3' UTR",3,15254353,15332586,78234,2]
[20152428,20152697,270,"ENSG00000114166","ENST00000263754","protein_coding",111982,"KAT2B","lysine acetyltransferase 2B [Source:HGNC Symbol;Acc:HGNC:8638]","GO:0000123(histone acetyltransferase complex);GO:0000125(PCAF complex);GO:0000776(kinetochore);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0003682(chromatin binding);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0004145(diamine N-acetyltransferase activity);GO:0004402(histone acetyltransferase activity);GO:0004468(lysine N-acetyltransferase activity, acting on acetyl phosphate as donor);GO:0004861(cyclin-dependent protein serine/threonine kinase inhibitor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005671(Ada2/Gcn5/Ada3 transcription activator complex);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005856(cytoskeleton);GO:0006338(chromatin remodeling);GO:0006355(regulation of transcription, DNA-templated);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0006473(protein acetylation);GO:0007049(cell cycle);GO:0007050(cell cycle arrest);GO:0007219(Notch signaling pathway);GO:0007221(positive regulation of transcription of Notch receptor target);GO:0007507(heart development);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell population proliferation);GO:0010835(regulation of protein ADP-ribosylation);GO:0016032(viral process);GO:0016407(acetyltransferase activity);GO:0016573(histone acetylation);GO:0016579(protein deubiquitination);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0018076(N-terminal peptidyl-lysine acetylation);GO:0018393(internal peptidyl-lysine acetylation);GO:0018394(peptidyl-lysine acetylation);GO:0019901(protein kinase binding);GO:0031672(A band);GO:0031674(I band);GO:0032869(cellular response to insulin stimulus);GO:0032991(protein-containing complex);GO:0035948(positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter);GO:0042641(actomyosin);GO:0042826(histone deacetylase binding);GO:0043966(histone H3 acetylation);GO:0043970(histone H3-K9 acetylation);GO:0045652(regulation of megakaryocyte differentiation);GO:0045736(negative regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045747(positive regulation of Notch signaling pathway);GO:0045815(positive regulation of gene expression, epigenetic);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046600(negative regulation of centriole replication);GO:0048511(rhythmic process);GO:0060173(limb development);GO:0061733(peptide-lysine-N-acetyltransferase activity)","04330(Notch signaling pathway);04919(Thyroid hormone signaling pathway);05166(Human T-cell leukemia virus 1 infection);05203(Viral carcinogenesis)",{"v":6.3E-10,"d":"0.00"},1,"270,",0,{"v":-0.821,"d":"-0.82"},{"v":0.0363078054770101,"d":"0.04"},-1.32,"3' UTR",3,20040446,20154404,113959,1]
[31632944,31633123,180,"ENSG00000163527","ENST00000295770","protein_coding",100154,"STT3B","STT3B, catalytic subunit of the oligosaccharyltransferase complex [Source:HGNC Symbol;Acc:HGNC:30611]","GO:0004576(oligosaccharyl transferase activity);GO:0004579(dolichyl-diphosphooligosaccharide-protein glycotransferase activity);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006486(protein glycosylation);GO:0006516(glycoprotein catabolic process);GO:0006986(response to unfolded protein);GO:0008250(oligosaccharyltransferase complex);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0018279(protein N-linked glycosylation via asparagine);GO:0030433(ubiquitin-dependent ERAD pathway);GO:0032991(protein-containing complex);GO:0034998(oligosaccharyltransferase I complex);GO:0043686(co-translational protein modification);GO:0043687(post-translational protein modification);GO:0046872(metal ion binding)","00510(N-Glycan biosynthesis);04141(Protein processing in endoplasmic reticulum)",{"v":7.9e-08,"d":"0.00"},1,"180,",0,{"v":-30.2,"d":"-30.20"},{"v":1.58489319246112e-33,"d":"0.00"},-1.37,"Exon (ENST00000295770/ENSG00000163527, exon 15 of 16)",3,31532790,31637622,104833,1]
[37302297,37319306,17010,"ENSG00000144674","ENST00000361924","protein_coding",59120,"GOLGA4","golgin A4 [Source:HGNC Symbol;Acc:HGNC:4427]","GO:0000139(Golgi membrane);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0043001(Golgi to plasma membrane protein transport);GO:0043231(intracellular membrane-bounded organelle);GO:0045773(positive regulation of axon extension);GO:0051020(GTPase binding);GO:0070062(extracellular exosome)","NA",{"v":6.3e-16,"d":"0.00"},5,"36,14,98,179,244,","0,459,11125,13123,16766",{"v":-1.2,"d":"-1.20"},{"v":0.0109647819614319,"d":"0.01"},{"v":-1.4,"d":"-1.40"},"Exon (ENST00000361924/ENSG00000144674, exon 10 of 24)",3,37243177,37366751,123575,1]
[37276160,37276335,176,"ENSG00000144674","ENST00000361924","protein_coding",32983,"GOLGA4","golgin A4 [Source:HGNC Symbol;Acc:HGNC:4427]","GO:0000139(Golgi membrane);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0043001(Golgi to plasma membrane protein transport);GO:0043231(intracellular membrane-bounded organelle);GO:0045773(positive regulation of axon extension);GO:0051020(GTPase binding);GO:0070062(extracellular exosome)","NA",{"v":6.3e-08,"d":"0.00"},1,"176,",0,-2.66,{"v":1.69824365246174E-4,"d":"0.00"},-1.87,"Exon (ENST00000420496/ENSG00000230409, exon 1 of 1)",3,37243177,37366751,123575,1]
[38506868,38519312,12445,"ENSG00000230683","ENST00000443589","processed_pseudogene",0,"DDTP1","D-dopachrome tautomerase pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:44546]","NA","NA",{"v":7.9e-15,"d":"0.00"},3,"101,119,51,","0,6882,12394",-1.03,{"v":0.0186208713666287,"d":"0.02"},-1.11,"3' UTR",3,38515448,38515830,383,2]
[42225530,42225800,271,"ENSG00000182606","ENST00000487159","protein_coding",211728,"TRAK1","trafficking kinesin protein 1 [Source:HGNC Symbol;Acc:HGNC:29947]","GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005768(endosome);GO:0005769(early endosome);GO:0005938(cell cortex);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006493(protein O-linked glycosylation);GO:0006605(protein targeting);GO:0008089(anterograde axonal transport);GO:0008104(protein localization);GO:0008333(endosome to lysosome transport);GO:0016020(membrane);GO:0017022(myosin binding);GO:0019896(axonal transport of mitochondrion);GO:0022008(neurogenesis);GO:0030425(dendrite);GO:0030911(TPR domain binding);GO:0031410(cytoplasmic vesicle);GO:0031966(mitochondrial membrane);GO:0032839(dendrite cytoplasm);GO:0044295(axonal growth cone);GO:0047496(vesicle transport along microtubule);GO:0048311(mitochondrion distribution);GO:0048471(perinuclear region of cytoplasm);GO:0048813(dendrite morphogenesis);GO:0050772(positive regulation of axonogenesis);GO:0050811(GABA receptor binding);GO:0098957(anterograde axonal transport of mitochondrion);GO:1904115(axon cytoplasm)","NA",{"v":3.2e-25,"d":"0.00"},1,"271,",0,-1.59,{"v":3.31131121482591E-3,"d":"0.00"},-1.09,"3' UTR",3,42013802,42225889,212088,1]
[42665042,42665341,300,"ENSG00000114853","ENST00000232974","protein_coding",11345,"ZBTB47","zinc finger and BTB domain containing 47 [Source:HGNC Symbol;Acc:HGNC:26955]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006974(cellular response to DNA damage stimulus);GO:0046872(metal ion binding)","NA",{"v":1.3E-13,"d":"0.00"},1,"300,",0,-2.42,{"v":0.000331131121482591,"d":"0.00"},-1.19,"3' UTR",3,42653697,42667580,13884,1]
[47243048,47244182,1135,"ENSG00000088727","ENST00000335044","protein_coding",38665,"KIF9","kinesin family member 9 [Source:HGNC Symbol;Acc:HGNC:16666]","GO:0000166(nucleotide binding);GO:0002102(podosome);GO:0003774(motor activity);GO:0003777(microtubule motor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005871(kinesin complex);GO:0005874(microtubule);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding);GO:0016887(ATPase activity);GO:0022617(extracellular matrix disassembly);GO:0031982(vesicle);GO:0046983(protein dimerization activity);GO:0071801(regulation of podosome assembly);GO:1903008(organelle disassembly)","NA",{"v":4e-13,"d":"0.00"},1,"1135,",0,-1.17,{"v":0.0120226443461741,"d":"0.01"},-1.15,"Exon (ENST00000429315/ENSG00000227398, exon 7 of 7)",3,47228026,47282847,54822,2]
[50061963,50065124,3162,"ENSG00000004534","ENST00000442092","protein_coding",121956,"RBM6","RNA binding motif protein 6 [Source:HGNC Symbol;Acc:HGNC:9903]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006396(RNA processing)","NA",{"v":6.3e-09,"d":"0.00"},2,"146,94,","0,3068",-7.32,{"v":1.09647819614318E-9,"d":"0.00"},-1.01,"3' UTR",3,49940007,50077249,137243,1]
[51395391,51395451,61,"ENSG00000259956","ENST00000563281","protein_coding",4106,"RBM15B","RNA binding motif protein 15B [Source:HGNC Symbol;Acc:HGNC:24303]","GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0001510(RNA methylation);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005654(nucleoplasm);GO:0006397(mRNA processing);GO:0006406(mRNA export from nucleus);GO:0008380(RNA splicing);GO:0009048(dosage compensation by inactivation of X chromosome);GO:0016032(viral process);GO:0016607(nuclear speck);GO:0036396(RNA N6-methyladenosine methyltransferase complex)","NA",{"v":0.0078,"d":"0.01"},1,"61,",0,{"v":-0.852,"d":"-0.85"},{"v":0.0331131121482591,"d":"0.03"},-1.17,"3' UTR",3,51391285,51397908,6624,1]
[51668457,51668637,181,"ENSG00000164080","ENST00000409535","protein_coding",126877,"RAD54L2","RAD54 like 2 [Source:HGNC Symbol;Acc:HGNC:29123]","GO:0000166(nucleotide binding);GO:0003677(DNA binding);GO:0004386(helicase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0016787(hydrolase activity)","NA",{"v":1.3e-05,"d":"0.00"},1,"181,",0,{"v":-0.864,"d":"-0.86"},{"v":0.0316227766016838,"d":"0.03"},-1.67,"3' UTR",3,51541580,51668667,127088,1]
[52686797,52686947,151,"ENSG00000163938","ENST00000479230","protein_coding",5641,"GNL3","G protein nucleolar 3 [Source:HGNC Symbol;Acc:HGNC:29931]","GO:0000166(nucleotide binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0008283(cell population proliferation);GO:0016020(membrane);GO:0016604(nuclear body);GO:0017145(stem cell division);GO:0019827(stem cell population maintenance);GO:0032206(positive regulation of telomere maintenance);GO:0033235(positive regulation of protein sumoylation);GO:0042127(regulation of cell population proliferation);GO:0048027(mRNA 5'-UTR binding);GO:1902895(positive regulation of pri-miRNA transcription by RNA polymerase II);GO:1904816(positive regulation of protein localization to chromosome, telomeric region)","03008(Ribosome biogenesis in eukaryotes)",{"v":0.00021,"d":"0.00"},1,"151,",0,-1.96,{"v":0.00114815362149688,"d":"0.00"},-1.02,"Exon (ENST00000479230/ENSG00000163938, exon 2 of 6)",3,52681156,52689105,7950,1]
[66380336,66380846,511,"ENSG00000144741","ENST00000464350","nonsense_mediated_decay",159272,"SLC25A26","solute carrier family 25 member 26 [Source:HGNC Symbol;Acc:HGNC:20661]","GO:0000095(S-adenosyl-L-methionine transmembrane transporter activity);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0006811(ion transport);GO:0015805(S-adenosyl-L-methionine transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport);GO:1901962(S-adenosyl-L-methionine transmembrane transport)","NA",{"v":1.5E-5,"d":"0.00"},1,"511,",0,{"v":-0.795,"d":"-0.80"},{"v":0.0398107170553497,"d":"0.04"},-1.33,"3' UTR",3,66221064,66388116,167053,1]
[113959128,113959398,271,"ENSG00000184307","ENST00000330212","protein_coding",11227,"ZDHHC23","zinc finger DHHC-type containing 23 [Source:HGNC Symbol;Acc:HGNC:28654]","GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0006612(protein targeting to membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0018230(peptidyl-L-cysteine S-palmitoylation);GO:0018345(protein palmitoylation);GO:0019706(protein-cysteine S-palmitoyltransferase activity);GO:0072659(protein localization to plasma membrane)","NA",{"v":2.6e-06,"d":"0.00"},1,"271,",0,-1.09,{"v":0.0151356124843621,"d":"0.02"},-1.42,"3' UTR",3,113947901,113962982,15082,1]
[122718368,122720263,1896,"ENSG00000173193","ENST00000475640","processed_transcript",0,"PARP14","poly(ADP-ribose) polymerase family member 14 [Source:HGNC Symbol;Acc:HGNC:29232]","GO:0002376(immune system process);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006471(protein ADP-ribosylation);GO:0010629(negative regulation of gene expression);GO:0016020(membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0019899(enzyme binding);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042532(negative regulation of tyrosine phosphorylation of STAT protein);GO:0045087(innate immune response);GO:0060336(negative regulation of interferon-gamma-mediated signaling pathway);GO:0140289(protein mono-ADP-ribosylation);GO:1902216(positive regulation of interleukin-4-mediated signaling pathway);GO:1990404(protein ADP-ribosylase activity)","NA",{"v":1e-144,"d":"0.00"},2,"591,9,","0,1887",{"v":-14.6,"d":"-14.60"},{"v":1.99526231496888E-17,"d":"0.00"},-1.31,"3' UTR",3,122718384,122720968,2585,1]
[74552651,74553950,1300,"ENSG00000115318","ENST00000264094","protein_coding",0,"LOXL3","lysyl oxidase like 3 [Source:HGNC Symbol;Acc:HGNC:13869]","GO:0001837(epithelial to mesenchymal transition);GO:0001968(fibronectin binding);GO:0004720(protein-lysine 6-oxidase activity);GO:0005044(scavenger receptor activity);GO:0005507(copper ion binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006898(receptor-mediated endocytosis);GO:0006954(inflammatory response);GO:0016020(membrane);GO:0016491(oxidoreductase activity);GO:0016641(oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor);GO:0018057(peptidyl-lysine oxidation);GO:0021510(spinal cord development);GO:0030199(collagen fibril organization);GO:0030324(lung development);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process);GO:0060021(roof of mouth development);GO:0061053(somite development);GO:1905590(fibronectin fibril organization);GO:2000329(negative regulation of T-helper 17 cell lineage commitment);GO:2001046(positive regulation of integrin-mediated signaling pathway)","NA",{"v":5e-13,"d":"0.00"},2,"434,75,","0,1225",{"v":-3.2,"d":"-3.20"},{"v":4.07380277804113e-05,"d":"0.00"},-2.14,"5' UTR",2,74532258,74553942,21685,2]
[149172984,149173313,330,"ENSG00000047457","ENST00000481169","nonsense_mediated_decay",48514,"CP","ceruloplasmin [Source:HGNC Symbol;Acc:HGNC:2295]","GO:0004322(ferroxidase activity);GO:0005507(copper ion binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005623(cell);GO:0005765(lysosomal membrane);GO:0005788(endoplasmic reticulum lumen);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006825(copper ion transport);GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0016491(oxidoreductase activity);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process);GO:0046872(metal ion binding);GO:0051087(chaperone binding);GO:0055072(iron ion homeostasis);GO:0055114(oxidation-reduction process);GO:0070062(extracellular exosome);GO:0072562(blood microparticle)","00860(Porphyrin and chlorophyll metabolism);04216(Ferroptosis)",{"v":2.5e-17,"d":"0.00"},1,"330,",0,-0.81,{"v":0.0380189396320561,"d":"0.04"},-1.99,"3' UTR",3,149162410,149221827,59418,2]
[158826055,158829122,3068,"ENSG00000118855","ENST00000392813","protein_coding",24129,"MFSD1","major facilitator superfamily domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25874]","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport)","NA",{"v":3.3e-06,"d":"0.00"},3,"8,58,144,","0,1225,2924",-1.29,{"v":0.00831763771102671,"d":"0.01"},-1.19,"3' UTR",3,158801926,158829718,27793,1]
[179148174,179199107,50934,"ENSG00000121879","ENST00000263967","protein_coding",0,"PIK3CA","phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [Source:HGNC Symbol;Acc:HGNC:8975]","GO:0000166(nucleotide binding);GO:0001525(angiogenesis);GO:0001889(liver development);GO:0001932(regulation of protein phosphorylation);GO:0001944(vasculature development);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005942(phosphatidylinositol 3-kinase complex);GO:0005943(phosphatidylinositol 3-kinase complex, class IA);GO:0006006(glucose metabolic process);GO:0006468(protein phosphorylation);GO:0006661(phosphatidylinositol biosynthetic process);GO:0006909(phagocytosis);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007411(axon guidance);GO:0010468(regulation of gene expression);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0016242(negative regulation of macroautophagy);GO:0016301(kinase activity);GO:0016303(1-phosphatidylinositol-3-kinase activity);GO:0016310(phosphorylation);GO:0016477(cell migration);GO:0016740(transferase activity);GO:0019221(cytokine-mediated signaling pathway);GO:0030027(lamellipodium);GO:0030168(platelet activation);GO:0030295(protein kinase activator activity);GO:0031295(T cell costimulation);GO:0032008(positive regulation of TOR signaling);GO:0032147(activation of protein kinase activity);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0035004(phosphatidylinositol 3-kinase activity);GO:0035005(1-phosphatidylinositol-4-phosphate 3-kinase activity);GO:0036092(phosphatidylinositol-3-phosphate biosynthetic process);GO:0038028(insulin receptor signaling pathway via phosphatidylinositol 3-kinase);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0038096(Fc-gamma receptor signaling pathway involved in phagocytosis);GO:0038128(ERBB2 signaling pathway);GO:0040014(regulation of multicellular organism growth);GO:0043276(anoikis);GO:0043457(regulation of cellular respiration);GO:0043491(protein kinase B signaling);GO:0043524(negative regulation of neuron apoptotic process);GO:0043542(endothelial cell migration);GO:0043560(insulin receptor substrate binding);GO:0044029(hypomethylation of CpG island);GO:0046854(phosphatidylinositol phosphorylation);GO:0046934(phosphatidylinositol-4,5-bisphosphate 3-kinase activity);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0048015(phosphatidylinositol-mediated signaling);GO:0050852(T cell receptor signaling pathway);GO:0050900(leukocyte migration);GO:0051897(positive regulation of protein kinase B signaling);GO:0060048(cardiac muscle contraction);GO:0060612(adipose tissue development);GO:0071333(cellular response to glucose stimulus);GO:0097009(energy homeostasis);GO:2000270(negative regulation of fibroblast apoptotic process);GO:2000653(regulation of genetic imprinting);GO:2000811(negative regulation of anoikis)","00562(Inositol phosphate metabolism);01521(EGFR tyrosine kinase inhibitor resistance);01522(Endocrine resistance);01524(Platinum drug resistance);04012(ErbB signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04024(cAMP signaling pathway);04062(Chemokine signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04070(Phosphatidylinositol signaling system);04071(Sphingolipid signaling pathway);04072(Phospholipase D signaling pathway);04140(Autophagy - animal);04150(mTOR signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04210(Apoptosis);04211(Longevity regulating pathway);04213(Longevity regulating pathway - multiple species);04218(Cellular senescence);04360(Axon guidance);04370(VEGF signaling pathway);04380(Osteoclast differentiation);04510(Focal adhesion);04550(Signaling pathways regulating pluripotency of stem cells);04611(Platelet activation);04620(Toll-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04630(Jak-STAT signaling pathway);04650(Natural killer cell mediated cytotoxicity);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04666(Fc gamma R-mediated phagocytosis);04668(TNF signaling pathway);04670(Leukocyte transendothelial migration);04722(Neurotrophin signaling pathway);04725(Cholinergic synapse);04750(Inflammatory mediator regulation of TRP channels);04810(Regulation of actin cytoskeleton);04910(Insulin signaling pathway);04914(Progesterone-mediated oocyte maturation);04915(Estrogen signaling pathway);04917(Prolactin signaling pathway);04919(Thyroid hormone signaling pathway);04923(Regulation of lipolysis in adipocytes);04926(Relaxin signaling pathway);04930(Type II diabetes mellitus);04931(Insulin resistance);04932(Non-alcoholic fatty liver disease (NAFLD));04933(AGE-RAGE signaling pathway in diabetic complications);04960(Aldosterone-regulated sodium reabsorption);04973(Carbohydrate digestion and absorption);05100(Bacterial invasion of epithelial cells);05142(Chagas disease (American trypanosomiasis));05146(Amoebiasis);05160(Hepatitis C);05161(Hepatitis B);05162(Measles);05163(Human cytomegalovirus infection);05164(Influenza A);05165(Human papillomavirus infection);05166(Human T-cell leukemia virus 1 infection);05167(Kaposi sarcoma-associated herpesvirus infection);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer);05203(Viral carcinogenesis);05205(Proteoglycans in cancer);05206(MicroRNAs in cancer);05210(Colorectal cancer);05211(Renal cell carcinoma);05212(Pancreatic cancer);05213(Endometrial cancer);05214(Glioma);05215(Prostate cancer);05218(Melanoma);05220(Chronic myeloid leukemia);05221(Acute myeloid leukemia);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05230(Central carbon metabolism in cancer);05231(Choline metabolism in cancer);05418(Fluid shear stress and atherosclerosis)",{"v":5E-56,"d":"0.00"},4,"46,247,190,358,","0,183,1353,50576",{"v":-0.965,"d":"-0.97"},{"v":0.0229086765276777,"d":"0.02"},{"v":-1.2,"d":"-1.20"},"5' UTR",3,179148357,179240093,91737,1]
[188609519,188609639,121,"ENSG00000145012","ENST00000448637","protein_coding",456235,"LPP","LIM domain containing preferred translocation partner in lipoma [Source:HGNC Symbol;Acc:HGNC:6679]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0007155(cell adhesion);GO:0008150(biological_process);GO:0016020(membrane);GO:0030054(cell junction);GO:0046872(metal ion binding)","NA",{"v":4.3e-05,"d":"0.00"},1,"121,",0,{"v":-2.1,"d":"-2.10"},{"v":0.000794328234724281,"d":"0.00"},-1.48,"Exon (ENST00000448637/ENSG00000145012, exon 6 of 7)",3,188153284,188712842,559559,1]
[15255342,15255492,151,"ENSG00000131370","ENST00000383791","protein_coding",77094,"SH3BP5","SH3 domain binding protein 5 [Source:HGNC Symbol;Acc:HGNC:10827]","GO:0004860(protein kinase inhibitor activity);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006469(negative regulation of protein kinase activity);GO:0007165(signal transduction);GO:0016020(membrane);GO:0016604(nuclear body);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017124(SH3 domain binding);GO:0030659(cytoplasmic vesicle membrane);GO:0031410(cytoplasmic vesicle);GO:0035556(intracellular signal transduction);GO:0061099(negative regulation of protein tyrosine kinase activity)","NA",{"v":5e-07,"d":"0.00"},1,"151,",0,{"v":-0.918,"d":"-0.92"},{"v":0.0269153480392692,"d":"0.03"},-1.31,"3' UTR",3,15254353,15332586,78234,2]
[37075098,37083767,8670,"ENSG00000093167","ENST00000440742","protein_coding",0,"LRRFIP2","LRR binding FLII interacting protein 2 [Source:HGNC Symbol;Acc:HGNC:6703]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0005515(protein binding);GO:0005575(cellular_component);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008150(biological_process);GO:0016055(Wnt signaling pathway);GO:0030275(LRR domain binding)","NA",{"v":0.0011,"d":"0.00"},2,"19,132,","0,8538",-5.49,{"v":1.09647819614319E-7,"d":"0.00"},-1.44,"Exon (ENST00000336686/ENSG00000093167, exon 19 of 28)",3,37058859,37083750,24892,2]
[47910286,47912202,1917,"ENSG00000047849","ENST00000383736","protein_coding",0,"MAP4","microtubule associated protein 4 [Source:HGNC Symbol;Acc:HGNC:6862]","GO:0000226(microtubule cytoskeleton organization);GO:0003723(RNA binding);GO:0005198(structural molecule activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005875(microtubule associated complex);GO:0005886(plasma membrane);GO:0005930(axoneme);GO:0007052(mitotic spindle organization);GO:0008017(microtubule binding);GO:0014069(postsynaptic density);GO:0015630(microtubule cytoskeleton);GO:0015631(tubulin binding);GO:0030424(axon);GO:0031175(neuron projection development);GO:0043005(neuron projection);GO:0051012(microtubule sliding);GO:0051294(establishment of spindle orientation);GO:0051301(cell division);GO:0072686(mitotic spindle);GO:1902856(negative regulation of non-motile cilium assembly)","NA",{"v":6.3e-13,"d":"0.00"},1,"1917,",0,-1.78,{"v":0.00194984459975805,"d":"0.00"},-1.11,"Exon (ENST00000426837/ENSG00000047849, exon 10 of 21)",3,47869212,47910388,41177,2]
[48403854,48404363,510,"ENSG00000164050","ENST00000296440","protein_coding",25723,"PLXNB1","plexin B1 [Source:HGNC Symbol;Acc:HGNC:9103]","GO:0002116(semaphorin receptor complex);GO:0004888(transmembrane signaling receptor activity);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007162(negative regulation of cell adhesion);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0008360(regulation of cell shape);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016477(cell migration);GO:0017154(semaphorin receptor activity);GO:0030215(semaphorin receptor binding);GO:0030334(regulation of cell migration);GO:0032794(GTPase activating protein binding);GO:0033689(negative regulation of osteoblast proliferation);GO:0035556(intracellular signal transduction);GO:0038023(signaling receptor activity);GO:0043087(regulation of GTPase activity);GO:0043547(positive regulation of GTPase activity);GO:0043931(ossification involved in bone maturation);GO:0048812(neuron projection morphogenesis);GO:0050772(positive regulation of axonogenesis);GO:0051493(regulation of cytoskeleton organization);GO:0071526(semaphorin-plexin signaling pathway);GO:1900220(semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis);GO:1902287(semaphorin-plexin signaling pathway involved in axon guidance);GO:1904862(inhibitory synapse assembly)","04360(Axon guidance)",{"v":5e-37,"d":"0.00"},1,"510,",0,-1.73,{"v":0.00229086765276777,"d":"0.00"},-1.06,"3' UTR",3,48403854,48430086,26233,2]
[78938646,79018845,80200,"ENSG00000169855","ENST00000467549","protein_coding",0,"ROBO1","roundabout guidance receptor 1 [Source:HGNC Symbol;Acc:HGNC:10249]","GO:0002042(cell migration involved in sprouting angiogenesis);GO:0003148(outflow tract septum morphogenesis);GO:0003180(aortic valve morphogenesis);GO:0003184(pulmonary valve morphogenesis);GO:0003272(endocardial cushion formation);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006935(chemotaxis);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007275(multicellular organism development);GO:0007399(nervous system development);GO:0007411(axon guidance);GO:0007507(heart development);GO:0008046(axon guidance receptor activity);GO:0009986(cell surface);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016199(axon midline choice point recognition);GO:0021836(chemorepulsion involved in postnatal olfactory bulb interneuron migration);GO:0030154(cell differentiation);GO:0030275(LRR domain binding);GO:0030336(negative regulation of cell migration);GO:0030424(axon);GO:0033116(endoplasmic reticulum-Golgi intermediate compartment membrane);GO:0033600(negative regulation of mammary gland epithelial cell proliferation);GO:0035025(positive regulation of Rho protein signal transduction);GO:0035385(Roundabout signaling pathway);GO:0035481(positive regulation of Notch signaling pathway involved in heart induction);GO:0035904(aorta development);GO:0042802(identical protein binding);GO:0042995(cell projection);GO:0043406(positive regulation of MAP kinase activity);GO:0050772(positive regulation of axonogenesis);GO:0050925(negative regulation of negative chemotaxis);GO:0060412(ventricular septum morphogenesis);GO:0070100(negative regulation of chemokine-mediated signaling pathway);GO:1900748(positive regulation of vascular endothelial growth factor signaling pathway)","04360(Axon guidance)",{"v":1e-122,"d":"0.00"},2,"282,439,","0,79761",{"v":-14.4,"d":"-14.40"},{"v":3.16227766016838e-17,"d":"0.00"},-1.33,"5' UTR",3,78598811,79018544,419734,2]
[97967477,97971643,4167,"ENSG00000170854","ENST00000514314","nonsense_mediated_decay",0,"RIOX2","ribosomal oxygenase 2 [Source:HGNC Symbol;Acc:HGNC:19441]","GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0016491(oxidoreductase activity);GO:0042254(ribosome biogenesis);GO:0042802(identical protein binding);GO:0046872(metal ion binding);GO:0051213(dioxygenase activity);GO:0055114(oxidation-reduction process);GO:1903507(negative regulation of nucleic acid-templated transcription)","NA",{"v":4.7e-08,"d":"0.00"},2,"156,54,","0,4113",-1.46,{"v":0.00501187233627272,"d":"0.01"},-1.15,"5' UTR",3,97947416,97967623,20208,2]
[123733991,123734291,301,"ENSG00000065534","ENST00000360772","protein_coding",150040,"MYLK","myosin light chain kinase [Source:HGNC Symbol;Acc:HGNC:7590]","GO:0000166(nucleotide binding);GO:0001725(stress fiber);GO:0003779(actin binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004687(myosin light chain kinase activity);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0006936(muscle contraction);GO:0006939(smooth muscle contraction);GO:0014820(tonic smooth muscle contraction);GO:0015629(actin cytoskeleton);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0030027(lamellipodium);GO:0030335(positive regulation of cell migration);GO:0032060(bleb assembly);GO:0032154(cleavage furrow);GO:0042995(cell projection);GO:0046872(metal ion binding);GO:0051928(positive regulation of calcium ion transport);GO:0060414(aorta smooth muscle tissue morphogenesis);GO:0071476(cellular hypotonic response);GO:0072358(cardiovascular system development);GO:0090303(positive regulation of wound healing)","04020(Calcium signaling pathway);04022(cGMP-PKG signaling pathway);04270(Vascular smooth muscle contraction);04371(Apelin signaling pathway);04510(Focal adhesion);04611(Platelet activation);04810(Regulation of actin cytoskeleton);04921(Oxytocin signaling pathway);04971(Gastric acid secretion)",{"v":2.4e-05,"d":"0.00"},1,"301,",0,-1.19,{"v":0.0112201845430196,"d":"0.01"},-1.15,"3' UTR",3,123610049,123884331,274283,2]
[123946860,123947100,241,"ENSG00000175455","ENST00000479903","protein_coding",0,"CCDC14","coiled-coil domain containing 14 [Source:HGNC Symbol;Acc:HGNC:25766]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005856(cytoskeleton);GO:0021762(substantia nigra development);GO:0034451(centriolar satellite);GO:0071539(protein localization to centrosome)","NA",{"v":1.8E-7,"d":"0.00"},1,"241,",0,-1.96,{"v":0.00117489755493953,"d":"0.00"},{"v":-1.2,"d":"-1.20"},"3' UTR",3,123897511,123946892,49382,2]
[125288173,125292619,4447,"ENSG00000163848","ENST00000360647","protein_coding",82735,"ZNF148","zinc finger protein 148 [Source:HGNC Symbol;Acc:HGNC:12933]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003690(double-stranded DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0006366(transcription by RNA polymerase II);GO:0006968(cellular defense response);GO:0007276(gamete generation);GO:0010629(negative regulation of gene expression);GO:0021762(substantia nigra development);GO:0043565(sequence-specific DNA binding);GO:0044212(transcription regulatory region DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0065003(protein-containing complex assembly)","NA",{"v":4.2e-05,"d":"0.00"},2,"56,155,","0,4292",{"v":-0.969,"d":"-0.97"},{"v":0.0223872113856834,"d":"0.02"},-1.73,"Exon (ENST00000360647/ENSG00000163848, exon 5 of 9)",3,125225561,125375354,149794,2]
[126352465,126352944,480,"ENSG00000163884","ENST00000296233","protein_coding",4464,"KLF15","Kruppel like factor 15 [Source:HGNC Symbol;Acc:HGNC:14536]","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001678(cellular glucose homeostasis);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0010001(glial cell differentiation);GO:0010468(regulation of gene expression);GO:0014898(cardiac muscle hypertrophy in response to stress);GO:0032868(response to insulin);GO:0044212(transcription regulatory region DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046326(positive regulation of glucose import);GO:0046872(metal ion binding);GO:0072112(glomerular visceral epithelial cell differentiation);GO:1901653(cellular response to peptide);GO:2000757(negative regulation of peptidyl-lysine acetylation)","NA",{"v":1.4e-06,"d":"0.00"},1,"480,",0,{"v":-0.878,"d":"-0.88"},{"v":0.0301995172040202,"d":"0.03"},-1.56,"5' UTR",3,126342635,126357408,14774,2]
[138088483,138088572,90,"ENSG00000158163","ENST00000327532","protein_coding",27036,"DZIP1L","DAZ interacting zinc finger protein 1 like [Source:HGNC Symbol;Acc:HGNC:26551]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005814(centriole);GO:0005856(cytoskeleton);GO:0005929(cilium);GO:0032880(regulation of protein localization);GO:0036064(ciliary basal body);GO:0042995(cell projection);GO:0046872(metal ion binding);GO:0060271(cilium assembly)","NA",{"v":0.0032,"d":"0.00"},1,"90,",0,{"v":-0.888,"d":"-0.89"},{"v":0.0295120922666639,"d":"0.03"},-1.44,"Exon (ENST00000327532/ENSG00000158163, exon 6 of 16)",3,138061990,138115608,53619,2]
[138092441,138097806,5366,"ENSG00000158163","ENST00000488595","processed_transcript",0,"DZIP1L","DAZ interacting zinc finger protein 1 like [Source:HGNC Symbol;Acc:HGNC:26551]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005814(centriole);GO:0005856(cytoskeleton);GO:0005929(cilium);GO:0032880(regulation of protein localization);GO:0036064(ciliary basal body);GO:0042995(cell projection);GO:0046872(metal ion binding);GO:0060271(cilium assembly)","NA",{"v":5e-11,"d":"0.00"},3,"104,122,44,","0,2421,5322",-1.18,{"v":0.0117489755493953,"d":"0.01"},-1.12,"Exon (ENST00000327532/ENSG00000158163, exon 3 of 16)",3,138068301,138092465,24165,2]
[77820777,77820957,181,"ENSG00000048649","ENST00000467567","retained_intron",0,"RSF1","remodeling and spacing factor 1 [Source:HGNC Symbol;Acc:HGNC:18118]","GO:0000123(histone acetyltransferase complex);GO:0000790(nuclear chromatin);GO:0004402(histone acetyltransferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006334(nucleosome assembly);GO:0006338(chromatin remodeling);GO:0006352(DNA-templated transcription, initiation);GO:0006355(regulation of transcription, DNA-templated);GO:0016573(histone acetylation);GO:0016584(nucleosome positioning);GO:0031213(RSF complex);GO:0034080(CENP-A containing nucleosome assembly);GO:0042393(histone binding);GO:0043392(negative regulation of DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0050434(positive regulation of viral transcription)","NA",{"v":0.0016,"d":"0.00"},1,"181,",0,-0.74,{"v":0.0478630092322638,"d":"0.05"},-2.14,"5' UTR",11,77762050,77820869,58820,2]
[539392,539511,120,"ENSG00000174227","ENST00000453061","protein_coding",40182,"PIGG","phosphatidylinositol glycan anchor biosynthesis class G [Source:HGNC Symbol;Acc:HGNC:25985]","GO:0003824(catalytic activity);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006506(GPI anchor biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016254(preassembly of GPI anchor in ER membrane);GO:0016740(transferase activity);GO:0016780(phosphotransferase activity, for other substituted phosphate groups);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0051267(CP2 mannose-ethanolamine phosphotransferase activity);GO:0051377(mannose-ethanolamine phosphotransferase activity)","00563(Glycosylphosphatidylinositol (GPI)-anchor biosynthesis)",{"v":7.2e-05,"d":"0.00"},1,"120,",0,{"v":-0.944,"d":"-0.94"},{"v":0.0245470891568503,"d":"0.02"},{"v":-1.8,"d":"-1.80"},"3' UTR",4,499210,540200,40991,1]
[681102,682033,932,"ENSG00000169026","ENST00000512400","retained_intron",3068,"SLC49A3","solute carrier family 49 member 3 [Source:HGNC Symbol;Acc:HGNC:26177]","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport)","NA",{"v":4e-16,"d":"0.00"},2,"39,141,","0,791",{"v":-0.741,"d":"-0.74"},{"v":0.0478630092322638,"d":"0.05"},-1.17,"3' UTR",4,681829,685101,3273,2]
[1738761,1739031,271,"ENSG00000013810","ENST00000651472","protein_coding",17683,"TACC3","transforming acidic coiled-coil containing protein 3 [Source:HGNC Symbol;Acc:HGNC:11524]","GO:0000226(microtubule cytoskeleton organization);GO:0000922(spindle pole);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005815(microtubule organizing center);GO:0005819(spindle);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0007049(cell cycle);GO:0007052(mitotic spindle organization);GO:0007091(metaphase/anaphase transition of mitotic cell cycle);GO:0008283(cell population proliferation);GO:0021987(cerebral cortex development);GO:0051301(cell division);GO:0060236(regulation of mitotic spindle organization);GO:0072686(mitotic spindle);GO:1902850(microtubule cytoskeleton organization involved in mitosis)","03013(RNA transport)",{"v":4.6E-5,"d":"0.00"},1,"271,",0,-1.95,{"v":0.00123026877081238,"d":"0.00"},-1.04,"3' UTR",4,1721078,1745127,24050,1]
[2833930,2834199,270,"ENSG00000087266","ENST00000503393","protein_coding",40845,"SH3BP2","SH3 domain binding protein 2 [Source:HGNC Symbol;Acc:HGNC:10825]","GO:0001784(phosphotyrosine residue binding);GO:0005070(SH3/SH2 adaptor activity);GO:0005515(protein binding);GO:0007165(signal transduction);GO:0009967(positive regulation of signal transduction);GO:0017124(SH3 domain binding)","04650(Natural killer cell mediated cytotoxicity)",{"v":6.2e-08,"d":"0.00"},1,"270,",0,-2.79,{"v":1.23026877081238E-4,"d":"0.00"},-1.25,"3' UTR",4,2793085,2841098,48014,1]
[5813767,5814305,539,"ENSG00000072832","ENST00000506216","processed_transcript",74166,"CRMP1","collapsin response mediator protein 1 [Source:HGNC Symbol;Acc:HGNC:2365]","GO:0000226(microtubule cytoskeleton organization);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005819(spindle);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006139(nucleobase-containing compound metabolic process);GO:0007399(nervous system development);GO:0007411(axon guidance);GO:0010977(negative regulation of neuron projection development);GO:0016787(hydrolase activity);GO:0016810(hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds);GO:0030496(midbody);GO:0031005(filamin binding);GO:0048666(neuron development);GO:1904530(negative regulation of actin filament binding)","NA",{"v":1e-123,"d":"0.00"},1,"539,",0,{"v":-10.2,"d":"-10.20"},{"v":7.94328234724282e-13,"d":"0.00"},-1.57,"3' UTR",4,5748084,5888471,140388,2]
[38014856,38018385,3530,"ENSG00000065882","ENST00000491553","retained_intron",0,"TBC1D1","TBC1 domain family member 1 [Source:HGNC Symbol;Acc:HGNC:11578]","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006886(intracellular protein transport);GO:0017137(Rab GTPase binding);GO:0032880(regulation of protein localization);GO:0061024(membrane organization);GO:0090630(activation of GTPase activity)","04152(AMPK signaling pathway)",{"v":6.6e-08,"d":"0.00"},2,"118,32,","0,3498",{"v":-7.5,"d":"-7.50"},{"v":7.24435960074989e-10,"d":"0.00"},-1.79,"Exon (ENST00000261439/ENSG00000065882, exon 3 of 20)",4,38014883,38020864,5982,1]
[52864548,52866044,1497,"ENSG00000128045","ENST00000248706","protein_coding",2231,"RASL11B","RAS like family 11 member B [Source:HGNC Symbol;Acc:HGNC:23804]","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005160(transforming growth factor beta receptor binding);GO:0005525(GTP binding);GO:0007165(signal transduction);GO:0016020(membrane);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway)","NA",{"v":6.3e-11,"d":"0.00"},2,"7,710,","0,787",-1.47,{"v":0.00478630092322639,"d":"0.00"},{"v":-1.1,"d":"-1.10"},"3' UTR",4,52862317,52866835,4519,1]
[52864535,52866030,1496,"ENSG00000128045","ENST00000248706","protein_coding",2218,"RASL11B","RAS like family 11 member B [Source:HGNC Symbol;Acc:HGNC:23804]","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005160(transforming growth factor beta receptor binding);GO:0005525(GTP binding);GO:0007165(signal transduction);GO:0016020(membrane);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway)","NA",{"v":4e-10,"d":"0.00"},2,"20,696,","0,800",-1.48,{"v":0.00467735141287198,"d":"0.00"},-1.12,"3' UTR",4,52862317,52866835,4519,1]
[56316376,56316616,241,"ENSG00000109265","ENST00000264229","protein_coding",146181,"KIAA1211","KIAA1211 [Source:HGNC Symbol;Acc:HGNC:29219]","NA","NA",{"v":5.9e-10,"d":"0.00"},1,"241,",0,-2.15,{"v":0.000691830970918936,"d":"0.00"},-1.12,"Exon (ENST00000264229/ENSG00000109265, exon 8 of 11)",4,56170195,56328625,158431,1]
[77157207,77158356,1150,"ENSG00000138764","ENST00000316355","protein_coding",0,"CCNG2","cyclin G2 [Source:HGNC Symbol;Acc:HGNC:1593]","GO:0000079(regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0000278(mitotic cell cycle);GO:0000307(cyclin-dependent protein kinase holoenzyme complex);GO:0004672(protein kinase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0007049(cell cycle);GO:0007088(regulation of mitotic nuclear division);GO:0008284(positive regulation of cell population proliferation);GO:0016538(cyclin-dependent protein serine/threonine kinase regulator activity);GO:0019901(protein kinase binding);GO:0045787(positive regulation of cell cycle);GO:0051301(cell division);GO:0051726(regulation of cell cycle)","04068(FoxO signaling pathway);04115(p53 signaling pathway)",{"v":1.6E-12,"d":"0.00"},2,"300,60,","0,1090",-1.17,{"v":0.0120226443461741,"d":"0.01"},-1.81,"5' UTR",4,77157207,77170060,12854,1]
[86701356,86701685,330,"ENSG00000163629","ENST00000427191","protein_coding",107041,"PTPN13","protein tyrosine phosphatase, non-receptor type 13 [Source:HGNC Symbol;Acc:HGNC:9646]","GO:0001933(negative regulation of protein phosphorylation);GO:0004721(phosphoprotein phosphatase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0006470(protein dephosphorylation);GO:0006661(phosphatidylinositol biosynthetic process);GO:0014066(regulation of phosphatidylinositol 3-kinase signaling);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0016791(phosphatase activity);GO:0030027(lamellipodium);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0036312(phosphatidylinositol 3-kinase regulatory subunit binding);GO:0042995(cell projection);GO:0043005(neuron projection);GO:0044297(cell body);GO:0070062(extracellular exosome);GO:0070830(bicellular tight junction assembly);GO:0071345(cellular response to cytokine stimulus)","04210(Apoptosis)",{"v":5e-24,"d":"0.00"},1,"330,",0,-0.79,{"v":0.0407380277804113,"d":"0.04"},-1.45,"Exon (ENST00000427191/ENSG00000163629, exon 7 of 47)",4,86594315,86815157,220843,1]
[87046892,87047072,181,"ENSG00000172493","ENST00000504956","retained_intron",111890,"AFF1","AF4/FMR2 family member 1 [Source:HGNC Symbol;Acc:HGNC:7135]","GO:0003690(double-stranded DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0008023(transcription elongation factor complex);GO:0032783(ELL-EAF complex)","05202(Transcriptional misregulation in cancer)",{"v":5.9e-08,"d":"0.00"},1,"181,",0,{"v":-2.4,"d":"-2.40"},{"v":0.000346736850452532,"d":"0.00"},-1.25,"Exon (ENST00000504956/ENSG00000172493, exon 3 of 3)",4,86935002,87048049,113048,1]
[87047132,87047611,480,"ENSG00000172493","ENST00000504956","retained_intron",112130,"AFF1","AF4/FMR2 family member 1 [Source:HGNC Symbol;Acc:HGNC:7135]","GO:0003690(double-stranded DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0008023(transcription elongation factor complex);GO:0032783(ELL-EAF complex)","05202(Transcriptional misregulation in cancer)",{"v":2e-32,"d":"0.00"},1,"480,",0,-9.04,{"v":1.58489319246111e-11,"d":"0.00"},-1.43,"Exon (ENST00000504956/ENSG00000172493, exon 3 of 3)",4,86935002,87048049,113048,1]
[88074828,88075625,798,"ENSG00000118762","ENST00000237596","protein_coding",67193,"PKD2","polycystin 2, transient receptor potential cation channel [Source:HGNC Symbol;Acc:HGNC:9009]","GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001822(kidney development);GO:0001889(liver development);GO:0001892(embryonic placenta development);GO:0001947(heart looping);GO:0002133(polycystin complex);GO:0003127(detection of nodal flow);GO:0005102(signaling receptor binding);GO:0005244(voltage-gated ion channel activity);GO:0005245(voltage-gated calcium channel activity);GO:0005248(voltage-gated sodium channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005261(cation channel activity);GO:0005262(calcium channel activity);GO:0005267(potassium channel activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005911(cell-cell junction);GO:0005929(cilium);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0006816(calcium ion transport);GO:0006874(cellular calcium ion homeostasis);GO:0007050(cell cycle arrest);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0007259(receptor signaling pathway via JAK-STAT);GO:0007368(determination of left/right symmetry);GO:0007507(heart development);GO:0008092(cytoskeletal protein binding);GO:0008285(negative regulation of cell population proliferation);GO:0009925(basal plasma membrane);GO:0010628(positive regulation of gene expression);GO:0015267(channel activity);GO:0015271(outward rectifier potassium channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0016323(basolateral plasma membrane);GO:0021510(spinal cord development);GO:0021915(neural tube development);GO:0022843(voltage-gated cation channel activity);GO:0030027(lamellipodium);GO:0030659(cytoplasmic vesicle membrane);GO:0031410(cytoplasmic vesicle);GO:0031514(motile cilium);GO:0031587(positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity);GO:0031941(filamentous actin);GO:0034614(cellular response to reactive oxygen species);GO:0034703(cation channel complex);GO:0034765(regulation of ion transmembrane transport);GO:0035502(metanephric part of ureteric bud development);GO:0035725(sodium ion transmembrane transport);GO:0035904(aorta development);GO:0036064(ciliary basal body);GO:0042127(regulation of cell population proliferation);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0042805(actinin binding);GO:0042994(cytoplasmic sequestering of transcription factor);GO:0042995(cell projection);GO:0043398(HLH domain binding);GO:0044325(ion channel binding);GO:0044782(cilium organization);GO:0045180(basal cortex);GO:0045429(positive regulation of nitric oxide biosynthetic process);GO:0045737(positive regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0048763(calcium-induced calcium release activity);GO:0050982(detection of mechanical stimulus);GO:0051117(ATPase binding);GO:0051209(release of sequestered calcium ion into cytosol);GO:0051219(phosphoprotein binding);GO:0051262(protein tetramerization);GO:0051289(protein homotetramerization);GO:0051290(protein heterotetramerization);GO:0051298(centrosome duplication);GO:0051371(muscle alpha-actinin binding);GO:0051393(alpha-actinin binding);GO:0060170(ciliary membrane);GO:0060315(negative regulation of ryanodine-sensitive calcium-release channel activity);GO:0060674(placenta blood vessel development);GO:0061333(renal tubule morphogenesis);GO:0061441(renal artery morphogenesis);GO:0070062(extracellular exosome);GO:0070588(calcium ion transmembrane transport);GO:0071158(positive regulation of cell cycle arrest);GO:0071277(cellular response to calcium ion);GO:0071320(cellular response to cAMP);GO:0071458(integral component of cytoplasmic side of endoplasmic reticulum membrane);GO:0071464(cellular response to hydrostatic pressure);GO:0071470(cellular response to osmotic stress);GO:0071498(cellular response to fluid shear stress);GO:0071556(integral component of lumenal side of endoplasmic reticulum membrane);GO:0071805(potassium ion transmembrane transport);GO:0071910(determination of liver left/right asymmetry);GO:0072075(metanephric mesenchyme development);GO:0072164(mesonephric tubule development);GO:0072177(mesonephric duct development);GO:0072208(metanephric smooth muscle tissue development);GO:0072214(metanephric cortex development);GO:0072218(metanephric ascending thin limb development);GO:0072219(metanephric cortical collecting duct development);GO:0072235(metanephric distal tubule development);GO:0072284(metanephric S-shaped body morphogenesis);GO:0072686(mitotic spindle);GO:0090279(regulation of calcium ion import);GO:0097730(non-motile cilium);GO:0098662(inorganic cation transmembrane transport);GO:0198738(cell-cell signaling by wnt);GO:2000134(negative regulation of G1/S transition of mitotic cell cycle)","NA",{"v":3.2e-14,"d":"0.00"},2,"132,168,","0,630",-4.52,{"v":1.31825673855641e-06,"d":"0.00"},{"v":-1.1,"d":"-1.10"},"Exon (ENST00000237596/ENSG00000118762, exon 14 of 15)",4,88007635,88077777,70143,1]
[105717890,105718010,121,"ENSG00000138780","ENST00000515255","processed_transcript",9106,"GSTCD","glutathione S-transferase C-terminal domain containing [Source:HGNC Symbol;Acc:HGNC:25806]","GO:0003674(molecular_function);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0008150(biological_process);GO:0070062(extracellular exosome)","NA",{"v":0.0017,"d":"0.00"},1,"121,",0,-1.46,{"v":0.00489778819368446,"d":"0.00"},-1.16,"Exon (ENST00000484843/ENSG00000138780, exon 2 of 6)",4,105708784,105845709,136926,1]
[122239819,122240179,361,"ENSG00000138688","ENST00000446180","protein_coding",0,"KIAA1109","KIAA1109 [Source:HGNC Symbol;Acc:HGNC:26953]","GO:0001558(regulation of cell growth);GO:0005515(protein binding);GO:0005634(nucleus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030856(regulation of epithelial cell differentiation);GO:0048488(synaptic vesicle endocytosis);GO:0098793(presynapse)","NA",{"v":1E-13,"d":"0.00"},1,"361,",0,{"v":-0.735,"d":"-0.74"},{"v":0.0489778819368446,"d":"0.05"},{"v":-1.9,"d":"-1.90"},"Exon (ENST00000264501/ENSG00000138688, exon 29 of 86)",4,122239965,122276189,36225,1]
[127830766,127832888,2123,"ENSG00000164070","ENST00000508776","protein_coding",48945,"HSPA4L","heat shock protein family A (Hsp70) member 4 like [Source:HGNC Symbol;Acc:HGNC:17041]","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006457(protein folding);GO:0006986(response to unfolded protein)","04141(Protein processing in endoplasmic reticulum)",{"v":3.2e-09,"d":"0.00"},2,"34,206,","0,1917",-7.53,{"v":6.76082975391982e-10,"d":"0.00"},-1.41,"3' UTR",4,127781821,127833042,51222,1]
[128028584,128028704,121,"ENSG00000164074","ENST00000398965","protein_coding",63278,"ABHD18","abhydrolase domain containing 18 [Source:HGNC Symbol;Acc:HGNC:26111]","GO:0005576(extracellular region)","NA",{"v":3.3e-05,"d":"0.00"},1,"121,",0,-1.05,{"v":0.0173780082874938,"d":"0.02"},-1.36,"3' UTR",4,127965306,128031290,65985,1]
[150102518,150102667,150,"ENSG00000170390","ENST00000296550","protein_coding",24073,"DCLK2","doublecortin like kinase 2 [Source:HGNC Symbol;Acc:HGNC:19002]","GO:0000166(nucleotide binding);GO:0000226(microtubule cytoskeleton organization);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018105(peptidyl-serine phosphorylation);GO:0021766(hippocampus development);GO:0021860(pyramidal neuron development);GO:0035556(intracellular signal transduction);GO:1900181(negative regulation of protein localization to nucleus)","NA",{"v":0.0012,"d":"0.00"},1,"150,",0,{"v":-0.973,"d":"-0.97"},{"v":0.0223872113856834,"d":"0.02"},-1.12,"Exon (ENST00000296550/ENSG00000170390, exon 2 of 16)",4,150078445,150257438,178994,1]
[186157984,186158224,241,"ENSG00000109794","ENST00000503432","protein_coding",53565,"FAM149A","family with sequence similarity 149 member A [Source:HGNC Symbol;Acc:HGNC:24527]","NA","NA",{"v":1.1e-07,"d":"0.00"},1,"241,",0,-1.52,{"v":0.00407380277804113,"d":"0.00"},-1.97,"Exon (ENST00000514829/ENSG00000109794, exon 9 of 9)",4,186104419,186172140,67722,1]
[31020852,31021564,713,"ENSG00000245614","ENST00000500527","antisense",52283,"DDX11-AS1","DDX11 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:44176]","NA","NA",{"v":2.5e-13,"d":"0.00"},1,"713,",0,{"v":-0.945,"d":"-0.95"},{"v":0.0245470891568503,"d":"0.02"},-2.15,"Exon (ENST00000500527/ENSG00000245614, exon 3 of 3)",12,31020763,31073847,53085,2]
[186158283,186158843,561,"ENSG00000109794","ENST00000503432","protein_coding",53864,"FAM149A","family with sequence similarity 149 member A [Source:HGNC Symbol;Acc:HGNC:24527]","NA","NA",{"v":2.5e-12,"d":"0.00"},2,"283,194,","0,367",-1.49,{"v":0.00457088189614875,"d":"0.00"},-1.96,"Exon (ENST00000514829/ENSG00000109794, exon 9 of 9)",4,186104419,186172140,67722,1]
[867218,867428,211,"ENSG00000178950","ENST00000510799","protein_coding",0,"GAK","cyclin G associated kinase [Source:HGNC Symbol;Acc:HGNC:4113]","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0006468(protein phosphorylation);GO:0006898(receptor-mediated endocytosis);GO:0007029(endoplasmic reticulum organization);GO:0007030(Golgi organization);GO:0007049(cell cycle);GO:0010977(negative regulation of neuron projection development);GO:0016020(membrane);GO:0016191(synaptic vesicle uncoating);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0030054(cell junction);GO:0030276(clathrin binding);GO:0030332(cyclin binding);GO:0031982(vesicle);GO:0034067(protein localization to Golgi apparatus);GO:0043231(intracellular membrane-bounded organelle);GO:0048471(perinuclear region of cytoplasm);GO:0051085(chaperone cofactor-dependent protein refolding);GO:0051087(chaperone binding);GO:0061024(membrane organization);GO:0072318(clathrin coat disassembly);GO:0072583(clathrin-dependent endocytosis);GO:0072659(protein localization to plasma membrane);GO:0090160(Golgi to lysosome transport);GO:0098793(presynapse);GO:1905224(clathrin-coated pit assembly)","NA",{"v":3.2e-23,"d":"0.00"},1,"211,",0,-15,{"v":6.30957344480194e-18,"d":"0.00"},-1.64,"Exon (ENST00000314167/ENSG00000178950, exon 21 of 28)",4,851853,867218,15366,2]
[4416160,4419323,3164,"ENSG00000168818","ENST00000505286","protein_coding",122687,"STX18","syntaxin 18 [Source:HGNC Symbol;Acc:HGNC:15942]","GO:0000139(Golgi membrane);GO:0005484(SNAP receptor activity);GO:0005515(protein binding);GO:0005623(cell);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0006886(intracellular protein transport);GO:0006890(retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum);GO:0015031(protein transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016192(vesicle-mediated transport);GO:0019904(protein domain specific binding);GO:0031201(SNARE complex);GO:0061025(membrane fusion);GO:0090158(endoplasmic reticulum membrane organization);GO:1902117(positive regulation of organelle assembly);GO:1902953(positive regulation of ER to Golgi vesicle-mediated transport);GO:1903358(regulation of Golgi organization)","04130(SNARE interactions in vesicular transport);04145(Phagosome)",{"v":1.3e-10,"d":"0.00"},2,"4,356,","0,2808",{"v":-0.975,"d":"-0.98"},{"v":0.0218776162394955,"d":"0.02"},-1.56,"3' UTR",4,4415742,4542010,126269,2]
[13572840,13577669,4830,"ENSG00000038219","ENST00000040738","protein_coding",50056,"BOD1L1","biorientation of chromosomes in cell division 1 like 1 [Source:HGNC Symbol;Acc:HGNC:31792]","GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0006281(DNA repair);GO:0006974(cellular response to DNA damage stimulus);GO:0031297(replication fork processing)","NA",{"v":4.7e-10,"d":"0.00"},4,"3,154,85,89,","0,3998,4563,4741",-0.79,{"v":0.0407380277804113,"d":"0.04"},-1.26,"Exon (ENST00000040738/ENSG00000038219, exon 23 of 26)",4,13568738,13627725,58988,2]
[15625262,15625770,509,"ENSG00000118564","ENST00000341285","protein_coding",29642,"FBXL5","F-box and leucine rich repeat protein 5 [Source:HGNC Symbol;Acc:HGNC:13602]","GO:0000151(ubiquitin ligase complex);GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005506(iron ion binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006879(cellular iron ion homeostasis);GO:0016567(protein ubiquitination);GO:0019005(SCF ubiquitin ligase complex);GO:0031146(SCF-dependent proteasomal ubiquitin-dependent protein catabolic process);GO:0043687(post-translational protein modification);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0055072(iron ion homeostasis);GO:1903364(positive regulation of cellular protein catabolic process)","NA",{"v":9.99999999999998e-263,"d":"0.00"},1,"509,",0,{"v":-59.2,"d":"-59.20"},{"v":6.30957344480189E-63,"d":"0.00"},-1.55,"3' UTR",4,15604539,15655412,50874,2]
[24838203,24853151,14949,"ENSG00000181982","ENST00000504487","protein_coding",59735,"CCDC149","coiled-coil domain containing 149 [Source:HGNC Symbol;Acc:HGNC:25405]","NA","NA",{"v":1.4E-3,"d":"0.00"},2,"70,80,","0,14869",{"v":-0.847,"d":"-0.85"},{"v":0.0338844156139203,"d":"0.03"},-1.17,"Exon (ENST00000504487/ENSG00000181982, exon 4 of 12)",4,24806117,24912886,106770,2]
[48540370,48540940,571,"ENSG00000075539","ENST00000512297","processed_transcript",0,"FRYL","FRY like transcription coactivator [Source:HGNC Symbol;Acc:HGNC:29127]","GO:0000902(cell morphogenesis);GO:0005938(cell cortex);GO:0031175(neuron projection development)","NA",{"v":1e-138,"d":"0.00"},1,"571,",0,{"v":-12.2,"d":"-12.20"},{"v":6.30957344480194e-15,"d":"0.00"},-1.42,"Exon (ENST00000503238/ENSG00000075539, exon 43 of 61)",4,48531301,48540535,9235,2]
[88071856,88077863,6008,"ENSG00000198707","ENST00000309041","protein_coding",63444,"CEP290","centrosomal protein 290 [Source:HGNC Symbol;Acc:HGNC:29021]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0000930(gamma-tubulin complex);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005929(cilium);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0015031(protein transport);GO:0016020(membrane);GO:0030030(cell projection organization);GO:0030902(hindbrain development);GO:0030916(otic vesicle formation);GO:0031410(cytoplasmic vesicle);GO:0032391(photoreceptor connecting cilium);GO:0032991(protein-containing complex);GO:0034451(centriolar satellite);GO:0035580(specific granule lumen);GO:0035869(ciliary transition zone);GO:0036038(MKS complex);GO:0036064(ciliary basal body);GO:0042462(eye photoreceptor cell development);GO:0042802(identical protein binding);GO:0042995(cell projection);GO:0043312(neutrophil degranulation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0048793(pronephros development);GO:0060271(cilium assembly);GO:0070201(regulation of establishment of protein localization);GO:0090316(positive regulation of intracellular protein transport);GO:0097711(ciliary basal body-plasma membrane docking)","NA",{"v":9.8e-10,"d":"0.00"},3,"71,123,167,","0,5366,5841",{"v":-0.946,"d":"-0.95"},{"v":0.0239883291901949,"d":"0.02"},-2.15,"Exon (ENST00000309041/ENSG00000198707, exon 39 of 53)",12,88049014,88141307,92294,2]
[80332114,80332474,361,"ENSG00000173821","ENST00000508628","protein_coding",71248,"AC124319","ring finger protein 213 [Source:NCBI gene;Acc:57674]","GO:0000209(protein polyubiquitination);GO:0001525(angiogenesis);GO:0002040(sprouting angiogenesis);GO:0004842(ubiquitin-protein transferase activity);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016020(membrane);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0016787(hydrolase activity);GO:0016887(ATPase activity);GO:0046872(metal ion binding);GO:0051260(protein homooligomerization);GO:0051865(protein autoubiquitination);GO:2000051(negative regulation of non-canonical Wnt signaling pathway)","NA",{"v":6.3e-06,"d":"0.00"},1,"361,",0,{"v":-30.2,"d":"-30.20"},{"v":1.58489319246112e-33,"d":"0.00"},-2.15,"Exon (ENST00000508628/ENSG00000173821, exon 22 of 69)",17,80260866,80395312,134447,1]
[67512546,67514588,2043,"ENSG00000145241","ENST00000506410","retained_intron",0,"CENPC","centromere protein C [Source:HGNC Symbol;Acc:HGNC:1854]","GO:0000278(mitotic cell cycle);GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000777(condensed chromosome kinetochore);GO:0000778(condensed nuclear chromosome kinetochore);GO:0000780(condensed nuclear chromosome, centromeric region);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005721(pericentric heterochromatin);GO:0005829(cytosol);GO:0007049(cell cycle);GO:0007059(chromosome segregation);GO:0016604(nuclear body);GO:0019237(centromeric DNA binding);GO:0030496(midbody);GO:0031618(nuclear pericentric heterochromatin);GO:0032154(cleavage furrow);GO:0034080(CENP-A containing nucleosome assembly);GO:0042802(identical protein binding);GO:0045171(intercellular bridge);GO:0051301(cell division);GO:0051315(attachment of mitotic spindle microtubules to kinetochore);GO:0051382(kinetochore assembly);GO:0051455(attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation);GO:0090543(Flemming body)","NA",{"v":5e-31,"d":"0.00"},2,"24,515,","0,1528",{"v":-0.919,"d":"-0.92"},{"v":0.0269153480392692,"d":"0.03"},{"v":-1.2,"d":"-1.20"},"Exon (ENST00000273853/ENSG00000145241, exon 8 of 19)",4,67512050,67514245,2196,2]
[84809952,84810252,301,"ENSG00000163625","ENST00000505923","processed_transcript",0,"WDFY3","WD repeat and FYVE domain containing 3 [Source:HGNC Symbol;Acc:HGNC:20751]","GO:0003831(beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity);GO:0005515(protein binding);GO:0005545(1-phosphatidylinositol binding);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005776(autophagosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006914(autophagy);GO:0007275(multicellular organism development);GO:0008289(lipid binding);GO:0016020(membrane);GO:0016234(inclusion body);GO:0016605(PML body);GO:0019898(extrinsic component of membrane);GO:0030424(axon);GO:0031965(nuclear membrane);GO:0034274(Atg12-Atg5-Atg16 complex);GO:0035973(aggrephagy);GO:0042995(cell projection);GO:0043204(perikaryon);GO:0046872(metal ion binding);GO:0097635(extrinsic component of autophagosome membrane)","NA",{"v":1e-12,"d":"0.00"},1,"301,",0,-2.59,{"v":0.000208929613085404,"d":"0.00"},-1.31,"Exon (ENST00000510449/ENSG00000251260, exon 3 of 3)",4,84801782,84810107,8326,2]
[99548976,99549245,270,"ENSG00000145331","ENST00000394877","protein_coding",14772,"TRMT10A","tRNA methyltransferase 10A [Source:HGNC Symbol;Acc:HGNC:28403]","GO:0000049(tRNA binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0008168(methyltransferase activity);GO:0009019(tRNA (guanine-N1-)-methyltransferase activity);GO:0015629(actin cytoskeleton);GO:0016740(transferase activity);GO:0030488(tRNA methylation);GO:0032259(methylation);GO:0052905(tRNA (guanine(9)-N(1))-methyltransferase activity);GO:0070062(extracellular exosome)","NA",{"v":2.7E-6,"d":"0.00"},1,"270,",0,{"v":-0.737,"d":"-0.74"},{"v":0.0489778819368446,"d":"0.05"},-1.77,"3' UTR",4,99546709,99564017,17309,2]
[39759812,39764467,4656,"ENSG00000151229","ENST00000280871","protein_coding",341614,"SLC2A13","solute carrier family 2 member 13 [Source:HGNC Symbol;Acc:HGNC:15956]","GO:0005215(transporter activity);GO:0005366(myo-inositol:proton symporter activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0015798(myo-inositol transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA",{"v":1E-10,"d":"0.00"},2,"441,8,","0,4648",{"v":-1.4,"d":"-1.40"},{"v":0.00588843655355589,"d":"0.01"},-2.16,"3' UTR",12,39755025,40106081,351057,2]
[150852163,150852403,241,"ENSG00000198589","ENST00000651943","protein_coding",162881,"LRBA","LPS responsive beige-like anchor protein [Source:HGNC Symbol;Acc:HGNC:1742]","GO:0003674(molecular_function);GO:0005515(protein binding);GO:0005764(lysosome);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0008150(biological_process);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":6.3e-11,"d":"0.00"},1,"241,",0,-7.13,{"v":1.77827941003892e-09,"d":"0.00"},-1.52,"Exon (ENST00000651943/ENSG00000198589, exon 23 of 57)",4,150264435,151015284,750850,2]
[185169060,185169209,150,"ENSG00000164323","ENST00000458385","protein_coding",34791,"CFAP97","cilia and flagella associated protein 97 [Source:HGNC Symbol;Acc:HGNC:29276]","NA","NA",{"v":7.6e-08,"d":"0.00"},1,"150,",0,-1.67,{"v":2.69153480392692E-3,"d":"0.00"},-1.23,"3' UTR",4,185159665,185204000,44336,2]
[50666767,50667586,820,"ENSG00000151883","ENST00000510040","retained_intron",0,"PARP8","poly(ADP-ribose) polymerase family member 8 [Source:HGNC Symbol;Acc:HGNC:26124]","GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005622(intracellular);GO:0006471(protein ADP-ribosylation);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0070213(protein auto-ADP-ribosylation);GO:0140289(protein mono-ADP-ribosylation);GO:1990404(protein ADP-ribosylase activity)","NA",{"v":0.00013,"d":"0.00"},2,"420,30,","0,790",-0.94,{"v":0.0245470891568503,"d":"0.02"},-1.39,"5' UTR",5,50666819,50669517,2699,1]
[50794895,50795375,481,"ENSG00000151883","ENST00000505697","protein_coding",128996,"PARP8","poly(ADP-ribose) polymerase family member 8 [Source:HGNC Symbol;Acc:HGNC:26124]","GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005622(intracellular);GO:0006471(protein ADP-ribosylation);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0070213(protein auto-ADP-ribosylation);GO:0140289(protein mono-ADP-ribosylation);GO:1990404(protein ADP-ribosylase activity)","NA",{"v":1.3e-16,"d":"0.00"},1,"481,",0,{"v":-0.863,"d":"-0.86"},{"v":0.0316227766016838,"d":"0.03"},-1.22,"3' UTR",5,50665899,50842068,176170,1]
[55307989,55322407,14419,"ENSG00000039123","ENST00000230640","protein_coding",0,"MTREX","Mtr4 exosome RNA helicase [Source:HGNC Symbol;Acc:HGNC:18734]","GO:0000166(nucleotide binding);GO:0000176(nuclear exosome (RNase complex));GO:0000178(exosome (RNase complex));GO:0000398(mRNA splicing, via spliceosome);GO:0000460(maturation of 5.8S rRNA);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003724(RNA helicase activity);GO:0004004(ATP-dependent RNA helicase activity);GO:0004386(helicase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0006397(mRNA processing);GO:0006401(RNA catabolic process);GO:0008380(RNA splicing);GO:0016787(hydrolase activity);GO:0031499(TRAMP complex);GO:0071013(catalytic step 2 spliceosome)","03018(RNA degradation)",{"v":6.3e-47,"d":"0.00"},2,"159,81,","0,14338",-3.73,{"v":1e-05,"d":"0.00"},-1.06,"5' UTR",5,55307989,55425579,117591,1]
[72142329,72144056,1728,"ENSG00000204131","ENST00000633930","protein_coding",231511,"NHSL2","NHS like 2 [Source:HGNC Symbol;Acc:HGNC:33737]","GO:0030154(cell differentiation)","NA",{"v":1.3E-33,"d":"0.00"},2,"36,804,","0,924",-2.06,{"v":0.000870963589956081,"d":"0.00"},-2.16,"3' UTR",23,71910818,72153286,242469,1]
[72205125,72205725,601,"ENSG00000131711","ENST00000296755","protein_coding",97650,"MAP1B","microtubule associated protein 1B [Source:HGNC Symbol;Acc:HGNC:6836]","GO:0000226(microtubule cytoskeleton organization);GO:0001578(microtubule bundle formation);GO:0001750(photoreceptor outer segment);GO:0001764(neuron migration);GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005515(protein binding);GO:0005543(phospholipid binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005875(microtubule associated complex);GO:0005886(plasma membrane);GO:0007026(negative regulation of microtubule depolymerization);GO:0007399(nervous system development);GO:0007409(axonogenesis);GO:0007416(synapse assembly);GO:0008017(microtubule binding);GO:0009611(response to wounding);GO:0009612(response to mechanical stimulus);GO:0009743(response to carbohydrate);GO:0009987(cellular process);GO:0010035(response to inorganic substance);GO:0014012(peripheral nervous system axon regeneration);GO:0014069(postsynaptic density);GO:0015631(tubulin binding);GO:0016358(dendrite development);GO:0017085(response to insecticide);GO:0021700(developmental maturation);GO:0030054(cell junction);GO:0030424(axon);GO:0030425(dendrite);GO:0030426(growth cone);GO:0031114(regulation of microtubule depolymerization);GO:0031116(positive regulation of microtubule polymerization);GO:0031667(response to nutrient levels);GO:0032355(response to estradiol);GO:0032387(negative regulation of intracellular transport);GO:0033189(response to vitamin A);GO:0036477(somatodendritic compartment);GO:0042493(response to drug);GO:0042995(cell projection);GO:0043025(neuronal cell body);GO:0043196(varicosity);GO:0043197(dendritic spine);GO:0043204(perikaryon);GO:0044877(protein-containing complex binding);GO:0045202(synapse);GO:0045666(positive regulation of neuron differentiation);GO:0045773(positive regulation of axon extension);GO:0047497(mitochondrion transport along microtubule);GO:0048471(perinuclear region of cytoplasm);GO:0048666(neuron development);GO:0048675(axon extension);GO:0048678(response to axon injury);GO:0051915(induction of synaptic plasticity by chemical substance);GO:0061162(establishment of monopolar cell polarity);GO:0071363(cellular response to growth factor stimulus);GO:0071375(cellular response to peptide hormone stimulus);GO:0097440(apical dendrite);GO:0097441(basal dendrite);GO:0097457(hippocampal mossy fiber)","NA",{"v":7.9e-19,"d":"0.00"},1,"601,",0,{"v":-0.811,"d":"-0.81"},{"v":0.0380189396320561,"d":"0.04"},-1.22,"3' UTR",5,72107475,72209565,102091,1]
[105137395,105137713,319,"ENSG00000251259","ENST00000504082","lincRNA",2906,"AC004069","novel transcript","NA","NA",{"v":2.6E-7,"d":"0.00"},1,"319,",0,-1.22,{"v":0.0102329299228075,"d":"0.01"},-2.17,"Exon (ENST00000504082/ENSG00000251259, exon 2 of 2)",4,105137280,105140619,3340,2]
[40557048,40557228,181,"ENSG00000160460","ENST00000595535","protein_coding",90807,"SPTBN4","spectrin beta, non-erythrocytic 4 [Source:HGNC Symbol;Acc:HGNC:14896]","GO:0000165(MAPK cascade);GO:0002028(regulation of sodium ion transport);GO:0003779(actin binding);GO:0005200(structural constituent of cytoskeleton);GO:0005515(protein binding);GO:0005543(phospholipid binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005912(adherens junction);GO:0005938(cell cortex);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0007010(cytoskeleton organization);GO:0007016(cytoskeletal anchoring at plasma membrane);GO:0007409(axonogenesis);GO:0007411(axon guidance);GO:0007605(sensory perception of sound);GO:0007628(adult walking behavior);GO:0008091(spectrin);GO:0009566(fertilization);GO:0010459(negative regulation of heart rate);GO:0014704(intercalated disc);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0016363(nuclear matrix);GO:0016605(PML body);GO:0019226(transmission of nerve impulse);GO:0019902(phosphatase binding);GO:0021952(central nervous system projection neuron axonogenesis);GO:0022414(reproductive process);GO:0030424(axon);GO:0030506(ankyrin binding);GO:0030507(spectrin binding);GO:0030534(adult behavior);GO:0033135(regulation of peptidyl-serine phosphorylation);GO:0033268(node of Ranvier);GO:0033270(paranode region of axon);GO:0034613(cellular protein localization);GO:0040018(positive regulation of multicellular organism growth);GO:0043025(neuronal cell body);GO:0043194(axon initial segment);GO:0043203(axon hillock);GO:0045162(clustering of voltage-gated sodium channels);GO:0051693(actin filament capping);GO:0061337(cardiac conduction);GO:0070062(extracellular exosome);GO:0070852(cell body fiber);GO:0072659(protein localization to plasma membrane)","NA",{"v":3.1E-4,"d":"0.00"},1,"181,",0,-1.27,{"v":0.0087096358995608,"d":"0.01"},-2.17,"3' UTR",19,40466241,40560507,94267,1]
[87391034,87391363,330,"ENSG00000134480","ENST00000645953","nonsense_mediated_decay",21545,"CCNH","cyclin H [Source:HGNC Symbol;Acc:HGNC:1594]","GO:0000079(regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0000082(G1/S transition of mitotic cell cycle);GO:0000086(G2/M transition of mitotic cell cycle);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005675(transcription factor TFIIH holo complex);GO:0006283(transcription-coupled nucleotide-excision repair);GO:0006294(nucleotide-excision repair, preincision complex assembly);GO:0006351(transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006361(transcription initiation from RNA polymerase I promoter);GO:0006362(transcription elongation from RNA polymerase I promoter);GO:0006363(termination of RNA polymerase I transcription);GO:0006366(transcription by RNA polymerase II);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0006368(transcription elongation from RNA polymerase II promoter);GO:0006370(7-methylguanosine mRNA capping);GO:0006468(protein phosphorylation);GO:0007049(cell cycle);GO:0008094(DNA-dependent ATPase activity);GO:0008353(RNA polymerase II CTD heptapeptide repeat kinase activity);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016538(cyclin-dependent protein serine/threonine kinase regulator activity);GO:0019907(cyclin-dependent protein kinase activating kinase holoenzyme complex);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050821(protein stabilization);GO:0070985(transcription factor TFIIK complex)","03022(Basal transcription factors);03420(Nucleotide excision repair);04110(Cell cycle)",{"v":4e-25,"d":"0.00"},1,"330,",0,-2.57,{"v":2.23872113856834E-4,"d":"0.00"},-1.04,"3' UTR",5,87318416,87412908,94493,2]
[96726785,96728601,1817,"ENSG00000153113","ENST00000348386","processed_transcript",0,"CAST","calpastatin [Source:HGNC Symbol;Acc:HGNC:1515]","GO:0002020(protease binding);GO:0003723(RNA binding);GO:0004866(endopeptidase inhibitor activity);GO:0004869(cysteine-type endopeptidase inhibitor activity);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0010466(negative regulation of peptidase activity);GO:0010859(calcium-dependent cysteine-type endopeptidase inhibitor activity);GO:0016020(membrane);GO:0030414(peptidase inhibitor activity);GO:0045296(cadherin binding);GO:0097340(inhibition of cysteine-type endopeptidase activity);GO:1990709(presynaptic active zone organization);GO:2000675(negative regulation of type B pancreatic cell apoptotic process)","NA",{"v":4e-17,"d":"0.00"},4,"75,42,110,14,","0,704,1524,1803",-6.97,{"v":2.69153480392691e-09,"d":"0.00"},-1.06,"5' UTR",5,96728309,96772819,44511,1]
[96879933,96880964,1032,"ENSG00000164308","ENST00000507346","protein_coding",0,"ERAP2","endoplasmic reticulum aminopeptidase 2 [Source:HGNC Symbol;Acc:HGNC:29499]","GO:0002250(adaptive immune response);GO:0002376(immune system process);GO:0002474(antigen processing and presentation of peptide antigen via MHC class I);GO:0004177(aminopeptidase activity);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005788(endoplasmic reticulum lumen);GO:0005789(endoplasmic reticulum membrane);GO:0006508(proteolysis);GO:0008217(regulation of blood pressure);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0019885(antigen processing and presentation of endogenous peptide antigen via MHC class I);GO:0042277(peptide binding);GO:0043171(peptide catabolic process);GO:0046872(metal ion binding);GO:0070006(metalloaminopeptidase activity)","NA",{"v":4e-18,"d":"0.00"},2,"328,32,","0,1000",-3.39,{"v":2.51188643150958e-05,"d":"0.00"},-1.41,"5' UTR",5,96880933,96883825,2893,1]
[111126764,111127063,300,"ENSG00000134987","ENST00000506538","protein_coding",35048,"WDR36","WD repeat domain 36 [Source:HGNC Symbol;Acc:HGNC:30696]","GO:0001895(retina homeostasis);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0007601(visual perception);GO:0008150(biological_process);GO:0030516(regulation of axon extension);GO:0032040(small-subunit processome);GO:0034388(Pwp2p-containing subcomplex of 90S preribosome);GO:0042254(ribosome biogenesis);GO:0050896(response to stimulus)","03008(Ribosome biogenesis in eukaryotes)",{"v":3.9e-09,"d":"0.00"},1,"300,",0,-2.48,{"v":2.75422870333817E-4,"d":"0.00"},-1.86,"3' UTR",5,111091716,111130502,38787,1]
[112892559,112893757,1199,"ENSG00000129625","ENST00000379638","protein_coding",28470,"REEP5","receptor accessory protein 5 [Source:HGNC Symbol;Acc:HGNC:30077]","GO:0003674(molecular_function);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0008150(biological_process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0071782(endoplasmic reticulum tubular network)","NA",{"v":1.6e-10,"d":"0.00"},1,"1199,",0,-1.16,{"v":0.0120226443461741,"d":"0.01"},-1.62,"3' UTR",5,112876385,112922227,45843,2]
[37167161,37169247,2087,"ENSG00000197603","ENST00000511824","protein_coding",0,"CPLANE1","ciliogenesis and planar polarity effector 1 [Source:HGNC Symbol;Acc:HGNC:25801]","GO:0001736(establishment of planar polarity);GO:0001822(kidney development);GO:0003279(cardiac septum development);GO:0003281(ventricular septum development);GO:0005515(protein binding);GO:0005929(cilium);GO:0007507(heart development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0021549(cerebellum development);GO:0030030(cell projection organization);GO:0035869(ciliary transition zone);GO:0042733(embryonic digit morphogenesis);GO:0042995(cell projection);GO:0060021(roof of mouth development);GO:0060271(cilium assembly);GO:0060976(coronary vasculature development);GO:1904491(protein localization to ciliary transition zone)","NA",{"v":5e-17,"d":"0.00"},2,"53,457,","0,1630",-1.04,{"v":0.0177827941003892,"d":"0.02"},-2.18,"Exon (ENST00000508244/ENSG00000197603, exon 33 of 51)",5,37153740,37169095,15356,2]
[113593878,113594028,151,"ENSG00000047188","ENST00000161863","protein_coding",80184,"YTHDC2","YTH domain containing 2 [Source:HGNC Symbol;Acc:HGNC:24721]","GO:0000166(nucleotide binding);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0004386(helicase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0007283(spermatogenesis);GO:0007286(spermatid development);GO:0008186(RNA-dependent ATPase activity);GO:0016787(hydrolase activity);GO:0030154(cell differentiation);GO:0034458(3'-5' RNA helicase activity);GO:0034459(ATP-dependent 3'-5' RNA helicase activity);GO:0034612(response to tumor necrosis factor);GO:0035770(ribonucleoprotein granule);GO:0044829(positive regulation by host of viral genome replication);GO:0048477(oogenesis);GO:0048599(oocyte development);GO:0051321(meiotic cell cycle);GO:0051729(germline cell cycle switching, mitotic to meiotic cell cycle);GO:0070063(RNA polymerase binding);GO:0070555(response to interleukin-1);GO:1990247(N6-methyladenosine-containing RNA binding)","NA",{"v":0.00079,"d":"0.00"},1,"151,",0,-1.07,{"v":0.0162181009735893,"d":"0.02"},-1.11,"3' UTR",5,113513694,113595284,81591,1]
[132394236,132394656,421,"ENSG00000197375","ENST00000245407","protein_coding",24484,"SLC22A5","solute carrier family 22 member 5 [Source:HGNC Symbol;Acc:HGNC:10969]","GO:0000166(nucleotide binding);GO:0005215(transporter activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006814(sodium ion transport);GO:0006855(drug transmembrane transport);GO:0015226(carnitine transmembrane transporter activity);GO:0015238(drug transmembrane transporter activity);GO:0015293(symporter activity);GO:0015651(quaternary ammonium group transmembrane transporter activity);GO:0015697(quaternary ammonium group transport);GO:0015879(carnitine transport);GO:0015893(drug transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane);GO:0022857(transmembrane transporter activity);GO:0030165(PDZ domain binding);GO:0031526(brush border membrane);GO:0052106(quorum sensing involved in interaction with host);GO:0055085(transmembrane transport);GO:0060731(positive regulation of intestinal epithelial structure maintenance);GO:0070062(extracellular exosome);GO:0070715(sodium-dependent organic cation transport);GO:1902603(carnitine transmembrane transport)","05231(Choline metabolism in cancer)",{"v":3.2e-21,"d":"0.00"},1,"421,",0,-2.77,{"v":0.000128824955169313,"d":"0.00"},-1.01,"3' UTR",5,132369752,132395614,25863,1]
[134661178,134661417,240,"ENSG00000113615","ENST00000398844","protein_coding",12393,"SEC24A","SEC24 homolog A, COPII coat complex component [Source:HGNC Symbol;Acc:HGNC:10703]","GO:0000139(Golgi membrane);GO:0002474(antigen processing and presentation of peptide antigen via MHC class I);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0006886(intracellular protein transport);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0008270(zinc ion binding);GO:0012507(ER to Golgi transport vesicle membrane);GO:0015031(protein transport);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0019886(antigen processing and presentation of exogenous peptide antigen via MHC class II);GO:0030127(COPII vesicle coat);GO:0031410(cytoplasmic vesicle);GO:0042632(cholesterol homeostasis);GO:0045714(regulation of low-density lipoprotein particle receptor biosynthetic process);GO:0046872(metal ion binding);GO:0048208(COPII vesicle coating);GO:0050714(positive regulation of protein secretion);GO:0090110(COPII-coated vesicle cargo loading)","04141(Protein processing in endoplasmic reticulum)",{"v":2e-06,"d":"0.00"},1,"240,",0,-2.47,{"v":0.000288403150312661,"d":"0.00"},-1.09,"Exon (ENST00000398844/ENSG00000113615, exon 2 of 23)",5,134648785,134727909,79125,1]
[87860746,87861404,659,"ENSG00000227268","ENST00000445946","protein_coding",2033,"KLLN","killin, p53 regulated DNA replication inhibitor [Source:HGNC Symbol;Acc:HGNC:37212]","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006915(apoptotic process);GO:0007049(cell cycle);GO:0007050(cell cycle arrest)","NA",{"v":4.6e-09,"d":"0.00"},1,"659,",0,{"v":-0.926,"d":"-0.93"},{"v":0.0257039578276886,"d":"0.03"},-2.18,"3' UTR",10,87859161,87863437,4277,2]
[141639981,141640129,149,"ENSG00000164620","ENST00000444782","protein_coding",3031,"RELL2","RELT like 2 [Source:HGNC Symbol;Acc:HGNC:26902]","GO:0005515(protein binding);GO:0005518(collagen binding);GO:0005604(basement membrane);GO:0005886(plasma membrane);GO:0010811(positive regulation of cell-substrate adhesion);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031012(extracellular matrix);GO:1900745(positive regulation of p38MAPK cascade)","NA",{"v":1.5E-6,"d":"0.00"},1,"149,",0,-1.42,{"v":0.00562341325190349,"d":"0.01"},{"v":-1.2,"d":"-1.20"},"3' UTR",5,141636950,141641063,4114,1]
[149836401,149840087,3687,"ENSG00000155846","ENST00000360453","protein_coding",106103,"PPARGC1B","PPARG coactivator 1 beta [Source:HGNC Symbol;Acc:HGNC:30022]","GO:0001503(ossification);GO:0003676(nucleic acid binding);GO:0003712(transcription coregulator activity);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0006355(regulation of transcription, DNA-templated);GO:0006390(mitochondrial transcription);GO:0007015(actin filament organization);GO:0008134(transcription factor binding);GO:0010694(positive regulation of alkaline phosphatase activity);GO:0016592(mediator complex);GO:0030331(estrogen receptor binding);GO:0030374(nuclear receptor transcription coactivator activity);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0034614(cellular response to reactive oxygen species);GO:0042327(positive regulation of phosphorylation);GO:0045672(positive regulation of osteoclast differentiation);GO:0045780(positive regulation of bone resorption);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050682(AF-2 domain binding);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051384(response to glucocorticoid);GO:0051591(response to cAMP);GO:0060346(bone trabecula formation);GO:0120162(positive regulation of cold-induced thermogenesis);GO:1903506(regulation of nucleic acid-templated transcription)","04931(Insulin resistance)",{"v":7.9e-30,"d":"0.00"},2,"673,47,","0,3640",-2.75,{"v":0.000138038426460289,"d":"0.00"},-1.06,"Exon (ENST00000360453/ENSG00000155846, exon 7 of 11)",5,149730298,149847562,117265,1]
[149853224,149853463,240,"ENSG00000155846","ENST00000309241","protein_coding",122914,"PPARGC1B","PPARG coactivator 1 beta [Source:HGNC Symbol;Acc:HGNC:30022]","GO:0001503(ossification);GO:0003676(nucleic acid binding);GO:0003712(transcription coregulator activity);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0006355(regulation of transcription, DNA-templated);GO:0006390(mitochondrial transcription);GO:0007015(actin filament organization);GO:0008134(transcription factor binding);GO:0010694(positive regulation of alkaline phosphatase activity);GO:0016592(mediator complex);GO:0030331(estrogen receptor binding);GO:0030374(nuclear receptor transcription coactivator activity);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0034614(cellular response to reactive oxygen species);GO:0042327(positive regulation of phosphorylation);GO:0045672(positive regulation of osteoclast differentiation);GO:0045780(positive regulation of bone resorption);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050682(AF-2 domain binding);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051384(response to glucocorticoid);GO:0051591(response to cAMP);GO:0060346(bone trabecula formation);GO:0120162(positive regulation of cold-induced thermogenesis);GO:1903506(regulation of nucleic acid-templated transcription)","04931(Insulin resistance)",{"v":8.1e-09,"d":"0.00"},1,"240,",0,{"v":-1.1,"d":"-1.10"},{"v":0.0151356124843621,"d":"0.02"},-1.05,"3' UTR",5,149730310,149855022,124713,1]
[151488999,151489597,599,"ENSG00000123643","ENST00000243389","protein_coding",41396,"SLC36A1","solute carrier family 36 member 1 [Source:HGNC Symbol;Acc:HGNC:18761]","GO:0003333(amino acid transmembrane transport);GO:0005280(amino acid:proton symporter activity);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006865(amino acid transport);GO:0015078(proton transmembrane transporter activity);GO:0015171(amino acid transmembrane transporter activity);GO:0015175(neutral amino acid transmembrane transporter activity);GO:0015180(L-alanine transmembrane transporter activity);GO:0015187(glycine transmembrane transporter activity);GO:0015193(L-proline transmembrane transporter activity);GO:0015293(symporter activity);GO:0015804(neutral amino acid transport);GO:0015808(L-alanine transport);GO:0015816(glycine transport);GO:0015824(proline transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0035524(proline transmembrane transport);GO:1902600(proton transmembrane transport)","04974(Protein digestion and absorption)",{"v":2.5e-29,"d":"0.00"},1,"599,",0,-4.26,{"v":2.51188643150958e-06,"d":"0.00"},{"v":-1.2,"d":"-1.20"},"3' UTR",5,151447603,151492379,44777,1]
[154418825,154419065,241,"ENSG00000164574","ENST00000297107","protein_coding",228092,"GALNT10","polypeptide N-acetylgalactosaminyltransferase 10 [Source:HGNC Symbol;Acc:HGNC:19873]","GO:0000139(Golgi membrane);GO:0004653(polypeptide N-acetylgalactosaminyltransferase activity);GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0006493(protein O-linked glycosylation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016266(O-glycan processing);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030246(carbohydrate binding);GO:0046872(metal ion binding)","00512(Mucin type O-glycan biosynthesis)",{"v":5.9e-08,"d":"0.00"},1,"241,",0,{"v":-1.9,"d":"-1.90"},{"v":0.00138038426460289,"d":"0.00"},-1.23,"3' UTR",5,154190733,154420984,230252,1]
[168414442,168414592,151,"ENSG00000113645","ENST00000265293","protein_coding",122791,"WWC1","WW and C2 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:29435]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007221(positive regulation of transcription of Notch receptor target);GO:0016020(membrane);GO:0016477(cell migration);GO:0019900(kinase binding);GO:0030010(establishment of cell polarity);GO:0032386(regulation of intracellular transport);GO:0032587(ruffle membrane);GO:0032947(protein-containing complex scaffold activity);GO:0032991(protein-containing complex);GO:0035329(hippo signaling);GO:0035330(regulation of hippo signaling);GO:0035331(negative regulation of hippo signaling);GO:0042995(cell projection);GO:0043410(positive regulation of MAPK cascade);GO:0046621(negative regulation of organ growth);GO:0048471(perinuclear region of cytoplasm)","04390(Hippo signaling pathway);04392(Hippo signaling pathway - multiple species)",{"v":3.1E-4,"d":"0.00"},1,"151,",0,-1.05,{"v":0.0173780082874938,"d":"0.02"},-1.04,"Exon (ENST00000265293/ENSG00000113645, exon 9 of 23)",5,168291651,168472303,180653,1]
[179032257,179033810,1554,"ENSG00000234284","ENST00000444149","protein_coding",8505,"ZNF879","zinc finger protein 879 [Source:HGNC Symbol;Acc:HGNC:37273]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":2.5e-31,"d":"0.00"},1,"1554,",0,-1.42,{"v":0.00562341325190349,"d":"0.01"},-1.07,"3' UTR",5,179023752,179035064,11313,1]
[67227532,67227862,331,"ENSG00000184226","ENST00000377865","protein_coding",2474,"PCDH9","protocadherin 9 [Source:HGNC Symbol;Acc:HGNC:8661]","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030426(growth cone);GO:0044291(cell-cell contact zone)","NA",{"v":2.5e-05,"d":"0.00"},1,"331,",0,{"v":-0.849,"d":"-0.85"},{"v":0.0331131121482591,"d":"0.03"},-2.18,"Exon (ENST00000377865/ENSG00000184226, exon 2 of 5)",13,66302834,67230336,927503,2]
[60597511,60597901,391,"ENSG00000035499","ENST00000265036","protein_coding",102265,"DEPDC1B","DEP domain containing 1B [Source:HGNC Symbol;Acc:HGNC:24902]","GO:0005096(GTPase activator activity);GO:0005829(cytosol);GO:0007165(signal transduction);GO:0016477(cell migration);GO:0030177(positive regulation of Wnt signaling pathway);GO:0035556(intracellular signal transduction);GO:0043547(positive regulation of GTPase activity);GO:0051056(regulation of small GTPase mediated signal transduction)","NA",{"v":4e-42,"d":"0.00"},1,"391,",0,-2.85,{"v":1.0471285480509E-4,"d":"0.00"},-1.02,"3' UTR",5,60596912,60700166,103255,2]
[64728114,64741261,13148,"ENSG00000153006","ENST00000513458","protein_coding",27430,"SREK1IP1","SREK1 interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:26716]","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0006397(mRNA processing);GO:0008270(zinc ion binding);GO:0008380(RNA splicing);GO:0046872(metal ion binding)","NA",{"v":2.5e-19,"d":"0.00"},2,"66,205,","0,12943",-2.63,{"v":1.90546071796325E-4,"d":"0.00"},-1.01,"Exon (ENST00000513458/ENSG00000153006, exon 3 of 5)",5,64718148,64768691,50544,2]
[42457562,42459288,1727,"ENSG00000127125","ENST00000469615","processed_transcript",0,"PPCS","phosphopantothenoylcysteine synthetase [Source:HGNC Symbol;Acc:HGNC:25686]","GO:0004632(phosphopantothenate--cysteine ligase activity);GO:0005829(cytosol);GO:0009108(coenzyme biosynthetic process);GO:0015937(coenzyme A biosynthetic process);GO:0016874(ligase activity)","00770(Pantothenate and CoA biosynthesis)",{"v":0.0011,"d":"0.00"},2,"6,85,","0,1642",-1.01,{"v":0.0199526231496888,"d":"0.02"},-2.19,"Exon (ENST00000482168/ENSG00000127125, exon 1 of 2)",1,42459204,42460278,1075,1]
[127940606,127941204,599,"ENSG00000230561","ENST00000514853","protein_coding",237217,"CCDC192","coiled-coil domain containing 192 [Source:HGNC Symbol;Acc:HGNC:49566]","NA","NA",{"v":1.3E-11,"d":"0.00"},1,"599,",0,-1.95,{"v":1.20226443461741E-3,"d":"0.00"},-1.24,"Exon (ENST00000514853/ENSG00000230561, exon 7 of 7)",5,127703389,127941634,238246,1]
[132824227,132824287,61,"ENSG00000164403","ENST00000378679","protein_coding",6611,"SHROOM1","shroom family member 1 [Source:HGNC Symbol;Acc:HGNC:24084]","GO:0000902(cell morphogenesis);GO:0003779(actin binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005912(adherens junction);GO:0007015(actin filament organization);GO:0016324(apical plasma membrane);GO:0030036(actin cytoskeleton organization);GO:0030864(cortical actin cytoskeleton);GO:0043296(apical junction complex);GO:0045159(myosin II binding);GO:0051015(actin filament binding);GO:0051017(actin filament bundle assembly)","NA",{"v":0.0032,"d":"0.00"},1,"61,",0,-2.15,{"v":0.000691830970918936,"d":"0.00"},{"v":-1.3,"d":"-1.30"},"Exon (ENST00000378679/ENSG00000164403, exon 7 of 10)",5,132822141,132830898,8758,2]
[132880930,132883353,2424,"ENSG00000072364","ENST00000265343","protein_coding",80281,"AFF4","AF4/FMR2 family member 4 [Source:HGNC Symbol;Acc:HGNC:17869]","GO:0001650(fibrillar center);GO:0003690(double-stranded DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006366(transcription by RNA polymerase II);GO:0006368(transcription elongation from RNA polymerase II promoter);GO:0007286(spermatid development);GO:0008023(transcription elongation factor complex);GO:0032783(ELL-EAF complex);GO:0035327(transcriptionally active chromatin)","NA",{"v":2e-44,"d":"0.00"},2,"257,14,","0,2410",{"v":-5.1,"d":"-5.10"},{"v":2.95120922666638e-07,"d":"0.00"},{"v":-1.1,"d":"-1.10"},"3' UTR",5,132875395,132963634,88240,2]
[151765897,151766239,343,"ENSG00000213433","ENST00000473923","transcribed_processed_pseudogene",0,"RPLP1P6","ribosomal protein lateral stalk subunit P1 pseudogene 6 [Source:HGNC Symbol;Acc:HGNC:35809]","NA","NA",{"v":4.4e-09,"d":"0.00"},1,"343,",0,{"v":-0.751,"d":"-0.75"},{"v":0.0467735141287198,"d":"0.05"},-1.05,"Exon (ENST00000518134/ENSG00000213433, exon 1 of 1)",5,151765897,151766239,343,2]
[172337225,172337554,330,"ENSG00000174705","ENST00000636523","protein_coding",116754,"SH3PXD2B","SH3 and PX domains 2B [Source:HGNC Symbol;Acc:HGNC:29242]","GO:0001501(skeletal system development);GO:0001654(eye development);GO:0002051(osteoblast fate commitment);GO:0002102(podosome);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006801(superoxide metabolic process);GO:0007507(heart development);GO:0010314(phosphatidylinositol-5-phosphate binding);GO:0010628(positive regulation of gene expression);GO:0016176(superoxide-generating NADPH oxidase activator activity);GO:0022617(extracellular matrix disassembly);GO:0030054(cell junction);GO:0030154(cell differentiation);GO:0032266(phosphatidylinositol-3-phosphate binding);GO:0035091(phosphatidylinositol binding);GO:0040018(positive regulation of multicellular organism growth);GO:0042169(SH2 domain binding);GO:0042995(cell projection);GO:0043085(positive regulation of catalytic activity);GO:0045600(positive regulation of fat cell differentiation);GO:0048705(skeletal system morphogenesis);GO:0051496(positive regulation of stress fiber assembly);GO:0060348(bone development);GO:0060378(regulation of brood size);GO:0060612(adipose tissue development);GO:0070273(phosphatidylinositol-4-phosphate binding);GO:0071800(podosome assembly);GO:0072657(protein localization to membrane);GO:0080025(phosphatidylinositol-3,5-bisphosphate binding);GO:1904179(positive regulation of adipose tissue development);GO:1904888(cranial skeletal system development)","NA",{"v":1.3E-23,"d":"0.00"},1,"330,",0,-4.28,{"v":2.39883291901949e-06,"d":"0.00"},-1.12,"3' UTR",5,172325000,172454308,129309,2]
[348782,348991,210,"ENSG00000112679","ENST00000344450","protein_coding",56685,"DUSP22","dual specificity phosphatase 22 [Source:HGNC Symbol;Acc:HGNC:16077]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000188(inactivation of MAPK activity);GO:0002710(negative regulation of T cell mediated immunity);GO:0004721(phosphoprotein phosphatase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0004726(non-membrane spanning protein tyrosine phosphatase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006470(protein dephosphorylation);GO:0006915(apoptotic process);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007275(multicellular organism development);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0008283(cell population proliferation);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0016791(phosphatase activity);GO:0030336(negative regulation of cell migration);GO:0031941(filamentous actin);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0042127(regulation of cell population proliferation);GO:0046330(positive regulation of JNK cascade);GO:0050860(negative regulation of T cell receptor signaling pathway);GO:0050868(negative regulation of T cell activation);GO:0051895(negative regulation of focal adhesion assembly);GO:0061851(leading edge of lamellipodium);GO:0071364(cellular response to epidermal growth factor stimulus);GO:1903996(negative regulation of non-membrane spanning protein tyrosine kinase activity);GO:1990782(protein tyrosine kinase binding)","NA",{"v":1.2E-9,"d":"0.00"},1,"210,",0,-3.35,{"v":2.75422870333816e-05,"d":"0.00"},-1.03,"3' UTR",6,292097,351355,59259,1]
[3022192,3022851,660,"ENSG00000124588","ENST00000380455","protein_coding",22298,"NQO2","N-ribosyldihydronicotinamide:quinone reductase 2 [Source:HGNC Symbol;Acc:HGNC:7856]","GO:0001512(dihydronicotinamide riboside quinone reductase activity);GO:0003955(NAD(P)H dehydrogenase (quinone) activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006805(xenobiotic metabolic process);GO:0007613(memory);GO:0008270(zinc ion binding);GO:0009055(electron transfer activity);GO:0016491(oxidoreductase activity);GO:0016661(oxidoreductase activity, acting on other nitrogenous compounds as donors);GO:0022900(electron transport chain);GO:0031404(chloride ion binding);GO:0042803(protein homodimerization activity);GO:0043525(positive regulation of neuron apoptotic process);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process);GO:0070062(extracellular exosome);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071949(FAD binding);GO:1904408(melatonin binding);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1905594(resveratrol binding);GO:2000379(positive regulation of reactive oxygen species metabolic process)","NA",{"v":3.2e-22,"d":"0.00"},1,"660,",0,{"v":-0.965,"d":"-0.97"},{"v":0.0229086765276777,"d":"0.02"},{"v":-1.3,"d":"-1.30"},"3' UTR",6,2999894,3028869,28976,1]
[5368794,5369152,359,"ENSG00000145982","ENST00000324331","protein_coding",107750,"FARS2","phenylalanyl-tRNA synthetase 2, mitochondrial [Source:HGNC Symbol;Acc:HGNC:21062]","GO:0000049(tRNA binding);GO:0000166(nucleotide binding);GO:0004812(aminoacyl-tRNA ligase activity);GO:0004826(phenylalanine-tRNA ligase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006412(translation);GO:0006418(tRNA aminoacylation for protein translation);GO:0006432(phenylalanyl-tRNA aminoacylation);GO:0008033(tRNA processing);GO:0016874(ligase activity);GO:0043039(tRNA aminoacylation)","00970(Aminoacyl-tRNA biosynthesis)",{"v":1.3e-89,"d":"0.00"},1,"359,",0,-6.58,{"v":6.91830970918936e-09,"d":"0.00"},-1.06,"Exon (ENST00000324331/ENSG00000145982, exon 2 of 7)",6,5261044,5771429,510386,1]
[7398739,7402658,3920,"ENSG00000124784","ENST00000475351","nonsense_mediated_decay",8946,"RIOK1","RIO kinase 1 [Source:HGNC Symbol;Acc:HGNC:18656]","GO:0000166(nucleotide binding);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0016787(hydrolase activity);GO:0030490(maturation of SSU-rRNA);GO:0030688(preribosome, small subunit precursor);GO:0034708(methyltransferase complex);GO:0042254(ribosome biogenesis);GO:0042274(ribosomal small subunit biogenesis);GO:0046872(metal ion binding);GO:2000234(positive regulation of rRNA processing)","03008(Ribosome biogenesis in eukaryotes)",{"v":3.3E-3,"d":"0.00"},3,"2,93,56,","0,2219,3864",-4.34,{"v":2.08929613085404e-06,"d":"0.00"},-1.42,"3' UTR",6,7389793,7402848,13056,1]
[27251464,27251819,356,"ENSG00000112812","ENST00000377456","processed_transcript",0,"PRSS16","serine protease 16 [Source:HGNC Symbol;Acc:HGNC:9480]","GO:0005764(lysosome);GO:0005768(endosome);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008236(serine-type peptidase activity);GO:0008239(dipeptidyl-peptidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0030163(protein catabolic process);GO:0031410(cytoplasmic vesicle)","NA",{"v":0.00016,"d":"0.00"},2,"38,232,","0,124",-0.75,{"v":0.0467735141287198,"d":"0.05"},-1.13,"Exon (ENST00000230582/ENSG00000112812, exon 8 of 12)",6,27251588,27256456,4869,1]
[33695734,33696184,451,"ENSG00000096433","ENST00000374316","protein_coding",75369,"ITPR3","inositol 1,4,5-trisphosphate receptor type 3 [Source:HGNC Symbol;Acc:HGNC:6182]","GO:0000822(inositol hexakisphosphate binding);GO:0005216(ion channel activity);GO:0005220(inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity);GO:0005262(calcium channel activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005640(nuclear outer membrane);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005903(brush border);GO:0006811(ion transport);GO:0006816(calcium ion transport);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0007613(memory);GO:0015278(calcium-release channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016529(sarcoplasmic reticulum);GO:0030168(platelet activation);GO:0030659(cytoplasmic vesicle membrane);GO:0030667(secretory granule membrane);GO:0031095(platelet dense tubular network membrane);GO:0035091(phosphatidylinositol binding);GO:0043025(neuronal cell body);GO:0043209(myelin sheath);GO:0043235(receptor complex);GO:0043533(inositol 1,3,4,5 tetrakisphosphate binding);GO:0045177(apical part of cell);GO:0048016(inositol phosphate-mediated signaling);GO:0050796(regulation of insulin secretion);GO:0050913(sensory perception of bitter taste);GO:0050916(sensory perception of sweet taste);GO:0050917(sensory perception of umami taste);GO:0051209(release of sequestered calcium ion into cytosol);GO:0051260(protein homooligomerization);GO:0051291(protein heterooligomerization);GO:0051592(response to calcium ion);GO:0055085(transmembrane transport);GO:0060291(long-term synaptic potentiation);GO:0060402(calcium ion transport into cytosol);GO:0070588(calcium ion transmembrane transport);GO:0070679(inositol 1,4,5 trisphosphate binding);GO:1903779(regulation of cardiac conduction)","04020(Calcium signaling pathway);04022(cGMP-PKG signaling pathway);04070(Phosphatidylinositol signaling system);04114(Oocyte meiosis);04210(Apoptosis);04218(Cellular senescence);04270(Vascular smooth muscle contraction);04371(Apelin signaling pathway);04540(Gap junction);04611(Platelet activation);04621(NOD-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04713(Circadian entrainment);04720(Long-term potentiation);04723(Retrograde endocannabinoid signaling);04724(Glutamatergic synapse);04725(Cholinergic synapse);04726(Serotonergic synapse);04728(Dopaminergic synapse);04730(Long-term depression);04742(Taste transduction);04750(Inflammatory mediator regulation of TRP channels);04911(Insulin secretion);04912(GnRH signaling pathway);04915(Estrogen signaling pathway);04918(Thyroid hormone synthesis);04921(Oxytocin signaling pathway);04922(Glucagon signaling pathway);04924(Renin secretion);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04928(Parathyroid hormone synthesis, secretion and action);04934(Cushing syndrome);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);05010(Alzheimer disease);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05170(Human immunodeficiency virus 1 infection);05205(Proteoglycans in cancer)",{"v":1.6E-53,"d":"0.00"},1,"451,",0,-6.92,{"v":3.01995172040202E-9,"d":"0.00"},-1.06,"3' UTR",6,33620365,33696574,76210,1]
[35342588,35347093,4506,"ENSG00000112033","ENST00000337400","protein_coding",0,"PPARD","peroxisome proliferator activated receptor delta [Source:HGNC Symbol;Acc:HGNC:9235]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001103(RNA polymerase II repressing transcription factor binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001890(placenta development);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0003713(transcription coactivator activity);GO:0004879(nuclear receptor activity);GO:0005504(fatty acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006006(glucose metabolic process);GO:0006029(proteoglycan metabolic process);GO:0006091(generation of precursor metabolites and energy);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0006635(fatty acid beta-oxidation);GO:0006776(vitamin A metabolic process);GO:0006915(apoptotic process);GO:0007275(multicellular organism development);GO:0007507(heart development);GO:0007566(embryo implantation);GO:0008134(transcription factor binding);GO:0008144(drug binding);GO:0008203(cholesterol metabolic process);GO:0008270(zinc ion binding);GO:0008283(cell population proliferation);GO:0008284(positive regulation of cell population proliferation);GO:0008289(lipid binding);GO:0008366(axon ensheathment);GO:0008654(phospholipid biosynthetic process);GO:0009062(fatty acid catabolic process);GO:0009299(mRNA transcription);GO:0009749(response to glucose);GO:0009755(hormone-mediated signaling pathway);GO:0010033(response to organic substance);GO:0010628(positive regulation of gene expression);GO:0010887(negative regulation of cholesterol storage);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0014823(response to activity);GO:0014842(regulation of skeletal muscle satellite cell proliferation);GO:0014912(negative regulation of smooth muscle cell migration);GO:0015908(fatty acid transport);GO:0019216(regulation of lipid metabolic process);GO:0019395(fatty acid oxidation);GO:0030154(cell differentiation);GO:0030308(negative regulation of cell growth);GO:0030374(nuclear receptor transcription coactivator activity);GO:0030522(intracellular receptor signaling pathway);GO:0031589(cell-substrate adhesion);GO:0032024(positive regulation of insulin secretion);GO:0032966(negative regulation of collagen biosynthetic process);GO:0033189(response to vitamin A);GO:0033993(response to lipid);GO:0038023(signaling receptor activity);GO:0042060(wound healing);GO:0042127(regulation of cell population proliferation);GO:0043066(negative regulation of apoptotic process);GO:0043401(steroid hormone mediated signaling pathway);GO:0043415(positive regulation of skeletal muscle tissue regeneration);GO:0043565(sequence-specific DNA binding);GO:0043616(keratinocyte proliferation);GO:0045598(regulation of fat cell differentiation);GO:0045600(positive regulation of fat cell differentiation);GO:0045662(negative regulation of myoblast differentiation);GO:0045684(positive regulation of epidermis development);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046697(decidualization);GO:0046872(metal ion binding);GO:0046982(protein heterodimerization activity);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0050680(negative regulation of epithelial cell proliferation);GO:0050728(negative regulation of inflammatory response);GO:0051059(NF-kappaB binding);GO:0051546(keratinocyte migration);GO:0060612(adipose tissue development);GO:0070539(linoleic acid binding);GO:0071222(cellular response to lipopolysaccharide);GO:0071456(cellular response to hypoxia);GO:0090575(RNA polymerase II transcription factor complex);GO:0097190(apoptotic signaling pathway);GO:0097755(positive regulation of blood vessel diameter);GO:1902894(negative regulation of pri-miRNA transcription by RNA polymerase II);GO:1903508(positive regulation of nucleic acid-templated transcription);GO:1904659(glucose transmembrane transport);GO:2000288(positive regulation of myoblast proliferation)","03320(PPAR signaling pathway);04310(Wnt signaling pathway);05200(Pathways in cancer);05221(Acute myeloid leukemia)",{"v":2.8e-06,"d":"0.00"},2,"94,27,","0,4479",-2.19,{"v":0.000616595001861482,"d":"0.00"},-1.14,"5' UTR",6,35342614,35425393,82780,1]
[36928754,36928934,181,"ENSG00000198663","ENST00000480824","protein_coding",42900,"C6orf89","chromosome 6 open reading frame 89 [Source:HGNC Symbol;Acc:HGNC:21114]","GO:0000139(Golgi membrane);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030496(midbody);GO:0042060(wound healing);GO:0045787(positive regulation of cell cycle);GO:0050673(epithelial cell proliferation);GO:1901727(positive regulation of histone deacetylase activity)","NA",{"v":1.1E-4,"d":"0.00"},1,"181,",0,{"v":-0.891,"d":"-0.89"},{"v":0.0288403150312661,"d":"0.03"},{"v":-1.4,"d":"-1.40"},"3' UTR",6,36885854,36928964,43111,1]
[37174198,37174528,331,"ENSG00000137193","ENST00000373509","protein_coding",4046,"PIM1","Pim-1 proto-oncogene, serine/threonine kinase [Source:HGNC Symbol;Acc:HGNC:8986]","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0006915(apoptotic process);GO:0007049(cell cycle);GO:0007275(multicellular organism development);GO:0008134(transcription factor binding);GO:0008283(cell population proliferation);GO:0016020(membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0019221(cytokine-mediated signaling pathway);GO:0030145(manganese ion binding);GO:0030212(hyaluronan metabolic process);GO:0043024(ribosomal small subunit binding);GO:0043066(negative regulation of apoptotic process);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046777(protein autophosphorylation);GO:0046872(metal ion binding);GO:0050821(protein stabilization);GO:0060045(positive regulation of cardiac muscle cell proliferation);GO:0070561(vitamin D receptor signaling pathway);GO:1902033(regulation of hematopoietic stem cell proliferation);GO:1905062(positive regulation of cardioblast proliferation)","04630(Jak-STAT signaling pathway);04933(AGE-RAGE signaling pathway in diabetic complications);05200(Pathways in cancer);05206(MicroRNAs in cancer);05221(Acute myeloid leukemia)",{"v":4.8e-06,"d":"0.00"},1,"331,",0,-1.51,{"v":0.00426579518801593,"d":"0.00"},-1.04,"3' UTR",6,37170152,37175428,5277,1]
[42080571,42080841,271,"ENSG00000137413","ENST00000456846","protein_coding",30049,"TAF8","TATA-box binding protein associated factor 8 [Source:HGNC Symbol;Acc:HGNC:17300]","GO:0001833(inner cell mass cell proliferation);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005669(transcription factor TFIID complex);GO:0005737(cytoplasm);GO:0007275(multicellular organism development);GO:0030154(cell differentiation);GO:0042795(snRNA transcription by RNA polymerase II);GO:0045598(regulation of fat cell differentiation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046982(protein heterodimerization activity);GO:0048471(perinuclear region of cytoplasm);GO:0051457(maintenance of protein location in nucleus)","03022(Basal transcription factors)",{"v":1.9e-07,"d":"0.00"},1,"271,",0,{"v":-0.903,"d":"-0.90"},{"v":0.0281838293126445,"d":"0.03"},-1.52,"3' UTR",6,42050522,42087071,36550,1]
[53920698,53922721,2024,"ENSG00000271218","ENST00000474641","antisense",0,"AL033384","novel transcript, antisense to LRRC1","NA","NA",{"v":7.2e-08,"d":"0.00"},2,"64,87,","0,1937",-2.19,{"v":0.000602559586074357,"d":"0.00"},{"v":-1.3,"d":"-1.30"},"Exon (ENST00000370888/ENSG00000137269, exon 13 of 14)",6,53918974,53920788,1815,2]
[70524452,70525952,1501,"ENSG00000082269","ENST00000418814","protein_coding",111144,"FAM135A","family with sequence similarity 135 member A [Source:HGNC Symbol;Acc:HGNC:21084]","GO:0044255(cellular lipid metabolic process)","NA",{"v":1.3e-21,"d":"0.00"},1,"1501,",0,{"v":-0.747,"d":"-0.75"},{"v":0.0467735141287198,"d":"0.05"},-1.32,"3' UTR",6,70413308,70561174,147867,1]
[75886963,75894840,7878,"ENSG00000196586","ENST00000430435","protein_coding",0,"MYO6","myosin VI [Source:HGNC Symbol;Acc:HGNC:7605]","GO:0000166(nucleotide binding);GO:0001726(ruffle);GO:0003774(motor activity);GO:0003779(actin binding);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005884(actin filament);GO:0005886(plasma membrane);GO:0005902(microvillus);GO:0005905(clathrin-coated pit);GO:0005938(cell cortex);GO:0006886(intracellular protein transport);GO:0006897(endocytosis);GO:0007605(sensory perception of sound);GO:0015031(protein transport);GO:0016020(membrane);GO:0016459(myosin complex);GO:0016461(unconventional myosin complex);GO:0016591(RNA polymerase II, holoenzyme);GO:0030048(actin filament-based movement);GO:0030139(endocytic vesicle);GO:0030330(DNA damage response, signal transduction by p53 class mediator);GO:0030665(clathrin-coated vesicle membrane);GO:0031410(cytoplasmic vesicle);GO:0031941(filamentous actin);GO:0031965(nuclear membrane);GO:0032587(ruffle membrane);GO:0032991(protein-containing complex);GO:0042493(response to drug);GO:0042995(cell projection);GO:0043231(intracellular membrane-bounded organelle);GO:0043531(ADP binding);GO:0045177(apical part of cell);GO:0045334(clathrin-coated endocytic vesicle);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048471(perinuclear region of cytoplasm);GO:0051015(actin filament binding);GO:0051046(regulation of secretion);GO:0060001(minus-end directed microfilament motor activity);GO:0070062(extracellular exosome)","NA",{"v":1E-153,"d":"0.00"},5,"32,209,79,164,27,","0,3094,4265,5567,7851",-7.75,{"v":3.80189396320561e-10,"d":"0.00"},-1.06,"Exon (ENST00000369981/ENSG00000196586, exon 25 of 36)",6,75890210,75908560,18351,1]
[79234239,79234774,536,"ENSG00000118418","ENST00000275036","protein_coding",0,"HMGN3","high mobility group nucleosomal binding domain 3 [Source:HGNC Symbol;Acc:HGNC:12312]","GO:0000785(chromatin);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006325(chromatin organization);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008150(biological_process);GO:0031492(nucleosomal DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046966(thyroid hormone receptor binding);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0061178(regulation of insulin secretion involved in cellular response to glucose stimulus)","NA",{"v":2.5e-13,"d":"0.00"},1,"536,",0,{"v":-0.943,"d":"-0.94"},{"v":0.0245470891568503,"d":"0.02"},-1.69,"5' UTR",6,79201245,79234689,33445,2]
[98199041,98199490,450,"ENSG00000095383","ENST00000465784","protein_coding",56159,"TBC1D2","TBC1 domain family member 2 [Source:HGNC Symbol;Acc:HGNC:18026]","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006886(intracellular protein transport);GO:0017137(Rab GTPase binding);GO:0030054(cell junction);GO:0031410(cytoplasmic vesicle);GO:0043547(positive regulation of GTPase activity);GO:0045296(cadherin binding);GO:0090630(activation of GTPase activity)","NA",{"v":1.7E-8,"d":"0.00"},1,"450,",0,-2.18,{"v":0.000630957344480193,"d":"0.00"},-2.19,"3' UTR",9,98199011,98255649,56639,2]
[116543854,116553910,10057,"ENSG00000164451","ENST00000368596","protein_coding",0,"CALHM4","calcium homeostasis modulator family member 4 [Source:HGNC Symbol;Acc:HGNC:21094]","GO:0005887(integral component of plasma membrane);GO:0006811(ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":2.1e-05,"d":"0.00"},2,"19,161,","0,9896",-1.26,{"v":0.00891250938133746,"d":"0.01"},-1.09,"5' UTR",6,116553750,116558575,4826,1]
[117709588,117709738,151,"ENSG00000153989","ENST00000368494","protein_coding",34119,"NUS1","NUS1, dehydrodolichyl diphosphate synthase subunit [Source:HGNC Symbol;Acc:HGNC:21042]","GO:0001525(angiogenesis);GO:0004659(prenyltransferase activity);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006486(protein glycosylation);GO:0006489(dolichyl diphosphate biosynthetic process);GO:0006629(lipid metabolic process);GO:0007275(multicellular organism development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016765(transferase activity, transferring alkyl or aryl (other than methyl) groups);GO:0019408(dolichol biosynthetic process);GO:0030154(cell differentiation);GO:0032383(regulation of intracellular cholesterol transport);GO:0035268(protein mannosylation);GO:0038084(vascular endothelial growth factor signaling pathway);GO:0042632(cholesterol homeostasis);GO:0043536(positive regulation of blood vessel endothelial cell migration);GO:0045547(dehydrodolichyl diphosphate synthase activity);GO:0051000(positive regulation of nitric-oxide synthase activity);GO:0055092(sterol homeostasis);GO:1904423(dehydrodolichyl diphosphate synthase complex)","00900(Terpenoid backbone biosynthesis)",{"v":5.4e-07,"d":"0.00"},1,"151,",0,-2.84,{"v":1.07151930523761E-4,"d":"0.00"},-1.99,"3' UTR",6,117675469,117710727,35259,1]
[142367736,142367856,121,"ENSG00000112414","ENST00000230173","protein_coding",65882,"ADGRG6","adhesion G protein-coupled receptor G6 [Source:HGNC Symbol;Acc:HGNC:13841]","GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005518(collagen binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007005(mitochondrion organization);GO:0007165(signal transduction);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0014037(Schwann cell differentiation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019933(cAMP-mediated signaling);GO:0022011(myelination in peripheral nervous system);GO:0042552(myelination);GO:0043236(laminin binding);GO:0050840(extracellular matrix binding);GO:0060347(heart trabecula formation)","NA",{"v":1.4E-3,"d":"0.00"},1,"121,",0,-4.67,{"v":8.91250938133746e-07,"d":"0.00"},-1.06,"Exon (ENST00000230173/ENSG00000112414, exon 3 of 26)",6,142301854,142446266,144413,1]
[142370205,142370684,480,"ENSG00000112414","ENST00000230173","protein_coding",68351,"ADGRG6","adhesion G protein-coupled receptor G6 [Source:HGNC Symbol;Acc:HGNC:13841]","GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005518(collagen binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007005(mitochondrion organization);GO:0007165(signal transduction);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0014037(Schwann cell differentiation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019933(cAMP-mediated signaling);GO:0022011(myelination in peripheral nervous system);GO:0042552(myelination);GO:0043236(laminin binding);GO:0050840(extracellular matrix binding);GO:0060347(heart trabecula formation)","NA",{"v":1E-119,"d":"0.00"},1,"480,",0,{"v":-25.4,"d":"-25.40"},{"v":1.25892541179417E-28,"d":"0.00"},-1.42,"Exon (ENST00000230173/ENSG00000112414, exon 4 of 26)",6,142301854,142446266,144413,1]
[82944506,82945135,630,"ENSG00000141556","ENST00000355528","protein_coding",192441,"TBCD","tubulin folding cofactor D [Source:HGNC Symbol;Acc:HGNC:11581]","GO:0000226(microtubule cytoskeleton organization);GO:0000278(mitotic cell cycle);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005886(plasma membrane);GO:0005912(adherens junction);GO:0005923(bicellular tight junction);GO:0006457(protein folding);GO:0007021(tubulin complex assembly);GO:0007023(post-chaperonin tubulin folding pathway);GO:0010812(negative regulation of cell-substrate adhesion);GO:0016020(membrane);GO:0016328(lateral plasma membrane);GO:0030054(cell junction);GO:0031115(negative regulation of microtubule polymerization);GO:0034333(adherens junction assembly);GO:0043547(positive regulation of GTPase activity);GO:0048487(beta-tubulin binding);GO:0048667(cell morphogenesis involved in neuron differentiation);GO:0051087(chaperone binding);GO:0070830(bicellular tight junction assembly)","NA",{"v":3e-06,"d":"0.00"},1,"630,",0,-1.19,{"v":0.0112201845430196,"d":"0.01"},-2.19,"3' UTR",17,82752065,82945914,193850,1]
[167033946,167039998,6053,"ENSG00000213066","ENST00000622353","protein_coding",34629,"FGFR1OP","FGFR1 oncogene partner [Source:HGNC Symbol;Acc:HGNC:17012]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006469(negative regulation of protein kinase activity);GO:0008284(positive regulation of cell population proliferation);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0019901(protein kinase binding);GO:0030030(cell projection organization);GO:0030292(protein tyrosine kinase inhibitor activity);GO:0030307(positive regulation of cell growth);GO:0030335(positive regulation of cell migration);GO:0034453(microtubule anchoring);GO:0042803(protein homodimerization activity);GO:0042995(cell projection);GO:0048471(perinuclear region of cytoplasm);GO:0061099(negative regulation of protein tyrosine kinase activity);GO:0097711(ciliary basal body-plasma membrane docking)","NA",{"v":0.0021,"d":"0.00"},2,"26,95,","0,5958",-4.45,{"v":1.54881661891248E-6,"d":"0.00"},-1.53,"3' UTR",6,166999317,167042418,43102,1]
[18236465,18237214,750,"ENSG00000124795","ENST00000652689","protein_coding",27316,"DEK","DEK proto-oncogene [Source:HGNC Symbol;Acc:HGNC:2768]","GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006366(transcription by RNA polymerase II);GO:0007165(signal transduction);GO:0019079(viral genome replication);GO:0042393(histone binding);GO:0043292(contractile fiber);GO:0045815(positive regulation of gene expression, epigenetic);GO:2000779(regulation of double-strand break repair);GO:2001032(regulation of double-strand break repair via nonhomologous end joining)","NA",{"v":2e-10,"d":"0.00"},2,"136,165,","0,585",-6.25,{"v":1.62181009735893E-8,"d":"0.00"},-1.04,"3' UTR",6,18223860,18264530,40671,2]
[78982903,78983052,150,"ENSG00000146247","ENST00000479165","processed_transcript",0,"PHIP","pleckstrin homology domain interacting protein [Source:HGNC Symbol;Acc:HGNC:15673]","GO:0001932(regulation of protein phosphorylation);GO:0005158(insulin receptor binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007010(cytoskeleton organization);GO:0008284(positive regulation of cell population proliferation);GO:0008286(insulin receptor signaling pathway);GO:0008360(regulation of cell shape);GO:0022604(regulation of cell morphogenesis);GO:0043066(negative regulation of apoptotic process);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0045840(positive regulation of mitotic nuclear division);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0070577(lysine-acetylated histone binding);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","NA",{"v":5.5e-05,"d":"0.00"},1,"150,",0,{"v":-0.907,"d":"-0.91"},{"v":0.0275422870333817,"d":"0.03"},{"v":-2.2,"d":"-2.20"},"Exon (ENST00000275034/ENSG00000146247, exon 23 of 40)",6,78940546,78982943,42398,2]
[864728,865117,390,"ENSG00000214063","ENST00000397411","protein_coding",21916,"TSPAN4","tetraspanin 4 [Source:HGNC Symbol;Acc:HGNC:11859]","GO:0003823(antigen binding);GO:0005178(integrin binding);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005925(focal adhesion);GO:0007166(cell surface receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031982(vesicle);GO:0065003(protein-containing complex assembly)","NA",{"v":2.8e-10,"d":"0.00"},1,"390,",0,-0.79,{"v":0.0407380277804113,"d":"0.04"},{"v":-2.2,"d":"-2.20"},"Exon (ENST00000464987/ENSG00000214063, exon 3 of 5)",11,842812,866817,24006,1]
[30542185,30542484,300,"ENSG00000204590","ENST00000376621","protein_coding",14690,"GNL1","G protein nucleolar 1 (putative) [Source:HGNC Symbol;Acc:HGNC:4413]","GO:0000166(nucleotide binding);GO:0002456(T cell mediated immunity);GO:0005198(structural molecule activity);GO:0005525(GTP binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0006974(cellular response to DNA damage stimulus);GO:0007165(signal transduction)","NA",{"v":3.5e-06,"d":"0.00"},1,"300,",0,{"v":-0.807,"d":"-0.81"},{"v":0.0380189396320561,"d":"0.04"},-1.09,"3' UTR",6,30541377,30557174,15798,2]
[33695726,33696174,449,"ENSG00000096433","ENST00000374316","protein_coding",75361,"ITPR3","inositol 1,4,5-trisphosphate receptor type 3 [Source:HGNC Symbol;Acc:HGNC:6182]","GO:0000822(inositol hexakisphosphate binding);GO:0005216(ion channel activity);GO:0005220(inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity);GO:0005262(calcium channel activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005640(nuclear outer membrane);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005903(brush border);GO:0006811(ion transport);GO:0006816(calcium ion transport);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0007613(memory);GO:0015278(calcium-release channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016529(sarcoplasmic reticulum);GO:0030168(platelet activation);GO:0030659(cytoplasmic vesicle membrane);GO:0030667(secretory granule membrane);GO:0031095(platelet dense tubular network membrane);GO:0035091(phosphatidylinositol binding);GO:0043025(neuronal cell body);GO:0043209(myelin sheath);GO:0043235(receptor complex);GO:0043533(inositol 1,3,4,5 tetrakisphosphate binding);GO:0045177(apical part of cell);GO:0048016(inositol phosphate-mediated signaling);GO:0050796(regulation of insulin secretion);GO:0050913(sensory perception of bitter taste);GO:0050916(sensory perception of sweet taste);GO:0050917(sensory perception of umami taste);GO:0051209(release of sequestered calcium ion into cytosol);GO:0051260(protein homooligomerization);GO:0051291(protein heterooligomerization);GO:0051592(response to calcium ion);GO:0055085(transmembrane transport);GO:0060291(long-term synaptic potentiation);GO:0060402(calcium ion transport into cytosol);GO:0070588(calcium ion transmembrane transport);GO:0070679(inositol 1,4,5 trisphosphate binding);GO:1903779(regulation of cardiac conduction)","04020(Calcium signaling pathway);04022(cGMP-PKG signaling pathway);04070(Phosphatidylinositol signaling system);04114(Oocyte meiosis);04210(Apoptosis);04218(Cellular senescence);04270(Vascular smooth muscle contraction);04371(Apelin signaling pathway);04540(Gap junction);04611(Platelet activation);04621(NOD-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04713(Circadian entrainment);04720(Long-term potentiation);04723(Retrograde endocannabinoid signaling);04724(Glutamatergic synapse);04725(Cholinergic synapse);04726(Serotonergic synapse);04728(Dopaminergic synapse);04730(Long-term depression);04742(Taste transduction);04750(Inflammatory mediator regulation of TRP channels);04911(Insulin secretion);04912(GnRH signaling pathway);04915(Estrogen signaling pathway);04918(Thyroid hormone synthesis);04921(Oxytocin signaling pathway);04922(Glucagon signaling pathway);04924(Renin secretion);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04928(Parathyroid hormone synthesis, secretion and action);04934(Cushing syndrome);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);05010(Alzheimer disease);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05170(Human immunodeficiency virus 1 infection);05205(Proteoglycans in cancer)",{"v":7.9e-57,"d":"0.00"},1,"449,",0,{"v":-4.9,"d":"-4.90"},{"v":5.01187233627272e-07,"d":"0.00"},-1.02,"3' UTR",6,33620365,33696574,76210,1]
[34425772,34426041,270,"ENSG00000124614","ENST00000467531","protein_coding",0,"RPS10","ribosomal protein S10 [Source:HGNC Symbol;Acc:HGNC:10383]","GO:0000028(ribosomal small subunit assembly);GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0003723(RNA binding);GO:0003735(structural constituent of ribosome);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005840(ribosome);GO:0005925(focal adhesion);GO:0006412(translation);GO:0006413(translational initiation);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0016020(membrane);GO:0019083(viral transcription);GO:0022627(cytosolic small ribosomal subunit)","03010(Ribosome)",{"v":4e-19,"d":"0.00"},1,"270,",0,-1.41,{"v":0.00562341325190349,"d":"0.01"},-1.14,"5' UTR",6,34417454,34425784,8331,2]
[34425781,34426065,285,"ENSG00000124614","ENST00000467531","protein_coding",0,"RPS10","ribosomal protein S10 [Source:HGNC Symbol;Acc:HGNC:10383]","GO:0000028(ribosomal small subunit assembly);GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0003723(RNA binding);GO:0003735(structural constituent of ribosome);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005840(ribosome);GO:0005925(focal adhesion);GO:0006412(translation);GO:0006413(translational initiation);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0016020(membrane);GO:0019083(viral transcription);GO:0022627(cytosolic small ribosomal subunit)","03010(Ribosome)",{"v":2.5e-19,"d":"0.00"},3,"4,231,34,","0,15,251",-1.39,{"v":0.00602559586074357,"d":"0.01"},-1.12,"5' UTR",6,34417454,34425784,8331,2]
[42268261,42268531,271,"ENSG00000124496","ENST00000541110","protein_coding",183520,"TRERF1","transcriptional regulating factor 1 [Source:HGNC Symbol;Acc:HGNC:18273]","GO:0000118(histone deacetylase complex);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003712(transcription coregulator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006694(steroid biosynthetic process);GO:0006707(cholesterol catabolic process);GO:0007275(multicellular organism development);GO:0008134(transcription factor binding);GO:0008301(DNA binding, bending);GO:0030374(nuclear receptor transcription coactivator activity);GO:0042592(homeostatic process);GO:0044212(transcription regulatory region DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0046885(regulation of hormone biosynthetic process)","NA",{"v":1.3E-7,"d":"0.00"},1,"271,",0,-2.25,{"v":0.000524807460249772,"d":"0.00"},-1.05,"Exon (ENST00000541110/ENSG00000124496, exon 5 of 18)",6,42224931,42452051,227121,2]
[236523131,236523726,596,"ENSG00000116977","ENST00000341872","protein_coding",0,"LGALS8","galectin 8 [Source:HGNC Symbol;Acc:HGNC:6569]","GO:0005178(integrin binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006914(autophagy);GO:0016020(membrane);GO:0030246(carbohydrate binding);GO:0031410(cytoplasmic vesicle);GO:0098586(cellular response to virus);GO:0098792(xenophagy);GO:1904977(lymphatic endothelial cell migration)","NA",{"v":6.3e-15,"d":"0.00"},1,"596,",0,-1.22,{"v":0.0102329299228075,"d":"0.01"},-2.22,"5' UTR",1,236523439,236549263,25825,1]
[98309425,98309724,300,"ENSG00000006453","ENST00000005260","protein_coding",91366,"BAIAP2L1","BAI1 associated protein 2 like 1 [Source:HGNC Symbol;Acc:HGNC:21649]","GO:0003779(actin binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005913(cell-cell adherens junction);GO:0007009(plasma membrane organization);GO:0009617(response to bacterium);GO:0015629(actin cytoskeleton);GO:0030833(regulation of actin filament polymerization);GO:0030838(positive regulation of actin filament polymerization);GO:0046626(regulation of insulin receptor signaling pathway);GO:0051017(actin filament bundle assembly);GO:0051764(actin crosslink formation);GO:0070062(extracellular exosome);GO:0070064(proline-rich region binding);GO:0098609(cell-cell adhesion);GO:0098641(cadherin binding involved in cell-cell adhesion);GO:2000251(positive regulation of actin cytoskeleton reorganization)","NA",{"v":2.5e-09,"d":"0.00"},1,"300,",0,-1.14,{"v":0.0131825673855641,"d":"0.01"},-2.22,"Exon (ENST00000485422/ENSG00000164713, exon 2 of 2)",7,98291650,98401090,109441,2]
[78988216,78997462,9247,"ENSG00000146247","ENST00000275034","protein_coding",80792,"PHIP","pleckstrin homology domain interacting protein [Source:HGNC Symbol;Acc:HGNC:15673]","GO:0001932(regulation of protein phosphorylation);GO:0005158(insulin receptor binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007010(cytoskeleton organization);GO:0008284(positive regulation of cell population proliferation);GO:0008286(insulin receptor signaling pathway);GO:0008360(regulation of cell shape);GO:0022604(regulation of cell morphogenesis);GO:0043066(negative regulation of apoptotic process);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0045840(positive regulation of mitotic nuclear division);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0070577(lysine-acetylated histone binding);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","NA",{"v":1.7e-10,"d":"0.00"},3,"134,118,49,","0,2652,9198",{"v":-0.798,"d":"-0.80"},{"v":0.0398107170553497,"d":"0.04"},-1.28,"Exon (ENST00000275034/ENSG00000146247, exon 19 of 40)",6,78934419,79078254,143836,2]
[100848221,100848670,450,"ENSG00000112249","ENST00000369162","protein_coding",32659,"ASCC3","activating signal cointegrator 1 complex subunit 3 [Source:HGNC Symbol;Acc:HGNC:18697]","GO:0000166(nucleotide binding);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0004386(helicase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006281(DNA repair);GO:0006307(DNA dealkylation involved in DNA repair);GO:0006974(cellular response to DNA damage stimulus);GO:0008026(ATP-dependent helicase activity);GO:0008283(cell population proliferation);GO:0016020(membrane);GO:0016607(nuclear speck);GO:0016787(hydrolase activity);GO:0032508(DNA duplex unwinding);GO:0043140(ATP-dependent 3'-5' DNA helicase activity);GO:0099053(activating signal cointegrator 1 complex)","NA",{"v":1.3E-18,"d":"0.00"},1,"450,",0,-3.39,{"v":2.51188643150958e-05,"d":"0.00"},-1.64,"3' UTR",6,100508194,100881329,373136,2]
[138422073,138422672,600,"ENSG00000051620","ENST00000607197","protein_coding",17850,"HEBP2","heme binding protein 2 [Source:HGNC Symbol;Acc:HGNC:15716]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0010917(negative regulation of mitochondrial membrane potential);GO:0010940(positive regulation of necrotic cell death);GO:0020037(heme binding);GO:0035578(azurophil granule lumen);GO:0035794(positive regulation of mitochondrial membrane permeability);GO:0043312(neutrophil degranulation);GO:0070062(extracellular exosome)","NA",{"v":7.9e-13,"d":"0.00"},1,"600,",0,-0.88,{"v":0.0301995172040202,"d":"0.03"},-1.12,"3' UTR",6,138404223,138422197,17975,1]
[151404882,151405121,240,"ENSG00000155906","ENST00000444024","protein_coding",47005,"RMND1","required for meiotic nuclear division 1 homolog [Source:HGNC Symbol;Acc:HGNC:21176]","GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0006412(translation);GO:0070131(positive regulation of mitochondrial translation)","NA",{"v":2.5e-21,"d":"0.00"},1,"240,",0,-2.78,{"v":0.000125892541179417,"d":"0.00"},-1.51,"3' UTR",6,151404762,151452126,47365,2]
[1586453,1587591,1139,"ENSG00000230487","ENST00000437621","lincRNA",16380,"PSMG3-AS1","PSMG3 antisense RNA 1 (head to head) [Source:HGNC Symbol;Acc:HGNC:22230]","NA","NA",{"v":2.5e-13,"d":"0.00"},1,"1139,",0,-2.35,{"v":0.000398107170553497,"d":"0.00"},-1.66,"Exon (ENST00000437621/ENSG00000230487, exon 4 of 4)",7,1570073,1589626,19554,1]
[5925653,5925982,330,"ENSG00000122674","ENST00000325974","protein_coding",26919,"CCZ1","CCZ1 homolog, vacuolar protein trafficking and biogenesis associated [Source:HGNC Symbol;Acc:HGNC:21691]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0005829(cytosol);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0016235(aggresome);GO:0035658(Mon1-Ccz1 complex);GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":1.6E-78,"d":"0.00"},1,"330,",0,{"v":-11.8,"d":"-11.80"},{"v":1.99526231496888E-14,"d":"0.00"},-1.34,"3' UTR",7,5898734,5925974,27241,1]
[6608517,6608726,210,"ENSG00000146576","ENST00000344417","protein_coding",18496,"C7orf26","chromosome 7 open reading frame 26 [Source:HGNC Symbol;Acc:HGNC:21702]","NA","NA",{"v":3.2e-18,"d":"0.00"},1,"210,",0,-1.63,{"v":0.00295120922666638,"d":"0.00"},-1,"3' UTR",7,6590021,6608726,18706,1]
[148254,149376,1123,"ENSG00000242474","ENST00000462565","lincRNA",0,"AC093627","novel transcript","NA","NA",{"v":2.6e-08,"d":"0.00"},2,"461,48,","0,1075",{"v":-0.929,"d":"-0.93"},{"v":0.0257039578276886,"d":"0.03"},-2.22,"Exon (ENST00000462565/ENSG00000242474, exon 1 of 4)",7,135853,149362,13510,2]
[7234378,7234706,329,"ENSG00000106392","ENST00000429911","protein_coding",77444,"C1GALT1","core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:24337]","GO:0000139(Golgi membrane);GO:0001525(angiogenesis);GO:0001822(kidney development);GO:0005515(protein binding);GO:0006486(protein glycosylation);GO:0006493(protein O-linked glycosylation);GO:0007275(multicellular organism development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016263(glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity);GO:0016266(O-glycan processing);GO:0016267(O-glycan processing, core 1);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030154(cell differentiation);GO:0046872(metal ion binding);GO:0060576(intestinal epithelial cell development)","00512(Mucin type O-glycan biosynthesis)",{"v":5e-14,"d":"0.00"},1,"329,",0,-1.27,{"v":0.0087096358995608,"d":"0.01"},-1.41,"Exon (ENST00000429911/ENSG00000106392, exon 3 of 4)",7,7156934,7238428,81495,1]
[10982449,10990711,8263,"ENSG00000106443","ENST00000642461","protein_coding",9113,"PHF14","PHD finger protein 14 [Source:HGNC Symbol;Acc:HGNC:22203]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0005515(protein binding);GO:0005634(nucleus);GO:0008285(negative regulation of cell population proliferation);GO:0046872(metal ion binding);GO:0048286(lung alveolus development);GO:0072201(negative regulation of mesenchymal cell proliferation);GO:2000584(negative regulation of platelet-derived growth factor receptor-alpha signaling pathway);GO:2000791(negative regulation of mesenchymal cell proliferation involved in lung development)","NA",{"v":1e-24,"d":"0.00"},2,"711,9,","0,8254",{"v":-12.6,"d":"-12.60"},{"v":2.51188643150958e-15,"d":"0.00"},-1.09,"Exon (ENST00000642461/ENSG00000106443, exon 3 of 16)",7,10973336,11110321,136986,1]
[11103344,11103674,331,"ENSG00000106443","ENST00000642461","protein_coding",130008,"PHF14","PHD finger protein 14 [Source:HGNC Symbol;Acc:HGNC:22203]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0005515(protein binding);GO:0005634(nucleus);GO:0008285(negative regulation of cell population proliferation);GO:0046872(metal ion binding);GO:0048286(lung alveolus development);GO:0072201(negative regulation of mesenchymal cell proliferation);GO:2000584(negative regulation of platelet-derived growth factor receptor-alpha signaling pathway);GO:2000791(negative regulation of mesenchymal cell proliferation involved in lung development)","NA",{"v":1E-14,"d":"0.00"},1,"331,",0,{"v":-0.811,"d":"-0.81"},{"v":0.0380189396320561,"d":"0.04"},-1.99,"3' UTR",7,10973336,11110321,136986,1]
[36154401,36238993,84593,"ENSG00000228770","ENST00000447461","processed_pseudogene",0,"AC007327","pseudogene similar to part of mitochondrially encoded NADH dehydrogenase 2 MT-ND2","NA","NA",{"v":1.3E-58,"d":"0.00"},2,"802,9,","0,84584",-6.86,{"v":3.54813389233576e-09,"d":"0.00"},-1.34,"Exon (ENST00000242108/ENSG00000122547, exon 2 of 8)",7,36228621,36228884,264,2]
[39570555,39570704,150,"ENSG00000241127","ENST00000474392","retained_intron",4170,"YAE1","YAE1, ABCE1 maturation factor [Source:HGNC Symbol;Acc:HGNC:24857]","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0106035(protein maturation by [4Fe-4S] cluster transfer)","NA",{"v":0.00045,"d":"0.00"},1,"150,",0,{"v":-0.737,"d":"-0.74"},{"v":0.0489778819368446,"d":"0.05"},-1.25,"Exon (ENST00000474392/ENSG00000241127, exon 2 of 2)",7,39566385,39571002,4618,1]
[44606572,44645435,38864,"ENSG00000105953","ENST00000439616","protein_coding",0,"OGDH","oxoglutarate dehydrogenase [Source:HGNC Symbol;Acc:HGNC:8124]","GO:0004591(oxoglutarate dehydrogenase (succinyl-transferring) activity);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006091(generation of precursor metabolites and energy);GO:0006096(glycolytic process);GO:0006099(tricarboxylic acid cycle);GO:0006103(2-oxoglutarate metabolic process);GO:0006104(succinyl-CoA metabolic process);GO:0006554(lysine catabolic process);GO:0006734(NADH metabolic process);GO:0016491(oxidoreductase activity);GO:0016624(oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor);GO:0021695(cerebellar cortex development);GO:0021756(striatum development);GO:0021766(hippocampus development);GO:0021794(thalamus development);GO:0021860(pyramidal neuron development);GO:0022028(tangential migration from the subventricular zone to the olfactory bulb);GO:0030976(thiamine pyrophosphate binding);GO:0031072(heat shock protein binding);GO:0031966(mitochondrial membrane);GO:0034602(oxoglutarate dehydrogenase (NAD+) activity);GO:0045252(oxoglutarate dehydrogenase complex);GO:0046872(metal ion binding);GO:0051087(chaperone binding);GO:0055114(oxidation-reduction process);GO:0061034(olfactory bulb mitral cell layer development);GO:0106077(histone succinylation)","00020(Citrate cycle (TCA cycle))",0,4,"82,70,249,109,","0,16234,17745,38755",{"v":-43.6,"d":"-43.60"},{"v":3.98107170553499e-47,"d":"0.00"},-1.15,"5' UTR",7,44606572,44708230,101659,1]
[55923598,55923838,241,"ENSG00000178665","ENST00000429591","protein_coding",36142,"ZNF713","zinc finger protein 713 [Source:HGNC Symbol;Acc:HGNC:22043]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":2.8e-07,"d":"0.00"},1,"241,",0,{"v":-0.772,"d":"-0.77"},{"v":0.0426579518801593,"d":"0.04"},{"v":-1.5,"d":"-1.50"},"3' UTR",7,55887456,55942225,54770,1]
[83539205,83540283,1079,"ENSG00000038427","ENST00000342785","protein_coding",67531,"VCAN","versican [Source:HGNC Symbol;Acc:HGNC:2464]","GO:0001501(skeletal system development);GO:0001649(osteoblast differentiation);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005539(glycosaminoglycan binding);GO:0005540(hyaluronic acid binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005788(endoplasmic reticulum lumen);GO:0005796(Golgi lumen);GO:0007155(cell adhesion);GO:0007275(multicellular organism development);GO:0007417(central nervous system development);GO:0008037(cell recognition);GO:0016020(membrane);GO:0030021(extracellular matrix structural constituent conferring compression resistance);GO:0030198(extracellular matrix organization);GO:0030206(chondroitin sulfate biosynthetic process);GO:0030207(chondroitin sulfate catabolic process);GO:0030208(dermatan sulfate biosynthetic process);GO:0030246(carbohydrate binding);GO:0031012(extracellular matrix);GO:0043202(lysosomal lumen);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process);GO:0062023(collagen-containing extracellular matrix)","04514(Cell adhesion molecules (CAMs))",{"v":1.3E-17,"d":"0.00"},1,"1079,",0,-1.17,{"v":0.0120226443461741,"d":"0.01"},-2.23,"Exon (ENST00000343200/ENSG00000038427, exon 7 of 14)",5,83471674,83582303,110630,1]
[33237037,33237409,373,"ENSG00000241255","ENST00000473603","processed_pseudogene",29,"AL136126","ribosomal protein S24 (RPS24) pseudogene","NA","NA",{"v":2E-12,"d":"0.00"},1,"373,",0,{"v":-0.764,"d":"-0.76"},{"v":0.0446683592150963,"d":"0.04"},-2.23,"Exon (ENST00000473603/ENSG00000241255, exon 1 of 1)",11,33237008,33237409,402,1]
[99456445,99456535,91,"ENSG00000106246","ENST00000430982","protein_coding",9628,"PTCD1","pentatricopeptide repeat domain 1 [Source:HGNC Symbol;Acc:HGNC:22198]","GO:0000049(tRNA binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0008033(tRNA processing);GO:0042780(tRNA 3'-end processing)","NA",{"v":2.2e-05,"d":"0.00"},1,"91,",0,-3.36,{"v":2.69153480392691e-05,"d":"0.00"},-1.35,"3' UTR",7,99433380,99466163,32784,2]
[99619671,99619761,91,"ENSG00000197037","ENST00000481424","retained_intron",2725,"ZSCAN25","zinc finger and SCAN domain containing 25 [Source:HGNC Symbol;Acc:HGNC:21961]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","NA",{"v":0.0024,"d":"0.00"},1,"91,",0,{"v":-0.886,"d":"-0.89"},{"v":0.0295120922666639,"d":"0.03"},-1.22,"Exon (ENST00000481424/ENSG00000197037, exon 4 of 7)",7,99616946,99632399,15454,1]
[102111993,102115428,3436,"ENSG00000257923","ENST00000437600","protein_coding",296089,"CUX1","cut like homeobox 1 [Source:HGNC Symbol;Acc:HGNC:2557]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000139(Golgi membrane);GO:0000301(retrograde transport, vesicle recycling within Golgi);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006891(intra-Golgi vesicle-mediated transport);GO:0007275(multicellular organism development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030173(integral component of Golgi membrane);GO:0030674(protein binding, bridging);GO:0043565(sequence-specific DNA binding);GO:0048193(Golgi vesicle transport);GO:0050775(positive regulation of dendrite morphogenesis)","NA",{"v":2.5e-09,"d":"0.00"},2,"18,222,","0,3214",-3.72,{"v":1.02329299228075e-05,"d":"0.00"},-1.75,"Exon (ENST00000437600/ENSG00000257923, exon 8 of 23)",7,101815904,102283958,468055,1]
[128809444,128811343,1900,"ENSG00000128596","ENST00000378685","protein_coding",18000,"CCDC136","coiled-coil domain containing 136 [Source:HGNC Symbol;Acc:HGNC:22225]","GO:0001675(acrosome assembly);GO:0002080(acrosomal membrane);GO:0007283(spermatogenesis);GO:0007338(single fertilization);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030154(cell differentiation);GO:0031410(cytoplasmic vesicle)","NA",{"v":6E-9,"d":"0.00"},3,"201,228,82,","0,695,1818",-1.93,{"v":1.28824955169313E-3,"d":"0.00"},-1.75,"Exon (ENST00000297788/ENSG00000128596, exon 11 of 18)",7,128791444,128822127,30684,1]
[129225053,129225203,151,"ENSG00000158467","ENST00000325006","protein_coding",30,"AHCYL2","adenosylhomocysteinase like 2 [Source:HGNC Symbol;Acc:HGNC:22204]","GO:0004013(adenosylhomocysteinase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006730(one-carbon metabolic process);GO:0016787(hydrolase activity);GO:0033353(S-adenosylmethionine cycle);GO:0043005(neuron projection);GO:0043231(intracellular membrane-bounded organelle)","00270(Cysteine and methionine metabolism)",{"v":6.9e-05,"d":"0.00"},1,"151,",0,-1.05,{"v":0.0173780082874938,"d":"0.02"},-1.96,"5' UTR",7,129225023,129430211,205189,1]
[129482974,129483154,181,"ENSG00000128578","ENST00000249344","protein_coding",48542,"STRIP2","striatin interacting protein 2 [Source:HGNC Symbol;Acc:HGNC:22209]","GO:0003674(molecular_function);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007010(cytoskeleton organization);GO:0008360(regulation of cell shape);GO:0016477(cell migration)","NA",{"v":3.8E-6,"d":"0.00"},1,"181,",0,-1.21,{"v":0.010471285480509,"d":"0.01"},-1.57,"3' UTR",7,129434432,129488399,53968,1]
[129485581,129485911,331,"ENSG00000128578","ENST00000249344","protein_coding",51149,"STRIP2","striatin interacting protein 2 [Source:HGNC Symbol;Acc:HGNC:22209]","GO:0003674(molecular_function);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007010(cytoskeleton organization);GO:0008360(regulation of cell shape);GO:0016477(cell migration)","NA",{"v":4e-20,"d":"0.00"},1,"331,",0,-1.94,{"v":0.00125892541179417,"d":"0.00"},-1.94,"3' UTR",7,129434432,129488399,53968,1]
[149862389,149864362,1974,"ENSG00000273419","ENST00000608963","antisense",0,"AC004877","novel transcript, antisense to ZNF862","NA","NA",{"v":7.2E-10,"d":"0.00"},2,"106,254,","0,1720",{"v":-1.5,"d":"-1.50"},{"v":0.00436515832240166,"d":"0.00"},-1.64,"3' UTR",7,149858400,149862492,4093,2]
[155742061,155746422,4362,"ENSG00000184863","ENST00000438356","protein_coding",0,"RBM33","RNA binding motif protein 33 [Source:HGNC Symbol;Acc:HGNC:27223]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding)","NA",{"v":1E-169,"d":"0.00"},3,"46,760,4,","0,2900,4358",{"v":-16.6,"d":"-16.60"},{"v":1.58489319246111e-19,"d":"0.00"},-1.07,"5' UTR",7,155746419,155766556,20138,1]
[232976505,232976835,331,"ENSG00000135778","ENST00000494689","processed_transcript",25900,"NTPCR","nucleoside-triphosphatase, cancer-related [Source:HGNC Symbol;Acc:HGNC:28204]","GO:0000166(nucleotide binding);GO:0003723(RNA binding);GO:0005524(ATP binding);GO:0016020(membrane);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0017111(nucleoside-triphosphatase activity);GO:0098519(nucleotide phosphatase activity, acting on free nucleotides)","00230(Purine metabolism);00730(Thiamine metabolism)",{"v":1.4E-8,"d":"0.00"},1,"331,",0,-2.08,{"v":0.000831763771102671,"d":"0.00"},-2.25,"3' UTR",1,232950605,232978482,27878,1]
[898778,899101,324,"ENSG00000105963","ENST00000265846","protein_coding",55579,"ADAP1","ArfGAP with dual PH domains 1 [Source:HGNC Symbol;Acc:HGNC:16486]","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005547(phosphatidylinositol-3,4,5-trisphosphate binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007166(cell surface receptor signaling pathway);GO:0043087(regulation of GTPase activity);GO:0043533(inositol 1,3,4,5 tetrakisphosphate binding);GO:0043547(positive regulation of GTPase activity);GO:0046872(metal ion binding);GO:1902936(phosphatidylinositol bisphosphate binding)","NA",{"v":5e-13,"d":"0.00"},2,"172,69,","0,255",-1.75,{"v":2.13796208950223E-3,"d":"0.00"},-1.37,"3' UTR",7,897900,954680,56781,2]
[5620917,5621247,331,"ENSG00000011275","ENST00000425013","protein_coding",160449,"RNF216","ring finger protein 216 [Source:HGNC Symbol;Acc:HGNC:21698]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006915(apoptotic process);GO:0016032(viral process);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0032480(negative regulation of type I interferon production);GO:0032648(regulation of interferon-beta production);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0046872(metal ion binding);GO:0050691(regulation of defense response to virus by host);GO:0061630(ubiquitin protein ligase activity);GO:0070936(protein K48-linked ubiquitination);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098843(postsynaptic endocytic zone);GO:0098978(glutamatergic synapse);GO:0099546(protein catabolic process, modulating synaptic transmission)","NA",{"v":1.3e-27,"d":"0.00"},1,"331,",0,-7.54,{"v":6.45654229034656e-10,"d":"0.00"},-1.59,"3' UTR",7,5620047,5781696,161650,2]
[5925610,5925968,359,"ENSG00000122674","ENST00000325974","protein_coding",26876,"CCZ1","CCZ1 homolog, vacuolar protein trafficking and biogenesis associated [Source:HGNC Symbol;Acc:HGNC:21691]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0005829(cytosol);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0016235(aggresome);GO:0035658(Mon1-Ccz1 complex);GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":7.9e-78,"d":"0.00"},1,"359,",0,-9.36,{"v":6.30957344480194e-12,"d":"0.00"},-1.24,"3' UTR",7,5898734,5925974,27241,1]
[86681657,86691971,10315,"ENSG00000122367","ENST00000429277","protein_coding",13208,"LDB3","LIM domain binding 3 [Source:HGNC Symbol;Acc:HGNC:15710]","GO:0005080(protein kinase C binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0008092(cytoskeletal protein binding);GO:0030018(Z disc);GO:0031143(pseudopodium);GO:0042995(cell projection);GO:0045214(sarcomere organization);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0051371(muscle alpha-actinin binding)","NA",{"v":2E-14,"d":"0.00"},4,"147,23,204,76,","0,4021,5412,10239",{"v":-0.929,"d":"-0.93"},{"v":0.0257039578276886,"d":"0.03"},-2.25,"3' UTR",10,86668449,86736068,67620,1]
[24698985,24699135,151,"ENSG00000105928","ENST00000645220","protein_coding",58329,"GSDME","gasdermin E [Source:HGNC Symbol;Acc:HGNC:2810]","GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007605(sensory perception of sound);GO:0008219(cell death);GO:0008285(negative regulation of cell population proliferation);GO:0012501(programmed cell death);GO:0016020(membrane);GO:0043410(positive regulation of MAPK cascade);GO:0060113(inner ear receptor cell differentiation);GO:0070265(necrotic cell death);GO:0070269(pyroptosis);GO:0071356(cellular response to tumor necrosis factor);GO:0098586(cellular response to virus);GO:1901612(cardiolipin binding);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway)","NA",{"v":1.7E-6,"d":"0.00"},1,"151,",0,{"v":-0.928,"d":"-0.93"},{"v":0.0257039578276886,"d":"0.03"},-1.07,"3' UTR",7,24698355,24757464,59110,2]
[30014775,30018997,4223,"ENSG00000106080","ENST00000222803","protein_coding",7687,"FKBP14","FKBP prolyl isomerase 14 [Source:HGNC Symbol;Acc:HGNC:18625]","GO:0000413(protein peptidyl-prolyl isomerization);GO:0003755(peptidyl-prolyl cis-trans isomerase activity);GO:0005509(calcium ion binding);GO:0005783(endoplasmic reticulum);GO:0005788(endoplasmic reticulum lumen);GO:0016853(isomerase activity);GO:0036498(IRE1-mediated unfolded protein response);GO:0046872(metal ion binding)","NA",{"v":0.00019,"d":"0.00"},2,"119,2,","0,4221",-2.26,{"v":0.000512861383991365,"d":"0.00"},{"v":-1.1,"d":"-1.10"},"3' UTR",7,30010587,30026684,16098,2]
[30558255,30559035,781,"ENSG00000196295","ENST00000434399","antisense",3790,"GARS-DT","GARS divergent transcript [Source:HGNC Symbol;Acc:HGNC:48951]","NA","NA",{"v":4.3e-10,"d":"0.00"},1,"781,",0,-1.12,{"v":0.0138038426460289,"d":"0.01"},-1.85,"Exon (ENST00000355837/ENSG00000196295, exon 2 of 2)",7,30516309,30562825,46517,2]
[74882917,74883155,239,"ENSG00000277072","ENST00000651031","processed_transcript",4556,"STAG3L2","stromal antigen 3-like 2 (pseudogene) [Source:HGNC Symbol;Acc:HGNC:33886]","NA","NA",{"v":3.7e-05,"d":"0.00"},1,"239,",0,{"v":-1.9,"d":"-1.90"},{"v":0.00138038426460289,"d":"0.00"},-1.09,"Exon (ENST00000651031/ENSG00000277072, exon 5 of 6)",7,74843754,74887711,43958,2]
[74883215,74883334,120,"ENSG00000277072","ENST00000651031","processed_transcript",4377,"STAG3L2","stromal antigen 3-like 2 (pseudogene) [Source:HGNC Symbol;Acc:HGNC:33886]","NA","NA",{"v":3.8E-6,"d":"0.00"},1,"120,",0,-2.22,{"v":0.000575439937337157,"d":"0.00"},-1.77,"Exon (ENST00000426587/ENSG00000277072, exon 8 of 8)",7,74843754,74887711,43958,2]
[92562170,92565668,3499,"ENSG00000234545","ENST00000438306","protein_coding",24725,"FAM133B","family with sequence similarity 133 member B [Source:HGNC Symbol;Acc:HGNC:28629]","GO:0003723(RNA binding)","NA",{"v":7.9e-16,"d":"0.00"},2,"199,161,","0,3338",-2.95,{"v":8.12830516164099e-05,"d":"0.00"},-1.16,"3' UTR",7,92560793,92590393,29601,2]
[92569867,92577269,7403,"ENSG00000234545","ENST00000468931","retained_intron",0,"FAM133B","family with sequence similarity 133 member B [Source:HGNC Symbol;Acc:HGNC:28629]","GO:0003723(RNA binding)","NA",{"v":1.9E-6,"d":"0.00"},3,"49,84,167,","0,5904,7236",-1.21,{"v":0.010471285480509,"d":"0.01"},{"v":-1.4,"d":"-1.40"},"3' UTR",7,92566050,92575854,9805,2]
[92578158,92579265,1108,"ENSG00000234545","ENST00000438306","protein_coding",11128,"FAM133B","family with sequence similarity 133 member B [Source:HGNC Symbol;Acc:HGNC:28629]","GO:0003723(RNA binding)","NA",{"v":8.5e-08,"d":"0.00"},3,"25,75,111,","0,161,997",-2.66,{"v":0.000173780082874938,"d":"0.00"},-1.78,"Exon (ENST00000438306/ENSG00000234545, exon 5 of 12)",7,92560793,92590393,29601,2]
[101313876,101314295,420,"ENSG00000128581","ENST00000621899","protein_coding",7528,"IFT22","intraflagellar transport 22 [Source:HGNC Symbol;Acc:HGNC:21895]","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005813(centrosome);GO:0005929(cilium);GO:0006886(intracellular protein transport);GO:0030992(intraciliary transport particle B);GO:0032482(Rab protein signal transduction);GO:0035735(intraciliary transport involved in cilium assembly);GO:0042995(cell projection);GO:0097542(ciliary tip)","NA",{"v":2.5e-16,"d":"0.00"},1,"420,",0,-1.16,{"v":0.0123026877081238,"d":"0.01"},-1.02,"3' UTR",7,101313367,101321823,8457,2]
[9265170,9265320,151,"ENSG00000184014","ENST00000328194","protein_coding",30,"DENND5A","DENN domain containing 5A [Source:HGNC Symbol;Acc:HGNC:19344]","GO:0000139(Golgi membrane);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0010977(negative regulation of neuron projection development);GO:0016020(membrane);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017137(Rab GTPase binding);GO:0030904(retromer complex);GO:0042147(retrograde transport, endosome to Golgi)","NA",{"v":0.00022,"d":"0.00"},1,"151,",0,{"v":-0.785,"d":"-0.79"},{"v":0.0416869383470335,"d":"0.04"},-2.26,"5' UTR",11,9138825,9265350,126526,2]
[141657147,141657387,241,"ENSG00000257093","ENST00000536163","protein_coding",44779,"KIAA1147","KIAA1147 [Source:HGNC Symbol;Acc:HGNC:29472]","NA","NA",{"v":2.5e-08,"d":"0.00"},1,"241,",0,-1.59,{"v":0.00338844156139203,"d":"0.00"},-1.69,"3' UTR",7,141656728,141702166,45439,2]
[148817290,148817530,241,"ENSG00000106462","ENST00000492143","nonsense_mediated_decay",66753,"EZH2","enhancer of zeste 2 polycomb repressive complex 2 subunit [Source:HGNC Symbol;Acc:HGNC:3527]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000781(chromosome, telomeric region);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000979(RNA polymerase II core promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001932(regulation of protein phosphorylation);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003714(transcription corepressor activity);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006306(DNA methylation);GO:0006325(chromatin organization);GO:0006348(chromatin silencing at telomere);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008168(methyltransferase activity);GO:0008284(positive regulation of cell population proliferation);GO:0010468(regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0010718(positive regulation of epithelial to mesenchymal transition);GO:0014013(regulation of gliogenesis);GO:0014834(skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration);GO:0014898(cardiac muscle hypertrophy in response to stress);GO:0016279(protein-lysine N-methyltransferase activity);GO:0016571(histone methylation);GO:0016740(transferase activity);GO:0018024(histone-lysine N-methyltransferase activity);GO:0021695(cerebellar cortex development);GO:0021766(hippocampus development);GO:0031490(chromatin DNA binding);GO:0032259(methylation);GO:0032355(response to estradiol);GO:0034244(negative regulation of transcription elongation from RNA polymerase II promoter);GO:0034968(histone lysine methylation);GO:0035098(ESC/E(Z) complex);GO:0035984(cellular response to trichostatin A);GO:0036333(hepatocyte homeostasis);GO:0042054(histone methyltransferase activity);GO:0042127(regulation of cell population proliferation);GO:0042752(regulation of circadian rhythm);GO:0043021(ribonucleoprotein complex binding);GO:0043406(positive regulation of MAP kinase activity);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0043547(positive regulation of GTPase activity);GO:0043565(sequence-specific DNA binding);GO:0044212(transcription regulatory region DNA binding);GO:0045120(pronucleus);GO:0045605(negative regulation of epidermal cell differentiation);GO:0045814(negative regulation of gene expression, epigenetic);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046976(histone methyltransferase activity (H3-K27 specific));GO:0048387(negative regulation of retinoic acid receptor signaling pathway);GO:0048511(rhythmic process);GO:0050767(regulation of neurogenesis);GO:0051154(negative regulation of striated muscle cell differentiation);GO:0070301(cellular response to hydrogen peroxide);GO:0070314(G1 to G0 transition);GO:0070317(negative regulation of G0 to G1 transition);GO:0070734(histone H3-K27 methylation);GO:0070878(primary miRNA binding);GO:0071168(protein localization to chromatin);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:0097421(liver regeneration);GO:0098532(histone H3-K27 trimethylation);GO:1900006(positive regulation of dendrite development);GO:1902808(positive regulation of cell cycle G1/S phase transition);GO:1904772(response to tetrachloromethane);GO:1990841(promoter-specific chromatin binding);GO:2000134(negative regulation of G1/S transition of mitotic cell cycle)","00310(Lysine degradation);05206(MicroRNAs in cancer)",{"v":1.6e-19,"d":"0.00"},1,"241,",0,-4.36,{"v":1.99526231496888E-6,"d":"0.00"},-1.07,"3' UTR",7,148807383,148884283,76901,2]
[149105316,149112124,6809,"ENSG00000204947","ENST00000378061","protein_coding",14200,"ZNF425","zinc finger protein 425 [Source:HGNC Symbol;Acc:HGNC:20690]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":3.4E-8,"d":"0.00"},2,"251,107,","0,6702",{"v":-2.2,"d":"-2.20"},{"v":0.000588843655355589,"d":"0.00"},-1.85,"Exon (ENST00000378061/ENSG00000204947, exon 4 of 4)",7,149102784,149126324,23541,2]
[19361282,19363851,2570,"ENSG00000104611","ENST00000522328","retained_intron",0,"SH2D4A","SH2 domain containing 4A [Source:HGNC Symbol;Acc:HGNC:26102]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0010923(negative regulation of phosphatase activity);GO:0019902(phosphatase binding)","NA",{"v":0.0051,"d":"0.01"},2,"47,43,","0,2527",{"v":-0.778,"d":"-0.78"},{"v":0.0426579518801593,"d":"0.04"},-1.23,"Exon (ENST00000265807/ENSG00000104611, exon 6 of 10)",8,19363809,19373617,9809,1]
[23084519,23100672,16154,"ENSG00000284948","ENST00000397703","lincRNA",164,"AC107959","novel transcript","NA","NA",{"v":0.00038,"d":"0.00"},3,"27,141,36,","0,5629,16118",{"v":-0.762,"d":"-0.76"},{"v":0.0446683592150963,"d":"0.04"},-1.49,"5' UTR",8,23084355,23103558,19204,1]
[24316418,24316987,570,"ENSG00000213903","ENST00000345363","protein_coding",4916,"LTB4R","leukotriene B4 receptor [Source:HGNC Symbol;Acc:HGNC:6713]","GO:0000166(nucleotide binding);GO:0001632(leukotriene B4 receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0004966(galanin receptor activity);GO:0004974(leukotriene receptor activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006936(muscle contraction);GO:0006954(inflammatory response);GO:0006955(immune response);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007200(phospholipase C-activating G protein-coupled receptor signaling pathway);GO:0007218(neuropeptide signaling pathway);GO:0008528(G protein-coupled peptide receptor activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0045121(membrane raft);GO:0061737(leukotriene signaling pathway)","04080(Neuroactive ligand-receptor interaction)",{"v":5e-21,"d":"0.00"},1,"570,",0,{"v":-0.988,"d":"-0.99"},{"v":0.0208929613085404,"d":"0.02"},-2.26,"3' UTR",14,24311502,24318036,6535,1]
[31076266,31081234,4969,"ENSG00000165392","ENST00000650667","nonsense_mediated_decay",42478,"WRN","Werner syndrome RecQ like helicase [Source:HGNC Symbol;Acc:HGNC:12791]","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0000400(four-way junction DNA binding);GO:0000403(Y-form DNA binding);GO:0000405(bubble DNA binding);GO:0000723(telomere maintenance);GO:0000724(double-strand break repair via homologous recombination);GO:0000731(DNA synthesis involved in DNA repair);GO:0000781(chromosome, telomeric region);GO:0001302(replicative cell aging);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003678(DNA helicase activity);GO:0003682(chromatin binding);GO:0003824(catalytic activity);GO:0004003(ATP-dependent DNA helicase activity);GO:0004386(helicase activity);GO:0004518(nuclease activity);GO:0004527(exonuclease activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005657(replication fork);GO:0005662(DNA replication factor A complex);GO:0005694(chromosome);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0006139(nucleobase-containing compound metabolic process);GO:0006259(DNA metabolic process);GO:0006260(DNA replication);GO:0006281(DNA repair);GO:0006284(base-excision repair);GO:0006302(double-strand break repair);GO:0006310(DNA recombination);GO:0006974(cellular response to DNA damage stimulus);GO:0006979(response to oxidative stress);GO:0007420(brain development);GO:0007568(aging);GO:0007569(cell aging);GO:0008026(ATP-dependent helicase activity);GO:0008152(metabolic process);GO:0008340(determination of adult lifespan);GO:0008408(3'-5' exonuclease activity);GO:0009267(cellular response to starvation);GO:0009378(four-way junction helicase activity);GO:0010225(response to UV-C);GO:0010259(multicellular organism aging);GO:0016607(nuclear speck);GO:0016787(hydrolase activity);GO:0016887(ATPase activity);GO:0030145(manganese ion binding);GO:0031297(replication fork processing);GO:0032405(MutLalpha complex binding);GO:0032508(DNA duplex unwinding);GO:0035861(site of double-strand break);GO:0040009(regulation of growth rate);GO:0042803(protein homodimerization activity);GO:0042981(regulation of apoptotic process);GO:0043005(neuron projection);GO:0043138(3'-5' DNA helicase activity);GO:0043140(ATP-dependent 3'-5' DNA helicase activity);GO:0044237(cellular metabolic process);GO:0044806(G-quadruplex DNA unwinding);GO:0044877(protein-containing complex binding);GO:0046872(metal ion binding);GO:0051345(positive regulation of hydrolase activity);GO:0051880(G-quadruplex DNA binding);GO:0061749(forked DNA-dependent helicase activity);GO:0061820(telomeric D-loop disassembly);GO:0061821(telomeric D-loop binding);GO:0061849(telomeric G-quadruplex DNA binding);GO:0070337(3'-flap-structured DNA binding);GO:0071480(cellular response to gamma radiation);GO:0090305(nucleic acid phosphodiester bond hydrolysis);GO:0090656(t-circle formation);GO:0098530(positive regulation of strand invasion);GO:1901796(regulation of signal transduction by p53 class mediator);GO:1902570(protein localization to nucleolus);GO:1905773(8-hydroxy-2'-deoxyguanosine DNA binding)","NA",{"v":8.9e-09,"d":"0.00"},2,"22,368,","0,4601",-1.35,{"v":0.00691830970918936,"d":"0.01"},-1.11,"3' UTR",8,31033788,31173738,139951,1]
[67095320,67103073,7754,"ENSG00000252637","ENST00000516828","rRNA_pseudogene",0,"RNA5SP268","RNA, 5S ribosomal pseudogene 268 [Source:HGNC Symbol;Acc:HGNC:43168]","NA","NA",{"v":1.6E-11,"d":"0.00"},2,"413,37,","0,7717",-2.34,{"v":0.000407380277804113,"d":"0.00"},-1.52,"5' UTR",8,67099302,67099425,124,1]
[93916917,93917775,859,"ENSG00000164951","ENST00000297598","protein_coding",0,"PDP1","pyruvate dehyrogenase phosphatase catalytic subunit 1 [Source:HGNC Symbol;Acc:HGNC:9279]","GO:0003824(catalytic activity);GO:0004721(phosphoprotein phosphatase activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0004724(magnesium-dependent protein serine/threonine phosphatase activity);GO:0004741([pyruvate dehydrogenase (lipoamide)] phosphatase activity);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006470(protein dephosphorylation);GO:0010510(regulation of acetyl-CoA biosynthetic process from pyruvate);GO:0016787(hydrolase activity);GO:0035970(peptidyl-threonine dephosphorylation);GO:0043169(cation binding);GO:0046872(metal ion binding);GO:1904184(positive regulation of pyruvate dehydrogenase activity)","NA",{"v":1.3E-13,"d":"0.00"},2,"302,29,","0,830",{"v":-0.814,"d":"-0.81"},{"v":0.0371535229097173,"d":"0.04"},-1.58,"5' UTR",8,93916923,93926068,9146,1]
[96761473,96785233,23761,"ENSG00000104324","ENST00000220763","protein_coding",116231,"CPQ","carboxypeptidase Q [Source:HGNC Symbol;Acc:HGNC:16910]","GO:0004180(carboxypeptidase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0006508(proteolysis);GO:0006590(thyroid hormone generation);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0016787(hydrolase activity);GO:0042246(tissue regeneration);GO:0042803(protein homodimerization activity);GO:0043171(peptide catabolic process);GO:0043231(intracellular membrane-bounded organelle);GO:0046872(metal ion binding);GO:0070062(extracellular exosome);GO:0070573(metallodipeptidase activity)","NA",{"v":4e-20,"d":"0.00"},2,"20,370,","0,23391",-8.96,{"v":1.99526231496888e-11,"d":"0.00"},-1.72,"5' UTR",8,96645242,97143501,498260,1]
[124568607,124579659,11053,"ENSG00000170873","ENST00000431961","protein_coding",0,"MTSS1","MTSS1, I-BAR domain containing [Source:HGNC Symbol;Acc:HGNC:20443]","GO:0001726(ruffle);GO:0003779(actin binding);GO:0003785(actin monomer binding);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0007009(plasma membrane organization);GO:0007155(cell adhesion);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0015629(actin cytoskeleton);GO:0030035(microspike assembly);GO:0030036(actin cytoskeleton organization);GO:0030139(endocytic vesicle);GO:0042802(identical protein binding);GO:0050680(negative regulation of epithelial cell proliferation);GO:0061333(renal tubule morphogenesis);GO:0071498(cellular response to fluid shear stress);GO:0072102(glomerulus morphogenesis);GO:0072160(nephron tubule epithelial cell differentiation);GO:2001013(epithelial cell proliferation involved in renal tubule morphogenesis)","NA",{"v":3.1E-6,"d":"0.00"},2,"308,82,","0,10971",{"v":-0.888,"d":"-0.89"},{"v":0.0295120922666639,"d":"0.03"},-1.48,"5' UTR",8,124552888,124568841,15954,2]
[132846138,132846618,481,"ENSG00000129292","ENST00000395386","protein_coding",70754,"PHF20L1","PHD finger protein 20 like 1 [Source:HGNC Symbol;Acc:HGNC:24280]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","NA",{"v":7.6e-06,"d":"0.00"},1,"481,",0,{"v":-0.878,"d":"-0.88"},{"v":0.0301995172040202,"d":"0.03"},-1.22,"3' UTR",8,132775384,132848807,73424,1]
[133408155,133408363,209,"ENSG00000225259","ENST00000522430","processed_pseudogene",149,"ST13P6","ST13, Hsp70 interacting protein pseudogene 6 [Source:HGNC Symbol;Acc:HGNC:18557]","NA","NA",{"v":2.9E-4,"d":"0.00"},1,"209,",0,-1.55,{"v":0.00380189396320561,"d":"0.00"},-1.23,"Exon (ENST00000522430/ENSG00000225259, exon 1 of 1)",8,133408006,133409107,1102,1]
[143250961,143274712,23752,"ENSG00000250571","ENST00000519876","processed_transcript",0,"GLI4","GLI family zinc finger 4 [Source:HGNC Symbol;Acc:HGNC:4320]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003674(molecular_function);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008150(biological_process);GO:0046872(metal ion binding)","NA",{"v":1e-12,"d":"0.00"},2,"380,9,","0,23743",-1.74,{"v":0.00218776162394955,"d":"0.00"},-1.35,"5' UTR",8,143267433,143273383,5951,1]
[144501822,144502121,300,"ENSG00000160972","ENST00000526183","retained_intron",23853,"PPP1R16A","protein phosphatase 1 regulatory subunit 16A [Source:HGNC Symbol;Acc:HGNC:14941]","GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0019888(protein phosphatase regulator activity);GO:0043666(regulation of phosphoprotein phosphatase activity)","NA",{"v":1.3E-17,"d":"0.00"},1,"300,",0,-2.65,{"v":1.77827941003892E-4,"d":"0.00"},-1.61,"3' UTR",8,144477969,144502120,24152,1]
[44726580,44732284,5705,"ENSG00000186654","ENST00000455389","processed_transcript",0,"PRR5","proline rich 5 [Source:HGNC Symbol;Acc:HGNC:31682]","GO:0001934(positive regulation of protein phosphorylation);GO:0005515(protein binding);GO:0005829(cytosol);GO:0007049(cell cycle);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0031932(TORC2 complex);GO:0032148(activation of protein kinase B activity);GO:0038203(TORC2 signaling)","04150(mTOR signaling pathway)",{"v":7.4e-08,"d":"0.00"},3,"55,92,34,","0,5150,5671",-3.71,{"v":1.07151930523761e-05,"d":"0.00"},-2.26,"5' UTR",22,44730804,44737632,6829,1]
[22690714,22691133,420,"ENSG00000179388","ENST00000317216","protein_coding",2347,"EGR3","early growth response 3 [Source:HGNC Symbol;Acc:HGNC:3240]","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001938(positive regulation of endothelial cell proliferation);GO:0002042(cell migration involved in sprouting angiogenesis);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007274(neuromuscular synaptic transmission);GO:0007422(peripheral nervous system development);GO:0007517(muscle organ development);GO:0007623(circadian rhythm);GO:0033089(positive regulation of T cell differentiation in thymus);GO:0035767(endothelial cell chemotaxis);GO:0035924(cellular response to vascular endothelial growth factor stimulus);GO:0043066(negative regulation of apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0044344(cellular response to fibroblast growth factor stimulus);GO:0045586(regulation of gamma-delta T cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0071363(cellular response to growth factor stimulus)","04625(C-type lectin receptor signaling pathway);05161(Hepatitis B);05203(Viral carcinogenesis)",{"v":1.5e-07,"d":"0.00"},1,"420,",0,-1.26,{"v":0.0091201083935591,"d":"0.01"},-1.81,"3' UTR",8,22687659,22693480,5822,2]
[23404010,23404130,121,"ENSG00000134013","ENST00000523833","protein_coding",0,"LOXL2","lysyl oxidase like 2 [Source:HGNC Symbol;Acc:HGNC:6666]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000785(chromatin);GO:0001666(response to hypoxia);GO:0001837(epithelial to mesenchymal transition);GO:0001935(endothelial cell proliferation);GO:0002040(sprouting angiogenesis);GO:0004720(protein-lysine 6-oxidase activity);GO:0005044(scavenger receptor activity);GO:0005507(copper ion binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005604(basement membrane);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005783(endoplasmic reticulum);GO:0006325(chromatin organization);GO:0006464(cellular protein modification process);GO:0006898(receptor-mediated endocytosis);GO:0007155(cell adhesion);GO:0007568(aging);GO:0009055(electron transfer activity);GO:0010718(positive regulation of epithelial to mesenchymal transition);GO:0016020(membrane);GO:0016491(oxidoreductase activity);GO:0016641(oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor);GO:0018057(peptidyl-lysine oxidation);GO:0022900(electron transport chain);GO:0030199(collagen fibril organization);GO:0032332(positive regulation of chondrocyte differentiation);GO:0043542(endothelial cell migration);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046688(response to copper ion);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process);GO:0062023(collagen-containing extracellular matrix);GO:0070492(oligosaccharide binding);GO:0070828(heterochromatin organization);GO:1902455(negative regulation of stem cell population maintenance)","NA",{"v":1.5E-3,"d":"0.00"},1,"121,",0,-1.47,{"v":0.00478630092322639,"d":"0.00"},-1.57,"5' UTR",8,23316984,23404126,87143,2]
[23437038,23439767,2730,"ENSG00000197217","ENST00000518471","protein_coding",0,"ENTPD4","ectonucleoside triphosphate diphosphohydrolase 4 [Source:HGNC Symbol;Acc:HGNC:14573]","GO:0000139(Golgi membrane);GO:0000421(autophagosome membrane);GO:0005794(Golgi apparatus);GO:0006256(UDP catabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0017110(nucleoside-diphosphatase activity);GO:0030173(integral component of Golgi membrane);GO:0031410(cytoplasmic vesicle);GO:0034656(nucleobase-containing small molecule catabolic process);GO:0045134(uridine-diphosphatase activity);GO:0097637(integral component of autophagosome membrane)","00230(Purine metabolism);00240(Pyrimidine metabolism);04142(Lysosome)",{"v":6.3e-15,"d":"0.00"},2,"221,19,","0,2711",-5.51,{"v":1.0471285480509E-7,"d":"0.00"},-1.06,"Exon (ENST00000518471/ENSG00000197217, exon 1 of 5)",8,23385783,23437092,51310,2]
[38329492,38331568,2077,"ENSG00000147548","ENST00000317025","protein_coding",50703,"NSD3","nuclear receptor binding SET domain protein 3 [Source:HGNC Symbol;Acc:HGNC:12767]","GO:0000785(chromatin);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0006325(chromatin organization);GO:0006355(regulation of transcription, DNA-templated);GO:0008168(methyltransferase activity);GO:0010452(histone H3-K36 methylation);GO:0016571(histone methylation);GO:0016740(transferase activity);GO:0018024(histone-lysine N-methyltransferase activity);GO:0032259(methylation);GO:0034968(histone lysine methylation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0046975(histone methyltransferase activity (H3-K36 specific));GO:2001255(positive regulation of histone H3-K36 trimethylation)","00310(Lysine degradation)",{"v":1E-127,"d":"0.00"},2,"402,138,","0,1939",{"v":-17.6,"d":"-17.60"},{"v":1.58489319246111e-20,"d":"0.00"},{"v":-1.2,"d":"-1.20"},"Exon (ENST00000317025/ENSG00000147548, exon 5 of 24)",8,38269704,38382271,112568,2]
[41937276,41938472,1197,"ENSG00000083168","ENST00000265713","protein_coding",113515,"KAT6A","lysine acetyltransferase 6A [Source:HGNC Symbol;Acc:HGNC:13013]","GO:0000123(histone acetyltransferase complex);GO:0000786(nucleosome);GO:0000790(nuclear chromatin);GO:0003677(DNA binding);GO:0003713(transcription coactivator activity);GO:0004402(histone acetyltransferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006323(DNA packaging);GO:0006325(chromatin organization);GO:0006334(nucleosome assembly);GO:0006355(regulation of transcription, DNA-templated);GO:0006473(protein acetylation);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0010485(H4 histone acetyltransferase activity);GO:0016407(acetyltransferase activity);GO:0016573(histone acetylation);GO:0016605(PML body);GO:0016607(nuclear speck);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0030099(myeloid cell differentiation);GO:0042393(histone binding);GO:0043966(histone H3 acetylation);GO:0043967(histone H4 acetylation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0048513(animal organ development);GO:0070776(MOZ/MORF histone acetyltransferase complex);GO:0090398(cellular senescence);GO:1901796(regulation of signal transduction by p53 class mediator);GO:1903508(positive regulation of nucleic acid-templated transcription)","04550(Signaling pathways regulating pluripotency of stem cells)",{"v":3.2e-18,"d":"0.00"},2,"293,128,","0,1069",-3.52,{"v":1.73780082874938e-05,"d":"0.00"},{"v":-1.1,"d":"-1.10"},"3' UTR",8,41929479,42051987,122509,2]
[42437137,42437346,210,"ENSG00000168575","ENST00000520262","protein_coding",63885,"SLC20A2","solute carrier family 20 member 2 [Source:HGNC Symbol;Acc:HGNC:10947]","GO:0001618(virus receptor activity);GO:0005315(inorganic phosphate transmembrane transporter activity);GO:0005436(sodium:phosphate symporter activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006811(ion transport);GO:0006814(sodium ion transport);GO:0006817(phosphate ion transport);GO:0015293(symporter activity);GO:0015319(sodium:inorganic phosphate symporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016032(viral process);GO:0035435(phosphate ion transmembrane transport);GO:0035725(sodium ion transmembrane transport);GO:0038023(signaling receptor activity);GO:0046718(viral entry into host cell);GO:0055085(transmembrane transport);GO:0070062(extracellular exosome)","NA",{"v":1.8E-5,"d":"0.00"},1,"210,",0,-2.24,{"v":0.000549540873857625,"d":"0.00"},-1.51,"Exon (ENST00000520262/ENSG00000168575, exon 8 of 11)",8,42416475,42501231,84757,2]
[47774158,47777686,3529,"ENSG00000253729","ENST00000314191","protein_coding",182497,"PRKDC","protein kinase, DNA-activated, catalytic subunit [Source:HGNC Symbol;Acc:HGNC:9413]","GO:0000166(nucleotide binding);GO:0000723(telomere maintenance);GO:0000784(nuclear chromosome, telomeric region);GO:0001756(somitogenesis);GO:0001933(negative regulation of protein phosphorylation);GO:0002218(activation of innate immune response);GO:0002326(B cell lineage commitment);GO:0002328(pro-B cell differentiation);GO:0002360(T cell lineage commitment);GO:0002376(immune system process);GO:0002377(immunoglobulin production);GO:0002638(negative regulation of immunoglobulin production);GO:0002684(positive regulation of immune system process);GO:0003677(DNA binding);GO:0003690(double-stranded DNA binding);GO:0003723(RNA binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004677(DNA-dependent protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0005958(DNA-dependent protein kinase-DNA ligase 4 complex);GO:0006281(DNA repair);GO:0006302(double-strand break repair);GO:0006303(double-strand break repair via nonhomologous end joining);GO:0006310(DNA recombination);GO:0006464(cellular protein modification process);GO:0006468(protein phosphorylation);GO:0006974(cellular response to DNA damage stimulus);GO:0007420(brain development);GO:0007507(heart development);GO:0008134(transcription factor binding);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0010212(response to ionizing radiation);GO:0010332(response to gamma radiation);GO:0014823(response to activity);GO:0016020(membrane);GO:0016233(telomere capping);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0018105(peptidyl-serine phosphorylation);GO:0019899(enzyme binding);GO:0019904(protein domain specific binding);GO:0030098(lymphocyte differentiation);GO:0031648(protein destabilization);GO:0032481(positive regulation of type I interferon production);GO:0032869(cellular response to insulin stimulus);GO:0032991(protein-containing complex);GO:0032993(protein-DNA complex);GO:0033077(T cell differentiation in thymus);GO:0033151(V(D)J recombination);GO:0033152(immunoglobulin V(D)J recombination);GO:0033153(T cell receptor V(D)J recombination);GO:0035234(ectopic germ cell programmed cell death);GO:0042752(regulation of circadian rhythm);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0045087(innate immune response);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048146(positive regulation of fibroblast proliferation);GO:0048511(rhythmic process);GO:0048536(spleen development);GO:0048538(thymus development);GO:0048639(positive regulation of developmental growth);GO:0048660(regulation of smooth muscle cell proliferation);GO:0050678(regulation of epithelial cell proliferation);GO:0070419(nonhomologous end joining complex);GO:0072431(signal transduction involved in mitotic G1 DNA damage checkpoint);GO:0097681(double-strand break repair via alternative nonhomologous end joining);GO:2000773(negative regulation of cellular senescence);GO:2001229(negative regulation of response to gamma radiation)","03450(Non-homologous end-joining);04110(Cell cycle)",{"v":1e-140,"d":"0.00"},3,"220,140,1,","0,2686,3528",{"v":-33.4,"d":"-33.40"},{"v":7.94328234724279e-37,"d":"0.00"},-1.06,"3' UTR",8,47773108,47960183,187076,2]
[94519035,94519424,390,"ENSG00000164944","ENST00000297591","protein_coding",34045,"VIRMA","vir like m6A methyltransferase associated [Source:HGNC Symbol;Acc:HGNC:24500]","GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006397(mRNA processing);GO:0007275(multicellular organism development);GO:0008380(RNA splicing);GO:0016604(nuclear body);GO:0016607(nuclear speck);GO:0036396(RNA N6-methyladenosine methyltransferase complex);GO:0080009(mRNA methylation);GO:0110104(mRNA alternative polyadenylation)","NA",{"v":1E-117,"d":"0.00"},1,"390,",0,{"v":-5.2,"d":"-5.20"},{"v":2.34422881531992e-07,"d":"0.00"},-1.04,"Exon (ENST00000297591/ENSG00000164944, exon 9 of 24)",8,94487689,94553469,65781,2]
[119731911,119732151,241,"ENSG00000064313","ENST00000378164","protein_coding",100690,"TAF2","TATA-box binding protein associated factor 2 [Source:HGNC Symbol;Acc:HGNC:11536]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0001094(TFIID-class transcription factor complex binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005669(transcription factor TFIID complex);GO:0006366(transcription by RNA polymerase II);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0014070(response to organic cyclic compound);GO:0033276(transcription factor TFTC complex);GO:0044212(transcription regulatory region DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1901796(regulation of signal transduction by p53 class mediator)","03022(Basal transcription factors)",{"v":2e-23,"d":"0.00"},1,"241,",0,-7.16,{"v":1.65958690743756E-9,"d":"0.00"},-1.31,"3' UTR",8,119730774,119832841,102068,2]
[133475904,133476532,629,"ENSG00000008513","ENST00000522204","retained_intron",0,"ST3GAL1","ST3 beta-galactoside alpha-2,3-sialyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:10862]","GO:0000139(Golgi membrane);GO:0003836(beta-galactoside (CMP) alpha-2,3-sialyltransferase activity);GO:0005576(extracellular region);GO:0005794(Golgi apparatus);GO:0006054(N-acetylneuraminate metabolic process);GO:0006464(cellular protein modification process);GO:0006468(protein phosphorylation);GO:0006486(protein glycosylation);GO:0006487(protein N-linked glycosylation);GO:0008373(sialyltransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016266(O-glycan processing);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0018146(keratan sulfate biosynthetic process);GO:0032580(Golgi cisterna membrane);GO:0070062(extracellular exosome);GO:0097503(sialylation)","00512(Mucin type O-glycan biosynthesis);00533(Glycosaminoglycan biosynthesis - keratan sulfate);00603(Glycosphingolipid biosynthesis - globo and isoglobo series);00604(Glycosphingolipid biosynthesis - ganglio series)",{"v":4.6e-09,"d":"0.00"},1,"629,",0,{"v":-0.776,"d":"-0.78"},{"v":0.0426579518801593,"d":"0.04"},-1.14,"5' UTR",8,133465642,133475934,10293,2]
[141126044,141126432,389,"ENSG00000105339","ENST00000519291","protein_coding",8766,"DENND3","DENN domain containing 3 [Source:HGNC Symbol;Acc:HGNC:29134]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008333(endosome to lysosome transport);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0044257(cellular protein catabolic process)","NA",{"v":1e-20,"d":"0.00"},1,"389,",0,-1.05,{"v":0.0169824365246174,"d":"0.02"},-1.55,"Exon (ENST00000520885/ENSG00000253210, exon 2 of 2)",8,141117278,141141276,23999,1]
[1221651,1222009,359,"ENSG00000116176","ENST00000234798","protein_coding",3248,"TPSG1","tryptase gamma 1 [Source:HGNC Symbol;Acc:HGNC:14134]","GO:0004252(serine-type endopeptidase activity);GO:0005615(extracellular space);GO:0005887(integral component of plasma membrane);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008236(serine-type peptidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity)","NA",{"v":1e-09,"d":"0.00"},1,"359,",0,-1.34,{"v":0.00707945784384138,"d":"0.01"},-2.27,"3' UTR",16,1221651,1225257,3607,2]
[38936280,38936548,269,"ENSG00000269486","ENST00000599320","lincRNA",2084,"ERVK9-11","endogenous retrovirus group K9, member 11 [Source:HGNC Symbol;Acc:HGNC:51160]","NA","NA",{"v":0.00054,"d":"0.00"},1,"269,",0,{"v":-0.863,"d":"-0.86"},{"v":0.0316227766016838,"d":"0.03"},-2.28,"Exon (ENST00000599320/ENSG00000269486, exon 1 of 1)",19,38935297,38938632,3336,2]
[6506215,6506305,91,"ENSG00000147854","ENST00000468435","nonsense_mediated_decay",93064,"UHRF2","ubiquitin like with PHD and ring finger domains 2 [Source:HGNC Symbol;Acc:HGNC:12557]","GO:0003677(DNA binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005720(nuclear heterochromatin);GO:0007049(cell cycle);GO:0010216(maintenance of DNA methylation);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0030154(cell differentiation);GO:0042393(histone binding);GO:0046872(metal ion binding);GO:0051726(regulation of cell cycle);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity);GO:0071158(positive regulation of cell cycle arrest)","NA",{"v":0.00046,"d":"0.00"},1,"91,",0,-1.33,{"v":7.2443596007499E-3,"d":"0.01"},-1.22,"3' UTR",9,6413151,6507054,93904,1]
[55147278,55148020,743,"ENSG00000105048","ENST00000593046","protein_coding",0,"TNNT1","troponin T1, slow skeletal type [Source:HGNC Symbol;Acc:HGNC:11948]","GO:0003009(skeletal muscle contraction);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005523(tropomyosin binding);GO:0005829(cytosol);GO:0005861(troponin complex);GO:0006936(muscle contraction);GO:0006937(regulation of muscle contraction);GO:0014883(transition between fast and slow fiber);GO:0030049(muscle filament sliding);GO:0030899(calcium-dependent ATPase activity);GO:0031014(troponin T binding);GO:0031444(slow-twitch skeletal muscle fiber contraction);GO:0045214(sarcomere organization);GO:0045932(negative regulation of muscle contraction);GO:0060048(cardiac muscle contraction)","NA",{"v":0.0039,"d":"0.00"},2,"69,22,","0,721",{"v":-0.946,"d":"-0.95"},{"v":0.0239883291901949,"d":"0.02"},-2.29,"5' UTR",19,55137103,55147346,10244,2]
[44931147,44931445,299,"ENSG00000259439","ENST00000437916","lincRNA",7754,"LINC01833","long intergenic non-protein coding RNA 1833 [Source:HGNC Symbol;Acc:HGNC:52644]","NA","NA",{"v":4.2E-10,"d":"0.00"},1,"299,",0,{"v":-0.962,"d":"-0.96"},{"v":0.0229086765276777,"d":"0.02"},-2.29,"Exon (ENST00000444871/ENSG00000259439, exon 3 of 3)",2,44921077,44939199,18123,2]
[69252810,69253049,240,"ENSG00000119139","ENST00000453658","protein_coding",131546,"TJP2","tight junction protein 2 [Source:HGNC Symbol;Acc:HGNC:11828]","GO:0004385(guanylate kinase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005912(adherens junction);GO:0005923(bicellular tight junction);GO:0016020(membrane);GO:0019904(protein domain specific binding);GO:0030054(cell junction);GO:0030674(protein binding, bridging);GO:0035329(hippo signaling);GO:0045296(cadherin binding);GO:0046037(GMP metabolic process);GO:0046710(GDP metabolic process);GO:0050892(intestinal absorption);GO:0090557(establishment of endothelial intestinal barrier);GO:0090559(regulation of membrane permeability)","04530(Tight junction);05110(Vibrio cholerae infection)",{"v":4e-11,"d":"0.00"},1,"240,",0,-2.19,{"v":0.000616595001861482,"d":"0.00"},-1.45,"3' UTR",9,69121264,69255208,133945,1]
[70282518,70300091,17574,"ENSG00000198887","ENST00000361138","protein_coding",23540,"SMC5","structural maintenance of chromosomes 5 [Source:HGNC Symbol;Acc:HGNC:20465]","GO:0000166(nucleotide binding);GO:0000722(telomere maintenance via recombination);GO:0000724(double-strand break repair via homologous recombination);GO:0000781(chromosome, telomeric region);GO:0000803(sex chromosome);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0006281(DNA repair);GO:0006310(DNA recombination);GO:0006974(cellular response to DNA damage stimulus);GO:0007049(cell cycle);GO:0007062(sister chromatid cohesion);GO:0016605(PML body);GO:0016607(nuclear speck);GO:0030054(cell junction);GO:0030915(Smc5-Smc6 complex);GO:0034184(positive regulation of maintenance of mitotic sister chromatid cohesion);GO:0035061(interchromatin granule);GO:0035861(site of double-strand break);GO:0051301(cell division);GO:0051984(positive regulation of chromosome segregation);GO:0090398(cellular senescence)","NA",{"v":9.1e-05,"d":"0.00"},5,"66,72,39,256,46,","0,3682,4228,15448,17528",-1.26,{"v":0.00891250938133746,"d":"0.01"},-1.05,"Exon (ENST00000361138/ENSG00000198887, exon 7 of 25)",9,70258978,70354873,95896,1]
[78266575,78266995,421,"ENSG00000148019","ENST00000424347","protein_coding",30513,"CEP78","centrosomal protein 78 [Source:HGNC Symbol;Acc:HGNC:25740]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005929(cilium);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0030030(cell projection organization);GO:0036064(ciliary basal body);GO:0042995(cell projection);GO:0044782(cilium organization);GO:0097711(ciliary basal body-plasma membrane docking)","NA",{"v":6.3e-83,"d":"0.00"},1,"421,",0,-8.37,{"v":7.94328234724282e-11,"d":"0.00"},-1.55,"3' UTR",9,78236062,78279690,43629,1]
[93317854,93318034,181,"ENSG00000165238","ENST00000297954","protein_coding",132924,"WNK2","WNK lysine deficient protein kinase 2 [Source:HGNC Symbol;Acc:HGNC:14542]","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0008285(negative regulation of cell population proliferation);GO:0010766(negative regulation of sodium ion transport);GO:0016020(membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0019869(chloride channel inhibitor activity);GO:0019870(potassium channel inhibitor activity);GO:0032414(positive regulation of ion transmembrane transporter activity);GO:0035556(intracellular signal transduction);GO:0046777(protein autophosphorylation);GO:0050801(ion homeostasis);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1903288(positive regulation of potassium ion import across plasma membrane);GO:2000651(positive regulation of sodium ion transmembrane transporter activity)","NA",{"v":3.7e-05,"d":"0.00"},1,"181,",0,{"v":-0.781,"d":"-0.78"},{"v":0.0416869383470335,"d":"0.04"},-1.78,"3' UTR",9,93184930,93318271,133342,1]
[95880988,95897902,16915,"ENSG00000182150","ENST00000288985","protein_coding",5287,"ERCC6L2","ERCC excision repair 6 like 2 [Source:HGNC Symbol;Acc:HGNC:26922]","GO:0000166(nucleotide binding);GO:0003677(DNA binding);GO:0004386(helicase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006281(DNA repair);GO:0006974(cellular response to DNA damage stimulus);GO:0016787(hydrolase activity);GO:0019901(protein kinase binding);GO:0032991(protein-containing complex);GO:0034614(cellular response to reactive oxygen species);GO:0036297(interstrand cross-link repair)","NA",{"v":3.2e-26,"d":"0.00"},2,"306,54,","0,16861",-1.63,{"v":3.01995172040202E-3,"d":"0.00"},-1.14,"Exon (ENST00000288985/ENSG00000182150, exon 2 of 14)",9,95875701,95968840,93140,1]
[98848855,98849245,391,"ENSG00000119514","ENST00000375011","protein_coding",41185,"GALNT12","polypeptide N-acetylgalactosaminyltransferase 12 [Source:HGNC Symbol;Acc:HGNC:19877]","GO:0000139(Golgi membrane);GO:0004653(polypeptide N-acetylgalactosaminyltransferase activity);GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016266(O-glycan processing);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030246(carbohydrate binding);GO:0046872(metal ion binding)","00512(Mucin type O-glycan biosynthesis)",{"v":1.3E-11,"d":"0.00"},2,"6,294,","0,97",-1.53,{"v":0.00407380277804113,"d":"0.00"},{"v":-1.2,"d":"-1.20"},"3' UTR",9,98807670,98850081,42412,1]
[114311523,114311763,241,"ENSG00000196739","ENST00000356083","protein_coding",155986,"COL27A1","collagen type XXVII alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:22986]","GO:0003431(growth plate cartilage chondrocyte development);GO:0005201(extracellular matrix structural constituent);GO:0005576(extracellular region);GO:0005581(collagen trimer);GO:0005583(fibrillar collagen trimer);GO:0005615(extracellular space);GO:0005788(endoplasmic reticulum lumen);GO:0030020(extracellular matrix structural constituent conferring tensile strength);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0046872(metal ion binding);GO:0062023(collagen-containing extracellular matrix)","04974(Protein digestion and absorption)",{"v":1.9e-09,"d":"0.00"},1,"241,",0,{"v":-0.816,"d":"-0.82"},{"v":0.0371535229097173,"d":"0.04"},-1.43,"3' UTR",9,114155537,114312511,156975,1]
[121167646,121169683,2038,"ENSG00000119397","ENST00000373855","protein_coding",92634,"CNTRL","centriolin [Source:HGNC Symbol;Acc:HGNC:1858]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0000278(mitotic cell cycle);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0007049(cell cycle);GO:0008092(cytoskeletal protein binding);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0016020(membrane);GO:0051301(cell division);GO:0051493(regulation of cytoskeleton organization);GO:0090543(Flemming body);GO:0097711(ciliary basal body-plasma membrane docking);GO:0120103(centriolar subdistal appendage)","NA",{"v":2e-07,"d":"0.00"},3,"32,226,73,","0,450,1965",{"v":-0.926,"d":"-0.93"},{"v":0.0257039578276886,"d":"0.03"},-1.38,"Exon (ENST00000373855/ENSG00000119397, exon 37 of 44)",9,121075012,121177608,102597,1]
[126700853,126701032,180,"ENSG00000136944","ENST00000355497","protein_coding",86410,"LMX1B","LIM homeobox transcription factor 1 beta [Source:HGNC Symbol;Acc:HGNC:6654]","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009953(dorsal/ventral pattern formation);GO:0030182(neuron differentiation);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0071542(dopaminergic neuron differentiation)","NA",{"v":3E-10,"d":"0.00"},1,"180,",0,{"v":-0.861,"d":"-0.86"},{"v":0.0323593656929628,"d":"0.03"},-1.17,"3' UTR",9,126614443,126701032,86590,1]
[130701341,130701819,479,"ENSG00000130713","ENST00000491115","processed_transcript",7620,"EXOSC2","exosome component 2 [Source:HGNC Symbol;Acc:HGNC:17097]","GO:0000175(3'-5'-exoribonuclease activity);GO:0000176(nuclear exosome (RNase complex));GO:0000177(cytoplasmic exosome (RNase complex));GO:0000178(exosome (RNase complex));GO:0000467(exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006364(rRNA processing);GO:0008312(7S RNA binding);GO:0030307(positive regulation of cell growth);GO:0034427(nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5');GO:0034475(U4 snRNA 3'-end processing);GO:0043488(regulation of mRNA stability);GO:0043928(exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay);GO:0071034(CUT catabolic process);GO:0071035(nuclear polyadenylation-dependent rRNA catabolic process);GO:0071038(nuclear polyadenylation-dependent tRNA catabolic process);GO:0071049(nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription);GO:0071051(polyadenylation-dependent snoRNA 3'-end processing)","03018(RNA degradation)",{"v":7.9e-66,"d":"0.00"},1,"479,",0,-1.64,{"v":0.00288403150312661,"d":"0.00"},-1.07,"Exon (ENST00000467138/ENSG00000130713, exon 1 of 3)",9,130693721,130703774,10054,1]
[131087795,131092022,4228,"ENSG00000050555","ENST00000480883","processed_transcript",78621,"LAMC3","laminin subunit gamma 3 [Source:HGNC Symbol;Acc:HGNC:6494]","GO:0000904(cell morphogenesis involved in differentiation);GO:0005198(structural molecule activity);GO:0005576(extracellular region);GO:0005604(basement membrane);GO:0007155(cell adhesion);GO:0007601(visual perception);GO:0014002(astrocyte development);GO:0016020(membrane);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0060041(retina development in camera-type eye)","04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04512(ECM-receptor interaction);05145(Toxoplasmosis);05146(Amoebiasis);05165(Human papillomavirus infection);05200(Pathways in cancer);05222(Small cell lung cancer)",{"v":3.2e-25,"d":"0.00"},2,"23,486,","0,3742",-3.22,{"v":3.98107170553497e-05,"d":"0.00"},-1.67,"3' UTR",9,131009174,131092109,82936,1]
[134158829,134159039,211,"ENSG00000196363","ENST00000358625","protein_coding",22741,"WDR5","WD repeat domain 5 [Source:HGNC Symbol;Acc:HGNC:12757]","GO:0000123(histone acetyltransferase complex);GO:0001501(skeletal system development);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005671(Ada2/Gcn5/Ada3 transcription activator complex);GO:0006325(chromatin organization);GO:0031175(neuron projection development);GO:0035064(methylated histone binding);GO:0035097(histone methyltransferase complex);GO:0035948(positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter);GO:0042393(histone binding);GO:0042800(histone methyltransferase activity (H3-K4 specific));GO:0043687(post-translational protein modification);GO:0043966(histone H3 acetylation);GO:0043981(histone H4-K5 acetylation);GO:0043982(histone H4-K8 acetylation);GO:0043984(histone H4-K16 acetylation);GO:0043995(histone acetyltransferase activity (H4-K5 specific));GO:0043996(histone acetyltransferase activity (H4-K8 specific));GO:0044666(MLL3/4 complex);GO:0045652(regulation of megakaryocyte differentiation);GO:0046972(histone acetyltransferase activity (H4-K16 specific));GO:0048188(Set1C/COMPASS complex);GO:0051568(histone H3-K4 methylation);GO:0071339(MLL1 complex)","04934(Cushing syndrome)",{"v":2E-12,"d":"0.00"},1,"211,",0,-1.37,{"v":0.00645654229034656,"d":"0.01"},{"v":-1.1,"d":"-1.10"},"3' UTR",9,134136088,134159968,23881,1]
[136356499,136358380,1882,"ENSG00000160360","ENST00000440944","protein_coding",28960,"GPSM1","G protein signaling modulator 1 [Source:HGNC Symbol;Acc:HGNC:17858]","GO:0000139(Golgi membrane);GO:0005092(GDP-dissociation inhibitor activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005938(cell cortex);GO:0007275(multicellular organism development);GO:0007399(nervous system development);GO:0016020(membrane);GO:0016239(positive regulation of macroautophagy);GO:0030154(cell differentiation);GO:0030695(GTPase regulator activity);GO:0032991(protein-containing complex);GO:0034260(negative regulation of GTPase activity);GO:0050790(regulation of catalytic activity);GO:1905098(negative regulation of guanyl-nucleotide exchange factor activity)","05030(Cocaine addiction)",{"v":6.3e-34,"d":"0.00"},2,"52,367,","0,1515",-3.15,{"v":4.67735141287198e-05,"d":"0.00"},-1.01,"3' UTR",9,136327539,136359601,32063,1]
[137613180,137613388,209,"ENSG00000197070","ENST00000468983","processed_transcript",0,"ARRDC1","arrestin domain containing 1 [Source:HGNC Symbol;Acc:HGNC:28633]","GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006858(extracellular transport);GO:0015031(protein transport);GO:0016020(membrane);GO:0016567(protein ubiquitination);GO:0031410(cytoplasmic vesicle);GO:0031625(ubiquitin protein ligase binding);GO:0042802(identical protein binding);GO:0045746(negative regulation of Notch signaling pathway);GO:0070062(extracellular exosome);GO:0140112(extracellular vesicle biogenesis);GO:1903561(extracellular vesicle);GO:1990756(protein binding, bridging involved in substrate recognition for ubiquitination);GO:1990763(arrestin family protein binding)","NA",{"v":1.8E-5,"d":"0.00"},1,"209,",0,-1.14,{"v":0.0131825673855641,"d":"0.01"},-1.17,"3' UTR",9,137613281,137613770,490,1]
[82648531,82648861,331,"ENSG00000214575","ENST00000566716","processed_transcript",0,"CPEB1","cytoplasmic polyadenylation element binding protein 1 [Source:HGNC Symbol;Acc:HGNC:21744]","GO:0000900(translation repressor activity, mRNA regulatory element binding);GO:0000932(P-body);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006397(mRNA processing);GO:0006412(translation);GO:0006417(regulation of translation);GO:0008135(translation factor activity, RNA binding);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0030054(cell junction);GO:0030425(dendrite);GO:0032869(cellular response to insulin stimulus);GO:0035925(mRNA 3'-UTR AU-rich region binding);GO:0042995(cell projection);GO:0043005(neuron projection);GO:0043022(ribosome binding);GO:0045182(translation regulator activity);GO:0045202(synapse);GO:0045211(postsynaptic membrane);GO:0046872(metal ion binding);GO:0071230(cellular response to amino acid stimulus);GO:0071456(cellular response to hypoxia);GO:1900365(positive regulation of mRNA polyadenylation);GO:1990124(messenger ribonucleoprotein complex);GO:2000766(negative regulation of cytoplasmic translation)","04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation)",{"v":4e-11,"d":"0.00"},1,"331,",0,{"v":-0.979,"d":"-0.98"},{"v":0.0218776162394955,"d":"0.02"},{"v":-2.3,"d":"-2.30"},"Exon (ENST00000560650/ENSG00000259462, exon 1 of 4)",15,82627289,82648861,21573,2]
[26842235,26866713,24479,"ENSG00000120159","ENST00000333916","protein_coding",26089,"CAAP1","caspase activity and apoptosis inhibitor 1 [Source:HGNC Symbol;Acc:HGNC:25834]","GO:0006915(apoptotic process);GO:0042981(regulation of apoptotic process);GO:2001268(negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway)","NA",{"v":1E-182,"d":"0.00"},3,"413,74,80,","0,18831,24399",{"v":-11.2,"d":"-11.20"},{"v":7.94328234724282e-14,"d":"0.00"},-1.02,"3' UTR",9,26840685,26892802,52118,2]
[16367961,16368380,420,"ENSG00000089177","ENST00000354981","protein_coding",205053,"KIF16B","kinesin family member 16B [Source:HGNC Symbol;Acc:HGNC:15869]","GO:0000166(nucleotide binding);GO:0001704(formation of primary germ layer);GO:0001919(regulation of receptor recycling);GO:0003774(motor activity);GO:0003777(microtubule motor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005547(phosphatidylinositol-3,4,5-trisphosphate binding);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005769(early endosome);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005871(kinesin complex);GO:0005874(microtubule);GO:0006895(Golgi to endosome transport);GO:0007018(microtubule-based movement);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007492(endoderm development);GO:0008017(microtubule binding);GO:0008289(lipid binding);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0008574(ATP-dependent microtubule motor activity, plus-end-directed);GO:0016020(membrane);GO:0016887(ATPase activity);GO:0017137(Rab GTPase binding);GO:0031901(early endosome membrane);GO:0032266(phosphatidylinositol-3-phosphate binding);GO:0032801(receptor catabolic process);GO:0035091(phosphatidylinositol binding);GO:0043325(phosphatidylinositol-3,4-bisphosphate binding);GO:0045022(early endosome to late endosome transport);GO:0045335(phagocytic vesicle);GO:0071346(cellular response to interferon-gamma);GO:0080025(phosphatidylinositol-3,5-bisphosphate binding)","NA",{"v":2.7E-10,"d":"0.00"},1,"420,",0,-2.07,{"v":0.000851138038202377,"d":"0.00"},-2.37,"Exon (ENST00000635823/ENSG00000089177, exon 2 of 2)",20,16272104,16573433,301330,2]
[92297538,92297717,180,"ENSG00000198000","ENST00000442668","protein_coding",27633,"NOL8","nucleolar protein 8 [Source:HGNC Symbol;Acc:HGNC:23387]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:1902570(protein localization to nucleolus);GO:1990904(ribonucleoprotein complex)","NA",{"v":0.00083,"d":"0.00"},1,"180,",0,{"v":-0.895,"d":"-0.90"},{"v":0.0288403150312661,"d":"0.03"},-1.82,"3' UTR",9,92297358,92325350,27993,2]
[92613183,92613872,690,"ENSG00000127080","ENST00000287996","protein_coding",56259,"IPPK","inositol-pentakisphosphate 2-kinase [Source:HGNC Symbol;Acc:HGNC:14645]","GO:0000166(nucleotide binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0032947(protein-containing complex scaffold activity);GO:0032958(inositol phosphate biosynthetic process);GO:0035299(inositol pentakisphosphate 2-kinase activity);GO:0043647(inositol phosphate metabolic process);GO:0052746(inositol phosphorylation);GO:1901838(positive regulation of transcription of nucleolar large rRNA by RNA polymerase I)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)",{"v":5e-19,"d":"0.00"},1,"690,",0,-1.68,{"v":2.63026799189538E-3,"d":"0.00"},-1.37,"3' UTR",9,92613183,92670131,56949,2]
[92614082,92614441,360,"ENSG00000127080","ENST00000287996","protein_coding",55690,"IPPK","inositol-pentakisphosphate 2-kinase [Source:HGNC Symbol;Acc:HGNC:14645]","GO:0000166(nucleotide binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0032947(protein-containing complex scaffold activity);GO:0032958(inositol phosphate biosynthetic process);GO:0035299(inositol pentakisphosphate 2-kinase activity);GO:0043647(inositol phosphate metabolic process);GO:0052746(inositol phosphorylation);GO:1901838(positive regulation of transcription of nucleolar large rRNA by RNA polymerase I)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)",{"v":0.00014,"d":"0.00"},1,"360,",0,{"v":-0.764,"d":"-0.76"},{"v":0.0446683592150963,"d":"0.04"},-1.16,"3' UTR",9,92613183,92670131,56949,2]
[92711363,92711573,211,"ENSG00000185963","ENST00000375512","protein_coding",53239,"BICD2","BICD cargo adaptor 2 [Source:HGNC Symbol;Acc:HGNC:17208]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005642(annulate lamellae);GO:0005643(nuclear pore);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0006890(retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum);GO:0007018(microtubule-based movement);GO:0008093(cytoskeletal adaptor activity);GO:0015031(protein transport);GO:0017137(Rab GTPase binding);GO:0031410(cytoplasmic vesicle);GO:0034067(protein localization to Golgi apparatus);GO:0034452(dynactin binding);GO:0051028(mRNA transport);GO:0051642(centrosome localization);GO:0051959(dynein light intermediate chain binding);GO:0070507(regulation of microtubule cytoskeleton organization);GO:0070840(dynein complex binding);GO:0072385(minus-end-directed organelle transport along microtubule);GO:0072393(microtubule anchoring at microtubule organizing center)","NA",{"v":1.6E-90,"d":"0.00"},1,"211,",0,{"v":-4.9,"d":"-4.90"},{"v":5.01187233627272e-07,"d":"0.00"},-1.05,"3' UTR",9,92711363,92764812,53450,2]
[18661893,18662072,180,"ENSG00000189375","ENST00000570881","retained_intron",0,"TBC1D28","TBC1 domain family member 28 [Source:HGNC Symbol;Acc:HGNC:26858]","GO:0005096(GTPase activator activity);GO:0005623(cell);GO:0006886(intracellular protein transport);GO:0017137(Rab GTPase binding);GO:0090630(activation of GTPase activity)","NA",{"v":0.00054,"d":"0.00"},1,"180,",0,{"v":-0.919,"d":"-0.92"},{"v":0.0263026799189538,"d":"0.03"},-2.38,"3' UTR",17,18638861,18661950,23090,2]
[98848936,98849235,300,"ENSG00000119514","ENST00000375011","protein_coding",41266,"GALNT12","polypeptide N-acetylgalactosaminyltransferase 12 [Source:HGNC Symbol;Acc:HGNC:19877]","GO:0000139(Golgi membrane);GO:0004653(polypeptide N-acetylgalactosaminyltransferase activity);GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016266(O-glycan processing);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030246(carbohydrate binding);GO:0046872(metal ion binding)","00512(Mucin type O-glycan biosynthesis)",{"v":4e-11,"d":"0.00"},1,"300,",0,-1.25,{"v":0.00933254300796992,"d":"0.01"},{"v":-1.1,"d":"-1.10"},"3' UTR",9,98807670,98850081,42412,1]
[122203984,122204582,599,"ENSG00000106852","ENST00000373755","protein_coding",23004,"LHX6","LIM homeobox 6 [Source:HGNC Symbol;Acc:HGNC:21735]","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0007399(nervous system development);GO:0021799(cerebral cortex radially oriented cell migration);GO:0021800(cerebral cortex tangential migration);GO:0021853(cerebral cortex GABAergic interneuron migration);GO:0021884(forebrain neuron development);GO:0030154(cell differentiation);GO:0030182(neuron differentiation);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0048469(cell maturation)","NA",{"v":8.3e-06,"d":"0.00"},1,"599,",0,-5.18,{"v":2.45470891568503e-07,"d":"0.00"},-1.25,"3' UTR",9,122202577,122227586,25010,2]
[129107432,129107732,301,"ENSG00000095321","ENST00000318080","protein_coding",3061,"CRAT","carnitine O-acetyltransferase [Source:HGNC Symbol;Acc:HGNC:2342]","GO:0004092(carnitine O-acetyltransferase activity);GO:0005102(signaling receptor binding);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005777(peroxisome);GO:0005782(peroxisomal matrix);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006625(protein targeting to peroxisome);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0016020(membrane);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0019254(carnitine metabolic process, CoA-linked);GO:0033540(fatty acid beta-oxidation using acyl-CoA oxidase)","04146(Peroxisome)",{"v":2.5e-23,"d":"0.00"},1,"301,",0,{"v":-1.5,"d":"-1.50"},{"v":0.00446683592150963,"d":"0.00"},-1.09,"3' UTR",9,129094794,129110793,16000,2]
[129110785,129111189,405,"ENSG00000095321","ENST00000318080","protein_coding",0,"CRAT","carnitine O-acetyltransferase [Source:HGNC Symbol;Acc:HGNC:2342]","GO:0004092(carnitine O-acetyltransferase activity);GO:0005102(signaling receptor binding);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005777(peroxisome);GO:0005782(peroxisomal matrix);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006625(protein targeting to peroxisome);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0016020(membrane);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0019254(carnitine metabolic process, CoA-linked);GO:0033540(fatty acid beta-oxidation using acyl-CoA oxidase)","04146(Peroxisome)",{"v":6.3e-28,"d":"0.00"},2,"9,232,","0,173",-1.24,{"v":0.00954992586021436,"d":"0.01"},-1.24,"5' UTR",9,129094794,129110793,16000,2]
[132905699,132906059,361,"ENSG00000165699","ENST00000298552","protein_coding",38574,"TSC1","TSC complex subunit 1 [Source:HGNC Symbol;Acc:HGNC:12362]","GO:0001822(kidney development);GO:0001843(neural tube closure);GO:0001952(regulation of cell-matrix adhesion);GO:0002250(adaptive immune response);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005811(lipid droplet);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005884(actin filament);GO:0005886(plasma membrane);GO:0005938(cell cortex);GO:0006407(rRNA export from nucleus);GO:0006417(regulation of translation);GO:0006813(potassium ion transport);GO:0007160(cell-matrix adhesion);GO:0007399(nervous system development);GO:0008285(negative regulation of cell population proliferation);GO:0008344(adult locomotory behavior);GO:0010977(negative regulation of neuron projection development);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016239(positive regulation of macroautophagy);GO:0016242(negative regulation of macroautophagy);GO:0017148(negative regulation of translation);GO:0021766(hippocampus development);GO:0021987(cerebral cortex development);GO:0030027(lamellipodium);GO:0030030(cell projection organization);GO:0030426(growth cone);GO:0030544(Hsp70 protein binding);GO:0032007(negative regulation of TOR signaling);GO:0032780(negative regulation of ATPase activity);GO:0032794(GTPase activating protein binding);GO:0032868(response to insulin);GO:0032991(protein-containing complex);GO:0033596(TSC1-TSC2 complex);GO:0034260(negative regulation of GTPase activity);GO:0042030(ATPase inhibitor activity);GO:0042552(myelination);GO:0042995(cell projection);GO:0043231(intracellular membrane-bounded organelle);GO:0043379(memory T cell differentiation);GO:0043666(regulation of phosphoprotein phosphatase activity);GO:0045792(negative regulation of cell size);GO:0045859(regulation of protein kinase activity);GO:0046323(glucose import);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0047485(protein N-terminus binding);GO:0048471(perinuclear region of cytoplasm);GO:0050808(synapse organization);GO:0050821(protein stabilization);GO:0051087(chaperone binding);GO:0051291(protein heterooligomerization);GO:0051492(regulation of stress fiber assembly);GO:0051496(positive regulation of stress fiber assembly);GO:0051726(regulation of cell cycle);GO:0051879(Hsp90 protein binding);GO:0051893(regulation of focal adhesion assembly);GO:0051894(positive regulation of focal adhesion assembly);GO:0055007(cardiac muscle cell differentiation);GO:0090630(activation of GTPase activity);GO:0090650(cellular response to oxygen-glucose deprivation);GO:0101031(chaperone complex);GO:1901214(regulation of neuron death);GO:1903204(negative regulation of oxidative stress-induced neuron death)","04072(Phospholipase D signaling pathway);04140(Autophagy - animal);04150(mTOR signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04211(Longevity regulating pathway);04218(Cellular senescence);04714(Thermogenesis);04910(Insulin signaling pathway);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05168(Herpes simplex virus 1 infection);05231(Choline metabolism in cancer)",{"v":1.6E-11,"d":"0.00"},1,"361,",0,-6.42,{"v":1.0471285480509e-08,"d":"0.00"},-1.91,"3' UTR",9,132891348,132944633,53286,2]
[1466865,1467254,390,"ENSG00000115266","ENST00000233607","protein_coding",16716,"APC2","APC2, WNT signaling pathway regulator [Source:HGNC Symbol;Acc:HGNC:24036]","GO:0000226(microtubule cytoskeleton organization);GO:0001708(cell fate specification);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005881(cytoplasmic microtubule);GO:0005884(actin filament);GO:0007026(negative regulation of microtubule depolymerization);GO:0007389(pattern specification process);GO:0008013(beta-catenin binding);GO:0008017(microtubule binding);GO:0015630(microtubule cytoskeleton);GO:0016055(Wnt signaling pathway);GO:0016342(catenin complex);GO:0016477(cell migration);GO:0030178(negative regulation of Wnt signaling pathway);GO:0030496(midbody);GO:0030877(beta-catenin destruction complex);GO:0031258(lamellipodium membrane);GO:0031941(filamentous actin);GO:0045171(intercellular bridge);GO:0045295(gamma-catenin binding);GO:0045595(regulation of cell differentiation);GO:0045732(positive regulation of protein catabolic process);GO:0048471(perinuclear region of cytoplasm);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0090630(activation of GTPase activity);GO:0098794(postsynapse)","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04810(Regulation of actin cytoskeleton);04934(Cushing syndrome);05165(Human papillomavirus infection);05200(Pathways in cancer);05206(MicroRNAs in cancer);05210(Colorectal cancer);05213(Endometrial cancer);05217(Basal cell carcinoma);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer)",{"v":5.9e-05,"d":"0.00"},1,"390,",0,-0.84,{"v":0.0346736850452532,"d":"0.03"},-2.43,"Exon (ENST00000233607/ENSG00000115266, exon 15 of 15)",19,1450149,1473244,23096,1]
[135464766,135471699,6934,"ENSG00000225361","ENST00000603624","antisense",550,"PPP1R26-AS1","PPP1R26 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:48717]","NA","NA",{"v":4.1e-09,"d":"0.00"},3,"85,622,74,","0,3322,6860",-1.04,{"v":0.0181970085860998,"d":"0.02"},-1.85,"Exon (ENST00000603624/ENSG00000225361, exon 2 of 3)",9,135462727,135472249,9523,2]
[136438411,136439397,987,"ENSG00000148384","ENST00000371712","protein_coding",448,"INPP5E","inositol polyphosphate-5-phosphatase E [Source:HGNC Symbol;Acc:HGNC:21474]","GO:0000139(Golgi membrane);GO:0001726(ruffle);GO:0004439(phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity);GO:0004445(inositol-polyphosphate 5-phosphatase activity);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005929(cilium);GO:0005930(axoneme);GO:0006629(lipid metabolic process);GO:0006661(phosphatidylinositol biosynthetic process);GO:0008150(biological_process);GO:0016020(membrane);GO:0016787(hydrolase activity);GO:0032580(Golgi cisterna membrane);GO:0042995(cell projection);GO:0046488(phosphatidylinositol metabolic process);GO:0046855(inositol phosphate dephosphorylation);GO:0046856(phosphatidylinositol dephosphorylation);GO:1903565(negative regulation of protein localization to cilium)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)",{"v":1.9e-09,"d":"0.00"},1,"987,",0,-2.07,{"v":0.000851138038202377,"d":"0.00"},-1.05,"Exon (ENST00000371712/ENSG00000148384, exon 1 of 10)",9,136428619,136439845,11227,2]
[136441384,136441743,360,"ENSG00000148396","ENST00000467838","processed_transcript",2339,"SEC16A","SEC16 homolog A, endoplasmic reticulum export factor [Source:HGNC Symbol;Acc:HGNC:29006]","GO:0000139(Golgi membrane);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0007029(endoplasmic reticulum organization);GO:0007030(Golgi organization);GO:0012507(ER to Golgi transport vesicle membrane);GO:0015031(protein transport);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0021762(substantia nigra development);GO:0031090(organelle membrane);GO:0032527(protein exit from endoplasmic reticulum);GO:0034976(response to endoplasmic reticulum stress);GO:0043000(Golgi to plasma membrane CFTR protein transport);GO:0043231(intracellular membrane-bounded organelle);GO:0048208(COPII vesicle coating);GO:0048471(perinuclear region of cytoplasm);GO:0050821(protein stabilization);GO:0070863(positive regulation of protein exit from endoplasmic reticulum);GO:0070971(endoplasmic reticulum exit site);GO:0070973(protein localization to endoplasmic reticulum exit site);GO:0072659(protein localization to plasma membrane)","NA",{"v":2.5e-22,"d":"0.00"},1,"360,",0,-7.06,{"v":2.13796208950223e-09,"d":"0.00"},-1.06,"3' UTR",9,136440096,136444082,3987,2]
[136804076,136804523,448,"ENSG00000213213","ENST00000479371","nonsense_mediated_decay",7726,"CCDC183","coiled-coil domain containing 183 [Source:HGNC Symbol;Acc:HGNC:28236]","NA","NA",{"v":7.9e-06,"d":"0.00"},1,"448,",0,-1.01,{"v":0.0199526231496888,"d":"0.02"},-1.33,"Exon (ENST00000479371/ENSG00000213213, exon 7 of 13)",9,136796350,136807741,11392,1]
[137174784,137175144,361,"ENSG00000176248","ENST00000487917","retained_intron",1928,"ANAPC2","anaphase promoting complex subunit 2 [Source:HGNC Symbol;Acc:HGNC:19989]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005680(anaphase-promoting complex);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007049(cell cycle);GO:0007399(nervous system development);GO:0016567(protein ubiquitination);GO:0030154(cell differentiation);GO:0031145(anaphase-promoting complex-dependent catabolic process);GO:0031625(ubiquitin protein ligase binding);GO:0031915(positive regulation of synaptic plasticity);GO:0045773(positive regulation of axon extension);GO:0050775(positive regulation of dendrite morphogenesis);GO:0051301(cell division);GO:0070979(protein K11-linked ubiquitination);GO:0090129(positive regulation of synapse maturation);GO:1901990(regulation of mitotic cell cycle phase transition)","04110(Cell cycle);04114(Oocyte meiosis);04120(Ubiquitin mediated proteolysis);04914(Progesterone-mediated oocyte maturation);05166(Human T-cell leukemia virus 1 infection)",{"v":2.9e-07,"d":"0.00"},1,"361,",0,-2.67,{"v":1.69824365246174E-4,"d":"0.00"},-1.25,"3' UTR",9,137174784,137177072,2289,2]
[12834528,12835007,480,"ENSG00000183049","ENST00000619168","protein_coding",485046,"CAMK1D","calcium/calmodulin dependent protein kinase ID [Source:HGNC Symbol;Acc:HGNC:19341]","GO:0000166(nucleotide binding);GO:0003824(catalytic activity);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004683(calmodulin-dependent protein kinase activity);GO:0005516(calmodulin binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0006954(inflammatory response);GO:0007399(nervous system development);GO:0008152(metabolic process);GO:0010976(positive regulation of neuron projection development);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0032793(positive regulation of CREB transcription factor activity);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0050766(positive regulation of phagocytosis);GO:0050773(regulation of dendrite development);GO:0060267(positive regulation of respiratory burst);GO:0071622(regulation of granulocyte chemotaxis);GO:0090023(positive regulation of neutrophil chemotaxis)","04020(Calcium signaling pathway);04921(Oxytocin signaling pathway);04925(Aldosterone synthesis and secretion);05214(Glioma)",{"v":3.7E-8,"d":"0.00"},1,"480,",0,-1.28,{"v":0.00851138038202377,"d":"0.01"},-1.24,"3' UTR",10,12349482,12835545,486064,1]
[13201497,13201647,151,"ENSG00000065328","ENST00000378714","protein_coding",39943,"MCM10","minichromosome maintenance 10 replication initiation factor [Source:HGNC Symbol;Acc:HGNC:18043]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0003677(DNA binding);GO:0003688(DNA replication origin binding);GO:0003690(double-stranded DNA binding);GO:0003697(single-stranded DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006260(DNA replication);GO:0006270(DNA replication initiation);GO:0006974(cellular response to DNA damage stimulus);GO:0008283(cell population proliferation);GO:0019899(enzyme binding);GO:0031298(replication fork protection complex);GO:0042802(identical protein binding);GO:0046872(metal ion binding)","NA",{"v":8.5E-9,"d":"0.00"},1,"151,",0,-1.92,{"v":0.00131825673855641,"d":"0.00"},-1.12,"Exon (ENST00000378714/ENSG00000065328, exon 17 of 20)",10,13161554,13211104,49551,1]
[42797093,42797213,121,"ENSG00000165733","ENST00000374518","protein_coding",14298,"BMS1","BMS1, ribosome biogenesis factor [Source:HGNC Symbol;Acc:HGNC:23505]","GO:0000166(nucleotide binding);GO:0000462(maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0003723(RNA binding);GO:0003924(GTPase activity);GO:0005524(ATP binding);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0030686(90S preribosome);GO:0034511(U3 snoRNA binding);GO:0042254(ribosome biogenesis)","03008(Ribosome biogenesis in eukaryotes)",{"v":1.5E-3,"d":"0.00"},1,"121,",0,-4.58,{"v":1.09647819614319E-6,"d":"0.00"},-1,"Exon (ENST00000374518/ENSG00000165733, exon 10 of 23)",10,42782795,42834937,52143,1]
[77257942,77258181,240,"ENSG00000165548","ENST00000298351","protein_coding",76144,"TMEM63C","transmembrane protein 63C [Source:HGNC Symbol;Acc:HGNC:23787]","GO:0005227(calcium activated cation channel activity);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006812(cation transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034220(ion transmembrane transport)","NA",{"v":2.6E-7,"d":"0.00"},1,"240,",0,{"v":-0.864,"d":"-0.86"},{"v":0.0316227766016838,"d":"0.03"},-2.45,"3' UTR",14,77181798,77259495,77698,1]
[43481688,43483181,1494,"ENSG00000243660","ENST00000652684","protein_coding",44840,"ZNF487","zinc finger protein 487 [Source:HGNC Symbol;Acc:HGNC:23488]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","NA",{"v":2.5E-15,"d":"0.00"},1,"1494,",0,-1.56,{"v":0.00371535229097172,"d":"0.00"},-1.06,"3' UTR",10,43436848,43483181,46334,1]
[46581966,46583806,1841,"ENSG00000204176","ENST00000374328","protein_coding",0,"SYT15","synaptotagmin 15 [Source:HGNC Symbol;Acc:HGNC:17167]","GO:0000149(SNARE binding);GO:0001786(phosphatidylserine binding);GO:0005509(calcium ion binding);GO:0005544(calcium-dependent phospholipid binding);GO:0005886(plasma membrane);GO:0014059(regulation of dopamine secretion);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016192(vesicle-mediated transport);GO:0017156(calcium ion regulated exocytosis);GO:0017158(regulation of calcium ion-dependent exocytosis);GO:0030276(clathrin binding);GO:0070382(exocytic vesicle);GO:0071277(cellular response to calcium ion)","NA",{"v":2.2e-09,"d":"0.00"},2,"226,75,","0,1766",{"v":-0.769,"d":"-0.77"},{"v":0.0436515832240166,"d":"0.04"},-1.37,"Exon (ENST00000374323/ENSG00000204176, exon 3 of 7)",10,46582171,46594173,12003,1]
[58368712,58368892,181,"ENSG00000072401","ENST00000615793","protein_coding",33733,"UBE2D1","ubiquitin conjugating enzyme E2 D1 [Source:HGNC Symbol;Acc:HGNC:12474]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000151(ubiquitin ligase complex);GO:0000166(nucleotide binding);GO:0000209(protein polyubiquitination);GO:0002756(MyD88-independent toll-like receptor signaling pathway);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006625(protein targeting to peroxisome);GO:0016567(protein ubiquitination);GO:0016579(protein deubiquitination);GO:0016740(transferase activity);GO:0030509(BMP signaling pathway);GO:0031145(anaphase-promoting complex-dependent catabolic process);GO:0031398(positive regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032991(protein-containing complex);GO:0035666(TRIF-dependent toll-like receptor signaling pathway);GO:0061631(ubiquitin conjugating enzyme activity);GO:0070936(protein K48-linked ubiquitination);GO:1901990(regulation of mitotic cell cycle phase transition);GO:1902916(positive regulation of protein polyubiquitination)","04120(Ubiquitin mediated proteolysis);04141(Protein processing in endoplasmic reticulum)",{"v":0.0012,"d":"0.00"},1,"181,",0,-1.28,{"v":0.00851138038202377,"d":"0.01"},-1.08,"3' UTR",10,58334979,58370751,35773,1]
[63619711,63620963,1253,"ENSG00000165476","ENST00000373758","protein_coding",98310,"REEP3","receptor accessory protein 3 [Source:HGNC Symbol;Acc:HGNC:23711]","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005874(microtubule);GO:0006998(nuclear envelope organization);GO:0007049(cell cycle);GO:0007084(mitotic nuclear envelope reassembly);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0051301(cell division)","NA",{"v":6.3e-14,"d":"0.00"},2,"90,151,","0,1102",{"v":-15.2,"d":"-15.20"},{"v":3.98107170553499e-18,"d":"0.00"},-1.06,"3' UTR",10,63521401,63625128,103728,1]
[67884686,67885014,329,"ENSG00000096717","ENST00000212015","protein_coding",30,"SIRT1","sirtuin 1 [Source:HGNC Symbol;Acc:HGNC:14929]","GO:0000012(single strand break repair);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000183(chromatin silencing at rDNA);GO:0000720(pyrimidine dimer repair by nucleotide-excision repair);GO:0000731(DNA synthesis involved in DNA repair);GO:0000785(chromatin);GO:0000790(nuclear chromatin);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001525(angiogenesis);GO:0001542(ovulation from ovarian follicle);GO:0001678(cellular glucose homeostasis);GO:0001934(positive regulation of protein phosphorylation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0002039(p53 binding);GO:0002821(positive regulation of adaptive immune response);GO:0003714(transcription corepressor activity);GO:0004407(histone deacetylase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005637(nuclear inner membrane);GO:0005654(nucleoplasm);GO:0005677(chromatin silencing complex);GO:0005719(nuclear euchromatin);GO:0005720(nuclear heterochromatin);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006325(chromatin organization);GO:0006342(chromatin silencing);GO:0006343(establishment of chromatin silencing);GO:0006344(maintenance of chromatin silencing);GO:0006346(methylation-dependent chromatin silencing);GO:0006364(rRNA processing);GO:0006476(protein deacetylation);GO:0006642(triglyceride mobilization);GO:0006915(apoptotic process);GO:0006974(cellular response to DNA damage stimulus);GO:0006979(response to oxidative stress);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007275(multicellular organism development);GO:0007283(spermatogenesis);GO:0007346(regulation of mitotic cell cycle);GO:0007517(muscle organ development);GO:0007569(cell aging);GO:0007623(circadian rhythm);GO:0008022(protein C-terminus binding);GO:0008134(transcription factor binding);GO:0008284(positive regulation of cell population proliferation);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0009267(cellular response to starvation);GO:0010629(negative regulation of gene expression);GO:0010875(positive regulation of cholesterol efflux);GO:0010883(regulation of lipid storage);GO:0010906(regulation of glucose metabolic process);GO:0010934(macrophage cytokine production);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0016032(viral process);GO:0016239(positive regulation of macroautophagy);GO:0016567(protein ubiquitination);GO:0016575(histone deacetylation);GO:0016605(PML body);GO:0016787(hydrolase activity);GO:0017136(NAD-dependent histone deacetylase activity);GO:0018394(peptidyl-lysine acetylation);GO:0019213(deacetylase activity);GO:0019899(enzyme binding);GO:0019904(protein domain specific binding);GO:0030154(cell differentiation);GO:0030225(macrophage differentiation);GO:0030308(negative regulation of cell growth);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0031393(negative regulation of prostaglandin biosynthetic process);GO:0031648(protein destabilization);GO:0031937(positive regulation of chromatin silencing);GO:0032007(negative regulation of TOR signaling);GO:0032071(regulation of endodeoxyribonuclease activity);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0032868(response to insulin);GO:0032922(circadian regulation of gene expression);GO:0033210(leptin-mediated signaling pathway);GO:0033553(rDNA heterochromatin);GO:0033558(protein deacetylase activity);GO:0034391(regulation of smooth muscle cell apoptotic process);GO:0034979(NAD-dependent protein deacetylase activity);GO:0034983(peptidyl-lysine deacetylation);GO:0035098(ESC/E(Z) complex);GO:0035257(nuclear hormone receptor binding);GO:0035356(cellular triglyceride homeostasis);GO:0035358(regulation of peroxisome proliferator activated receptor signaling pathway);GO:0042127(regulation of cell population proliferation);GO:0042326(negative regulation of phosphorylation);GO:0042393(histone binding);GO:0042542(response to hydrogen peroxide);GO:0042595(behavioral response to starvation);GO:0042632(cholesterol homeostasis);GO:0042771(intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043398(HLH domain binding);GO:0043425(bHLH transcription factor binding);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0043518(negative regulation of DNA damage response, signal transduction by p53 class mediator);GO:0043536(positive regulation of blood vessel endothelial cell migration);GO:0044321(response to leptin);GO:0045348(positive regulation of MHC class II biosynthetic process);GO:0045599(negative regulation of fat cell differentiation);GO:0045722(positive regulation of gluconeogenesis);GO:0045739(positive regulation of DNA repair);GO:0045766(positive regulation of angiogenesis);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0046872(metal ion binding);GO:0046969(NAD-dependent histone deacetylase activity (H3-K9 specific));GO:0048511(rhythmic process);GO:0050872(white fat cell differentiation);GO:0051019(mitogen-activated protein kinase binding);GO:0051097(negative regulation of helicase activity);GO:0051152(positive regulation of smooth muscle cell differentiation);GO:0051574(positive regulation of histone H3-K9 methylation);GO:0051898(negative regulation of protein kinase B signaling);GO:0055089(fatty acid homeostasis);GO:0060766(negative regulation of androgen receptor signaling pathway);GO:0061647(histone H3-K9 modification);GO:0070301(cellular response to hydrogen peroxide);GO:0070403(NAD+ binding);GO:0070857(regulation of bile acid biosynthetic process);GO:0070914(UV-damage excision repair);GO:0070932(histone H3 deacetylation);GO:0071356(cellular response to tumor necrosis factor);GO:0071441(negative regulation of histone H3-K14 acetylation);GO:0071456(cellular response to hypoxia);GO:0071479(cellular response to ionizing radiation);GO:0071900(regulation of protein serine/threonine kinase activity);GO:0090335(regulation of brown fat cell differentiation);GO:0090400(stress-induced premature senescence);GO:1900034(regulation of cellular response to heat);GO:1900113(negative regulation of histone H3-K9 trimethylation);GO:1901215(negative regulation of neuron death);GO:1901984(negative regulation of protein acetylation);GO:1902166(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:1902176(negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway);GO:1902237(positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway);GO:1904179(positive regulation of adipose tissue development);GO:1990254(keratin filament binding);GO:1990619(histone H3-K9 deacetylation);GO:1990830(cellular response to leukemia inhibitory factor);GO:2000111(positive regulation of macrophage apoptotic process);GO:2000480(negative regulation of cAMP-dependent protein kinase activity);GO:2000481(positive regulation of cAMP-dependent protein kinase activity);GO:2000619(negative regulation of histone H4-K16 acetylation);GO:2000655(negative regulation of cellular response to testosterone stimulus);GO:2000757(negative regulation of peptidyl-lysine acetylation);GO:2000773(negative regulation of cellular senescence);GO:2000774(positive regulation of cellular senescence)","04068(FoxO signaling pathway);04152(AMPK signaling pathway);04211(Longevity regulating pathway);04213(Longevity regulating pathway - multiple species);04218(Cellular senescence);04922(Glucagon signaling pathway);05031(Amphetamine addiction);05206(MicroRNAs in cancer)",{"v":1.7E-5,"d":"0.00"},1,"329,",0,-1.05,{"v":0.0173780082874938,"d":"0.02"},-1.67,"5' UTR",10,67884656,67918390,33735,1]
[74151215,74174554,23340,"ENSG00000156110","ENST00000286621","protein_coding",0,"ADK","adenosine kinase [Source:HGNC Symbol;Acc:HGNC:257]","GO:0000166(nucleotide binding);GO:0003723(RNA binding);GO:0004001(adenosine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006166(purine ribonucleoside salvage);GO:0006167(AMP biosynthetic process);GO:0006175(dATP biosynthetic process);GO:0009156(ribonucleoside monophosphate biosynthetic process);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0016773(phosphotransferase activity, alcohol group as acceptor);GO:0043101(purine-containing compound salvage);GO:0044209(AMP salvage);GO:0046872(metal ion binding)","00230(Purine metabolism)",{"v":3e-07,"d":"0.00"},2,"129,139,","0,23201",{"v":-0.746,"d":"-0.75"},{"v":0.0478630092322638,"d":"0.05"},-1.28,"5' UTR",10,74151229,74708475,557247,1]
[89216283,89217206,924,"ENSG00000259877","ENST00000570267","antisense",447,"AC009113","novel transcript, antisense to ZNF778","NA","NA",{"v":1.3E-23,"d":"0.00"},1,"924,",0,-1.36,{"v":6.60693448007596E-3,"d":"0.01"},-2.46,"Exon (ENST00000570267/ENSG00000259877, exon 1 of 1)",16,89215211,89217653,2443,2]
[95876368,95876607,240,"ENSG00000138185","ENST00000371205","protein_coding",120205,"ENTPD1","ectonucleoside triphosphate diphosphohydrolase 1 [Source:HGNC Symbol;Acc:HGNC:3363]","GO:0000166(nucleotide binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0007596(blood coagulation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0034656(nucleobase-containing small molecule catabolic process);GO:0070062(extracellular exosome);GO:0102485(dATP phosphohydrolase activity);GO:0102486(dCTP phosphohydrolase activity);GO:0102487(dUTP phosphohydrolase activity);GO:0102488(dTTP phosphohydrolase activity);GO:0102489(GTP phosphohydrolase activity);GO:0102490(8-oxo-dGTP phosphohydrolase activity);GO:0102491(dGTP phosphohydrolase activity)","00230(Purine metabolism);00240(Pyrimidine metabolism);05169(Epstein-Barr virus infection)",{"v":4.7e-05,"d":"0.00"},1,"240,",0,-1.27,{"v":0.0087096358995608,"d":"0.01"},-1.75,"3' UTR",10,95756163,95877266,121104,1]
[112892599,112893079,481,"ENSG00000129625","ENST00000379638","protein_coding",29148,"REEP5","receptor accessory protein 5 [Source:HGNC Symbol;Acc:HGNC:30077]","GO:0003674(molecular_function);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0008150(biological_process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0071782(endoplasmic reticulum tubular network)","NA",{"v":1.9e-07,"d":"0.00"},1,"481,",0,{"v":-1.1,"d":"-1.10"},{"v":0.0144543977074593,"d":"0.01"},-2.47,"3' UTR",5,112876385,112922227,45843,2]
[114975277,114975337,61,"ENSG00000165832","ENST00000298746","protein_coding",37082,"TRUB1","TruB pseudouridine synthase family member 1 [Source:HGNC Symbol;Acc:HGNC:16060]","GO:0001522(pseudouridine synthesis);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006396(RNA processing);GO:0006400(tRNA modification);GO:0009451(RNA modification);GO:0009982(pseudouridine synthase activity);GO:0016853(isomerase activity);GO:1990481(mRNA pseudouridine synthesis)","NA",{"v":0.005,"d":"0.01"},1,"61,",0,-1.05,{"v":0.0173780082874938,"d":"0.02"},-1.07,"Exon (ENST00000298746/ENSG00000165832, exon 8 of 8)",10,114938195,114977676,39482,1]
[41938984,41949168,10185,"ENSG00000204815","ENST00000377540","protein_coding",8367,"TTC25","tetratricopeptide repeat domain 25 [Source:HGNC Symbol;Acc:HGNC:25280]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0042995(cell projection)","NA",{"v":1.4E-5,"d":"0.00"},3,"189,124,16,","0,6152,10169",-1.38,{"v":0.00630957344480193,"d":"0.01"},-2.47,"3' UTR",17,41930617,41966503,35887,1]
[132375130,132375429,300,"ENSG00000148814","ENST00000368614","protein_coding",42937,"LRRC27","leucine rich repeat containing 27 [Source:HGNC Symbol;Acc:HGNC:29346]","GO:0005515(protein binding)","NA",{"v":1.4E-5,"d":"0.00"},1,"300,",0,-1.09,{"v":0.0154881661891248,"d":"0.02"},-1.92,"3' UTR",10,132332193,132381508,49316,1]
[70025247,70025651,405,"ENSG00000205572","ENST00000380751","protein_coding",0,"SERF1B","small EDRK-rich factor 1B [Source:HGNC Symbol;Acc:HGNC:10756]","GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0007399(nervous system development);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":2.5e-12,"d":"0.00"},2,"212,118,","0,287",-3.86,{"v":7.07945784384137e-06,"d":"0.00"},{"v":-2.5,"d":"-2.50"},"5' UTR",5,70025247,70032696,7450,1]
[806944,808054,1111,"ENSG00000107929","ENST00000614908","protein_coding",6956,"LARP4B","La ribonucleoprotein domain family member 4B [Source:HGNC Symbol;Acc:HGNC:28987]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006417(regulation of translation);GO:0010494(cytoplasmic stress granule);GO:0016020(membrane);GO:0042788(polysomal ribosome);GO:0045727(positive regulation of translation)","NA",{"v":3.2e-17,"d":"0.00"},1,"1111,",0,{"v":-0.962,"d":"-0.96"},{"v":0.0229086765276777,"d":"0.02"},-1.24,"3' UTR",10,806914,815010,8097,2]
[13443463,13443643,181,"ENSG00000165626","ENST00000486542","processed_transcript",16440,"BEND7","BEN domain containing 7 [Source:HGNC Symbol;Acc:HGNC:23514]","GO:0005515(protein binding);GO:0070062(extracellular exosome)","NA",{"v":0.00071,"d":"0.00"},1,"181,",0,{"v":-1.1,"d":"-1.10"},{"v":0.0151356124843621,"d":"0.02"},-1.58,"3' UTR",10,13438484,13460083,21600,2]
[29550773,29551042,270,"ENSG00000197321","ENST00000375400","protein_coding",184762,"SVIL","supervillin [Source:HGNC Symbol;Acc:HGNC:11480]","GO:0002102(podosome);GO:0003779(actin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0007010(cytoskeleton organization);GO:0007519(skeletal muscle tissue development);GO:0015629(actin cytoskeleton);GO:0016020(membrane);GO:0030054(cell junction);GO:0030496(midbody);GO:0032154(cleavage furrow);GO:0032467(positive regulation of cytokinesis);GO:0036449(microtubule minus-end);GO:0042995(cell projection);GO:0043034(costamere);GO:0051015(actin filament binding);GO:0071437(invadopodium)","NA",{"v":1.3E-53,"d":"0.00"},1,"270,",0,-9.77,{"v":2.51188643150958e-12,"d":"0.00"},-1.03,"Exon (ENST00000375400/ENSG00000197321, exon 8 of 36)",10,29457338,29735804,278467,2]
[32900318,32900497,180,"ENSG00000150093","ENST00000302278","protein_coding",57733,"ITGB1","integrin subunit beta 1 [Source:HGNC Symbol;Acc:HGNC:6153]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0001618(virus receptor activity);GO:0001701(in utero embryonic development);GO:0001708(cell fate specification);GO:0001726(ruffle);GO:0001968(fibronectin binding);GO:0002020(protease binding);GO:0002042(cell migration involved in sprouting angiogenesis);GO:0003779(actin binding);GO:0005178(integrin binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006909(phagocytosis);GO:0006968(cellular defense response);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007159(leukocyte cell-cell adhesion);GO:0007160(cell-matrix adhesion);GO:0007161(calcium-independent cell-matrix adhesion);GO:0007229(integrin-mediated signaling pathway);GO:0008284(positive regulation of cell population proliferation);GO:0008305(integrin complex);GO:0008354(germ cell migration);GO:0008542(visual learning);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0010710(regulation of collagen catabolic process);GO:0014704(intercalated disc);GO:0015026(coreceptor activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016032(viral process);GO:0016477(cell migration);GO:0019221(cytokine-mediated signaling pathway);GO:0019960(C-X3-C chemokine binding);GO:0021943(formation of radial glial scaffolds);GO:0030027(lamellipodium);GO:0030030(cell projection organization);GO:0030032(lamellipodium assembly);GO:0030054(cell junction);GO:0030175(filopodium);GO:0030183(B cell differentiation);GO:0030198(extracellular matrix organization);GO:0031175(neuron projection development);GO:0031410(cytoplasmic vesicle);GO:0031589(cell-substrate adhesion);GO:0031594(neuromuscular junction);GO:0031623(receptor internalization);GO:0032154(cleavage furrow);GO:0032587(ruffle membrane);GO:0033627(cell adhesion mediated by integrin);GO:0033631(cell-cell adhesion mediated by integrin);GO:0034113(heterotypic cell-cell adhesion);GO:0034665(integrin alpha1-beta1 complex);GO:0034666(integrin alpha2-beta1 complex);GO:0034667(integrin alpha3-beta1 complex);GO:0034677(integrin alpha7-beta1 complex);GO:0034678(integrin alpha8-beta1 complex);GO:0034680(integrin alpha10-beta1 complex);GO:0034681(integrin alpha11-beta1 complex);GO:0035024(negative regulation of Rho protein signal transduction);GO:0035748(myelin sheath abaxonal region);GO:0038023(signaling receptor activity);GO:0042383(sarcolemma);GO:0042470(melanosome);GO:0042995(cell projection);GO:0043065(positive regulation of apoptotic process);GO:0043197(dendritic spine);GO:0043235(receptor complex);GO:0043236(laminin binding);GO:0043547(positive regulation of GTPase activity);GO:0044877(protein-containing complex binding);GO:0045121(membrane raft);GO:0045202(synapse);GO:0045214(sarcomere organization);GO:0045296(cadherin binding);GO:0045596(negative regulation of cell differentiation);GO:0045766(positive regulation of angiogenesis);GO:0046718(viral entry into host cell);GO:0046872(metal ion binding);GO:0046982(protein heterodimerization activity);GO:0048333(mesodermal cell differentiation);GO:0048471(perinuclear region of cytoplasm);GO:0048675(axon extension);GO:0048813(dendrite morphogenesis);GO:0050776(regulation of immune response);GO:0050804(modulation of chemical synaptic transmission);GO:0050839(cell adhesion molecule binding);GO:0050900(leukocyte migration);GO:0050901(leukocyte tethering or rolling);GO:0051726(regulation of cell cycle);GO:0051897(positive regulation of protein kinase B signaling);GO:0055007(cardiac muscle cell differentiation);GO:0055037(recycling endosome);GO:0070062(extracellular exosome);GO:0071404(cellular response to low-density lipoprotein particle stimulus);GO:0071438(invadopodium membrane);GO:0071711(basement membrane organization);GO:0097060(synaptic membrane);GO:0097386(glial cell projection);GO:0098639(collagen binding involved in cell-matrix adhesion);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098978(glutamatergic synapse);GO:0099699(integral component of synaptic membrane);GO:1903078(positive regulation of protein localization to plasma membrane);GO:2000273(positive regulation of signaling receptor activity);GO:2000811(negative regulation of anoikis)","04015(Rap1 signaling pathway);04145(Phagosome);04151(PI3K-Akt signaling pathway);04360(Axon guidance);04510(Focal adhesion);04512(ECM-receptor interaction);04514(Cell adhesion molecules (CAMs));04530(Tight junction);04611(Platelet activation);04670(Leukocyte transendothelial migration);04810(Regulation of actin cytoskeleton);05100(Bacterial invasion of epithelial cells);05130(Pathogenic Escherichia coli infection);05131(Shigellosis);05133(Pertussis);05140(Leishmaniasis);05145(Toxoplasmosis);05165(Human papillomavirus infection);05200(Pathways in cancer);05205(Proteoglycans in cancer);05222(Small cell lung cancer);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM))",{"v":2e-40,"d":"0.00"},1,"180,",0,-7.75,{"v":3.80189396320561e-10,"d":"0.00"},-1.45,"3' UTR",10,32900318,32958230,57913,2]
[32901275,32901395,121,"ENSG00000150093","ENST00000302278","protein_coding",56835,"ITGB1","integrin subunit beta 1 [Source:HGNC Symbol;Acc:HGNC:6153]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0001618(virus receptor activity);GO:0001701(in utero embryonic development);GO:0001708(cell fate specification);GO:0001726(ruffle);GO:0001968(fibronectin binding);GO:0002020(protease binding);GO:0002042(cell migration involved in sprouting angiogenesis);GO:0003779(actin binding);GO:0005178(integrin binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006909(phagocytosis);GO:0006968(cellular defense response);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007159(leukocyte cell-cell adhesion);GO:0007160(cell-matrix adhesion);GO:0007161(calcium-independent cell-matrix adhesion);GO:0007229(integrin-mediated signaling pathway);GO:0008284(positive regulation of cell population proliferation);GO:0008305(integrin complex);GO:0008354(germ cell migration);GO:0008542(visual learning);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0010710(regulation of collagen catabolic process);GO:0014704(intercalated disc);GO:0015026(coreceptor activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016032(viral process);GO:0016477(cell migration);GO:0019221(cytokine-mediated signaling pathway);GO:0019960(C-X3-C chemokine binding);GO:0021943(formation of radial glial scaffolds);GO:0030027(lamellipodium);GO:0030030(cell projection organization);GO:0030032(lamellipodium assembly);GO:0030054(cell junction);GO:0030175(filopodium);GO:0030183(B cell differentiation);GO:0030198(extracellular matrix organization);GO:0031175(neuron projection development);GO:0031410(cytoplasmic vesicle);GO:0031589(cell-substrate adhesion);GO:0031594(neuromuscular junction);GO:0031623(receptor internalization);GO:0032154(cleavage furrow);GO:0032587(ruffle membrane);GO:0033627(cell adhesion mediated by integrin);GO:0033631(cell-cell adhesion mediated by integrin);GO:0034113(heterotypic cell-cell adhesion);GO:0034665(integrin alpha1-beta1 complex);GO:0034666(integrin alpha2-beta1 complex);GO:0034667(integrin alpha3-beta1 complex);GO:0034677(integrin alpha7-beta1 complex);GO:0034678(integrin alpha8-beta1 complex);GO:0034680(integrin alpha10-beta1 complex);GO:0034681(integrin alpha11-beta1 complex);GO:0035024(negative regulation of Rho protein signal transduction);GO:0035748(myelin sheath abaxonal region);GO:0038023(signaling receptor activity);GO:0042383(sarcolemma);GO:0042470(melanosome);GO:0042995(cell projection);GO:0043065(positive regulation of apoptotic process);GO:0043197(dendritic spine);GO:0043235(receptor complex);GO:0043236(laminin binding);GO:0043547(positive regulation of GTPase activity);GO:0044877(protein-containing complex binding);GO:0045121(membrane raft);GO:0045202(synapse);GO:0045214(sarcomere organization);GO:0045296(cadherin binding);GO:0045596(negative regulation of cell differentiation);GO:0045766(positive regulation of angiogenesis);GO:0046718(viral entry into host cell);GO:0046872(metal ion binding);GO:0046982(protein heterodimerization activity);GO:0048333(mesodermal cell differentiation);GO:0048471(perinuclear region of cytoplasm);GO:0048675(axon extension);GO:0048813(dendrite morphogenesis);GO:0050776(regulation of immune response);GO:0050804(modulation of chemical synaptic transmission);GO:0050839(cell adhesion molecule binding);GO:0050900(leukocyte migration);GO:0050901(leukocyte tethering or rolling);GO:0051726(regulation of cell cycle);GO:0051897(positive regulation of protein kinase B signaling);GO:0055007(cardiac muscle cell differentiation);GO:0055037(recycling endosome);GO:0070062(extracellular exosome);GO:0071404(cellular response to low-density lipoprotein particle stimulus);GO:0071438(invadopodium membrane);GO:0071711(basement membrane organization);GO:0097060(synaptic membrane);GO:0097386(glial cell projection);GO:0098639(collagen binding involved in cell-matrix adhesion);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098978(glutamatergic synapse);GO:0099699(integral component of synaptic membrane);GO:1903078(positive regulation of protein localization to plasma membrane);GO:2000273(positive regulation of signaling receptor activity);GO:2000811(negative regulation of anoikis)","04015(Rap1 signaling pathway);04145(Phagosome);04151(PI3K-Akt signaling pathway);04360(Axon guidance);04510(Focal adhesion);04512(ECM-receptor interaction);04514(Cell adhesion molecules (CAMs));04530(Tight junction);04611(Platelet activation);04670(Leukocyte transendothelial migration);04810(Regulation of actin cytoskeleton);05100(Bacterial invasion of epithelial cells);05130(Pathogenic Escherichia coli infection);05131(Shigellosis);05133(Pertussis);05140(Leishmaniasis);05145(Toxoplasmosis);05165(Human papillomavirus infection);05200(Pathways in cancer);05205(Proteoglycans in cancer);05222(Small cell lung cancer);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM))",{"v":2.5e-26,"d":"0.00"},1,"121,",0,{"v":-7.4,"d":"-7.40"},{"v":9.12010839355912e-10,"d":"0.00"},-1.05,"3' UTR",10,32900318,32958230,57913,2]
[63208267,63208775,509,"ENSG00000171988","ENST00000639129","protein_coding",8936,"JMJD1C","jumonji domain containing 1C [Source:HGNC Symbol;Acc:HGNC:12313]","GO:0000785(chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006355(regulation of transcription, DNA-templated);GO:0007596(blood coagulation);GO:0016491(oxidoreductase activity);GO:0031490(chromatin DNA binding);GO:0032454(histone demethylase activity (H3-K9 specific));GO:0033169(histone H3-K9 demethylation);GO:0046872(metal ion binding);GO:0046966(thyroid hormone receptor binding);GO:0051213(dioxygenase activity);GO:0055114(oxidation-reduction process)","05202(Transcriptional misregulation in cancer)",{"v":5e-28,"d":"0.00"},1,"509,",0,{"v":-0.838,"d":"-0.84"},{"v":0.0346736850452532,"d":"0.03"},-1.49,"Exon (ENST00000639129/ENSG00000171988, exon 7 of 23)",10,63167221,63217711,50491,2]
[63213692,63214350,659,"ENSG00000171988","ENST00000639129","protein_coding",3361,"JMJD1C","jumonji domain containing 1C [Source:HGNC Symbol;Acc:HGNC:12313]","GO:0000785(chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006355(regulation of transcription, DNA-templated);GO:0007596(blood coagulation);GO:0016491(oxidoreductase activity);GO:0031490(chromatin DNA binding);GO:0032454(histone demethylase activity (H3-K9 specific));GO:0033169(histone H3-K9 demethylation);GO:0046872(metal ion binding);GO:0046966(thyroid hormone receptor binding);GO:0051213(dioxygenase activity);GO:0055114(oxidation-reduction process)","05202(Transcriptional misregulation in cancer)",{"v":2E-19,"d":"0.00"},1,"659,",0,{"v":-0.889,"d":"-0.89"},{"v":0.0295120922666639,"d":"0.03"},-1.22,"Exon (ENST00000639129/ENSG00000171988, exon 5 of 23)",10,63167221,63217711,50491,2]
[70113918,70114276,359,"ENSG00000042286","ENST00000373248","protein_coding",9826,"AIFM2","apoptosis inducing factor, mitochondria associated 2 [Source:HGNC Symbol;Acc:HGNC:21411]","GO:0003677(DNA binding);GO:0004174(electron-transferring-flavoprotein dehydrogenase activity);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005811(lipid droplet);GO:0005829(cytosol);GO:0006915(apoptotic process);GO:0008637(apoptotic mitochondrial changes);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0022904(respiratory electron transport chain);GO:0042981(regulation of apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0050660(flavin adenine dinucleotide binding);GO:0055114(oxidation-reduction process)","04115(p53 signaling pathway)",{"v":3.2e-12,"d":"0.00"},1,"359,",0,-1.42,{"v":0.00549540873857625,"d":"0.01"},-1.61,"3' UTR",10,70098223,70124102,25880,2]
[67372653,67373506,854,"ENSG00000103599","ENST00000335894","protein_coding",117867,"IQCH","IQ motif containing H [Source:HGNC Symbol;Acc:HGNC:25721]","GO:0003674(molecular_function);GO:0005515(protein binding);GO:0005575(cellular_component);GO:0008150(biological_process)","NA",{"v":0.0031,"d":"0.00"},2,"10,140,","0,714",{"v":-0.951,"d":"-0.95"},{"v":0.0239883291901949,"d":"0.02"},{"v":-2.5,"d":"-2.50"},"3' UTR",15,67254786,67501804,247019,1]
[99610522,99613556,3035,"ENSG00000155287","ENST00000434701","protein_coding",6591,"SLC25A28","solute carrier family 25 member 28 [Source:HGNC Symbol;Acc:HGNC:23472]","GO:0005381(iron ion transmembrane transporter activity);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0006811(ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0048250(iron import into the mitochondrion);GO:0055072(iron ion homeostasis);GO:0055085(transmembrane transport)","NA",{"v":1e-252,"d":"0.00"},3,"845,57,88,","0,2021,2947",{"v":-50.8,"d":"-50.80"},{"v":1.58489319246112e-54,"d":"0.00"},-1.19,"3' UTR",10,99610522,99620147,9626,2]
[103595406,103595526,121,"ENSG00000107957","ENST00000369774","protein_coding",260017,"SH3PXD2A","SH3 and PX domains 2A [Source:HGNC Symbol;Acc:HGNC:23664]","GO:0002020(protease binding);GO:0002102(podosome);GO:0005515(protein binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006801(superoxide metabolic process);GO:0010314(phosphatidylinositol-5-phosphate binding);GO:0016176(superoxide-generating NADPH oxidase activator activity);GO:0030054(cell junction);GO:0030198(extracellular matrix organization);GO:0032266(phosphatidylinositol-3-phosphate binding);GO:0035091(phosphatidylinositol binding);GO:0042995(cell projection);GO:0043085(positive regulation of catalytic activity);GO:0043325(phosphatidylinositol-3,4-bisphosphate binding);GO:0070273(phosphatidylinositol-4-phosphate binding);GO:0072593(reactive oxygen species metabolic process);GO:0072675(osteoclast fusion)","NA",{"v":0.0026,"d":"0.00"},1,"121,",0,-1.76,{"v":0.00204173794466953,"d":"0.00"},-1.12,"3' UTR",10,103594027,103855543,261517,2]
[112445292,112445621,330,"ENSG00000023041","ENST00000626395","protein_coding",1296,"ZDHHC6","zinc finger DHHC-type containing 6 [Source:HGNC Symbol;Acc:HGNC:19160]","GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0006612(protein targeting to membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016409(palmitoyltransferase activity);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0018230(peptidyl-L-cysteine S-palmitoylation);GO:0018345(protein palmitoylation);GO:0019706(protein-cysteine S-palmitoyltransferase activity)","NA",{"v":1.3E-11,"d":"0.00"},1,"330,",0,-2.37,{"v":0.000380189396320561,"d":"0.00"},-1.09,"5' UTR",10,112424428,112446917,22490,2]
[133420726,133420994,269,"ENSG00000148824","ENST00000317502","protein_coding",26569,"MTG1","mitochondrial ribosome associated GTPase 1 [Source:HGNC Symbol;Acc:HGNC:32159]","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005759(mitochondrial matrix);GO:0005761(mitochondrial ribosome);GO:0006417(regulation of translation);GO:0016020(membrane);GO:0044065(regulation of respiratory system process);GO:0070129(regulation of mitochondrial translation)","NA",{"v":2.4e-07,"d":"0.00"},1,"269,",0,-1.41,{"v":0.00562341325190349,"d":"0.01"},-1.42,"3' UTR",10,133394157,133422520,28364,1]
[49476630,49476929,300,"ENSG00000136169","ENST00000354234","protein_coding",32256,"SETDB2","SET domain bifurcated histone lysine methyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:20263]","GO:0000278(mitotic cell cycle);GO:0001947(heart looping);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005829(cytosol);GO:0006325(chromatin organization);GO:0007049(cell cycle);GO:0007059(chromosome segregation);GO:0007275(multicellular organism development);GO:0008168(methyltransferase activity);GO:0008270(zinc ion binding);GO:0016740(transferase activity);GO:0018024(histone-lysine N-methyltransferase activity);GO:0032259(methylation);GO:0034968(histone lysine methylation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0046974(histone methyltransferase activity (H3-K9 specific));GO:0051301(cell division);GO:0051567(histone H3-K9 methylation);GO:0070986(left/right axis specification)","00310(Lysine degradation)",{"v":8.5e-06,"d":"0.00"},1,"300,",0,-1.25,{"v":0.00933254300796992,"d":"0.01"},-2.54,"Exon (ENST00000354234/ENSG00000136169, exon 7 of 15)",13,49444374,49495003,50630,1]
[186157896,186158223,328,"ENSG00000250327","ENST00000504462","processed_pseudogene",0,"RPSAP70","ribosomal protein SA pseudogene 70 [Source:HGNC Symbol;Acc:HGNC:51923]","NA","NA",{"v":1.3E-7,"d":"0.00"},1,"328,",0,-2.16,{"v":0.000660693448007596,"d":"0.00"},-2.57,"Exon (ENST00000514829/ENSG00000109794, exon 9 of 9)",4,186157896,186158843,948,1]
[12937123,12937363,241,"ENSG00000187079","ENST00000527636","protein_coding",262702,"TEAD1","TEA domain transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:11714]","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0000987(proximal promoter sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001134(transcription regulator recruiting activity);GO:0001223(transcription coactivator binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0006355(regulation of transcription, DNA-templated);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0035329(hippo signaling);GO:0043565(sequence-specific DNA binding);GO:0044212(transcription regulatory region DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046982(protein heterodimerization activity);GO:0065003(protein-containing complex assembly);GO:0071148(TEAD-1-YAP complex);GO:1902895(positive regulation of pri-miRNA transcription by RNA polymerase II)","04390(Hippo signaling pathway);04392(Hippo signaling pathway - multiple species)",{"v":1.3E-24,"d":"0.00"},1,"241,",0,-5.22,{"v":2.23872113856834e-07,"d":"0.00"},-1.35,"3' UTR",11,12674421,12944737,270317,1]
[82655576,82656701,1126,"ENSG00000141542","ENST00000571995","protein_coding",41997,"RAB40B","RAB40B, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:18284]","GO:0000139(Golgi membrane);GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005635(nuclear envelope);GO:0005886(plasma membrane);GO:0006886(intracellular protein transport);GO:0016020(membrane);GO:0016567(protein ubiquitination);GO:0032482(Rab protein signal transduction);GO:0035556(intracellular signal transduction);GO:0048471(perinuclear region of cytoplasm);GO:1990967(multi-organism toxin transport)","NA",{"v":1.3E-6,"d":"0.00"},2,"92,209,","0,917",{"v":-0.957,"d":"-0.96"},{"v":0.0234422881531992,"d":"0.02"},-2.57,"3' UTR",17,82654973,82698698,43726,2]
[33544976,33545246,271,"ENSG00000110427","ENST00000526400","protein_coding",168510,"KIAA1549L","KIAA1549 like [Source:HGNC Symbol;Acc:HGNC:24836]","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":0.0011,"d":"0.00"},1,"271,",0,-1.72,{"v":0.00229086765276777,"d":"0.00"},-1.62,"Exon (ENST00000526400/ENSG00000110427, exon 3 of 15)",11,33376466,33609892,233427,1]
[43339332,43342651,3320,"ENSG00000166181","ENST00000534695","protein_coding",27369,"API5","apoptosis inhibitor 5 [Source:HGNC Symbol;Acc:HGNC:594]","GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005681(spliceosomal complex);GO:0005737(cytoplasm);GO:0006915(apoptotic process);GO:0016020(membrane);GO:0016607(nuclear speck);GO:0017134(fibroblast growth factor binding);GO:0043066(negative regulation of apoptotic process);GO:2000270(negative regulation of fibroblast apoptotic process)","NA",{"v":4e-12,"d":"0.00"},3,"42,3,224,","0,892,3096",-6.61,{"v":6.45654229034656e-09,"d":"0.00"},-1.08,"3' UTR",11,43311963,43342676,30714,1]
[44107927,44109200,1274,"ENSG00000151348","ENST00000529186","processed_transcript",0,"EXT2","exostosin glycosyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:3513]","GO:0000139(Golgi membrane);GO:0001503(ossification);GO:0001707(mesoderm formation);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0006024(glycosaminoglycan biosynthetic process);GO:0006486(protein glycosylation);GO:0007165(signal transduction);GO:0008375(acetylglucosaminyltransferase activity);GO:0015012(heparan sulfate proteoglycan biosynthetic process);GO:0015014(heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process);GO:0015020(glucuronosyltransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030154(cell differentiation);GO:0033692(cellular polysaccharide biosynthetic process);GO:0042328(heparan sulfate N-acetylglucosaminyltransferase activity);GO:0043541(UDP-N-acetylglucosamine transferase complex);GO:0046872(metal ion binding);GO:0046982(protein heterodimerization activity);GO:0050508(glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity);GO:0050509(N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity);GO:0070062(extracellular exosome)","00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)",{"v":1.6e-25,"d":"0.00"},2,"322,7,","0,1267",{"v":-53.2,"d":"-53.20"},{"v":6.30957344480189e-57,"d":"0.00"},{"v":-1.5,"d":"-1.50"},"Exon (ENST00000533608/ENSG00000151348, exon 2 of 14)",11,44108015,44116839,8825,1]
[45208885,45209215,331,"ENSG00000019485","ENST00000530656","protein_coding",113079,"PRDM11","PR/SET domain 11 [Source:HGNC Symbol;Acc:HGNC:13996]","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001047(core promoter binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008168(methyltransferase activity);GO:0016740(transferase activity);GO:0030308(negative regulation of cell growth);GO:0031490(chromatin DNA binding);GO:0032259(methylation);GO:0043408(regulation of MAPK cascade);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0051726(regulation of cell cycle);GO:2000271(positive regulation of fibroblast apoptotic process)","NA",{"v":2.8e-09,"d":"0.00"},1,"331,",0,{"v":-0.922,"d":"-0.92"},{"v":0.0263026799189538,"d":"0.03"},-1.96,"Exon (ENST00000534751/ENSG00000019485, exon 5 of 6)",11,45095806,45224908,129103,1]
[46674160,46674489,330,"ENSG00000175224","ENST00000526508","protein_coding",56597,"ATG13","autophagy related 13 [Source:HGNC Symbol;Acc:HGNC:29091]","GO:0000045(autophagosome assembly);GO:0000407(phagophore assembly site);GO:0000422(autophagy of mitochondrion);GO:0000423(mitophagy);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0006914(autophagy);GO:0016236(macroautophagy);GO:0016241(regulation of macroautophagy);GO:0019887(protein kinase regulator activity);GO:0019898(extrinsic component of membrane);GO:0019901(protein kinase binding);GO:0032147(activation of protein kinase activity);GO:0034497(protein localization to phagophore assembly site);GO:0034727(piecemeal microautophagy of the nucleus);GO:0098780(response to mitochondrial depolarisation);GO:1903955(positive regulation of protein targeting to mitochondrion);GO:1990316(Atg1/ULK1 kinase complex)","04136(Autophagy - other);04140(Autophagy - animal);04211(Longevity regulating pathway)",{"v":6.3e-31,"d":"0.00"},1,"330,",0,-4.09,{"v":3.98107170553497E-6,"d":"0.00"},-1.18,"3' UTR",11,46617563,46674520,56958,1]
[124987495,124988124,630,"ENSG00000149548","ENST00000529051","protein_coding",33374,"CCDC15","coiled-coil domain containing 15 [Source:HGNC Symbol;Acc:HGNC:25798]","GO:0005813(centrosome)","NA",{"v":3.3e-05,"d":"0.00"},1,"630,",0,{"v":-0.747,"d":"-0.75"},{"v":0.0467735141287198,"d":"0.05"},-2.58,"Exon (ENST00000529051/ENSG00000149548, exon 8 of 16)",11,124954121,125041487,87367,1]
[13663347,13663526,180,"ENSG00000177150","ENST00000651643","protein_coding",63032,"FAM210A","family with sequence similarity 210 member A [Source:HGNC Symbol;Acc:HGNC:28346]","GO:0003674(molecular_function);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0008150(biological_process);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":2.5e-05,"d":"0.00"},1,"180,",0,-1.27,{"v":0.0087096358995608,"d":"0.01"},-2.58,"3' UTR",18,13663347,13726558,63212,2]
[64933875,64934055,181,"ENSG00000068971","ENST00000164133","protein_coding",9186,"PPP2R5B","protein phosphatase 2 regulatory subunit B'beta [Source:HGNC Symbol;Acc:HGNC:9310]","GO:0000159(protein phosphatase type 2A complex);GO:0001932(regulation of protein phosphorylation);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006470(protein dephosphorylation);GO:0007165(signal transduction);GO:0010469(regulation of signaling receptor activity);GO:0010976(positive regulation of neuron projection development);GO:0014066(regulation of phosphatidylinositol 3-kinase signaling);GO:0019888(protein phosphatase regulator activity);GO:0031334(positive regulation of protein complex assembly);GO:0031952(regulation of protein autophosphorylation);GO:0036498(IRE1-mediated unfolded protein response);GO:0043666(regulation of phosphoprotein phosphatase activity);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050730(regulation of peptidyl-tyrosine phosphorylation);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051388(positive regulation of neurotrophin TRK receptor signaling pathway);GO:0051898(negative regulation of protein kinase B signaling);GO:0070317(negative regulation of G0 to G1 transition);GO:0071158(positive regulation of cell cycle arrest);GO:0071363(cellular response to growth factor stimulus);GO:0072542(protein phosphatase activator activity)","03015(mRNA surveillance pathway);04071(Sphingolipid signaling pathway);04114(Oocyte meiosis);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04728(Dopaminergic synapse);05165(Human papillomavirus infection)",{"v":6.2e-06,"d":"0.00"},1,"181,",0,-1.58,{"v":0.00346736850452532,"d":"0.00"},-1.02,"3' UTR",11,64924689,64934475,9787,1]
[68348020,68348080,61,"ENSG00000162337","ENST00000294304","protein_coding",35429,"LRP5","LDL receptor related protein 5 [Source:HGNC Symbol;Acc:HGNC:6697]","GO:0001702(gastrulation with mouth forming second);GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0002076(osteoblast development);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006007(glucose catabolic process);GO:0006897(endocytosis);GO:0007275(multicellular organism development);GO:0008217(regulation of blood pressure);GO:0008284(positive regulation of cell population proliferation);GO:0009952(anterior/posterior pattern specification);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0017147(Wnt-protein binding);GO:0042632(cholesterol homeostasis);GO:0042813(Wnt-activated receptor activity);GO:0043235(receptor complex);GO:0045600(positive regulation of fat cell differentiation);GO:0045668(negative regulation of osteoblast differentiation);GO:0045669(positive regulation of osteoblast differentiation);GO:0045840(positive regulation of mitotic nuclear division);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046849(bone remodeling);GO:0048539(bone marrow development);GO:0060042(retina morphogenesis in camera-type eye);GO:0060070(canonical Wnt signaling pathway);GO:0060349(bone morphogenesis);GO:0060444(branching involved in mammary gland duct morphogenesis);GO:0060612(adipose tissue development);GO:0061178(regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0061304(retinal blood vessel morphogenesis);GO:0071901(negative regulation of protein serine/threonine kinase activity);GO:0071936(coreceptor activity involved in Wnt signaling pathway);GO:1901998(toxin transport);GO:1904928(coreceptor activity involved in canonical Wnt signaling pathway);GO:1990851(Wnt-Frizzled-LRP5/6 complex);GO:1990909(Wnt signalosome)","04150(mTOR signaling pathway);04310(Wnt signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);05200(Pathways in cancer);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer)",{"v":0.0013,"d":"0.00"},1,"61,",0,-1.33,{"v":7.2443596007499E-3,"d":"0.01"},{"v":-1.1,"d":"-1.10"},"Exon (ENST00000294304/ENSG00000162337, exon 2 of 23)",11,68312591,68449275,136685,1]
[71796121,71796447,327,"ENSG00000158483","ENST00000346333","protein_coding",8611,"FAM86C1","family with sequence similarity 86 member C1 [Source:HGNC Symbol;Acc:HGNC:25561]","GO:0005515(protein binding);GO:0008168(methyltransferase activity);GO:0016740(transferase activity);GO:0032259(methylation);GO:0032991(protein-containing complex)","NA",{"v":4.5e-09,"d":"0.00"},1,"327,",0,{"v":-0.867,"d":"-0.87"},{"v":0.0316227766016838,"d":"0.03"},{"v":-1.2,"d":"-1.20"},"3' UTR",11,71787510,71801234,13725,1]
[102347241,102347449,209,"ENSG00000110330","ENST00000532672","protein_coding",0,"BIRC2","baculoviral IAP repeat containing 2 [Source:HGNC Symbol;Acc:HGNC:590]","GO:0000209(protein polyubiquitination);GO:0001666(response to hypoxia);GO:0001741(XY body);GO:0001890(placenta development);GO:0002756(MyD88-independent toll-like receptor signaling pathway);GO:0003713(transcription coactivator activity);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006915(apoptotic process);GO:0007166(cell surface receptor signaling pathway);GO:0007249(I-kappaB kinase/NF-kappaB signaling);GO:0008270(zinc ion binding);GO:0009898(cytoplasmic side of plasma membrane);GO:0010243(response to organonitrogen compound);GO:0010803(regulation of tumor necrosis factor-mediated signaling pathway);GO:0014070(response to organic cyclic compound);GO:0016579(protein deubiquitination);GO:0016740(transferase activity);GO:0032991(protein-containing complex);GO:0033209(tumor necrosis factor-mediated signaling pathway);GO:0034121(regulation of toll-like receptor signaling pathway);GO:0035631(CD40 receptor complex);GO:0035666(TRIF-dependent toll-like receptor signaling pathway);GO:0038061(NIK/NF-kappaB signaling);GO:0039535(regulation of RIG-I signaling pathway);GO:0042127(regulation of cell population proliferation);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043027(cysteine-type endopeptidase inhibitor activity involved in apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043130(ubiquitin binding);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0045088(regulation of innate immune response);GO:0045121(membrane raft);GO:0045471(response to ethanol);GO:0045595(regulation of cell differentiation);GO:0046872(metal ion binding);GO:0047485(protein N-terminus binding);GO:0050727(regulation of inflammatory response);GO:0051087(chaperone binding);GO:0051291(protein heterooligomerization);GO:0051591(response to cAMP);GO:0051726(regulation of cell cycle);GO:0060544(regulation of necroptotic process);GO:0060546(negative regulation of necroptotic process);GO:0061630(ubiquitin protein ligase activity);GO:0070266(necroptotic process);GO:0070424(regulation of nucleotide-binding oligomerization domain containing signaling pathway);GO:0071356(cellular response to tumor necrosis factor);GO:0098770(FBXO family protein binding);GO:1901222(regulation of NIK/NF-kappaB signaling);GO:1902443(negative regulation of ripoptosome assembly involved in necroptotic process);GO:1902523(positive regulation of protein K63-linked ubiquitination);GO:1902524(positive regulation of protein K48-linked ubiquitination);GO:1902527(positive regulation of protein monoubiquitination);GO:1902916(positive regulation of protein polyubiquitination);GO:1903508(positive regulation of nucleic acid-templated transcription);GO:1990001(inhibition of cysteine-type endopeptidase activity involved in apoptotic process);GO:2000116(regulation of cysteine-type endopeptidase activity);GO:2000377(regulation of reactive oxygen species metabolic process)","01524(Platinum drug resistance);04064(NF-kappa B signaling pathway);04120(Ubiquitin mediated proteolysis);04210(Apoptosis);04215(Apoptosis - multiple species);04217(Necroptosis);04390(Hippo signaling pathway);04510(Focal adhesion);04621(NOD-like receptor signaling pathway);04668(TNF signaling pathway);05145(Toxoplasmosis);05168(Herpes simplex virus 1 infection);05200(Pathways in cancer);05222(Small cell lung cancer)",{"v":4.8e-05,"d":"0.00"},1,"209,",0,{"v":-0.878,"d":"-0.88"},{"v":0.0301995172040202,"d":"0.03"},-1.49,"5' UTR",11,102347247,102378669,31423,1]
[62368887,62369426,540,"ENSG00000141655","ENST00000269485","protein_coding",43600,"TNFRSF11A","TNF receptor superfamily member 11a [Source:HGNC Symbol;Acc:HGNC:11908]","GO:0001503(ossification);GO:0002250(adaptive immune response);GO:0002548(monocyte chemotaxis);GO:0004888(transmembrane signaling receptor activity);GO:0005031(tumor necrosis factor-activated receptor activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007267(cell-cell signaling);GO:0007275(multicellular organism development);GO:0008284(positive regulation of cell population proliferation);GO:0009314(response to radiation);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019955(cytokine binding);GO:0030316(osteoclast differentiation);GO:0032496(response to lipopolysaccharide);GO:0033209(tumor necrosis factor-mediated signaling pathway);GO:0034097(response to cytokine);GO:0034612(response to tumor necrosis factor);GO:0038023(signaling receptor activity);GO:0043507(positive regulation of JUN kinase activity);GO:0045780(positive regulation of bone resorption);GO:0046872(metal ion binding);GO:0048535(lymph node development);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0060086(circadian temperature homeostasis);GO:0060749(mammary gland alveolus development);GO:0070555(response to interleukin-1);GO:0071812(positive regulation of fever generation by positive regulation of prostaglandin secretion);GO:0071847(TNFSF11-mediated signaling pathway);GO:0071848(positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling);GO:0072674(multinuclear osteoclast differentiation)","04060(Cytokine-cytokine receptor interaction);04064(NF-kappa B signaling pathway);04380(Osteoclast differentiation);04917(Prolactin signaling pathway);05323(Rheumatoid arthritis)",{"v":3.2e-15,"d":"0.00"},1,"540,",0,{"v":-0.771,"d":"-0.77"},{"v":0.0436515832240166,"d":"0.04"},{"v":-2.6,"d":"-2.60"},"Exon (ENST00000586569/ENSG00000141655, exon 9 of 10)",18,62325287,62387659,62373,1]
[119160916,119161395,480,"ENSG00000172350","ENST00000619701","protein_coding",11864,"ABCG4","ATP binding cassette subfamily G member 4 [Source:HGNC Symbol;Acc:HGNC:13884]","GO:0000166(nucleotide binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0033344(cholesterol efflux);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0055085(transmembrane transport);GO:1990830(cellular response to leukemia inhibitory factor)","02010(ABC transporters)",{"v":1.6e-06,"d":"0.00"},1,"480,",0,{"v":-1.1,"d":"-1.10"},{"v":0.0147910838816821,"d":"0.01"},-1.55,"3' UTR",11,119149052,119162653,13602,1]
[120336803,120385450,48648,"ENSG00000196914","ENST00000356641","protein_coding",0,"ARHGEF12","Rho guanine nucleotide exchange factor 12 [Source:HGNC Symbol;Acc:HGNC:14193]","GO:0001664(G protein-coupled receptor binding);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007266(Rho protein signal transduction);GO:0016020(membrane);GO:0035023(regulation of Rho protein signal transduction);GO:0035556(intracellular signal transduction);GO:0043065(positive regulation of apoptotic process);GO:0043547(positive regulation of GTPase activity);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0070062(extracellular exosome)","04270(Vascular smooth muscle contraction);04360(Axon guidance);04611(Platelet activation);04625(C-type lectin receptor signaling pathway);04810(Regulation of actin cytoskeleton);05152(Tuberculosis);05163(Human cytomegalovirus infection);05200(Pathways in cancer);05205(Proteoglycans in cancer)",{"v":7.9e-100,"d":"0.00"},2,"473,157,","0,48491",-5.84,{"v":4.46683592150963E-8,"d":"0.00"},-1.01,"5' UTR",11,120336914,120487060,150147,1]
[30285397,30285755,359,"ENSG00000243753","ENST00000482052","processed_transcript",25813,"HLA-L","major histocompatibility complex, class I, L (pseudogene) [Source:HGNC Symbol;Acc:HGNC:4970]","NA","NA",{"v":3.6e-05,"d":"0.00"},1,"359,",0,{"v":-0.759,"d":"-0.76"},{"v":0.0446683592150963,"d":"0.04"},-2.63,"Exon (ENST00000624252/ENSG00000280128, exon 1 of 1)",6,30259584,30293014,33431,1]
[23414693,23416154,1462,"ENSG00000136231","ENST00000258729","protein_coding",54337,"IGF2BP3","insulin like growth factor 2 mRNA binding protein 3 [Source:HGNC Symbol;Acc:HGNC:28868]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006412(translation);GO:0006417(regulation of translation);GO:0009653(anatomical structure morphogenesis);GO:0017148(negative regulation of translation);GO:0042035(regulation of cytokine biosynthetic process);GO:0043488(regulation of mRNA stability);GO:0045182(translation regulator activity);GO:0048027(mRNA 5'-UTR binding);GO:0051028(mRNA transport)","NA",{"v":5e-13,"d":"0.00"},2,"873,26,","0,1436",{"v":-0.804,"d":"-0.80"},{"v":0.0389045144994281,"d":"0.04"},-2.63,"Exon (ENST00000465058/ENSG00000136231, exon 3 of 6)",7,23310209,23470491,160283,2]
[126277772,126278131,360,"ENSG00000110074","ENST00000263578","protein_coding",8639,"FOXRED1","FAD dependent oxidoreductase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:26927]","GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005747(mitochondrial respiratory chain complex I);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0032981(mitochondrial respiratory chain complex I assembly);GO:0055114(oxidation-reduction process);GO:0070469(respirasome)","NA",{"v":3.2e-81,"d":"0.00"},1,"360,",0,-4.52,{"v":1.31825673855641e-06,"d":"0.00"},-1.32,"3' UTR",11,126269133,126278124,8992,1]
[1276375,1276614,240,"ENSG00000078902","ENST00000317204","protein_coding",33018,"TOLLIP","toll interacting protein [Source:HGNC Symbol;Acc:HGNC:16476]","GO:0002376(immune system process);GO:0005150(interleukin-1, type I receptor binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006914(autophagy);GO:0006954(inflammatory response);GO:0007165(signal transduction);GO:0007267(cell-cell signaling);GO:0016310(phosphorylation);GO:0016604(nuclear body);GO:0019900(kinase binding);GO:0030855(epithelial cell differentiation);GO:0031624(ubiquitin conjugating enzyme binding);GO:0031625(ubiquitin protein ligase binding);GO:0032183(SUMO binding);GO:0033235(positive regulation of protein sumoylation);GO:0035325(Toll-like receptor binding);GO:0035556(intracellular signal transduction);GO:0035578(azurophil granule lumen);GO:0035580(specific granule lumen);GO:0036010(protein localization to endosome);GO:0043130(ubiquitin binding);GO:0043312(neutrophil degranulation);GO:0045087(innate immune response);GO:0045092(interleukin-18 receptor complex);GO:0045321(leukocyte activation);GO:0045323(interleukin-1 receptor complex);GO:0048471(perinuclear region of cytoplasm);GO:0070062(extracellular exosome);GO:0070498(interleukin-1-mediated signaling pathway)","04620(Toll-like receptor signaling pathway)",{"v":1.4e-06,"d":"0.00"},1,"240,",0,{"v":-2.1,"d":"-2.10"},{"v":0.000794328234724281,"d":"0.00"},{"v":-1.3,"d":"-1.30"},"3' UTR",11,1274371,1309632,35262,2]
[6488990,6489258,269,"ENSG00000254595","ENST00000524809","processed_pseudogene",119,"AC084337","voltage-dependent anion channel 1(VDAC1) pseudogene","NA","NA",{"v":1.9e-05,"d":"0.00"},1,"269,",0,-1.53,{"v":0.00398107170553497,"d":"0.00"},-1.95,"Exon (ENST00000524809/ENSG00000254595, exon 1 of 2)",11,6488186,6489377,1192,2]
[107592492,107593188,697,"ENSG00000110675","ENST00000531234","protein_coding",1401,"ELMOD1","ELMO domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25334]","GO:0005096(GTPase activator activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0043547(positive regulation of GTPase activity)","NA",{"v":5e-14,"d":"0.00"},2,"10,499,","0,198",-0.77,{"v":0.0436515832240166,"d":"0.04"},-2.63,"Exon (ENST00000529675/ENSG00000110675, exon 2 of 3)",11,107591091,107665484,74394,1]
[16777627,16777927,301,"ENSG00000166689","ENST00000531066","protein_coding",236487,"PLEKHA7","pleckstrin homology domain containing A7 [Source:HGNC Symbol;Acc:HGNC:27049]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005911(cell-cell junction);GO:0005912(adherens junction);GO:0005915(zonula adherens);GO:0030054(cell junction);GO:0044331(cell-cell adhesion mediated by cadherin);GO:0045218(zonula adherens maintenance);GO:0070062(extracellular exosome);GO:0070097(delta-catenin binding);GO:0090136(epithelial cell-cell adhesion)","NA",{"v":1.1e-10,"d":"0.00"},1,"301,",0,-1.04,{"v":0.0181970085860998,"d":"0.02"},-1.24,"3' UTR",11,16777297,17014414,237118,2]
[17169407,17207893,38487,"ENSG00000011405","ENST00000265970","protein_coding",0,"PIK3C2A","phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha [Source:HGNC Symbol;Acc:HGNC:8971]","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005942(phosphatidylinositol 3-kinase complex);GO:0006661(phosphatidylinositol biosynthetic process);GO:0006887(exocytosis);GO:0006897(endocytosis);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0008286(insulin receptor signaling pathway);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0014829(vascular smooth muscle contraction);GO:0016020(membrane);GO:0016301(kinase activity);GO:0016303(1-phosphatidylinositol-3-kinase activity);GO:0016310(phosphorylation);GO:0016477(cell migration);GO:0016740(transferase activity);GO:0030136(clathrin-coated vesicle);GO:0031410(cytoplasmic vesicle);GO:0031982(vesicle);GO:0035004(phosphatidylinositol 3-kinase activity);GO:0035005(1-phosphatidylinositol-4-phosphate 3-kinase activity);GO:0035091(phosphatidylinositol binding);GO:0036092(phosphatidylinositol-3-phosphate biosynthetic process);GO:0046854(phosphatidylinositol phosphorylation);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048015(phosphatidylinositol-mediated signaling);GO:0048268(clathrin coat assembly);GO:0061024(membrane organization);GO:0070062(extracellular exosome);GO:0090050(positive regulation of cell migration involved in sprouting angiogenesis)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)",{"v":4e-48,"d":"0.00"},4,"400,26,69,46,","0,24982,34900,38441",-2.16,{"v":0.000660693448007596,"d":"0.00"},-1.85,"5' UTR",11,17086572,17169741,83170,2]
[33742798,33743038,241,"ENSG00000110429","ENST00000526785","protein_coding",31309,"FBXO3","F-box protein 3 [Source:HGNC Symbol;Acc:HGNC:13582]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0016567(protein ubiquitination)","NA",{"v":7.9e-11,"d":"0.00"},1,"241,",0,{"v":-0.841,"d":"-0.84"},{"v":0.0346736850452532,"d":"0.03"},-1.91,"3' UTR",11,33740939,33774347,33409,2]
[60850933,60851141,209,"ENSG00000256813","ENST00000538705","antisense",0,"AP000777","novel transcript","NA","NA",{"v":1.6e-32,"d":"0.00"},1,"209,",0,{"v":-0.793,"d":"-0.79"},{"v":0.0398107170553497,"d":"0.04"},-1.02,"3' UTR",11,60841806,60851081,9276,2]
[64894576,64895204,629,"ENSG00000110046","ENST00000418259","protein_coding",18191,"ATG2A","autophagy related 2A [Source:HGNC Symbol;Acc:HGNC:29028]","GO:0000045(autophagosome assembly);GO:0000407(phagophore assembly site);GO:0000422(autophagy of mitochondrion);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005811(lipid droplet);GO:0005829(cytosol);GO:0006914(autophagy);GO:0016020(membrane);GO:0019898(extrinsic component of membrane);GO:0034045(phagophore assembly site membrane);GO:0043231(intracellular membrane-bounded organelle)","04136(Autophagy - other);04140(Autophagy - animal)",{"v":5e-57,"d":"0.00"},1,"629,",0,-3.35,{"v":2.81838293126445e-05,"d":"0.00"},-1.11,"3' UTR",11,64894546,64913395,18850,2]
[65538805,65539104,300,"ENSG00000168056","ENST00000322147","protein_coding",18855,"LTBP3","latent transforming growth factor beta binding protein 3 [Source:HGNC Symbol;Acc:HGNC:6716]","GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0019838(growth factor binding);GO:0036363(transforming growth factor beta activation);GO:0050431(transforming growth factor beta binding);GO:0062023(collagen-containing extracellular matrix);GO:0070062(extracellular exosome);GO:1902462(positive regulation of mesenchymal stem cell proliferation);GO:2000741(positive regulation of mesenchymal stem cell differentiation)","NA",{"v":1.6e-16,"d":"0.00"},1,"300,",0,-1.53,{"v":0.00398107170553497,"d":"0.00"},-1.06,"3' UTR",11,65538805,65557959,19155,2]
[65866501,65866891,391,"ENSG00000172638","ENST00000527277","nonsense_mediated_decay",189,"EFEMP2","EGF containing fibulin extracellular matrix protein 2 [Source:HGNC Symbol;Acc:HGNC:3219]","GO:0005201(extracellular matrix structural constituent);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005604(basement membrane);GO:0005615(extracellular space);GO:0048251(elastic fiber assembly);GO:0062023(collagen-containing extracellular matrix);GO:0070062(extracellular exosome);GO:1903561(extracellular vesicle)","NA",{"v":8.5e-10,"d":"0.00"},1,"391,",0,-1.03,{"v":0.0186208713666287,"d":"0.02"},-1.42,"3' UTR",11,65866441,65867080,640,2]
[65900244,65900423,180,"ENSG00000175592","ENST00000448083","protein_coding",0,"FOSL1","FOS like 1, AP-1 transcription factor subunit [Source:HGNC Symbol;Acc:HGNC:13718]","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006366(transcription by RNA polymerase II);GO:0006935(chemotaxis);GO:0006968(cellular defense response);GO:0007296(vitellogenesis);GO:0007565(female pregnancy);GO:0007612(learning);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0009612(response to mechanical stimulus);GO:0009615(response to virus);GO:0009629(response to gravity);GO:0014070(response to organic cyclic compound);GO:0031668(cellular response to extracellular stimulus);GO:0032570(response to progesterone);GO:0034097(response to cytokine);GO:0042493(response to drug);GO:0042542(response to hydrogen peroxide);GO:0042734(presynaptic membrane);GO:0043005(neuron projection);GO:0043065(positive regulation of apoptotic process);GO:0043231(intracellular membrane-bounded organelle);GO:0045787(positive regulation of cell cycle);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051412(response to corticosterone);GO:0051591(response to cAMP);GO:0060674(placenta blood vessel development);GO:0061614(pri-miRNA transcription by RNA polymerase II);GO:2000144(positive regulation of DNA-templated transcription, initiation)","04310(Wnt signaling pathway);04380(Osteoclast differentiation);04657(IL-17 signaling pathway);05166(Human T-cell leukemia virus 1 infection)",{"v":5e-11,"d":"0.00"},1,"180,",0,{"v":-0.967,"d":"-0.97"},{"v":0.0223872113856834,"d":"0.02"},-1.17,"5' UTR",11,65892049,65900419,8371,2]
[72793149,72793269,121,"ENSG00000186635","ENST00000359373","protein_coding",330,"ARAP1","ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 [Source:HGNC Symbol;Acc:HGNC:16925]","GO:0001921(positive regulation of receptor recycling);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005547(phosphatidylinositol-3,4,5-trisphosphate binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0008360(regulation of cell shape);GO:0016020(membrane);GO:0030037(actin filament reorganization involved in cell cycle);GO:0031410(cytoplasmic vesicle);GO:0031702(type 1 angiotensin receptor binding);GO:0032580(Golgi cisterna membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0043547(positive regulation of GTPase activity);GO:0045742(positive regulation of epidermal growth factor receptor signaling pathway);GO:0046872(metal ion binding);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0051270(regulation of cellular component movement);GO:0051491(positive regulation of filopodium assembly);GO:0051497(negative regulation of stress fiber assembly)","04144(Endocytosis)",{"v":1E-3,"d":"0.00"},1,"121,",0,{"v":-0.742,"d":"-0.74"},{"v":0.0478630092322638,"d":"0.05"},-1.91,"5' UTR",11,72685069,72793599,108531,2]
[74033840,74034259,420,"ENSG00000168014","ENST00000542452","processed_transcript",0,"C2CD3","C2 calcium dependent domain containing 3 [Source:HGNC Symbol;Acc:HGNC:24564]","GO:0001701(in utero embryonic development);GO:0001947(heart looping);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0007389(pattern specification process);GO:0007420(brain development);GO:0008589(regulation of smoothened signaling pathway);GO:0016485(protein processing);GO:0021915(neural tube development);GO:0021997(neural plate axis specification);GO:0030030(cell projection organization);GO:0030162(regulation of proteolysis);GO:0030326(embryonic limb morphogenesis);GO:0034451(centriolar satellite);GO:0036064(ciliary basal body);GO:0042733(embryonic digit morphogenesis);GO:0042995(cell projection);GO:0060271(cilium assembly);GO:0061511(centriole elongation);GO:0071539(protein localization to centrosome);GO:0097711(ciliary basal body-plasma membrane docking);GO:1905515(non-motile cilium assembly)","NA",{"v":2.5E-36,"d":"0.00"},1,"420,",0,-3.43,{"v":2.23872113856834E-5,"d":"0.00"},{"v":-1.1,"d":"-1.10"},"3' UTR",11,74013444,74033909,20466,2]
[53066726,53067026,301,"ENSG00000170949","ENST00000599056","protein_coding",36325,"ZNF160","zinc finger protein 160 [Source:HGNC Symbol;Acc:HGNC:12948]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0030097(hemopoiesis);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":0.0003,"d":"0.00"},1,"301,",0,-1.39,{"v":0.00602559586074357,"d":"0.01"},-2.63,"3' UTR",19,53066606,53103351,36746,2]
[83541661,83541900,240,"ENSG00000038427","ENST00000342785","protein_coding",69987,"VCAN","versican [Source:HGNC Symbol;Acc:HGNC:2464]","GO:0001501(skeletal system development);GO:0001649(osteoblast differentiation);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005539(glycosaminoglycan binding);GO:0005540(hyaluronic acid binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005788(endoplasmic reticulum lumen);GO:0005796(Golgi lumen);GO:0007155(cell adhesion);GO:0007275(multicellular organism development);GO:0007417(central nervous system development);GO:0008037(cell recognition);GO:0016020(membrane);GO:0030021(extracellular matrix structural constituent conferring compression resistance);GO:0030198(extracellular matrix organization);GO:0030206(chondroitin sulfate biosynthetic process);GO:0030207(chondroitin sulfate catabolic process);GO:0030208(dermatan sulfate biosynthetic process);GO:0030246(carbohydrate binding);GO:0031012(extracellular matrix);GO:0043202(lysosomal lumen);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process);GO:0062023(collagen-containing extracellular matrix)","04514(Cell adhesion molecules (CAMs))",{"v":1.1E-5,"d":"0.00"},1,"240,",0,{"v":-0.752,"d":"-0.75"},{"v":0.0467735141287198,"d":"0.05"},-2.65,"Exon (ENST00000343200/ENSG00000038427, exon 7 of 14)",5,83471674,83582303,110630,1]
[119355275,119355425,151,"ENSG00000036672","ENST00000260187","protein_coding",26265,"USP2","ubiquitin specific peptidase 2 [Source:HGNC Symbol;Acc:HGNC:12618]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0004197(cysteine-type endopeptidase activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0006508(proteolysis);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007049(cell cycle);GO:0007517(muscle organ development);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0016020(membrane);GO:0016579(protein deubiquitination);GO:0016787(hydrolase activity);GO:0030332(cyclin binding);GO:0031625(ubiquitin protein ligase binding);GO:0032922(circadian regulation of gene expression);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042802(identical protein binding);GO:0043153(entrainment of circadian clock by photoperiod);GO:0045475(locomotor rhythm);GO:0045931(positive regulation of mitotic cell cycle);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0048511(rhythmic process);GO:0048512(circadian behavior);GO:0050821(protein stabilization)","NA",{"v":9.5E-4,"d":"0.00"},1,"151,",0,{"v":-0.769,"d":"-0.77"},{"v":0.0436515832240166,"d":"0.04"},-1.15,"3' UTR",11,119355215,119381690,26476,2]
[12463259,12463617,359,"ENSG00000196826","ENST00000428311","protein_coding",87857,"AC008758","novel zinc finger protein","GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated)","NA",{"v":7.6e-08,"d":"0.00"},1,"359,",0,{"v":-0.752,"d":"-0.75"},{"v":0.0457088189614875,"d":"0.05"},-2.65,"3' UTR",19,12461559,12551474,89916,2]
[754077,754317,241,"ENSG00000060237","ENST00000315939","protein_coding",1498,"WNK1","WNK lysine deficient protein kinase 1 [Source:HGNC Symbol;Acc:HGNC:14540]","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0002028(regulation of sodium ion transport);GO:0003084(positive regulation of systemic arterial blood pressure);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004860(protein kinase inhibitor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0006469(negative regulation of protein kinase activity);GO:0006811(ion transport);GO:0010766(negative regulation of sodium ion transport);GO:0010820(positive regulation of T cell chemotaxis);GO:0010923(negative regulation of phosphatase activity);GO:0016020(membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0019869(chloride channel inhibitor activity);GO:0019870(potassium channel inhibitor activity);GO:0019901(protein kinase binding);GO:0019902(phosphatase binding);GO:0023016(signal transduction by trans-phosphorylation);GO:0030291(protein serine/threonine kinase inhibitor activity);GO:0030295(protein kinase activator activity);GO:0032147(activation of protein kinase activity);GO:0032414(positive regulation of ion transmembrane transporter activity);GO:0033633(negative regulation of cell-cell adhesion mediated by integrin);GO:0033673(negative regulation of kinase activity);GO:0034115(negative regulation of heterotypic cell-cell adhesion);GO:0034260(negative regulation of GTPase activity);GO:0035556(intracellular signal transduction);GO:0038116(chemokine (C-C motif) ligand 21 signaling pathway);GO:0046777(protein autophosphorylation);GO:0048666(neuron development);GO:0050794(regulation of cellular process);GO:0050801(ion homeostasis);GO:0050852(T cell receptor signaling pathway);GO:0071277(cellular response to calcium ion);GO:0071901(negative regulation of protein serine/threonine kinase activity);GO:0090188(negative regulation of pancreatic juice secretion);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:0097022(lymphocyte migration into lymph node);GO:1903038(negative regulation of leukocyte cell-cell adhesion);GO:1903288(positive regulation of potassium ion import across plasma membrane);GO:1990869(cellular response to chemokine);GO:2000651(positive regulation of sodium ion transmembrane transporter activity)","NA",{"v":1.3E-11,"d":"0.00"},1,"241,",0,-9.49,{"v":5.01187233627271e-12,"d":"0.00"},{"v":-1.3,"d":"-1.30"},"Exon (ENST00000315939/ENSG00000060237, exon 1 of 28)",12,752579,911452,158874,1]
[3043402,3043819,418,"ENSG00000250899","ENST00000513358","lincRNA",1965,"AC125807","novel transcript","NA","NA",{"v":7.9e-37,"d":"0.00"},1,"418,",0,-1.74,{"v":0.00218776162394955,"d":"0.00"},-1.08,"Exon (ENST00000513358/ENSG00000250899, exon 1 of 1)",12,3041437,3044950,3514,1]
[3200552,3201150,599,"ENSG00000011105","ENST00000537971","protein_coding",123197,"TSPAN9","tetraspanin 9 [Source:HGNC Symbol;Acc:HGNC:21640]","GO:0003674(molecular_function);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005925(focal adhesion);GO:0007166(cell surface receptor signaling pathway);GO:0008150(biological_process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0097197(tetraspanin-enriched microdomain)","NA",{"v":3.2e-14,"d":"0.00"},1,"599,",0,-1.08,{"v":0.0158489319246111,"d":"0.02"},-1.58,"5' UTR",12,3077355,3286564,209210,1]
[6450925,6451718,794,"ENSG00000139192","ENST00000539384","processed_transcript",0,"TAPBPL","TAP binding protein like [Source:HGNC Symbol;Acc:HGNC:30683]","GO:0000139(Golgi membrane);GO:0002376(immune system process);GO:0002502(peptide antigen assembly with MHC class I protein complex);GO:0002590(negative regulation of antigen processing and presentation of peptide antigen via MHC class I);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0023024(MHC class I protein complex binding);GO:0031090(organelle membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0044877(protein-containing complex binding)","NA",{"v":4.6e-07,"d":"0.00"},2,"90,451,","0,343",{"v":-1.3,"d":"-1.30"},{"v":0.00812830516164099,"d":"0.01"},-1.47,"3' UTR",12,6451690,6462322,10633,1]
[26964739,26964948,210,"ENSG00000111790","ENST00000229395","protein_coding",26269,"FGFR1OP2","FGFR1 oncogene partner 2 [Source:HGNC Symbol;Acc:HGNC:23098]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0009611(response to wounding);GO:0042060(wound healing);GO:0042803(protein homodimerization activity)","NA",{"v":1.5e-07,"d":"0.00"},1,"210,",0,{"v":-0.903,"d":"-0.90"},{"v":0.0281838293126445,"d":"0.03"},{"v":-1.5,"d":"-1.50"},"3' UTR",12,26938470,26966648,28179,1]
[27656631,27656780,150,"ENSG00000110841","ENST00000545381","non_stop_decay",132489,"PPFIBP1","PPFIA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:9249]","GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0007155(cell adhesion);GO:0045296(cadherin binding)","NA",{"v":0.0032,"d":"0.00"},1,"150,",0,{"v":-1.8,"d":"-1.80"},{"v":1.81970085860998E-3,"d":"0.00"},-1.38,"Exon (ENST00000545381/ENSG00000110841, exon 9 of 10)",12,27524142,27658848,134707,1]
[49351305,49352083,779,"ENSG00000178401","ENST00000552651","processed_transcript",0,"DNAJC22","DnaJ heat shock protein family (Hsp40) member C22 [Source:HGNC Symbol;Acc:HGNC:25802]","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":3.2e-22,"d":"0.00"},1,"779,",0,{"v":-1.3,"d":"-1.30"},{"v":0.00794328234724281,"d":"0.01"},-1.77,"3' UTR",12,49351557,49357546,5990,1]
[55927319,55930466,3148,"ENSG00000065357","ENST00000546878","protein_coding",0,"DGKA","diacylglycerol kinase alpha [Source:HGNC Symbol;Acc:HGNC:2849]","GO:0000166(nucleotide binding);GO:0003951(NAD+ kinase activity);GO:0004143(diacylglycerol kinase activity);GO:0005509(calcium ion binding);GO:0005524(ATP binding);GO:0005543(phospholipid binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006654(phosphatidic acid biosynthetic process);GO:0007165(signal transduction);GO:0007205(protein kinase C-activating G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0030168(platelet activation);GO:0035556(intracellular signal transduction);GO:0046339(diacylglycerol metabolic process);GO:0046486(glycerolipid metabolic process);GO:0046834(lipid phosphorylation);GO:0046872(metal ion binding)","00561(Glycerolipid metabolism);00564(Glycerophospholipid metabolism);04070(Phosphatidylinositol signaling system);04072(Phospholipase D signaling pathway);05231(Choline metabolism in cancer)",{"v":9.8e-10,"d":"0.00"},3,"301,80,39,","0,936,3109",{"v":-0.738,"d":"-0.74"},{"v":0.0489778819368446,"d":"0.05"},-1.06,"5' UTR",12,55927319,55937443,10125,1]
[56101590,56102128,539,"ENSG00000065361","ENST00000267101","protein_coding",21729,"ERBB3","erb-b2 receptor tyrosine kinase 3 [Source:HGNC Symbol;Acc:HGNC:3431]","GO:0000165(MAPK cascade);GO:0000166(nucleotide binding);GO:0003197(endocardial cushion development);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007162(negative regulation of cell adhesion);GO:0007165(signal transduction);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007399(nervous system development);GO:0007422(peripheral nervous system development);GO:0007507(heart development);GO:0008284(positive regulation of cell population proliferation);GO:0009925(basal plasma membrane);GO:0009968(negative regulation of signal transduction);GO:0010628(positive regulation of gene expression);GO:0014037(Schwann cell differentiation);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0016328(lateral plasma membrane);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019838(growth factor binding);GO:0021545(cranial nerve development);GO:0030296(protein tyrosine kinase activator activity);GO:0031625(ubiquitin protein ligase binding);GO:0038128(ERBB2 signaling pathway);GO:0038131(neuregulin receptor activity);GO:0038132(neuregulin binding);GO:0042060(wound healing);GO:0042127(regulation of cell population proliferation);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043235(receptor complex);GO:0043524(negative regulation of neuron apoptotic process);GO:0046982(protein heterodimerization activity);GO:0051048(negative regulation of secretion);GO:0051402(neuron apoptotic process);GO:0051897(positive regulation of protein kinase B signaling);GO:0055025(positive regulation of cardiac muscle tissue development);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0070886(positive regulation of calcineurin-NFAT signaling cascade);GO:0097192(extrinsic apoptotic signaling pathway in absence of ligand);GO:2000145(regulation of cell motility)","01521(EGFR tyrosine kinase inhibitor resistance);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04020(Calcium signaling pathway);04151(PI3K-Akt signaling pathway);05205(Proteoglycans in cancer);05206(MicroRNAs in cancer)",{"v":3.2e-52,"d":"0.00"},1,"539,",0,{"v":-11.1,"d":"-11.10"},{"v":7.94328234724282e-14,"d":"0.00"},-1.14,"3' UTR",12,56079861,56103505,23645,1]
[73062265,73062564,300,"ENSG00000102554","ENST00000477333","processed_transcript",7289,"KLF5","Kruppel like factor 5 [Source:HGNC Symbol;Acc:HGNC:6349]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001525(angiogenesis);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005794(Golgi apparatus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006366(transcription by RNA polymerase II);GO:0008134(transcription factor binding);GO:0008284(positive regulation of cell population proliferation);GO:0010468(regulation of gene expression);GO:0014816(skeletal muscle satellite cell differentiation);GO:0014901(satellite cell activation involved in skeletal muscle regeneration);GO:0014908(myotube differentiation involved in skeletal muscle regeneration);GO:0030033(microvillus assembly);GO:0032534(regulation of microvillus assembly);GO:0035914(skeletal muscle cell differentiation);GO:0043231(intracellular membrane-bounded organelle);GO:0043403(skeletal muscle tissue regeneration);GO:0043426(MRF binding);GO:0043565(sequence-specific DNA binding);GO:0045600(positive regulation of fat cell differentiation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0060576(intestinal epithelial cell development);GO:0061586(positive regulation of transcription by transcription factor localization);GO:0071407(cellular response to organic cyclic compound);GO:0099156(cell-cell signaling via exosome);GO:1901653(cellular response to peptide);GO:1902895(positive regulation of pri-miRNA transcription by RNA polymerase II);GO:1990830(cellular response to leukemia inhibitory factor)","NA",{"v":7.8e-10,"d":"0.00"},1,"300,",0,{"v":-0.769,"d":"-0.77"},{"v":0.0436515832240166,"d":"0.04"},-2.66,"Exon (ENST00000477333/ENSG00000102554, exon 2 of 2)",13,73054976,73062661,7686,1]
[112941844,112942262,419,"ENSG00000111331","ENST00000551007","protein_coding",3400,"OAS3","2'-5'-oligoadenylate synthetase 3 [Source:HGNC Symbol;Acc:HGNC:8088]","GO:0000166(nucleotide binding);GO:0001730(2'-5'-oligoadenylate synthetase activity);GO:0002376(immune system process);GO:0003723(RNA binding);GO:0003725(double-stranded RNA binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006139(nucleobase-containing compound metabolic process);GO:0006955(immune response);GO:0009615(response to virus);GO:0016740(transferase activity);GO:0016779(nucleotidyltransferase activity);GO:0043231(intracellular membrane-bounded organelle);GO:0045071(negative regulation of viral genome replication);GO:0045087(innate immune response);GO:0046872(metal ion binding);GO:0051607(defense response to virus);GO:0060333(interferon-gamma-mediated signaling pathway);GO:0060337(type I interferon signaling pathway);GO:0060700(regulation of ribonuclease activity)","04621(NOD-like receptor signaling pathway);05160(Hepatitis C);05162(Measles);05164(Influenza A);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection)",{"v":6.3e-35,"d":"0.00"},1,"419,",0,-3.91,{"v":6.30957344480193e-06,"d":"0.00"},-1.26,"3' UTR",12,112938444,112942303,3860,1]
[113296066,113296216,151,"ENSG00000186815","ENST00000335509","protein_coding",74628,"TPCN1","two pore segment channel 1 [Source:HGNC Symbol;Acc:HGNC:18182]","GO:0005216(ion channel activity);GO:0005227(calcium activated cation channel activity);GO:0005244(voltage-gated ion channel activity);GO:0005245(voltage-gated calcium channel activity);GO:0005262(calcium channel activity);GO:0005515(protein binding);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0005768(endosome);GO:0006811(ion transport);GO:0006816(calcium ion transport);GO:0010008(endosome membrane);GO:0010508(positive regulation of autophagy);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030317(flagellated sperm motility);GO:0034220(ion transmembrane transport);GO:0034765(regulation of ion transmembrane transport);GO:0036128(CatSper complex);GO:0042802(identical protein binding);GO:0051209(release of sequestered calcium ion into cytosol);GO:0055085(transmembrane transport);GO:0070588(calcium ion transmembrane transport);GO:0072345(NAADP-sensitive calcium-release channel activity)","04020(Calcium signaling pathway)",{"v":0.00026,"d":"0.00"},1,"151,",0,-1.59,{"v":0.00338844156139203,"d":"0.00"},-1.96,"3' UTR",12,113221438,113298585,77148,1]
[122147224,122147344,121,"ENSG00000175727","ENST00000319080","protein_coding",68468,"MLXIP","MLX interacting protein [Source:HGNC Symbol;Acc:HGNC:17055]","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0016020(membrane);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:1900402(regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter)","04931(Insulin resistance);04932(Non-alcoholic fatty liver disease (NAFLD))",{"v":1.1E-4,"d":"0.00"},1,"121,",0,{"v":-0.867,"d":"-0.87"},{"v":0.0316227766016838,"d":"0.03"},-1.29,"3' UTR",12,122078756,122147344,68589,1]
[123409233,123409353,121,"ENSG00000183955","ENST00000330479","protein_coding",25460,"KMT5A","lysine methyltransferase 5A [Source:HGNC Symbol;Acc:HGNC:29489]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0002039(p53 binding);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005829(cytosol);GO:0006325(chromatin organization);GO:0007049(cell cycle);GO:0008168(methyltransferase activity);GO:0016278(lysine N-methyltransferase activity);GO:0016279(protein-lysine N-methyltransferase activity);GO:0016740(transferase activity);GO:0018024(histone-lysine N-methyltransferase activity);GO:0018026(peptidyl-lysine monomethylation);GO:0032259(methylation);GO:0034770(histone H4-K20 methylation);GO:0034968(histone lysine methylation);GO:0042799(histone methyltransferase activity (H4-K20 specific));GO:0043516(regulation of DNA damage response, signal transduction by p53 class mediator);GO:0045892(negative regulation of transcription, DNA-templated);GO:0051301(cell division);GO:1901796(regulation of signal transduction by p53 class mediator)","00310(Lysine degradation)",{"v":3.5e-10,"d":"0.00"},1,"121,",0,-1.98,{"v":1.12201845430196E-3,"d":"0.00"},-1.79,"3' UTR",12,123383773,123409351,25579,1]
[123974133,123974521,389,"ENSG00000178882","ENST00000389727","protein_coding",892,"RFLNA","refilin A [Source:HGNC Symbol;Acc:HGNC:27051]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0031005(filamin binding);GO:0032432(actin filament bundle);GO:0048705(skeletal system morphogenesis);GO:0061181(regulation of chondrocyte development);GO:0061182(negative regulation of chondrocyte development);GO:0061572(actin filament bundle organization);GO:1900158(negative regulation of bone mineralization involved in bone maturation)","NA",{"v":2E-19,"d":"0.00"},1,"389,",0,-2,{"v":0.0010471285480509,"d":"0.00"},-1.88,"Exon (ENST00000540009/ENSG00000179195, exon 2 of 2)",12,123973241,124316022,342782,1]
[132080203,132080473,271,"ENSG00000257000","ENST00000542422","antisense",0,"AC137590","novel transcript","NA","NA",{"v":4.1E-5,"d":"0.00"},1,"271,",0,{"v":-0.763,"d":"-0.76"},{"v":0.0446683592150963,"d":"0.04"},{"v":-1.2,"d":"-1.20"},"3' UTR",12,132077803,132080460,2658,2]
[132105069,132108785,3717,"ENSG00000185684","ENST00000446190","processed_transcript",20786,"EP400P1","EP400 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:26602]","NA","NA",{"v":4e-62,"d":"0.00"},2,"236,214,","0,3503",-1.49,{"v":0.00446683592150963,"d":"0.00"},-1.21,"Exon (ENST00000446190/ENSG00000185684, exon 3 of 8)",12,132084283,132123580,39298,1]
[12162230,12162380,151,"ENSG00000070018","ENST00000261349","protein_coding",104664,"LRP6","LDL receptor related protein 6 [Source:HGNC Symbol;Acc:HGNC:6698]","GO:0001702(gastrulation with mouth forming second);GO:0001843(neural tube closure);GO:0001933(negative regulation of protein phosphorylation);GO:0003344(pericardium morphogenesis);GO:0005041(low-density lipoprotein particle receptor activity);GO:0005102(signaling receptor binding);GO:0005109(frizzled binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005769(early endosome);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0006355(regulation of transcription, DNA-templated);GO:0006469(negative regulation of protein kinase activity);GO:0006897(endocytosis);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0007268(chemical synaptic transmission);GO:0007275(multicellular organism development);GO:0009880(embryonic pattern specification);GO:0009952(anterior/posterior pattern specification);GO:0009986(cell surface);GO:0014029(neural crest formation);GO:0014033(neural crest cell differentiation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0017147(Wnt-protein binding);GO:0019210(kinase inhibitor activity);GO:0019534(toxin transmembrane transporter activity);GO:0021587(cerebellum morphogenesis);GO:0021794(thalamus development);GO:0021987(cerebral cortex development);GO:0030326(embryonic limb morphogenesis);GO:0030901(midbrain development);GO:0030917(midbrain-hindbrain boundary development);GO:0031410(cytoplasmic vesicle);GO:0031901(early endosome membrane);GO:0034185(apolipoprotein binding);GO:0034392(negative regulation of smooth muscle cell apoptotic process);GO:0035261(external genitalia morphogenesis);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0042813(Wnt-activated receptor activity);GO:0043025(neuronal cell body);GO:0043434(response to peptide hormone);GO:0044335(canonical Wnt signaling pathway involved in neural crest cell differentiation);GO:0044340(canonical Wnt signaling pathway involved in regulation of cell proliferation);GO:0045121(membrane raft);GO:0045202(synapse);GO:0045787(positive regulation of cell cycle);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046849(bone remodeling);GO:0048596(embryonic camera-type eye morphogenesis);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0060021(roof of mouth development);GO:0060026(convergent extension);GO:0060059(embryonic retina morphogenesis in camera-type eye);GO:0060070(canonical Wnt signaling pathway);GO:0060325(face morphogenesis);GO:0060349(bone morphogenesis);GO:0060444(branching involved in mammary gland duct morphogenesis);GO:0060535(trachea cartilage morphogenesis);GO:0071397(cellular response to cholesterol);GO:0071542(dopaminergic neuron differentiation);GO:0071901(negative regulation of protein serine/threonine kinase activity);GO:0071936(coreceptor activity involved in Wnt signaling pathway);GO:0072659(protein localization to plasma membrane);GO:0090009(primitive streak formation);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0090118(receptor-mediated endocytosis involved in cholesterol transport);GO:0090244(Wnt signaling pathway involved in somitogenesis);GO:0090245(axis elongation involved in somitogenesis);GO:0098609(cell-cell adhesion);GO:1901998(toxin transport);GO:1904886(beta-catenin destruction complex disassembly);GO:1904928(coreceptor activity involved in canonical Wnt signaling pathway);GO:1904948(midbrain dopaminergic neuron differentiation);GO:1904953(Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation);GO:1990851(Wnt-Frizzled-LRP5/6 complex);GO:1990909(Wnt signalosome)","04150(mTOR signaling pathway);04310(Wnt signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);05200(Pathways in cancer);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer)",{"v":0.00093,"d":"0.00"},1,"151,",0,-1.99,{"v":0.00109647819614319,"d":"0.00"},-1.02,"Exon (ENST00000261349/ENSG00000070018, exon 10 of 23)",12,12116025,12267044,151020,2]
[12181043,12181373,331,"ENSG00000070018","ENST00000261349","protein_coding",85671,"LRP6","LDL receptor related protein 6 [Source:HGNC Symbol;Acc:HGNC:6698]","GO:0001702(gastrulation with mouth forming second);GO:0001843(neural tube closure);GO:0001933(negative regulation of protein phosphorylation);GO:0003344(pericardium morphogenesis);GO:0005041(low-density lipoprotein particle receptor activity);GO:0005102(signaling receptor binding);GO:0005109(frizzled binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005769(early endosome);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0006355(regulation of transcription, DNA-templated);GO:0006469(negative regulation of protein kinase activity);GO:0006897(endocytosis);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0007268(chemical synaptic transmission);GO:0007275(multicellular organism development);GO:0009880(embryonic pattern specification);GO:0009952(anterior/posterior pattern specification);GO:0009986(cell surface);GO:0014029(neural crest formation);GO:0014033(neural crest cell differentiation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0017147(Wnt-protein binding);GO:0019210(kinase inhibitor activity);GO:0019534(toxin transmembrane transporter activity);GO:0021587(cerebellum morphogenesis);GO:0021794(thalamus development);GO:0021987(cerebral cortex development);GO:0030326(embryonic limb morphogenesis);GO:0030901(midbrain development);GO:0030917(midbrain-hindbrain boundary development);GO:0031410(cytoplasmic vesicle);GO:0031901(early endosome membrane);GO:0034185(apolipoprotein binding);GO:0034392(negative regulation of smooth muscle cell apoptotic process);GO:0035261(external genitalia morphogenesis);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0042813(Wnt-activated receptor activity);GO:0043025(neuronal cell body);GO:0043434(response to peptide hormone);GO:0044335(canonical Wnt signaling pathway involved in neural crest cell differentiation);GO:0044340(canonical Wnt signaling pathway involved in regulation of cell proliferation);GO:0045121(membrane raft);GO:0045202(synapse);GO:0045787(positive regulation of cell cycle);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046849(bone remodeling);GO:0048596(embryonic camera-type eye morphogenesis);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0060021(roof of mouth development);GO:0060026(convergent extension);GO:0060059(embryonic retina morphogenesis in camera-type eye);GO:0060070(canonical Wnt signaling pathway);GO:0060325(face morphogenesis);GO:0060349(bone morphogenesis);GO:0060444(branching involved in mammary gland duct morphogenesis);GO:0060535(trachea cartilage morphogenesis);GO:0071397(cellular response to cholesterol);GO:0071542(dopaminergic neuron differentiation);GO:0071901(negative regulation of protein serine/threonine kinase activity);GO:0071936(coreceptor activity involved in Wnt signaling pathway);GO:0072659(protein localization to plasma membrane);GO:0090009(primitive streak formation);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0090118(receptor-mediated endocytosis involved in cholesterol transport);GO:0090244(Wnt signaling pathway involved in somitogenesis);GO:0090245(axis elongation involved in somitogenesis);GO:0098609(cell-cell adhesion);GO:1901998(toxin transport);GO:1904886(beta-catenin destruction complex disassembly);GO:1904928(coreceptor activity involved in canonical Wnt signaling pathway);GO:1904948(midbrain dopaminergic neuron differentiation);GO:1904953(Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation);GO:1990851(Wnt-Frizzled-LRP5/6 complex);GO:1990909(Wnt signalosome)","04150(mTOR signaling pathway);04310(Wnt signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);05200(Pathways in cancer);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer)",{"v":1e-38,"d":"0.00"},1,"331,",0,-9.58,{"v":3.98107170553497e-12,"d":"0.00"},-1.51,"Exon (ENST00000261349/ENSG00000070018, exon 6 of 23)",12,12116025,12267044,151020,2]
[63045211,63045331,121,"ENSG00000140416","ENST00000288398","protein_coding",2579,"TPM1","tropomyosin 1 [Source:HGNC Symbol;Acc:HGNC:12010]","GO:0001701(in utero embryonic development);GO:0001725(stress fiber);GO:0003065(positive regulation of heart rate by epinephrine);GO:0003779(actin binding);GO:0005200(structural constituent of cytoskeleton);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005862(muscle thin filament tropomyosin);GO:0005884(actin filament);GO:0006936(muscle contraction);GO:0006937(regulation of muscle contraction);GO:0007010(cytoskeleton organization);GO:0007015(actin filament organization);GO:0008016(regulation of heart contraction);GO:0008092(cytoskeletal protein binding);GO:0008307(structural constituent of muscle);GO:0008360(regulation of cell shape);GO:0015629(actin cytoskeleton);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030016(myofibril);GO:0030017(sarcomere);GO:0030049(muscle filament sliding);GO:0030336(negative regulation of cell migration);GO:0031529(ruffle organization);GO:0032059(bleb);GO:0032587(ruffle membrane);GO:0032781(positive regulation of ATPase activity);GO:0034614(cellular response to reactive oxygen species);GO:0042060(wound healing);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0045214(sarcomere organization);GO:0045785(positive regulation of cell adhesion);GO:0046982(protein heterodimerization activity);GO:0051015(actin filament binding);GO:0051496(positive regulation of stress fiber assembly);GO:0055010(ventricular cardiac muscle tissue morphogenesis);GO:0060048(cardiac muscle contraction);GO:1904706(negative regulation of vascular smooth muscle cell proliferation);GO:1904753(negative regulation of vascular associated smooth muscle cell migration)","04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);05206(MicroRNAs in cancer);05410(Hypertrophic cardiomyopathy (HCM));05414(Dilated cardiomyopathy (DCM))",{"v":0.0005,"d":"0.00"},1,"121,",0,{"v":-1.2,"d":"-1.20"},{"v":0.0107151930523761,"d":"0.01"},-2.66,"3' UTR",15,63042632,63066093,23462,1]
[31060682,31073373,12692,"ENSG00000245614","ENST00000535870","antisense",0,"DDX11-AS1","DDX11 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:44176]","NA","NA",{"v":1.9E-6,"d":"0.00"},2,"89,179,","0,12513",{"v":-0.987,"d":"-0.99"},{"v":0.0213796208950223,"d":"0.02"},-1.85,"Exon (ENST00000500527/ENSG00000245614, exon 1 of 3)",12,31050916,31060750,9835,2]
[67165159,67165458,300,"ENSG00000102878","ENST00000522870","retained_intron",478,"HSF4","heat shock transcription factor 4 [Source:HGNC Symbol;Acc:HGNC:5227]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001654(eye development);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0007601(visual perception);GO:0008284(positive regulation of cell population proliferation);GO:0016607(nuclear speck);GO:0033169(histone H3-K9 demethylation);GO:0034605(cellular response to heat);GO:0043010(camera-type eye development);GO:0043565(sequence-specific DNA binding);GO:0045597(positive regulation of cell differentiation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048468(cell development);GO:0051260(protein homooligomerization);GO:0061408(positive regulation of transcription from RNA polymerase II promoter in response to heat stress);GO:0070207(protein homotrimerization)","NA",{"v":1.2e-06,"d":"0.00"},1,"300,",0,{"v":-0.737,"d":"-0.74"},{"v":0.0489778819368446,"d":"0.05"},-2.66,"3' UTR",16,67164681,67168883,4203,1]
[56332972,56333516,545,"ENSG00000135473","ENST00000610546","protein_coding",537,"PAN2","poly(A) specific ribonuclease subunit PAN2 [Source:HGNC Symbol;Acc:HGNC:20074]","GO:0000175(3'-5'-exoribonuclease activity);GO:0000288(nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay);GO:0000289(nuclear-transcribed mRNA poly(A) tail shortening);GO:0000932(P-body);GO:0003676(nucleic acid binding);GO:0004518(nuclease activity);GO:0004527(exonuclease activity);GO:0004535(poly(A)-specific ribonuclease activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006397(mRNA processing);GO:0010606(positive regulation of cytoplasmic mRNA processing body assembly);GO:0016787(hydrolase activity);GO:0031251(PAN complex);GO:0046872(metal ion binding);GO:0090305(nucleic acid phosphodiester bond hydrolysis);GO:0090503(RNA phosphodiester bond hydrolysis, exonucleolytic)","03018(RNA degradation)",{"v":1.5e-07,"d":"0.00"},2,"237,34,","0,511",{"v":-0.983,"d":"-0.98"},{"v":0.0213796208950223,"d":"0.02"},-1.21,"5' UTR",12,56316223,56334053,17831,2]
[56412745,56413160,416,"ENSG00000276272","ENST00000610448","lincRNA",30,"AC024884","novel transcript","NA","NA",{"v":6.8e-06,"d":"0.00"},1,"416,",0,{"v":-0.918,"d":"-0.92"},{"v":0.0269153480392692,"d":"0.03"},-1.91,"Exon (ENST00000610448/ENSG00000276272, exon 1 of 1)",12,56411944,56413190,1247,2]
[79797269,79798517,1249,"ENSG00000058272","ENST00000551781","retained_intron",0,"PPP1R12A","protein phosphatase 1 regulatory subunit 12A [Source:HGNC Symbol;Acc:HGNC:7618]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0000278(mitotic cell cycle);GO:0000776(kinetochore);GO:0004857(enzyme inhibitor activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005925(focal adhesion);GO:0006470(protein dephosphorylation);GO:0007098(centrosome cycle);GO:0007165(signal transduction);GO:0015629(actin cytoskeleton);GO:0019208(phosphatase regulator activity);GO:0019901(protein kinase binding);GO:0030018(Z disc);GO:0030155(regulation of cell adhesion);GO:0031672(A band);GO:0035507(regulation of myosin-light-chain-phosphatase activity);GO:0035508(positive regulation of myosin-light-chain-phosphatase activity);GO:0035690(cellular response to drug);GO:0043086(negative regulation of catalytic activity);GO:0043292(contractile fiber);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046822(regulation of nucleocytoplasmic transport);GO:0050790(regulation of catalytic activity);GO:0071889(14-3-3 protein binding);GO:0072357(PTW/PP1 phosphatase complex)","04022(cGMP-PKG signaling pathway);04024(cAMP signaling pathway);04270(Vascular smooth muscle contraction);04510(Focal adhesion);04611(Platelet activation);04810(Regulation of actin cytoskeleton);04921(Oxytocin signaling pathway);05205(Proteoglycans in cancer)",{"v":4e-11,"d":"0.00"},2,"127,24,","0,1225",-1.84,{"v":1.62181009735893E-3,"d":"0.00"},-1.02,"Exon (ENST00000261207/ENSG00000058272, exon 16 of 26)",12,79793797,79798498,4702,2]
[79952723,79952932,210,"ENSG00000167291","ENST00000310924","protein_coding",82940,"TBC1D16","TBC1 domain family member 16 [Source:HGNC Symbol;Acc:HGNC:28356]","GO:0001919(regulation of receptor recycling);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005769(early endosome);GO:0005829(cytosol);GO:0006886(intracellular protein transport);GO:0017137(Rab GTPase binding);GO:0090630(activation of GTPase activity)","NA",{"v":6.6e-08,"d":"0.00"},1,"210,",0,-4.58,{"v":1.12201845430196e-06,"d":"0.00"},-2.68,"5' UTR",17,79932343,80035872,103530,2]
[100157241,100157421,181,"ENSG00000238105","ENST00000304813","retained_intron",3857,"GOLGA2P5","GOLGA2 pseudogene 5 [Source:HGNC Symbol;Acc:HGNC:25315]","NA","NA",{"v":0.00023,"d":"0.00"},1,"181,",0,-1.35,{"v":0.00691830970918936,"d":"0.01"},-1.62,"Exon (ENST00000304813/ENSG00000238105, exon 6 of 7)",12,100156357,100161278,4922,2]
[113334472,113334802,331,"ENSG00000089060","ENST00000552613","nonsense_mediated_decay",0,"SLC8B1","solute carrier family 8 member B1 [Source:HGNC Symbol;Acc:HGNC:26175]","GO:0005432(calcium:sodium antiporter activity);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006814(sodium ion transport);GO:0006816(calcium ion transport);GO:0006851(mitochondrial calcium ion transmembrane transport);GO:0015297(antiporter activity);GO:0015368(calcium:cation antiporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030061(mitochondrial crista);GO:0032592(integral component of mitochondrial membrane);GO:0035725(sodium ion transmembrane transport);GO:0042383(sarcolemma);GO:0042593(glucose homeostasis);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0050796(regulation of insulin secretion);GO:0050896(response to stimulus);GO:0051480(regulation of cytosolic calcium ion concentration);GO:0051560(mitochondrial calcium ion homeostasis);GO:0055085(transmembrane transport);GO:0070588(calcium ion transmembrane transport);GO:0086036(regulation of cardiac muscle cell membrane potential);GO:0086038(calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential);GO:0099093(calcium export from the mitochondrion);GO:1901623(regulation of lymphocyte chemotaxis);GO:2001256(regulation of store-operated calcium entry)","NA",{"v":1.3E-28,"d":"0.00"},1,"331,",0,-2.97,{"v":7.76247116628691e-05,"d":"0.00"},-1.17,"5' UTR",12,113320850,113334613,13764,2]
[120490387,120490595,209,"ENSG00000088986","ENST00000392509","protein_coding",20537,"DYNLL1","dynein light chain LC8-type 1 [Source:HGNC Symbol;Acc:HGNC:15476]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0000776(kinetochore);GO:0003774(motor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005868(cytoplasmic dynein complex);GO:0005874(microtubule);GO:0005875(microtubule associated complex);GO:0005886(plasma membrane);GO:0005929(cilium);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0006915(apoptotic process);GO:0007017(microtubule-based process);GO:0008180(COP9 signalosome);GO:0008574(ATP-dependent microtubule motor activity, plus-end-directed);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0016020(membrane);GO:0016032(viral process);GO:0016236(macroautophagy);GO:0019886(antigen processing and presentation of exogenous peptide antigen via MHC class II);GO:0021762(substantia nigra development);GO:0030286(dynein complex);GO:0035735(intraciliary transport involved in cilium assembly);GO:0042326(negative regulation of phosphorylation);GO:0043312(neutrophil degranulation);GO:0045505(dynein intermediate chain binding);GO:0050790(regulation of catalytic activity);GO:0051959(dynein light intermediate chain binding);GO:0070821(tertiary granule membrane);GO:0072686(mitotic spindle);GO:0097542(ciliary tip);GO:0097711(ciliary basal body-plasma membrane docking);GO:0101003(ficolin-1-rich granule membrane);GO:2000582(positive regulation of ATP-dependent microtubule motor activity, plus-end-directed)","04962(Vasopressin-regulated water reabsorption)",{"v":6.6e-08,"d":"0.00"},1,"209,",0,-0.92,{"v":0.0263026799189538,"d":"0.03"},-1.06,"Exon (ENST00000500741/ENSG00000248008, exon 2 of 2)",12,120469850,120498493,28644,1]
[122272751,122273021,271,"ENSG00000130779","ENST00000361654","protein_coding",149567,"CLIP1","CAP-Gly domain containing linker protein 1 [Source:HGNC Symbol;Acc:HGNC:10461]","GO:0000278(mitotic cell cycle);GO:0000776(kinetochore);GO:0001578(microtubule bundle formation);GO:0001726(ruffle);GO:0005515(protein binding);GO:0005635(nuclear envelope);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005881(cytoplasmic microtubule);GO:0005882(intermediate filament);GO:0008017(microtubule binding);GO:0008270(zinc ion binding);GO:0015630(microtubule cytoskeleton);GO:0015631(tubulin binding);GO:0016020(membrane);GO:0030659(cytoplasmic vesicle membrane);GO:0031116(positive regulation of microtubule polymerization);GO:0031410(cytoplasmic vesicle);GO:0035371(microtubule plus-end);GO:0042803(protein homodimerization activity);GO:0042995(cell projection);GO:0044354(macropinosome);GO:0044861(protein transport into plasma membrane raft);GO:0046872(metal ion binding);GO:0051010(microtubule plus-end binding)","04150(mTOR signaling pathway)",{"v":1.3E-20,"d":"0.00"},1,"271,",0,-3.11,{"v":5.24807460249772e-05,"d":"0.00"},-1,"3' UTR",12,122271432,122422588,151157,2]
[132137073,132137223,151,"ENSG00000185163","ENST00000397333","protein_coding",7096,"DDX51","DEAD-box helicase 51 [Source:HGNC Symbol;Acc:HGNC:20082]","GO:0000166(nucleotide binding);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0016020(membrane);GO:0016787(hydrolase activity);GO:0042254(ribosome biogenesis)","NA",{"v":0.00059,"d":"0.00"},1,"151,",0,-1.12,{"v":0.0138038426460289,"d":"0.01"},-1.32,"3' UTR",12,132136594,132144319,7726,2]
[132808137,132808527,391,"ENSG00000090615","ENST00000450791","protein_coding",20337,"GOLGA3","golgin A3 [Source:HGNC Symbol;Acc:HGNC:4426]","GO:0000139(Golgi membrane);GO:0005215(transporter activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006891(intra-Golgi vesicle-mediated transport);GO:0007283(spermatogenesis);GO:0016020(membrane);GO:0017119(Golgi transport complex);GO:0032580(Golgi cisterna membrane);GO:0045296(cadherin binding);GO:0090498(extrinsic component of Golgi membrane)","NA",{"v":3.2e-42,"d":"0.00"},1,"391,",0,{"v":-15.2,"d":"-15.20"},{"v":3.98107170553499e-18,"d":"0.00"},-1.26,"Exon (ENST00000450791/ENSG00000090615, exon 5 of 24)",12,132768914,132828864,59951,2]
[21147923,21148101,179,"ENSG00000150459","ENST00000382533","protein_coding",7409,"SAP18","Sin3A associated protein 18 [Source:HGNC Symbol;Acc:HGNC:10530]","GO:0000118(histone deacetylase complex);GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0003714(transcription corepressor activity);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006397(mRNA processing);GO:0008380(RNA splicing);GO:0016604(nuclear body);GO:0016607(nuclear speck);GO:0035145(exon-exon junction complex);GO:0043065(positive regulation of apoptotic process);GO:0048025(negative regulation of mRNA splicing, via spliceosome);GO:0061574(ASAP complex);GO:1903507(negative regulation of nucleic acid-templated transcription)","03013(RNA transport);03015(mRNA surveillance pathway)",{"v":2.5e-05,"d":"0.00"},1,"179,",0,-1.15,{"v":0.0128824955169313,"d":"0.01"},{"v":-1.2,"d":"-1.20"},"3' UTR",13,21140514,21149082,8569,1]
[27650259,27651458,1200,"ENSG00000186184","ENST00000637180","protein_coding",29340,"POLR1D","RNA polymerase I and III subunit D [Source:HGNC Symbol;Acc:HGNC:20422]","GO:0003677(DNA binding);GO:0003899(DNA-directed 5'-3' RNA polymerase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005736(RNA polymerase I complex);GO:0005829(cytosol);GO:0006351(transcription, DNA-templated);GO:0006361(transcription initiation from RNA polymerase I promoter);GO:0006362(transcription elongation from RNA polymerase I promoter);GO:0006363(termination of RNA polymerase I transcription);GO:0032481(positive regulation of type I interferon production);GO:0045815(positive regulation of gene expression, epigenetic);GO:0046983(protein dimerization activity)","03020(RNA polymerase);04623(Cytosolic DNA-sensing pathway)",{"v":2.5e-38,"d":"0.00"},1,"1200,",0,-2.79,{"v":1.23026877081238E-4,"d":"0.00"},-1.13,"3' UTR",13,27620919,27667353,46435,1]
[44328136,44328553,418,"ENSG00000062370","ENST00000354340","protein_coding",28121,"ZNF112","zinc finger protein 112 [Source:HGNC Symbol;Acc:HGNC:12892]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":6.2e-06,"d":"0.00"},1,"418,",0,{"v":-0.861,"d":"-0.86"},{"v":0.0323593656929628,"d":"0.03"},-2.73,"Exon (ENST00000354340/ENSG00000062370, exon 4 of 4)",19,44326555,44356674,30120,2]
[122959288,122959558,271,"ENSG00000109944","ENST00000227349","protein_coding",76760,"JHY","junctional cadherin complex regulator [Source:HGNC Symbol;Acc:HGNC:26288]","GO:0007420(brain development);GO:0030030(cell projection organization);GO:0032053(ciliary basal body organization);GO:0033326(cerebrospinal fluid secretion);GO:0035082(axoneme assembly)","NA",{"v":1E-3,"d":"0.00"},1,"271,",0,{"v":-0.758,"d":"-0.76"},{"v":0.0457088189614875,"d":"0.05"},-2.74,"3' UTR",11,122882528,122959721,77194,1]
[133224794,133225153,360,"ENSG00000171798","ENST00000304613","protein_coding",64575,"KNDC1","kinase non-catalytic C-lobe domain containing 1 [Source:HGNC Symbol;Acc:HGNC:29374]","GO:0001934(positive regulation of protein phosphorylation);GO:0003674(molecular_function);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005088(Ras guanyl-nucleotide exchange factor activity);GO:0005575(cellular_component);GO:0007264(small GTPase mediated signal transduction);GO:0008150(biological_process);GO:0021707(cerebellar granule cell differentiation);GO:0030425(dendrite);GO:0032045(guanyl-nucleotide exchange factor complex);GO:0042995(cell projection);GO:0043025(neuronal cell body);GO:0043204(perikaryon);GO:0048814(regulation of dendrite morphogenesis);GO:0050773(regulation of dendrite development)","NA",{"v":2.5e-12,"d":"0.00"},1,"360,",0,-2.46,{"v":0.000295120922666638,"d":"0.00"},-2.75,"3' UTR",10,133160219,133226412,66194,1]
[91693332,91693661,330,"ENSG00000179399","ENST00000377067","protein_coding",294711,"GPC5","glypican 5 [Source:HGNC Symbol;Acc:HGNC:4453]","GO:0001523(retinoid metabolic process);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005796(Golgi lumen);GO:0005886(plasma membrane);GO:0006024(glycosaminoglycan biosynthetic process);GO:0006027(glycosaminoglycan catabolic process);GO:0009966(regulation of signal transduction);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031225(anchored component of membrane);GO:0043202(lysosomal lumen);GO:0046658(anchored component of plasma membrane);GO:0062023(collagen-containing extracellular matrix)","NA",{"v":2.5e-24,"d":"0.00"},1,"330,",0,-1.96,{"v":0.00117489755493953,"d":"0.00"},-1.31,"Exon (ENST00000377067/ENSG00000179399, exon 3 of 8)",13,91398621,92867237,1468617,1]
[113865473,113866419,947,"ENSG00000272695","ENST00000608651","lincRNA",1305,"GAS6-DT","GAS6 divergent transcript [Source:HGNC Symbol;Acc:HGNC:43694]","NA","NA",{"v":3.4e-10,"d":"0.00"},1,"947,",0,{"v":-0.872,"d":"-0.87"},{"v":0.0309029543251359,"d":"0.03"},-1.78,"Exon (ENST00000608651/ENSG00000272695, exon 2 of 2)",13,113864168,113866833,2666,1]
[23751506,23751745,240,"ENSG00000119778","ENST00000238789","protein_coding",175378,"ATAD2B","ATPase family, AAA domain containing 2B [Source:HGNC Symbol;Acc:HGNC:29230]","GO:0000166(nucleotide binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016887(ATPase activity);GO:0031936(negative regulation of chromatin silencing);GO:0042393(histone binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0070577(lysine-acetylated histone binding)","NA",{"v":1.7E-5,"d":"0.00"},1,"240,",0,{"v":-0.819,"d":"-0.82"},{"v":0.0371535229097173,"d":"0.04"},-2.76,"3' UTR",2,23748664,23927123,178460,2]
[53365197,53365347,151,"ENSG00000184178","ENST00000401642","protein_coding",714,"SCFD2","sec1 family domain containing 2 [Source:HGNC Symbol;Acc:HGNC:30676]","GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0006904(vesicle docking involved in exocytosis);GO:0008150(biological_process);GO:0015031(protein transport);GO:0016192(vesicle-mediated transport)","NA",{"v":1e-06,"d":"0.00"},1,"151,",0,-7.53,{"v":6.76082975391982e-10,"d":"0.00"},-2.77,"5' UTR",4,52872982,53366061,493080,2]
[6675339,6675614,276,"ENSG00000232946","ENST00000427308","processed_pseudogene",55,"AL354707","60S ribosomal protein L35a (RPL35A) pseudogene","NA","NA",{"v":1.4e-09,"d":"0.00"},1,"276,",0,{"v":-0.843,"d":"-0.84"},{"v":0.0338844156139203,"d":"0.03"},-2.77,"Exon (ENST00000427308/ENSG00000232946, exon 1 of 1)",9,6675284,6675614,331,1]
[67165170,67165499,330,"ENSG00000102878","ENST00000522870","retained_intron",489,"HSF4","heat shock transcription factor 4 [Source:HGNC Symbol;Acc:HGNC:5227]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001654(eye development);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0007601(visual perception);GO:0008284(positive regulation of cell population proliferation);GO:0016607(nuclear speck);GO:0033169(histone H3-K9 demethylation);GO:0034605(cellular response to heat);GO:0043010(camera-type eye development);GO:0043565(sequence-specific DNA binding);GO:0045597(positive regulation of cell differentiation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048468(cell development);GO:0051260(protein homooligomerization);GO:0061408(positive regulation of transcription from RNA polymerase II promoter in response to heat stress);GO:0070207(protein homotrimerization)","NA",{"v":3.1E-6,"d":"0.00"},1,"330,",0,{"v":-0.819,"d":"-0.82"},{"v":0.0371535229097173,"d":"0.04"},-2.77,"3' UTR",16,67164681,67168883,4203,1]
[64471930,64472468,539,"ENSG00000089775","ENST00000555220","protein_coding",32745,"ZBTB25","zinc finger and BTB domain containing 25 [Source:HGNC Symbol;Acc:HGNC:13112]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0010467(gene expression);GO:0046872(metal ion binding)","NA",{"v":2e-22,"d":"0.00"},1,"539,",0,{"v":-0.924,"d":"-0.92"},{"v":0.0263026799189538,"d":"0.03"},-1.78,"3' UTR",14,64449106,64505213,56108,2]
[67181474,67181773,300,"ENSG00000171723","ENST00000315266","protein_coding",674067,"GPHN","gephyrin [Source:HGNC Symbol;Acc:HGNC:15465]","GO:0000166(nucleotide binding);GO:0003824(catalytic activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0006777(Mo-molybdopterin cofactor biosynthetic process);GO:0007529(establishment of synaptic specificity at neuromuscular junction);GO:0008152(metabolic process);GO:0008940(nitrate reductase activity);GO:0010038(response to metal ion);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0016740(transferase activity);GO:0018315(molybdenum incorporation into molybdenum-molybdopterin complex);GO:0030054(cell junction);GO:0030425(dendrite);GO:0032324(molybdopterin cofactor biosynthetic process);GO:0042995(cell projection);GO:0043546(molybdopterin cofactor binding);GO:0045202(synapse);GO:0045211(postsynaptic membrane);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process);GO:0061598(molybdopterin adenylyltransferase activity);GO:0061599(molybdopterin molybdotransferase activity);GO:0072579(glycine receptor clustering);GO:0097112(gamma-aminobutyric acid receptor clustering);GO:0098970(postsynaptic neurotransmitter receptor diffusion trapping);GO:0099572(postsynaptic specialization);GO:0099634(postsynaptic specialization membrane)","00790(Folate biosynthesis);04727(GABAergic synapse)",{"v":6.3e-25,"d":"0.00"},1,"300,",0,-3.05,{"v":6.16595001861482e-05,"d":"0.00"},-1.27,"3' UTR",14,66507407,67181798,674392,1]
[73099671,73099910,240,"ENSG00000119707","ENST00000527432","protein_coding",41139,"RBM25","RNA binding motif protein 25 [Source:HGNC Symbol;Acc:HGNC:23244]","GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006397(mRNA processing);GO:0008380(RNA splicing);GO:0016607(nuclear speck);GO:0042981(regulation of apoptotic process)","03040(Spliceosome)",{"v":2e-30,"d":"0.00"},1,"240,",0,-7.23,{"v":1.41253754462276E-9,"d":"0.00"},-1.09,"3' UTR",14,73058532,73120391,61860,1]
[128538282,128538631,350,"ENSG00000239405","ENST00000474255","processed_pseudogene",262,"TMED10P2","transmembrane p24 trafficking protein 10 pseudogene 2 [Source:HGNC Symbol;Acc:HGNC:38105]","NA","NA",{"v":4e-28,"d":"0.00"},1,"350,",0,-1.01,{"v":0.0199526231496888,"d":"0.02"},-2.78,"Exon (ENST00000474255/ENSG00000239405, exon 1 of 1)",3,128538020,128538631,612,1]
[90185615,90185853,239,"ENSG00000152315","ENST00000282146","protein_coding",123621,"KCNK13","potassium two pore domain channel subfamily K member 13 [Source:HGNC Symbol;Acc:HGNC:6275]","GO:0005244(voltage-gated ion channel activity);GO:0005267(potassium channel activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022841(potassium ion leak channel activity);GO:0030322(stabilization of membrane potential);GO:0034765(regulation of ion transmembrane transport);GO:0071805(potassium ion transmembrane transport)","NA",{"v":3.7e-10,"d":"0.00"},1,"239,",0,-1.07,{"v":0.0165958690743756,"d":"0.02"},-1.22,"3' UTR",14,90061994,90185853,123860,1]
[100376687,100381640,4954,"ENSG00000140105","ENST00000355338","protein_coding",0,"WARS","tryptophanyl-tRNA synthetase [Source:HGNC Symbol;Acc:HGNC:12729]","GO:0000166(nucleotide binding);GO:0001525(angiogenesis);GO:0001933(negative regulation of protein phosphorylation);GO:0004812(aminoacyl-tRNA ligase activity);GO:0004830(tryptophan-tRNA ligase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006412(translation);GO:0006418(tRNA aminoacylation for protein translation);GO:0006436(tryptophanyl-tRNA aminoacylation);GO:0006469(negative regulation of protein kinase activity);GO:0008285(negative regulation of cell population proliferation);GO:0010628(positive regulation of gene expression);GO:0010835(regulation of protein ADP-ribosylation);GO:0016874(ligase activity);GO:0019210(kinase inhibitor activity);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0031334(positive regulation of protein complex assembly);GO:0032991(protein-containing complex);GO:0042803(protein homodimerization activity);GO:0045765(regulation of angiogenesis);GO:0070062(extracellular exosome)","00970(Aminoacyl-tRNA biosynthesis)",{"v":1.3e-46,"d":"0.00"},2,"18,731,","0,4223",-3.44,{"v":2.18776162394955e-05,"d":"0.00"},-1.19,"5' UTR",14,100333818,100376805,42988,2]
[102933574,102933869,296,"ENSG00000259515","ENST00000560931","antisense",0,"AL117209","novel transcript, antisense to CDC42BPB","NA","NA",{"v":1E-26,"d":"0.00"},1,"296,",0,-9.61,{"v":3.98107170553497e-12,"d":"0.00"},{"v":-1.1,"d":"-1.10"},"3' UTR",14,102933574,102937177,3604,1]
[104986491,104989326,2836,"ENSG00000140104","ENST00000549584","processed_transcript",0,"CLBA1","clathrin binding box of aftiphilin containing 1 [Source:HGNC Symbol;Acc:HGNC:20126]","GO:0005737(cytoplasm);GO:0008565(protein transporter activity);GO:0015031(protein transport);GO:0030121(AP-1 adaptor complex);GO:0030276(clathrin binding);GO:0032588(trans-Golgi network membrane);GO:0046907(intracellular transport)","NA",{"v":1E-14,"d":"0.00"},2,"364,384,","0,2452",-3.61,{"v":1.38038426460288E-5,"d":"0.00"},-1.14,"5' UTR",14,104986696,104999527,12832,1]
[19299802,19301389,1588,"ENSG00000244306","ENST00000648085","processed_transcript",36280,"AL589743","double homeobox A pseudogene 10","NA","NA",{"v":1.6e-19,"d":"0.00"},1,"1588,",0,{"v":-0.803,"d":"-0.80"},{"v":0.0389045144994281,"d":"0.04"},{"v":-1.1,"d":"-1.10"},"Exon (ENST00000624585/ENSG00000244306, exon 8 of 8)",14,19268853,19337669,68817,2]
[41383873,41384083,211,"ENSG00000142046","ENST00000539627","protein_coding",32962,"TMEM91","transmembrane protein 91 [Source:HGNC Symbol;Acc:HGNC:32393]","GO:0002244(hematopoietic progenitor cell differentiation);GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0008150(biological_process);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":3.5e-08,"d":"0.00"},1,"211,",0,{"v":-0.797,"d":"-0.80"},{"v":0.0398107170553497,"d":"0.04"},-2.79,"3' UTR",19,41350911,41384083,33173,1]
[23049164,23049635,472,"ENSG00000139880","ENST00000397359","protein_coding",7903,"CDH24","cadherin 24 [Source:HGNC Symbol;Acc:HGNC:14265]","GO:0000902(cell morphogenesis);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005913(cell-cell adherens junction);GO:0007043(cell-cell junction assembly);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0008092(cytoskeletal protein binding);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016339(calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0016342(catenin complex);GO:0034332(adherens junction organization);GO:0042803(protein homodimerization activity);GO:0044331(cell-cell adhesion mediated by cadherin);GO:0045296(cadherin binding);GO:0046872(metal ion binding);GO:0098609(cell-cell adhesion)","NA",{"v":1.9E-3,"d":"0.00"},2,"112,9,","0,463",-1.33,{"v":0.00741310241300918,"d":"0.01"},-1.32,"Exon (ENST00000397359/ENSG00000139880, exon 11 of 14)",14,23047062,23057538,10477,2]
[24146858,24147540,683,"ENSG00000092098","ENST00000559438","processed_transcript",0,"RNF31","ring finger protein 31 [Source:HGNC Symbol;Acc:HGNC:16031]","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007249(I-kappaB kinase/NF-kappaB signaling);GO:0009898(cytoplasmic side of plasma membrane);GO:0010803(regulation of tumor necrosis factor-mediated signaling pathway);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0023035(CD40 signaling pathway);GO:0031625(ubiquitin protein ligase binding);GO:0035631(CD40 receptor complex);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043130(ubiquitin binding);GO:0046872(metal ion binding);GO:0050852(T cell receptor signaling pathway);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0071797(LUBAC complex);GO:0097039(protein linear polyubiquitination);GO:1903955(positive regulation of protein targeting to mitochondrion)","04217(Necroptosis);04621(NOD-like receptor signaling pathway)",{"v":1.3e-12,"d":"0.00"},2,"401,18,","0,665",-1.25,{"v":0.00933254300796992,"d":"0.01"},-1.26,"5' UTR",14,24146875,24149431,2557,1]
[53103772,53149880,46109,"ENSG00000100523","ENST00000612692","protein_coding",3218,"DDHD1","DDHD domain containing 1 [Source:HGNC Symbol;Acc:HGNC:19714]","GO:0004620(phospholipase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006629(lipid metabolic process);GO:0006654(phosphatidic acid biosynthetic process);GO:0016042(lipid catabolic process);GO:0016787(hydrolase activity);GO:0046872(metal ion binding);GO:0090141(positive regulation of mitochondrial fission)","NA",{"v":0.0003,"d":"0.00"},2,"85,96,","0,46013",-1.14,{"v":0.0128824955169313,"d":"0.01"},{"v":-1.8,"d":"-1.80"},"5' UTR",14,53036745,53153098,116354,2]
[67797747,67798484,738,"ENSG00000072121","ENST00000347230","protein_coding",18106,"ZFYVE26","zinc finger FYVE-type containing 26 [Source:HGNC Symbol;Acc:HGNC:20761]","GO:0000281(mitotic cytokinesis);GO:0000724(double-strand break repair via homologous recombination);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005856(cytoskeleton);GO:0006281(DNA repair);GO:0006974(cellular response to DNA damage stimulus);GO:0007049(cell cycle);GO:0008289(lipid binding);GO:0030496(midbody);GO:0032266(phosphatidylinositol-3-phosphate binding);GO:0032465(regulation of cytokinesis);GO:0046872(metal ion binding);GO:0051301(cell division)","NA",{"v":1e-18,"d":"0.00"},2,"9,471,","0,267",-3.47,{"v":1.99526231496888E-5,"d":"0.00"},-1.27,"3' UTR",14,67746522,67816590,70069,2]
[73276483,73276663,181,"ENSG00000133961","ENST00000554546","protein_coding",181954,"NUMB","NUMB, endocytic adaptor protein [Source:HGNC Symbol;Acc:HGNC:8060]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005769(early endosome);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0007275(multicellular organism development);GO:0007399(nervous system development);GO:0007405(neuroblast proliferation);GO:0007409(axonogenesis);GO:0008013(beta-catenin binding);GO:0016020(membrane);GO:0016323(basolateral plasma membrane);GO:0019897(extrinsic component of plasma membrane);GO:0021670(lateral ventricle development);GO:0021849(neuroblast division in subventricular zone);GO:0030136(clathrin-coated vesicle);GO:0030335(positive regulation of cell migration);GO:0030900(forebrain development);GO:0031410(cytoplasmic vesicle);GO:0034332(adherens junction organization);GO:0045177(apical part of cell);GO:0045294(alpha-catenin binding);GO:0045296(cadherin binding);GO:0050769(positive regulation of neurogenesis);GO:0098978(glutamatergic synapse);GO:0099149(regulation of postsynaptic neurotransmitter receptor internalization);GO:1903077(negative regulation of protein localization to plasma membrane)","04330(Notch signaling pathway)",{"v":1.1e-09,"d":"0.00"},1,"181,",0,-3.62,{"v":1.34896288259165e-05,"d":"0.00"},-1.03,"3' UTR",14,73275107,73458617,183511,2]
[75047585,75048005,421,"ENSG00000119684","ENST00000355774","protein_coding",3527,"MLH3","mutL homolog 3 [Source:HGNC Symbol;Acc:HGNC:7128]","GO:0000793(condensed chromosome);GO:0000794(condensed nuclear chromosome);GO:0000795(synaptonemal complex);GO:0001673(male germ cell nucleus);GO:0003682(chromatin binding);GO:0003696(satellite DNA binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005712(chiasma);GO:0006281(DNA repair);GO:0006298(mismatch repair);GO:0006974(cellular response to DNA damage stimulus);GO:0007130(synaptonemal complex assembly);GO:0007131(reciprocal meiotic recombination);GO:0007140(male meiotic nuclear division);GO:0007144(female meiosis I);GO:0008104(protein localization);GO:0016887(ATPase activity);GO:0019237(centromeric DNA binding);GO:0030983(mismatched DNA binding);GO:0032300(mismatch repair complex);GO:0032389(MutLalpha complex)","03430(Mismatch repair)",{"v":5e-11,"d":"0.00"},1,"421,",0,-0.95,{"v":0.0239883291901949,"d":"0.02"},-1.83,"Exon (ENST00000355774/ENSG00000119684, exon 2 of 13)",14,75013764,75051532,37769,2]
[95124198,95126588,2391,"ENSG00000100697","ENST00000532458","processed_transcript",0,"DICER1","dicer 1, ribonuclease III [Source:HGNC Symbol;Acc:HGNC:17098]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000166(nucleotide binding);GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0003725(double-stranded RNA binding);GO:0004386(helicase activity);GO:0004518(nuclease activity);GO:0004519(endonuclease activity);GO:0004521(endoribonuclease activity);GO:0004525(ribonuclease III activity);GO:0004530(deoxyribonuclease I activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005829(cytosol);GO:0006309(apoptotic DNA fragmentation);GO:0006396(RNA processing);GO:0010586(miRNA metabolic process);GO:0010626(negative regulation of Schwann cell proliferation);GO:0014040(positive regulation of Schwann cell differentiation);GO:0016442(RISC complex);GO:0016787(hydrolase activity);GO:0016891(endoribonuclease activity, producing 5'-phosphomonoesters);GO:0019904(protein domain specific binding);GO:0021675(nerve development);GO:0030422(production of siRNA involved in RNA interference);GO:0030423(targeting of mRNA for destruction involved in RNA interference);GO:0030424(axon);GO:0030425(dendrite);GO:0030426(growth cone);GO:0031047(gene silencing by RNA);GO:0031054(pre-miRNA processing);GO:0031643(positive regulation of myelination);GO:0032290(peripheral nervous system myelin formation);GO:0032720(negative regulation of tumor necrosis factor production);GO:0033167(ARC complex);GO:0033168(conversion of ds siRNA to ss siRNA involved in RNA interference);GO:0035068(micro-ribonucleoprotein complex);GO:0035087(siRNA loading onto RISC involved in RNA interference);GO:0035196(production of miRNAs involved in gene silencing by miRNA);GO:0035197(siRNA binding);GO:0035280(miRNA loading onto RISC involved in gene silencing by miRNA);GO:0036404(conversion of ds siRNA to ss siRNA);GO:0038061(NIK/NF-kappaB signaling);GO:0046872(metal ion binding);GO:0048812(neuron projection morphogenesis);GO:0070062(extracellular exosome);GO:0070578(RISC-loading complex);GO:0070883(pre-miRNA binding);GO:0090501(RNA phosphodiester bond hydrolysis);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic)","05206(MicroRNAs in cancer)",{"v":3.2e-48,"d":"0.00"},2,"471,9,","0,2382",-5.26,{"v":1.99526231496888E-7,"d":"0.00"},-1.16,"Exon (ENST00000343455/ENSG00000100697, exon 7 of 27)",14,95113130,95124275,11146,2]
[95203362,95203752,391,"ENSG00000165959","ENST00000298912","protein_coding",116156,"CLMN","calmin [Source:HGNC Symbol;Acc:HGNC:19972]","GO:0003779(actin binding);GO:0005515(protein binding);GO:0005640(nuclear outer membrane);GO:0005737(cytoplasm);GO:0007097(nuclear migration);GO:0008285(negative regulation of cell population proliferation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031175(neuron projection development);GO:0034993(meiotic nuclear membrane microtubule tethering complex);GO:0051015(actin filament binding);GO:0051647(nucleus localization);GO:0090286(cytoskeletal anchoring at nuclear membrane)","NA",{"v":4.2e-05,"d":"0.00"},1,"391,",0,{"v":-1.9,"d":"-1.90"},{"v":0.00141253754462275,"d":"0.00"},-1.62,"Exon (ENST00000298912/ENSG00000165959, exon 9 of 13)",14,95181940,95319908,137969,2]
[102933639,102938109,4471,"ENSG00000198752","ENST00000361246","protein_coding",119440,"CDC42BPB","CDC42 binding protein kinase beta [Source:HGNC Symbol;Acc:HGNC:1738]","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0006468(protein phosphorylation);GO:0007010(cytoskeleton organization);GO:0007163(establishment or maintenance of cell polarity);GO:0007165(signal transduction);GO:0016020(membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016477(cell migration);GO:0016740(transferase activity);GO:0017048(Rho GTPase binding);GO:0030027(lamellipodium);GO:0030036(actin cytoskeleton organization);GO:0030054(cell junction);GO:0031032(actomyosin structure organization);GO:0031252(cell leading edge);GO:0031532(actin cytoskeleton reorganization);GO:0035556(intracellular signal transduction);GO:0042641(actomyosin);GO:0042995(cell projection);GO:0044877(protein-containing complex binding);GO:0046872(metal ion binding);GO:0070062(extracellular exosome)","NA",{"v":1.3E-23,"d":"0.00"},2,"205,6,","0,4465",-8.16,{"v":1.38038426460289E-10,"d":"0.00"},-1.02,"3' UTR",14,102932380,103057549,125170,2]
[135400288,135400703,416,"ENSG00000270021","ENST00000602502","antisense",1008,"AC026691","novel transcript, antisense to H2AFY","NA","NA",{"v":6E-9,"d":"0.00"},1,"416,",0,{"v":-0.813,"d":"-0.81"},{"v":0.0380189396320561,"d":"0.04"},-2.81,"Exon (ENST00000602502/ENSG00000270021, exon 1 of 1)",5,135399280,135401296,2017,1]
[25119198,25119408,211,"ENSG00000224078","ENST00000640631","antisense",77509,"SNHG14","small nucleolar RNA host gene 14 [Source:HGNC Symbol;Acc:HGNC:37462]","NA","NA",{"v":4.6e-10,"d":"0.00"},1,"211,",0,-2.74,{"v":0.000138038426460289,"d":"0.00"},-1.31,"Exon (ENST00000640631/ENSG00000224078, exon 38 of 38)",15,25041689,25120432,78744,1]
[30903882,30905504,1623,"ENSG00000198690","ENST00000561607","protein_coding",0,"FAN1","FANCD2 and FANCI associated nuclease 1 [Source:HGNC Symbol;Acc:HGNC:29170]","GO:0000287(magnesium ion binding);GO:0000724(double-strand break repair via homologous recombination);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0004518(nuclease activity);GO:0004519(endonuclease activity);GO:0004527(exonuclease activity);GO:0004528(phosphodiesterase I activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006281(DNA repair);GO:0006289(nucleotide-excision repair);GO:0006974(cellular response to DNA damage stimulus);GO:0008409(5'-3' exonuclease activity);GO:0016787(hydrolase activity);GO:0016788(hydrolase activity, acting on ester bonds);GO:0017108(5'-flap endonuclease activity);GO:0033683(nucleotide-excision repair, DNA incision);GO:0036297(interstrand cross-link repair);GO:0045171(intercellular bridge);GO:0046872(metal ion binding);GO:0070336(flap-structured DNA binding);GO:0090305(nucleic acid phosphodiester bond hydrolysis);GO:0140036(ubiquitin-dependent protein binding)","03460(Fanconi anemia pathway)",{"v":1.6e-19,"d":"0.00"},2,"143,995,","0,628",{"v":-11.1,"d":"-11.10"},{"v":1E-13,"d":"0.00"},{"v":-1.1,"d":"-1.10"},"5' UTR",15,30903892,30911643,7752,1]
[39967587,39967737,151,"ENSG00000128829","ENST00000263791","protein_coding",33472,"EIF2AK4","eukaryotic translation initiation factor 2 alpha kinase 4 [Source:HGNC Symbol;Acc:HGNC:19687]","GO:0000049(tRNA binding);GO:0000077(DNA damage checkpoint);GO:0000166(nucleotide binding);GO:0002230(positive regulation of defense response to virus by host);GO:0002250(adaptive immune response);GO:0002286(T cell activation involved in immune response);GO:0002376(immune system process);GO:0002821(positive regulation of adaptive immune response);GO:0003723(RNA binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004694(eukaryotic translation initiation factor 2alpha kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005844(polysome);GO:0006417(regulation of translation);GO:0006446(regulation of translational initiation);GO:0006468(protein phosphorylation);GO:0007049(cell cycle);GO:0007050(cell cycle arrest);GO:0007399(nervous system development);GO:0007612(learning);GO:0007616(long-term memory);GO:0010998(regulation of translational initiation by eIF2 alpha phosphorylation);GO:0016032(viral process);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0019081(viral translation);GO:0022626(cytosolic ribosome);GO:0032057(negative regulation of translational initiation in response to stress);GO:0032792(negative regulation of CREB transcription factor activity);GO:0034198(cellular response to amino acid starvation);GO:0034644(cellular response to UV);GO:0036492(eiF2alpha phosphorylation in response to endoplasmic reticulum stress);GO:0039520(induction by virus of host autophagy);GO:0044828(negative regulation by host of viral genome replication);GO:0045665(negative regulation of neuron differentiation);GO:0045947(negative regulation of translational initiation);GO:0046777(protein autophosphorylation);GO:0051607(defense response to virus);GO:0060259(regulation of feeding behavior);GO:0060733(regulation of eIF2 alpha phosphorylation by amino acid starvation);GO:0061630(ubiquitin protein ligase activity);GO:0070417(cellular response to cold);GO:0071264(positive regulation of translational initiation in response to starvation);GO:1900273(positive regulation of long-term synaptic potentiation);GO:1990138(neuron projection extension);GO:1990253(cellular response to leucine starvation)","04140(Autophagy - animal);04141(Protein processing in endoplasmic reticulum);05160(Hepatitis C);05162(Measles);05164(Influenza A);05168(Herpes simplex virus 1 infection)",{"v":2.9E-5,"d":"0.00"},1,"151,",0,{"v":-12.1,"d":"-12.10"},{"v":7.94328234724282e-15,"d":"0.00"},{"v":-1.5,"d":"-1.50"},"Exon (ENST00000263791/ENSG00000128829, exon 9 of 39)",15,39934115,40035591,101477,1]
[39975410,39976813,1404,"ENSG00000128829","ENST00000263791","protein_coding",41295,"EIF2AK4","eukaryotic translation initiation factor 2 alpha kinase 4 [Source:HGNC Symbol;Acc:HGNC:19687]","GO:0000049(tRNA binding);GO:0000077(DNA damage checkpoint);GO:0000166(nucleotide binding);GO:0002230(positive regulation of defense response to virus by host);GO:0002250(adaptive immune response);GO:0002286(T cell activation involved in immune response);GO:0002376(immune system process);GO:0002821(positive regulation of adaptive immune response);GO:0003723(RNA binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004694(eukaryotic translation initiation factor 2alpha kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005844(polysome);GO:0006417(regulation of translation);GO:0006446(regulation of translational initiation);GO:0006468(protein phosphorylation);GO:0007049(cell cycle);GO:0007050(cell cycle arrest);GO:0007399(nervous system development);GO:0007612(learning);GO:0007616(long-term memory);GO:0010998(regulation of translational initiation by eIF2 alpha phosphorylation);GO:0016032(viral process);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0019081(viral translation);GO:0022626(cytosolic ribosome);GO:0032057(negative regulation of translational initiation in response to stress);GO:0032792(negative regulation of CREB transcription factor activity);GO:0034198(cellular response to amino acid starvation);GO:0034644(cellular response to UV);GO:0036492(eiF2alpha phosphorylation in response to endoplasmic reticulum stress);GO:0039520(induction by virus of host autophagy);GO:0044828(negative regulation by host of viral genome replication);GO:0045665(negative regulation of neuron differentiation);GO:0045947(negative regulation of translational initiation);GO:0046777(protein autophosphorylation);GO:0051607(defense response to virus);GO:0060259(regulation of feeding behavior);GO:0060733(regulation of eIF2 alpha phosphorylation by amino acid starvation);GO:0061630(ubiquitin protein ligase activity);GO:0070417(cellular response to cold);GO:0071264(positive regulation of translational initiation in response to starvation);GO:1900273(positive regulation of long-term synaptic potentiation);GO:1990138(neuron projection extension);GO:1990253(cellular response to leucine starvation)","04140(Autophagy - animal);04141(Protein processing in endoplasmic reticulum);05160(Hepatitis C);05162(Measles);05164(Influenza A);05168(Herpes simplex virus 1 infection)",{"v":5e-32,"d":"0.00"},2,"20,400,","0,1004",-5.53,{"v":1e-07,"d":"0.00"},{"v":-1.2,"d":"-1.20"},"3' UTR",15,39934115,40035591,101477,1]
[73830084,73830592,509,"ENSG00000189143","ENST00000435050","protein_coding",2340,"CLDN4","claudin 4 [Source:HGNC Symbol;Acc:HGNC:2046]","GO:0004888(transmembrane signaling receptor activity);GO:0005198(structural molecule activity);GO:0005254(chloride channel activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005923(bicellular tight junction);GO:0006811(ion transport);GO:0006821(chloride transport);GO:0007565(female pregnancy);GO:0007623(circadian rhythm);GO:0009925(basal plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane);GO:0016327(apicolateral plasma membrane);GO:0016328(lateral plasma membrane);GO:0016338(calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules);GO:0030054(cell junction);GO:0032570(response to progesterone);GO:0034707(chloride channel complex);GO:0042802(identical protein binding);GO:0061436(establishment of skin barrier);GO:0070293(renal absorption);GO:1902476(chloride transmembrane transport)","04514(Cell adhesion molecules (CAMs));04530(Tight junction);04670(Leukocyte transendothelial migration);05160(Hepatitis C)",{"v":1.6E-11,"d":"0.00"},1,"509,",0,{"v":-0.902,"d":"-0.90"},{"v":0.0281838293126445,"d":"0.03"},-2.81,"5' UTR",7,73827744,73832684,4941,1]
[29067279,29067454,176,"ENSG00000259607","ENST00000560714","antisense",0,"AC108449","novel transcript, antisense to KIF13B","NA","NA",{"v":4.1e-08,"d":"0.00"},1,"176,",0,{"v":-0.749,"d":"-0.75"},{"v":0.0467735141287198,"d":"0.05"},-2.82,"3' UTR",8,29067279,29068454,1176,1]
[66547276,66548693,1418,"ENSG00000174442","ENST00000535141","protein_coding",42317,"ZWILCH","zwilch kinetochore protein [Source:HGNC Symbol;Acc:HGNC:25468]","GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000777(condensed chromosome kinetochore);GO:0005515(protein binding);GO:0005694(chromosome);GO:0005829(cytosol);GO:0007049(cell cycle);GO:0007093(mitotic cell cycle checkpoint);GO:0051301(cell division);GO:1990423(RZZ complex)","NA",{"v":5e-29,"d":"0.00"},2,"17,343,","0,1075",-5.52,{"v":1.02329299228075e-07,"d":"0.00"},-1.48,"3' UTR",15,66504959,66548426,43468,1]
[44805780,44805900,121,"ENSG00000173846","ENST00000372201","protein_coding",5403,"PLK3","polo like kinase 3 [Source:HGNC Symbol;Acc:HGNC:2154]","GO:0000082(G1/S transition of mitotic cell cycle);GO:0000086(G2/M transition of mitotic cell cycle);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000166(nucleotide binding);GO:0000278(mitotic cell cycle);GO:0000302(response to reactive oxygen species);GO:0000922(spindle pole);GO:0002039(p53 binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005795(Golgi stack);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0006915(apoptotic process);GO:0006970(response to osmotic stress);GO:0006974(cellular response to DNA damage stimulus);GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest);GO:0007049(cell cycle);GO:0007093(mitotic cell cycle checkpoint);GO:0007113(endomitotic cell cycle);GO:0009314(response to radiation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0030425(dendrite);GO:0031122(cytoplasmic microtubule organization);GO:0032465(regulation of cytokinesis);GO:0043025(neuronal cell body);GO:0043066(negative regulation of apoptotic process);GO:0043491(protein kinase B signaling);GO:0044819(mitotic G1/S transition checkpoint);GO:0051302(regulation of cell division);GO:0090166(Golgi disassembly);GO:0090316(positive regulation of intracellular protein transport);GO:1901796(regulation of signal transduction by p53 class mediator);GO:1904716(positive regulation of chaperone-mediated autophagy);GO:2000777(positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia)","04068(FoxO signaling pathway);04625(C-type lectin receptor signaling pathway);05152(Tuberculosis)",{"v":1E-3,"d":"0.00"},1,"121,",0,{"v":-0.968,"d":"-0.97"},{"v":0.0223872113856834,"d":"0.02"},-2.83,"3' UTR",1,44800377,44805990,5614,1]
[74638100,74638310,211,"ENSG00000179151","ENST00000315127","protein_coding",57714,"EDC3","enhancer of mRNA decapping 3 [Source:HGNC Symbol;Acc:HGNC:26114]","GO:0000932(P-body);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0016020(membrane);GO:0031087(deadenylation-independent decapping of nuclear-transcribed mRNA);GO:0033962(cytoplasmic mRNA processing body assembly);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0042802(identical protein binding);GO:0043928(exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic);GO:1990174(phosphodiesterase decapping endonuclease activity)","03018(RNA degradation)",{"v":6e-08,"d":"0.00"},1,"211,",0,{"v":-0.935,"d":"-0.94"},{"v":0.0251188643150958,"d":"0.03"},-1.35,"3' UTR",15,74630558,74696024,65467,2]
[75859982,75876193,16212,"ENSG00000140367","ENST00000567921","nonsense_mediated_decay",0,"UBE2Q2","ubiquitin conjugating enzyme E2 Q2 [Source:HGNC Symbol;Acc:HGNC:19248]","GO:0000166(nucleotide binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0061631(ubiquitin conjugating enzyme activity);GO:0070936(protein K48-linked ubiquitination)","04120(Ubiquitin mediated proteolysis)",{"v":2.5e-12,"d":"0.00"},4,"1,60,141,7,","0,8969,13446,16205",-3.94,{"v":5.75439937337157e-06,"d":"0.00"},-1.16,"Exon (ENST00000267938/ENSG00000140367, exon 3 of 13)",15,75868951,75899577,30627,1]
[146138317,146139919,1603,"ENSG00000271425","ENST00000583866","protein_coding",4885,"NBPF10","NBPF member 10 [Source:HGNC Symbol;Acc:HGNC:31992]","GO:0005509(calcium ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":1.6E-11,"d":"0.00"},2,"129,111,","0,1492",-1.34,{"v":7.2443596007499E-3,"d":"0.01"},-2.83,"5' UTR",1,146064699,146144804,80106,2]
[82648546,82650162,1617,"ENSG00000214575","ENST00000566716","processed_transcript",0,"CPEB1","cytoplasmic polyadenylation element binding protein 1 [Source:HGNC Symbol;Acc:HGNC:21744]","GO:0000900(translation repressor activity, mRNA regulatory element binding);GO:0000932(P-body);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006397(mRNA processing);GO:0006412(translation);GO:0006417(regulation of translation);GO:0008135(translation factor activity, RNA binding);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0030054(cell junction);GO:0030425(dendrite);GO:0032869(cellular response to insulin stimulus);GO:0035925(mRNA 3'-UTR AU-rich region binding);GO:0042995(cell projection);GO:0043005(neuron projection);GO:0043022(ribosome binding);GO:0045182(translation regulator activity);GO:0045202(synapse);GO:0045211(postsynaptic membrane);GO:0046872(metal ion binding);GO:0071230(cellular response to amino acid stimulus);GO:0071456(cellular response to hypoxia);GO:1900365(positive regulation of mRNA polyadenylation);GO:1990124(messenger ribonucleoprotein complex);GO:2000766(negative regulation of cytoplasmic translation)","04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation)",{"v":2E-12,"d":"0.00"},3,"263,171,134,","0,1225,1483",-1.09,{"v":0.0154881661891248,"d":"0.02"},-1.82,"Exon (ENST00000560650/ENSG00000259462, exon 1 of 4)",15,82627289,82648861,21573,2]
[85580285,85581065,781,"ENSG00000170776","ENST00000559362","protein_coding",199698,"AKAP13","A-kinase anchoring protein 13 [Source:HGNC Symbol;Acc:HGNC:371]","GO:0004691(cAMP-dependent protein kinase activity);GO:0005078(MAP-kinase scaffold activity);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005884(actin filament);GO:0005938(cell cortex);GO:0006468(protein phosphorylation);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007507(heart development);GO:0015629(actin cytoskeleton);GO:0016020(membrane);GO:0017048(Rho GTPase binding);GO:0030864(cortical actin cytoskeleton);GO:0032947(protein-containing complex scaffold activity);GO:0035023(regulation of Rho protein signal transduction);GO:0035025(positive regulation of Rho protein signal transduction);GO:0035556(intracellular signal transduction);GO:0043065(positive regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043406(positive regulation of MAP kinase activity);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0051018(protein kinase A binding);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0051168(nuclear export);GO:0055007(cardiac muscle cell differentiation);GO:0060297(regulation of sarcomere organization);GO:0060348(bone development);GO:0061049(cell growth involved in cardiac muscle cell development);GO:0071875(adrenergic receptor signaling pathway);GO:0086023(adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process);GO:1900169(regulation of glucocorticoid mediated signaling pathway)","04928(Parathyroid hormone synthesis, secretion and action);05163(Human cytomegalovirus infection)",{"v":7.9e-16,"d":"0.00"},1,"781,",0,-6.58,{"v":7.07945784384137e-09,"d":"0.00"},-1,"Exon (ENST00000559362/ENSG00000170776, exon 7 of 15)",15,85380587,85684874,304288,1]
[92924521,92939648,15128,"ENSG00000173575","ENST00000626874","protein_coding",24332,"CHD2","chromodomain helicase DNA binding protein 2 [Source:HGNC Symbol;Acc:HGNC:1917]","GO:0000166(nucleotide binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0004003(ATP-dependent DNA helicase activity);GO:0004386(helicase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006325(chromatin organization);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006974(cellular response to DNA damage stimulus);GO:0007517(muscle organ development);GO:0016787(hydrolase activity);GO:0032508(DNA duplex unwinding);GO:0042393(histone binding);GO:0043044(ATP-dependent chromatin remodeling);GO:0043231(intracellular membrane-bounded organelle);GO:0060218(hematopoietic stem cell differentiation)","NA",{"v":1.3E-18,"d":"0.00"},5,"32,87,62,108,71,","0,2723,4509,12997,15057",-6.71,{"v":5.01187233627271e-09,"d":"0.00"},-1.12,"5' UTR",15,92900189,93022162,121974,1]
[92924519,92939677,15159,"ENSG00000173575","ENST00000637613","protein_coding",0,"CHD2","chromodomain helicase DNA binding protein 2 [Source:HGNC Symbol;Acc:HGNC:1917]","GO:0000166(nucleotide binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0004003(ATP-dependent DNA helicase activity);GO:0004386(helicase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006325(chromatin organization);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006974(cellular response to DNA damage stimulus);GO:0007517(muscle organ development);GO:0016787(hydrolase activity);GO:0032508(DNA duplex unwinding);GO:0042393(histone binding);GO:0043044(ATP-dependent chromatin remodeling);GO:0043231(intracellular membrane-bounded organelle);GO:0060218(hematopoietic stem cell differentiation)","NA",{"v":5e-18,"d":"0.00"},5,"34,87,62,108,100,","0,2725,4511,12999,15059",-7.23,{"v":1.38038426460289E-9,"d":"0.00"},-1.12,"5' UTR",15,92939654,92949228,9575,1]
[101070710,101071009,300,"ENSG00000154237","ENST00000388948","protein_coding",151353,"LRRK1","leucine rich repeat kinase 1 [Source:HGNC Symbol;Acc:HGNC:18608]","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0036035(osteoclast development);GO:0042802(identical protein binding);GO:0045453(bone resorption);GO:0046872(metal ion binding);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050732(negative regulation of peptidyl-tyrosine phosphorylation);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1902533(positive regulation of intracellular signal transduction)","NA",{"v":6.8E-8,"d":"0.00"},1,"300,",0,{"v":-0.945,"d":"-0.95"},{"v":0.0245470891568503,"d":"0.02"},-1.23,"3' UTR",15,100919357,101078257,158901,1]
[34419734,34420183,450,"ENSG00000175265","ENST00000569781","processed_transcript",17283,"GOLGA8A","golgin A8 family member A [Source:HGNC Symbol;Acc:HGNC:31972]","GO:0000137(Golgi cis cisterna);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:0005829(cytosol);GO:0007030(Golgi organization);GO:0016020(membrane);GO:0032580(Golgi cisterna membrane)","NA",{"v":8.1e-07,"d":"0.00"},1,"450,",0,-1.08,{"v":0.0158489319246111,"d":"0.02"},-1.67,"Exon (ENST00000623619/ENSG00000279092, exon 1 of 1)",15,34404970,34437466,32497,2]
[34969562,34969712,151,"ENSG00000021776","ENST00000156471","protein_coding",30,"AQR","aquarius intron-binding spliceosomal factor [Source:HGNC Symbol;Acc:HGNC:29513]","GO:0000166(nucleotide binding);GO:0000398(mRNA splicing, via spliceosome);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0004386(helicase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex);GO:0006283(transcription-coupled nucleotide-excision repair);GO:0006397(mRNA processing);GO:0008380(RNA splicing);GO:0016020(membrane);GO:0016787(hydrolase activity);GO:0071007(U2-type catalytic step 2 spliceosome);GO:0071013(catalytic step 2 spliceosome)","03040(Spliceosome)",{"v":0.00024,"d":"0.00"},1,"151,",0,-1.06,{"v":0.0169824365246174,"d":"0.02"},-1.06,"5' UTR",15,34851782,34969742,117961,2]
[42439129,42439728,600,"ENSG00000103994","ENST00000263805","protein_coding",17804,"ZNF106","zinc finger protein 106 [Source:HGNC Symbol;Acc:HGNC:12886]","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0008286(insulin receptor signaling pathway);GO:0016020(membrane);GO:0016607(nuclear speck);GO:0017124(SH3 domain binding);GO:0046872(metal ion binding)","NA",{"v":1e-111,"d":"0.00"},1,"600,",0,{"v":-12.3,"d":"-12.30"},{"v":5.01187233627271e-15,"d":"0.00"},-1.08,"Exon (ENST00000263805/ENSG00000103994, exon 8 of 19)",15,42412823,42457532,44710,2]
[43428149,43432504,4356,"ENSG00000067369","ENST00000382044","protein_coding",60667,"TP53BP1","tumor protein p53 binding protein 1 [Source:HGNC Symbol;Acc:HGNC:11999]","GO:0000077(DNA damage checkpoint);GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000777(condensed chromosome kinetochore);GO:0000781(chromosome, telomeric region);GO:0000784(nuclear chromosome, telomeric region);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0002039(p53 binding);GO:0003677(DNA binding);GO:0003684(damaged DNA binding);GO:0003712(transcription coregulator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005657(replication fork);GO:0005694(chromosome);GO:0005737(cytoplasm);GO:0006281(DNA repair);GO:0006303(double-strand break repair via nonhomologous end joining);GO:0006974(cellular response to DNA damage stimulus);GO:0016604(nuclear body);GO:0035064(methylated histone binding);GO:0035861(site of double-strand break);GO:0042162(telomeric DNA binding);GO:0042393(histone binding);GO:0043565(sequence-specific DNA binding);GO:0045830(positive regulation of isotype switching);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051260(protein homooligomerization);GO:0061649(ubiquitin modification-dependent histone binding);GO:0071481(cellular response to X-ray);GO:1990391(DNA repair complex);GO:2000042(negative regulation of double-strand break repair via homologous recombination)","04621(NOD-like receptor signaling pathway)",{"v":7.9e-37,"d":"0.00"},2,"20,311,","0,4045",{"v":-17.5,"d":"-17.50"},{"v":1.99526231496888e-20,"d":"0.00"},-1.48,"3' UTR",15,43403061,43493171,90111,2]
[43455962,43456651,690,"ENSG00000067369","ENST00000411772","nonsense_mediated_decay",0,"TP53BP1","tumor protein p53 binding protein 1 [Source:HGNC Symbol;Acc:HGNC:11999]","GO:0000077(DNA damage checkpoint);GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000777(condensed chromosome kinetochore);GO:0000781(chromosome, telomeric region);GO:0000784(nuclear chromosome, telomeric region);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0002039(p53 binding);GO:0003677(DNA binding);GO:0003684(damaged DNA binding);GO:0003712(transcription coregulator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005657(replication fork);GO:0005694(chromosome);GO:0005737(cytoplasm);GO:0006281(DNA repair);GO:0006303(double-strand break repair via nonhomologous end joining);GO:0006974(cellular response to DNA damage stimulus);GO:0016604(nuclear body);GO:0035064(methylated histone binding);GO:0035861(site of double-strand break);GO:0042162(telomeric DNA binding);GO:0042393(histone binding);GO:0043565(sequence-specific DNA binding);GO:0045830(positive regulation of isotype switching);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051260(protein homooligomerization);GO:0061649(ubiquitin modification-dependent histone binding);GO:0071481(cellular response to X-ray);GO:1990391(DNA repair complex);GO:2000042(negative regulation of double-strand break repair via homologous recombination)","04621(NOD-like receptor signaling pathway)",{"v":1e-118,"d":"0.00"},1,"690,",0,{"v":-32.1,"d":"-32.10"},{"v":1.99526231496887E-35,"d":"0.00"},-1.41,"Exon (ENST00000382044/ENSG00000067369, exon 12 of 28)",15,43407214,43456331,49118,2]
[50592091,50592241,151,"ENSG00000092439","ENST00000313478","protein_coding",94556,"TRPM7","transient receptor potential cation channel subfamily M member 7 [Source:HGNC Symbol;Acc:HGNC:17994]","GO:0000166(nucleotide binding);GO:0001726(ruffle);GO:0003779(actin binding);GO:0004674(protein serine/threonine kinase activity);GO:0005216(ion channel activity);GO:0005262(calcium channel activity);GO:0005524(ATP binding);GO:0005623(cell);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0006811(ion transport);GO:0006812(cation transport);GO:0006816(calcium ion transport);GO:0010961(cellular magnesium ion homeostasis);GO:0012501(programmed cell death);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016340(calcium-dependent cell-matrix adhesion);GO:0016740(transferase activity);GO:0017022(myosin binding);GO:0031032(actomyosin structure organization);GO:0034220(ion transmembrane transport);GO:0046777(protein autophosphorylation);GO:0046872(metal ion binding);GO:0051262(protein tetramerization);GO:0055085(transmembrane transport);GO:0070266(necroptotic process);GO:0070588(calcium ion transmembrane transport)","04217(Necroptosis);04218(Cellular senescence);04621(NOD-like receptor signaling pathway);04978(Mineral absorption)",{"v":3.2e-15,"d":"0.00"},1,"151,",0,-1.03,{"v":0.0181970085860998,"d":"0.02"},-1.08,"Exon (ENST00000313478/ENSG00000092439, exon 26 of 39)",15,50557158,50686797,129640,2]
[51480816,51481146,331,"ENSG00000104093","ENST00000251076","protein_coding",141687,"DMXL2","Dmx like 2 [Source:HGNC Symbol;Acc:HGNC:2938]","GO:0005515(protein binding);GO:0005615(extracellular space);GO:0007035(vacuolar acidification);GO:0008021(synaptic vesicle);GO:0016020(membrane);GO:0017137(Rab GTPase binding);GO:0030054(cell junction);GO:0030672(synaptic vesicle membrane);GO:0031410(cytoplasmic vesicle);GO:0043291(RAVE complex);GO:0045202(synapse)","NA",{"v":8.9e-07,"d":"0.00"},1,"331,",0,-1.13,{"v":0.0134896288259165,"d":"0.01"},-1.03,"Exon (ENST00000251076/ENSG00000104093, exon 24 of 43)",15,51447711,51622833,175123,2]
[51481355,51486074,4720,"ENSG00000104093","ENST00000560891","protein_coding",0,"DMXL2","Dmx like 2 [Source:HGNC Symbol;Acc:HGNC:2938]","GO:0005515(protein binding);GO:0005615(extracellular space);GO:0007035(vacuolar acidification);GO:0008021(synaptic vesicle);GO:0016020(membrane);GO:0017137(Rab GTPase binding);GO:0030054(cell junction);GO:0030672(synaptic vesicle membrane);GO:0031410(cytoplasmic vesicle);GO:0043291(RAVE complex);GO:0045202(synapse)","NA",{"v":3.2E-13,"d":"0.00"},2,"269,2,","0,4718",{"v":-0.798,"d":"-0.80"},{"v":0.0398107170553497,"d":"0.04"},-1.06,"Exon (ENST00000251076/ENSG00000104093, exon 23 of 43)",15,51447776,51481479,33704,2]
[64213896,64214106,211,"ENSG00000169118","ENST00000303052","protein_coding",142067,"CSNK1G1","casein kinase 1 gamma 1 [Source:HGNC Symbol;Acc:HGNC:2454]","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0006897(endocytosis);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0090263(positive regulation of canonical Wnt signaling pathway)","04340(Hedgehog signaling pathway)",{"v":1.3E-13,"d":"0.00"},1,"211,",0,-3.45,{"v":2.08929613085404e-05,"d":"0.00"},-1.26,"3' UTR",15,64165525,64356173,190649,2]
[64251567,64316886,65320,"ENSG00000169118","ENST00000561349","protein_coding",0,"CSNK1G1","casein kinase 1 gamma 1 [Source:HGNC Symbol;Acc:HGNC:2454]","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0006897(endocytosis);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0090263(positive regulation of canonical Wnt signaling pathway)","04340(Hedgehog signaling pathway)",{"v":5e-70,"d":"0.00"},5,"15,41,405,49,30,","0,7634,48752,64136,65290",-8.59,{"v":5.01187233627271e-11,"d":"0.00"},-1.45,"5' UTR",15,64165737,64300697,134961,2]
[64213905,64214114,210,"ENSG00000169118","ENST00000303052","protein_coding",142059,"CSNK1G1","casein kinase 1 gamma 1 [Source:HGNC Symbol;Acc:HGNC:2454]","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0006897(endocytosis);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0090263(positive regulation of canonical Wnt signaling pathway)","04340(Hedgehog signaling pathway)",{"v":6.3e-14,"d":"0.00"},1,"210,",0,-3.77,{"v":9.1201083935591e-06,"d":"0.00"},-1.31,"3' UTR",15,64165525,64356173,190649,2]
[64265893,64335836,69944,"ENSG00000169118","ENST00000561349","protein_coding",0,"CSNK1G1","casein kinase 1 gamma 1 [Source:HGNC Symbol;Acc:HGNC:2454]","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0006897(endocytosis);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0090263(positive regulation of canonical Wnt signaling pathway)","04340(Hedgehog signaling pathway)",{"v":1.3E-70,"d":"0.00"},3,"22,405,52,","0,34426,69892",-7.17,{"v":1.62181009735893E-9,"d":"0.00"},-1.45,"5' UTR",15,64165737,64300697,134961,2]
[66548341,66551751,3411,"ENSG00000174442","ENST00000535141","protein_coding",43382,"ZWILCH","zwilch kinetochore protein [Source:HGNC Symbol;Acc:HGNC:25468]","GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000777(condensed chromosome kinetochore);GO:0005515(protein binding);GO:0005694(chromosome);GO:0005829(cytosol);GO:0007049(cell cycle);GO:0007093(mitotic cell cycle checkpoint);GO:0051301(cell division);GO:1990423(RZZ complex)","NA",{"v":1.3E-28,"d":"0.00"},3,"265,64,90,","0,1700,3321",-4.99,{"v":3.98107170553497e-07,"d":"0.00"},-1.41,"3' UTR",15,66504959,66548426,43468,1]
[71164770,71165210,441,"ENSG00000187720","ENST00000355327","protein_coding",67818,"THSD4","thrombospondin type 1 domain containing 4 [Source:HGNC Symbol;Acc:HGNC:25835]","GO:0001527(microfibril);GO:0005201(extracellular matrix structural constituent);GO:0005576(extracellular region);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0016787(hydrolase activity);GO:0031012(extracellular matrix);GO:0048251(elastic fiber assembly);GO:0062023(collagen-containing extracellular matrix);GO:0070062(extracellular exosome)","NA",{"v":1E-180,"d":"0.00"},1,"441,",0,-223,{"v":9.99999999999999e-227,"d":"0.00"},-1.95,"Exon (ENST00000569046/ENSG00000259781, exon 1 of 1)",15,71096952,71783383,686432,1]
[77615448,77615746,299,"ENSG00000169783","ENST00000355300","protein_coding",16744,"LINGO1","leucine rich repeat and Ig domain containing 1 [Source:HGNC Symbol;Acc:HGNC:21205]","GO:0005154(epidermal growth factor receptor binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031012(extracellular matrix);GO:0050771(negative regulation of axonogenesis)","NA",{"v":5.2e-09,"d":"0.00"},1,"299,",0,-1.13,{"v":0.0134896288259165,"d":"0.01"},{"v":-1.7,"d":"-1.70"},"Exon (ENST00000355300/ENSG00000169783, exon 2 of 2)",15,77613027,77632490,19464,2]
[78593172,78595460,2289,"ENSG00000080644","ENST00000559002","processed_transcript",1272,"CHRNA3","cholinergic receptor nicotinic alpha 3 subunit [Source:HGNC Symbol;Acc:HGNC:1957]","GO:0004888(transmembrane signaling receptor activity);GO:0005216(ion channel activity);GO:0005230(extracellular ligand-gated ion channel activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005892(acetylcholine-gated channel complex);GO:0006811(ion transport);GO:0006940(regulation of smooth muscle contraction);GO:0007165(signal transduction);GO:0007171(activation of transmembrane receptor protein tyrosine kinase activity);GO:0007268(chemical synaptic transmission);GO:0007271(synaptic transmission, cholinergic);GO:0007274(neuromuscular synaptic transmission);GO:0007399(nervous system development);GO:0007626(locomotory behavior);GO:0014056(regulation of acetylcholine secretion, neurotransmission);GO:0014069(postsynaptic density);GO:0015276(ligand-gated ion channel activity);GO:0015464(acetylcholine receptor activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022848(acetylcholine-gated cation-selective channel activity);GO:0030054(cell junction);GO:0030425(dendrite);GO:0034220(ion transmembrane transport);GO:0035094(response to nicotine);GO:0035095(behavioral response to nicotine);GO:0042166(acetylcholine binding);GO:0042391(regulation of membrane potential);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0044853(plasma membrane raft);GO:0045202(synapse);GO:0045211(postsynaptic membrane);GO:0048814(regulation of dendrite morphogenesis);GO:0050877(nervous system process);GO:0060079(excitatory postsynaptic potential);GO:0060084(synaptic transmission involved in micturition);GO:0095500(acetylcholine receptor signaling pathway);GO:1905144(response to acetylcholine)","04080(Neuroactive ligand-receptor interaction);04725(Cholinergic synapse)",{"v":3.3E-4,"d":"0.00"},3,"20,98,152,","0,742,2137",-1.16,{"v":0.0123026877081238,"d":"0.01"},-1.39,"3' UTR",15,78593052,78596732,3681,2]
[113909144,113909354,211,"ENSG00000196865","ENST00000369301","protein_coding",54483,"NHLRC2","NHL repeat containing 2 [Source:HGNC Symbol;Acc:HGNC:24731]","GO:0002576(platelet degranulation);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0031093(platelet alpha granule lumen);GO:0045454(cell redox homeostasis)","NA",{"v":1.3e-08,"d":"0.00"},1,"211,",0,{"v":-1.8,"d":"-1.80"},{"v":0.00186208713666287,"d":"0.00"},-2.83,"3' UTR",10,113854661,113917194,62534,1]
[99727788,99728298,511,"ENSG00000183060","ENST00000604213","processed_transcript",5093,"LYSMD4","LysM domain containing 4 [Source:HGNC Symbol;Acc:HGNC:26571]","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":1.6e-31,"d":"0.00"},1,"511,",0,-1.67,{"v":2.69153480392692E-3,"d":"0.00"},-1.47,"3' UTR",15,99715697,99733391,17695,2]
[101347483,101364908,17426,"ENSG00000140479","ENST00000558951","protein_coding",1354,"PCSK6","proprotein convertase subtilisin/kexin type 6 [Source:HGNC Symbol;Acc:HGNC:8569]","GO:0004175(endopeptidase activity);GO:0004252(serine-type endopeptidase activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005783(endoplasmic reticulum);GO:0005796(Golgi lumen);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0007354(zygotic determination of anterior/posterior axis, embryo);GO:0007368(determination of left/right symmetry);GO:0008201(heparin binding);GO:0008233(peptidase activity);GO:0008236(serine-type peptidase activity);GO:0009100(glycoprotein metabolic process);GO:0009986(cell surface);GO:0012505(endomembrane system);GO:0016020(membrane);GO:0016485(protein processing);GO:0016486(peptide hormone processing);GO:0016787(hydrolase activity);GO:0030510(regulation of BMP signaling pathway);GO:0032455(nerve growth factor processing);GO:0032902(nerve growth factor production);GO:0032940(secretion by cell);GO:0048406(nerve growth factor binding);GO:0051004(regulation of lipoprotein lipase activity);GO:0062023(collagen-containing extracellular matrix);GO:0070268(cornification)","NA",{"v":6.3e-13,"d":"0.00"},2,"295,35,","0,17391",{"v":-0.755,"d":"-0.76"},{"v":0.0457088189614875,"d":"0.05"},-1.34,"3' UTR",15,101300613,101366262,65650,2]
[582998,583208,211,"ENSG00000007541","ENST00000409527","protein_coding",15989,"PIGQ","phosphatidylinositol glycan anchor biosynthesis class Q [Source:HGNC Symbol;Acc:HGNC:14135]","GO:0000506(glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex);GO:0005789(endoplasmic reticulum membrane);GO:0005975(carbohydrate metabolic process);GO:0006506(GPI anchor biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016254(preassembly of GPI anchor in ER membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0017176(phosphatidylinositol N-acetylglucosaminyltransferase activity)","00563(Glycosylphosphatidylinositol (GPI)-anchor biosynthesis)",{"v":2.3e-08,"d":"0.00"},1,"211,",0,-2.18,{"v":0.000630957344480193,"d":"0.00"},-1.21,"3' UTR",16,567009,583035,16027,1]
[2241643,2241818,176,"ENSG00000167969","ENST00000301729","protein_coding",9769,"ECI1","enoyl-CoA delta isomerase 1 [Source:HGNC Symbol;Acc:HGNC:2703]","GO:0003824(catalytic activity);GO:0004165(dodecenoyl-CoA delta-isomerase activity);GO:0004300(enoyl-CoA hydratase activity);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0006635(fatty acid beta-oxidation);GO:0016853(isomerase activity)","00071(Fatty acid degradation)",{"v":2.5e-47,"d":"0.00"},1,"176,",0,{"v":-0.958,"d":"-0.96"},{"v":0.0234422881531992,"d":"0.02"},-1.31,"Exon (ENST00000565709/ENSG00000261663, exon 2 of 2)",16,2239402,2251587,12186,2]
[2614067,2629627,15561,"ENSG00000279057","ENST00000624558","TEC",0,"AC141586","tec","NA","NA",{"v":1.6E-15,"d":"0.00"},2,"5,803,","0,14758",{"v":-0.852,"d":"-0.85"},{"v":0.0331131121482591,"d":"0.03"},-1.03,"Exon (ENST00000399702/ENSG00000215154, exon 3 of 4)",16,2620222,2621794,1573,2]
[3204394,3204835,442,"ENSG00000168124","ENST00000304646","protein_coding",147,"OR1F1","olfactory receptor family 1 subfamily F member 1 [Source:HGNC Symbol;Acc:HGNC:8194]","GO:0004930(G protein-coupled receptor activity);GO:0004984(olfactory receptor activity);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007608(sensory perception of smell);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0050896(response to stimulus);GO:0050911(detection of chemical stimulus involved in sensory perception of smell)","04740(Olfactory transduction)",{"v":4.1e-06,"d":"0.00"},1,"442,",0,-1.25,{"v":0.00933254300796992,"d":"0.01"},-1.67,"Exon (ENST00000304646/ENSG00000168124, exon 1 of 1)",16,3204247,3205188,942,1]
[82462695,82462994,300,"ENSG00000276710","ENST00000456932","transcribed_unprocessed_pseudogene",3223,"CSPG4P10","chondroitin sulfate proteoglycan 4 pseudogene 10 [Source:HGNC Symbol;Acc:HGNC:48361]","NA","NA",{"v":1.4E-8,"d":"0.00"},1,"300,",0,{"v":-0.833,"d":"-0.83"},{"v":0.0354813389233576,"d":"0.04"},-2.85,"Exon (ENST00000456932/ENSG00000276710, exon 2 of 7)",15,82459472,82470008,10537,1]
[12051866,12052076,211,"ENSG00000048471","ENST00000566228","protein_coding",75132,"SNX29","sorting nexin 29 [Source:HGNC Symbol;Acc:HGNC:30542]","GO:0035091(phosphatidylinositol binding)","NA",{"v":3.5e-10,"d":"0.00"},1,"211,",0,-1.19,{"v":0.0112201845430196,"d":"0.01"},-1.19,"Exon (ENST00000566228/ENSG00000048471, exon 8 of 21)",16,11976734,12574287,597554,1]
[149173005,149173304,300,"ENSG00000047457","ENST00000481169","nonsense_mediated_decay",48523,"CP","ceruloplasmin [Source:HGNC Symbol;Acc:HGNC:2295]","GO:0004322(ferroxidase activity);GO:0005507(copper ion binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005623(cell);GO:0005765(lysosomal membrane);GO:0005788(endoplasmic reticulum lumen);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006825(copper ion transport);GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0016491(oxidoreductase activity);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process);GO:0046872(metal ion binding);GO:0051087(chaperone binding);GO:0055072(iron ion homeostasis);GO:0055114(oxidation-reduction process);GO:0070062(extracellular exosome);GO:0072562(blood microparticle)","00860(Porphyrin and chlorophyll metabolism);04216(Ferroptosis)",{"v":1.3E-18,"d":"0.00"},1,"300,",0,-1.03,{"v":0.0186208713666287,"d":"0.02"},-2.86,"3' UTR",3,149162410,149221827,59418,2]
[22533646,22534095,450,"ENSG00000243716","ENST00000415654","processed_transcript",54525,"NPIPB5","nuclear pore complex interacting protein family member B5 [Source:HGNC Symbol;Acc:HGNC:37233]","GO:0005654(nucleoplasm);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":1.8E-9,"d":"0.00"},1,"450,",0,-2.31,{"v":0.000446683592150963,"d":"0.00"},-1.02,"3' UTR",16,22479121,22536513,57393,1]
[23676932,23677262,331,"ENSG00000166847","ENST00000300087","protein_coding",35466,"DCTN5","dynactin subunit 5 [Source:HGNC Symbol;Acc:HGNC:24594]","GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000777(condensed chromosome kinetochore);GO:0003281(ventricular septum development);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0019886(antigen processing and presentation of exogenous peptide antigen via MHC class II);GO:0031965(nuclear membrane);GO:0035904(aorta development);GO:0060976(coronary vasculature development)","04962(Vasopressin-regulated water reabsorption)",{"v":1.7E-8,"d":"0.00"},1,"331,",0,-1.13,{"v":0.0134896288259165,"d":"0.01"},-1.04,"3' UTR",16,23641466,23677472,36007,1]
[28591640,28591790,151,"ENSG00000176476","ENST00000317058","protein_coding",37720,"SGF29","SAGA complex associated factor 29 [Source:HGNC Symbol;Acc:HGNC:25156]","GO:0000124(SAGA complex);GO:0001135(RNA polymerase II transcription regulator recruiting activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005671(Ada2/Gcn5/Ada3 transcription activator complex);GO:0006325(chromatin organization);GO:0016573(histone acetylation);GO:0019899(enzyme binding);GO:0035064(methylated histone binding);GO:0043966(histone H3 acetylation);GO:0047485(protein N-terminus binding);GO:0051123(RNA polymerase II preinitiation complex assembly);GO:0070461(SAGA-type complex);GO:0071169(establishment of protein localization to chromatin)","NA",{"v":7.9e-13,"d":"0.00"},1,"151,",0,{"v":-0.959,"d":"-0.96"},{"v":0.0234422881531992,"d":"0.02"},-1.33,"3' UTR",16,28553920,28591790,37871,1]
[28723132,28724729,1598,"ENSG00000278340","ENST00000614755","miRNA",0,"MIR6862-2","microRNA 6862-2 [Source:HGNC Symbol;Acc:HGNC:50192]","NA","NA",0,4,"192,104,142,72,","0,316,1190,1526",{"v":-66.3,"d":"-66.30"},{"v":3.98107170553492e-70,"d":"0.00"},-1.23,"Exon (ENST00000566501/ENSG00000184110, exon 9 of 21)",16,28724252,28724321,70,1]
[2656810,2657229,420,"ENSG00000223773","ENST00000435581","processed_transcript",47418,"CD99P1","CD99 molecule pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:7083]","NA","NA",{"v":1.1e-08,"d":"0.00"},1,"420,",0,{"v":-0.764,"d":"-0.76"},{"v":0.0446683592150963,"d":"0.04"},-2.86,"Exon (ENST00000435581/ENSG00000223773, exon 9 of 9)",23,2609392,2657229,47838,1]
[50749673,50750063,391,"ENSG00000083799","ENST00000563629","retained_intron",0,"CYLD","CYLD lysine 63 deubiquitinase [Source:HGNC Symbol;Acc:HGNC:2584]","GO:0002376(immune system process);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005819(spindle);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005881(cytoplasmic microtubule);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007049(cell cycle);GO:0007346(regulation of mitotic cell cycle);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0008270(zinc ion binding);GO:0010803(regulation of tumor necrosis factor-mediated signaling pathway);GO:0016020(membrane);GO:0016055(Wnt signaling pathway);GO:0016579(protein deubiquitination);GO:0016787(hydrolase activity);GO:0019901(protein kinase binding);GO:0030496(midbody);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0032480(negative regulation of type I interferon production);GO:0036064(ciliary basal body);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042995(cell projection);GO:0043369(CD4-positive or CD8-positive, alpha-beta T cell lineage commitment);GO:0043393(regulation of protein binding);GO:0045087(innate immune response);GO:0045577(regulation of B cell differentiation);GO:0045582(positive regulation of T cell differentiation);GO:0046329(negative regulation of JNK cascade);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0048872(homeostasis of number of cells);GO:0050727(regulation of inflammatory response);GO:0050862(positive regulation of T cell receptor signaling pathway);GO:0060544(regulation of necroptotic process);GO:0061578(Lys63-specific deubiquitinase activity);GO:0070064(proline-rich region binding);GO:0070266(necroptotic process);GO:0070423(nucleotide-binding oligomerization domain containing signaling pathway);GO:0070507(regulation of microtubule cytoskeleton organization);GO:0070536(protein K63-linked deubiquitination);GO:0071108(protein K48-linked deubiquitination);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0097542(ciliary tip);GO:1901026(ripoptosome assembly involved in necroptotic process);GO:1901223(negative regulation of NIK/NF-kappaB signaling);GO:1902017(regulation of cilium assembly);GO:1903753(negative regulation of p38MAPK cascade);GO:1903829(positive regulation of cellular protein localization);GO:1990108(protein linear deubiquitination);GO:1990380(Lys48-specific deubiquitinase activity);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway);GO:2001242(regulation of intrinsic apoptotic signaling pathway)","04217(Necroptosis);04380(Osteoclast differentiation);04622(RIG-I-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway)",{"v":5e-21,"d":"0.00"},1,"391,",0,-2.83,{"v":1.09647819614319E-4,"d":"0.00"},-1.11,"5' UTR",16,50749963,50787746,37784,1]
[53826046,53826406,361,"ENSG00000140718","ENST00000563011","protein_coding",0,"FTO","FTO, alpha-ketoglutarate dependent dioxygenase [Source:HGNC Symbol;Acc:HGNC:24678]","GO:0001659(temperature homeostasis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006307(DNA dealkylation involved in DNA repair);GO:0008198(ferrous iron binding);GO:0010883(regulation of lipid storage);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0016607(nuclear speck);GO:0016740(transferase activity);GO:0035515(oxidative RNA demethylase activity);GO:0035516(oxidative DNA demethylase activity);GO:0035552(oxidative single-stranded DNA demethylation);GO:0035553(oxidative single-stranded RNA demethylation);GO:0040014(regulation of multicellular organism growth);GO:0042245(RNA repair);GO:0043734(DNA-N1-methyladenine dioxygenase activity);GO:0044065(regulation of respiratory system process);GO:0046872(metal ion binding);GO:0051213(dioxygenase activity);GO:0055114(oxidation-reduction process);GO:0060612(adipose tissue development);GO:0061157(mRNA destabilization);GO:0070350(regulation of white fat cell proliferation);GO:0070989(oxidative demethylation);GO:0080111(DNA demethylation);GO:0090335(regulation of brown fat cell differentiation);GO:1990931(RNA N6-methyladenosine dioxygenase activity);GO:1990984(tRNA demethylase activity)","NA",{"v":1.4E-8,"d":"0.00"},1,"361,",0,{"v":-18.8,"d":"-18.80"},{"v":7.94328234724279e-22,"d":"0.00"},-1.66,"Exon (ENST00000636491/ENSG00000140718, exon 4 of 10)",16,53826361,54040726,214366,1]
[57025994,57026923,930,"ENSG00000140853","ENST00000538110","protein_coding",0,"NLRC5","NLR family CARD domain containing 5 [Source:HGNC Symbol;Acc:HGNC:29933]","GO:0000166(nucleotide binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0002376(immune system process);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0009617(response to bacterium);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0032480(negative regulation of type I interferon production);GO:0035556(intracellular signal transduction);GO:0043549(regulation of kinase activity);GO:0045087(innate immune response);GO:0045345(positive regulation of MHC class I biosynthetic process);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051607(defense response to virus);GO:0060335(positive regulation of interferon-gamma-mediated signaling pathway);GO:0060339(negative regulation of type I interferon-mediated signaling pathway);GO:0060340(positive regulation of type I interferon-mediated signaling pathway)","NA",{"v":1e-115,"d":"0.00"},1,"930,",0,-7.25,{"v":1.3182567385564E-9,"d":"0.00"},-1.01,"Exon (ENST00000539881/ENSG00000140853, exon 6 of 25)",16,57026423,57061933,35511,1]
[66890650,66890740,91,"ENSG00000172840","ENST00000311765","protein_coding",10289,"PDP2","pyruvate dehyrogenase phosphatase catalytic subunit 2 [Source:HGNC Symbol;Acc:HGNC:30263]","GO:0003824(catalytic activity);GO:0004721(phosphoprotein phosphatase activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0004724(magnesium-dependent protein serine/threonine phosphatase activity);GO:0004741([pyruvate dehydrogenase (lipoamide)] phosphatase activity);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006470(protein dephosphorylation);GO:0010510(regulation of acetyl-CoA biosynthetic process from pyruvate);GO:0016787(hydrolase activity);GO:0043169(cation binding);GO:0046872(metal ion binding);GO:1904184(positive regulation of pyruvate dehydrogenase activity)","NA",{"v":0.00025,"d":"0.00"},1,"91,",0,{"v":-0.953,"d":"-0.95"},{"v":0.0234422881531992,"d":"0.02"},-1.48,"3' UTR",16,66880361,66891096,10736,1]
[64896977,64898397,1421,"ENSG00000176809","ENST00000319651","protein_coding",0,"LRRC37A3","leucine rich repeat containing 37 member A3 [Source:HGNC Symbol;Acc:HGNC:32427]","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":2.9e-09,"d":"0.00"},2,"684,36,","0,1385",-0.75,{"v":0.0467735141287198,"d":"0.05"},-2.87,"5' UTR",17,64854370,64897660,43291,2]
[52167739,52168037,299,"ENSG00000217576","ENST00000451298","processed_transcript",123520,"AL158066","novel transcript","NA","NA",{"v":8.1e-09,"d":"0.00"},1,"299,",0,{"v":-0.896,"d":"-0.90"},{"v":0.0288403150312661,"d":"0.03"},-2.88,"Exon (ENST00000416599/ENSG00000243406, exon 9 of 9)",13,52167709,52291557,123849,2]
[67171714,67172890,1177,"ENSG00000140939","ENST00000565560","protein_coding",1560,"AC074143","nucleolar protein 3 [Source:NCBI gene;Acc:8996]","GO:0001666(response to hypoxia);GO:0001974(blood vessel remodeling);GO:0002931(response to ischemia);GO:0003723(RNA binding);GO:0005102(signaling receptor binding);GO:0005123(death receptor binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006376(mRNA splice site selection);GO:0006397(mRNA processing);GO:0006915(apoptotic process);GO:0008380(RNA splicing);GO:0010468(regulation of gene expression);GO:0010659(cardiac muscle cell apoptotic process);GO:0010664(negative regulation of striated muscle cell apoptotic process);GO:0010667(negative regulation of cardiac muscle cell apoptotic process);GO:0010804(negative regulation of tumor necrosis factor-mediated signaling pathway);GO:0014736(negative regulation of muscle atrophy);GO:0014808(release of sequestered calcium ion into cytosol by sarcoplasmic reticulum);GO:0014876(response to injury involved in regulation of muscle adaptation);GO:0016020(membrane);GO:0016528(sarcoplasm);GO:0016529(sarcoplasmic reticulum);GO:0035877(death effector domain binding);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043027(cysteine-type endopeptidase inhibitor activity involved in apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0046872(metal ion binding);GO:0051259(protein complex oligomerization);GO:0060547(negative regulation of necrotic cell death);GO:0089720(caspase binding);GO:0090201(negative regulation of release of cytochrome c from mitochondria);GO:0097193(intrinsic apoptotic signaling pathway);GO:1901222(regulation of NIK/NF-kappaB signaling);GO:1902109(negative regulation of mitochondrial membrane permeability involved in apoptotic process);GO:1902176(negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway);GO:1903298(negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway);GO:1990001(inhibition of cysteine-type endopeptidase activity involved in apoptotic process);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","NA",{"v":2E-16,"d":"0.00"},2,"289,131,","0,1046",-1.26,{"v":0.00891250938133746,"d":"0.01"},-1.21,"Exon (ENST00000568199/ENSG00000140939, exon 1 of 2)",16,67170154,67174848,4695,1]
[69326461,69326640,180,"ENSG00000132612","ENST00000254950","protein_coding",15111,"VPS4A","vacuolar protein sorting 4 homolog A [Source:HGNC Symbol;Acc:HGNC:13488]","GO:0000166(nucleotide binding);GO:0000916(actomyosin contractile ring contraction);GO:0000922(spindle pole);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005768(endosome);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005774(vacuolar membrane);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006622(protein targeting to lysosome);GO:0006900(vesicle budding from membrane);GO:0006997(nucleus organization);GO:0006998(nuclear envelope organization);GO:0007033(vacuole organization);GO:0007049(cell cycle);GO:0007080(mitotic metaphase plate congression);GO:0008022(protein C-terminus binding);GO:0009838(abscission);GO:0010008(endosome membrane);GO:0015031(protein transport);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0016197(endosomal transport);GO:0016236(macroautophagy);GO:0016787(hydrolase activity);GO:0016887(ATPase activity);GO:0019058(viral life cycle);GO:0019076(viral release from host cell);GO:0019904(protein domain specific binding);GO:0030496(midbody);GO:0031468(nuclear envelope reassembly);GO:0031902(late endosome membrane);GO:0032367(intracellular cholesterol transport);GO:0032466(negative regulation of cytokinesis);GO:0032880(regulation of protein localization);GO:0034058(endosomal vesicle fusion);GO:0036258(multivesicular body assembly);GO:0039702(viral budding via host ESCRT complex);GO:0042623(ATPase activity, coupled);GO:0043162(ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway);GO:0044877(protein-containing complex binding);GO:0044878(mitotic cytokinesis checkpoint);GO:0048471(perinuclear region of cytoplasm);GO:0051301(cell division);GO:0061640(cytoskeleton-dependent cytokinesis);GO:0061738(late endosomal microautophagy);GO:0061952(midbody abscission);GO:0070062(extracellular exosome);GO:0072319(vesicle uncoating);GO:0090543(Flemming body);GO:0090611(ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway);GO:1902188(positive regulation of viral release from host cell);GO:1903076(regulation of protein localization to plasma membrane);GO:1903543(positive regulation of exosomal secretion);GO:1903774(positive regulation of viral budding via host ESCRT complex);GO:1903902(positive regulation of viral life cycle);GO:1904896(ESCRT complex disassembly);GO:1904903(ESCRT III complex disassembly)","04144(Endocytosis);04217(Necroptosis)",{"v":1.1E-5,"d":"0.00"},1,"180,",0,-1.64,{"v":0.00288403150312661,"d":"0.00"},-1.34,"3' UTR",16,69311350,69326939,15590,1]
[69695198,69695468,271,"ENSG00000102908","ENST00000426654","nonsense_mediated_decay",130104,"NFAT5","nuclear factor of activated T cells 5 [Source:HGNC Symbol;Acc:HGNC:7774]","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001816(cytokine production);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006366(transcription by RNA polymerase II);GO:0006970(response to osmotic stress);GO:0007165(signal transduction);GO:0007588(excretion);GO:0008134(transcription factor binding);GO:0010628(positive regulation of gene expression);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0033173(calcineurin-NFAT signaling cascade);GO:0044798(nuclear transcription factor complex);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0070884(regulation of calcineurin-NFAT signaling cascade);GO:0071345(cellular response to cytokine stimulus);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:1904996(positive regulation of leukocyte adhesion to vascular endothelial cell)","NA",{"v":4e-15,"d":"0.00"},1,"271,",0,-1.84,{"v":1.65958690743756E-3,"d":"0.00"},-1.04,"3' UTR",16,69565094,69704650,139557,1]
[75110515,75110844,330,"ENSG00000247033","ENST00000499110","antisense",0,"AC099508","novel transcript, antisense to ZNRF1","NA","NA",{"v":2.3E-5,"d":"0.00"},1,"330,",0,{"v":-0.957,"d":"-0.96"},{"v":0.0234422881531992,"d":"0.02"},-1.31,"3' UTR",16,75108601,75110712,2112,2]
[77191194,77191403,210,"ENSG00000103111","ENST00000545553","protein_coding",0,"MON1B","MON1 homolog B, secretory trafficking associated [Source:HGNC Symbol;Acc:HGNC:25020]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0019085(early viral transcription);GO:0019086(late viral transcription);GO:0035658(Mon1-Ccz1 complex)","NA",{"v":4e-11,"d":"0.00"},1,"210,",0,-2.85,{"v":1.0471285480509E-4,"d":"0.00"},-1.33,"5' UTR",16,77191200,77198894,7695,1]
[81958037,81958307,271,"ENSG00000197943","ENST00000564138","protein_coding",178746,"PLCG2","phospholipase C gamma 2 [Source:HGNC Symbol;Acc:HGNC:9066]","GO:0001784(phosphotyrosine residue binding);GO:0002092(positive regulation of receptor internalization);GO:0002223(stimulatory C-type lectin receptor signaling pathway);GO:0002316(follicular B cell differentiation);GO:0004435(phosphatidylinositol phospholipase C activity);GO:0004629(phospholipase C activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006629(lipid metabolic process);GO:0006661(phosphatidylinositol biosynthetic process);GO:0007165(signal transduction);GO:0008081(phosphoric diester hydrolase activity);GO:0009395(phospholipid catabolic process);GO:0010468(regulation of gene expression);GO:0016042(lipid catabolic process);GO:0016055(Wnt signaling pathway);GO:0016787(hydrolase activity);GO:0019722(calcium-mediated signaling);GO:0030168(platelet activation);GO:0030183(B cell differentiation);GO:0032237(activation of store-operated calcium channel activity);GO:0032481(positive regulation of type I interferon production);GO:0032496(response to lipopolysaccharide);GO:0032959(inositol trisphosphate biosynthetic process);GO:0035556(intracellular signal transduction);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0038096(Fc-gamma receptor signaling pathway involved in phagocytosis);GO:0043069(negative regulation of programmed cell death);GO:0043647(inositol phosphate metabolic process);GO:0048015(phosphatidylinositol-mediated signaling);GO:0050852(T cell receptor signaling pathway);GO:0050853(B cell receptor signaling pathway);GO:0051209(release of sequestered calcium ion into cytosol);GO:0070062(extracellular exosome)","00562(Inositol phosphate metabolism);01521(EGFR tyrosine kinase inhibitor resistance);04012(ErbB signaling pathway);04014(Ras signaling pathway);04020(Calcium signaling pathway);04064(NF-kappa B signaling pathway);04066(HIF-1 signaling pathway);04070(Phosphatidylinositol signaling system);04072(Phospholipase D signaling pathway);04360(Axon guidance);04370(VEGF signaling pathway);04380(Osteoclast differentiation);04611(Platelet activation);04625(C-type lectin receptor signaling pathway);04650(Natural killer cell mediated cytotoxicity);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04666(Fc gamma R-mediated phagocytosis);04670(Leukocyte transendothelial migration);04722(Neurotrophin signaling pathway);04750(Inflammatory mediator regulation of TRP channels);04919(Thyroid hormone signaling pathway);04933(AGE-RAGE signaling pathway in diabetic complications);05110(Vibrio cholerae infection);05120(Epithelial cell signaling in Helicobacter pylori infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer);05205(Proteoglycans in cancer);05206(MicroRNAs in cancer);05214(Glioma);05223(Non-small cell lung cancer);05225(Hepatocellular carcinoma)",{"v":2.4E-8,"d":"0.00"},1,"271,",0,-1.88,{"v":0.00147910838816821,"d":"0.00"},{"v":-1.4,"d":"-1.40"},"3' UTR",16,81779291,81962685,183395,1]
[83912233,83912473,241,"ENSG00000103150","ENST00000262430","protein_coding",13118,"MLYCD","malonyl-CoA decarboxylase [Source:HGNC Symbol;Acc:HGNC:7150]","GO:0002931(response to ischemia);GO:0005102(signaling receptor binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005777(peroxisome);GO:0005782(peroxisomal matrix);GO:0005829(cytosol);GO:0006085(acetyl-CoA biosynthetic process);GO:0006625(protein targeting to peroxisome);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0006637(acyl-CoA metabolic process);GO:0010906(regulation of glucose metabolic process);GO:0016829(lyase activity);GO:0016831(carboxy-lyase activity);GO:0019395(fatty acid oxidation);GO:0031998(regulation of fatty acid beta-oxidation);GO:0042802(identical protein binding);GO:0046320(regulation of fatty acid oxidation);GO:0046321(positive regulation of fatty acid oxidation);GO:0050080(malonyl-CoA decarboxylase activity);GO:2001294(malonyl-CoA catabolic process)","00410(beta-Alanine metabolism);00640(Propanoate metabolism);04146(Peroxisome);04152(AMPK signaling pathway)",{"v":3.2e-11,"d":"0.00"},1,"241,",0,-2.69,{"v":0.000158489319246111,"d":"0.00"},-1.63,"Exon (ENST00000262430/ENSG00000103150, exon 4 of 5)",16,83899115,83927031,27917,1]
[83912277,83932255,19979,"ENSG00000260300","ENST00000566667","processed_transcript",0,"AC009119","novel protein","GO:0006633(fatty acid biosynthetic process);GO:0050080(malonyl-CoA decarboxylase activity)","NA",{"v":7.9e-11,"d":"0.00"},3,"91,108,11,","0,19034,19968",-2.81,{"v":1.14815362149688E-4,"d":"0.00"},-1.58,"3' UTR",16,83931311,83949114,17804,1]
[89913268,89913627,360,"ENSG00000258839","ENST00000555427","protein_coding",0,"MC1R","melanocortin 1 receptor [Source:HGNC Symbol;Acc:HGNC:6929]","GO:0004930(G protein-coupled receptor activity);GO:0004977(melanocortin receptor activity);GO:0004980(melanocyte-stimulating hormone receptor activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007187(G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0007275(multicellular organism development);GO:0008528(G protein-coupled peptide receptor activity);GO:0009650(UV protection);GO:0010739(positive regulation of protein kinase A signaling);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019233(sensory perception of pain);GO:0031625(ubiquitin protein ligase binding);GO:0032720(negative regulation of tumor necrosis factor production);GO:0035556(intracellular signal transduction);GO:0042438(melanin biosynthetic process);GO:0043473(pigmentation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051897(positive regulation of protein kinase B signaling);GO:0070914(UV-damage excision repair);GO:0090037(positive regulation of protein kinase C signaling)","04080(Neuroactive ligand-receptor interaction);04916(Melanogenesis)",{"v":1e-05,"d":"0.00"},1,"360,",0,{"v":-0.829,"d":"-0.83"},{"v":0.0354813389233576,"d":"0.04"},-1.55,"5' UTR",16,89913418,89920973,7556,1]
[89913274,89913573,300,"ENSG00000258839","ENST00000555427","protein_coding",0,"MC1R","melanocortin 1 receptor [Source:HGNC Symbol;Acc:HGNC:6929]","GO:0004930(G protein-coupled receptor activity);GO:0004977(melanocortin receptor activity);GO:0004980(melanocyte-stimulating hormone receptor activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007187(G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0007275(multicellular organism development);GO:0008528(G protein-coupled peptide receptor activity);GO:0009650(UV protection);GO:0010739(positive regulation of protein kinase A signaling);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019233(sensory perception of pain);GO:0031625(ubiquitin protein ligase binding);GO:0032720(negative regulation of tumor necrosis factor production);GO:0035556(intracellular signal transduction);GO:0042438(melanin biosynthetic process);GO:0043473(pigmentation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051897(positive regulation of protein kinase B signaling);GO:0070914(UV-damage excision repair);GO:0090037(positive regulation of protein kinase C signaling)","04080(Neuroactive ligand-receptor interaction);04916(Melanogenesis)",{"v":1e-05,"d":"0.00"},1,"300,",0,{"v":-0.869,"d":"-0.87"},{"v":0.0316227766016838,"d":"0.03"},-1.61,"5' UTR",16,89913418,89920973,7556,1]
[89948764,89949516,753,"ENSG00000140995","ENST00000561741","protein_coding",0,"DEF8","differentially expressed in FDCP 8 homolog [Source:HGNC Symbol;Acc:HGNC:25969]","GO:0032418(lysosome localization);GO:0035556(intracellular signal transduction);GO:0045780(positive regulation of bone resorption);GO:0046872(metal ion binding);GO:1900029(positive regulation of ruffle assembly)","NA",{"v":2.7E-4,"d":"0.00"},2,"51,100,","0,653",-1.95,{"v":0.00123026877081238,"d":"0.00"},-1.08,"5' UTR",16,89948775,89959097,10323,1]
[52167739,52168038,300,"ENSG00000217576","ENST00000451298","processed_transcript",123519,"AL158066","novel transcript","NA","NA",{"v":8.1e-09,"d":"0.00"},1,"300,",0,{"v":-0.896,"d":"-0.90"},{"v":0.0288403150312661,"d":"0.03"},-2.88,"Exon (ENST00000416599/ENSG00000243406, exon 9 of 9)",13,52167709,52291557,123849,2]
[1364201,1366148,1948,"ENSG00000059145","ENST00000562537","processed_transcript",0,"UNKL","unk like zinc finger [Source:HGNC Symbol;Acc:HGNC:14184]","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0046872(metal ion binding)","NA",{"v":1.6e-06,"d":"0.00"},2,"55,131,","0,1817",{"v":-1.9,"d":"-1.90"},{"v":0.00138038426460289,"d":"0.00"},-1.57,"3' UTR",16,1364174,1366148,1975,2]
[1981128,1984192,3065,"ENSG00000196408","ENST00000356120","protein_coding",0,"NOXO1","NADPH oxidase organizer 1 [Source:HGNC Symbol;Acc:HGNC:19404]","GO:0005515(protein binding);GO:0005543(phospholipid binding);GO:0005886(plasma membrane);GO:0006801(superoxide metabolic process);GO:0008289(lipid binding);GO:0010310(regulation of hydrogen peroxide metabolic process);GO:0016020(membrane);GO:0016176(superoxide-generating NADPH oxidase activator activity);GO:0019899(enzyme binding);GO:0022617(extracellular matrix disassembly);GO:0035091(phosphatidylinositol binding);GO:0043020(NADPH oxidase complex);GO:0043085(positive regulation of catalytic activity);GO:0060263(regulation of respiratory burst)","NA",{"v":4e-19,"d":"0.00"},3,"422,92,26,","0,1532,3039",{"v":-0.761,"d":"-0.76"},{"v":0.0446683592150963,"d":"0.04"},-1.09,"5' UTR",16,1978917,1981467,2551,2]
[2039845,2040140,296,"ENSG00000065057","ENST00000651570","protein_coding",7694,"NTHL1","nth like DNA glycosylase 1 [Source:HGNC Symbol;Acc:HGNC:8028]","GO:0000703(oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity);GO:0003677(DNA binding);GO:0003690(double-stranded DNA binding);GO:0003824(catalytic activity);GO:0003906(DNA-(apurinic or apyrimidinic site) endonuclease activity);GO:0004519(endonuclease activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0006281(DNA repair);GO:0006284(base-excision repair);GO:0006285(base-excision repair, AP site formation);GO:0006296(nucleotide-excision repair, DNA incision, 5'-to lesion);GO:0006974(cellular response to DNA damage stimulus);GO:0008152(metabolic process);GO:0008534(oxidized purine nucleobase lesion DNA N-glycosylase activity);GO:0016787(hydrolase activity);GO:0016798(hydrolase activity, acting on glycosyl bonds);GO:0016829(lyase activity);GO:0019104(DNA N-glycosylase activity);GO:0045008(depyrimidination);GO:0046872(metal ion binding);GO:0051536(iron-sulfur cluster binding);GO:0051539(4 iron, 4 sulfur cluster binding);GO:0140078(class I DNA-(apurinic or apyrimidinic site) endonuclease activity)","03410(Base excision repair)",{"v":2.5e-11,"d":"0.00"},2,"203,8,","0,288",-2.49,{"v":2.75422870333817E-4,"d":"0.00"},-1.13,"3' UTR",16,2039815,2047834,8020,2]
[2089640,2089789,150,"ENSG00000008710","ENST00000262304","protein_coding",46109,"PKD1","polycystin 1, transient receptor potential channel interacting [Source:HGNC Symbol;Acc:HGNC:9008]","GO:0000139(Golgi membrane);GO:0001502(cartilage condensation);GO:0001568(blood vessel development);GO:0001701(in utero embryonic development);GO:0001822(kidney development);GO:0001889(liver development);GO:0001892(embryonic placenta development);GO:0002133(polycystin complex);GO:0005262(calcium channel activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005929(cilium);GO:0006611(protein export from nucleus);GO:0006807(nitrogen compound metabolic process);GO:0006816(calcium ion transport);GO:0007050(cell cycle arrest);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007160(cell-matrix adhesion);GO:0007161(calcium-independent cell-matrix adhesion);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0007259(receptor signaling pathway via JAK-STAT);GO:0007507(heart development);GO:0009653(anatomical structure morphogenesis);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0016323(basolateral plasma membrane);GO:0016328(lateral plasma membrane);GO:0018105(peptidyl-serine phosphorylation);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0021510(spinal cord development);GO:0021915(neural tube development);GO:0030010(establishment of cell polarity);GO:0030155(regulation of cell adhesion);GO:0030246(carbohydrate binding);GO:0030660(Golgi-associated vesicle membrane);GO:0031514(motile cilium);GO:0032092(positive regulation of protein binding);GO:0034405(response to fluid shear stress);GO:0034703(cation channel complex);GO:0034704(calcium channel complex);GO:0036303(lymph vessel morphogenesis);GO:0042813(Wnt-activated receptor activity);GO:0042994(cytoplasmic sequestering of transcription factor);GO:0042995(cell projection);GO:0043588(skin development);GO:0044325(ion channel binding);GO:0045737(positive regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048565(digestive tract development);GO:0048754(branching morphogenesis of an epithelial tube);GO:0048806(genitalia development);GO:0050982(detection of mechanical stimulus);GO:0051216(cartilage development);GO:0051290(protein heterotetramerization);GO:0060170(ciliary membrane);GO:0060236(regulation of mitotic spindle organization);GO:0060428(lung epithelium development);GO:0060674(placenta blood vessel development);GO:0061136(regulation of proteasomal protein catabolic process);GO:0070062(extracellular exosome);GO:0070588(calcium ion transmembrane transport);GO:0072164(mesonephric tubule development);GO:0072177(mesonephric duct development);GO:0072205(metanephric collecting duct development);GO:0072218(metanephric ascending thin limb development);GO:0072237(metanephric proximal tubule development);GO:0072287(metanephric distal tubule morphogenesis);GO:0098609(cell-cell adhesion);GO:0198738(cell-cell signaling by wnt);GO:2000045(regulation of G1/S transition of mitotic cell cycle)","NA",{"v":1.1e-06,"d":"0.00"},1,"150,",0,-2.01,{"v":0.00102329299228075,"d":"0.00"},-1.42,"3' UTR",16,2088710,2135898,47189,2]
[3609403,3611606,2204,"ENSG00000188827","ENST00000294008","protein_coding",0,"SLX4","SLX4 structure-specific endonuclease subunit [Source:HGNC Symbol;Acc:HGNC:23845]","GO:0000706(meiotic DNA double-strand break processing);GO:0000712(resolution of meiotic recombination intermediates);GO:0000724(double-strand break repair via homologous recombination);GO:0000781(chromosome, telomeric region);GO:0000784(nuclear chromosome, telomeric region);GO:0000790(nuclear chromatin);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006260(DNA replication);GO:0006281(DNA repair);GO:0006289(nucleotide-excision repair);GO:0006310(DNA recombination);GO:0006974(cellular response to DNA damage stimulus);GO:0008047(enzyme activator activity);GO:0008821(crossover junction endodeoxyribonuclease activity);GO:0010792(DNA double-strand break processing involved in repair via single-strand annealing);GO:0017108(5'-flap endonuclease activity);GO:0030054(cell junction);GO:0033557(Slx1-Slx4 complex);GO:0036297(interstrand cross-link repair);GO:0043085(positive regulation of catalytic activity);GO:0048257(3'-flap endonuclease activity);GO:0048476(Holliday junction resolvase complex);GO:0061820(telomeric D-loop disassembly);GO:0070522(ERCC4-ERCC1 complex);GO:0072429(response to intra-S DNA damage checkpoint signaling);GO:0090656(t-circle formation);GO:1904357(negative regulation of telomere maintenance via telomere lengthening);GO:1904431(positive regulation of t-circle formation)","03460(Fanconi anemia pathway)",{"v":8.1e-08,"d":"0.00"},2,"164,47,","0,2157",{"v":-0.736,"d":"-0.74"},{"v":0.0489778819368446,"d":"0.05"},-1.25,"5' UTR",16,3581181,3611606,30426,2]
[4801483,4801633,151,"ENSG00000067836","ENST00000322048","protein_coding",1317,"ROGDI","rogdi atypical leucine zipper [Source:HGNC Symbol;Acc:HGNC:29478]","GO:0005622(intracellular);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005886(plasma membrane);GO:0007035(vacuolar acidification);GO:0007420(brain development);GO:0008021(synaptic vesicle);GO:0008284(positive regulation of cell population proliferation);GO:0016020(membrane);GO:0022008(neurogenesis);GO:0030054(cell junction);GO:0030097(hemopoiesis);GO:0030424(axon);GO:0030425(dendrite);GO:0031410(cytoplasmic vesicle);GO:0032502(developmental process);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042734(presynaptic membrane);GO:0042995(cell projection);GO:0043204(perikaryon);GO:0043291(RAVE complex);GO:0045202(synapse);GO:0098793(presynapse)","NA",{"v":0.0026,"d":"0.00"},1,"151,",0,-0.81,{"v":0.0380189396320561,"d":"0.04"},-1.02,"Exon (ENST00000322048/ENSG00000067836, exon 3 of 11)",16,4796968,4802950,5983,2]
[5024844,5025653,810,"ENSG00000103174","ENST00000381955","protein_coding",8281,"NAGPA","N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase [Source:HGNC Symbol;Acc:HGNC:17378]","GO:0003944(N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity);GO:0005515(protein binding);GO:0005794(Golgi apparatus);GO:0005975(carbohydrate metabolic process);GO:0006464(cellular protein modification process);GO:0006486(protein glycosylation);GO:0006622(protein targeting to lysosome);GO:0007040(lysosome organization);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0032580(Golgi cisterna membrane);GO:0033299(secretion of lysosomal enzymes)","04142(Lysosome)",{"v":2e-59,"d":"0.00"},1,"810,",0,{"v":-2.8,"d":"-2.80"},{"v":1.20226443461741E-4,"d":"0.00"},-1.06,"3' UTR",16,5024844,5033934,9091,2]
[23079754,23082469,2716,"ENSG00000103404","ENST00000219689","protein_coding",66801,"USP31","ubiquitin specific peptidase 31 [Source:HGNC Symbol;Acc:HGNC:20060]","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005634(nucleus);GO:0006508(proteolysis);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0016579(protein deubiquitination);GO:0016787(hydrolase activity);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity)","NA",{"v":2e-27,"d":"0.00"},2,"418,32,","0,2684",-1.94,{"v":0.00123026877081238,"d":"0.00"},-1.31,"Exon (ENST00000219689/ENSG00000103404, exon 12 of 16)",16,23061406,23149270,87865,2]
[28842710,28843008,299,"ENSG00000178952","ENST00000313511","protein_coding",3340,"TUFM","Tu translation elongation factor, mitochondrial [Source:HGNC Symbol;Acc:HGNC:12420]","GO:0000166(nucleotide binding);GO:0003723(RNA binding);GO:0003746(translation elongation factor activity);GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005622(intracellular);GO:0005739(mitochondrion);GO:0006412(translation);GO:0006414(translational elongation);GO:0016020(membrane);GO:0042645(mitochondrial nucleoid);GO:0045202(synapse);GO:0045471(response to ethanol);GO:0070062(extracellular exosome);GO:0070125(mitochondrial translational elongation)","NA",{"v":1e-145,"d":"0.00"},1,"299,",0,{"v":-76.6,"d":"-76.60"},{"v":1.58489319246112e-80,"d":"0.00"},-1.17,"3' UTR",16,28842411,28846348,3938,2]
[18358176,18361133,2958,"ENSG00000233024","ENST00000327792","protein_coding",0,"NPIPA9","nuclear pore complex interacting protein family, member A9 [Source:HGNC Symbol;Acc:HGNC:41984]","GO:0005654(nucleoplasm)","NA",{"v":7.2E-10,"d":"0.00"},5,"413,70,150,61,87,","0,1206,1658,1917,2871",-2.22,{"v":0.000575439937337157,"d":"0.00"},{"v":-2.9,"d":"-2.90"},"3' UTR",16,18358121,18358582,462,2]
[30532305,30533020,716,"ENSG00000169955","ENST00000395094","protein_coding",1898,"ZNF747","zinc finger protein 747 [Source:HGNC Symbol;Acc:HGNC:28350]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","NA",{"v":2.5e-12,"d":"0.00"},1,"716,",0,{"v":-0.995,"d":"-1.00"},{"v":0.0204173794466953,"d":"0.02"},-1.28,"3' UTR",16,30530367,30534918,4552,2]
[53696025,53696295,271,"ENSG00000103494","ENST00000647211","protein_coding",7564,"RPGRIP1L","RPGRIP1 like [Source:HGNC Symbol;Acc:HGNC:29168]","GO:0001701(in utero embryonic development);GO:0001736(establishment of planar polarity);GO:0001822(kidney development);GO:0001889(liver development);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005879(axonemal microtubule);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005923(bicellular tight junction);GO:0005929(cilium);GO:0005930(axoneme);GO:0007163(establishment or maintenance of cell polarity);GO:0007368(determination of left/right symmetry);GO:0007420(brain development);GO:0008589(regulation of smoothened signaling pathway);GO:0021532(neural tube patterning);GO:0021537(telencephalon development);GO:0021549(cerebellum development);GO:0021670(lateral ventricle development);GO:0021772(olfactory bulb development);GO:0022038(corpus callosum development);GO:0030054(cell junction);GO:0031870(thromboxane A2 receptor binding);GO:0032391(photoreceptor connecting cilium);GO:0032502(developmental process);GO:0035108(limb morphogenesis);GO:0035115(embryonic forelimb morphogenesis);GO:0035116(embryonic hindlimb morphogenesis);GO:0035253(ciliary rootlet);GO:0035869(ciliary transition zone);GO:0036064(ciliary basal body);GO:0042995(cell projection);GO:0043010(camera-type eye development);GO:0043584(nose development);GO:0045744(negative regulation of G protein-coupled receptor signaling pathway);GO:0060039(pericardium development);GO:0060271(cilium assembly);GO:0060322(head development);GO:0090102(cochlea development);GO:0097711(ciliary basal body-plasma membrane docking);GO:1905515(non-motile cilium assembly)","NA",{"v":1.6e-05,"d":"0.00"},1,"271,",0,-1.84,{"v":1.62181009735893E-3,"d":"0.00"},-1.19,"3' UTR",16,53598153,53703859,105707,2]
[67666126,67666876,751,"ENSG00000124074","ENST00000243878","protein_coding",0,"ENKD1","enkurin domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25246]","GO:0005515(protein binding);GO:0005881(cytoplasmic microtubule);GO:0015630(microtubule cytoskeleton)","NA",{"v":3.2e-32,"d":"0.00"},3,"149,393,88,","0,232,663",-2.27,{"v":0.000489778819368446,"d":"0.00"},-1.15,"5' UTR",16,67662945,67666750,3806,2]
[69365392,69365632,241,"ENSG00000132604","ENST00000254942","protein_coding",20375,"TERF2","telomeric repeat binding factor 2 [Source:HGNC Symbol;Acc:HGNC:11729]","GO:0000723(telomere maintenance);GO:0000781(chromosome, telomeric region);GO:0000783(nuclear telomere cap complex);GO:0000784(nuclear chromosome, telomeric region);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003691(double-stranded telomeric DNA binding);GO:0003720(telomerase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0006278(RNA-dependent DNA biosynthetic process);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007049(cell cycle);GO:0008022(protein C-terminus binding);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0016233(telomere capping);GO:0016604(nuclear body);GO:0019899(enzyme binding);GO:0030870(Mre11 complex);GO:0031627(telomeric loop formation);GO:0031848(protection from non-homologous end joining at telomere);GO:0032204(regulation of telomere maintenance);GO:0032205(negative regulation of telomere maintenance);GO:0032208(negative regulation of telomere maintenance via recombination);GO:0032210(regulation of telomere maintenance via telomerase);GO:0032211(negative regulation of telomere maintenance via telomerase);GO:0032214(negative regulation of telomere maintenance via semi-conservative replication);GO:0042162(telomeric DNA binding);GO:0042803(protein homodimerization activity);GO:0044877(protein-containing complex binding);GO:0051000(positive regulation of nitric-oxide synthase activity);GO:0061820(telomeric D-loop disassembly);GO:0070187(shelterin complex);GO:0070198(protein localization to chromosome, telomeric region);GO:0090398(cellular senescence);GO:0098505(G-rich strand telomeric DNA binding);GO:0099087(anterograde axonal transport of messenger ribonucleoprotein complex);GO:1903770(negative regulation of beta-galactosidase activity);GO:1903824(negative regulation of telomere single strand break repair);GO:1904115(axon cytoplasm);GO:1904354(negative regulation of telomere capping);GO:1904357(negative regulation of telomere maintenance via telomere lengthening);GO:1904430(negative regulation of t-circle formation);GO:1905778(negative regulation of exonuclease activity);GO:1905839(negative regulation of telomeric D-loop disassembly);GO:2000773(negative regulation of cellular senescence)","NA",{"v":7.4e-09,"d":"0.00"},1,"241,",0,{"v":-1.6,"d":"-1.60"},{"v":0.00323593656929628,"d":"0.00"},-1.32,"3' UTR",16,69355567,69386007,30441,2]
[75228211,75228690,480,"ENSG00000050820","ENST00000162330","protein_coding",22934,"BCAR1","BCAR1, Cas family scaffold protein [Source:HGNC Symbol;Acc:HGNC:971]","GO:0001558(regulation of cell growth);GO:0001726(ruffle);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0007015(actin filament organization);GO:0007155(cell adhesion);GO:0007165(signal transduction);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007229(integrin-mediated signaling pathway);GO:0008283(cell population proliferation);GO:0008286(insulin receptor signaling pathway);GO:0010595(positive regulation of endothelial cell migration);GO:0015629(actin cytoskeleton);GO:0016477(cell migration);GO:0017124(SH3 domain binding);GO:0019901(protein kinase binding);GO:0030027(lamellipodium);GO:0030054(cell junction);GO:0030335(positive regulation of cell migration);GO:0035729(cellular response to hepatocyte growth factor stimulus);GO:0042981(regulation of apoptotic process);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0048011(neurotrophin TRK receptor signaling pathway);GO:0048012(hepatocyte growth factor receptor signaling pathway);GO:0050851(antigen receptor-mediated signaling pathway);GO:0050852(T cell receptor signaling pathway);GO:0050853(B cell receptor signaling pathway);GO:0051301(cell division);GO:0060326(cell chemotaxis);GO:0090527(actin filament reorganization)","04015(Rap1 signaling pathway);04062(Chemokine signaling pathway);04510(Focal adhesion);04670(Leukocyte transendothelial migration);04810(Regulation of actin cytoskeleton);05100(Bacterial invasion of epithelial cells);05163(Human cytomegalovirus infection)",{"v":1.5E-5,"d":"0.00"},1,"480,",0,-0.76,{"v":0.0446683592150963,"d":"0.04"},-1.84,"3' UTR",16,75228181,75251624,23444,2]
[75612273,75612811,539,"ENSG00000065457","ENST00000566445","nonsense_mediated_decay",9655,"ADAT1","adenosine deaminase, tRNA specific 1 [Source:HGNC Symbol;Acc:HGNC:228]","GO:0003723(RNA binding);GO:0004000(adenosine deaminase activity);GO:0006396(RNA processing);GO:0008033(tRNA processing);GO:0008251(tRNA-specific adenosine deaminase activity);GO:0016787(hydrolase activity);GO:0046872(metal ion binding)","NA",{"v":7.9e-89,"d":"0.00"},1,"539,",0,{"v":-15.2,"d":"-15.20"},{"v":5.01187233627271e-18,"d":"0.00"},-1.57,"3' UTR",16,75599100,75622466,23367,2]
[59762518,59762698,181,"ENSG00000172456","ENST00000634606","nonsense_mediated_decay",465711,"FGGY","FGGY carbohydrate kinase domain containing [Source:HGNC Symbol;Acc:HGNC:25610]","GO:0005575(cellular_component);GO:0005623(cell);GO:0005975(carbohydrate metabolic process);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0016773(phosphotransferase activity, alcohol group as acceptor);GO:0019150(D-ribulokinase activity);GO:0019321(pentose metabolic process);GO:0046835(carbohydrate phosphorylation);GO:0070050(neuron cellular homeostasis)","NA",{"v":1.1E-4,"d":"0.00"},1,"181,",0,{"v":-0.792,"d":"-0.79"},{"v":0.0407380277804113,"d":"0.04"},-2.91,"3' UTR",1,59296807,59810647,513841,1]
[4143467,4143706,240,"ENSG00000167740","ENST00000573984","protein_coding",0,"CYB5D2","cytochrome b5 domain containing 2 [Source:HGNC Symbol;Acc:HGNC:28471]","GO:0005576(extracellular region);GO:0007399(nervous system development);GO:0020037(heme binding);GO:0045666(positive regulation of neuron differentiation)","NA",{"v":4e-13,"d":"0.00"},1,"240,",0,{"v":-0.806,"d":"-0.81"},{"v":0.0389045144994281,"d":"0.04"},-1.03,"5' UTR",17,4143702,4187310,43609,1]
[8269203,8269622,420,"ENSG00000178921","ENST00000580356","nonsense_mediated_decay",19917,"PFAS","phosphoribosylformylglycinamidine synthase [Source:HGNC Symbol;Acc:HGNC:8863]","GO:0000166(nucleotide binding);GO:0004642(phosphoribosylformylglycinamidine synthase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006164(purine nucleotide biosynthetic process);GO:0006189('de novo' IMP biosynthetic process);GO:0006541(glutamine metabolic process);GO:0009156(ribonucleoside monophosphate biosynthetic process);GO:0009168(purine ribonucleoside monophosphate biosynthetic process);GO:0016874(ligase activity);GO:0042493(response to drug);GO:0046872(metal ion binding);GO:0070062(extracellular exosome);GO:0097065(anterior head development)","00230(Purine metabolism)",{"v":3.2e-90,"d":"0.00"},1,"420,",0,-17,{"v":6.30957344480194e-20,"d":"0.00"},-1.31,"3' UTR",17,8249286,8269430,20145,1]
[18007448,18016590,9143,"ENSG00000171962","ENST00000583995","processed_transcript",0,"DRC3","dynein regulatory complex subunit 3 [Source:HGNC Symbol;Acc:HGNC:25384]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005929(cilium);GO:0005930(axoneme);GO:0031514(motile cilium);GO:0042995(cell projection)","NA",{"v":2.5e-26,"d":"0.00"},3,"487,469,33,","0,8279,9110",-2.39,{"v":3.54813389233575E-4,"d":"0.00"},-1,"3' UTR",17,18015727,18016889,1163,1]
[22413355,22413714,360,"ENSG00000276399","ENST00000612344","lincRNA",7336,"AC209154","novel transcript, piRNA host","NA","NA",{"v":1e-17,"d":"0.00"},1,"360,",0,{"v":-1.9,"d":"-1.90"},{"v":0.00138038426460289,"d":"0.00"},-1.25,"Exon (ENST00000612344/ENSG00000276399, exon 2 of 2)",17,22406019,22413744,7726,1]
[28402223,28402433,211,"ENSG00000004139","ENST00000585482","protein_coding",30529,"SARM1","sterile alpha and TIR motif containing 1 [Source:HGNC Symbol;Acc:HGNC:17074]","GO:0002376(immune system process);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0005874(microtubule);GO:0007165(signal transduction);GO:0007399(nervous system development);GO:0009749(response to glucose);GO:0009967(positive regulation of signal transduction);GO:0015630(microtubule cytoskeleton);GO:0030054(cell junction);GO:0030154(cell differentiation);GO:0030424(axon);GO:0030425(dendrite);GO:0031315(extrinsic component of mitochondrial outer membrane);GO:0034128(negative regulation of MyD88-independent toll-like receptor signaling pathway);GO:0035591(signaling adaptor activity);GO:0042981(regulation of apoptotic process);GO:0042995(cell projection);GO:0045087(innate immune response);GO:0045202(synapse);GO:0048678(response to axon injury);GO:0048814(regulation of dendrite morphogenesis);GO:1901214(regulation of neuron death)","NA",{"v":1.4e-10,"d":"0.00"},1,"211,",0,{"v":-0.785,"d":"-0.79"},{"v":0.0416869383470335,"d":"0.04"},-1.35,"3' UTR",17,28371694,28404049,32356,1]
[28634586,28635505,920,"ENSG00000007202","ENST00000581064","retained_intron",0,"KIAA0100","KIAA0100 [Source:HGNC Symbol;Acc:HGNC:28960]","GO:0005515(protein binding);GO:0005576(extracellular region)","NA",{"v":1e-239,"d":"0.00"},2,"155,440,","0,480",{"v":-33.7,"d":"-33.70"},{"v":3.98107170553499e-37,"d":"0.00"},-1.01,"Exon (ENST00000583787/ENSG00000264044, exon 3 of 3)",17,28633686,28634670,985,2]
[30523698,30523968,271,"ENSG00000108587","ENST00000225724","protein_coding",46336,"GOSR1","golgi SNAP receptor complex member 1 [Source:HGNC Symbol;Acc:HGNC:4430]","GO:0000139(Golgi membrane);GO:0005484(SNAP receptor activity);GO:0005794(Golgi apparatus);GO:0005797(Golgi medial cisterna);GO:0005801(cis-Golgi network);GO:0005829(cytosol);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0006891(intra-Golgi vesicle-mediated transport);GO:0006906(vesicle fusion);GO:0015031(protein transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016192(vesicle-mediated transport);GO:0030133(transport vesicle);GO:0031201(SNARE complex);GO:0042147(retrograde transport, endosome to Golgi);GO:0048209(regulation of vesicle targeting, to, from or within Golgi)","04130(SNARE interactions in vesicular transport)",{"v":7.9e-14,"d":"0.00"},1,"271,",0,{"v":-3.3,"d":"-3.30"},{"v":3.16227766016838e-05,"d":"0.00"},-1.17,"3' UTR",17,30477362,30527592,50231,1]
[31525161,31525311,151,"ENSG00000131242","ENST00000621161","protein_coding",133486,"RAB11FIP4","RAB11 family interacting protein 4 [Source:HGNC Symbol;Acc:HGNC:30267]","GO:0003407(neural retina development);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005819(spindle);GO:0005856(cytoskeleton);GO:0016020(membrane);GO:0016032(viral process);GO:0017137(Rab GTPase binding);GO:0030139(endocytic vesicle);GO:0030306(ADP-ribosylation factor binding);GO:0030496(midbody);GO:0031410(cytoplasmic vesicle);GO:0032154(cleavage furrow);GO:0032456(endocytic recycling);GO:0032465(regulation of cytokinesis);GO:0042803(protein homodimerization activity);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0055038(recycling endosome membrane);GO:1903452(positive regulation of G1 to G0 transition)","04144(Endocytosis)",{"v":0.0029,"d":"0.00"},1,"151,",0,{"v":-0.833,"d":"-0.83"},{"v":0.0354813389233576,"d":"0.04"},-1.02,"Exon (ENST00000621161/ENSG00000131242, exon 10 of 15)",17,31391675,31538211,146537,1]
[32021394,32021634,241,"ENSG00000185158","ENST00000583342","protein_coding",13522,"LRRC37B","leucine rich repeat containing 37B [Source:HGNC Symbol;Acc:HGNC:29070]","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":9.5e-07,"d":"0.00"},1,"241,",0,{"v":-0.858,"d":"-0.86"},{"v":0.0323593656929628,"d":"0.03"},{"v":-1.5,"d":"-1.50"},"Exon (ENST00000583342/ENSG00000185158, exon 2 of 2)",17,32007872,32021856,13985,1]
[32021753,32021903,151,"ENSG00000185158","ENST00000583342","protein_coding",13881,"LRRC37B","leucine rich repeat containing 37B [Source:HGNC Symbol;Acc:HGNC:29070]","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":0.00037,"d":"0.00"},1,"151,",0,-1.04,{"v":0.0177827941003892,"d":"0.02"},-1.57,"Exon (ENST00000583342/ENSG00000185158, exon 2 of 2)",17,32007872,32021856,13985,1]
[37609739,37613841,4103,"ENSG00000277688","ENST00000619099","antisense",0,"AC243585","novel transcript, antisense DDX52","NA","NA",{"v":1.5E-6,"d":"0.00"},2,"430,78,","0,4025",-0.85,{"v":0.0331131121482591,"d":"0.03"},-1.44,"3' UTR",17,37609739,37613841,4103,1]
[38750199,38750888,690,"ENSG00000277182","ENST00000610658","antisense",839,"AC006449","novel transcript, antisense to PCGF2","NA","NA",{"v":2.3e-10,"d":"0.00"},1,"690,",0,{"v":-0.942,"d":"-0.94"},{"v":0.0245470891568503,"d":"0.02"},-1.44,"Exon (ENST00000610658/ENSG00000277182, exon 1 of 1)",17,38749360,38751457,2098,1]
[4585438,4585796,359,"ENSG00000106686","ENST00000485616","nonsense_mediated_decay",80712,"SPATA6L","spermatogenesis associated 6 like [Source:HGNC Symbol;Acc:HGNC:25472]","NA","NA",{"v":2e-29,"d":"0.00"},1,"359,",0,-1.14,{"v":0.0128824955169313,"d":"0.01"},-2.91,"3' UTR",9,4553386,4666508,113123,2]
[41965072,41965668,597,"ENSG00000204815","ENST00000377540","protein_coding",34455,"TTC25","tetratricopeptide repeat domain 25 [Source:HGNC Symbol;Acc:HGNC:25280]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0042995(cell projection)","NA",{"v":2.5e-12,"d":"0.00"},1,"597,",0,-1.02,{"v":0.0190546071796325,"d":"0.02"},-1.43,"3' UTR",17,41930617,41966503,35887,1]
[50752211,50752660,450,"ENSG00000108848","ENST00000240304","protein_coding",32608,"LUC7L3","LUC7 like 3 pre-mRNA splicing factor [Source:HGNC Symbol;Acc:HGNC:24309]","GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005685(U1 snRNP);GO:0006376(mRNA splice site selection);GO:0006397(mRNA processing);GO:0008380(RNA splicing);GO:0016607(nuclear speck);GO:0071004(U2-type prespliceosome)","NA",{"v":1e-159,"d":"0.00"},1,"450,",0,-2.05,{"v":0.000891250938133746,"d":"0.00"},-1.17,"3' UTR",17,50719603,50752709,33107,1]
[63354937,63355117,181,"ENSG00000170921","ENST00000583545","retained_intron",0,"TANC2","tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 [Source:HGNC Symbol;Acc:HGNC:30212]","GO:0001701(in utero embryonic development);GO:0005515(protein binding);GO:0098978(glutamatergic synapse);GO:0099092(postsynaptic density, intracellular component)","NA",{"v":0.00098,"d":"0.00"},1,"181,",0,-1.21,{"v":0.0107151930523761,"d":"0.01"},-1.51,"Exon (ENST00000424789/ENSG00000170921, exon 12 of 25)",17,63355055,63391757,36703,1]
[67912833,67912923,91,"ENSG00000171634","ENST00000306378","protein_coding",87330,"BPTF","bromodomain PHD finger transcription factor [Source:HGNC Symbol;Acc:HGNC:3581]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0001892(embryonic placenta development);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006325(chromatin organization);GO:0006338(chromatin remodeling);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007420(brain development);GO:0007492(endoderm development);GO:0008094(DNA-dependent ATPase activity);GO:0008134(transcription factor binding);GO:0009952(anterior/posterior pattern specification);GO:0016589(NURF complex);GO:0035064(methylated histone binding);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0048188(Set1C/COMPASS complex);GO:0070062(extracellular exosome)","NA",{"v":0.00025,"d":"0.00"},1,"91,",0,-1.01,{"v":0.0199526231496888,"d":"0.02"},-1.55,"Exon (ENST00000306378/ENSG00000171634, exon 11 of 28)",17,67825503,67984378,158876,1]
[30283156,30283544,389,"ENSG00000243753","ENST00000482052","processed_transcript",23572,"HLA-L","major histocompatibility complex, class I, L (pseudogene) [Source:HGNC Symbol;Acc:HGNC:4970]","NA","NA",{"v":1.5E-9,"d":"0.00"},1,"389,",0,{"v":-0.917,"d":"-0.92"},{"v":0.0269153480392692,"d":"0.03"},-2.92,"Exon (ENST00000624252/ENSG00000280128, exon 1 of 1)",6,30259584,30293014,33431,1]
[75616104,75616568,465,"ENSG00000266714","ENST00000584516","nonsense_mediated_decay",28046,"MYO15B","myosin XVB [Source:HGNC Symbol;Acc:HGNC:14083]","GO:0000166(nucleotide binding);GO:0003674(molecular_function);GO:0003774(motor activity);GO:0003779(actin binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005575(cellular_component);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005903(brush border);GO:0008150(biological_process);GO:0016459(myosin complex)","NA",{"v":2.1e-06,"d":"0.00"},2,"44,257,","0,208",{"v":-0.851,"d":"-0.85"},{"v":0.0331131121482591,"d":"0.03"},-1.83,"3' UTR",17,75588058,75616390,28333,1]
[56597919,56598508,590,"ENSG00000151914","ENST00000244364","protein_coding",44488,"DST","dystonin [Source:HGNC Symbol;Acc:HGNC:1090]","GO:0002162(dystroglycan binding);GO:0003779(actin binding);GO:0005178(integrin binding);GO:0005198(structural molecule activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005604(basement membrane);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005882(intermediate filament);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0005938(cell cortex);GO:0007010(cytoskeleton organization);GO:0007155(cell adhesion);GO:0007229(integrin-mediated signaling pathway);GO:0008017(microtubule binding);GO:0008022(protein C-terminus binding);GO:0008090(retrograde axonal transport);GO:0008092(cytoskeletal protein binding);GO:0009611(response to wounding);GO:0009925(basal plasma membrane);GO:0015630(microtubule cytoskeleton);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030011(maintenance of cell polarity);GO:0030018(Z disc);GO:0030054(cell junction);GO:0030056(hemidesmosome);GO:0030424(axon);GO:0031122(cytoplasmic microtubule organization);GO:0031252(cell leading edge);GO:0031410(cytoplasmic vesicle);GO:0031581(hemidesmosome assembly);GO:0031673(H zone);GO:0035371(microtubule plus-end);GO:0042060(wound healing);GO:0042995(cell projection);GO:0045104(intermediate filament cytoskeleton organization);GO:0046872(metal ion binding);GO:0048870(cell motility);GO:0051010(microtubule plus-end binding);GO:1904115(axon cytoplasm)","NA",{"v":0.0016,"d":"0.00"},2,"88,33,","0,557",{"v":-0.937,"d":"-0.94"},{"v":0.0251188643150958,"d":"0.03"},-2.93,"Exon (ENST00000244364/ENSG00000151914, exon 27 of 84)",6,56457987,56642996,185010,2]
[80317275,80320237,2963,"ENSG00000173821","ENST00000508628","protein_coding",56409,"AC124319","ring finger protein 213 [Source:NCBI gene;Acc:57674]","GO:0000209(protein polyubiquitination);GO:0001525(angiogenesis);GO:0002040(sprouting angiogenesis);GO:0004842(ubiquitin-protein transferase activity);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016020(membrane);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0016787(hydrolase activity);GO:0016887(ATPase activity);GO:0046872(metal ion binding);GO:0051260(protein homooligomerization);GO:0051865(protein autoubiquitination);GO:2000051(negative regulation of non-canonical Wnt signaling pathway)","NA",{"v":1.3E-76,"d":"0.00"},2,"3,1048,","0,1915",-8.18,{"v":1.3182567385564E-10,"d":"0.00"},-1.11,"3' UTR",17,80260866,80395312,134447,1]
[48744282,48744921,640,"ENSG00000260086","ENST00000568150","lincRNA",120846,"AC007611","novel transcript","NA","NA",{"v":1.4e-09,"d":"0.00"},2,"48,455,","0,185",{"v":-0.994,"d":"-0.99"},{"v":0.0208929613085404,"d":"0.02"},-2.93,"Exon (ENST00000568150/ENSG00000260086, exon 3 of 4)",16,48623436,48744921,121486,1]
[80337995,80339648,1654,"ENSG00000173821","ENST00000508628","protein_coding",77129,"AC124319","ring finger protein 213 [Source:NCBI gene;Acc:57674]","GO:0000209(protein polyubiquitination);GO:0001525(angiogenesis);GO:0002040(sprouting angiogenesis);GO:0004842(ubiquitin-protein transferase activity);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016020(membrane);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0016787(hydrolase activity);GO:0016887(ATPase activity);GO:0046872(metal ion binding);GO:0051260(protein homooligomerization);GO:0051865(protein autoubiquitination);GO:2000051(negative regulation of non-canonical Wnt signaling pathway)","NA",{"v":1.6E-52,"d":"0.00"},2,"3,448,","0,1206",{"v":-10.6,"d":"-10.60"},{"v":3.16227766016838e-13,"d":"0.00"},-1.16,"Exon (ENST00000508628/ENSG00000173821, exon 26 of 69)",17,80260866,80395312,134447,1]
[80429840,80430289,450,"ENSG00000173818","ENST00000522577","nonsense_mediated_decay",14673,"ENDOV","endonuclease V [Source:HGNC Symbol;Acc:HGNC:26640]","GO:0000287(magnesium ion binding);GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0003727(single-stranded RNA binding);GO:0004518(nuclease activity);GO:0004519(endonuclease activity);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006281(DNA repair);GO:0016787(hydrolase activity);GO:0016888(endodeoxyribonuclease activity, producing 5'-phosphomonoesters);GO:0016891(endoribonuclease activity, producing 5'-phosphomonoesters);GO:0046872(metal ion binding);GO:0090305(nucleic acid phosphodiester bond hydrolysis);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic)","NA",{"v":7.9e-22,"d":"0.00"},1,"450,",0,-2.94,{"v":8.31763771102671e-05,"d":"0.00"},{"v":-1.7,"d":"-1.70"},"3' UTR",17,80415167,80429842,14676,1]
[80544819,80545238,420,"ENSG00000141564","ENST00000574767","nonsense_mediated_decay",0,"RPTOR","regulatory associated protein of MTOR complex 1 [Source:HGNC Symbol;Acc:HGNC:30287]","GO:0001030(RNA polymerase III type 1 promoter DNA binding);GO:0001031(RNA polymerase III type 2 promoter DNA binding);GO:0001032(RNA polymerase III type 3 promoter DNA binding);GO:0001156(TFIIIC-class transcription factor complex binding);GO:0001558(regulation of cell growth);GO:0001938(positive regulation of endothelial cell proliferation);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0005829(cytosol);GO:0007050(cell cycle arrest);GO:0008361(regulation of cell size);GO:0009267(cellular response to starvation);GO:0010494(cytoplasmic stress granule);GO:0010800(positive regulation of peptidyl-threonine phosphorylation);GO:0016032(viral process);GO:0016241(regulation of macroautophagy);GO:0019901(protein kinase binding);GO:0030291(protein serine/threonine kinase inhibitor activity);GO:0030295(protein kinase activator activity);GO:0030307(positive regulation of cell growth);GO:0030425(dendrite);GO:0030674(protein binding, bridging);GO:0031669(cellular response to nutrient levels);GO:0031929(TOR signaling);GO:0031931(TORC1 complex);GO:0032008(positive regulation of TOR signaling);GO:0032147(activation of protein kinase activity);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0038202(TORC1 signaling);GO:0042325(regulation of phosphorylation);GO:0043025(neuronal cell body);GO:0044877(protein-containing complex binding);GO:0045945(positive regulation of transcription by RNA polymerase III);GO:0071230(cellular response to amino acid stimulus);GO:0071233(cellular response to leucine);GO:0071889(14-3-3 protein binding);GO:0071901(negative regulation of protein serine/threonine kinase activity);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:1900034(regulation of cellular response to heat);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle)","04136(Autophagy - other);04140(Autophagy - animal);04150(mTOR signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04211(Longevity regulating pathway);04213(Longevity regulating pathway - multiple species);04714(Thermogenesis);04910(Insulin signaling pathway);05206(MicroRNAs in cancer)",{"v":5e-14,"d":"0.00"},1,"420,",0,-3.04,{"v":6.30957344480193e-05,"d":"0.00"},-1.04,"5' UTR",17,80544819,80858124,313306,1]
[82488078,82488558,481,"ENSG00000141562","ENST00000390006","protein_coding",29893,"NARF","nuclear prelamin A recognition factor [Source:HGNC Symbol;Acc:HGNC:29916]","GO:0005521(lamin binding);GO:0005634(nucleus);GO:0005638(lamin filament);GO:0005652(nuclear lamina);GO:0005730(nucleolus);GO:0031981(nuclear lumen)","NA",{"v":2.5e-17,"d":"0.00"},1,"481,",0,-3.72,{"v":1.02329299228075e-05,"d":"0.00"},-1.25,"3' UTR",17,82458185,82488255,30071,1]
[83870577,83880422,9846,"ENSG00000165115","ENST00000297814","protein_coding",41010,"KIF27","kinesin family member 27 [Source:HGNC Symbol;Acc:HGNC:18632]","GO:0000166(nucleotide binding);GO:0003351(epithelial cilium movement);GO:0003774(motor activity);GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005871(kinesin complex);GO:0005874(microtubule);GO:0005929(cilium);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding);GO:0016887(ATPase activity);GO:0021591(ventricular system development);GO:0030030(cell projection organization);GO:0042995(cell projection);GO:0060271(cilium assembly)","NA",{"v":8.7e-06,"d":"0.00"},2,"56,305,","0,9541",-1.03,{"v":0.0186208713666287,"d":"0.02"},-2.95,"3' UTR",9,83834099,83921432,87334,2]
[54953397,54953576,180,"ENSG00000141198","ENST00000445275","protein_coding",52645,"TOM1L1","target of myb1 like 1 membrane trafficking protein [Source:HGNC Symbol;Acc:HGNC:11983]","GO:0005515(protein binding);GO:0005622(intracellular);GO:0005623(cell);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005768(endosome);GO:0005794(Golgi apparatus);GO:0005795(Golgi stack);GO:0005829(cytosol);GO:0006886(intracellular protein transport);GO:0007165(signal transduction);GO:0010008(endosome membrane);GO:0015031(protein transport);GO:0016020(membrane);GO:0017124(SH3 domain binding);GO:0019901(protein kinase binding);GO:0030276(clathrin binding);GO:0030295(protein kinase activator activity);GO:0031954(positive regulation of protein autophosphorylation);GO:0032147(activation of protein kinase activity);GO:0043130(ubiquitin binding);GO:0043162(ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway);GO:0045839(negative regulation of mitotic nuclear division);GO:0070062(extracellular exosome)","NA",{"v":0.00013,"d":"0.00"},1,"180,",0,{"v":-0.773,"d":"-0.77"},{"v":0.0426579518801593,"d":"0.04"},-2.96,"Exon (ENST00000572088/ENSG00000166260, exon 1 of 1)",17,54900752,54961949,61198,1]
[517003,517243,241,"ENSG00000141252","ENST00000437048","protein_coding",197596,"VPS53","VPS53, GARP complex subunit [Source:HGNC Symbol;Acc:HGNC:25608]","GO:0000938(GARP complex);GO:0005515(protein binding);GO:0005768(endosome);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0007041(lysosomal transport);GO:0010008(endosome membrane);GO:0015031(protein transport);GO:0016020(membrane);GO:0032456(endocytic recycling);GO:0032588(trans-Golgi network membrane);GO:0042147(retrograde transport, endosome to Golgi);GO:0048471(perinuclear region of cytoplasm);GO:0055037(recycling endosome);GO:1990745(EARP complex)","NA",{"v":0.0006,"d":"0.00"},1,"241,",0,-2.41,{"v":3.38844156139203E-4,"d":"0.00"},-1.48,"3' UTR",17,508668,714839,206172,2]
[2081828,2082278,451,"ENSG00000070366","ENST00000263073","protein_coding",221507,"SMG6","SMG6, nonsense mediated mRNA decay factor [Source:HGNC Symbol;Acc:HGNC:17809]","GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0000781(chromosome, telomeric region);GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0004518(nuclease activity);GO:0004519(endonuclease activity);GO:0004521(endoribonuclease activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0005697(telomerase holoenzyme complex);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006406(mRNA export from nucleus);GO:0007004(telomere maintenance via telomerase);GO:0016787(hydrolase activity);GO:0032204(regulation of telomere maintenance);GO:0032210(regulation of telomere maintenance via telomerase);GO:0035145(exon-exon junction complex);GO:0035303(regulation of dephosphorylation);GO:0042162(telomeric DNA binding);GO:0043021(ribonucleoprotein complex binding);GO:0043487(regulation of RNA stability);GO:0046872(metal ion binding);GO:0051972(regulation of telomerase activity);GO:0070034(telomerase RNA binding);GO:0070182(DNA polymerase binding);GO:0090305(nucleic acid phosphodiester bond hydrolysis);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic);GO:1904354(negative regulation of telomere capping)","03015(mRNA surveillance pathway)",{"v":4.9e-05,"d":"0.00"},2,"129,52,","0,399",-1.19,{"v":0.0112201845430196,"d":"0.01"},-1.01,"Exon (ENST00000263073/ENSG00000070366, exon 15 of 19)",17,2059843,2303785,243943,2]
[4242318,4242378,61,"ENSG00000185722","ENST00000341657","protein_coding",21601,"ANKFY1","ankyrin repeat and FYVE domain containing 1 [Source:HGNC Symbol;Acc:HGNC:20763]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005768(endosome);GO:0005769(early endosome);GO:0005829(cytosol);GO:0006897(endocytosis);GO:0010008(endosome membrane);GO:0016020(membrane);GO:0016197(endosomal transport);GO:0017137(Rab GTPase binding);GO:0030904(retromer complex);GO:0034058(endosomal vesicle fusion);GO:0042147(retrograde transport, endosome to Golgi);GO:0043231(intracellular membrane-bounded organelle);GO:0044354(macropinosome);GO:0046872(metal ion binding);GO:0048549(positive regulation of pinocytosis);GO:0070062(extracellular exosome);GO:0090160(Golgi to lysosome transport);GO:1901981(phosphatidylinositol phosphate binding)","NA",{"v":0.0003,"d":"0.00"},1,"61,",0,-1.22,0.01,-1.17,"Exon (ENST00000341657/ENSG00000185722, exon 2 of 25)",17,4163821,4263979,100159,2]
[12991612,12991881,270,"ENSG00000006740","ENST00000379672","protein_coding",202114,"ARHGAP44","Rho GTPase activating protein 44 [Source:HGNC Symbol;Acc:HGNC:29096]","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005543(phospholipid binding);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005829(cytosol);GO:0006887(exocytosis);GO:0007165(signal transduction);GO:0014069(postsynaptic density);GO:0030054(cell junction);GO:0031256(leading edge membrane);GO:0032956(regulation of actin cytoskeleton organization);GO:0035021(negative regulation of Rac protein signal transduction);GO:0042995(cell projection);GO:0043087(regulation of GTPase activity);GO:0043197(dendritic spine);GO:0043547(positive regulation of GTPase activity);GO:0045202(synapse);GO:0048365(Rac GTPase binding);GO:0048786(presynaptic active zone);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0055037(recycling endosome);GO:0061001(regulation of dendritic spine morphogenesis);GO:0098886(modification of dendritic spine);GO:0098887(neurotransmitter receptor transport, endosome to postsynaptic membrane);GO:0098978(glutamatergic synapse);GO:0099010(modification of postsynaptic structure);GO:0099152(regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane)","NA",{"v":1.3e-12,"d":"0.00"},1,"270,",0,{"v":-0.954,"d":"-0.95"},{"v":0.0234422881531992,"d":"0.02"},-1.45,"3' UTR",17,12789498,12991643,202146,1]
[16101258,16101677,420,"ENSG00000141027","ENST00000268712","protein_coding",113857,"NCOR1","nuclear receptor corepressor 1 [Source:HGNC Symbol;Acc:HGNC:7672]","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001012(RNA polymerase II regulatory region DNA binding);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006325(chromatin organization);GO:0006366(transcription by RNA polymerase II);GO:0007623(circadian rhythm);GO:0016020(membrane);GO:0016580(Sin3 complex);GO:0017053(transcriptional repressor complex);GO:0019216(regulation of lipid metabolic process);GO:0035257(nuclear hormone receptor binding);GO:0042826(histone deacetylase binding);GO:0043565(sequence-specific DNA binding);GO:0044212(transcription regulatory region DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046329(negative regulation of JNK cascade);GO:0046966(thyroid hormone receptor binding);GO:0051225(spindle assembly);GO:0060766(negative regulation of androgen receptor signaling pathway);GO:0072362(regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter);GO:0072368(regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter);GO:0072686(mitotic spindle);GO:1903799(negative regulation of production of miRNAs involved in gene silencing by miRNA);GO:2000191(regulation of fatty acid transport)","01522(Endocrine resistance);04919(Thyroid hormone signaling pathway);05202(Transcriptional misregulation in cancer)",0,1,"420,",0,{"v":-44.6,"d":"-44.60"},{"v":3.98107170553499e-48,"d":"0.00"},-1.08,"Exon (ENST00000268712/ENSG00000141027, exon 20 of 46)",17,16029157,16215534,186378,2]
[50127719,50128225,507,"ENSG00000176124","ENST00000486895","lincRNA",45548,"DLEU1","deleted in lymphocytic leukemia 1 [Source:HGNC Symbol;Acc:HGNC:13747]","NA","NA",{"v":8.7e-06,"d":"0.00"},1,"507,",0,{"v":-0.949,"d":"-0.95"},{"v":0.0239883291901949,"d":"0.02"},-2.98,"Exon (ENST00000618151/ENSG00000274270, exon 1 of 1)",13,50082171,50390291,308121,1]
[98770953,98771661,709,"ENSG00000174136","ENST00000504776","processed_transcript",2303,"RGMB","repulsive guidance molecule BMP co-receptor b [Source:HGNC Symbol;Acc:HGNC:26896]","GO:0005515(protein binding);GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007165(signal transduction);GO:0015026(coreceptor activity);GO:0016020(membrane);GO:0030509(BMP signaling pathway);GO:0031225(anchored component of membrane);GO:0042802(identical protein binding);GO:0045121(membrane raft);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046658(anchored component of plasma membrane)","04350(TGF-beta signaling pathway)",{"v":0.00015,"d":"0.00"},2,"232,6,","0,703",{"v":-0.814,"d":"-0.81"},{"v":0.0380189396320561,"d":"0.04"},-2.99,"Exon (ENST00000501938/ENSG00000246763, exon 2 of 2)",5,98768650,98779919,11270,1]
[28634537,28635496,960,"ENSG00000007202","ENST00000581064","retained_intron",0,"KIAA0100","KIAA0100 [Source:HGNC Symbol;Acc:HGNC:28960]","GO:0005515(protein binding);GO:0005576(extracellular region)","NA",0,1,"960,",0,{"v":-64.2,"d":"-64.20"},{"v":6.30957344480189e-68,"d":"0.00"},-1.07,"Exon (ENST00000583787/ENSG00000264044, exon 3 of 3)",17,28633686,28634670,985,2]
[36495633,36496323,691,"ENSG00000273611","ENST00000619730","protein_coding",9004,"ZNHIT3","zinc finger HIT-type containing 3 [Source:HGNC Symbol;Acc:HGNC:12309]","GO:0000463(maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0046966(thyroid hormone receptor binding);GO:0048254(snoRNA localization);GO:0070761(pre-snoRNP complex)","NA",{"v":2.5e-84,"d":"0.00"},1,"691,",0,{"v":-36.5,"d":"-36.50"},{"v":6.30957344480189e-40,"d":"0.00"},-1.19,"3' UTR",17,36486629,36495823,9195,1]
[37609739,37610128,390,"ENSG00000277688","ENST00000619099","antisense",0,"AC243585","novel transcript, antisense DDX52","NA","NA",{"v":2.3E-6,"d":"0.00"},1,"390,",0,{"v":-0.798,"d":"-0.80"},{"v":0.0398107170553497,"d":"0.04"},-1.67,"3' UTR",17,37609739,37613841,4103,1]
[42201357,42201507,151,"ENSG00000173757","ENST00000293328","protein_coding",74899,"STAT5B","signal transducer and activator of transcription 5B [Source:HGNC Symbol;Acc:HGNC:11367]","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001553(luteinization);GO:0001779(natural killer cell differentiation);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007165(signal transduction);GO:0007259(receptor signaling pathway via JAK-STAT);GO:0007548(sex differentiation);GO:0007565(female pregnancy);GO:0007595(lactation);GO:0008284(positive regulation of cell population proliferation);GO:0019218(regulation of steroid metabolic process);GO:0019221(cytokine-mediated signaling pathway);GO:0019530(taurine metabolic process);GO:0019915(lipid storage);GO:0030155(regulation of cell adhesion);GO:0030856(regulation of epithelial cell differentiation);GO:0032355(response to estradiol);GO:0032819(positive regulation of natural killer cell proliferation);GO:0032825(positive regulation of natural killer cell differentiation);GO:0032870(cellular response to hormone stimulus);GO:0033077(T cell differentiation in thymus);GO:0035259(glucocorticoid receptor binding);GO:0035723(interleukin-15-mediated signaling pathway);GO:0038110(interleukin-2-mediated signaling pathway);GO:0038111(interleukin-7-mediated signaling pathway);GO:0038113(interleukin-9-mediated signaling pathway);GO:0040014(regulation of multicellular organism growth);GO:0040018(positive regulation of multicellular organism growth);GO:0042104(positive regulation of activated T cell proliferation);GO:0042448(progesterone metabolic process);GO:0043029(T cell homeostasis);GO:0043066(negative regulation of apoptotic process);GO:0045086(positive regulation of interleukin-2 biosynthetic process);GO:0045579(positive regulation of B cell differentiation);GO:0045588(positive regulation of gamma-delta T cell differentiation);GO:0045621(positive regulation of lymphocyte differentiation);GO:0045647(negative regulation of erythrocyte differentiation);GO:0045648(positive regulation of erythrocyte differentiation);GO:0045931(positive regulation of mitotic cell cycle);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045954(positive regulation of natural killer cell mediated cytotoxicity);GO:0046543(development of secondary female sexual characteristics);GO:0046544(development of secondary male sexual characteristics);GO:0046983(protein dimerization activity);GO:0048541(Peyer's patch development);GO:0050729(positive regulation of inflammatory response);GO:0060397(growth hormone receptor signaling pathway via JAK-STAT);GO:0070669(response to interleukin-2);GO:0070670(response to interleukin-4);GO:0070672(response to interleukin-15);GO:0071363(cellular response to growth factor stimulus);GO:0071364(cellular response to epidermal growth factor stimulus);GO:0097531(mast cell migration)","04012(ErbB signaling pathway);04062(Chemokine signaling pathway);04217(Necroptosis);04630(Jak-STAT signaling pathway);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04917(Prolactin signaling pathway);04933(AGE-RAGE signaling pathway in diabetic complications);05161(Hepatitis B);05162(Measles);05166(Human T-cell leukemia virus 1 infection);05200(Pathways in cancer);05203(Viral carcinogenesis);05220(Chronic myeloid leukemia);05221(Acute myeloid leukemia);05223(Non-small cell lung cancer)",{"v":1.1e-06,"d":"0.00"},1,"151,",0,-4.92,{"v":4.67735141287198e-07,"d":"0.00"},-1.17,"3' UTR",17,42199168,42276406,77239,2]
[47100048,47100293,246,"ENSG00000262879","ENST00000573341","lincRNA",0,"AC068152","novel transcript","NA","NA",{"v":8.3e-07,"d":"0.00"},2,"201,39,","0,207",-1.06,{"v":0.0165958690743756,"d":"0.02"},-1.49,"Exon (ENST00000573341/ENSG00000262879, exon 1 of 3)",17,47056609,47100248,43640,2]
[47682417,47682683,267,"ENSG00000264558","ENST00000578482","antisense",0,"AC015674","novel transcript, antisense to KPNB1","NA","NA",{"v":9.99999999999999e-291,"d":"0.00"},1,"267,",0,{"v":-36.7,"d":"-36.70"},{"v":3.98107170553499e-40,"d":"0.00"},-1.06,"3' UTR",17,47682417,47682683,267,2]
[50134905,50135144,240,"ENSG00000108819","ENST00000612501","protein_coding",15533,"PPP1R9B","protein phosphatase 1 regulatory subunit 9B [Source:HGNC Symbol;Acc:HGNC:9298]","GO:0001932(regulation of protein phosphorylation);GO:0001975(response to amphetamine);GO:0003006(developmental process involved in reproduction);GO:0003779(actin binding);GO:0004672(protein kinase activity);GO:0004864(protein phosphatase inhibitor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0007015(actin filament organization);GO:0007568(aging);GO:0007612(learning);GO:0008022(protein C-terminus binding);GO:0008157(protein phosphatase 1 binding);GO:0010243(response to organonitrogen compound);GO:0014069(postsynaptic density);GO:0014070(response to organic cyclic compound);GO:0015629(actin cytoskeleton);GO:0016358(dendrite development);GO:0019722(calcium-mediated signaling);GO:0019900(kinase binding);GO:0021766(hippocampus development);GO:0021987(cerebral cortex development);GO:0030042(actin filament depolymerization);GO:0030175(filopodium);GO:0030426(growth cone);GO:0030864(cortical actin cytoskeleton);GO:0031749(D2 dopamine receptor binding);GO:0032355(response to estradiol);GO:0032515(negative regulation of phosphoprotein phosphatase activity);GO:0032591(dendritic spine membrane);GO:0034695(response to prostaglandin E);GO:0035094(response to nicotine);GO:0035690(cellular response to drug);GO:0035902(response to immobilization stress);GO:0042127(regulation of cell population proliferation);GO:0042493(response to drug);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0043197(dendritic spine);GO:0043200(response to amino acid);GO:0044325(ion channel binding);GO:0044326(dendritic spine neck);GO:0044327(dendritic spine head);GO:0044877(protein-containing complex binding);GO:0048545(response to steroid hormone);GO:0050804(modulation of chemical synaptic transmission);GO:0051015(actin filament binding);GO:0060179(male mating behavior);GO:0061458(reproductive system development);GO:0071315(cellular response to morphine);GO:0071364(cellular response to epidermal growth factor stimulus);GO:0071392(cellular response to estradiol stimulus);GO:0071407(cellular response to organic cyclic compound);GO:0097338(response to clozapine);GO:1901653(cellular response to peptide);GO:1903078(positive regulation of protein localization to plasma membrane);GO:1903119(protein localization to actin cytoskeleton);GO:1903829(positive regulation of cellular protein localization);GO:1904372(positive regulation of protein localization to actin cortical patch);GO:1904373(response to kainic acid);GO:1904386(response to L-phenylalanine derivative);GO:1990778(protein localization to cell periphery);GO:1990780(cytoplasmic side of dendritic spine plasma membrane);GO:2000474(regulation of opioid receptor signaling pathway)","NA",{"v":7.9e-23,"d":"0.00"},1,"240,",0,{"v":-10.3,"d":"-10.30"},{"v":6.30957344480194e-13,"d":"0.00"},-1.02,"3' UTR",17,50133737,50150677,16941,2]
[1062799,1063288,490,"ENSG00000217801","ENST00000456409","processed_transcript",0,"AL390719","protein tyrosine phosphatase family pseudogene","NA","NA",{"v":2.5e-31,"d":"0.00"},2,"10,228,","0,262",-0.96,{"v":0.0234422881531992,"d":"0.02"},-3.02,"Exon (ENST00000394517/ENSG00000217801, exon 4 of 5)",1,1063079,1066456,3378,1]
[64800332,64800721,390,"ENSG00000214176","ENST00000578036","processed_transcript",36418,"PLEKHM1P1","pleckstrin homology and RUN domain containing M1 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:35411]","NA","NA",{"v":3.1E-6,"d":"0.00"},1,"390,",0,-1.02,{"v":0.0190546071796325,"d":"0.02"},-1.49,"Exon (ENST00000578036/ENSG00000214176, exon 7 of 18)",17,64779259,64837139,57881,2]
[236543250,236543460,211,"ENSG00000116977","ENST00000525789","retained_intron",0,"LGALS8","galectin 8 [Source:HGNC Symbol;Acc:HGNC:6569]","GO:0005178(integrin binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006914(autophagy);GO:0016020(membrane);GO:0030246(carbohydrate binding);GO:0031410(cytoplasmic vesicle);GO:0098586(cellular response to virus);GO:0098792(xenophagy);GO:1904977(lymphatic endothelial cell migration)","NA",{"v":0.00054,"d":"0.00"},1,"211,",0,{"v":-0.924,"d":"-0.92"},{"v":0.0263026799189538,"d":"0.03"},-3.05,"Exon (ENST00000366583/ENSG00000116977, exon 7 of 7)",1,236543296,236545201,1906,1]
[75266585,75266644,60,"ENSG00000125457","ENST00000325102","protein_coding",4574,"MIF4GD","MIF4G domain containing [Source:HGNC Symbol;Acc:HGNC:24030]","GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006417(regulation of translation);GO:0006446(regulation of translational initiation);GO:0008022(protein C-terminus binding);GO:0008494(translation activator activity);GO:0042802(identical protein binding);GO:0045727(positive regulation of translation)","NA",{"v":9.5E-4,"d":"0.00"},1,"60,",0,-2.91,{"v":8.91250938133746e-05,"d":"0.00"},-1.17,"3' UTR",17,75266228,75271218,4991,2]
[78797345,78797884,540,"ENSG00000055483","ENST00000587010","nonsense_mediated_decay",1106,"USP36","ubiquitin specific peptidase 36 [Source:HGNC Symbol;Acc:HGNC:20062]","GO:0003723(RNA binding);GO:0004197(cysteine-type endopeptidase activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007000(nucleolus organization);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0016242(negative regulation of macroautophagy);GO:0016578(histone deubiquitination);GO:0016579(protein deubiquitination);GO:0016607(nuclear speck);GO:0016787(hydrolase activity);GO:0031647(regulation of protein stability);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042981(regulation of apoptotic process);GO:0050821(protein stabilization);GO:1903146(regulation of autophagy of mitochondrion);GO:1903955(positive regulation of protein targeting to mitochondrion);GO:2000232(regulation of rRNA processing)","NA",{"v":4e-34,"d":"0.00"},1,"540,",0,-3.52,{"v":1.73780082874938e-05,"d":"0.00"},-1.19,"3' UTR",17,78787381,78798990,11610,2]
[79952726,80010538,57813,"ENSG00000167291","ENST00000571872","protein_coding",0,"TBC1D16","TBC1 domain family member 16 [Source:HGNC Symbol;Acc:HGNC:28356]","GO:0001919(regulation of receptor recycling);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005769(early endosome);GO:0005829(cytosol);GO:0006886(intracellular protein transport);GO:0017137(Rab GTPase binding);GO:0090630(activation of GTPase activity)","NA",{"v":6.3e-16,"d":"0.00"},3,"93,39,379,","0,40870,57434",-5.63,{"v":7.76247116628691e-08,"d":"0.00"},-1.55,"5' UTR",17,79950571,79993634,43064,2]
[37725845,37726204,360,"ENSG00000100101","ENST00000455236","nonsense_mediated_decay",39431,"Z83844","novel transcript","GO:0003697(single-stranded DNA binding);GO:0005515(protein binding);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0007000(nucleolus organization);GO:0008284(positive regulation of cell population proliferation);GO:0019843(rRNA binding);GO:0030307(positive regulation of cell growth);GO:0043066(negative regulation of apoptotic process)","NA",{"v":7.9e-09,"d":"0.00"},1,"360,",0,{"v":-0.911,"d":"-0.91"},{"v":0.0275422870333817,"d":"0.03"},-3.05,"3' UTR",22,37686414,37726503,40090,1]
[8718543,8782157,63615,"ENSG00000168502","ENST00000520495","nonsense_mediated_decay",0,"MTCL1","microtubule crosslinking factor 1 [Source:HGNC Symbol;Acc:HGNC:29121]","GO:0000922(spindle pole);GO:0001578(microtubule bundle formation);GO:0003723(RNA binding);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0008017(microtubule binding);GO:0010506(regulation of autophagy);GO:0016020(membrane);GO:0016324(apical plasma membrane);GO:0016327(apicolateral plasma membrane);GO:0016328(lateral plasma membrane);GO:0030496(midbody);GO:0042803(protein homodimerization activity);GO:0045197(establishment or maintenance of epithelial cell apical/basal polarity);GO:0090314(positive regulation of protein targeting to membrane);GO:0097427(microtubule bundle);GO:2000576(positive regulation of microtubule motor activity)","NA",{"v":7.1e-10,"d":"0.00"},4,"106,159,145,70,","0,1795,59290,63545",-5.54,{"v":9.54992586021437e-08,"d":"0.00"},-1.69,"5' UTR",18,8782088,8810002,27915,1]
[36175642,36175822,181,"ENSG00000134759","ENST00000358232","protein_coding",45743,"ELP2","elongator acetyltransferase complex subunit 2 [Source:HGNC Symbol;Acc:HGNC:18248]","GO:0000993(RNA polymerase II complex binding);GO:0002098(tRNA wobble uridine modification);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006368(transcription elongation from RNA polymerase II promoter);GO:0008023(transcription elongation factor complex);GO:0033588(Elongator holoenzyme complex)","NA",{"v":0.00018,"d":"0.00"},1,"181,",0,{"v":-0.736,"d":"-0.74"},{"v":0.0489778819368446,"d":"0.05"},-1.42,"3' UTR",18,36129899,36180557,50659,1]
[58750256,58751094,839,"ENSG00000172175","ENST00000348428","protein_coding",78870,"MALT1","MALT1 paracaspase [Source:HGNC Symbol;Acc:HGNC:6819]","GO:0001650(fibrillar center);GO:0001923(B-1 B cell differentiation);GO:0002020(protease binding);GO:0002223(stimulatory C-type lectin receptor signaling pathway);GO:0002237(response to molecule of bacterial origin);GO:0002726(positive regulation of T cell cytokine production);GO:0004197(cysteine-type endopeptidase activity);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0006952(defense response);GO:0007250(activation of NF-kappaB-inducing kinase activity);GO:0008233(peptidase activity);GO:0009620(response to fungus);GO:0016567(protein ubiquitination);GO:0016787(hydrolase activity);GO:0019209(kinase activator activity);GO:0031398(positive regulation of protein ubiquitination);GO:0031663(lipopolysaccharide-mediated signaling pathway);GO:0032449(CBM complex);GO:0032743(positive regulation of interleukin-2 production);GO:0032991(protein-containing complex);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0042098(T cell proliferation);GO:0042113(B cell activation);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043621(protein self-association);GO:0045087(innate immune response);GO:0048471(perinuclear region of cytoplasm);GO:0050852(T cell receptor signaling pathway);GO:0050856(regulation of T cell receptor signaling pathway);GO:0050870(positive regulation of T cell activation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051168(nuclear export);GO:0051259(protein complex oligomerization);GO:2000321(positive regulation of T-helper 17 cell differentiation)","04064(NF-kappa B signaling pathway);04625(C-type lectin receptor signaling pathway);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);05152(Tuberculosis)",{"v":7.9e-11,"d":"0.00"},1,"839,",0,{"v":-0.794,"d":"-0.79"},{"v":0.0398107170553497,"d":"0.04"},-1.95,"3' UTR",18,58671386,58754477,83092,1]
[54154634,54154724,91,"ENSG00000088038","ENST00000618939","retained_intron",16872,"CNOT3","CCR4-NOT transcription complex subunit 3 [Source:HGNC Symbol;Acc:HGNC:7879]","GO:0000289(nuclear-transcribed mRNA poly(A) tail shortening);GO:0000932(P-body);GO:0001829(trophectodermal cell differentiation);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006417(regulation of translation);GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest);GO:0007275(multicellular organism development);GO:0017148(negative regulation of translation);GO:0030014(CCR4-NOT complex);GO:0030015(CCR4-NOT core complex);GO:0031047(gene silencing by RNA);GO:0120162(positive regulation of cold-induced thermogenesis);GO:2000036(regulation of stem cell population maintenance)","03018(RNA degradation)",{"v":1.9E-3,"d":"0.00"},1,"91,",0,{"v":-0.792,"d":"-0.79"},{"v":0.0407380277804113,"d":"0.04"},-3.06,"3' UTR",19,54137762,54155680,17919,1]
[12425762,12425940,179,"ENSG00000145002","ENST00000262365","protein_coding",10403,"FAM86B2","family with sequence similarity 86 member B2 [Source:HGNC Symbol;Acc:HGNC:32222]","GO:0005515(protein binding);GO:0008150(biological_process);GO:0008168(methyltransferase activity);GO:0016740(transferase activity);GO:0032259(methylation);GO:0032991(protein-containing complex)","NA",{"v":9.3e-05,"d":"0.00"},1,"179,",0,-1.99,{"v":0.00107151930523761,"d":"0.00"},-3.08,"3' UTR",8,12425614,12436343,10730,2]
[31830496,31830795,300,"ENSG00000153339","ENST00000283351","protein_coding",112333,"TRAPPC8","trafficking protein particle complex 8 [Source:HGNC Symbol;Acc:HGNC:29169]","GO:0000045(autophagosome assembly);GO:0000407(phagophore assembly site);GO:0005515(protein binding);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0007030(Golgi organization);GO:0016192(vesicle-mediated transport);GO:0030008(TRAPP complex);GO:0030242(autophagy of peroxisome);GO:0031410(cytoplasmic vesicle);GO:0032258(protein localization by the Cvt pathway);GO:0034497(protein localization to phagophore assembly site);GO:1990072(TRAPPIII protein complex)","NA",{"v":6.6e-06,"d":"0.00"},1,"300,",0,-0.86,{"v":0.0323593656929628,"d":"0.03"},-1.16,"3' UTR",18,31829180,31943128,113949,2]
[35262548,35262938,391,"ENSG00000186812","ENST00000589420","processed_transcript",21497,"ZNF397","zinc finger protein 397 [Source:HGNC Symbol;Acc:HGNC:18818]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0015630(microtubule cytoskeleton);GO:0046872(metal ion binding)","NA",{"v":4.1e-08,"d":"0.00"},1,"391,",0,{"v":-0.854,"d":"-0.85"},{"v":0.0331131121482591,"d":"0.03"},-1.58,"3' UTR",18,35241051,35267133,26083,1]
[35264205,35264445,241,"ENSG00000186814","ENST00000639929","protein_coding",0,"ZSCAN30","zinc finger and SCAN domain containing 30 [Source:HGNC Symbol;Acc:HGNC:33517]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","NA",{"v":9.1e-06,"d":"0.00"},1,"241,",0,-1.23,{"v":0.00977237220955811,"d":"0.01"},-1.76,"5' UTR",18,35253459,35264223,10765,2]
[35497770,35497940,171,"ENSG00000153391","ENST00000592173","protein_coding",0,"INO80C","INO80 complex subunit C [Source:HGNC Symbol;Acc:HGNC:26994]","GO:0001650(fibrillar center);GO:0003674(molecular_function);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006281(DNA repair);GO:0006310(DNA recombination);GO:0006338(chromatin remodeling);GO:0006974(cellular response to DNA damage stimulus);GO:0008150(biological_process);GO:0016579(protein deubiquitination);GO:0031011(Ino80 complex);GO:0071339(MLL1 complex)","NA",{"v":6.3e-08,"d":"0.00"},1,"171,",0,-1.08,{"v":0.0158489319246111,"d":"0.02"},-1.12,"5' UTR",18,35452230,35497933,45704,2]
[35497752,35497961,210,"ENSG00000153391","ENST00000592173","protein_coding",0,"INO80C","INO80 complex subunit C [Source:HGNC Symbol;Acc:HGNC:26994]","GO:0001650(fibrillar center);GO:0003674(molecular_function);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006281(DNA repair);GO:0006310(DNA recombination);GO:0006338(chromatin remodeling);GO:0006974(cellular response to DNA damage stimulus);GO:0008150(biological_process);GO:0016579(protein deubiquitination);GO:0031011(Ino80 complex);GO:0071339(MLL1 complex)","NA",{"v":1.2e-07,"d":"0.00"},1,"210,",0,-1.25,{"v":0.0091201083935591,"d":"0.01"},{"v":-1.2,"d":"-1.20"},"5' UTR",18,35452230,35497933,45704,2]
[131971202,131971533,332,"ENSG00000277959","ENST00000614406","antisense",0,"AL162274","novel transcript, antisense to BNIP3","NA","NA",{"v":7.9e-14,"d":"0.00"},1,"332,",0,-1.16,{"v":0.0120226443461741,"d":"0.01"},-3.09,"Exon (ENST00000614406/ENSG00000277959, exon 1 of 1)",10,131971202,131971533,332,1]
[82945195,82945465,271,"ENSG00000141556","ENST00000355528","protein_coding",193130,"TBCD","tubulin folding cofactor D [Source:HGNC Symbol;Acc:HGNC:11581]","GO:0000226(microtubule cytoskeleton organization);GO:0000278(mitotic cell cycle);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005886(plasma membrane);GO:0005912(adherens junction);GO:0005923(bicellular tight junction);GO:0006457(protein folding);GO:0007021(tubulin complex assembly);GO:0007023(post-chaperonin tubulin folding pathway);GO:0010812(negative regulation of cell-substrate adhesion);GO:0016020(membrane);GO:0016328(lateral plasma membrane);GO:0030054(cell junction);GO:0031115(negative regulation of microtubule polymerization);GO:0034333(adherens junction assembly);GO:0043547(positive regulation of GTPase activity);GO:0048487(beta-tubulin binding);GO:0048667(cell morphogenesis involved in neuron differentiation);GO:0051087(chaperone binding);GO:0070830(bicellular tight junction assembly)","NA",{"v":4.9e-06,"d":"0.00"},1,"271,",0,-1.36,{"v":6.60693448007596E-3,"d":"0.01"},-3.11,"3' UTR",17,82752065,82945914,193850,1]
[5909074,5909430,357,"ENSG00000187650","ENST00000339485","protein_coding",4216,"VMAC","vimentin type intermediate filament associated coiled-coil protein [Source:HGNC Symbol;Acc:HGNC:33803]","GO:0005737(cytoplasm);GO:0045098(type III intermediate filament)","NA",{"v":7.9e-20,"d":"0.00"},1,"357,",0,-1.25,{"v":0.00933254300796992,"d":"0.01"},-1.13,"3' UTR",19,5904858,5910853,5996,1]
[5909697,5910201,505,"ENSG00000187650","ENST00000339485","protein_coding",4839,"VMAC","vimentin type intermediate filament associated coiled-coil protein [Source:HGNC Symbol;Acc:HGNC:33803]","GO:0005737(cytoplasm);GO:0045098(type III intermediate filament)","NA",{"v":2.3e-08,"d":"0.00"},1,"505,",0,{"v":-0.788,"d":"-0.79"},{"v":0.0407380277804113,"d":"0.04"},-1.09,"3' UTR",19,5904858,5910853,5996,1]
[10684552,10684881,330,"ENSG00000129351","ENST00000449870","protein_coding",30291,"ILF3","interleukin enhancer binding factor 3 [Source:HGNC Symbol;Acc:HGNC:6038]","GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0003725(double-stranded RNA binding);GO:0003727(single-stranded RNA binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006468(protein phosphorylation);GO:0016020(membrane);GO:0017091(AU-rich element binding);GO:0017148(negative regulation of translation);GO:0045071(negative regulation of viral genome replication);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0051607(defense response to virus);GO:1990904(ribonucleoprotein complex)","NA",{"v":2.5E-51,"d":"0.00"},1,"330,",0,{"v":-31.6,"d":"-31.60"},{"v":6.30957344480189e-35,"d":"0.00"},-1.07,"3' UTR",19,10654261,10692417,38157,1]
[11538946,11539429,484,"ENSG00000130176","ENST00000592923","protein_coding",179,"CNN1","calponin 1 [Source:HGNC Symbol;Acc:HGNC:2155]","GO:0003779(actin binding);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005856(cytoskeleton);GO:0005925(focal adhesion);GO:0006940(regulation of smooth muscle contraction);GO:0031032(actomyosin structure organization);GO:1904706(negative regulation of vascular smooth muscle cell proliferation)","NA",{"v":4.1E-5,"d":"0.00"},2,"45,135,","0,349",{"v":-0.747,"d":"-0.75"},{"v":0.0467735141287198,"d":"0.05"},{"v":-1.2,"d":"-1.20"},"5' UTR",19,11538767,11550322,11556,1]
[11978151,11978691,541,"ENSG00000197054","ENST00000592625","protein_coding",13114,"ZNF763","zinc finger protein 763 [Source:HGNC Symbol;Acc:HGNC:27614]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":2.3E-6,"d":"0.00"},1,"541,",0,{"v":-0.748,"d":"-0.75"},{"v":0.0467735141287198,"d":"0.05"},-1.97,"5' UTR",19,11965037,11978395,13359,1]
[11978136,11978675,540,"ENSG00000197054","ENST00000592625","protein_coding",13099,"ZNF763","zinc finger protein 763 [Source:HGNC Symbol;Acc:HGNC:27614]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":4.3e-07,"d":"0.00"},1,"540,",0,{"v":-0.739,"d":"-0.74"},{"v":0.0489778819368446,"d":"0.05"},-1.96,"5' UTR",19,11965037,11978395,13359,1]
[16688769,16689276,508,"ENSG00000072954","ENST00000187762","protein_coding",27630,"TMEM38A","transmembrane protein 38A [Source:HGNC Symbol;Acc:HGNC:28462]","GO:0005261(cation channel activity);GO:0005267(potassium channel activity);GO:0005634(nucleus);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0007029(endoplasmic reticulum organization);GO:0010881(regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion);GO:0014808(release of sequestered calcium ion into cytosol by sarcoplasmic reticulum);GO:0015672(monovalent inorganic cation transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016529(sarcoplasmic reticulum);GO:0031965(nuclear membrane);GO:0033017(sarcoplasmic reticulum membrane);GO:0034220(ion transmembrane transport);GO:0070062(extracellular exosome);GO:0070207(protein homotrimerization);GO:0071313(cellular response to caffeine);GO:0071805(potassium ion transmembrane transport);GO:0098655(cation transmembrane transport)","NA",{"v":6.3e-52,"d":"0.00"},1,"508,",0,-5.38,{"v":1.47910838816821E-7,"d":"0.00"},-1.12,"3' UTR",19,16661139,16690023,28885,1]
[27793488,27963277,169790,"ENSG00000261824","ENST00000590523","lincRNA",0,"LINC00662","long intergenic non-protein coding RNA 662 [Source:HGNC Symbol;Acc:HGNC:27122]","NA","NA",{"v":1.6e-28,"d":"0.00"},4,"163,79,75,12,","0,126292,162714,169778",-1.64,{"v":0.00288403150312661,"d":"0.00"},-1.32,"Exon (ENST00000588122/ENSG00000267575, exon 1 of 4)",19,27790491,27793940,3450,2]
[34504029,34504239,211,"ENSG00000142279","ENST00000590071","protein_coding",22391,"WTIP","WT1 interacting protein [Source:HGNC Symbol;Acc:HGNC:20964]","GO:0000932(P-body);GO:0001666(response to hypoxia);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005911(cell-cell junction);GO:0005912(adherens junction);GO:0007010(cytoskeleton organization);GO:0022604(regulation of cell morphogenesis);GO:0030030(cell projection organization);GO:0030054(cell junction);GO:0031047(gene silencing by RNA);GO:0035195(gene silencing by miRNA);GO:0035331(negative regulation of hippo signaling);GO:0046872(metal ion binding);GO:1903507(negative regulation of nucleic acid-templated transcription);GO:2000637(positive regulation of gene silencing by miRNA)","04390(Hippo signaling pathway);04392(Hippo signaling pathway - multiple species)",{"v":1.9e-05,"d":"0.00"},1,"211,",0,{"v":-0.881,"d":"-0.88"},{"v":0.0301995172040202,"d":"0.03"},{"v":-1.2,"d":"-1.20"},"3' UTR",19,34481638,34512304,30667,1]
[35248360,35249044,685,"ENSG00000105699","ENST00000602122","protein_coding",0,"LSR","lipolysis stimulated lipoprotein receptor [Source:HGNC Symbol;Acc:HGNC:29572]","GO:0001889(liver development);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019216(regulation of lipid metabolic process);GO:0034361(very-low-density lipoprotein particle);GO:0034362(low-density lipoprotein particle);GO:0042627(chylomicron);GO:0060856(establishment of blood-brain barrier);GO:0061689(tricellular tight junction);GO:0070062(extracellular exosome);GO:1904274(tricellular tight junction assembly)","NA",{"v":1.6e-36,"d":"0.00"},1,"685,",0,-2.05,{"v":0.00091201083935591,"d":"0.00"},-1.07,"5' UTR",19,35248392,35267962,19571,1]
[55386756,55387235,480,"ENSG00000249700","ENST00000619203","retained_intron",0,"SRD5A3-AS1","SRD5A3 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:44138]","NA","NA",{"v":2.6e-08,"d":"0.00"},1,"480,",0,{"v":-2.1,"d":"-2.10"},{"v":0.000794328234724281,"d":"0.00"},-3.12,"Exon (ENST00000619203/ENSG00000249700, exon 1 of 4)",4,55374924,55386892,11969,2]
[42242834,42243191,358,"ENSG00000268643","ENST00000594664","protein_coding",11941,"AC006486","novel protein","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","NA",{"v":7.6e-07,"d":"0.00"},1,"358,",0,{"v":-0.775,"d":"-0.78"},{"v":0.0426579518801593,"d":"0.04"},-3.12,"Exon (ENST00000624246/ENSG00000279539, exon 1 of 1)",19,42234583,42255132,20550,2]
[41506391,41506659,269,"ENSG00000268034","ENST00000600996","processed_pseudogene",239,"AC243960","tropomyosin pseudogene","NA","NA",{"v":4.6e-08,"d":"0.00"},1,"269,",0,-2.26,{"v":0.000501187233627273,"d":"0.00"},-1.77,"Exon (ENST00000600996/ENSG00000268034, exon 1 of 1)",19,41506152,41506898,747,1]
[11505601,11505809,209,"ENSG00000267477","ENST00000585656","nonsense_mediated_decay",0,"AC008481","novel transcript","NA","NA",{"v":4.3e-07,"d":"0.00"},1,"209,",0,{"v":-1.3,"d":"-1.30"},{"v":0.00794328234724281,"d":"0.01"},-3.12,"5' UTR",19,11466240,11505698,39459,2]
[42295228,42295378,151,"ENSG00000079432","ENST00000572681","protein_coding",26691,"CIC","capicua transcriptional repressor [Source:HGNC Symbol;Acc:HGNC:14214]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0007420(brain development);GO:0007612(learning);GO:0007613(memory);GO:0032991(protein-containing complex);GO:0035176(social behavior);GO:0043231(intracellular membrane-bounded organelle);GO:0045892(negative regulation of transcription, DNA-templated);GO:0048286(lung alveolus development)","NA",{"v":1.9e-05,"d":"0.00"},1,"151,",0,-2.62,{"v":0.000194984459975805,"d":"0.00"},-1.29,"3' UTR",19,42268537,42295796,27260,1]
[43535623,43535981,359,"ENSG00000176472","ENST00000458714","protein_coding",10126,"ZNF575","zinc finger protein 575 [Source:HGNC Symbol;Acc:HGNC:27606]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","NA",{"v":3.2e-11,"d":"0.00"},1,"359,",0,{"v":-0.793,"d":"-0.79"},{"v":0.0398107170553497,"d":"0.04"},-1.61,"3' UTR",19,43525497,43536130,10634,1]
[48704425,48705143,719,"ENSG00000176920","ENST00000425340","protein_coding",8450,"FUT2","fucosyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:4013]","GO:0005794(Golgi apparatus);GO:0005975(carbohydrate metabolic process);GO:0006486(protein glycosylation);GO:0008107(galactoside 2-alpha-L-fucosyltransferase activity);GO:0008417(fucosyltransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0032580(Golgi cisterna membrane);GO:0036065(fucosylation);GO:0042355(L-fucose catabolic process);GO:0070062(extracellular exosome)","00601(Glycosphingolipid biosynthesis - lacto and neolacto series);00603(Glycosphingolipid biosynthesis - globo and isoglobo series)",{"v":4e-17,"d":"0.00"},1,"719,",0,{"v":-0.786,"d":"-0.79"},{"v":0.0407380277804113,"d":"0.04"},-1.39,"3' UTR",19,48695975,48705950,9976,1]
[53410522,53411331,810,"ENSG00000196417","ENST00000504146","processed_transcript",20729,"ZNF765","zinc finger protein 765 [Source:HGNC Symbol;Acc:HGNC:25092]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":2e-21,"d":"0.00"},1,"810,",0,-1.18,{"v":0.0114815362149688,"d":"0.01"},-1.72,"3' UTR",19,53389793,53423097,33305,1]
[53578143,53578442,300,"ENSG00000130844","ENST00000648236","protein_coding",57195,"ZNF331","zinc finger protein 331 [Source:HGNC Symbol;Acc:HGNC:15489]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008270(zinc ion binding);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":0.00014,"d":"0.00"},1,"300,",0,-1.01,{"v":0.0199526231496888,"d":"0.02"},-1.07,"3' UTR",19,53520948,53580202,59255,1]
[19302498,19303516,1019,"ENSG00000228294","ENST00000444357","processed_transcript",794,"BMS1P17","BMS1, ribosome biogenesis factor pseudogene 17 [Source:HGNC Symbol;Acc:HGNC:49162]","NA","NA",{"v":5e-28,"d":"0.00"},1,"1019,",0,-5.17,{"v":2.45470891568503e-07,"d":"0.00"},-3.13,"Exon (ENST00000624585/ENSG00000244306, exon 8 of 8)",14,19301704,19316800,15097,1]
[55044170,55046595,2426,"ENSG00000160439","ENST00000591868","processed_transcript",0,"RDH13","retinol dehydrogenase 13 [Source:HGNC Symbol;Acc:HGNC:19978]","GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0009644(response to high light intensity);GO:0010842(retina layer formation);GO:0016020(membrane);GO:0016491(oxidoreductase activity);GO:0042462(eye photoreceptor cell development);GO:0042572(retinol metabolic process);GO:0042574(retinal metabolic process);GO:0052650(NADP-retinol dehydrogenase activity);GO:0055114(oxidation-reduction process)","NA",{"v":5e-12,"d":"0.00"},2,"148,122,","0,2304",-1.22,{"v":0.0102329299228075,"d":"0.01"},-1.17,"3' UTR",19,55042039,55044949,2911,2]
[56141292,56142381,1090,"ENSG00000167685","ENST00000586123","protein_coding",0,"ZNF444","zinc finger protein 444 [Source:HGNC Symbol;Acc:HGNC:16052]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","NA",{"v":3.2e-26,"d":"0.00"},3,"66,68,106,","0,435,984",-1.95,{"v":1.20226443461741E-3,"d":"0.00"},-1.52,"5' UTR",19,56141303,56147123,5821,1]
[56576734,56578320,1587,"ENSG00000197016","ENST00000330619","protein_coding",9266,"ZNF470","zinc finger protein 470 [Source:HGNC Symbol;Acc:HGNC:22220]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0016604(nuclear body);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":1.3E-28,"d":"0.00"},1,"1587,",0,-1.63,{"v":3.01995172040202E-3,"d":"0.00"},-1.45,"Exon (ENST00000330619/ENSG00000197016, exon 6 of 6)",19,56567468,56582894,15427,1]
[57506683,57506832,150,"ENSG00000152439","ENST00000593916","protein_coding",6768,"ZNF773","zinc finger protein 773 [Source:HGNC Symbol;Acc:HGNC:30487]","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":0.00043,"d":"0.00"},1,"150,",0,{"v":-1.3,"d":"-1.30"},{"v":0.00794328234724281,"d":"0.01"},-1.59,"Exon (ENST00000598770/ENSG00000152439, exon 4 of 4)",19,57499915,57513144,13230,1]
[334482,344815,10334,"ENSG00000105556","ENST00000264819","protein_coding",0,"MIER2","MIER family member 2 [Source:HGNC Symbol;Acc:HGNC:29210]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001103(RNA polymerase II repressing transcription factor binding);GO:0003677(DNA binding);GO:0003714(transcription corepressor activity);GO:0004407(histone deacetylase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0016575(histone deacetylation);GO:0032991(protein-containing complex);GO:0042826(histone deacetylase binding)","NA",{"v":2E-12,"d":"0.00"},4,"61,112,86,42,","0,1601,6032,10292",-1.08,{"v":0.0158489319246111,"d":"0.02"},-1.01,"5' UTR",19,301444,344782,43339,2]
[1986065,1986364,300,"ENSG00000133243","ENST00000592895","retained_intron",2205,"BTBD2","BTB domain containing 2 [Source:HGNC Symbol;Acc:HGNC:15504]","GO:0000932(P-body);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0022008(neurogenesis)","NA",{"v":2.5e-63,"d":"0.00"},1,"300,",0,{"v":-11.6,"d":"-11.60"},{"v":2.51188643150958e-14,"d":"0.00"},-1.06,"3' UTR",19,1985438,1988569,3132,2]
[2112789,2113094,306,"ENSG00000065000","ENST00000585652","retained_intron",0,"AP3D1","adaptor related protein complex 3 subunit delta 1 [Source:HGNC Symbol;Acc:HGNC:568]","GO:0000139(Golgi membrane);GO:0005215(transporter activity);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0006623(protein targeting to vacuole);GO:0006726(eye pigment biosynthetic process);GO:0006886(intracellular protein transport);GO:0006896(Golgi to vacuole transport);GO:0008089(anterograde axonal transport);GO:0010008(endosome membrane);GO:0015031(protein transport);GO:0016020(membrane);GO:0016182(synaptic vesicle budding from endosome);GO:0016192(vesicle-mediated transport);GO:0019882(antigen processing and presentation);GO:0030117(membrane coat);GO:0030123(AP-3 adaptor complex);GO:0030424(axon);GO:0032438(melanosome organization);GO:0033365(protein localization to organelle);GO:0035646(endosome to melanosome transport);GO:0043195(terminal bouton);GO:0048007(antigen processing and presentation, exogenous lipid antigen via MHC class Ib);GO:0048490(anterograde synaptic vesicle transport);GO:0048499(synaptic vesicle membrane organization);GO:0051138(positive regulation of NK T cell differentiation);GO:0061088(regulation of sequestering of zinc ion);GO:0072657(protein localization to membrane);GO:0098793(presynapse);GO:0098794(postsynapse);GO:0098830(presynaptic endosome);GO:0098943(neurotransmitter receptor transport, postsynaptic endosome to lysosome);GO:0098978(glutamatergic synapse);GO:0099003(vesicle-mediated transport in synapse);GO:1904115(axon cytoplasm)","04142(Lysosome)",{"v":1e-28,"d":"0.00"},2,"35,235,","0,71",-3.89,{"v":6.60693448007596e-06,"d":"0.00"},-1.13,"Exon (ENST00000643116/ENSG00000065000, exon 24 of 32)",19,2100995,2112823,11829,2]
[5916139,5916348,210,"ENSG00000031823","ENST00000439268","protein_coding",61760,"RANBP3","RAN binding protein 3 [Source:HGNC Symbol;Acc:HGNC:9850]","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005643(nuclear pore);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006611(protein export from nucleus);GO:0008536(Ran GTPase binding);GO:0015031(protein transport);GO:0043547(positive regulation of GTPase activity);GO:0046907(intracellular transport);GO:0070412(R-SMAD binding)","05166(Human T-cell leukemia virus 1 infection)",{"v":2e-11,"d":"0.00"},1,"210,",0,-1.64,{"v":0.00295120922666638,"d":"0.00"},-1.05,"3' UTR",19,5916139,5978108,61970,2]
[9648422,9648542,121,"ENSG00000171466","ENST00000453372","protein_coding",26558,"ZNF562","zinc finger protein 562 [Source:HGNC Symbol;Acc:HGNC:25950]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":0.0011,"d":"0.00"},1,"121,",0,-0.79,{"v":0.0407380277804113,"d":"0.04"},-1.31,"3' UTR",19,9641807,9675100,33294,2]
[166383635,166384081,447,"ENSG00000261420","ENST00000568025","antisense",446,"AL022069","novel transcript, antisense to BRP44L","NA","NA",{"v":1.4e-07,"d":"0.00"},1,"447,",0,-1.12,{"v":0.0138038426460289,"d":"0.01"},-3.14,"Exon (ENST00000568025/ENSG00000261420, exon 1 of 1)",6,166383189,166384824,1636,1]
[115939993,115940920,928,"ENSG00000105967","ENST00000457268","protein_coding",27393,"TFEC","transcription factor EC [Source:HGNC Symbol;Acc:HGNC:11754]","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0034605(cellular response to heat);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:1903507(negative regulation of nucleic acid-templated transcription)","NA",{"v":4e-28,"d":"0.00"},1,"928,",0,-1.54,{"v":0.0038904514499428,"d":"0.00"},-3.14,"3' UTR",7,115935148,115968313,33166,2]
[12723437,12723981,545,"ENSG00000105576","ENST00000589337","protein_coding",0,"TNPO2","transportin 2 [Source:HGNC Symbol;Acc:HGNC:19998]","GO:0005515(protein binding);GO:0005623(cell);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006606(protein import into nucleus);GO:0006607(NLS-bearing protein import into nucleus);GO:0006610(ribosomal protein import into nucleus);GO:0006886(intracellular protein transport);GO:0008139(nuclear localization sequence binding);GO:0008536(Ran GTPase binding);GO:0008565(protein transporter activity);GO:0015031(protein transport);GO:0031965(nuclear membrane);GO:0034399(nuclear periphery)","NA",{"v":3.3e-08,"d":"0.00"},2,"177,213,","0,332",{"v":-1.9,"d":"-1.90"},{"v":0.00141253754462275,"d":"0.00"},-1.06,"5' UTR",19,12719098,12723932,4835,2]
[15353504,15353892,389,"ENSG00000105127","ENST00000269701","protein_coding",25895,"AKAP8","A-kinase anchoring protein 8 [Source:HGNC Symbol;Acc:HGNC:378]","GO:0000278(mitotic cell cycle);GO:0000793(condensed chromosome);GO:0001939(female pronucleus);GO:0002376(immune system process);GO:0003677(DNA binding);GO:0003690(double-stranded DNA binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005794(Golgi apparatus);GO:0007076(mitotic chromosome condensation);GO:0007165(signal transduction);GO:0008270(zinc ion binding);GO:0015031(protein transport);GO:0016020(membrane);GO:0016363(nuclear matrix);GO:0031065(positive regulation of histone deacetylation);GO:0032720(negative regulation of tumor necrosis factor production);GO:0033127(regulation of histone phosphorylation);GO:0034237(protein kinase A regulatory subunit binding);GO:0042826(histone deacetylase binding);GO:0044839(cell cycle G2/M phase transition);GO:0045087(innate immune response);GO:0046872(metal ion binding);GO:0051059(NF-kappaB binding);GO:0071222(cellular response to lipopolysaccharide);GO:0071380(cellular response to prostaglandin E stimulus)","NA",{"v":1.6e-29,"d":"0.00"},1,"389,",0,{"v":-2.4,"d":"-2.40"},{"v":0.000346736850452532,"d":"0.00"},-1.14,"3' UTR",19,15353385,15379787,26403,2]
[16355598,16355807,210,"ENSG00000127527","ENST00000594851","protein_coding",6146,"EPS15L1","epidermal growth factor receptor pathway substrate 15 like 1 [Source:HGNC Symbol;Acc:HGNC:24634]","GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005905(clathrin-coated pit);GO:0006897(endocytosis);GO:0016020(membrane);GO:0030132(clathrin coat of coated pit);GO:0042059(negative regulation of epidermal growth factor receptor signaling pathway);GO:0045296(cadherin binding);GO:0046872(metal ion binding);GO:0061024(membrane organization)","04144(Endocytosis)",{"v":4e-12,"d":"0.00"},1,"210,",0,-2.45,{"v":0.000309029543251359,"d":"0.00"},-1.17,"3' UTR",19,16355239,16361953,6715,2]
[17292131,17292397,267,"ENSG00000127220","ENST00000247706","protein_coding",11028,"ABHD8","abhydrolase domain containing 8 [Source:HGNC Symbol;Acc:HGNC:23759]","GO:0003824(catalytic activity);GO:0016787(hydrolase activity);GO:0052689(carboxylic ester hydrolase activity);GO:0055088(lipid homeostasis);GO:0070062(extracellular exosome)","NA",{"v":7.1e-07,"d":"0.00"},1,"267,",0,-1.43,{"v":0.00537031796370253,"d":"0.01"},-1.09,"3' UTR",19,17292131,17303425,11295,2]
[17655921,17656341,421,"ENSG00000130477","ENST00000519716","protein_coding",31858,"UNC13A","unc-13 homolog A [Source:HGNC Symbol;Acc:HGNC:23150]","GO:0001956(positive regulation of neurotransmitter secretion);GO:0005509(calcium ion binding);GO:0005516(calmodulin binding);GO:0005543(phospholipid binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006887(exocytosis);GO:0007268(chemical synaptic transmission);GO:0007269(neurotransmitter secretion);GO:0007528(neuromuscular junction development);GO:0016020(membrane);GO:0016079(synaptic vesicle exocytosis);GO:0016081(synaptic vesicle docking);GO:0016082(synaptic vesicle priming);GO:0016188(synaptic vesicle maturation);GO:0017075(syntaxin-1 binding);GO:0019992(diacylglycerol binding);GO:0030054(cell junction);GO:0030154(cell differentiation);GO:0030424(axon);GO:0030672(synaptic vesicle membrane);GO:0031594(neuromuscular junction);GO:0031915(positive regulation of synaptic plasticity);GO:0035249(synaptic transmission, glutamatergic);GO:0035556(intracellular signal transduction);GO:0042734(presynaptic membrane);GO:0043005(neuron projection);GO:0043195(terminal bouton);GO:0044305(calyx of Held);GO:0045202(synapse);GO:0046872(metal ion binding);GO:0048172(regulation of short-term neuronal synaptic plasticity);GO:0048786(presynaptic active zone);GO:0050435(amyloid-beta metabolic process);GO:0051966(regulation of synaptic transmission, glutamatergic);GO:0060384(innervation);GO:0061789(dense core granule priming);GO:0098793(presynapse);GO:0098831(presynaptic active zone cytoplasmic component);GO:0098978(glutamatergic synapse);GO:0099525(presynaptic dense core vesicle exocytosis);GO:1900451(positive regulation of glutamate receptor signaling pathway);GO:1902991(regulation of amyloid precursor protein catabolic process);GO:1903861(positive regulation of dendrite extension)","04721(Synaptic vesicle cycle)",{"v":1.3E-20,"d":"0.00"},1,"421,",0,-3.97,{"v":5.37031796370253e-06,"d":"0.00"},-1.19,"Exon (ENST00000519716/ENSG00000130477, exon 10 of 44)",19,17601328,17688199,86872,2]
[19638219,19638440,222,"ENSG00000089639","ENST00000203556","protein_coding",5217,"GMIP","GEM interacting protein [Source:HGNC Symbol;Acc:HGNC:24852]","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0034260(negative regulation of GTPase activity);GO:0035556(intracellular signal transduction);GO:0043547(positive regulation of GTPase activity);GO:0046872(metal ion binding);GO:0051056(regulation of small GTPase mediated signal transduction)","NA",{"v":1.4E-5,"d":"0.00"},2,"111,39,","0,183",-1.05,{"v":0.0173780082874938,"d":"0.02"},-1.09,"3' UTR",19,19629476,19643657,14182,2]
[23360279,23361147,869,"ENSG00000167232","ENST00000596989","processed_transcript",34324,"ZNF91","zinc finger protein 91 [Source:HGNC Symbol;Acc:HGNC:13166]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008270(zinc ion binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0070895(negative regulation of transposon integration)","05168(Herpes simplex virus 1 infection)",{"v":1.6e-25,"d":"0.00"},1,"869,",0,{"v":-0.797,"d":"-0.80"},{"v":0.0398107170553497,"d":"0.04"},-1.19,"Exon (ENST00000300619/ENSG00000167232, exon 4 of 4)",19,23308903,23395471,86569,2]
[27793384,27793820,437,"ENSG00000261824","ENST00000590677","lincRNA",0,"LINC00662","long intergenic non-protein coding RNA 662 [Source:HGNC Symbol;Acc:HGNC:27122]","NA","NA",{"v":1.6e-21,"d":"0.00"},2,"11,289,","0,148",-2.12,{"v":0.000758577575029184,"d":"0.00"},-1.67,"Exon (ENST00000588122/ENSG00000267575, exon 1 of 4)",19,27715786,27793394,77609,2]
[8648787,8648936,150,"ENSG00000067365","ENST00000381920","protein_coding",27099,"METTL22","methyltransferase like 22 [Source:HGNC Symbol;Acc:HGNC:28368]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006479(protein methylation);GO:0008168(methyltransferase activity);GO:0008276(protein methyltransferase activity);GO:0016279(protein-lysine N-methyltransferase activity);GO:0016740(transferase activity);GO:0018022(peptidyl-lysine methylation);GO:0031072(heat shock protein binding);GO:0032259(methylation);GO:0032991(protein-containing complex)","NA",{"v":0.0017,"d":"0.00"},1,"150,",0,{"v":-0.778,"d":"-0.78"},{"v":0.0426579518801593,"d":"0.04"},-3.15,"3' UTR",16,8621688,8649654,27967,1]
[39014429,39024082,9654,"ENSG00000161243","ENST00000598394","protein_coding",2878,"FBXO27","F-box protein 27 [Source:HGNC Symbol;Acc:HGNC:18753]","GO:0000209(protein polyubiquitination);GO:0005515(protein binding);GO:0005829(cytosol);GO:0019005(SCF ubiquitin ligase complex);GO:0043687(post-translational protein modification)","NA",{"v":3.7e-05,"d":"0.00"},2,"119,62,","0,9592",{"v":-0.767,"d":"-0.77"},{"v":0.0436515832240166,"d":"0.04"},-1.66,"3' UTR",19,38990714,39026960,36247,2]
[43592798,43593007,210,"ENSG00000167378","ENST00000601520","processed_transcript",0,"IRGQ","immunity related GTPase Q [Source:HGNC Symbol;Acc:HGNC:24868]","GO:0005525(GTP binding)","NA",{"v":1.6e-16,"d":"0.00"},1,"210,",0,-1.03,{"v":0.0186208713666287,"d":"0.02"},-1.17,"Exon (ENST00000594374/ENSG00000268361, exon 1 of 3)",19,43586277,43593007,6731,2]
[2656242,2656571,330,"ENSG00000223773","ENST00000435581","processed_transcript",46850,"CD99P1","CD99 molecule pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:7083]","NA","NA",{"v":1.5E-5,"d":"0.00"},1,"330,",0,{"v":-0.921,"d":"-0.92"},{"v":0.0263026799189538,"d":"0.03"},-3.15,"Exon (ENST00000435581/ENSG00000223773, exon 9 of 9)",23,2609392,2657229,47838,1]
[45789377,45789735,359,"ENSG00000185800","ENST00000377735","protein_coding",3067,"DMWD","DM1 locus, WD repeat containing [Source:HGNC Symbol;Acc:HGNC:2936]","GO:0003674(molecular_function);GO:0005515(protein binding);GO:0005575(cellular_component);GO:0005634(nucleus);GO:0030425(dendrite);GO:0042995(cell projection);GO:0043204(perikaryon)","NA",{"v":3.2e-24,"d":"0.00"},1,"359,",0,-1.24,{"v":0.00954992586021436,"d":"0.01"},-1,"Exon (ENST00000597053/ENSG00000185800, exon 2 of 2)",19,45782947,45792802,9856,2]
[46390515,46390852,338,"ENSG00000269151","ENST00000598616","antisense",0,"AC007193","novel transcript, antisense to PPP5C","NA","NA",{"v":4e-12,"d":"0.00"},2,"74,114,","0,224",-1.18,{"v":0.0114815362149688,"d":"0.01"},-1.05,"3' UTR",19,46390515,46390852,338,2]
[78226638,78226787,150,"ENSG00000033327","ENST00000361507","protein_coding",191033,"GAB2","GRB2 associated binding protein 2 [Source:HGNC Symbol;Acc:HGNC:14458]","GO:0005068(transmembrane receptor protein tyrosine kinase adaptor activity);GO:0005515(protein binding);GO:0005547(phosphatidylinositol-3,4,5-trisphosphate binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007411(axon guidance);GO:0008284(positive regulation of cell population proliferation);GO:0016020(membrane);GO:0019221(cytokine-mediated signaling pathway);GO:0030316(osteoclast differentiation);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0043306(positive regulation of mast cell degranulation);GO:0043325(phosphatidylinositol-3,4-bisphosphate binding);GO:0048015(phosphatidylinositol-mediated signaling)","04014(Ras signaling pathway);04071(Sphingolipid signaling pathway);04072(Phospholipase D signaling pathway);04380(Osteoclast differentiation);04664(Fc epsilon RI signaling pathway);04666(Fc gamma R-mediated phagocytosis);05220(Chronic myeloid leukemia)",{"v":1E-3,"d":"0.00"},1,"150,",0,{"v":-0.942,"d":"-0.94"},{"v":0.0245470891568503,"d":"0.02"},-3.17,"Exon (ENST00000361507/ENSG00000033327, exon 4 of 10)",11,78215293,78417820,202528,2]
[53116310,53122520,6211,"ENSG00000170954","ENST00000600120","nonsense_mediated_decay",10355,"ZNF415","zinc finger protein 415 [Source:HGNC Symbol;Acc:HGNC:20636]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001650(fibrillar center);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0015630(microtubule cytoskeleton);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":3.5e-08,"d":"0.00"},2,"124,117,","0,6094",-1.25,{"v":0.0091201083935591,"d":"0.01"},-1.65,"5' UTR",19,53107879,53132875,24997,2]
[109111306,109125594,14289,"ENSG00000076555","ENST00000338432","protein_coding",0,"ACACB","acetyl-CoA carboxylase beta [Source:HGNC Symbol;Acc:HGNC:85]","GO:0000166(nucleotide binding);GO:0003824(catalytic activity);GO:0003989(acetyl-CoA carboxylase activity);GO:0004075(biotin carboxylase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005829(cytosol);GO:0006084(acetyl-CoA metabolic process);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0006853(carnitine shuttle);GO:0008152(metabolic process);GO:0009374(biotin binding);GO:0010629(negative regulation of gene expression);GO:0010884(positive regulation of lipid storage);GO:0010906(regulation of glucose metabolic process);GO:0012505(endomembrane system);GO:0014070(response to organic cyclic compound);GO:0016020(membrane);GO:0016874(ligase activity);GO:0031325(positive regulation of cellular metabolic process);GO:0031667(response to nutrient levels);GO:0031999(negative regulation of fatty acid beta-oxidation);GO:0042493(response to drug);GO:0042802(identical protein binding);GO:0043086(negative regulation of catalytic activity);GO:0045540(regulation of cholesterol biosynthetic process);GO:0046322(negative regulation of fatty acid oxidation);GO:0046872(metal ion binding);GO:0050995(negative regulation of lipid catabolic process);GO:0051289(protein homotetramerization);GO:0060421(positive regulation of heart growth);GO:0097009(energy homeostasis);GO:2001295(malonyl-CoA biosynthetic process)","00061(Fatty acid biosynthesis);00620(Pyruvate metabolism);00640(Propanoate metabolism);04152(AMPK signaling pathway);04910(Insulin signaling pathway);04920(Adipocytokine signaling pathway);04922(Glucagon signaling pathway);04931(Insulin resistance)",{"v":1.8E-10,"d":"0.00"},3,"167,321,334,","0,1789,13955",-2.79,{"v":1.23026877081238E-4,"d":"0.00"},-3.21,"5' UTR",12,109116595,109268226,151632,1]
[56440254,56441153,900,"ENSG00000198046","ENST00000591790","protein_coding",31915,"ZNF667","zinc finger protein 667 [Source:HGNC Symbol;Acc:HGNC:28854]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":4e-25,"d":"0.00"},1,"900,",0,-1.38,{"v":0.00630957344480193,"d":"0.01"},{"v":-1.4,"d":"-1.40"},"3' UTR",19,56439325,56473068,33744,2]
[58563156,58563365,210,"ENSG00000099326","ENST00000600004","retained_intron",1248,"MZF1","myeloid zinc finger 1 [Source:HGNC Symbol;Acc:HGNC:13108]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0042803(protein homodimerization activity);GO:0044212(transcription regulatory region DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","NA",{"v":7.9e-05,"d":"0.00"},1,"210,",0,-0.88,{"v":0.0301995172040202,"d":"0.03"},-1.47,"3' UTR",19,58561931,58564613,2683,2]
[32359573,32360037,465,"ENSG00000171456","ENST00000306058","protein_coding",0,"ASXL1","ASXL transcriptional regulator 1 [Source:HGNC Symbol;Acc:HGNC:18318]","GO:0000790(nuclear chromatin);GO:0000902(cell morphogenesis);GO:0003007(heart morphogenesis);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0009887(animal organ morphogenesis);GO:0016579(protein deubiquitination);GO:0030097(hemopoiesis);GO:0032526(response to retinoic acid);GO:0035359(negative regulation of peroxisome proliferator activated receptor signaling pathway);GO:0035517(PR-DUB complex);GO:0035522(monoubiquitinated histone H2A deubiquitination);GO:0042974(retinoic acid receptor binding);GO:0042975(peroxisome proliferator activated receptor binding);GO:0045599(negative regulation of fat cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0048386(positive regulation of retinoic acid receptor signaling pathway);GO:0048534(hematopoietic or lymphoid organ development);GO:0048538(thymus development);GO:0048539(bone marrow development);GO:0048872(homeostasis of number of cells);GO:0060348(bone development);GO:0060430(lung saccule development)","NA",{"v":2.6e-06,"d":"0.00"},2,"279,21,","0,444",{"v":-0.761,"d":"-0.76"},{"v":0.0446683592150963,"d":"0.04"},-1.13,"5' UTR",20,32359747,32439318,79572,1]
[35514005,35514814,810,"ENSG00000126001","ENST00000397527","protein_coding",58407,"CEP250","centrosomal protein 250 [Source:HGNC Symbol;Acc:HGNC:1859]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0000278(mitotic cell cycle);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005929(cilium);GO:0007049(cell cycle);GO:0008022(protein C-terminus binding);GO:0008104(protein localization);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0010457(centriole-centriole cohesion);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0030997(regulation of centriole-centriole cohesion);GO:0032991(protein-containing complex);GO:0033365(protein localization to organelle);GO:0042995(cell projection);GO:0048471(perinuclear region of cytoplasm);GO:0070062(extracellular exosome);GO:0097711(ciliary basal body-plasma membrane docking);GO:1904781(positive regulation of protein localization to centrosome);GO:1905515(non-motile cilium assembly)","NA",{"v":2.1E-10,"d":"0.00"},1,"810,",0,-1.58,{"v":0.00346736850452532,"d":"0.00"},-1.05,"3' UTR",20,35455598,35519280,63683,1]
[37725821,37726211,391,"ENSG00000100101","ENST00000455236","nonsense_mediated_decay",39407,"Z83844","novel transcript","GO:0003697(single-stranded DNA binding);GO:0005515(protein binding);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0007000(nucleolus organization);GO:0008284(positive regulation of cell population proliferation);GO:0019843(rRNA binding);GO:0030307(positive regulation of cell growth);GO:0043066(negative regulation of apoptotic process)","NA",{"v":7.9e-09,"d":"0.00"},1,"391,",0,-1.07,{"v":0.0165958690743756,"d":"0.02"},-3.22,"3' UTR",22,37686414,37726503,40090,1]
[62801041,62801699,659,"ENSG00000101189","ENST00000370487","protein_coding",4568,"MRGBP","MRG domain binding protein [Source:HGNC Symbol;Acc:HGNC:15866]","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0016573(histone acetylation);GO:0035267(NuA4 histone acetyltransferase complex);GO:0040008(regulation of growth);GO:0043189(H4/H2A histone acetyltransferase complex)","NA",{"v":2.5e-13,"d":"0.00"},1,"659,",0,-1.07,{"v":0.0165958690743756,"d":"0.02"},-1.26,"3' UTR",20,62796473,62801729,5257,1]
[63736343,63736793,451,"ENSG00000203896","ENST00000465591","retained_intron",0,"LIME1","Lck interacting transmembrane adaptor 1 [Source:HGNC Symbol;Acc:HGNC:26016]","GO:0002250(adaptive immune response);GO:0002376(immune system process);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0006357(regulation of transcription by RNA polymerase II);GO:0014066(regulation of phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019815(B cell receptor complex);GO:0019901(protein kinase binding);GO:0043122(regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043405(regulation of MAP kinase activity);GO:0050852(T cell receptor signaling pathway);GO:0050853(B cell receptor signaling pathway);GO:0051279(regulation of release of sequestered calcium ion into cytosol);GO:1901222(regulation of NIK/NF-kappaB signaling)","NA",{"v":6.5e-07,"d":"0.00"},1,"451,",0,{"v":-1.1,"d":"-1.10"},{"v":0.0147910838816821,"d":"0.01"},-1.77,"5' UTR",20,63736460,63738132,1673,1]
[46646771,46647330,560,"ENSG00000213997","ENST00000413837","processed_pseudogene",0,"PGAM1P7","phosphoglycerate mutase 1 pseudogene 7 [Source:HGNC Symbol;Acc:HGNC:42454]","NA","NA",{"v":1.5e-08,"d":"0.00"},1,"560,",0,-1.15,{"v":0.0128824955169313,"d":"0.01"},-3.24,"Exon (ENST00000413837/ENSG00000213997, exon 1 of 1)",23,46646594,46647330,737,2]
[16368679,16369098,420,"ENSG00000089177","ENST00000354981","protein_coding",204335,"KIF16B","kinesin family member 16B [Source:HGNC Symbol;Acc:HGNC:15869]","GO:0000166(nucleotide binding);GO:0001704(formation of primary germ layer);GO:0001919(regulation of receptor recycling);GO:0003774(motor activity);GO:0003777(microtubule motor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005547(phosphatidylinositol-3,4,5-trisphosphate binding);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005769(early endosome);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005871(kinesin complex);GO:0005874(microtubule);GO:0006895(Golgi to endosome transport);GO:0007018(microtubule-based movement);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007492(endoderm development);GO:0008017(microtubule binding);GO:0008289(lipid binding);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0008574(ATP-dependent microtubule motor activity, plus-end-directed);GO:0016020(membrane);GO:0016887(ATPase activity);GO:0017137(Rab GTPase binding);GO:0031901(early endosome membrane);GO:0032266(phosphatidylinositol-3-phosphate binding);GO:0032801(receptor catabolic process);GO:0035091(phosphatidylinositol binding);GO:0043325(phosphatidylinositol-3,4-bisphosphate binding);GO:0045022(early endosome to late endosome transport);GO:0045335(phagocytic vesicle);GO:0071346(cellular response to interferon-gamma);GO:0080025(phosphatidylinositol-3,5-bisphosphate binding)","NA",{"v":8.1e-08,"d":"0.00"},1,"420,",0,-1.35,{"v":0.00691830970918936,"d":"0.01"},-1.61,"Exon (ENST00000635823/ENSG00000089177, exon 2 of 2)",20,16272104,16573433,301330,2]
[25226448,25226735,288,"ENSG00000279322","ENST00000624174","TEC",0,"AL035252","TEC","NA","NA",{"v":7.9e-17,"d":"0.00"},1,"288,",0,-2.19,{"v":0.000616595001861482,"d":"0.00"},-1.19,"3' UTR",20,25226448,25226735,288,2]
[33989236,33992315,3080,"ENSG00000285230","ENST00000618285","lincRNA",0,"RALY-AS1","RALY antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:50743]","NA","NA",{"v":7.9e-19,"d":"0.00"},2,"778,541,","0,2539",-1.13,{"v":0.0134896288259165,"d":"0.01"},-1.28,"Exon (ENST00000645622/ENSG00000285230, exon 1 of 2)",20,33985617,33991818,6202,2]
[34776412,34782263,5852,"ENSG00000198646","ENST00000374796","protein_coding",39376,"NCOA6","nuclear receptor coactivator 6 [Source:HGNC Symbol;Acc:HGNC:15936]","GO:0003682(chromatin binding);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005829(cytosol);GO:0006260(DNA replication);GO:0006281(DNA repair);GO:0006310(DNA recombination);GO:0006352(DNA-templated transcription, initiation);GO:0006974(cellular response to DNA damage stimulus);GO:0007420(brain development);GO:0007507(heart development);GO:0009725(response to hormone);GO:0019216(regulation of lipid metabolic process);GO:0019899(enzyme binding);GO:0030099(myeloid cell differentiation);GO:0030331(estrogen receptor binding);GO:0030374(nuclear receptor transcription coactivator activity);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0035097(histone methyltransferase complex);GO:0042921(glucocorticoid receptor signaling pathway);GO:0043231(intracellular membrane-bounded organelle);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046965(retinoid X receptor binding);GO:0046966(thyroid hormone receptor binding);GO:1903508(positive regulation of nucleic acid-templated transcription)","NA",{"v":5.1e-06,"d":"0.00"},2,"37,143,","0,5709",-4.83,{"v":5.88843655355588e-07,"d":"0.00"},{"v":-1.4,"d":"-1.40"},"Exon (ENST00000374796/ENSG00000198646, exon 4 of 16)",20,34714774,34821639,106866,2]
[36752059,36752297,239,"ENSG00000149636","ENST00000426836","protein_coding",21454,"DSN1","DSN1 homolog, MIS12 kinetochore complex component [Source:HGNC Symbol;Acc:HGNC:16165]","GO:0000070(mitotic sister chromatid segregation);GO:0000444(MIS12/MIND type complex);GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000777(condensed chromosome kinetochore);GO:0000818(nuclear MIS12/MIND complex);GO:0000922(spindle pole);GO:0000941(condensed nuclear chromosome inner kinetochore);GO:0001650(fibrillar center);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005634(nucleus);GO:0005694(chromosome);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0007049(cell cycle);GO:0007059(chromosome segregation);GO:0016604(nuclear body);GO:0035578(azurophil granule lumen);GO:0043312(neutrophil degranulation);GO:0051301(cell division)","NA",{"v":3.1E-9,"d":"0.00"},1,"239,",0,-3.36,{"v":2.75422870333816e-05,"d":"0.00"},-1.22,"3' UTR",20,36751791,36773751,21961,2]
[36752476,36752803,328,"ENSG00000149636","ENST00000426836","protein_coding",20948,"DSN1","DSN1 homolog, MIS12 kinetochore complex component [Source:HGNC Symbol;Acc:HGNC:16165]","GO:0000070(mitotic sister chromatid segregation);GO:0000444(MIS12/MIND type complex);GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000777(condensed chromosome kinetochore);GO:0000818(nuclear MIS12/MIND complex);GO:0000922(spindle pole);GO:0000941(condensed nuclear chromosome inner kinetochore);GO:0001650(fibrillar center);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005634(nucleus);GO:0005694(chromosome);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0007049(cell cycle);GO:0007059(chromosome segregation);GO:0016604(nuclear body);GO:0035578(azurophil granule lumen);GO:0043312(neutrophil degranulation);GO:0051301(cell division)","NA",{"v":1.6e-42,"d":"0.00"},1,"328,",0,-7.17,{"v":1.58489319246111e-09,"d":"0.00"},-1.27,"3' UTR",20,36751791,36773751,21961,2]
[45948660,45948989,330,"ENSG00000198026","ENST00000322927","protein_coding",23214,"ZNF335","zinc finger protein 335 [Source:HGNC Symbol;Acc:HGNC:15807]","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000979(RNA polymerase II core promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0002052(positive regulation of neuroblast proliferation);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007275(multicellular organism development);GO:0007420(brain development);GO:0010468(regulation of gene expression);GO:0021895(cerebral cortex neuron differentiation);GO:0035097(histone methyltransferase complex);GO:0040029(regulation of gene expression, epigenetic);GO:0044212(transcription regulatory region DNA binding);GO:0046872(metal ion binding);GO:0048812(neuron projection morphogenesis);GO:0048854(brain morphogenesis);GO:0050671(positive regulation of lymphocyte proliferation);GO:0050767(regulation of neurogenesis);GO:0050769(positive regulation of neurogenesis);GO:0051569(regulation of histone H3-K4 methylation);GO:0080182(histone H3-K4 trimethylation)","NA",{"v":2.5e-90,"d":"0.00"},1,"330,",0,-3.19,{"v":4.16869383470336e-05,"d":"0.00"},-1.12,"3' UTR",20,45948660,45972203,23544,2]
[59938335,59938544,210,"ENSG00000132825","ENST00000370996","protein_coding",1761,"PPP1R3D","protein phosphatase 1 regulatory subunit 3D [Source:HGNC Symbol;Acc:HGNC:9294]","GO:0004721(phosphoprotein phosphatase activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0005515(protein binding);GO:0005975(carbohydrate metabolic process);GO:0005977(glycogen metabolic process);GO:0005979(regulation of glycogen biosynthetic process);GO:0005981(regulation of glycogen catabolic process);GO:0006470(protein dephosphorylation);GO:0019899(enzyme binding);GO:0042587(glycogen granule);GO:0043231(intracellular membrane-bounded organelle)","04910(Insulin signaling pathway);04931(Insulin resistance)",{"v":1.3E-6,"d":"0.00"},1,"210,",0,-3.54,{"v":1.65958690743756e-05,"d":"0.00"},-1.52,"3' UTR",20,59936663,59940305,3643,2]
[62841712,62845200,3489,"ENSG00000101190","ENST00000335351","protein_coding",16563,"TCFL5","transcription factor like 5 [Source:HGNC Symbol;Acc:HGNC:11646]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001673(male germ cell nucleus);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006366(transcription by RNA polymerase II);GO:0007275(multicellular organism development);GO:0007283(spermatogenesis);GO:0030154(cell differentiation);GO:0042127(regulation of cell population proliferation);GO:0045595(regulation of cell differentiation);GO:0046983(protein dimerization activity)","NA",{"v":1e-227,"d":"0.00"},2,"386,63,","0,3426",-7.46,{"v":7.76247116628693e-10,"d":"0.00"},-1.19,"3' UTR",20,62841115,62861763,20649,2]
[148532703,148534688,1986,"ENSG00000270629","ENST00000614999","protein_coding",61029,"NBPF14","NBPF member 14 [Source:HGNC Symbol;Acc:HGNC:25232]","NA","NA",{"v":2e-62,"d":"0.00"},3,"546,109,5,","0,1158,1981",{"v":-47.3,"d":"-47.30"},{"v":6.30957344480189E-51,"d":"0.00"},-3.28,"3' UTR",1,148531385,148595717,64333,2]
[63789873,63790203,331,"ENSG00000130584","ENST00000245663","protein_coding",41011,"ZBTB46","zinc finger and BTB domain containing 46 [Source:HGNC Symbol;Acc:HGNC:16094]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0030853(negative regulation of granulocyte differentiation);GO:0045650(negative regulation of macrophage differentiation);GO:0045656(negative regulation of monocyte differentiation);GO:0046872(metal ion binding);GO:2001199(negative regulation of dendritic cell differentiation);GO:2001200(positive regulation of dendritic cell differentiation)","NA",{"v":1e-16,"d":"0.00"},1,"331,",0,{"v":-0.944,"d":"-0.94"},{"v":0.0245470891568503,"d":"0.02"},-1.07,"Exon (ENST00000245663/ENSG00000130584, exon 2 of 5)",20,63743666,63831214,87549,2]
[48950015,48950584,570,"ENSG00000101665","ENST00000589634","protein_coding",0,"SMAD7","SMAD family member 7 [Source:HGNC Symbol;Acc:HGNC:6773]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001650(fibrillar center);GO:0001657(ureteric bud development);GO:0002725(negative regulation of T cell cytokine production);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005518(collagen binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005913(cell-cell adherens junction);GO:0006355(regulation of transcription, DNA-templated);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0008013(beta-catenin binding);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0010801(negative regulation of peptidyl-threonine phosphorylation);GO:0010944(negative regulation of transcription by competitive promoter binding);GO:0016342(catenin complex);GO:0016579(protein deubiquitination);GO:0017015(regulation of transforming growth factor beta receptor signaling pathway);GO:0022409(positive regulation of cell-cell adhesion);GO:0030336(negative regulation of cell migration);GO:0030509(BMP signaling pathway);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0030514(negative regulation of BMP signaling pathway);GO:0030617(transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity);GO:0031397(negative regulation of protein ubiquitination);GO:0031398(positive regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0032925(regulation of activin receptor signaling pathway);GO:0032991(protein-containing complex);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0034333(adherens junction assembly);GO:0034616(response to laminar fluid shear stress);GO:0034629(cellular protein-containing complex localization);GO:0034713(type I transforming growth factor beta receptor binding);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0044212(transcription regulatory region DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0048185(activin binding);GO:0048844(artery morphogenesis);GO:0050821(protein stabilization);GO:0051444(negative regulation of ubiquitin-protein transferase activity);GO:0055010(ventricular cardiac muscle tissue morphogenesis);GO:0055117(regulation of cardiac muscle contraction);GO:0060373(regulation of ventricular cardiac muscle cell membrane depolarization);GO:0060389(pathway-restricted SMAD protein phosphorylation);GO:0060394(negative regulation of pathway-restricted SMAD protein phosphorylation);GO:0060412(ventricular septum morphogenesis);GO:0070411(I-SMAD binding);GO:0071560(cellular response to transforming growth factor beta stimulus);GO:1990830(cellular response to leukemia inhibitory factor);GO:2000317(negative regulation of T-helper 17 type immune response);GO:2000320(negative regulation of T-helper 17 cell differentiation)","04350(TGF-beta signaling pathway);04390(Hippo signaling pathway)",{"v":1.6e-24,"d":"0.00"},1,"570,",0,-1.37,{"v":0.00645654229034656,"d":"0.01"},-3.28,"5' UTR",18,48921372,48950424,29053,2]
[37172690,37185781,13092,"ENSG00000182670","ENST00000355666","protein_coding",99419,"TTC3","tetratricopeptide repeat domain 3 [Source:HGNC Symbol;Acc:HGNC:12393]","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0046872(metal ion binding);GO:0070936(protein K48-linked ubiquitination)","NA",{"v":7.9e-19,"d":"0.00"},3,"55,140,76,","0,10084,13016",-3.46,{"v":2.04173794466953e-05,"d":"0.00"},-1.08,"Exon (ENST00000355666/ENSG00000182670, exon 35 of 46)",21,37073271,37203103,129833,1]
[41280048,41280227,180,"ENSG00000182240","ENST00000347667","protein_coding",112247,"BACE2","beta-secretase 2 [Source:HGNC Symbol;Acc:HGNC:934]","GO:0001540(amyloid-beta binding);GO:0004190(aspartic-type endopeptidase activity);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0006509(membrane protein ectodomain proteolysis);GO:0008233(peptidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016486(peptide hormone processing);GO:0016787(hydrolase activity);GO:0030163(protein catabolic process);GO:0031045(dense core granule);GO:0042593(glucose homeostasis);GO:0042985(negative regulation of amyloid precursor protein biosynthetic process);GO:0048143(astrocyte activation);GO:0050435(amyloid-beta metabolic process)","05010(Alzheimer disease)",{"v":1.1E-4,"d":"0.00"},1,"180,",0,{"v":-0.845,"d":"-0.85"},{"v":0.0338844156139203,"d":"0.03"},-1.92,"3' UTR",21,41167801,41282518,114718,1]
[44978832,44979245,414,"ENSG00000276529","ENST00000616815","lincRNA",0,"AP001505","novel transcript","NA","NA",{"v":1.3e-38,"d":"0.00"},1,"414,",0,-5.97,{"v":3.23593656929628e-08,"d":"0.00"},-1.95,"Exon (ENST00000616815/ENSG00000276529, exon 1 of 1)",21,44978832,44979274,443,1]
[46004513,46005050,538,"ENSG00000142156","ENST00000361866","protein_coding",22776,"COL6A1","collagen type VI alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2211]","GO:0001649(osteoblast differentiation);GO:0003429(growth plate cartilage chondrocyte morphogenesis);GO:0005576(extracellular region);GO:0005581(collagen trimer);GO:0005589(collagen type VI trimer);GO:0005615(extracellular space);GO:0005765(lysosomal membrane);GO:0005788(endoplasmic reticulum lumen);GO:0007155(cell adhesion);GO:0016020(membrane);GO:0030020(extracellular matrix structural constituent conferring tensile strength);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0032991(protein-containing complex);GO:0035987(endodermal cell differentiation);GO:0042383(sarcolemma);GO:0048407(platelet-derived growth factor binding);GO:0062023(collagen-containing extracellular matrix);GO:0070062(extracellular exosome);GO:0070208(protein heterotrimerization);GO:0071230(cellular response to amino acid stimulus)","04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04512(ECM-receptor interaction);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":1.3E-83,"d":"0.00"},1,"538,",0,{"v":-12.3,"d":"-12.30"},{"v":5.01187233627271e-15,"d":"0.00"},{"v":-1.5,"d":"-1.50"},"3' UTR",21,45981737,46005050,23314,1]
[46129329,46129748,420,"ENSG00000142173","ENST00000300527","protein_coding",31232,"COL6A2","collagen type VI alpha 2 chain [Source:HGNC Symbol;Acc:HGNC:2212]","GO:0003429(growth plate cartilage chondrocyte morphogenesis);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005581(collagen trimer);GO:0005615(extracellular space);GO:0005788(endoplasmic reticulum lumen);GO:0007155(cell adhesion);GO:0009749(response to glucose);GO:0016020(membrane);GO:0030020(extracellular matrix structural constituent conferring tensile strength);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0032991(protein-containing complex);GO:0042383(sarcolemma);GO:0062023(collagen-containing extracellular matrix);GO:0070062(extracellular exosome);GO:0070208(protein heterotrimerization);GO:1903561(extracellular vesicle)","04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04512(ECM-receptor interaction);04974(Protein digestion and absorption);05165(Human papillomavirus infection)",{"v":1.4e-06,"d":"0.00"},1,"420,",0,-1.55,{"v":0.00380189396320561,"d":"0.00"},-1.74,"3' UTR",21,46098097,46132849,34753,1]
[46249743,46250462,720,"ENSG00000160294","ENST00000467026","processed_transcript",8803,"MCM3AP","minichromosome maintenance complex component 3 associated protein [Source:HGNC Symbol;Acc:HGNC:6946]","GO:0002376(immune system process);GO:0003676(nucleic acid binding);GO:0003682(chromatin binding);GO:0004402(histone acetyltransferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005643(nuclear pore);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006406(mRNA export from nucleus);GO:0010484(H3 histone acetyltransferase activity);GO:0015031(protein transport);GO:0016446(somatic hypermutation of immunoglobulin genes);GO:0016573(histone acetylation);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0016973(poly(A)+ mRNA export from nucleus);GO:0031965(nuclear membrane);GO:0034728(nucleosome organization);GO:0042393(histone binding);GO:0043966(histone H3 acetylation);GO:0044615(nuclear pore nuclear basket);GO:0051028(mRNA transport);GO:0070390(transcription export complex 2)","NA",{"v":1.3E-17,"d":"0.00"},1,"720,",0,-1,{"v":0.0199526231496888,"d":"0.02"},-1.06,"Exon (ENST00000414659/ENSG00000215424, exon 4 of 4)",21,46235133,46259265,24133,2]
[46326421,46326540,120,"ENSG00000160299","ENST00000490468","processed_transcript",2280,"PCNT","pericentrin [Source:HGNC Symbol;Acc:HGNC:16068]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0000226(microtubule cytoskeleton organization);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0007052(mitotic spindle organization);GO:0007165(signal transduction);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0016020(membrane);GO:0032947(protein-containing complex scaffold activity);GO:0034451(centriolar satellite);GO:0060271(cilium assembly);GO:0090316(positive regulation of intracellular protein transport);GO:0097711(ciliary basal body-plasma membrane docking)","NA",{"v":0.003,"d":"0.00"},1,"120,",0,-1.64,{"v":0.00295120922666638,"d":"0.00"},-1.23,"Exon (ENST00000490468/ENSG00000160299, exon 2 of 8)",21,46324141,46349800,25660,1]
[46357063,46363800,6738,"ENSG00000160299","ENST00000359568","protein_coding",32907,"PCNT","pericentrin [Source:HGNC Symbol;Acc:HGNC:16068]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0000226(microtubule cytoskeleton organization);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0007052(mitotic spindle organization);GO:0007165(signal transduction);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0016020(membrane);GO:0032947(protein-containing complex scaffold activity);GO:0034451(centriolar satellite);GO:0060271(cilium assembly);GO:0090316(positive regulation of intracellular protein transport);GO:0097711(ciliary basal body-plasma membrane docking)","NA",{"v":1e-105,"d":"0.00"},2,"129,321,","0,6417",-6.59,{"v":6.91830970918936e-09,"d":"0.00"},-1.14,"Exon (ENST00000359568/ENSG00000160299, exon 13 of 47)",21,46324156,46445769,121614,1]
[46366778,46367108,331,"ENSG00000160299","ENST00000359568","protein_coding",42622,"PCNT","pericentrin [Source:HGNC Symbol;Acc:HGNC:16068]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0000226(microtubule cytoskeleton organization);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0007052(mitotic spindle organization);GO:0007165(signal transduction);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0016020(membrane);GO:0032947(protein-containing complex scaffold activity);GO:0034451(centriolar satellite);GO:0060271(cilium assembly);GO:0090316(positive regulation of intracellular protein transport);GO:0097711(ciliary basal body-plasma membrane docking)","NA",{"v":5e-14,"d":"0.00"},1,"331,",0,-5.88,{"v":3.98107170553497e-08,"d":"0.00"},-1.86,"Exon (ENST00000359568/ENSG00000160299, exon 15 of 47)",21,46324156,46445769,121614,1]
[46389203,46389413,211,"ENSG00000160299","ENST00000359568","protein_coding",65047,"PCNT","pericentrin [Source:HGNC Symbol;Acc:HGNC:16068]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0000226(microtubule cytoskeleton organization);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0007052(mitotic spindle organization);GO:0007165(signal transduction);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0016020(membrane);GO:0032947(protein-containing complex scaffold activity);GO:0034451(centriolar satellite);GO:0060271(cilium assembly);GO:0090316(positive regulation of intracellular protein transport);GO:0097711(ciliary basal body-plasma membrane docking)","NA",{"v":0.0011,"d":"0.00"},1,"211,",0,-1.04,{"v":0.0177827941003892,"d":"0.02"},-1.16,"Exon (ENST00000359568/ENSG00000160299, exon 19 of 47)",21,46324156,46445769,121614,1]
[46416104,46416762,659,"ENSG00000160299","ENST00000359568","protein_coding",91948,"PCNT","pericentrin [Source:HGNC Symbol;Acc:HGNC:16068]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0000226(microtubule cytoskeleton organization);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0007052(mitotic spindle organization);GO:0007165(signal transduction);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0016020(membrane);GO:0032947(protein-containing complex scaffold activity);GO:0034451(centriolar satellite);GO:0060271(cilium assembly);GO:0090316(positive regulation of intracellular protein transport);GO:0097711(ciliary basal body-plasma membrane docking)","NA",{"v":5e-60,"d":"0.00"},1,"659,",0,-9.83,{"v":1.99526231496888e-12,"d":"0.00"},-1.39,"Exon (ENST00000359568/ENSG00000160299, exon 30 of 47)",21,46324156,46445769,121614,1]
[58624070,58624218,149,"ENSG00000242689","ENST00000361987","protein_coding",1405,"CNTF","ciliary neurotrophic factor [Source:HGNC Symbol;Acc:HGNC:2169]","GO:0005125(cytokine activity);GO:0005127(ciliary neurotrophic factor receptor binding);GO:0005138(interleukin-6 receptor binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0007165(signal transduction);GO:0007275(multicellular organism development);GO:0007399(nervous system development);GO:0008083(growth factor activity);GO:0008284(positive regulation of cell population proliferation);GO:0010469(regulation of signaling receptor activity);GO:0010628(positive regulation of gene expression);GO:0019221(cytokine-mediated signaling pathway);GO:0030154(cell differentiation);GO:0030424(axon);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0043524(negative regulation of neuron apoptotic process);GO:0044877(protein-containing complex binding);GO:0046533(negative regulation of photoreceptor cell differentiation);GO:0046668(regulation of retinal cell programmed cell death);GO:0048143(astrocyte activation);GO:0048644(muscle organ morphogenesis);GO:0048666(neuron development);GO:0048680(positive regulation of axon regeneration);GO:0070120(ciliary neurotrophic factor-mediated signaling pathway)","04060(Cytokine-cytokine receptor interaction);04630(Jak-STAT signaling pathway)",{"v":0.00085,"d":"0.00"},1,"149,",0,{"v":-0.892,"d":"-0.89"},{"v":0.0288403150312661,"d":"0.03"},-3.39,"3' UTR",11,58622665,58625733,3069,1]
[6729912,6730002,91,"ENSG00000187953","ENST00000486256","processed_transcript",19784,"PMS2CL","PMS2 C-terminal like pseudogene [Source:HGNC Symbol;Acc:HGNC:30061]","NA","NA",{"v":0.00047,"d":"0.00"},1,"91,",0,-1.58,{"v":0.00354813389233575,"d":"0.00"},-3.46,"Exon (ENST00000348899/ENSG00000187953, exon 1 of 2)",7,6710128,6753862,43735,1]
[132943496,132944601,1106,"ENSG00000165699","ENST00000642344","nonsense_mediated_decay",0,"TSC1","TSC complex subunit 1 [Source:HGNC Symbol;Acc:HGNC:12362]","GO:0001822(kidney development);GO:0001843(neural tube closure);GO:0001952(regulation of cell-matrix adhesion);GO:0002250(adaptive immune response);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005811(lipid droplet);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005884(actin filament);GO:0005886(plasma membrane);GO:0005938(cell cortex);GO:0006407(rRNA export from nucleus);GO:0006417(regulation of translation);GO:0006813(potassium ion transport);GO:0007160(cell-matrix adhesion);GO:0007399(nervous system development);GO:0008285(negative regulation of cell population proliferation);GO:0008344(adult locomotory behavior);GO:0010977(negative regulation of neuron projection development);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016239(positive regulation of macroautophagy);GO:0016242(negative regulation of macroautophagy);GO:0017148(negative regulation of translation);GO:0021766(hippocampus development);GO:0021987(cerebral cortex development);GO:0030027(lamellipodium);GO:0030030(cell projection organization);GO:0030426(growth cone);GO:0030544(Hsp70 protein binding);GO:0032007(negative regulation of TOR signaling);GO:0032780(negative regulation of ATPase activity);GO:0032794(GTPase activating protein binding);GO:0032868(response to insulin);GO:0032991(protein-containing complex);GO:0033596(TSC1-TSC2 complex);GO:0034260(negative regulation of GTPase activity);GO:0042030(ATPase inhibitor activity);GO:0042552(myelination);GO:0042995(cell projection);GO:0043231(intracellular membrane-bounded organelle);GO:0043379(memory T cell differentiation);GO:0043666(regulation of phosphoprotein phosphatase activity);GO:0045792(negative regulation of cell size);GO:0045859(regulation of protein kinase activity);GO:0046323(glucose import);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0047485(protein N-terminus binding);GO:0048471(perinuclear region of cytoplasm);GO:0050808(synapse organization);GO:0050821(protein stabilization);GO:0051087(chaperone binding);GO:0051291(protein heterooligomerization);GO:0051492(regulation of stress fiber assembly);GO:0051496(positive regulation of stress fiber assembly);GO:0051726(regulation of cell cycle);GO:0051879(Hsp90 protein binding);GO:0051893(regulation of focal adhesion assembly);GO:0051894(positive regulation of focal adhesion assembly);GO:0055007(cardiac muscle cell differentiation);GO:0090630(activation of GTPase activity);GO:0090650(cellular response to oxygen-glucose deprivation);GO:0101031(chaperone complex);GO:1901214(regulation of neuron death);GO:1903204(negative regulation of oxidative stress-induced neuron death)","04072(Phospholipase D signaling pathway);04140(Autophagy - animal);04150(mTOR signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04211(Longevity regulating pathway);04218(Cellular senescence);04714(Thermogenesis);04910(Insulin signaling pathway);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05168(Herpes simplex virus 1 infection);05231(Choline metabolism in cancer)",{"v":2.6e-08,"d":"0.00"},2,"211,59,","0,1047",-1.24,{"v":0.00954992586021436,"d":"0.01"},-3.49,"5' UTR",9,132906751,132944572,37822,2]
[245702575,245703054,480,"ENSG00000162849","ENST00000407071","protein_coding",547590,"KIF26B","kinesin family member 26B [Source:HGNC Symbol;Acc:HGNC:25484]","GO:0000166(nucleotide binding);GO:0003774(motor activity);GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005871(kinesin complex);GO:0005874(microtubule);GO:0007018(microtubule-based movement);GO:0007275(multicellular organism development);GO:0008017(microtubule binding);GO:0022409(positive regulation of cell-cell adhesion);GO:0030010(establishment of cell polarity);GO:0072092(ureteric bud invasion)","NA",{"v":2.5e-20,"d":"0.00"},1,"480,",0,{"v":-0.803,"d":"-0.80"},{"v":0.0389045144994281,"d":"0.04"},-3.61,"3' UTR",1,245154985,245709432,554448,1]
[32347060,32347719,660,"ENSG00000142207","ENST00000382751","protein_coding",45293,"URB1","URB1 ribosome biogenesis homolog [Source:HGNC Symbol;Acc:HGNC:17344]","GO:0000463(maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0000466(maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0001650(fibrillar center);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0008150(biological_process)","NA",{"v":2e-37,"d":"0.00"},1,"660,",0,-5.25,{"v":2.04173794466953e-07,"d":"0.00"},-1.14,"Exon (ENST00000382751/ENSG00000142207, exon 22 of 39)",21,32311018,32393012,81995,2]
[43772571,43772958,388,"ENSG00000160213","ENST00000639959","protein_coding",3280,"CSTB","cystatin B [Source:HGNC Symbol;Acc:HGNC:2482]","GO:0002020(protease binding);GO:0003723(RNA binding);GO:0004866(endopeptidase inhibitor activity);GO:0004869(cysteine-type endopeptidase inhibitor activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008344(adult locomotory behavior);GO:0010466(negative regulation of peptidase activity);GO:0010951(negative regulation of endopeptidase activity);GO:0030414(peptidase inhibitor activity);GO:0034774(secretory granule lumen);GO:0043312(neutrophil degranulation);GO:0045861(negative regulation of proteolysis);GO:0062023(collagen-containing extracellular matrix);GO:0070062(extracellular exosome);GO:1904724(tertiary granule lumen);GO:1904813(ficolin-1-rich granule lumen)","NA",{"v":2.7e-05,"d":"0.00"},1,"388,",0,-0.92,{"v":0.0263026799189538,"d":"0.03"},-1.93,"3' UTR",21,43772511,43776238,3728,2]
[46301141,46301439,299,"ENSG00000160298","ENST00000491666","nonsense_mediated_decay",16767,"C21orf58","chromosome 21 open reading frame 58 [Source:HGNC Symbol;Acc:HGNC:1300]","NA","NA",{"v":1.9E-6,"d":"0.00"},1,"299,",0,-1.24,{"v":0.00954992586021436,"d":"0.01"},-1.84,"3' UTR",21,46300181,46318206,18026,2]
[17542313,17542912,600,"ENSG00000099954","ENST00000400585","protein_coding",182364,"CECR2","CECR2, histone acetyl-lysine reader [Source:HGNC Symbol;Acc:HGNC:1840]","GO:0001842(neural fold formation);GO:0001843(neural tube closure);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005719(nuclear euchromatin);GO:0006309(apoptotic DNA fragmentation);GO:0006325(chromatin organization);GO:0007010(cytoskeleton organization);GO:0007338(single fertilization);GO:0016192(vesicle-mediated transport);GO:0021915(neural tube development);GO:0031010(ISWI-type complex);GO:0043044(ATP-dependent chromatin remodeling);GO:0060122(inner ear receptor cell stereocilium organization);GO:0061640(cytoskeleton-dependent cytokinesis);GO:0090102(cochlea development);GO:0090537(CERF complex);GO:0097194(execution phase of apoptosis)","NA",{"v":2.1e-06,"d":"0.00"},1,"600,",0,-1.48,{"v":0.00467735141287198,"d":"0.00"},-1.65,"Exon (ENST00000400585/ENSG00000099954, exon 16 of 19)",22,17359949,17553332,193384,1]
[20145281,20145581,301,"ENSG00000099904","ENST00000334554","protein_coding",13474,"ZDHHC8","zinc finger DHHC-type containing 8 [Source:HGNC Symbol;Acc:HGNC:18474]","GO:0005739(mitochondrion);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0007626(locomotory behavior);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016409(palmitoyltransferase activity);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0018345(protein palmitoylation);GO:0019706(protein-cysteine S-palmitoyltransferase activity);GO:0030659(cytoplasmic vesicle membrane);GO:0031410(cytoplasmic vesicle);GO:0034380(high-density lipoprotein particle assembly)","NA",{"v":1.3e-10,"d":"0.00"},1,"301,",0,-4.22,{"v":2.81838293126446e-06,"d":"0.00"},-1.25,"3' UTR",22,20131807,20148007,16201,1]
[20145761,20146240,480,"ENSG00000099904","ENST00000334554","protein_coding",13954,"ZDHHC8","zinc finger DHHC-type containing 8 [Source:HGNC Symbol;Acc:HGNC:18474]","GO:0005739(mitochondrion);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0007626(locomotory behavior);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016409(palmitoyltransferase activity);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0018345(protein palmitoylation);GO:0019706(protein-cysteine S-palmitoyltransferase activity);GO:0030659(cytoplasmic vesicle membrane);GO:0031410(cytoplasmic vesicle);GO:0034380(high-density lipoprotein particle assembly)","NA",{"v":2.5e-13,"d":"0.00"},1,"480,",0,-3.08,{"v":5.62341325190349E-5,"d":"0.00"},-1.14,"3' UTR",22,20131807,20148007,16201,1]
[20405411,20405889,479,"ENSG00000185252","ENST00000611540","protein_coding",11296,"ZNF74","zinc finger protein 74 [Source:HGNC Symbol;Acc:HGNC:13144]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007275(multicellular organism development);GO:0015629(actin cytoskeleton);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":3.2e-45,"d":"0.00"},1,"479,",0,-4.06,{"v":4.26579518801593e-06,"d":"0.00"},-1.29,"3' UTR",22,20394115,20408461,14347,1]
[20407414,20407713,300,"ENSG00000185252","ENST00000611540","protein_coding",13299,"ZNF74","zinc finger protein 74 [Source:HGNC Symbol;Acc:HGNC:13144]","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007275(multicellular organism development);GO:0015629(actin cytoskeleton);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)",{"v":2.8e-10,"d":"0.00"},1,"300,",0,-3.02,{"v":6.60693448007596e-05,"d":"0.00"},-1.05,"3' UTR",22,20394115,20408461,14347,1]
[20451018,20451197,180,"ENSG00000099910","ENST00000328879","protein_coding",44598,"KLHL22","kelch like family member 22 [Source:HGNC Symbol;Acc:HGNC:25888]","GO:0000070(mitotic sister chromatid segregation);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005819(spindle);GO:0005827(polar microtubule);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006513(protein monoubiquitination);GO:0007049(cell cycle);GO:0007094(mitotic spindle assembly checkpoint);GO:0010507(negative regulation of autophagy);GO:0016567(protein ubiquitination);GO:0030307(positive regulation of cell growth);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0043687(post-translational protein modification);GO:0051301(cell division);GO:0071230(cellular response to amino acid stimulus);GO:0071233(cellular response to leucine);GO:0071889(14-3-3 protein binding);GO:0072686(mitotic spindle);GO:1904263(positive regulation of TORC1 signaling)","NA",{"v":4.7e-05,"d":"0.00"},1,"180,",0,{"v":-0.843,"d":"-0.84"},{"v":0.0338844156139203,"d":"0.03"},-1.81,"Exon (ENST00000426448/ENSG00000215493, exon 1 of 1)",22,20441519,20495795,54277,2]
[21956997,21957357,361,"ENSG00000100038","ENST00000357179","protein_coding",25459,"TOP3B","DNA topoisomerase III beta [Source:HGNC Symbol;Acc:HGNC:11993]","GO:0000793(condensed chromosome);GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0003916(DNA topoisomerase activity);GO:0003917(DNA topoisomerase type I activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006265(DNA topological change);GO:0007059(chromosome segregation);GO:0016853(isomerase activity)","03440(Homologous recombination);03460(Fanconi anemia pathway)",{"v":1.3E-25,"d":"0.00"},1,"361,",0,-1.15,{"v":0.0128824955169313,"d":"0.01"},-1.17,"3' UTR",22,21957025,21982816,25792,2]
[26434119,26442553,8435,"ENSG00000128203","ENST00000215906","protein_coding",4859,"ASPHD2","aspartate beta-hydroxylase domain containing 2 [Source:HGNC Symbol;Acc:HGNC:30437]","GO:0004597(peptide-aspartate beta-dioxygenase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0018193(peptidyl-amino acid modification);GO:0042264(peptidyl-aspartic acid hydroxylation);GO:0046872(metal ion binding);GO:0051213(dioxygenase activity);GO:0055114(oxidation-reduction process)","NA",{"v":5e-44,"d":"0.00"},2,"383,95,","0,8340",-2.73,{"v":0.000144543977074593,"d":"0.00"},-1.28,"Exon (ENST00000215906/ENSG00000128203, exon 2 of 4)",22,26429260,26445015,15756,1]
[30969245,30969754,510,"ENSG00000253352","ENST00000646021","bidirectional_promoter_lncRNA",0,"TUG1","taurine up-regulated 1 [Source:HGNC Symbol;Acc:HGNC:26066]","NA","NA",{"v":4.1e-09,"d":"0.00"},1,"510,",0,{"v":-0.815,"d":"-0.82"},{"v":0.0371535229097173,"d":"0.04"},-1.57,"Exon (ENST00000646021/ENSG00000253352, exon 1 of 2)",22,30969245,30971483,2239,1]
[61369300,61369509,210,"ENSG00000149483","ENST00000278826","protein_coding",6926,"TMEM138","transmembrane protein 138 [Source:HGNC Symbol;Acc:HGNC:26944]","GO:0005773(vacuole);GO:0005774(vacuolar membrane);GO:0005929(cilium);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030030(cell projection organization);GO:0042995(cell projection);GO:0060271(cilium assembly)","NA",{"v":1.4e-06,"d":"0.00"},1,"210,",0,{"v":-1.1,"d":"-1.10"},{"v":0.0147910838816821,"d":"0.01"},-3.66,"3' UTR",11,61362374,61369509,7136,1]
[143729407,143729570,164,"ENSG00000206737","ENST00000384010","snRNA",0,"RNVU1-18","RNA, variant U1 small nuclear 18 [Source:HGNC Symbol;Acc:HGNC:37496]","NA","NA",{"v":2.8E-5,"d":"0.00"},1,"164,",0,{"v":-1.1,"d":"-1.10"},{"v":0.0147910838816821,"d":"0.01"},-4.25,"Exon (ENST00000384010/ENSG00000206737, exon 1 of 1)",1,143729407,143729570,164,2]
[41958248,41958844,597,"ENSG00000205704","ENST00000381348","processed_transcript",6074,"LINC00634","long intergenic non-protein coding RNA 634 [Source:HGNC Symbol;Acc:HGNC:27930]","NA","NA",{"v":2.5e-09,"d":"0.00"},1,"597,",0,-1.56,{"v":0.00371535229097172,"d":"0.00"},-1.66,"Exon (ENST00000381348/ENSG00000205704, exon 2 of 2)",22,41952174,41958933,6760,1]
[43996320,44010531,14212,"ENSG00000188677","ENST00000406477","protein_coding",0,"PARVB","parvin beta [Source:HGNC Symbol;Acc:HGNC:14653]","GO:0003779(actin binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0007155(cell adhesion);GO:0007163(establishment or maintenance of cell polarity);GO:0015629(actin cytoskeleton);GO:0016020(membrane);GO:0030017(sarcomere);GO:0030018(Z disc);GO:0030027(lamellipodium);GO:0030031(cell projection assembly);GO:0030032(lamellipodium assembly);GO:0030054(cell junction);GO:0031532(actin cytoskeleton reorganization);GO:0034446(substrate adhesion-dependent cell spreading);GO:0042995(cell projection);GO:0071963(establishment or maintenance of cell polarity regulating cell shape)","04510(Focal adhesion)",{"v":5e-70,"d":"0.00"},3,"210,50,40,","0,13157,14172",-3.55,{"v":1.62181009735893e-05,"d":"0.00"},-1.02,"5' UTR",22,43999211,44168923,169713,1]
[44725294,44730753,5460,"ENSG00000186654","ENST00000611394","protein_coding",56747,"PRR5","proline rich 5 [Source:HGNC Symbol;Acc:HGNC:31682]","GO:0001934(positive regulation of protein phosphorylation);GO:0005515(protein binding);GO:0005829(cytosol);GO:0007049(cell cycle);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0031932(TORC2 complex);GO:0032148(activation of protein kinase B activity);GO:0038203(TORC2 signaling)","04150(mTOR signaling pathway)",{"v":4e-12,"d":"0.00"},4,"3,58,95,144,","0,1283,4020,5316",-2.83,{"v":1.09647819614319E-4,"d":"0.00"},-1.94,"5' UTR",22,44668547,44737681,69135,1]
[44736962,44737352,391,"ENSG00000186654","ENST00000611394","protein_coding",68415,"PRR5","proline rich 5 [Source:HGNC Symbol;Acc:HGNC:31682]","GO:0001934(positive regulation of protein phosphorylation);GO:0005515(protein binding);GO:0005829(cytosol);GO:0007049(cell cycle);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0031932(TORC2 complex);GO:0032148(activation of protein kinase B activity);GO:0038203(TORC2 signaling)","04150(mTOR signaling pathway)",{"v":2e-20,"d":"0.00"},1,"391,",0,-1.69,{"v":0.00251188643150958,"d":"0.00"},-1.14,"3' UTR",22,44668547,44737681,69135,1]
[5158219,5158608,390,"ENSG00000280433","ENST00000623998","protein_coding",5087,"FP565260","novel protein, similar to trafficking protein particle complex 10 TRAPPC10","GO:0005829(cytosol);GO:0006891(intra-Golgi vesicle-mediated transport);GO:1990071(TRAPPII protein complex)","NA",{"v":4e-10,"d":"0.00"},1,"390,",0,{"v":-1.3,"d":"-1.30"},{"v":0.00794328234724281,"d":"0.01"},-4.29,"3' UTR",21,5155499,5163695,8197,2]
[50393957,50394017,61,"ENSG00000100239","ENST00000359139","protein_coding",50653,"PPP6R2","protein phosphatase 6 regulatory subunit 2 [Source:HGNC Symbol;Acc:HGNC:19253]","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0043231(intracellular membrane-bounded organelle)","NA",{"v":0.0006,"d":"0.00"},1,"61,",0,-2.31,{"v":0.000446683592150963,"d":"0.00"},-1.03,"Exon (ENST00000359139/ENSG00000100239, exon 3 of 23)",22,50343304,50445090,101787,1]
[50731113,50731861,749,"ENSG00000251322","ENST00000414786","processed_transcript",56698,"SHANK3","SH3 and multiple ankyrin repeat domains 3 [Source:HGNC Symbol;Acc:HGNC:14294]","GO:0000165(MAPK cascade);GO:0001838(embryonic epithelial tube formation);GO:0005515(protein binding);GO:0007416(synapse assembly);GO:0007611(learning or memory);GO:0007612(learning);GO:0007613(memory);GO:0007626(locomotory behavior);GO:0008022(protein C-terminus binding);GO:0021773(striatal medium spiny neuron differentiation);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0032232(negative regulation of actin filament bundle assembly);GO:0035176(social behavior);GO:0035255(ionotropic glutamate receptor binding);GO:0035640(exploration behavior);GO:0035641(locomotory exploration behavior);GO:0040011(locomotion);GO:0043005(neuron projection);GO:0044309(neuron spine);GO:0045794(negative regulation of cell volume);GO:0048167(regulation of synaptic plasticity);GO:0048170(positive regulation of long-term neuronal synaptic plasticity);GO:0048854(brain morphogenesis);GO:0050885(neuromuscular process controlling balance);GO:0051835(positive regulation of synapse structural plasticity);GO:0051968(positive regulation of synaptic transmission, glutamatergic);GO:0060291(long-term synaptic potentiation);GO:0060292(long-term synaptic depression);GO:0060997(dendritic spine morphogenesis);GO:0060999(positive regulation of dendritic spine development);GO:0061001(regulation of dendritic spine morphogenesis);GO:0071625(vocalization behavior);GO:0097107(postsynaptic density assembly);GO:0097110(scaffold protein binding);GO:0097113(AMPA glutamate receptor clustering);GO:0097114(NMDA glutamate receptor clustering);GO:0097117(guanylate kinase-associated protein clustering);GO:0098919(structural constituent of postsynaptic density);GO:0098978(glutamatergic synapse);GO:0099562(maintenance of postsynaptic density structure);GO:1900271(regulation of long-term synaptic potentiation);GO:1900273(positive regulation of long-term synaptic potentiation);GO:1900451(positive regulation of glutamate receptor signaling pathway);GO:1900452(regulation of long-term synaptic depression);GO:1904717(regulation of AMPA glutamate receptor clustering);GO:2000463(positive regulation of excitatory postsynaptic potential);GO:2000821(regulation of grooming behavior);GO:2000822(regulation of behavioral fear response);GO:2000969(positive regulation of AMPA receptor activity)","04724(Glutamatergic synapse)",{"v":1E-25,"d":"0.00"},1,"749,",0,-4.61,{"v":1.0471285480509E-6,"d":"0.00"},-1.48,"3' UTR",22,50674415,50733298,58884,1]
[19931077,19932484,1408,"ENSG00000184470","ENST00000400518","protein_coding",69,"TXNRD2","thioredoxin reductase 2 [Source:HGNC Symbol;Acc:HGNC:18155]","GO:0000305(response to oxygen radical);GO:0004791(thioredoxin-disulfide reductase activity);GO:0005515(protein binding);GO:0005623(cell);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005829(cytosol);GO:0009055(electron transfer activity);GO:0016491(oxidoreductase activity);GO:0016668(oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor);GO:0022900(electron transport chain);GO:0034599(cellular response to oxidative stress);GO:0045454(cell redox homeostasis);GO:0050660(flavin adenine dinucleotide binding);GO:0055114(oxidation-reduction process);GO:0098869(cellular oxidant detoxification)","00450(Selenocompound metabolism);05200(Pathways in cancer);05225(Hepatocellular carcinoma)",{"v":2.5e-17,"d":"0.00"},2,"22,128,","0,1280",-1.43,{"v":0.00537031796370253,"d":"0.01"},-1.97,"5' UTR",22,19875517,19932553,57037,2]
[20064581,20064785,205,"ENSG00000183597","ENST00000401886","protein_coding",47567,"TANGO2","transport and golgi organization 2 homolog [Source:HGNC Symbol;Acc:HGNC:25439]","GO:0005794(Golgi apparatus);GO:0007030(Golgi organization);GO:0009306(protein secretion)","NA",{"v":3.2e-21,"d":"0.00"},1,"205,",0,-2.86,{"v":0.000102329299228075,"d":"0.00"},-1.01,"3' UTR",22,20017014,20065358,48345,1]
[21957025,21957354,330,"ENSG00000100038","ENST00000357179","protein_coding",25462,"TOP3B","DNA topoisomerase III beta [Source:HGNC Symbol;Acc:HGNC:11993]","GO:0000793(condensed chromosome);GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0003916(DNA topoisomerase activity);GO:0003917(DNA topoisomerase type I activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006265(DNA topological change);GO:0007059(chromosome segregation);GO:0016853(isomerase activity)","03440(Homologous recombination);03460(Fanconi anemia pathway)",{"v":6.3e-26,"d":"0.00"},1,"330,",0,{"v":-0.962,"d":"-0.96"},{"v":0.0229086765276777,"d":"0.02"},{"v":-1.1,"d":"-1.10"},"3' UTR",22,21957025,21982816,25792,2]
[23658424,23658963,540,"ENSG00000228315","ENST00000455485","processed_transcript",34188,"GUSBP11","glucuronidase, beta pseudogene 11 [Source:HGNC Symbol;Acc:HGNC:42325]","NA","NA",{"v":2.5e-07,"d":"0.00"},1,"540,",0,{"v":-0.854,"d":"-0.85"},{"v":0.0331131121482591,"d":"0.03"},-1.01,"Exon (ENST00000417194/ENSG00000272578, exon 3 of 3)",22,23638487,23693151,54665,2]
[26481723,26482827,1105,"ENSG00000100099","ENST00000398145","protein_coding",985,"HPS4","HPS4, biogenesis of lysosomal organelles complex 3 subunit 2 [Source:HGNC Symbol;Acc:HGNC:15844]","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005829(cytosol);GO:0006605(protein targeting);GO:0006996(organelle organization);GO:0007040(lysosome organization);GO:0007596(blood coagulation);GO:0007599(hemostasis);GO:0016020(membrane);GO:0017137(Rab GTPase binding);GO:0030318(melanocyte differentiation);GO:0031085(BLOC-3 complex);GO:0031410(cytoplasmic vesicle);GO:0042470(melanosome);GO:0042803(protein homodimerization activity);GO:0042827(platelet dense granule);GO:0046983(protein dimerization activity);GO:0048075(positive regulation of eye pigmentation);GO:0050821(protein stabilization);GO:1903232(melanosome assembly);GO:1903955(positive regulation of protein targeting to mitochondrion)","NA",{"v":4e-89,"d":"0.00"},2,"518,82,","0,1023",-9.09,{"v":1.25892541179417E-11,"d":"0.00"},-1.01,"5' UTR",22,26451480,26483812,32333,2]
[28105356,28108113,2758,"ENSG00000100154","ENST00000612946","protein_coding",198532,"TTC28","tetratricopeptide repeat domain 28 [Source:HGNC Symbol;Acc:HGNC:29179]","GO:0000922(spindle pole);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005815(microtubule organizing center);GO:0005819(spindle);GO:0005856(cytoskeleton);GO:0007049(cell cycle);GO:0007346(regulation of mitotic cell cycle);GO:0019900(kinase binding);GO:0030496(midbody);GO:0051301(cell division);GO:0072686(mitotic spindle)","NA",{"v":7.9e-78,"d":"0.00"},2,"447,1052,","0,1706",{"v":-22.6,"d":"-22.60"},{"v":1E-25,"d":"0.00"},-1.18,"Exon (ENST00000612946/ENSG00000100154, exon 5 of 21)",22,27978014,28306645,328632,2]
[51978976,52012125,33150,"ENSG00000123191","ENST00000242839","protein_coding",0,"ATP7B","ATPase copper transporting beta [Source:HGNC Symbol;Acc:HGNC:870]","GO:0000139(Golgi membrane);GO:0000166(nucleotide binding);GO:0004008(copper-exporting ATPase activity);GO:0005375(copper ion transmembrane transporter activity);GO:0005507(copper ion binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005768(endosome);GO:0005770(late endosome);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005887(integral component of plasma membrane);GO:0006811(ion transport);GO:0006812(cation transport);GO:0006825(copper ion transport);GO:0006878(cellular copper ion homeostasis);GO:0006882(cellular zinc ion homeostasis);GO:0007595(lactation);GO:0015677(copper ion import);GO:0015680(protein maturation by copper ion transfer);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0019829(cation-transporting ATPase activity);GO:0030001(metal ion transport);GO:0031410(cytoplasmic vesicle);GO:0032588(trans-Golgi network membrane);GO:0034220(ion transmembrane transport);GO:0035434(copper ion transmembrane transport);GO:0043682(copper-transporting ATPase activity);GO:0046688(response to copper ion);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0051208(sequestering of calcium ion);GO:0060003(copper ion export);GO:0099132(ATP hydrolysis coupled cation transmembrane transport)","01524(Platinum drug resistance)",{"v":1E-8,"d":"0.00"},3,"16,208,106,","0,32311,33044",-3.19,{"v":4.16869383470336e-05,"d":"0.00"},-4.44,"5' UTR",13,51932673,52011494,78822,2]
[42508344,42508824,481,"ENSG00000172250","ENST00000652221","retained_intron",7776,"SERHL","serine hydrolase-like (pseudogene) [Source:HGNC Symbol;Acc:HGNC:14408]","NA","NA",{"v":4e-10,"d":"0.00"},1,"481,",0,-0.88,{"v":0.0301995172040202,"d":"0.03"},-1.17,"3' UTR",22,42500568,42512544,11977,1]
[68241966,68243203,1238,"ENSG00000196873","ENST00000622755","nonsense_mediated_decay",0,"CBWD3","COBW domain containing 3 [Source:HGNC Symbol;Acc:HGNC:18519]","GO:0000166(nucleotide binding);GO:0005524(ATP binding)","NA",{"v":1.4E-8,"d":"0.00"},2,"220,21,","0,1217",-2.75,{"v":0.000134896288259165,"d":"0.00"},-4.61,"5' UTR",9,68241985,68298191,56207,1]
[50944507,50944686,180,"ENSG00000000419","ENST00000371588","protein_coding",13864,"DPM1","dolichyl-phosphate mannosyltransferase subunit 1, catalytic [Source:HGNC Symbol;Acc:HGNC:3005]","GO:0004169(dolichyl-phosphate-mannose-protein mannosyltransferase activity);GO:0004582(dolichyl-phosphate beta-D-mannosyltransferase activity);GO:0005515(protein binding);GO:0005537(mannose binding);GO:0005634(nucleus);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006486(protein glycosylation);GO:0006506(GPI anchor biosynthetic process);GO:0016020(membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0018279(protein N-linked glycosylation via asparagine);GO:0019348(dolichol metabolic process);GO:0019673(GDP-mannose metabolic process);GO:0033185(dolichol-phosphate-mannose synthase complex);GO:0035268(protein mannosylation);GO:0035269(protein O-linked mannosylation);GO:0043178(alcohol binding);GO:0043231(intracellular membrane-bounded organelle);GO:0097502(mannosylation)","00510(N-Glycan biosynthesis)",{"v":0.0003,"d":"0.00"},1,"180,",0,-2.04,{"v":0.000933254300796991,"d":"0.00"},-4.61,"Exon (ENST00000558899/ENSG00000259456, exon 3 of 3)",20,50934867,50958550,23684,2]
[13763826,13768016,4191,"ENSG00000046651","ENST00000474705","processed_transcript",0,"OFD1","OFD1, centriole and centriolar satellite protein [Source:HGNC Symbol;Acc:HGNC:2567]","GO:0000086(G2/M transition of mitotic cell cycle);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005929(cilium);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0016020(membrane);GO:0030030(cell projection organization);GO:0034451(centriolar satellite);GO:0036064(ciliary basal body);GO:0042802(identical protein binding);GO:0042995(cell projection);GO:0043014(alpha-tubulin binding);GO:0043015(gamma-tubulin binding);GO:0060271(cilium assembly);GO:0060287(epithelial cilium movement involved in determination of left/right asymmetry);GO:0097711(ciliary basal body-plasma membrane docking)","NA",{"v":7.9e-17,"d":"0.00"},3,"30,158,112,","0,3301,4079",-1.23,0.01,-1.46,"3' UTR",23,13767905,13769173,1269,1]
[15703456,15703724,269,"ENSG00000169239","ENST00000498004","protein_coding",14626,"CA5B","carbonic anhydrase 5B [Source:HGNC Symbol;Acc:HGNC:1378]","GO:0004089(carbonate dehydratase activity);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0008270(zinc ion binding);GO:0009617(response to bacterium);GO:0015701(bicarbonate transport);GO:0016829(lyase activity);GO:0046872(metal ion binding)","00910(Nitrogen metabolism)",{"v":3.2e-12,"d":"0.00"},1,"269,",0,-1.82,{"v":1.73780082874938E-3,"d":"0.00"},-1.63,"Exon (ENST00000380334/ENSG00000186312, exon 4 of 4)",23,15688830,15764665,75836,1]
[15784435,15785660,1226,"ENSG00000169239","ENST00000318636","protein_coding",46165,"CA5B","carbonic anhydrase 5B [Source:HGNC Symbol;Acc:HGNC:1378]","GO:0004089(carbonate dehydratase activity);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0008270(zinc ion binding);GO:0009617(response to bacterium);GO:0015701(bicarbonate transport);GO:0016829(lyase activity);GO:0046872(metal ion binding)","00910(Nitrogen metabolism)",{"v":2e-31,"d":"0.00"},1,"1226,",0,{"v":-1.2,"d":"-1.20"},{"v":0.0109647819614319,"d":"0.01"},-1.09,"3' UTR",23,15738270,15788411,50142,1]
[48823010,48823309,300,"ENSG00000094631","ENST00000334136","protein_coding",21015,"HDAC6","histone deacetylase 6 [Source:HGNC Symbol;Acc:HGNC:14064]","GO:0000118(histone deacetylase complex);GO:0000209(protein polyubiquitination);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0003779(actin binding);GO:0004407(histone deacetylase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005771(multivesicular body);GO:0005829(cytosol);GO:0005874(microtubule);GO:0005875(microtubule associated complex);GO:0005881(cytoplasmic microtubule);GO:0005901(caveola);GO:0006325(chromatin organization);GO:0006476(protein deacetylation);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006515(protein quality control for misfolded or incompletely synthesized proteins);GO:0006886(intracellular protein transport);GO:0006914(autophagy);GO:0007026(negative regulation of microtubule depolymerization);GO:0008013(beta-catenin binding);GO:0008017(microtubule binding);GO:0008270(zinc ion binding);GO:0009636(response to toxic substance);GO:0009967(positive regulation of signal transduction);GO:0010033(response to organic substance);GO:0010469(regulation of signaling receptor activity);GO:0010506(regulation of autophagy);GO:0010634(positive regulation of epithelial cell migration);GO:0010727(negative regulation of hydrogen peroxide metabolic process);GO:0010870(positive regulation of receptor biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016234(inclusion body);GO:0016235(aggresome);GO:0016241(regulation of macroautophagy);GO:0016575(histone deacetylation);GO:0016787(hydrolase activity);GO:0019899(enzyme binding);GO:0030286(dynein complex);GO:0030424(axon);GO:0030425(dendrite);GO:0031252(cell leading edge);GO:0031593(polyubiquitin modification-dependent protein binding);GO:0031625(ubiquitin protein ligase binding);GO:0031647(regulation of protein stability);GO:0032041(NAD-dependent histone deacetylase activity (H3-K14 specific));GO:0032418(lysosome localization);GO:0032461(positive regulation of protein oligomerization);GO:0032984(protein-containing complex disassembly);GO:0032991(protein-containing complex);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0033558(protein deacetylase activity);GO:0034983(peptidyl-lysine deacetylation);GO:0035967(cellular response to topologically incorrect protein);GO:0040029(regulation of gene expression, epigenetic);GO:0042826(histone deacetylase binding);GO:0042903(tubulin deacetylase activity);GO:0042995(cell projection);GO:0043005(neuron projection);GO:0043014(alpha-tubulin binding);GO:0043130(ubiquitin binding);GO:0043162(ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway);GO:0043204(perikaryon);GO:0043242(negative regulation of protein complex disassembly);GO:0044297(cell body);GO:0045598(regulation of fat cell differentiation);GO:0045861(negative regulation of proteolysis);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0048156(tau protein binding);GO:0048471(perinuclear region of cytoplasm);GO:0048487(beta-tubulin binding);GO:0048668(collateral sprouting);GO:0051354(negative regulation of oxidoreductase activity);GO:0051646(mitochondrion localization);GO:0051787(misfolded protein binding);GO:0051788(response to misfolded protein);GO:0051879(Hsp90 protein binding);GO:0060271(cilium assembly);GO:0060632(regulation of microtubule-based movement);GO:0060765(regulation of androgen receptor signaling pathway);GO:0060997(dendritic spine morphogenesis);GO:0061734(parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization);GO:0070201(regulation of establishment of protein localization);GO:0070301(cellular response to hydrogen peroxide);GO:0070840(dynein complex binding);GO:0070842(aggresome assembly);GO:0070845(polyubiquitinated misfolded protein transport);GO:0070846(Hsp90 deacetylation);GO:0070848(response to growth factor);GO:0070932(histone H3 deacetylation);GO:0071218(cellular response to misfolded protein);GO:0090035(positive regulation of chaperone-mediated protein complex assembly);GO:0090042(tubulin deacetylation);GO:0098779(positive regulation of mitophagy in response to mitochondrial depolarization);GO:1901300(positive regulation of hydrogen peroxide-mediated programmed cell death);GO:1903146(regulation of autophagy of mitochondrion)","05034(Alcoholism);05203(Viral carcinogenesis)",{"v":1.3e-19,"d":"0.00"},1,"300,",0,{"v":-11.1,"d":"-11.10"},{"v":1E-13,"d":"0.00"},-1.24,"3' UTR",23,48801995,48824982,22988,1]
[53085242,53085422,181,"ENSG00000184205","ENST00000553557","retained_intron",2875,"TSPYL2","TSPY like 2 [Source:HGNC Symbol;Acc:HGNC:24358]","GO:0000182(rDNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006325(chromatin organization);GO:0006334(nucleosome assembly);GO:0007049(cell cycle);GO:0008156(negative regulation of DNA replication);GO:0009966(regulation of signal transduction);GO:0030308(negative regulation of cell growth);GO:0036498(IRE1-mediated unfolded protein response);GO:0045786(negative regulation of cell cycle);GO:0045859(regulation of protein kinase activity)","NA",{"v":6e-05,"d":"0.00"},1,"181,",0,-1.49,{"v":0.00446683592150963,"d":"0.00"},-1.04,"3' UTR",23,53082367,53086413,4047,1]
[54564893,54565192,300,"ENSG00000130119","ENST00000360845","protein_coding",34674,"GNL3L","G protein nucleolar 3 like [Source:HGNC Symbol;Acc:HGNC:25553]","GO:0000166(nucleotide binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005697(telomerase holoenzyme complex);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0016020(membrane);GO:0031397(negative regulation of protein ubiquitination);GO:0031647(regulation of protein stability);GO:0032091(negative regulation of protein binding);GO:0032211(negative regulation of telomere maintenance via telomerase);GO:0033234(negative regulation of protein sumoylation);GO:0042254(ribosome biogenesis);GO:0090073(positive regulation of protein homodimerization activity);GO:1904816(positive regulation of protein localization to chromosome, telomeric region)","03008(Ribosome biogenesis in eukaryotes)",{"v":5.5e-08,"d":"0.00"},1,"300,",0,-2.11,{"v":0.000776247116628692,"d":"0.00"},-1.07,"3' UTR",23,54530219,54567289,37071,1]
[65398688,65489319,90632,"ENSG00000102053","ENST00000338957","protein_coding",0,"ZC3H12B","zinc finger CCCH-type containing 12B [Source:HGNC Symbol;Acc:HGNC:17407]","GO:0004518(nuclease activity);GO:0004519(endonuclease activity);GO:0016787(hydrolase activity);GO:0046872(metal ion binding);GO:0090305(nucleic acid phosphodiester bond hydrolysis)","NA",{"v":9.1e-10,"d":"0.00"},2,"17,674,","0,89958",-1.26,{"v":0.00891250938133746,"d":"0.01"},-1.09,"5' UTR",23,65488735,65507887,19153,1]
[40367277,40367546,270,"ENSG00000140323","ENST00000267889","protein_coding",9058,"DISP2","dispatched RND transporter family member 2 [Source:HGNC Symbol;Acc:HGNC:19712]","GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0005886(plasma membrane);GO:0007224(smoothened signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA",{"v":1.9e-08,"d":"0.00"},1,"270,",0,-2.31,{"v":0.000446683592150963,"d":"0.00"},-4.67,"Exon (ENST00000267889/ENSG00000140323, exon 8 of 8)",15,40358219,40378621,20403,1]
[85087718,85087778,61,"ENSG00000155008","ENST00000373173","protein_coding",83841,"APOOL","apolipoprotein O like [Source:HGNC Symbol;Acc:HGNC:24009]","GO:0002576(platelet degranulation);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031093(platelet alpha granule lumen);GO:0042407(cristae formation);GO:0061617(MICOS complex)","NA",{"v":0.00016,"d":"0.00"},1,"61,",0,-1.19,{"v":0.0112201845430196,"d":"0.01"},{"v":-1.5,"d":"-1.50"},"3' UTR",23,85003877,85093315,89439,1]
[100833269,100833329,61,"ENSG00000101811","ENST00000415585","protein_coding",12910,"CSTF2","cleavage stimulation factor subunit 2 [Source:HGNC Symbol;Acc:HGNC:2484]","GO:0000398(mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005847(mRNA cleavage and polyadenylation specificity factor complex);GO:0006369(termination of RNA polymerase II transcription);GO:0006378(mRNA polyadenylation);GO:0006388(tRNA splicing, via endonucleolytic cleavage and ligation);GO:0006397(mRNA processing);GO:0016604(nuclear body);GO:0031124(mRNA 3'-end processing);GO:0071920(cleavage body);GO:0098789(pre-mRNA cleavage required for polyadenylation);GO:1990090(cellular response to nerve growth factor stimulus)","03015(mRNA surveillance pathway)",{"v":0.00093,"d":"0.00"},1,"61,",0,-1.63,{"v":3.01995172040202E-3,"d":"0.00"},-1.02,"Exon (ENST00000415585/ENSG00000101811, exon 12 of 15)",23,100820359,100840932,20574,1]
[103628704,103629501,798,"ENSG00000172465","ENST00000372626","protein_coding",0,"TCEAL1","transcription elongation factor A like 1 [Source:HGNC Symbol;Acc:HGNC:11616]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0050699(WW domain binding)","NA",{"v":2.6e-06,"d":"0.00"},3,"90,51,8,","0,271,790",{"v":-0.779,"d":"-0.78"},{"v":0.0416869383470335,"d":"0.04"},-1.43,"5' UTR",23,103628704,103630447,1744,1]
[104189624,104189744,121,"ENSG00000123575","ENST00000493442","protein_coding",23171,"FAM199X","family with sequence similarity 199, X-linked [Source:HGNC Symbol;Acc:HGNC:25195]","GO:0005515(protein binding)","NA",{"v":4.2E-7,"d":"0.00"},1,"121,",0,-2.01,{"v":1E-3,"d":"0.00"},-1.04,"Exon (ENST00000493442/ENSG00000123575, exon 6 of 6)",23,104166453,104195902,29450,1]
[107826399,107854635,28237,"ENSG00000080561","ENST00000443968","protein_coding",0,"MID2","midline 2 [Source:HGNC Symbol;Acc:HGNC:7096]","GO:0005515(protein binding);GO:0005622(intracellular);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0008017(microtubule binding);GO:0008270(zinc ion binding);GO:0010508(positive regulation of autophagy);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0032897(negative regulation of viral transcription);GO:0035372(protein localization to microtubule);GO:0042803(protein homodimerization activity);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0045087(innate immune response);GO:0046597(negative regulation of viral entry into host cell);GO:0046872(metal ion binding);GO:0046982(protein heterodimerization activity);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051219(phosphoprotein binding);GO:0070062(extracellular exosome);GO:1902187(negative regulation of viral release from host cell)","NA",{"v":3.2e-59,"d":"0.00"},3,"32,716,27,","0,14271,28210",-5.89,{"v":3.98107170553497e-08,"d":"0.00"},-1.02,"5' UTR",23,107826414,107927193,100780,1]
[123603432,123603550,119,"ENSG00000125676","ENST00000448128","protein_coding",17609,"THOC2","THO complex 2 [Source:HGNC Symbol;Acc:HGNC:19073]","GO:0000346(transcription export complex);GO:0000347(THO complex);GO:0000445(THO complex part of transcription export complex);GO:0000784(nuclear chromosome, telomeric region);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006397(mRNA processing);GO:0006405(RNA export from nucleus);GO:0006406(mRNA export from nucleus);GO:0008380(RNA splicing);GO:0016607(nuclear speck);GO:0016973(poly(A)+ mRNA export from nucleus);GO:0031124(mRNA 3'-end processing);GO:0046784(viral mRNA export from host cell nucleus);GO:0048666(neuron development);GO:0048699(generation of neurons);GO:0051028(mRNA transport)","03013(RNA transport);03040(Spliceosome)",{"v":0.0002,"d":"0.00"},1,"119,",0,{"v":-0.827,"d":"-0.83"},{"v":0.0363078054770101,"d":"0.04"},-1.66,"3' UTR",23,123600561,123621159,20599,2]
[130409332,130411238,1907,"ENSG00000134597","ENST00000487274","processed_transcript",0,"RBMX2","RNA binding motif protein X-linked 2 [Source:HGNC Symbol;Acc:HGNC:24282]","GO:0000384(first spliceosomal transesterification activity);GO:0000398(mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005681(spliceosomal complex);GO:0005686(U2 snRNP);GO:0006397(mRNA processing);GO:0008380(RNA splicing);GO:0071005(U2-type precatalytic spliceosome)","NA",{"v":0.0025,"d":"0.00"},2,"55,36,","0,1871",-1.83,{"v":1.65958690743756E-3,"d":"0.00"},-1.05,"Exon (ENST00000305536/ENSG00000134597, exon 4 of 6)",23,130411203,130412395,1193,1]
[153074690,153074988,299,"ENSG00000235961","ENST00000421798","protein_coding",2208,"PNMA6A","PNMA family member 6A [Source:HGNC Symbol;Acc:HGNC:28248]","GO:0005515(protein binding)","NA",{"v":4.3e-08,"d":"0.00"},1,"299,",0,{"v":-0.749,"d":"-0.75"},{"v":0.0467735141287198,"d":"0.05"},-1.02,"3' UTR",23,153072482,153075018,2537,1]
[154421039,154421248,210,"ENSG00000102125","ENST00000612460","protein_coding",9500,"TAZ","tafazzin [Source:HGNC Symbol;Acc:HGNC:11577]","GO:0003841(1-acylglycerol-3-phosphate O-acyltransferase activity);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0006644(phospholipid metabolic process);GO:0006936(muscle contraction);GO:0007007(inner mitochondrial membrane organization);GO:0007507(heart development);GO:0007519(skeletal muscle tissue development);GO:0008374(O-acyltransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016746(transferase activity, transferring acyl groups);GO:0030097(hemopoiesis);GO:0032049(cardiolipin biosynthetic process);GO:0032981(mitochondrial respiratory chain complex I assembly);GO:0035965(cardiolipin acyl-chain remodeling);GO:0042407(cristae formation);GO:0042775(mitochondrial ATP synthesis coupled electron transport);GO:0047184(1-acylglycerophosphocholine O-acyltransferase activity);GO:0048738(cardiac muscle tissue development);GO:0060048(cardiac muscle contraction);GO:1900210(positive regulation of cardiolipin metabolic process);GO:2001171(positive regulation of ATP biosynthetic process)","00564(Glycerophospholipid metabolism)",{"v":7.8e-08,"d":"0.00"},1,"210,",0,{"v":-10.1,"d":"-10.10"},{"v":1.25892541179417e-12,"d":"0.00"},-1.56,"3' UTR",23,154411539,154421700,10162,1]
[6493047,6493287,241,"ENSG00000275895","ENST00000623375","protein_coding",3643,"U2AF1L5","U2 small nuclear RNA auxiliary factor 1 like 5 [Source:HGNC Symbol;Acc:HGNC:51830]","GO:0000398(mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex);GO:0016607(nuclear speck);GO:0030628(pre-mRNA 3'-splice site binding);GO:0046872(metal ion binding);GO:0050733(RS domain binding);GO:0089701(U2AF)","03040(Spliceosome);05131(Shigellosis)",{"v":5e-12,"d":"0.00"},1,"241,",0,-4.28,{"v":2.39883291901949e-06,"d":"0.00"},-5.04,"5' UTR",21,6484623,6496930,12308,2]
[53236420,53237465,1046,"ENSG00000124313","ENST00000638869","protein_coding",10691,"IQSEC2","IQ motif and Sec7 domain 2 [Source:HGNC Symbol;Acc:HGNC:29059]","GO:0005086(ARF guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0030036(actin cytoskeleton organization);GO:0032012(regulation of ARF protein signal transduction);GO:0050804(modulation of chemical synaptic transmission);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098696(regulation of neurotransmitter receptor localization to postsynaptic specialization membrane)","04144(Endocytosis)",{"v":6.9e-05,"d":"0.00"},2,"76,45,","0,1001",-1.11,{"v":0.0144543977074593,"d":"0.01"},-1.17,"3' UTR",23,53225828,53248156,22329,2]
[53250362,53250571,210,"ENSG00000124313","ENST00000638521","protein_coding",0,"IQSEC2","IQ motif and Sec7 domain 2 [Source:HGNC Symbol;Acc:HGNC:29059]","GO:0005086(ARF guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0030036(actin cytoskeleton organization);GO:0032012(regulation of ARF protein signal transduction);GO:0050804(modulation of chemical synaptic transmission);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098696(regulation of neurotransmitter receptor localization to postsynaptic specialization membrane)","04144(Endocytosis)",{"v":1.5e-07,"d":"0.00"},1,"210,",0,{"v":-2.5,"d":"-2.50"},{"v":0.000269153480392692,"d":"0.00"},-1.42,"Exon (ENST00000638521/ENSG00000124313, exon 1 of 11)",23,53228823,53250527,21705,2]
[30285438,30286267,830,"ENSG00000183604","ENST00000529428","transcribed_unprocessed_pseudogene",48787,"SMG1P5","SMG1 pseudogene 5 [Source:HGNC Symbol;Acc:HGNC:49862]","NA","NA",{"v":1.4e-06,"d":"0.00"},2,"20,101,","0,729",-1.53,{"v":0.00398107170553497,"d":"0.00"},-5.32,"Exon (ENST00000529428/ENSG00000183604, exon 12 of 29)",16,30267553,30335054,67502,2]
[103825260,103825799,540,"ENSG00000123570","ENST00000243298","protein_coding",6458,"RAB9B","RAB9B, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:14090]","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006886(intracellular protein transport);GO:0015031(protein transport);GO:0016020(membrane);GO:0019003(GDP binding);GO:0030667(secretory granule membrane);GO:0030670(phagocytic vesicle membrane);GO:0031410(cytoplasmic vesicle);GO:0032482(Rab protein signal transduction);GO:0042147(retrograde transport, endosome to Golgi);GO:0042802(identical protein binding);GO:0043312(neutrophil degranulation);GO:0045335(phagocytic vesicle)","05162(Measles)",{"v":7.9e-24,"d":"0.00"},1,"540,",0,{"v":-0.753,"d":"-0.75"},{"v":0.0457088189614875,"d":"0.05"},-1.91,"5' UTR",23,103822327,103832257,9931,2]
[123603407,123603557,151,"ENSG00000125676","ENST00000448128","protein_coding",17602,"THOC2","THO complex 2 [Source:HGNC Symbol;Acc:HGNC:19073]","GO:0000346(transcription export complex);GO:0000347(THO complex);GO:0000445(THO complex part of transcription export complex);GO:0000784(nuclear chromosome, telomeric region);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006397(mRNA processing);GO:0006405(RNA export from nucleus);GO:0006406(mRNA export from nucleus);GO:0008380(RNA splicing);GO:0016607(nuclear speck);GO:0016973(poly(A)+ mRNA export from nucleus);GO:0031124(mRNA 3'-end processing);GO:0046784(viral mRNA export from host cell nucleus);GO:0048666(neuron development);GO:0048699(generation of neurons);GO:0051028(mRNA transport)","03013(RNA transport);03040(Spliceosome)",{"v":0.00019,"d":"0.00"},1,"151,",0,{"v":-0.769,"d":"-0.77"},{"v":0.0436515832240166,"d":"0.04"},-1.35,"3' UTR",23,123600561,123621159,20599,2]
[123613527,123614102,576,"ENSG00000125676","ENST00000455053","protein_coding",0,"THOC2","THO complex 2 [Source:HGNC Symbol;Acc:HGNC:19073]","GO:0000346(transcription export complex);GO:0000347(THO complex);GO:0000445(THO complex part of transcription export complex);GO:0000784(nuclear chromosome, telomeric region);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006397(mRNA processing);GO:0006405(RNA export from nucleus);GO:0006406(mRNA export from nucleus);GO:0008380(RNA splicing);GO:0016607(nuclear speck);GO:0016973(poly(A)+ mRNA export from nucleus);GO:0031124(mRNA 3'-end processing);GO:0046784(viral mRNA export from host cell nucleus);GO:0048666(neuron development);GO:0048699(generation of neurons);GO:0051028(mRNA transport)","03013(RNA transport);03040(Spliceosome)",{"v":2.7E-4,"d":"0.00"},3,"30,70,51,","0,112,525",-1.26,{"v":0.00891250938133746,"d":"0.01"},-1.09,"3' UTR",23,123603449,123613554,10106,2]
[20704507,20704897,391,"ENSG00000117245","ENST00000375044","protein_coding",12594,"KIF17","kinesin family member 17 [Source:HGNC Symbol;Acc:HGNC:19167]","GO:0000166(nucleotide binding);GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005871(kinesin complex);GO:0005874(microtubule);GO:0005929(cilium);GO:0005930(axoneme);GO:0007017(microtubule-based process);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding);GO:0008574(ATP-dependent microtubule motor activity, plus-end-directed);GO:0015031(protein transport);GO:0015630(microtubule cytoskeleton);GO:0016192(vesicle-mediated transport);GO:0016887(ATPase activity);GO:0030030(cell projection organization);GO:0030992(intraciliary transport particle B);GO:0031503(protein-containing complex localization);GO:0032391(photoreceptor connecting cilium);GO:0032839(dendrite cytoplasm);GO:0035735(intraciliary transport involved in cilium assembly);GO:0036064(ciliary basal body);GO:0042995(cell projection);GO:0043005(neuron projection);GO:0098971(anterograde dendritic transport of neurotransmitter receptor complex);GO:1990075(periciliary membrane compartment)","NA",{"v":1.6e-08,"d":"0.00"},1,"391,",0,-5.68,{"v":6.76082975391982e-08,"d":"0.00"},-1.55,"Exon (ENST00000375044/ENSG00000117245, exon 5 of 15)",1,20664014,20717491,53478,2]
[236523141,236523765,625,"ENSG00000116977","ENST00000341872","protein_coding",0,"LGALS8","galectin 8 [Source:HGNC Symbol;Acc:HGNC:6569]","GO:0005178(integrin binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006914(autophagy);GO:0016020(membrane);GO:0030246(carbohydrate binding);GO:0031410(cytoplasmic vesicle);GO:0098586(cellular response to virus);GO:0098792(xenophagy);GO:1904977(lymphatic endothelial cell migration)","NA",{"v":2.5e-14,"d":"0.00"},1,"625,",0,{"v":-0.962,"d":"-0.96"},{"v":0.0229086765276777,"d":"0.02"},{"v":-1.8,"d":"-1.80"},"5' UTR",1,236523439,236549263,25825,1]
[38075788,38109752,33965,"ENSG00000138061","ENST00000610745","protein_coding",0,"CYP1B1","cytochrome P450 family 1 subfamily B member 1 [Source:HGNC Symbol;Acc:HGNC:2597]","GO:0001525(angiogenesis);GO:0002930(trabecular meshwork development);GO:0004497(monooxygenase activity);GO:0005506(iron ion binding);GO:0005739(mitochondrion);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006725(cellular aromatic compound metabolic process);GO:0006805(xenobiotic metabolic process);GO:0006809(nitric oxide biosynthetic process);GO:0007155(cell adhesion);GO:0007601(visual perception);GO:0008202(steroid metabolic process);GO:0008210(estrogen metabolic process);GO:0008285(negative regulation of cell population proliferation);GO:0008631(intrinsic apoptotic signaling pathway in response to oxidative stress);GO:0009404(toxin metabolic process);GO:0009636(response to toxic substance);GO:0010575(positive regulation of vascular endothelial growth factor production);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016125(sterol metabolic process);GO:0016491(oxidoreductase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0016712(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen);GO:0019369(arachidonic acid metabolic process);GO:0019373(epoxygenase P450 pathway);GO:0019825(oxygen binding);GO:0020037(heme binding);GO:0030199(collagen fibril organization);GO:0030336(negative regulation of cell migration);GO:0031090(organelle membrane);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0033629(negative regulation of cell adhesion mediated by integrin);GO:0042572(retinol metabolic process);GO:0042574(retinal metabolic process);GO:0043065(positive regulation of apoptotic process);GO:0043231(intracellular membrane-bounded organelle);GO:0043542(endothelial cell migration);GO:0045766(positive regulation of angiogenesis);GO:0046427(positive regulation of receptor signaling pathway via JAK-STAT);GO:0046466(membrane lipid catabolic process);GO:0046872(metal ion binding);GO:0048514(blood vessel morphogenesis);GO:0055114(oxidation-reduction process);GO:0061298(retina vasculature development in camera-type eye);GO:0061304(retinal blood vessel morphogenesis);GO:0070301(cellular response to hydrogen peroxide);GO:0070330(aromatase activity);GO:0071407(cellular response to organic cyclic compound);GO:0071603(endothelial cell-cell adhesion);GO:0097267(omega-hydroxylase P450 pathway);GO:2000377(regulation of reactive oxygen species metabolic process)","00140(Steroid hormone biosynthesis);00380(Tryptophan metabolism);00980(Metabolism of xenobiotics by cytochrome P450);04913(Ovarian steroidogenesis);05204(Chemical carcinogenesis);05206(MicroRNAs in cancer)",{"v":1E-8,"d":"0.00"},2,"367,84,","0,33881",-1.55,{"v":0.00380189396320561,"d":"0.00"},-1.59,"5' UTR",2,38067509,38076151,8643,2]
[5158697,5163589,4893,"ENSG00000280433","ENST00000623998","protein_coding",106,"FP565260","novel protein, similar to trafficking protein particle complex 10 TRAPPC10","GO:0005829(cytosol);GO:0006891(intra-Golgi vesicle-mediated transport);GO:1990071(TRAPPII protein complex)","NA",{"v":5.9e-05,"d":"0.00"},3,"63,195,72,","0,383,4821",{"v":-0.938,"d":"-0.94"},{"v":0.0251188643150958,"d":"0.03"},-5.52,"Exon (ENST00000623998/ENSG00000280433, exon 1 of 3)",21,5155499,5163695,8197,2]
[241495489,241495669,181,"ENSG00000115694","ENST00000316586","protein_coding",12915,"STK25","serine/threonine kinase 25 [Source:HGNC Symbol;Acc:HGNC:11404]","GO:0000139(Golgi membrane);GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0006468(protein phosphorylation);GO:0006979(response to oxidative stress);GO:0007163(establishment or maintenance of cell polarity);GO:0007165(signal transduction);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0023014(signal transduction by protein phosphorylation);GO:0031098(stress-activated protein kinase signaling cascade);GO:0032147(activation of protein kinase activity);GO:0032874(positive regulation of stress-activated MAPK cascade);GO:0036481(intrinsic apoptotic signaling pathway in response to hydrogen peroxide);GO:0042542(response to hydrogen peroxide);GO:0042803(protein homodimerization activity);GO:0046777(protein autophosphorylation);GO:0046872(metal ion binding);GO:0050772(positive regulation of axonogenesis);GO:0051645(Golgi localization);GO:0051683(establishment of Golgi localization);GO:0070062(extracellular exosome);GO:0090168(Golgi reassembly)","NA",{"v":9.5e-08,"d":"0.00"},1,"181,",0,{"v":-20.4,"d":"-20.40"},{"v":1.58489319246111e-23,"d":"0.00"},-1.13,"3' UTR",2,241492670,241508584,15915,2]
[49643086,49643326,241,"ENSG00000110844","ENST00000548825","protein_coding",19650,"PRPF40B","pre-mRNA processing factor 40 homolog B [Source:HGNC Symbol;Acc:HGNC:25031]","GO:0000398(mRNA splicing, via spliceosome);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005685(U1 snRNP);GO:0006397(mRNA processing);GO:0008380(RNA splicing);GO:0016607(nuclear speck);GO:0045292(mRNA cis splicing, via spliceosome);GO:0071004(U2-type prespliceosome)","03040(Spliceosome)",{"v":1.2E-10,"d":"0.00"},1,"241,",0,-1.75,{"v":2.13796208950223E-3,"d":"0.00"},{"v":-1.3,"d":"-1.30"},"3' UTR",12,49623436,49644665,21230,1]
[112319360,112319690,331,"ENSG00000173064","ENST00000550722","protein_coding",62402,"HECTD4","HECT domain E3 ubiquitin protein ligase 4 [Source:HGNC Symbol;Acc:HGNC:26611]","GO:0004842(ubiquitin-protein transferase activity);GO:0016567(protein ubiquitination);GO:0016740(transferase activity)","NA",{"v":2.6e-06,"d":"0.00"},1,"331,",0,-3.49,{"v":1.86208713666287e-05,"d":"0.00"},-1.32,"5' UTR",12,112160188,112382092,221905,2]
[116008654,116009014,361,"ENSG00000123066","ENST00000281928","protein_coding",268705,"MED13L","mediator complex subunit 13 like [Source:HGNC Symbol;Acc:HGNC:22962]","GO:0003712(transcription coregulator activity);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0016592(mediator complex)","04919(Thyroid hormone signaling pathway)",{"v":1.7e-10,"d":"0.00"},1,"361,",0,-5.17,{"v":2.51188643150958e-07,"d":"0.00"},-1.23,"Exon (ENST00000281928/ENSG00000123066, exon 10 of 31)",12,115953872,116277719,323848,2]
[26244917,26245156,240,"ENSG00000138029","ENST00000479347","retained_intron",0,"HADHB","hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta [Source:HGNC Symbol;Acc:HGNC:4803]","GO:0003723(RNA binding);GO:0003824(catalytic activity);GO:0003857(3-hydroxyacyl-CoA dehydrogenase activity);GO:0003988(acetyl-CoA C-acyltransferase activity);GO:0004300(enoyl-CoA hydratase activity);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005740(mitochondrial envelope);GO:0005741(mitochondrial outer membrane);GO:0005743(mitochondrial inner membrane);GO:0005783(endoplasmic reticulum);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0006635(fatty acid beta-oxidation);GO:0016020(membrane);GO:0016508(long-chain-enoyl-CoA hydratase activity);GO:0016509(long-chain-3-hydroxyacyl-CoA dehydrogenase activity);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0016747(transferase activity, transferring acyl groups other than amino-acyl groups);GO:0035965(cardiolipin acyl-chain remodeling);GO:0042645(mitochondrial nucleoid)","00062(Fatty acid elongation);00071(Fatty acid degradation);00280(Valine, leucine and isoleucine degradation)",{"v":6.3e-39,"d":"0.00"},1,"240,",0,-3.14,{"v":4.89778819368447e-05,"d":"0.00"},-6.54,"5' UTR",2,26244920,26254956,10037,1]
[23532993,23533672,680,"ENSG00000136367","ENST00000419474","protein_coding",18093,"ZFHX2","zinc finger homeobox 2 [Source:HGNC Symbol;Acc:HGNC:20152]","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0030534(adult behavior);GO:0043565(sequence-specific DNA binding);GO:0044212(transcription regulatory region DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0051930(regulation of sensory perception of pain)","NA",{"v":7.2e-07,"d":"0.00"},2,"92,388,","0,292",{"v":-0.942,"d":"-0.94"},{"v":0.0245470891568503,"d":"0.02"},-1.02,"Exon (ENST00000419474/ENSG00000136367, exon 2 of 10)",14,23520857,23551765,30909,2]
[89333408,89333497,90,"ENSG00000140521","ENST00000631044","nonsense_mediated_decay",1320,"POLG","DNA polymerase gamma, catalytic subunit [Source:HGNC Symbol;Acc:HGNC:9179]","GO:0002020(protease binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003887(DNA-directed DNA polymerase activity);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005760(gamma DNA polymerase complex);GO:0006259(DNA metabolic process);GO:0006260(DNA replication);GO:0006261(DNA-dependent DNA replication);GO:0006264(mitochondrial DNA replication);GO:0006287(base-excision repair, gap-filling);GO:0007568(aging);GO:0008408(3'-5' exonuclease activity);GO:0009416(response to light stimulus);GO:0010332(response to gamma radiation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016779(nucleotidyltransferase activity);GO:0032991(protein-containing complex);GO:0042645(mitochondrial nucleoid);GO:0043195(terminal bouton);GO:0055093(response to hyperoxia);GO:0071333(cellular response to glucose stimulus);GO:0071897(DNA biosynthetic process);GO:0090305(nucleic acid phosphodiester bond hydrolysis)","NA",{"v":0.00034,"d":"0.00"},1,"90,",0,{"v":-0.929,"d":"-0.93"},{"v":0.0257039578276886,"d":"0.03"},-1.23,"Exon (ENST00000631044/ENSG00000140521, exon 2 of 24)",15,89316305,89334817,18513,2]
[8859930,8860456,527,"ENSG00000153048","ENST00000396593","protein_coding",7945,"CARHSP1","calcium regulated heat stable protein 1 [Source:HGNC Symbol;Acc:HGNC:17150]","GO:0000177(cytoplasmic exosome (RNase complex));GO:0000932(P-body);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0019902(phosphatase binding);GO:0035556(intracellular signal transduction);GO:0043186(P granule);GO:0043488(regulation of mRNA stability)","NA",{"v":1.9e-10,"d":"0.00"},1,"527,",0,{"v":-0.734,"d":"-0.73"},{"v":0.0489778819368446,"d":"0.05"},-1.22,"5' UTR",16,8852942,8868401,15460,2]
[148749012,148749188,177,"ENSG00000177144","ENST00000322209","protein_coding",118,"NUDT4B","nudix hydrolase 4B [Source:HGNC Symbol;Acc:HGNC:18012]","GO:0003723(RNA binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008486(diphosphoinositol-polyphosphate diphosphatase activity);GO:0016787(hydrolase activity);GO:0046872(metal ion binding);GO:0052840(inositol diphosphate tetrakisphosphate diphosphatase activity);GO:0052842(inositol diphosphate pentakisphosphate diphosphatase activity)","NA",{"v":1.1E-4,"d":"0.00"},1,"177,",0,-5.71,{"v":6.30957344480193e-08,"d":"0.00"},-6.79,"Exon (ENST00000322209/ENSG00000177144, exon 1 of 1)",1,148748894,148750099,1206,1]
[1505650,1506039,390,"ENSG00000185761","ENST00000591077","processed_transcript",0,"ADAMTSL5","ADAMTS like 5 [Source:HGNC Symbol;Acc:HGNC:27912]","GO:0005515(protein binding);GO:0005576(extracellular region);GO:0031012(extracellular matrix)","NA",{"v":2.5e-30,"d":"0.00"},1,"390,",0,-4.16,{"v":3.23593656929628e-06,"d":"0.00"},{"v":-1.4,"d":"-1.40"},"3' UTR",19,1505041,1505995,955,2]